data_1kzw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1kzw _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.302 96.4 m-85 . . . . . 0 N--CA 1.498 1.969 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -76.84 82.45 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.832 1.197 . . . . 0.0 112.847 -171.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.9 m -170.59 172.85 5.71 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 124.86 1.264 . . . . 0.0 110.832 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.6 m -83.63 113.93 21.19 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.089 -1.007 . . . . 0.0 111.217 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -118.04 113.76 22.11 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.547 0.739 . . . . 0.0 109.914 -175.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -108.33 140.71 41.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.509 -0.745 . . . . 0.0 112.398 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.8 p -62.35 119.19 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -91.35 -54.26 3.99 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 123.765 0.826 . . . . 0.0 112.641 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -148.22 122.85 9.83 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 118.679 0.672 . . . . 0.0 110.226 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.9 m -108.83 115.06 29.36 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.466 0.706 . . . . 0.0 110.843 -172.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -110.99 111.86 23.28 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -161.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.281 12.5 t30 67.07 19.65 10.46 Favored 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 117.573 2.435 . . . . 0.0 117.573 -174.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -72.56 -38.4 67.96 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.48 -29.01 69.7 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 165.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -72.24 -53.3 12.93 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 119.551 1.069 . . . . 0.0 113.595 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -42.82 -53.93 4.38 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 162.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.9 mtt -65.45 -27.13 68.29 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 116.755 2.132 . . . . 0.0 116.755 172.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -64.4 -39.87 94.68 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 166.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -63.17 -32.3 73.66 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 165.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.6 mtm -73.94 -14.35 61.03 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 169.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.11 56.49 2.7 Favored Glycine 0 N--CA 1.487 2.039 0 CA-C-N 120.118 1.327 . . . . 0.0 115.824 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.261 6.0 p -125.35 142.47 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-O 121.795 0.807 . . . . 0.0 112.614 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -62.39 146.2 51.95 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -172.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.288 0.0 OUTLIER -44.26 -46.89 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 176.408 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.8 t -55.53 -61.57 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 C-N-CA 124.204 1.002 . . . . 0.0 113.345 171.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -60.23 -42.65 95.68 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 173.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.8 ttp85 -59.02 -48.21 82.42 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 173.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -66.22 -38.58 88.28 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.9 mt -65.29 -33.24 75.5 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 167.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.13 -32.77 70.93 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 168.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.97 -57.07 14.44 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 154.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -90.05 66.06 6.68 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.56 1.172 . . . . 0.0 112.054 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -101.95 -31.71 10.55 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 116.733 2.123 . . . . 0.0 116.733 -162.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 64.61 50.28 2.17 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 119.781 1.173 . . . . 0.0 113.986 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 tp -89.45 112.13 23.19 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.081 -1.012 . . . . 0.0 111.264 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -103.4 108.67 20.0 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.963 1.305 . . . . 0.0 109.046 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.6 mt -100.21 104.05 15.54 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.607 0.763 . . . . 0.0 109.542 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.2 m -94.9 102.72 14.57 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.557 -0.714 . . . . 0.0 109.448 171.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.9 mt -86.34 121.68 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.776 0.83 . . . . 0.0 108.983 -175.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.4 p -128.34 119.53 25.25 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.618 -0.676 . . . . 0.0 110.429 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -74.84 127.89 34.27 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 122.443 1.115 . . . . 0.0 112.348 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -110.94 -28.3 8.42 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -168.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.05 74.37 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 C-N-CA 124.6 1.095 . . . . 0.0 110.568 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.29 14.7 t-20 66.73 -55.96 0.42 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -150.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -53.59 148.97 8.64 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -113.95 114.8 26.69 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 171.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.1 m -87.17 100.47 12.69 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 170.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.1 t -107.21 113.59 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -171.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -83.39 109.22 17.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.357 0.663 . . . . 0.0 109.52 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -103.82 88.65 3.1 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -170.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.4 m -96.0 120.25 35.95 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.777 0.831 . . . . 0.0 111.142 -171.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.1 p -142.94 169.29 17.84 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.782 1.031 . . . . 0.0 113.782 -172.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.52 -31.27 61.94 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 163.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -79.92 -51.26 9.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 170.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -159.23 148.57 18.54 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -165.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -103.62 102.77 12.65 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 164.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.5 pt -119.05 123.96 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.613 -0.68 . . . . 0.0 111.114 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -90.25 105.4 17.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 0.0 109.935 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.5 105.68 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -170.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.7 t -91.68 99.14 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -110.79 132.63 54.03 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.244 0.545 . . . . 0.0 111.883 178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -84.78 145.7 27.75 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.443 0.64 . . . . 0.0 111.593 168.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.0 mt -63.57 102.13 0.4 Allowed 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.36 -5.16 44.58 Favored Glycine 0 CA--C 1.551 2.342 0 N-CA-C 119.19 2.436 . . . . 0.0 119.19 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.2 p -78.26 139.73 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 120.963 2.381 . . . . 0.0 112.895 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 66.0 m -86.4 105.95 17.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.556 -0.715 . . . . 0.0 109.87 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -132.0 158.37 41.67 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.436 0.694 . . . . 0.0 111.971 -175.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -82.33 95.75 7.71 Favored 'General case' 0 CA--C 1.568 1.652 0 O-C-N 121.647 -0.658 . . . . 0.0 111.202 174.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -83.92 137.81 33.47 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.558 0.694 . . . . 0.0 111.589 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -120.17 133.27 55.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.718 -0.614 . . . . 0.0 109.969 177.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.0 mt -81.72 -132.04 0.03 OUTLIER 'General case' 0 CA--C 1.576 1.958 0 O-C-N 122.093 -0.379 . . . . 0.0 111.31 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.55 -45.57 11.64 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.6 p30 -99.26 -76.38 0.54 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.741 0.816 . . . . 0.0 111.958 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.88 82.05 0.12 Allowed Glycine 0 N--CA 1.482 1.722 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -169.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.0 m -143.1 100.38 3.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.62 113.92 22.9 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.581 0.705 . . . . 0.0 111.516 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.0 mt -118.28 105.84 12.17 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.514 0.726 . . . . 0.0 110.826 -169.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -79.46 119.85 23.04 Favored 'General case' 0 CA--C 1.566 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 111.589 172.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.25 -158.37 30.41 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.8 p -127.17 142.79 51.41 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 123.135 0.574 . . . . 0.0 112.536 -158.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -100.64 116.58 32.9 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.53 -0.731 . . . . 0.0 109.316 158.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 t -122.77 130.29 52.74 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.276 0.631 . . . . 0.0 111.748 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.8 tp -84.06 116.4 22.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.849 -1.157 . . . . 0.0 111.961 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -139.78 100.29 3.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.895 -0.503 . . . . 0.0 110.923 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.27 67.29 2.13 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 116.444 1.337 . . . . 0.0 116.444 174.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.288 21.1 t-20 72.91 -55.55 0.68 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 113.763 1.024 . . . . 0.0 113.763 -157.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -81.77 134.76 35.47 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -152.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.8 mt -85.83 108.32 18.07 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.805 0.812 . . . . 0.0 109.018 170.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.7 mm -96.35 113.02 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -170.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.59 87.87 1.55 Allowed Glycine 0 N--CA 1.48 1.578 0 CA-C-O 119.558 -0.579 . . . . 0.0 112.951 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -86.58 97.68 10.66 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.744 0.783 . . . . 0.0 109.62 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -120.23 161.95 20.22 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-O 123.421 1.581 . . . . 0.0 111.92 -174.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -143.54 149.03 36.86 Favored 'General case' 0 CA--C 1.559 1.325 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.739 164.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -67.46 113.19 5.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.019 -1.051 . . . . 0.0 112.576 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.5 t -65.78 -19.81 66.03 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 165.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.14 -28.58 70.16 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 117.159 2.281 . . . . 0.0 117.159 157.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -130.23 -46.11 1.11 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 -167.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.34 -24.41 24.49 Favored Glycine 0 CA--C 1.554 2.527 0 N-CA-C 117.432 1.733 . . . . 0.0 117.432 -155.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -76.97 139.74 40.22 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 119.842 1.821 . . . . 0.0 114.577 -174.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.04 141.1 49.29 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tt -129.91 120.93 25.68 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.145 0.578 . . . . 0.0 110.061 171.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -109.87 113.9 27.02 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.934 -1.104 . . . . 0.0 109.38 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.1 m -114.35 102.53 10.19 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 119.279 0.945 . . . . 0.0 110.479 -177.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.7 t -90.23 106.13 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 120.809 -1.182 . . . . 0.0 109.595 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -86.03 115.42 23.62 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 123.477 0.711 . . . . 0.0 110.907 170.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -140.45 144.19 35.96 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 123.516 0.727 . . . . 0.0 111.914 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.3 mm -97.76 109.64 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.28 -0.888 . . . . 0.0 109.122 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.252 11.0 tp -93.01 85.02 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-O 121.945 0.878 . . . . 0.0 110.225 169.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.32 -86.89 0.91 Allowed Glycine 0 N--CA 1.49 2.282 0 O-C-N 121.289 -0.882 . . . . 0.0 114.589 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -135.42 53.57 1.96 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.386 0.613 . . . . 0.0 111.995 166.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -146.43 121.25 9.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.126 -0.984 . . . . 0.0 108.359 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.9 tp -82.7 101.23 10.73 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.3 m -101.6 105.47 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.631 -0.668 . . . . 0.0 109.279 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -92.77 109.25 20.67 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.633 -0.667 . . . . 0.0 111.246 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.3 m -91.21 108.62 20.0 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -97.64 119.49 36.31 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 123.977 0.911 . . . . 0.0 109.688 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.6 t -118.29 106.33 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -99.12 116.15 30.67 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 119.038 0.835 . . . . 0.0 109.77 172.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.265 42.0 mt-10 66.12 -79.33 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 123.65 0.78 . . . . 0.0 112.046 -176.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -148.86 42.25 0.83 Allowed Glycine 0 CA--C 1.553 2.455 0 CA-C-O 118.441 -1.199 . . . . 0.0 116.072 157.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -114.41 115.46 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-N 119.729 1.764 . . . . 0.0 110.625 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -81.99 130.34 35.05 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.45 126.13 34.26 Favored 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 123.235 0.614 . . . . 0.0 111.177 163.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -114.64 105.24 12.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.658 -0.651 . . . . 0.0 111.1 -169.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -98.58 117.83 33.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.88 -0.513 . . . . 0.0 111.209 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.9 mt -93.04 115.25 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -103.88 116.86 33.05 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -83.43 157.4 22.49 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 121.611 0.72 . . . . 0.0 111.674 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -66.64 104.27 1.26 Allowed 'General case' 0 CA--C 1.57 1.715 0 O-C-N 120.974 -1.079 . . . . 0.0 112.027 176.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 N--CA 1.491 1.594 0 C-N-CA 124.923 1.289 . . . . 0.0 114.25 -173.761 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.323 88.9 m-85 . . . . . 0 N--CA 1.5 2.053 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.25 80.92 1.33 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 120.007 1.276 . . . . 0.0 112.857 -172.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.3 m -174.58 175.69 2.46 Favored 'General case' 0 CA--C 1.572 1.793 0 C-N-CA 125.381 1.473 . . . . 0.0 110.325 -173.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 t -98.62 134.6 41.33 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.906 -1.121 . . . . 0.0 111.462 168.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -126.78 105.01 8.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.431 -0.793 . . . . 0.0 109.15 -166.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -97.02 137.91 35.37 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.493 -0.754 . . . . 0.0 112.513 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -64.3 128.65 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.831 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -170.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -111.12 -49.56 3.01 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.96 135.98 12.82 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 120.295 1.407 . . . . 0.0 111.722 173.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.1 p -107.2 129.64 54.83 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.929 0.892 . . . . 0.0 112.037 174.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -69.68 -66.52 0.58 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -141.92 59.7 1.48 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.158 0.89 . . . . 0.0 111.852 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -82.87 54.68 2.79 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.391 -1.443 . . . . 0.0 112.947 174.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -154.78 -55.79 0.1 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.595 1.558 . . . . 0.0 108.72 -170.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -68.77 -30.41 69.0 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 121.292 1.86 . . . . 0.0 115.67 160.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -52.22 -53.11 47.56 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 121.302 1.865 . . . . 0.0 114.644 156.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -40.27 93.71 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 170.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.27 -32.92 74.45 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 167.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -62.61 -39.08 92.66 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 159.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.1 mmm -63.18 -34.96 78.76 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 116.029 1.862 . . . . 0.0 116.029 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.71 52.81 0.74 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.7 m -130.54 143.67 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 122.127 0.965 . . . . 0.0 112.533 -174.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -65.33 157.82 28.13 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.268 10.8 tp -49.78 -39.48 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 N-CA-C 118.447 2.758 . . . . 0.0 118.447 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.5 t -62.01 -54.04 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-N 119.491 1.041 . . . . 0.0 112.381 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -56.98 -36.69 70.63 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 167.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.4 mtm-85 -62.58 -46.08 89.94 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 121.219 1.827 . . . . 0.0 115.183 169.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -58.07 -49.24 77.6 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 166.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.53 -35.42 70.68 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 116.493 2.034 . . . . 0.0 116.493 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.36 99.07 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 163.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.85 -58.44 8.37 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 162.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -90.24 56.26 3.33 Favored 'General case' 0 CA--C 1.574 1.873 0 CA-C-O 122.316 1.055 . . . . 0.0 113.112 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -88.96 -31.83 17.96 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 71.02 64.11 0.17 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 124.722 1.209 . . . . 0.0 113.409 173.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.6 tp -97.44 125.8 42.31 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.707 0.765 . . . . 0.0 113.042 -167.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -103.36 126.07 50.32 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.891 163.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.9 mt -104.16 103.76 13.59 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 m -91.3 107.88 19.51 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.227 -0.92 . . . . 0.0 108.822 172.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 73.5 mt -100.76 96.95 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -169.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.0 m -98.95 100.49 11.67 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -87.49 121.67 30.22 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 121.6 -0.687 . . . . 0.0 111.813 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -109.36 82.45 1.6 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.18 0.991 . . . . 0.0 109.741 161.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.11 -110.69 3.29 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 114.807 0.683 . . . . 0.0 114.807 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -81.65 -23.6 36.82 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -81.07 115.89 20.74 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 119.871 1.214 . . . . 0.0 111.482 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -101.83 110.37 22.34 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.7 m -91.36 97.39 11.06 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.6 t -95.75 106.27 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -85.21 106.84 16.94 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -94.8 90.4 6.04 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -173.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 m -104.49 115.89 31.14 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.403 0.681 . . . . 0.0 111.018 -173.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.3 p -146.84 -178.5 6.22 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.61 54.22 0.59 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -175.92 -57.29 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.859 0 C-N-CA 125.731 1.612 . . . . 0.0 109.797 -159.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.5 ptp85 -146.33 149.18 33.33 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.175 0.99 . . . . 0.0 111.777 -160.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -135.09 94.27 3.12 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 165.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.8 pt -129.69 124.24 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.323 0.582 . . . . 0.0 111.073 -172.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.42 101.65 14.33 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.982 0.913 . . . . 0.0 111.747 176.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.4 t -91.78 106.4 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.58 106.46 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -122.14 137.07 54.96 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.489 0.662 . . . . 0.0 112.305 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -81.61 140.25 34.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.381 -0.825 . . . . 0.0 111.579 167.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.83 113.59 2.58 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.32 -11.72 56.92 Favored Glycine 0 CA--C 1.55 2.232 0 N-CA-C 118.506 2.162 . . . . 0.0 118.506 -171.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.2 p -78.48 140.27 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-N 120.53 2.165 . . . . 0.0 113.569 -171.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.2 m -84.88 104.18 14.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.728 -0.608 . . . . 0.0 109.539 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -136.99 165.34 26.22 Favored 'General case' 0 CA--C 1.569 1.711 0 CA-C-O 121.675 0.75 . . . . 0.0 112.581 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -87.57 98.9 11.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.559 -0.713 . . . . 0.0 111.791 175.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -86.55 156.37 20.1 Favored 'General case' 0 CA--C 1.567 1.618 0 C-N-CA 123.631 0.772 . . . . 0.0 112.421 173.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -128.75 131.96 47.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.724 -1.235 . . . . 0.0 110.695 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 33.8 mt -86.72 169.97 12.18 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.847 0.832 . . . . 0.0 113.066 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.35 46.9 0.11 Allowed 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 118.773 2.879 . . . . 0.0 118.773 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -138.9 -80.56 0.32 Allowed 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 159.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.19 79.74 0.05 OUTLIER Glycine 0 N--CA 1.48 1.589 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 97.2 m -152.46 128.8 10.57 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.462 -1.022 . . . . 0.0 111.143 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -79.62 131.33 35.96 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.9 mt -124.05 104.32 8.81 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.677 0.791 . . . . 0.0 110.879 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -76.38 114.8 15.48 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.983 0.913 . . . . 0.0 112.095 172.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.94 -164.02 36.78 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 117.083 1.593 . . . . 0.0 117.083 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.9 p -120.57 121.93 39.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -160.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -86.32 112.86 21.82 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 122.906 0.482 . . . . 0.0 110.776 161.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.3 m -119.17 130.2 55.4 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.738 -0.601 . . . . 0.0 112.431 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.8 tp -88.72 130.48 35.32 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.185 -0.947 . . . . 0.0 112.258 177.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -107.45 -79.05 0.58 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 123.512 0.725 . . . . 0.0 110.903 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.15 88.92 0.11 Allowed Glycine 0 N--CA 1.49 2.298 0 CA-C-N 119.803 1.183 . . . . 0.0 111.852 -173.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.26 63.0 m-80 65.4 10.03 6.22 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -156.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -132.99 117.73 17.98 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.374 1.069 . . . . 0.0 109.78 -169.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.37 109.24 20.84 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 168.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.9 tp -91.93 117.67 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.415 -0.803 . . . . 0.0 110.248 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.21 98.21 2.02 Favored Glycine 0 N--CA 1.483 1.795 0 C-N-CA 123.461 0.553 . . . . 0.0 112.424 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -94.84 98.1 10.49 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -124.06 146.48 48.55 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.021 0.915 . . . . 0.0 113.044 -166.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -120.12 148.76 43.21 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.527 0.731 . . . . 0.0 109.693 164.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -73.9 148.55 42.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.148 -1.595 . . . . 0.0 113.433 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.7 p -70.97 -73.59 0.17 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.568 -0.707 . . . . 0.0 111.754 167.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.86 -41.78 97.7 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.844 2.165 . . . . 0.0 116.844 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.31 -14.1 39.13 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 174.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.05 -39.57 2.98 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 118.327 2.091 . . . . 0.0 118.327 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -80.27 162.08 24.79 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -156.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.26 135.66 47.57 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -177.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.5 tt -125.61 130.8 52.36 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 124.185 0.994 . . . . 0.0 109.395 168.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -107.21 129.15 54.9 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.209 -0.932 . . . . 0.0 109.702 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -123.74 108.53 12.63 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.41 -0.806 . . . . 0.0 109.182 171.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.8 t -98.12 110.22 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -87.58 114.99 24.7 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.496 0.718 . . . . 0.0 111.122 172.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -132.19 133.92 44.77 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 119.284 0.947 . . . . 0.0 111.869 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.39 108.77 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.952 -1.093 . . . . 0.0 108.541 173.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.0 pt -97.23 94.03 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 C-N-CA 124.296 1.039 . . . . 0.0 109.028 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.1 -101.67 1.36 Allowed Glycine 0 N--CA 1.492 2.38 0 O-C-N 121.239 -0.913 . . . . 0.0 113.01 -169.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -131.74 53.31 2.0 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.368 0.604 . . . . 0.0 112.009 161.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -134.99 125.37 26.45 Favored 'General case' 0 CA--C 1.563 1.448 0 O-C-N 121.44 -0.787 . . . . 0.0 109.381 167.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.7 tp -78.29 107.67 11.06 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.746 0.818 . . . . 0.0 110.487 175.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -92.38 118.85 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.334 -0.854 . . . . 0.0 110.931 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -95.27 106.89 18.97 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.79 0.836 . . . . 0.0 109.679 172.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.1 m -91.47 104.12 16.66 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.083 0.553 . . . . 0.0 109.864 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -95.61 121.22 37.08 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.181 0.592 . . . . 0.0 111.749 -174.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.6 t -120.63 121.04 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -136.52 98.31 3.78 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.862 -0.524 . . . . 0.0 110.191 168.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 66.19 68.53 0.45 Allowed 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 168.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.68 44.47 57.02 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 118.303 2.081 . . . . 0.0 118.303 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -156.53 150.99 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 118.439 1.12 . . . . 0.0 110.401 -176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.47 126.12 32.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.165 -0.96 . . . . 0.0 110.313 174.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -128.02 105.67 8.55 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.071 0.548 . . . . 0.0 111.286 171.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -85.42 118.47 24.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 110.967 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.4 mtt-85 -99.84 110.32 22.69 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 164.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.7 mt -81.65 133.27 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -120.65 121.78 39.07 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.065 0.946 . . . . 0.0 109.189 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -77.7 142.37 38.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 112.609 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -69.16 111.25 4.99 Favored 'General case' 0 CA--C 1.568 1.655 0 O-C-N 121.451 -0.78 . . . . 0.0 111.785 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 N--CA 1.488 1.468 0 C-N-CA 124.938 1.295 . . . . 0.0 112.587 -170.148 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.328 54.2 m-85 . . . . . 0 N--CA 1.499 1.978 0 N-CA-C 117.712 2.486 . . . . 0.0 117.712 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -75.35 76.59 2.44 Favored 'General case' 0 CA--C 1.573 1.838 0 CA-C-N 120.459 1.481 . . . . 0.0 113.979 -170.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.685 ' HG ' ' NZ ' ' A' ' 130' ' ' LYS . 13.0 t -162.71 -178.86 6.44 Favored 'General case' 0 CA--C 1.576 1.974 0 CA-C-O 122.682 1.229 . . . . 0.0 112.367 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.1 m -87.58 129.08 35.23 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.243 1.017 . . . . 0.0 110.42 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -128.01 111.75 13.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.828 -0.545 . . . . 0.0 109.603 -173.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.52 137.54 36.3 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.418 0.687 . . . . 0.0 111.756 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.1 p -64.36 118.14 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -105.75 -59.87 1.71 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.758 0.823 . . . . 0.0 112.076 -174.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -134.24 166.62 22.37 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.55 1.167 . . . . 0.0 111.372 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.6 m -151.51 123.73 8.25 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 119.581 -1.949 . . . . 0.0 109.761 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -82.4 -81.46 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -159.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -108.32 55.97 0.63 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 120.29 1.405 . . . . 0.0 112.435 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -87.38 66.11 8.98 Favored 'General case' 0 CA--C 1.573 1.843 0 CA-C-O 122.63 1.205 . . . . 0.0 111.543 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -158.05 -66.35 0.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.969 0.908 . . . . 0.0 109.961 -167.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -60.67 -47.28 86.96 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 166.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -44.61 -58.69 2.87 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 162.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 37.4 mtp -59.07 -43.32 91.74 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -61.06 -41.74 97.19 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 166.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -62.24 -37.07 84.01 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 168.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 55.7 mtm -65.14 -20.03 66.26 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 164.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.24 47.64 2.78 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.3 m -123.12 142.51 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-N 118.385 1.092 . . . . 0.0 111.504 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -75.24 169.67 17.59 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.27 0.3 OUTLIER -52.91 -42.21 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 176.19 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.3 t -58.36 -48.87 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.027 -1.046 . . . . 0.0 113.357 170.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -61.79 -40.32 94.79 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 168.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 mpp_? -57.15 -34.6 68.59 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 164.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -70.25 -55.79 8.39 Favored 'General case' 0 CA--C 1.572 1.827 0 CA-C-N 120.364 1.438 . . . . 0.0 113.434 164.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.0 mt -66.08 -52.59 47.34 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.74 -4.7 36.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 172.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.36 -57.95 3.51 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 119.692 1.133 . . . . 0.0 113.123 152.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -90.49 52.96 2.32 Favored 'General case' 0 CA--C 1.573 1.841 0 C-N-CA 123.767 0.827 . . . . 0.0 112.903 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -92.98 2.25 56.89 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 55.25 58.45 4.67 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 124.687 1.195 . . . . 0.0 113.957 -175.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.3 tp -92.09 116.47 28.96 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-O 122.065 0.936 . . . . 0.0 111.873 -166.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -115.52 112.1 21.71 Favored 'General case' 0 CA--C 1.561 1.378 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.391 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.0 mt -99.09 100.13 11.24 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.0 m -92.62 108.96 20.37 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.335 -0.853 . . . . 0.0 109.613 174.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -107.96 137.6 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 C-N-CA 124.298 1.039 . . . . 0.0 108.673 -165.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 93.1 m -147.75 122.56 9.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.139 -1.6 . . . . 0.0 110.481 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -86.97 108.97 19.06 Favored 'General case' 0 CA--C 1.565 1.522 0 O-C-N 121.55 -0.719 . . . . 0.0 112.112 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -91.71 76.11 5.7 Favored 'General case' 0 CA--C 1.57 1.725 0 O-C-N 121.477 -0.765 . . . . 0.0 110.054 168.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.69 -98.57 0.54 Allowed Glycine 0 N--CA 1.492 2.404 0 O-C-N 121.443 -0.786 . . . . 0.0 114.778 -174.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -95.74 -11.59 26.77 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 165.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -95.76 101.97 13.71 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 120.791 1.632 . . . . 0.0 110.551 -175.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.49 111.55 18.61 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.379 -0.826 . . . . 0.0 111.135 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.2 m -86.24 105.22 16.46 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.735 0.814 . . . . 0.0 109.069 174.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.5 t -112.52 103.26 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -85.79 107.43 17.63 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.284 0.634 . . . . 0.0 110.722 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -98.49 87.46 3.85 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.1 t -88.35 117.44 27.28 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 122.856 0.462 . . . . 0.0 111.171 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.3 p -146.73 165.04 30.83 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.623 0.725 . . . . 0.0 112.678 -172.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.68 -27.2 62.68 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 118.012 2.597 . . . . 0.0 118.012 165.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -75.42 -51.88 12.04 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 167.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -162.36 151.43 15.37 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.595 0.758 . . . . 0.0 111.727 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -113.88 91.67 3.72 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.801 0.84 . . . . 0.0 110.532 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.6 pt -114.89 125.0 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 121.448 0.642 . . . . 0.0 111.88 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -86.26 101.21 12.85 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.6 0.76 . . . . 0.0 110.971 172.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.69 105.44 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -174.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.3 t -94.58 96.93 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -105.97 128.04 53.55 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.431 0.634 . . . . 0.0 112.077 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -85.23 129.08 34.88 Favored 'General case' 0 CA--C 1.563 1.474 0 O-C-N 121.511 -0.743 . . . . 0.0 111.157 173.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.0 125.92 25.54 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -173.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.79 -16.75 44.6 Favored Glycine 0 CA--C 1.555 2.533 0 N-CA-C 119.106 2.403 . . . . 0.0 119.106 -168.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.3 t -86.26 130.78 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 120.278 2.039 . . . . 0.0 109.938 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.5 t -75.21 121.9 22.84 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -142.7 161.68 37.44 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-O 121.732 0.777 . . . . 0.0 112.201 -172.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -91.63 104.2 16.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.489 -0.757 . . . . 0.0 111.517 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -100.85 142.02 32.91 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 124.164 0.986 . . . . 0.0 111.631 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -134.82 100.94 4.75 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.907 -1.121 . . . . 0.0 110.615 -167.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.0 mt -76.36 93.34 3.45 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -168.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.3 . . 58.07 -64.31 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 119.85 3.278 . . . . 0.0 119.85 170.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -82.98 -83.71 0.13 Allowed 'General case' 0 CA--C 1.57 1.719 0 CA-C-N 118.853 0.752 . . . . 0.0 109.73 164.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.48 55.01 0.2 Allowed Glycine 0 N--CA 1.487 2.057 0 N-CA-C 116.267 1.267 . . . . 0.0 116.267 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.8 m -88.02 101.11 13.46 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 118.068 0.934 . . . . 0.0 108.545 165.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -88.63 112.41 23.05 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 122.794 0.438 . . . . 0.0 111.076 -169.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.8 mt -127.38 112.29 14.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.748 -0.595 . . . . 0.0 111.716 -161.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 51.5 ptt85 -90.94 118.19 30.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.104 -0.997 . . . . 0.0 111.338 172.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.3 -158.94 32.1 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 117.776 1.87 . . . . 0.0 117.776 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.7 p -130.15 129.85 44.01 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -156.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -92.48 132.26 36.95 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.033 -1.042 . . . . 0.0 111.081 164.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.5 m -129.97 127.31 39.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.566 -0.708 . . . . 0.0 111.425 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.6 tp -81.9 125.25 30.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.462 -0.774 . . . . 0.0 111.638 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -130.96 79.59 1.9 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.381 -0.824 . . . . 0.0 109.115 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.47 -109.5 3.02 Favored Glycine 0 N--CA 1.488 2.11 0 O-C-N 121.648 -0.657 . . . . 0.0 113.747 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -111.02 44.22 1.33 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 167.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -144.5 114.06 7.14 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 25.1 mt -89.49 107.49 19.1 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 167.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.9 tt -96.88 119.47 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.296 -0.878 . . . . 0.0 110.409 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -101.95 98.88 1.8 Allowed Glycine 0 N--CA 1.482 1.76 0 C-N-CA 124.1 0.857 . . . . 0.0 113.215 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.17 101.55 13.93 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -121.88 143.11 49.63 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.707 0.765 . . . . 0.0 111.916 -173.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -110.72 138.73 46.74 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.69 0.757 . . . . 0.0 109.384 163.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -62.0 111.34 1.88 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.288 -0.882 . . . . 0.0 112.597 171.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.297 5.8 t -68.66 -14.74 63.22 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 174.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -73.78 -20.46 60.47 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 158.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -133.92 -41.44 0.83 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -166.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.85 -26.94 22.32 Favored Glycine 0 CA--C 1.556 2.643 0 N-CA-C 117.368 1.707 . . . . 0.0 117.368 -153.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -66.06 129.92 41.45 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -167.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.04 129.68 35.54 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -175.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.9 tt -121.7 120.29 34.26 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 124.917 1.287 . . . . 0.0 108.908 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -105.47 113.13 26.51 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.314 -0.866 . . . . 0.0 109.065 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.6 m -101.93 111.48 23.75 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.303 -0.873 . . . . 0.0 110.368 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.34 102.5 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -80.82 115.99 20.58 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.767 0.827 . . . . 0.0 110.194 167.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -143.97 142.24 30.62 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -95.15 106.14 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.899 . . . . 0.0 109.44 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.0 pt -88.75 72.82 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.924 0 O-C-N 121.017 -1.052 . . . . 0.0 111.158 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 85.15 -86.84 1.55 Allowed Glycine 0 N--CA 1.491 2.312 0 O-C-N 120.531 -1.355 . . . . 0.0 113.096 -168.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -139.43 53.81 1.71 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 166.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -144.79 118.19 9.05 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 121.212 -0.93 . . . . 0.0 108.6 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.3 tp -78.53 110.23 13.43 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.107 0.956 . . . . 0.0 110.92 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.5 t -97.77 115.32 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -96.82 93.88 6.93 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.733 0.813 . . . . 0.0 109.778 171.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 48.8 m -84.04 101.97 12.15 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 122.864 0.466 . . . . 0.0 109.784 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -87.09 111.05 20.53 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.128 0.571 . . . . 0.0 110.892 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.3 t -103.1 102.06 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -128.85 109.91 11.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.779 -0.576 . . . . 0.0 109.723 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 53.63 57.59 5.96 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 174.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.35 -33.73 3.16 Favored Glycine 0 CA--C 1.552 2.405 0 N-CA-C 118.758 2.263 . . . . 0.0 118.758 -167.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.4 t -89.87 121.28 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 119.887 1.843 . . . . 0.0 110.708 -166.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -89.4 123.87 33.95 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.229 0.612 . . . . 0.0 111.348 166.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.94 108.47 8.42 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.012 0.525 . . . . 0.0 110.881 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -88.91 114.83 25.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 111.622 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -89.64 121.78 32.15 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 119.275 0.943 . . . . 0.0 109.873 162.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.6 mt -120.54 120.72 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -163.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -118.67 126.57 52.21 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.012 0.925 . . . . 0.0 110.747 -165.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -87.23 152.93 21.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.162 -0.961 . . . . 0.0 113.261 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.685 ' NZ ' ' HG ' ' A' ' 4' ' ' SER . 26.1 tptp -62.18 110.95 1.77 Allowed 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 124.063 0.945 . . . . 0.0 113.309 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.489 1.484 0 C-N-CA 125.175 1.39 . . . . 0.0 113.251 -174.498 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 . . . . . 0 N--CA 1.497 1.879 0 CA-C-O 121.377 0.608 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -88.12 88.42 7.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.997 -1.065 . . . . 0.0 111.744 -166.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.1 m -171.6 164.62 6.78 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 122.754 1.264 . . . . 0.0 113.24 -172.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.6 m -89.72 131.08 35.87 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 124.024 0.93 . . . . 0.0 110.9 170.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -131.33 110.12 10.85 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.356 0.662 . . . . 0.0 109.779 -170.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -100.84 135.64 41.98 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.01 -1.056 . . . . 0.0 112.303 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.7 121.88 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -106.53 -49.08 3.4 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -153.17 111.52 3.66 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 118.911 0.778 . . . . 0.0 109.746 -164.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.2 p -102.0 108.62 20.12 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.512 0.725 . . . . 0.0 112.385 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -102.93 115.46 30.65 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.285 38.7 t30 67.93 11.43 8.36 Favored 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 118.458 2.762 . . . . 0.0 118.458 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -64.79 -42.84 94.75 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -61.17 -32.53 72.27 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 170.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -72.99 -42.73 63.0 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 171.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -46.48 -54.31 9.51 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 160.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.7 mtt -61.75 -39.16 90.63 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 172.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -53.35 -48.76 68.27 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 166.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.1 tttp -62.18 -28.63 69.8 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 168.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.5 mmt -65.47 -43.83 89.08 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 168.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.89 63.72 0.36 Allowed Glycine 0 N--CA 1.487 2.099 0 C-N-CA 123.855 0.741 . . . . 0.0 113.742 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 p -138.25 146.49 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.403 1.097 . . . . 0.0 111.638 -176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -59.2 143.92 47.55 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.31 12.9 tt -52.89 -44.15 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.8 t -56.58 -56.55 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.305 0.957 . . . . 0.0 113.197 170.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -63.6 -45.15 91.67 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.2 ptt85 -67.66 -30.61 70.19 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 171.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -68.55 -43.4 76.71 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 120.009 1.277 . . . . 0.0 114.219 165.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.5 mt -62.35 -50.57 71.06 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 169.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.65 -12.53 54.2 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 118.6 2.815 . . . . 0.0 118.6 168.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.76 -59.96 2.55 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 155.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -91.62 53.53 2.27 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 118.765 0.711 . . . . 0.0 112.82 -170.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.6 p30 -102.97 -4.22 24.98 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 118.582 2.808 . . . . 0.0 118.582 -171.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 59.18 56.16 4.02 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-N 121.655 2.025 . . . . 0.0 114.131 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.4 tp -82.63 119.75 24.68 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.981 -1.074 . . . . 0.0 112.1 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -101.55 119.85 39.4 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.199 170.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.8 mt -102.42 107.34 18.29 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.251 88.6 m -88.13 101.09 13.47 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.854 -1.154 . . . . 0.0 108.736 163.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 85.5 mt -94.99 119.45 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.8 t -127.82 131.21 49.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.808 -0.558 . . . . 0.0 111.614 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -79.73 127.21 31.93 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 121.768 0.794 . . . . 0.0 111.472 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -131.96 64.48 1.59 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 124.05 0.94 . . . . 0.0 110.563 -168.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.3 69.25 1.37 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 116.756 1.463 . . . . 0.0 116.756 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.281 14.9 t30 66.82 -15.04 0.15 Allowed 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 -164.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -92.19 154.23 18.8 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 120.684 -1.26 . . . . 0.0 112.231 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -116.4 120.3 38.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.476 -0.765 . . . . 0.0 109.392 165.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.9 m -89.03 107.62 19.14 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 167.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.0 t -104.25 108.01 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -93.18 104.19 16.4 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -86.28 126.3 34.2 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.189 0.595 . . . . 0.0 110.71 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.2 t -135.17 118.73 16.95 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 122.765 0.426 . . . . 0.0 110.255 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 p -147.61 172.83 13.41 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.46 59.08 0.79 Allowed 'General case' 0 CA--C 1.575 1.925 0 O-C-N 120.513 -1.367 . . . . 0.0 113.491 154.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -168.78 -60.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.114 0.966 . . . . 0.0 110.174 -175.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -154.58 143.57 21.01 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 118.588 0.631 . . . . 0.0 111.951 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -115.2 103.11 10.52 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 173.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.6 pt -138.29 141.18 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 121.5 0.667 . . . . 0.0 111.909 -174.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -104.13 105.78 16.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.171 -0.956 . . . . 0.0 109.7 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.32 103.19 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.2 t -97.89 104.11 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -117.78 149.71 40.35 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.125 0.57 . . . . 0.0 112.476 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -94.07 142.41 27.43 Favored 'General case' 0 CA--C 1.568 1.635 0 O-C-N 121.733 -0.604 . . . . 0.0 111.698 171.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.1 mt -71.95 101.91 2.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.004 -1.06 . . . . 0.0 111.699 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.6 -46.15 1.07 Allowed Glycine 0 CA--C 1.549 2.215 0 N-CA-C 116.37 1.308 . . . . 0.0 116.37 -168.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.73 141.46 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.844 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.1 m -92.51 77.86 5.0 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.191 0.996 . . . . 0.0 110.729 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -101.64 166.27 10.79 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -167.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -82.24 93.75 7.17 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-O 121.62 0.724 . . . . 0.0 111.531 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -84.52 164.98 18.44 Favored 'General case' 0 CA--C 1.571 1.756 0 CA-C-O 122.141 0.972 . . . . 0.0 111.498 166.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -153.65 132.75 12.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.325 -1.485 . . . . 0.0 110.801 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.3 mt -75.6 -64.04 1.16 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -164.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -154.36 -70.99 0.13 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 118.926 0.785 . . . . 0.0 111.391 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -83.24 -69.53 0.63 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.958 0.799 . . . . 0.0 112.941 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.74 50.58 0.4 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 116.734 1.454 . . . . 0.0 116.734 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.1 m -112.71 98.33 7.15 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -92.79 140.73 29.21 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 122.439 1.114 . . . . 0.0 112.147 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.8 mt -136.59 119.82 16.72 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 123.78 0.832 . . . . 0.0 110.206 -162.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -90.47 122.91 33.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.964 -1.085 . . . . 0.0 110.034 169.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.75 -173.32 45.46 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 117.633 1.813 . . . . 0.0 117.633 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 75.9 p -115.59 131.47 56.92 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.092 -1.054 . . . . 0.0 111.327 -170.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -87.78 113.92 23.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.195 -0.94 . . . . 0.0 109.621 161.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.6 m -110.94 117.42 33.33 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.419 0.688 . . . . 0.0 110.909 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.9 tp -84.76 99.1 10.64 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.144 -0.972 . . . . 0.0 111.584 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -95.52 85.21 4.14 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.444 0.698 . . . . 0.0 110.687 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.37 -90.59 0.62 Allowed Glycine 0 N--CA 1.491 2.359 0 O-C-N 121.425 -0.797 . . . . 0.0 114.601 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -125.52 53.44 1.55 Allowed 'General case' 0 CA--C 1.575 1.935 0 CA-C-O 121.363 0.601 . . . . 0.0 111.552 162.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -145.0 111.15 5.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.089 -1.007 . . . . 0.0 108.533 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 mt -85.89 102.34 13.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.968 . . . . 0.0 109.075 172.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.6 mt -100.6 108.55 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -172.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.12 101.72 2.75 Favored Glycine 0 N--CA 1.482 1.705 0 C-N-CA 123.235 0.445 . . . . 0.0 113.18 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -95.34 94.28 7.76 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.551 0.74 . . . . 0.0 109.06 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -121.47 138.33 54.33 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -163.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -119.49 138.4 53.17 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.516 0.726 . . . . 0.0 110.085 170.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -70.08 130.21 41.51 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -171.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 36.9 p -81.43 68.69 7.86 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.337 1.065 . . . . 0.0 110.851 170.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -177.7 -62.28 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.774 0 C-N-CA 125.927 1.691 . . . . 0.0 107.417 -164.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -135.37 20.37 3.39 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.4 10.6 36.57 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 121.03 3.172 . . . . 0.0 121.03 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -95.46 138.71 32.76 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 118.121 0.96 . . . . 0.0 112.217 -159.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -80.34 128.25 33.34 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -163.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.86 122.87 39.13 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 124.742 1.217 . . . . 0.0 108.423 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -98.61 114.7 27.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.618 -0.676 . . . . 0.0 109.278 172.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.1 m -108.22 96.85 6.65 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 119.564 1.075 . . . . 0.0 109.701 175.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.3 t -95.65 105.17 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.885 -1.134 . . . . 0.0 108.91 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -88.9 122.02 31.85 Favored 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 123.565 0.746 . . . . 0.0 111.052 169.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -144.87 155.24 43.35 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.281 -0.887 . . . . 0.0 112.38 171.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mp -94.76 118.79 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.649 -1.282 . . . . 0.0 109.657 -176.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.7 mt -95.79 87.55 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 106.941 -1.504 . . . . 0.0 106.941 164.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.0 -94.83 0.38 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 115.742 1.057 . . . . 0.0 115.742 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -101.75 14.56 31.6 Favored 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 169.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -134.38 109.76 8.99 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 119.717 1.144 . . . . 0.0 111.002 -161.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.6 tp -76.46 104.61 7.07 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.918 0.887 . . . . 0.0 110.899 173.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.5 p -88.47 104.77 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 123.05 0.54 . . . . 0.0 110.219 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -90.0 99.85 12.78 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.456 0.646 . . . . 0.0 109.421 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 33.4 m -98.96 104.89 16.97 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.006 -168.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -87.1 125.79 34.36 Favored 'General case' 0 CA--C 1.563 1.476 0 C-N-CA 123.257 0.623 . . . . 0.0 111.048 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.4 t -121.69 109.0 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 168.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -113.87 107.11 15.26 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.265 10.2 mm-40 65.03 -78.68 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 123.914 0.885 . . . . 0.0 112.992 -171.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -152.6 58.32 0.42 Allowed Glycine 0 N--CA 1.486 2.001 0 CA-C-O 119.511 -0.605 . . . . 0.0 114.108 164.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.9 p -129.19 104.21 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -89.43 112.31 23.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.602 -0.687 . . . . 0.0 110.915 -176.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.77 117.34 25.46 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.019 0.527 . . . . 0.0 112.236 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -105.62 102.22 11.69 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.456 0.703 . . . . 0.0 109.704 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . 0.258 15.1 ptm180 -95.92 111.98 23.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.441 -0.787 . . . . 0.0 110.733 168.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.4 mt -97.94 125.01 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -170.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -105.45 116.73 32.44 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.618 0.767 . . . . 0.0 109.068 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -82.78 141.93 31.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.231 -0.918 . . . . 0.0 111.745 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -66.94 124.36 22.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 113.338 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 124.822 1.249 . . . . 0.0 111.88 -170.103 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 . . . . . 0 N--CA 1.502 2.16 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -130.55 75.83 1.68 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.952 -1.093 . . . . 0.0 110.701 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.652 ' HG ' ' NZ ' ' A' ' 130' ' ' LYS . 88.1 p -171.15 168.63 6.75 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.795 1.284 . . . . 0.0 113.5 -175.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.7 m -77.23 135.87 38.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.219 -0.926 . . . . 0.0 111.75 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -133.16 101.74 5.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.678 -0.639 . . . . 0.0 109.393 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -97.31 137.84 35.7 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.252 -0.905 . . . . 0.0 112.223 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.266 4.5 p -63.03 115.54 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.81 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -173.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -84.55 -47.4 10.61 Favored 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 123.687 0.795 . . . . 0.0 113.054 170.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -155.15 159.0 39.84 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 122.563 1.173 . . . . 0.0 111.033 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.7 m -147.66 113.03 5.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 119.871 -1.768 . . . . 0.0 109.315 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -83.36 -95.79 0.06 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -162.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -85.06 52.56 2.47 Favored 'General case' 0 CA--C 1.579 2.063 0 CA-C-N 120.635 1.561 . . . . 0.0 113.523 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -82.9 -48.45 10.7 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.526 1.13 . . . . 0.0 114.03 -172.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -58.0 -29.27 65.15 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 169.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 -46.48 34.11 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 169.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -47.64 -51.2 22.28 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 161.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.0 mtm -59.27 -30.77 68.53 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 170.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -65.74 -44.38 86.16 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 166.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -58.63 -37.49 76.01 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 165.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.5 mmm -64.84 -41.57 95.62 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 167.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.43 48.37 0.81 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 115.989 1.156 . . . . 0.0 115.989 174.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.29 10.7 p -113.12 138.84 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 118.534 1.167 . . . . 0.0 112.309 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -62.69 152.39 35.58 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 12.5 tt -48.11 -40.16 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 118.285 2.698 . . . . 0.0 118.285 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.4 t -66.11 -62.28 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-N 119.861 1.209 . . . . 0.0 111.96 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -62.56 -20.03 64.28 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 117.949 2.574 . . . . 0.0 117.949 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.5 ttp85 -76.37 -49.44 16.79 Favored 'General case' 0 CA--C 1.569 1.708 0 C-N-CA 125.292 1.437 . . . . 0.0 114.26 167.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -41.54 98.61 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 169.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.28 -40.63 86.69 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 165.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.72 -31.19 71.69 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 117.729 2.492 . . . . 0.0 117.729 169.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.9 -43.72 69.92 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 157.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -82.41 14.93 2.72 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.313 19.4 p30 -78.36 92.99 4.61 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 121.534 1.97 . . . . 0.0 110.597 170.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -68.8 84.68 0.31 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.767 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.0 tp -86.91 124.75 33.46 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 122.489 1.138 . . . . 0.0 112.731 -167.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -99.48 114.81 27.99 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.57 165.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.2 mt -96.96 95.52 7.88 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.9 m -88.32 98.19 11.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.035 -1.041 . . . . 0.0 108.473 173.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.0 mt -89.76 119.11 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.3 p -121.59 122.14 38.99 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -97.37 130.61 44.5 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -118.02 77.18 1.13 Allowed 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 162.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.61 -106.5 1.08 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 116.404 1.322 . . . . 0.0 116.404 -175.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -84.64 -15.9 43.85 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 169.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -89.03 153.76 20.75 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 119.809 1.186 . . . . 0.0 112.346 168.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -143.51 136.54 27.72 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.606 0.763 . . . . 0.0 109.836 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.9 m -109.82 111.45 22.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.236 -0.915 . . . . 0.0 108.884 164.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.4 p -95.68 120.48 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 121.428 0.632 . . . . 0.0 110.123 168.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -82.4 114.44 20.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 109.484 173.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -93.06 91.25 7.25 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.7 t -112.34 105.42 13.7 Favored 'General case' 0 CA--C 1.562 1.418 0 CA-C-O 121.384 0.611 . . . . 0.0 111.105 -172.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.0 p -143.91 -179.16 6.31 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.393 1.077 . . . . 0.0 111.904 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.11 -25.82 24.11 Favored 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 118.265 2.691 . . . . 0.0 118.265 160.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -96.76 -18.02 19.89 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -148.61 146.43 28.23 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 120.469 1.486 . . . . 0.0 112.155 -171.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -135.19 77.79 1.7 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 156.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.0 pt -126.88 139.88 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 121.216 -0.928 . . . . 0.0 111.953 -167.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.17 105.44 17.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.575 -0.703 . . . . 0.0 109.797 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.3 t -89.69 98.05 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.0 t -89.97 106.85 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -121.63 164.02 18.01 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-O 122.619 1.2 . . . . 0.0 112.752 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -126.5 145.68 50.41 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.452 -0.78 . . . . 0.0 109.683 171.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.75 108.53 1.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.974 . . . . 0.0 113.584 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.65 -23.87 27.03 Favored Glycine 0 CA--C 1.548 2.146 0 N-CA-C 117.985 1.954 . . . . 0.0 117.985 -170.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.8 p -68.67 134.92 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 120.308 2.054 . . . . 0.0 113.588 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -85.38 106.42 16.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.751 -0.593 . . . . 0.0 109.796 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -127.5 158.04 38.48 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.766 0.793 . . . . 0.0 112.151 -176.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -85.72 107.5 17.62 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.549 -0.719 . . . . 0.0 111.413 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -105.54 128.99 53.9 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 124.074 0.95 . . . . 0.0 110.236 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -107.19 125.51 51.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.595 -0.691 . . . . 0.0 111.65 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.9 mt -92.6 78.34 4.91 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.308 . . 63.57 -51.44 0.23 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 120.322 3.453 . . . . 0.0 120.322 162.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -74.22 -81.52 0.07 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 121.39 1.905 . . . . 0.0 109.33 167.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.9 80.88 0.06 OUTLIER Glycine 0 N--CA 1.481 1.692 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.6 m -145.75 109.94 4.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.407 -1.055 . . . . 0.0 108.752 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -84.56 121.84 28.18 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.922 0.867 . . . . 0.0 112.373 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mt -129.65 120.21 24.82 Favored 'General case' 0 CA--C 1.562 1.412 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.515 -168.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -93.08 118.99 31.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.922 . . . . 0.0 111.97 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.51 -170.55 42.06 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 118.069 1.988 . . . . 0.0 118.069 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.0 p -126.24 121.22 32.07 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.49 -0.855 . . . . 0.0 111.679 -163.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -78.29 123.05 26.51 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 119.048 0.84 . . . . 0.0 110.995 160.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.8 m -125.3 137.38 54.07 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.364 0.665 . . . . 0.0 111.721 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 tp -91.25 104.51 17.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 111.586 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -91.46 82.64 5.36 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.63 -0.669 . . . . 0.0 109.55 171.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.44 -94.75 0.66 Allowed Glycine 0 N--CA 1.492 2.373 0 O-C-N 121.545 -0.722 . . . . 0.0 114.382 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -125.23 59.62 1.24 Allowed 'General case' 0 CA--C 1.571 1.788 0 CA-C-O 121.802 0.811 . . . . 0.0 110.926 159.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -140.77 111.49 6.95 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 170.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.5 mt -84.44 100.55 11.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.192 -0.943 . . . . 0.0 109.561 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.6 tt -97.78 128.9 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 123.743 0.817 . . . . 0.0 110.798 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.64 102.77 0.64 Allowed Glycine 0 N--CA 1.481 1.658 0 CA-C-O 119.234 -0.759 . . . . 0.0 114.005 -172.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -90.32 98.55 11.84 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.051 0.925 . . . . 0.0 109.492 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -110.53 106.5 15.82 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.639 0.733 . . . . 0.0 110.576 -171.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -90.99 125.87 35.91 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.224 -0.923 . . . . 0.0 111.772 -168.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.8 ttp85 -66.18 119.66 11.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.132 -0.98 . . . . 0.0 112.432 -174.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.303 5.4 t -59.87 -35.08 74.06 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 117.316 2.339 . . . . 0.0 117.316 -169.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -98.37 42.68 1.09 Allowed 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 168.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -156.62 -50.99 0.08 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.736 -1.228 . . . . 0.0 113.591 173.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.32 8.72 62.54 Favored Glycine 0 CA--C 1.555 2.544 0 N-CA-C 118.471 2.148 . . . . 0.0 118.471 -160.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -89.11 119.78 29.92 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 119.965 1.883 . . . . 0.0 111.389 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -73.07 122.8 22.38 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.6 tt -97.12 108.97 21.8 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -96.23 98.82 10.61 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -165.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.1 m -104.88 108.31 19.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.795 -0.565 . . . . 0.0 109.9 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.7 t -98.72 105.9 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.4 mtm180 -87.58 105.76 17.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.663 -0.648 . . . . 0.0 110.002 167.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.01 162.72 26.15 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.659 0.783 . . . . 0.0 111.729 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.3 mt -127.78 135.61 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.536 -1.352 . . . . 0.0 110.142 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.7 mm -98.15 -76.54 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.74 -112.08 3.44 Favored Glycine 0 N--CA 1.491 2.332 0 CA-C-N 118.687 0.676 . . . . 0.0 111.802 170.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -92.91 47.11 1.26 Allowed 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -146.93 118.78 8.11 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.401 1.08 . . . . 0.0 108.74 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.0 tp -81.91 115.5 21.12 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.482 0.713 . . . . 0.0 109.512 167.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.3 t -100.65 103.53 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -96.81 103.25 15.15 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 123.446 0.698 . . . . 0.0 109.825 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.8 m -99.64 103.25 14.93 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 123.266 0.626 . . . . 0.0 109.835 -173.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -95.0 123.8 38.68 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.775 0.83 . . . . 0.0 111.207 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.02 102.11 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-N 119.307 0.958 . . . . 0.0 108.779 173.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -86.51 102.96 14.59 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.183 -0.948 . . . . 0.0 110.007 167.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.319 0.1 OUTLIER 62.01 -41.42 0.15 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 120.001 3.334 . . . . 0.0 120.001 177.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -173.82 25.42 0.08 OUTLIER Glycine 0 CA--C 1.552 2.369 0 N-CA-C 117.716 1.846 . . . . 0.0 117.716 172.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.0 t -136.57 121.63 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 120.304 2.052 . . . . 0.0 107.532 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.24 140.19 29.8 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -174.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -129.79 125.1 34.98 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.545 0.738 . . . . 0.0 112.045 166.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -99.27 108.88 21.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.704 -0.622 . . . . 0.0 110.601 174.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -96.16 117.99 31.83 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 169.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 76.5 mt -108.55 120.8 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -171.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -117.32 122.77 44.81 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.835 0.854 . . . . 0.0 109.268 -172.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -77.86 148.27 34.73 Favored 'General case' 0 CA--C 1.568 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 112.837 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.652 ' NZ ' ' HG ' ' A' ' 4' ' ' SER . 41.9 tptt -58.9 113.57 2.13 Favored 'General case' 0 CA--C 1.57 1.721 0 C-N-CA 123.906 0.882 . . . . 0.0 113.131 175.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 N--CA 1.489 1.495 0 C-N-CA 124.826 1.251 . . . . 0.0 112.752 -171.328 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.254 91.7 m-85 . . . . . 0 N--CA 1.507 2.398 0 N-CA-C 118.99 2.959 . . . . 0.0 118.99 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.99 81.63 5.24 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 124.744 1.218 . . . . 0.0 112.897 -164.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.6 m -168.13 173.97 7.56 Favored 'General case' 0 CA--C 1.57 1.738 0 CA-C-O 122.607 1.194 . . . . 0.0 111.703 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.3 m -86.92 131.62 34.05 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.808 0.843 . . . . 0.0 110.804 170.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -132.65 109.36 9.66 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -172.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.24 134.46 48.32 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.281 -0.887 . . . . 0.0 111.716 -175.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -57.7 118.95 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -176.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -114.26 -52.8 2.71 Favored 'General case' 0 CA--C 1.564 1.509 0 C-N-CA 123.592 0.757 . . . . 0.0 113.023 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -144.75 74.17 1.4 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 119.466 1.03 . . . . 0.0 111.918 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.9 p -74.95 127.46 33.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.978 . . . . 0.0 113.454 175.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -79.22 -73.02 0.36 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -166.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -91.97 118.76 31.08 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 156.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -135.34 46.01 2.43 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-O 121.725 0.774 . . . . 0.0 112.406 164.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -146.05 -57.43 0.3 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.166 -0.959 . . . . 0.0 110.551 -173.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -62.39 -33.31 74.5 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 170.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -54.64 -59.77 4.25 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 120.141 1.337 . . . . 0.0 114.144 163.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.51 -47.39 63.31 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 169.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -59.83 -42.95 94.67 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 171.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -56.7 -39.32 73.65 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 165.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 90.5 mtp -64.41 -22.92 67.11 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 172.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.73 39.84 4.85 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 116.712 1.445 . . . . 0.0 116.712 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 m -105.76 138.05 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.631 0.729 . . . . 0.0 110.938 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -63.08 160.73 14.6 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.277 9.8 tp -53.57 -39.59 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.34 -52.85 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-N 119.647 1.112 . . . . 0.0 112.631 169.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -59.24 -34.79 72.63 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 168.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 84.6 mtm-85 -64.3 -47.92 77.61 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 121.428 1.922 . . . . 0.0 114.797 168.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -58.87 -48.96 79.56 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 168.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.4 mt -58.18 -53.36 59.2 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.611 1.338 . . . . 0.0 114.611 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.42 -47.55 78.8 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 116.431 2.012 . . . . 0.0 116.431 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.88 -47.66 67.69 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 168.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -98.69 32.98 2.4 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -85.78 -19.64 30.42 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -168.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 65.5 63.47 0.63 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 120.018 1.281 . . . . 0.0 113.572 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.74 117.28 21.93 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.204 -0.935 . . . . 0.0 111.792 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -103.21 110.8 22.9 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.534 174.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.7 mt -94.48 101.49 13.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 122.992 0.517 . . . . 0.0 109.776 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.9 m -94.94 111.98 23.72 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.36 136.63 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 124.089 0.956 . . . . 0.0 108.703 -168.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.1 m -149.13 124.24 10.1 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 119.903 -1.748 . . . . 0.0 111.235 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -77.34 132.54 38.64 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.374 1.07 . . . . 0.0 112.034 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -130.33 80.96 1.98 Allowed 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 123.524 0.73 . . . . 0.0 109.364 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.39 70.61 0.93 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 117.269 1.667 . . . . 0.0 117.269 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.309 17.3 m120 69.89 -23.49 0.16 Allowed 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -169.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -86.99 152.9 21.99 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 120.037 1.29 . . . . 0.0 112.785 169.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -121.73 133.68 54.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 111.054 173.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.0 m -97.69 117.79 32.77 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.0 t -120.37 112.57 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -83.2 117.21 22.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 0.0 110.85 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -95.32 80.07 3.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.815 -0.553 . . . . 0.0 110.903 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.5 t -97.42 111.36 23.65 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -171.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.5 p -149.93 177.01 10.24 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.77 59.08 0.21 Allowed 'General case' 0 CA--C 1.58 2.126 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 165.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -145.27 -53.84 0.29 Allowed 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 125.746 1.618 . . . . 0.0 110.096 167.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -156.95 -50.57 0.07 Allowed 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -172.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.299 36.6 t-20 76.62 106.13 0.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 120.06 1.3 . . . . 0.0 112.729 -165.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.8 pt -134.7 139.27 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-O 121.294 0.569 . . . . 0.0 111.257 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.73 124.46 30.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.516 -0.74 . . . . 0.0 111.829 168.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.4 t -110.4 101.62 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.9 t -101.04 115.03 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -140.94 151.89 44.57 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -171.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -90.56 139.39 30.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.497 -0.752 . . . . 0.0 111.882 168.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.07 131.46 49.63 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.08 -8.91 59.16 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 119.816 2.686 . . . . 0.0 119.816 -174.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.3 t -89.13 137.02 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-N 120.201 2.001 . . . . 0.0 110.193 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.1 p -76.11 97.85 4.2 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.48 -0.762 . . . . 0.0 111.19 176.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -118.41 164.56 15.06 Favored 'General case' 0 CA--C 1.569 1.689 0 C-N-CA 123.968 0.907 . . . . 0.0 111.879 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -86.31 98.56 11.03 Favored 'General case' 0 CA--C 1.568 1.65 0 O-C-N 121.363 -0.836 . . . . 0.0 111.171 173.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -82.69 114.14 20.85 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 124.074 0.95 . . . . 0.0 110.824 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -96.48 100.09 11.7 Favored 'General case' 0 CA--C 1.566 1.588 0 O-C-N 121.762 -0.586 . . . . 0.0 109.792 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.81 150.08 42.5 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -37.03 -48.9 0.81 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 119.966 3.321 . . . . 0.0 119.966 -176.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -66.26 -23.19 66.36 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 170.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.68 17.99 1.03 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 119.363 2.505 . . . . 0.0 119.363 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.8 m -109.25 126.51 53.4 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 120.477 2.138 . . . . 0.0 112.015 -162.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -96.77 106.86 19.23 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-O 121.486 0.66 . . . . 0.0 111.717 -167.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.3 mt -104.82 116.61 32.3 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.223 1.009 . . . . 0.0 112.256 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 59.7 ttp85 -86.97 117.55 25.76 Favored 'General case' 0 CA--C 1.567 1.618 0 O-C-N 120.834 -1.166 . . . . 0.0 111.27 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 160.6 -165.64 35.12 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.2 p -106.48 138.37 42.77 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.329 -0.512 . . . . 0.0 112.062 -168.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -88.86 106.63 18.51 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 146.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.2 m -106.4 135.9 47.08 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.019 0.527 . . . . 0.0 110.872 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.5 tp -85.01 98.84 10.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.962 -1.086 . . . . 0.0 110.942 175.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.19 79.44 5.72 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.471 0.653 . . . . 0.0 109.347 175.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.2 -99.43 0.32 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -89.7 -10.46 45.66 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -102.04 140.14 36.72 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 121.155 1.798 . . . . 0.0 111.577 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.9 mt -94.84 97.25 9.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.951 -1.093 . . . . 0.0 108.795 161.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.0 tt -90.1 117.38 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 122.15 0.976 . . . . 0.0 110.551 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.71 93.51 1.89 Allowed Glycine 0 N--CA 1.477 1.38 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.425 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -90.2 87.86 7.01 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -117.19 145.96 43.53 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.81 0.814 . . . . 0.0 112.139 -170.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -124.67 131.02 53.49 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.552 0.741 . . . . 0.0 109.001 172.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -76.28 122.78 24.9 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 121.093 -1.005 . . . . 0.0 113.109 -172.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 73.0 p -55.34 -52.4 63.6 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -89.64 65.35 6.87 Favored 'General case' 0 CA--C 1.572 1.797 0 CA-C-N 118.879 0.763 . . . . 0.0 111.824 167.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.54 -47.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 164.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.25 -20.97 47.9 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 118.064 1.986 . . . . 0.0 118.064 -157.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -77.98 147.84 34.71 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.57 1.148 . . . . 0.0 114.007 -172.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.22 133.29 35.42 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.9 tt -117.06 100.09 7.5 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -90.64 110.21 21.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.457 -0.777 . . . . 0.0 109.709 -173.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.3 m -109.97 98.13 7.5 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 119.657 1.117 . . . . 0.0 110.926 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.2 t -93.7 94.92 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.564 -1.335 . . . . 0.0 109.073 -174.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -83.18 127.82 33.95 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.738 0.699 . . . . 0.0 112.242 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -142.43 140.83 32.09 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.326 0.584 . . . . 0.0 112.422 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.4 mm -87.12 119.58 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.426 -0.796 . . . . 0.0 109.12 171.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.9 mt -113.4 88.81 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.84 -107.92 2.2 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 115.728 1.051 . . . . 0.0 115.728 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -90.45 13.78 14.75 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 172.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -138.97 127.62 23.26 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 120.01 1.277 . . . . 0.0 111.192 -172.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.4 tp -78.95 105.87 10.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.453 -0.78 . . . . 0.0 109.159 162.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.5 t -96.08 110.08 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 174.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -113.51 123.28 49.63 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.5 m -96.78 111.4 23.59 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 122.75 0.42 . . . . 0.0 110.001 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -83.7 123.15 29.53 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.987 0.515 . . . . 0.0 110.596 167.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.1 t -117.42 106.14 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 168.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -109.19 101.98 10.96 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.063 0.545 . . . . 0.0 109.639 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 52.24 53.51 12.3 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.15 -31.46 3.44 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 118.722 2.249 . . . . 0.0 118.722 -167.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 98.0 t -78.13 109.54 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 119.869 1.834 . . . . 0.0 110.307 -169.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.48 132.05 39.55 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 123.491 0.716 . . . . 0.0 112.535 -170.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -138.62 112.48 8.43 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.689 0.796 . . . . 0.0 111.427 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -95.19 110.34 22.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.607 -0.683 . . . . 0.0 110.375 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.8 mmm-85 -91.05 116.96 29.21 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.7 mt -104.87 106.4 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -101.53 121.52 42.13 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.908 0.883 . . . . 0.0 110.01 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -82.7 153.32 25.4 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 121.157 -0.964 . . . . 0.0 113.286 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -59.33 105.68 0.37 Allowed 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 178.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.6 t0 . . . . . 0 N--CA 1.489 1.478 0 C-N-CA 125.34 1.456 . . . . 0.0 114.828 178.129 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.334 55.7 m-85 . . . . . 0 N--CA 1.498 1.969 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 38.18 54.09 1.7 Allowed 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 119.214 3.042 . . . . 0.0 119.214 161.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.4 m -175.62 170.6 2.89 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.702 1.201 . . . . 0.0 110.155 -168.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.3 m -79.36 123.42 27.47 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.043 -1.036 . . . . 0.0 110.58 164.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -121.99 118.52 29.02 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -104.68 137.06 43.06 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.417 -0.802 . . . . 0.0 111.417 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.251 4.0 p -66.13 117.96 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.868 0 O-C-N 121.074 -1.016 . . . . 0.0 113.183 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -90.91 -55.76 3.43 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 124.256 1.022 . . . . 0.0 112.715 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.436 ' C ' ' HG ' ' A' ' 11' ' ' SER . 7.7 ptm85 -144.71 174.44 10.97 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-O 122.441 1.115 . . . . 0.0 111.968 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.436 ' HG ' ' C ' ' A' ' 10' ' ' ARG . 67.1 m -156.93 145.29 19.61 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 119.603 -1.935 . . . . 0.0 111.623 -176.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.16 -110.02 0.18 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.951 -174.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -82.13 60.44 4.91 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 122.063 2.21 . . . . 0.0 113.75 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -104.81 67.68 0.81 Allowed 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 122.679 1.228 . . . . 0.0 111.828 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -158.22 -48.44 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.707 1.203 . . . . 0.0 110.039 165.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -57.2 -36.97 71.5 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 164.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -48.72 -51.96 26.07 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 160.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -63.52 -39.76 95.26 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -60.83 -45.03 96.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.447 -1.408 . . . . 0.0 114.644 168.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -55.36 -37.92 68.14 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 165.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.4 mmt -66.47 -16.06 63.83 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 164.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.32 39.51 6.79 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 117.266 1.666 . . . . 0.0 117.266 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.9 m -111.96 143.35 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 118.445 1.123 . . . . 0.0 111.909 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -64.31 157.97 24.67 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -174.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.29 0.1 OUTLIER -52.52 -49.65 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 -177.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.0 t -62.43 -45.43 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-N 119.683 1.128 . . . . 0.0 113.483 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -53.18 -43.75 67.37 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 166.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 82.5 mtm-85 -62.49 -41.35 98.74 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 168.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.78 -45.25 95.11 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 168.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.0 mt -63.13 -44.45 95.58 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.72 -34.6 78.7 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 169.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.42 -55.97 27.94 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 120.159 1.345 . . . . 0.0 114.545 160.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -80.97 58.18 3.34 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 122.581 1.181 . . . . 0.0 113.165 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -86.36 -26.46 24.82 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 117.838 2.532 . . . . 0.0 117.838 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.379 19.7 p30 46.28 47.9 13.44 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 117.799 2.518 . . . . 0.0 117.799 -168.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.7 tp -73.37 124.56 25.99 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 122.113 0.958 . . . . 0.0 113.519 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -118.86 125.55 49.78 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.199 1.0 . . . . 0.0 109.032 175.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.8 mt -106.94 100.89 10.36 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.441 0.696 . . . . 0.0 109.562 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.1 m -93.25 110.14 21.66 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.466 -0.771 . . . . 0.0 108.978 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.1 mt -98.92 112.52 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -168.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.443 ' HG1' ' NZ ' ' A' ' 50' ' ' LYS . 48.5 m -111.02 104.87 13.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -88.92 112.03 22.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.078 -1.014 . . . . 0.0 112.265 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.81 78.94 2.62 Favored 'General case' 0 CA--C 1.568 1.653 0 CA-C-O 121.641 0.734 . . . . 0.0 109.943 163.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.65 -104.15 1.02 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 115.369 0.908 . . . . 0.0 115.369 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -81.03 -27.88 35.62 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 166.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -75.34 109.66 9.05 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.397 1.453 . . . . 0.0 112.173 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -90.85 106.93 18.86 Favored 'General case' 0 CA--C 1.559 1.324 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 169.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.6 m -90.14 95.93 10.43 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.1 t -99.84 108.99 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -171.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.443 ' NZ ' ' HG1' ' A' ' 41' ' ' THR . 74.8 mttt -87.72 100.46 12.85 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.709 0.804 . . . . 0.0 109.166 -173.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -92.77 86.56 5.56 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.022 0.529 . . . . 0.0 110.346 -170.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.4 t -90.53 122.19 33.13 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.01 0.524 . . . . 0.0 111.769 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.7 p -147.92 168.82 21.27 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -167.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.77 38.38 0.03 OUTLIER 'General case' 0 CA--C 1.584 2.271 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 164.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -150.59 -57.12 0.17 Allowed 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 126.533 1.933 . . . . 0.0 108.536 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -155.25 156.85 36.32 Favored 'General case' 0 CA--C 1.566 1.558 0 C-N-CA 124.232 1.013 . . . . 0.0 111.539 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -114.61 106.96 14.86 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.459 0.704 . . . . 0.0 109.336 164.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.7 pt -126.14 128.63 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.668 -0.645 . . . . 0.0 111.217 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -82.47 99.78 9.66 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 121.656 0.741 . . . . 0.0 111.972 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -85.27 100.37 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.48 110.48 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -129.92 127.97 41.2 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.358 0.599 . . . . 0.0 111.652 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.1 mp0 -71.66 141.63 49.9 Favored 'General case' 0 CA--C 1.566 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 110.915 161.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.21 109.11 1.43 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.246 -0.909 . . . . 0.0 113.141 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.84 -0.76 48.44 Favored Glycine 0 CA--C 1.553 2.46 0 N-CA-C 119.026 2.37 . . . . 0.0 119.026 -167.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.0 p -81.24 139.17 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 120.983 2.392 . . . . 0.0 113.223 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.3 m -89.03 109.51 20.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.745 -0.597 . . . . 0.0 109.67 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -138.81 162.04 35.76 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 123.325 0.65 . . . . 0.0 112.34 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -87.57 103.6 15.71 Favored 'General case' 0 CA--C 1.568 1.659 0 O-C-N 121.234 -0.916 . . . . 0.0 111.704 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -89.75 141.23 28.81 Favored 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 123.78 0.832 . . . . 0.0 111.989 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -136.73 107.5 6.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.999 -1.063 . . . . 0.0 110.856 -169.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.7 mt -77.59 88.24 3.9 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -171.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.288 . . 63.41 -53.25 0.21 Allowed 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 119.099 3.0 . . . . 0.0 119.099 174.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -91.59 -76.63 0.44 Allowed 'General case' 0 CA--C 1.572 1.792 0 CA-C-N 119.128 0.876 . . . . 0.0 110.7 170.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.73 56.81 0.1 OUTLIER Glycine 0 N--CA 1.494 2.533 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.3 m -69.76 -36.23 75.59 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.159 2.281 . . . . 0.0 117.159 -173.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 77.32 78.57 0.08 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 124.637 1.175 . . . . 0.0 112.634 164.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.0 mt -127.96 103.44 7.25 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.057 0.543 . . . . 0.0 111.286 -161.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -76.53 120.29 21.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.921 -1.112 . . . . 0.0 112.533 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.51 -169.61 42.44 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 118.098 1.999 . . . . 0.0 118.098 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 p -125.77 135.55 52.16 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 114.136 -1.032 . . . . 0.0 111.774 -164.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -95.11 116.18 28.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.754 -0.591 . . . . 0.0 110.425 164.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.8 t -109.81 132.32 54.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.9 -0.5 . . . . 0.0 111.914 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.5 tp -86.73 106.11 17.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.055 -1.028 . . . . 0.0 112.374 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -84.99 168.84 14.57 Favored 'General case' 0 CA--C 1.577 1.999 0 C-N-CA 123.518 0.727 . . . . 0.0 110.683 157.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -33.32 -63.29 0.35 Allowed Glycine 0 N--CA 1.502 3.052 0 N-CA-C 121.239 3.256 . . . . 0.0 121.239 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -108.16 17.63 22.06 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 165.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -139.37 124.19 18.6 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 121.066 1.757 . . . . 0.0 112.308 -161.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.8 mt -89.29 106.77 18.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.938 -1.101 . . . . 0.0 108.787 162.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.2 113.38 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.794 0.807 . . . . 0.0 109.998 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.99 93.02 1.33 Allowed Glycine 0 N--CA 1.479 1.534 0 C-N-CA 123.844 0.735 . . . . 0.0 112.833 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -89.33 104.29 16.85 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.511 0.672 . . . . 0.0 110.329 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -124.6 149.64 46.84 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.072 0.949 . . . . 0.0 111.972 -168.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -125.02 139.75 53.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.356 -0.84 . . . . 0.0 110.751 169.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -66.69 119.85 12.48 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.0 p -82.86 72.16 9.95 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 122.542 1.163 . . . . 0.0 109.901 167.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 175.91 -64.09 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 126.114 1.766 . . . . 0.0 107.37 -167.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -93.6 -33.31 13.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.68 -35.06 4.2 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 116.865 1.506 . . . . 0.0 116.865 -154.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -53.53 147.61 10.71 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 117.367 2.358 . . . . 0.0 117.367 -173.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -86.21 129.71 34.76 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -175.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.6 tt -113.75 124.11 51.47 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.203 1.001 . . . . 0.0 108.991 169.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -113.7 111.98 22.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.43 -0.793 . . . . 0.0 109.21 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 m -102.5 112.88 25.81 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.767 0.712 . . . . 0.0 110.315 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.4 t -97.88 88.47 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.289 -0.882 . . . . 0.0 108.694 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -79.12 106.43 11.15 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.545 0.738 . . . . 0.0 110.985 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -137.6 140.63 41.07 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -171.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.1 mp -86.65 113.76 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -96.16 91.31 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.2 -89.77 0.7 Allowed Glycine 0 N--CA 1.491 2.345 0 O-C-N 121.016 -1.052 . . . . 0.0 114.745 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -134.4 42.39 2.86 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 166.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -136.66 125.95 24.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.892 -1.13 . . . . 0.0 109.058 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.5 tp -84.23 105.6 15.21 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.88 123.1 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . 0.274 17.9 pt20 -116.85 104.04 10.91 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.373 0.606 . . . . 0.0 112.379 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.0 m -87.13 109.75 19.65 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.727 0.811 . . . . 0.0 109.974 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -87.43 113.59 23.27 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.158 0.583 . . . . 0.0 110.701 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -101.58 98.54 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -115.54 104.14 11.43 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 118.832 0.742 . . . . 0.0 110.106 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 54.64 55.02 8.42 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 174.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.15 -23.46 6.08 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 119.066 2.386 . . . . 0.0 119.066 -167.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.3 t -90.03 111.06 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 120.062 1.931 . . . . 0.0 108.929 -172.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.93 114.65 27.24 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.389 0.675 . . . . 0.0 111.405 174.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -121.12 108.35 13.7 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.319 0.647 . . . . 0.0 111.294 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.24 126.79 40.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 111.787 -176.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.7 mmm-85 -103.66 127.93 51.05 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 167.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.81 120.91 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -175.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -114.26 133.07 55.9 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.857 0.863 . . . . 0.0 111.374 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -95.5 153.69 17.58 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-O 122.155 0.979 . . . . 0.0 112.051 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -65.45 109.18 2.22 Favored 'General case' 0 CA--C 1.571 1.759 0 C-N-CA 124.097 0.959 . . . . 0.0 113.025 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 t70 . . . . . 0 N--CA 1.489 1.5 0 C-N-CA 125.188 1.395 . . . . 0.0 113.96 -178.949 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 . . . . . 0 CA--C 1.568 1.644 0 CA-C-O 119.277 -0.392 . . . . 0.0 111.581 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.9 t70 48.37 64.09 1.81 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.0 m -167.41 156.65 10.19 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 122.619 1.199 . . . . 0.0 114.147 -163.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.6 m -94.25 127.83 40.34 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.834 0.853 . . . . 0.0 110.963 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -128.03 104.87 8.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.656 -0.652 . . . . 0.0 109.875 -172.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -98.25 138.02 36.14 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.184 -0.948 . . . . 0.0 112.468 -177.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.9 p -62.92 120.97 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -99.65 -57.37 2.16 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 124.188 0.995 . . . . 0.0 112.112 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -152.84 124.43 7.76 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 119.859 1.209 . . . . 0.0 112.367 -176.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.7 p -97.02 103.45 15.38 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.585 0.754 . . . . 0.0 112.663 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -100.51 116.01 31.46 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.915 0.486 . . . . 0.0 110.323 -164.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.278 39.0 t30 65.73 20.29 11.49 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 -169.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -72.08 -36.37 69.49 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -57.33 -32.24 66.5 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.886 2.18 . . . . 0.0 116.886 169.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -71.98 -47.05 54.9 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -50.6 -52.9 34.94 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 163.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.2 mmt -47.65 -57.35 5.6 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 166.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -43.83 -52.13 6.93 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 168.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -56.7 -35.72 68.82 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 171.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 27.5 mtm -73.41 -19.81 60.89 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.37 63.59 0.98 Allowed Glycine 0 N--CA 1.491 2.321 0 CA-C-N 120.367 1.44 . . . . 0.0 114.659 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.7 m -126.91 156.08 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 121.675 0.75 . . . . 0.0 112.437 -169.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -70.28 153.2 43.32 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.857 -1.152 . . . . 0.0 113.733 168.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 11.9 tt -59.21 -38.41 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 172.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.3 t -58.7 -48.16 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 C-N-CA 123.798 0.839 . . . . 0.0 113.253 166.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -55.94 -38.86 70.88 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 167.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -57.58 -52.04 67.02 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 120.587 1.54 . . . . 0.0 115.084 168.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -60.16 -46.46 89.62 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.81 -45.94 90.29 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 171.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.09 92.67 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.84 -57.12 11.28 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 161.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -93.95 52.76 1.69 Allowed 'General case' 0 CA--C 1.575 1.938 0 CA-C-N 119.635 1.107 . . . . 0.0 113.432 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -85.44 -13.35 49.53 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 -173.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 57.93 45.46 18.21 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -174.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.8 tp -82.93 120.57 25.86 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-O 122.06 0.933 . . . . 0.0 112.39 -172.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -104.75 112.05 25.01 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.456 169.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.9 mt -90.17 100.98 13.71 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 m -93.47 92.39 7.59 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.5 mt -94.76 95.84 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -168.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 86.0 m -99.01 126.52 44.73 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.287 0.635 . . . . 0.0 109.769 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -83.18 126.08 32.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.909 . . . . 0.0 112.014 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -131.01 58.58 1.71 Allowed 'General case' 0 CA--C 1.574 1.866 0 C-N-CA 123.669 0.788 . . . . 0.0 111.869 -167.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.23 72.19 0.74 Allowed Glycine 0 N--CA 1.497 2.732 0 N-CA-C 116.591 1.397 . . . . 0.0 116.591 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.294 18.4 t30 68.63 -24.45 0.14 Allowed 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 -164.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -83.79 155.93 22.77 Favored 'General case' 0 CA--C 1.561 1.391 0 O-C-N 120.656 -1.277 . . . . 0.0 113.604 169.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -119.58 121.59 39.69 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 164.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.9 m -93.8 102.8 14.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.36 103.71 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -172.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -81.14 110.4 16.61 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -97.92 83.97 3.24 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.358 0.663 . . . . 0.0 109.733 -175.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.7 t -94.94 115.16 27.1 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.601 0.36 . . . . 0.0 111.936 -170.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.5 p -150.67 168.0 25.66 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.836 0.854 . . . . 0.0 113.134 -166.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.1 -30.03 65.95 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 118.027 2.602 . . . . 0.0 118.027 166.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -73.6 -43.96 58.36 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 167.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.55 154.65 12.07 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.82 0.848 . . . . 0.0 112.428 -165.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -119.66 108.2 14.16 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 161.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.0 pt -129.73 128.37 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.558 -0.714 . . . . 0.0 111.073 -174.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.32 99.62 12.38 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.841 0.857 . . . . 0.0 111.387 173.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.3 t -92.09 102.45 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -176.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.15 93.22 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -106.5 143.49 34.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.716 -0.615 . . . . 0.0 111.78 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -87.73 146.19 25.78 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 121.658 -0.651 . . . . 0.0 112.0 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.6 mt -70.26 109.75 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.095 -1.003 . . . . 0.0 111.839 169.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.42 52.73 2.44 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 116.394 1.318 . . . . 0.0 116.394 -171.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.5 p -143.63 138.48 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 118.327 1.064 . . . . 0.0 109.971 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.3 m -83.74 108.08 16.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.342 -0.849 . . . . 0.0 109.8 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -131.95 165.95 22.77 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-O 121.682 0.753 . . . . 0.0 112.331 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -90.1 108.77 19.94 Favored 'General case' 0 CA--C 1.571 1.779 0 O-C-N 121.619 -0.675 . . . . 0.0 111.506 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -100.5 117.68 35.15 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.742 0.817 . . . . 0.0 110.444 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -98.54 123.66 42.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.119 -0.988 . . . . 0.0 112.919 -175.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.07 158.61 25.0 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.4 69.96 2.93 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 170.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -171.8 -70.36 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 125.292 1.437 . . . . 0.0 108.273 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.45 68.24 0.01 OUTLIER Glycine 0 N--CA 1.483 1.796 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -171.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.3 m -162.14 127.74 3.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.584 -0.951 . . . . 0.0 109.846 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -97.95 126.08 43.18 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.901 0.88 . . . . 0.0 110.439 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.73 111.5 22.51 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.753 -0.592 . . . . 0.0 110.607 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -84.47 123.39 30.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.157 -0.965 . . . . 0.0 111.527 171.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.53 -168.26 39.39 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 117.659 1.824 . . . . 0.0 117.659 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 71.3 p -124.27 123.6 40.58 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.544 -0.828 . . . . 0.0 111.62 -163.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -83.98 114.67 21.87 Favored 'General case' 0 CA--C 1.57 1.735 0 O-C-N 121.992 -0.442 . . . . 0.0 111.433 163.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.532 ' HG ' ' NZ ' ' A' ' 92' ' ' LYS . 50.7 m -114.36 126.54 55.11 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 123.396 0.679 . . . . 0.0 111.071 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.2 tp -94.12 115.56 27.87 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.176 -0.953 . . . . 0.0 112.103 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -100.3 80.94 2.31 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 170.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.88 -87.23 0.55 Allowed Glycine 0 N--CA 1.494 2.515 0 O-C-N 121.052 -1.03 . . . . 0.0 115.083 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -123.39 29.4 6.67 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 166.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -125.06 109.68 13.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.461 -1.399 . . . . 0.0 108.972 177.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.81 106.4 18.44 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.354 0.661 . . . . 0.0 109.524 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.8 tt -96.93 118.67 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.866 -1.146 . . . . 0.0 110.644 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.72 98.06 2.35 Favored Glycine 0 N--CA 1.48 1.605 0 C-N-CA 123.249 0.452 . . . . 0.0 112.098 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.532 ' NZ ' ' HG ' ' A' ' 83' ' ' SER . 20.3 mttt -85.4 93.87 8.84 Favored 'General case' 0 CA--C 1.565 1.552 0 C-N-CA 123.251 0.621 . . . . 0.0 109.354 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -121.79 143.63 49.28 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.298 1.047 . . . . 0.0 113.442 -166.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -119.34 137.8 53.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.391 -0.818 . . . . 0.0 109.146 165.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -69.78 107.34 3.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 0.0 111.664 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.312 13.8 t -74.81 -5.88 45.92 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 118.139 2.644 . . . . 0.0 118.139 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -95.0 -18.1 21.36 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 158.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -123.79 -21.64 5.12 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 117.29 2.329 . . . . 0.0 117.29 -173.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.24 -30.92 7.12 Favored Glycine 0 N--CA 1.496 2.684 0 CA-C-N 121.885 2.129 . . . . 0.0 118.351 -175.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -78.76 151.56 31.96 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 118.45 1.125 . . . . 0.0 113.585 -167.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -98.63 132.62 43.89 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.599 0.714 . . . . 0.0 112.004 -164.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.3 tt -131.11 122.55 26.86 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 124.1 0.96 . . . . 0.0 109.908 -170.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -109.85 116.84 32.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.126 -0.984 . . . . 0.0 109.352 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.7 m -106.52 104.06 13.67 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 119.019 0.827 . . . . 0.0 110.008 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.5 t -92.36 107.8 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.25 -0.906 . . . . 0.0 108.675 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -85.3 103.76 14.53 Favored 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 124.074 0.95 . . . . 0.0 110.433 170.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -127.46 147.35 50.3 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 124.254 1.022 . . . . 0.0 109.534 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . 0.25 5.8 mt -113.72 117.47 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 119.771 -1.83 . . . . 0.0 111.175 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.2 tp -92.35 74.71 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.769 0 CA-C-O 122.124 0.964 . . . . 0.0 110.741 172.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.94 -98.48 0.71 Allowed Glycine 0 N--CA 1.49 2.281 0 O-C-N 121.067 -1.021 . . . . 0.0 115.193 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -80.7 -10.62 59.72 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.892 2.553 . . . . 0.0 117.892 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -128.28 127.64 43.15 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-N 119.736 1.153 . . . . 0.0 112.457 -165.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.9 tp -80.94 124.11 28.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.858 0.863 . . . . 0.0 111.147 170.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.2 m -103.17 116.54 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.524 ' NE2' ' HH ' ' A' ' 117' ' ' TYR . 21.2 mt-30 -91.13 103.49 16.18 Favored 'General case' 0 CA--C 1.558 1.281 0 O-C-N 121.277 -0.889 . . . . 0.0 109.093 167.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.4 m -90.66 104.57 17.14 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.524 ' HH ' ' NE2' ' A' ' 115' ' ' GLN . 70.3 m-85 -92.16 106.92 18.83 Favored 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 123.76 0.824 . . . . 0.0 110.621 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.89 111.39 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -142.04 110.82 6.19 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.988 0.515 . . . . 0.0 110.463 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 54.31 50.52 16.14 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 168.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.69 38.01 44.1 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 118.507 2.163 . . . . 0.0 118.507 -170.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.55 148.15 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 118.812 1.306 . . . . 0.0 110.216 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -130.06 115.82 17.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.729 -0.607 . . . . 0.0 109.981 171.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.22 127.3 54.64 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.009 0.524 . . . . 0.0 112.276 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -108.71 105.09 14.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.595 -0.691 . . . . 0.0 110.099 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -87.85 115.13 25.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.346 -0.847 . . . . 0.0 110.494 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 22.7 mt -99.53 123.16 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -120.99 119.54 32.83 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 124.291 1.036 . . . . 0.0 109.604 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -80.36 142.85 34.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.913 -1.117 . . . . 0.0 113.073 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 52.6 tttt -69.34 113.67 6.87 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.7 t70 . . . . . 0 N--CA 1.49 1.552 0 C-N-CA 124.761 1.224 . . . . 0.0 113.734 172.675 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 N--CA 1.5 2.067 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -148.99 81.29 1.43 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.659 -0.651 . . . . 0.0 110.431 -176.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.3 m -171.95 170.26 5.45 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.577 1.179 . . . . 0.0 111.763 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.2 m -90.39 130.73 36.44 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.912 -1.117 . . . . 0.0 110.712 170.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -135.39 113.56 11.33 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.576 -0.703 . . . . 0.0 109.762 -171.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -116.13 143.38 45.56 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.651 -1.281 . . . . 0.0 113.649 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.88 115.86 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -168.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.08 -48.75 7.19 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 124.388 1.075 . . . . 0.0 112.86 169.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -136.61 109.73 7.75 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 119.377 0.99 . . . . 0.0 110.225 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.0 p -91.98 101.06 13.61 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.018 -1.051 . . . . 0.0 111.013 167.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -106.96 113.11 26.39 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -165.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.294 13.1 t30 69.67 16.65 7.94 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 117.53 2.419 . . . . 0.0 117.53 -176.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -66.73 -37.92 85.62 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.44 -43.17 83.68 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 167.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -69.29 -43.15 74.44 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 171.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -48.62 -54.34 15.0 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 162.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 mtt -66.7 -24.7 66.29 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 170.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.65 -42.92 81.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.295 -1.503 . . . . 0.0 114.216 164.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -57.47 -33.15 67.69 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 163.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 mmt -64.05 -42.58 96.99 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 164.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.87 56.35 0.96 Allowed Glycine 0 N--CA 1.485 1.951 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -117.44 147.86 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-N 117.983 0.892 . . . . 0.0 112.512 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -56.45 139.72 48.16 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.297 0.0 OUTLIER -47.35 -45.54 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 178.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.4 t -55.07 -60.02 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 C-N-CA 124.288 1.035 . . . . 0.0 113.643 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -63.19 -38.73 92.31 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -58.03 -49.67 76.09 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 170.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -59.18 -47.77 84.08 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 167.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.4 mt -59.0 -41.5 87.8 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 171.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.86 -41.46 87.27 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.84 -52.79 64.02 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 161.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -91.4 35.72 0.94 Allowed 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -77.89 -22.68 49.36 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 66.61 60.6 0.57 Allowed 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 120.472 1.487 . . . . 0.0 113.056 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.4 tp -86.7 120.87 28.46 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 121.415 -0.803 . . . . 0.0 112.979 -171.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -98.4 121.2 40.03 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 124.53 1.132 . . . . 0.0 110.355 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.4 mt -101.76 101.64 12.15 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 123.709 0.804 . . . . 0.0 109.253 174.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.4 m -88.84 95.03 10.13 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.155 -0.966 . . . . 0.0 108.775 172.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 73.6 mt -93.06 118.7 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -173.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -137.01 146.78 45.71 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 123.33 0.652 . . . . 0.0 110.725 171.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -130.53 157.92 41.37 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -127.55 84.23 2.23 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-N 114.482 -1.235 . . . . 0.0 108.706 167.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.73 -82.2 0.84 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 116.206 1.243 . . . . 0.0 116.206 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -116.07 -16.33 11.05 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 168.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -85.79 131.19 34.37 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 121.245 1.839 . . . . 0.0 111.833 173.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -113.61 131.16 56.22 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 124.363 1.065 . . . . 0.0 110.023 177.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 m -103.71 111.87 24.55 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 163.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.7 t -108.99 102.87 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -84.98 109.82 18.45 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -108.16 103.95 13.25 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.896 0.478 . . . . 0.0 110.043 -166.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 t -115.32 118.95 34.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.305 0.642 . . . . 0.0 111.745 -172.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.5 p -138.38 175.5 9.52 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.779 0.8 . . . . 0.0 112.965 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.74 62.26 1.05 Allowed 'General case' 0 CA--C 1.576 1.98 0 O-C-N 120.395 -1.441 . . . . 0.0 113.54 153.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -169.18 -61.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.932 1.293 . . . . 0.0 109.225 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.411 ' HG3' HH11 ' A' ' 56' ' ' ARG . 32.0 ptt85 -142.47 141.49 32.16 Favored 'General case' 0 CA--C 1.567 1.608 0 C-N-CA 124.035 0.934 . . . . 0.0 110.545 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -129.68 92.43 3.33 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.17 153.02 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 CA-C-O 121.91 0.862 . . . . 0.0 111.879 -170.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.38 108.41 18.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.932 . . . . 0.0 110.564 168.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.84 97.77 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.3 t -102.7 125.65 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -173.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -150.77 151.05 31.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.606 -0.684 . . . . 0.0 111.662 -176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -97.3 143.82 27.69 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.285 -0.885 . . . . 0.0 111.004 165.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.8 mt -57.35 122.03 11.59 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.88 -4.77 73.47 Favored Glycine 0 CA--C 1.555 2.537 0 N-CA-C 119.868 2.707 . . . . 0.0 119.868 -170.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -93.64 132.18 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-N 120.489 2.144 . . . . 0.0 109.769 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -74.94 117.98 17.39 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -134.8 161.09 36.16 Favored 'General case' 0 CA--C 1.571 1.753 0 C-N-CA 123.844 0.858 . . . . 0.0 112.013 -176.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -89.41 115.89 27.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.357 -0.84 . . . . 0.0 111.88 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -113.23 129.92 56.38 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 123.868 0.867 . . . . 0.0 111.129 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -98.49 131.32 44.83 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.996 -1.065 . . . . 0.0 110.895 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.6 mt -62.89 -56.1 20.23 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 170.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -154.95 -65.15 0.13 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 119.116 0.871 . . . . 0.0 111.948 177.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -84.16 -76.08 0.31 Allowed 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.396 0.679 . . . . 0.0 111.96 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.66 58.23 0.4 Allowed Glycine 0 N--CA 1.488 2.151 0 CA-C-N 118.795 0.725 . . . . 0.0 114.51 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 m -105.94 90.95 3.53 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -82.59 117.67 22.73 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.936 0.874 . . . . 0.0 112.44 -168.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.8 mt -115.58 108.66 16.71 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.671 0.789 . . . . 0.0 109.393 -171.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -98.1 96.72 8.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.758 -0.589 . . . . 0.0 110.669 -170.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.29 -153.46 10.97 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 116.338 1.295 . . . . 0.0 116.338 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.7 p -129.68 128.8 43.29 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -152.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -91.22 119.51 31.36 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.057 -1.027 . . . . 0.0 109.393 158.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.3 m -122.02 136.04 54.89 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.267 0.556 . . . . 0.0 111.308 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.8 tp -86.12 109.11 18.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.961 -1.087 . . . . 0.0 111.138 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.23 15.08 2.55 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 171.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.09 -80.53 0.27 Allowed Glycine 0 N--CA 1.488 2.148 0 O-C-N 120.827 -1.171 . . . . 0.0 112.087 -170.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -83.89 -28.8 27.67 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -125.45 140.06 53.1 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.781 1.173 . . . . 0.0 111.556 -165.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.5 mt -89.24 104.54 17.08 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 167.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.1 pt -93.97 116.41 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.997 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.82 99.95 2.61 Favored Glycine 0 N--CA 1.482 1.703 0 C-N-CA 123.591 0.615 . . . . 0.0 112.944 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -97.05 98.44 10.06 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -128.61 167.39 17.23 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-O 123.338 1.542 . . . . 0.0 111.657 -170.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.0 154.64 36.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.706 -1.246 . . . . 0.0 110.256 165.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -70.66 109.99 5.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 112.195 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.8 t -66.4 -17.87 65.03 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -84.96 -22.21 29.26 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 165.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -120.12 -22.49 6.63 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.98 -39.4 2.78 Favored Glycine 0 N--CA 1.492 2.37 0 CA-C-N 121.37 1.895 . . . . 0.0 117.258 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -72.05 144.86 48.6 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -165.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.66 140.39 55.46 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -173.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.1 tt -126.16 127.24 45.41 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.549 0.69 . . . . 0.0 111.323 167.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -96.67 149.08 22.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.506 -0.746 . . . . 0.0 110.604 163.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.4 m -145.32 105.54 4.06 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 119.928 -1.732 . . . . 0.0 109.589 162.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.7 t -93.11 114.26 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.094 -1.004 . . . . 0.0 109.03 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.4 mtm-85 -89.05 121.57 31.53 Favored 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 123.787 0.835 . . . . 0.0 111.265 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -143.61 141.48 30.64 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 123.671 0.788 . . . . 0.0 110.424 -177.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.29 126.57 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 120.733 -1.23 . . . . 0.0 109.759 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.1 tp -116.52 91.68 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.754 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 164.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.04 -112.32 4.15 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 120.898 -1.126 . . . . 0.0 114.611 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -99.62 20.31 14.22 Favored 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 167.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -126.14 127.16 45.32 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.788 1.176 . . . . 0.0 111.056 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.5 tp -87.62 114.78 24.54 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.241 1.016 . . . . 0.0 109.982 171.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.4 m -91.35 119.43 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.585 -0.697 . . . . 0.0 109.876 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -99.71 103.68 15.36 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 166.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.5 m -89.81 94.96 10.03 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -81.08 131.45 35.3 Favored 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 123.944 0.898 . . . . 0.0 111.249 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.1 t -134.98 114.37 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 CA-C-N 119.147 0.885 . . . . 0.0 109.274 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -113.94 122.12 45.99 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.31 5.2 mm-40 70.69 -85.47 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 124.23 1.012 . . . . 0.0 112.0 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -151.22 50.49 0.53 Allowed Glycine 0 N--CA 1.487 2.1 0 CA-C-O 119.416 -0.658 . . . . 0.0 114.109 158.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.35 109.08 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -77.81 129.61 35.65 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -124.08 114.3 19.53 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.532 0.682 . . . . 0.0 110.622 163.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -99.7 104.39 16.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.861 -0.525 . . . . 0.0 109.683 -176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 -93.3 112.7 24.7 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.531 0.682 . . . . 0.0 109.612 172.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.8 mt -99.1 114.74 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.555 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -173.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -108.44 111.33 23.17 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.685 0.794 . . . . 0.0 109.891 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -79.97 144.79 32.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.003 -1.061 . . . . 0.0 112.467 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -66.1 120.34 13.02 Favored 'General case' 0 CA--C 1.569 1.692 0 CA-C-O 121.684 0.754 . . . . 0.0 112.961 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.8 t70 . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -158.895 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 . . . . . 0 N--CA 1.502 2.156 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -146.71 51.82 1.11 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.379 -1.45 . . . . 0.0 113.78 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 p -160.87 176.75 11.1 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.127 -0.983 . . . . 0.0 113.593 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.4 m -78.4 116.58 18.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.72 . . . . 0.0 110.264 160.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -109.73 111.34 22.73 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -95.04 138.65 32.48 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.429 -0.794 . . . . 0.0 111.75 -177.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.02 122.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -110.29 -55.62 2.44 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.581 0.752 . . . . 0.0 112.742 -174.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -158.56 119.8 3.43 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 120.042 1.292 . . . . 0.0 111.064 -171.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.0 p -110.29 124.72 52.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.031 -1.043 . . . . 0.0 113.099 -174.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -78.43 -48.4 15.5 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -170.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -134.83 54.75 1.93 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 119.97 1.259 . . . . 0.0 112.599 168.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -84.45 58.77 5.04 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.018 -1.676 . . . . 0.0 112.419 167.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -151.61 -61.19 0.17 Allowed 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 125.101 1.36 . . . . 0.0 109.43 -176.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -62.02 -48.95 77.97 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 120.846 1.657 . . . . 0.0 114.096 170.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -47.65 -52.8 16.83 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 163.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.8 mtp -55.17 -49.14 72.62 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 171.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -52.84 -46.38 67.78 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 165.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -60.13 -36.22 77.0 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 170.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.7 mtm -72.34 -59.14 2.88 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 119.607 1.094 . . . . 0.0 113.114 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.89 72.14 0.02 OUTLIER Glycine 0 N--CA 1.487 2.047 0 CA-C-N 118.268 0.486 . . . . 0.0 113.779 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 m -118.36 155.44 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-O 122.025 0.917 . . . . 0.0 112.605 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -79.2 153.29 30.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.353 -0.842 . . . . 0.0 110.921 152.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.29 12.9 tt -56.78 -37.61 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 172.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.9 t -58.75 -53.73 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 C-N-CA 124.362 1.065 . . . . 0.0 113.276 166.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -55.34 -36.16 65.98 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 168.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -57.36 -52.08 66.81 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 172.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -64.61 -44.74 89.59 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 166.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -60.98 -58.06 10.02 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.66 -15.9 63.82 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 173.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.96 -52.47 42.41 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 156.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -91.51 -18.31 24.33 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 118.216 2.673 . . . . 0.0 118.216 -172.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -73.32 62.17 0.69 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 50.12 51.58 16.41 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 163.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 tt -91.07 109.55 20.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.116 -0.99 . . . . 0.0 111.588 -170.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -97.75 138.15 35.55 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-O 121.848 0.832 . . . . 0.0 111.937 166.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.2 mt -103.91 97.41 7.41 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 164.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.2 m -88.26 103.43 15.79 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.173 -0.955 . . . . 0.0 108.907 176.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.3 mt -94.01 108.58 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -168.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 m -105.26 111.19 23.84 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -87.34 137.92 31.92 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -135.84 80.36 1.82 Allowed 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 124.123 0.969 . . . . 0.0 109.166 172.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.12 -89.58 0.5 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 116.061 1.184 . . . . 0.0 116.061 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.13 15.33 19.5 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 167.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -134.3 116.13 14.91 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 119.942 1.246 . . . . 0.0 110.259 -166.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -104.8 129.53 53.06 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.715 -0.616 . . . . 0.0 110.847 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.1 m -100.77 104.43 15.69 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 164.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.2 t -101.47 108.39 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -80.21 110.35 15.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 111.003 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -83.73 95.07 8.29 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 t -116.55 114.71 24.53 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.005 0.907 . . . . 0.0 111.31 -170.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.8 t -154.53 175.41 13.65 Favored 'General case' 0 CA--C 1.572 1.8 0 C-N-CA 125.968 1.707 . . . . 0.0 109.087 -171.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.2 -27.11 63.59 Favored 'General case' 0 CA--C 1.581 2.171 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 155.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -85.42 -32.58 22.27 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.1 mmt-85 -137.42 140.41 41.3 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.197 0.908 . . . . 0.0 110.32 -175.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -135.33 76.07 1.6 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 158.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.3 142.6 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 122.026 0.917 . . . . 0.0 111.058 -168.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.4 113.67 26.0 Favored 'General case' 0 CA--C 1.564 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 111.461 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.1 t -90.93 98.35 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.5 t -91.6 119.4 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -136.6 129.78 31.31 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.159 0.504 . . . . 0.0 112.315 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.12 135.82 33.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.801 -0.562 . . . . 0.0 110.5 164.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.43 125.24 22.94 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.75 -16.76 44.37 Favored Glycine 0 CA--C 1.556 2.601 0 N-CA-C 119.447 2.539 . . . . 0.0 119.447 -167.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.0 t -86.21 130.28 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 CA-C-N 120.561 2.18 . . . . 0.0 109.98 -177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.0 t -74.44 121.33 21.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.575 -0.703 . . . . 0.0 112.76 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -142.58 164.72 29.36 Favored 'General case' 0 CA--C 1.573 1.86 0 C-N-CA 123.333 0.653 . . . . 0.0 111.775 -172.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -87.45 116.33 25.49 Favored 'General case' 0 CA--C 1.569 1.696 0 O-C-N 121.339 -0.851 . . . . 0.0 112.909 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -98.99 143.41 29.3 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.876 0.87 . . . . 0.0 111.231 166.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -120.59 132.63 55.24 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.983 0.897 . . . . 0.0 110.682 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.8 mt -84.54 168.19 15.63 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 121.979 0.895 . . . . 0.0 112.9 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.11 -36.67 80.33 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 118.94 2.941 . . . . 0.0 118.94 -173.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.34 -76.48 0.1 Allowed 'General case' 0 CA--C 1.571 1.775 0 CA-C-N 120.113 1.324 . . . . 0.0 111.697 169.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.44 64.0 0.05 OUTLIER Glycine 0 N--CA 1.483 1.806 0 O-C-N 121.841 -0.537 . . . . 0.0 112.543 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.8 m -123.04 107.17 11.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -95.26 128.91 42.47 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-O 122.07 0.938 . . . . 0.0 111.419 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.3 mt -132.69 116.24 16.37 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.076 -156.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -92.47 118.68 31.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.475 -0.765 . . . . 0.0 110.667 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.76 -177.92 42.45 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 117.981 1.953 . . . . 0.0 117.981 -173.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.6 p -126.28 132.13 51.73 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 113.972 -1.114 . . . . 0.0 110.37 -173.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -92.59 122.66 35.23 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.335 -0.853 . . . . 0.0 110.541 169.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.3 m -109.66 118.81 37.53 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.318 0.647 . . . . 0.0 110.831 175.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.5 tp -82.83 103.93 12.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.515 -0.74 . . . . 0.0 111.85 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -105.25 89.78 3.23 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.191 0.52 . . . . 0.0 110.26 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.69 -94.49 0.76 Allowed Glycine 0 N--CA 1.492 2.389 0 O-C-N 121.501 -0.75 . . . . 0.0 113.782 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -127.36 48.4 2.23 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 159.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -129.8 111.87 13.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.089 -1.007 . . . . 0.0 108.49 173.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.4 mt -84.55 108.37 17.28 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.439 -0.788 . . . . 0.0 109.452 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.0 mt -102.22 104.22 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -172.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.51 100.71 2.67 Favored Glycine 0 N--CA 1.483 1.812 0 C-N-CA 123.886 0.755 . . . . 0.0 113.096 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.52 95.92 9.91 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.973 0.509 . . . . 0.0 109.729 -175.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -110.76 147.75 33.78 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.589 0.709 . . . . 0.0 112.868 -171.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -119.04 139.43 51.74 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.644 0.778 . . . . 0.0 109.131 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -69.17 114.9 7.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.928 -1.107 . . . . 0.0 112.885 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 t -66.09 -16.77 64.22 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 117.916 2.562 . . . . 0.0 117.916 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -92.56 -10.65 36.84 Favored 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 165.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -141.15 -16.9 0.83 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 -169.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.94 -42.5 2.76 Favored Glycine 0 N--CA 1.493 2.458 0 CA-C-N 121.949 2.159 . . . . 0.0 117.707 -175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -70.24 147.91 49.19 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -161.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -77.43 132.2 38.36 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -173.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.0 tt -123.61 111.45 16.25 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 124.352 1.061 . . . . 0.0 108.751 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -101.63 113.62 26.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.104 -0.997 . . . . 0.0 109.577 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.0 m -107.2 108.69 20.24 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 119.196 0.907 . . . . 0.0 111.027 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.2 97.86 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.006 -1.059 . . . . 0.0 108.376 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -86.89 117.91 25.93 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.088 0.955 . . . . 0.0 110.899 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -146.97 142.81 27.92 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.326 -0.859 . . . . 0.0 112.864 -178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.2 mp -90.84 110.01 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.0 tp -90.07 80.42 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.119 0.962 . . . . 0.0 110.155 169.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.67 -88.92 0.74 Allowed Glycine 0 N--CA 1.49 2.266 0 O-C-N 121.209 -0.932 . . . . 0.0 114.933 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -117.84 22.05 12.52 Favored 'General case' 0 CA--C 1.581 2.171 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 175.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -137.99 123.6 19.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.53 -1.356 . . . . 0.0 109.858 -175.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.7 tp -78.49 110.03 13.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.524 -0.735 . . . . 0.0 110.127 168.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.89 118.12 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.277 -0.89 . . . . 0.0 108.871 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . 0.269 21.3 pt20 -103.52 104.42 14.49 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.777 0.799 . . . . 0.0 110.724 172.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.0 m -91.56 108.39 19.87 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.755 0.822 . . . . 0.0 109.152 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -94.14 112.13 23.92 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.386 0.674 . . . . 0.0 110.865 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.01 97.39 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -109.6 113.19 25.76 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.152 0.581 . . . . 0.0 109.873 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 54.78 46.14 25.2 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.04 -25.23 4.86 Favored Glycine 0 CA--C 1.556 2.65 0 N-CA-C 119.125 2.41 . . . . 0.0 119.125 -166.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.5 t -83.6 108.61 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 119.989 1.894 . . . . 0.0 110.069 -168.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -86.46 119.47 26.76 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.151 0.58 . . . . 0.0 112.479 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -124.97 117.0 23.06 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.645 0.778 . . . . 0.0 111.888 175.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -106.45 108.68 20.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.537 -0.727 . . . . 0.0 110.174 -170.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -97.43 116.01 28.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.911 -0.493 . . . . 0.0 110.482 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.7 mt -90.48 118.81 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -111.63 123.83 51.05 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.372 1.069 . . . . 0.0 109.221 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -83.92 148.35 26.99 Favored 'General case' 0 CA--C 1.565 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 112.721 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -59.24 113.42 2.13 Favored 'General case' 0 CA--C 1.57 1.735 0 C-N-CA 123.687 0.795 . . . . 0.0 113.05 167.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 N--CA 1.489 1.488 0 C-N-CA 124.949 1.3 . . . . 0.0 113.096 -175.139 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.327 62.9 m-85 . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.13 93.88 1.09 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 120.259 1.39 . . . . 0.0 112.374 -170.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.4 m -176.76 166.45 2.57 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 122.651 1.215 . . . . 0.0 111.805 -163.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.3 m -94.94 122.79 37.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.485 -0.759 . . . . 0.0 110.326 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -127.14 111.79 14.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.762 -0.586 . . . . 0.0 109.691 -170.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -105.34 133.19 50.51 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.977 -1.077 . . . . 0.0 112.011 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.58 115.79 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -98.47 -54.71 2.96 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 124.483 1.113 . . . . 0.0 111.85 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 56.1 mtm-85 -133.79 106.98 7.62 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.427 1.012 . . . . 0.0 109.458 -177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.5 p -94.34 97.74 10.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.856 -0.527 . . . . 0.0 111.196 174.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.4 127.03 52.76 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.157 0.583 . . . . 0.0 110.06 -159.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.269 37.8 t30 62.76 40.45 9.97 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -169.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -77.99 -49.82 13.32 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -172.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.02 -40.79 77.38 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 171.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -62.76 -47.65 82.6 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.21 1.368 . . . . 0.0 114.629 171.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -53.52 -53.03 57.39 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 166.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.9 mtp -60.83 -41.89 96.65 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -60.02 -42.52 94.51 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 165.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -40.69 73.89 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 166.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 56.6 mtm -61.84 -54.77 37.6 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-N 119.552 1.069 . . . . 0.0 112.763 166.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.99 54.83 0.08 OUTLIER Glycine 0 N--CA 1.487 2.041 0 CA-C-O 119.122 -0.821 . . . . 0.0 113.909 164.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.4 m -126.77 151.18 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 122.651 1.215 . . . . 0.0 112.911 -169.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -72.77 164.48 26.49 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.259 14.0 tt -55.43 -36.86 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 175.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.9 t -65.18 -51.57 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-N 120.09 1.314 . . . . 0.0 112.658 173.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -52.16 -47.08 65.66 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 166.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -57.87 -48.51 79.63 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -60.91 -46.25 91.42 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 171.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.5 mt -60.59 -48.16 83.02 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 171.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.24 -21.14 62.16 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.11 -49.36 15.44 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 120.962 1.71 . . . . 0.0 114.415 167.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -77.91 17.62 0.56 Allowed 'General case' 0 CA--C 1.58 2.124 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 175.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.2 p30 -74.94 -17.91 60.48 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 118.93 2.937 . . . . 0.0 118.93 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 61.53 62.19 1.36 Allowed 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 120.562 1.528 . . . . 0.0 113.484 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 tt -88.56 117.52 27.57 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.418 -0.801 . . . . 0.0 112.257 -164.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -101.21 127.83 47.6 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.54 0.736 . . . . 0.0 110.173 173.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.4 mt -98.48 102.4 14.13 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 166.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.5 m -94.62 107.56 19.55 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.098 -1.002 . . . . 0.0 108.441 171.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.7 mt -104.07 129.01 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -165.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 89.3 m -135.53 123.54 22.8 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.271 -0.893 . . . . 0.0 109.326 174.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.7 tm0? -98.74 132.94 43.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.321 -0.862 . . . . 0.0 112.186 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -127.69 87.6 2.65 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 123.565 0.746 . . . . 0.0 110.947 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.78 -89.5 0.96 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 115.139 0.816 . . . . 0.0 115.139 173.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -108.65 -2.5 18.68 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 166.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -108.99 144.13 37.37 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.34 1.427 . . . . 0.0 112.415 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -110.19 120.42 42.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.4 0.68 . . . . 0.0 109.986 167.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.1 m -86.41 102.72 14.3 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 164.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.3 t -104.6 101.52 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -83.8 107.44 16.21 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.262 -0.899 . . . . 0.0 110.017 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -86.6 92.9 9.05 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.005 0.522 . . . . 0.0 110.066 176.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.3 m -96.24 108.72 21.24 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 120.941 0.4 . . . . 0.0 109.991 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.3 p -143.51 158.02 43.98 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.468 0.651 . . . . 0.0 111.776 -174.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.61 -25.0 64.27 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.429 2.381 . . . . 0.0 117.429 165.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -53.96 15.66 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 165.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.79 152.52 25.19 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-N 119.148 0.886 . . . . 0.0 111.676 174.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -106.08 98.14 7.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.689 -0.632 . . . . 0.0 109.837 166.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.2 pt -122.93 132.85 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 121.989 0.9 . . . . 0.0 111.765 -174.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -94.85 98.46 10.75 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.693 0.797 . . . . 0.0 108.917 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.45 93.3 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -166.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.6 t -94.21 98.42 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -176.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -109.88 141.49 42.52 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.285 0.564 . . . . 0.0 112.116 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.38 138.75 31.16 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.465 0.65 . . . . 0.0 111.292 166.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.66 129.03 39.08 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.95 -7.12 63.95 Favored Glycine 0 CA--C 1.555 2.569 0 N-CA-C 119.969 2.748 . . . . 0.0 119.969 -170.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.9 t -97.78 133.74 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 120.634 2.217 . . . . 0.0 110.414 -170.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.7 p -74.57 104.35 5.23 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.439 0.696 . . . . 0.0 112.626 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -118.07 138.74 52.03 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 123.292 0.637 . . . . 0.0 111.928 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 -74.77 115.37 14.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.581 -0.7 . . . . 0.0 112.244 172.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -111.56 152.02 28.04 Favored 'General case' 0 CA--C 1.569 1.689 0 C-N-CA 124.093 0.957 . . . . 0.0 112.591 -175.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -119.81 136.39 54.48 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.086 0.954 . . . . 0.0 111.633 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.2 mt -105.99 64.12 0.68 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.292 -0.88 . . . . 0.0 113.097 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.32 . . 66.47 -66.76 0.17 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.29 -22.33 41.02 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 119.926 3.306 . . . . 0.0 119.926 176.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.49 21.94 8.93 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 118.229 2.052 . . . . 0.0 118.229 -170.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 83.8 m -82.32 108.01 15.43 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 119.763 1.782 . . . . 0.0 109.334 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -78.33 128.57 33.86 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.267 0.627 . . . . 0.0 112.342 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.0 mt -140.37 105.1 4.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.993 -0.442 . . . . 0.0 110.759 -166.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -81.76 123.79 29.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.654 -1.279 . . . . 0.0 110.896 171.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.22 176.84 40.12 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 118.649 2.22 . . . . 0.0 118.649 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.5 p -126.03 130.2 50.69 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 113.674 -1.263 . . . . 0.0 110.866 -169.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -97.72 123.48 41.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.677 -0.639 . . . . 0.0 111.744 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.2 m -106.07 120.19 41.15 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.408 0.683 . . . . 0.0 110.67 172.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.3 tp -84.22 121.14 27.07 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.336 0.588 . . . . 0.0 111.542 175.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -89.43 -48.21 7.49 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 164.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.56 -87.05 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 CA-C-N 119.177 0.899 . . . . 0.0 110.988 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -82.17 -4.32 56.75 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 156.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.98 138.15 43.69 Favored 'General case' 0 CA--C 1.57 1.714 0 C-N-CA 125.183 1.393 . . . . 0.0 111.69 174.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mt -130.12 124.56 33.0 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 169.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.15 119.4 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.17 -0.956 . . . . 0.0 110.377 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.22 108.78 3.12 Favored Glycine 0 N--CA 1.486 1.99 0 C-N-CA 123.587 0.613 . . . . 0.0 112.972 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.57 94.12 7.57 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.2 0.6 . . . . 0.0 110.652 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.94 142.13 41.73 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -170.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -124.72 138.3 54.29 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.305 1.042 . . . . 0.0 108.194 174.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.79 107.94 9.47 Favored 'General case' 0 CA--C 1.568 1.672 0 O-C-N 120.817 -1.177 . . . . 0.0 113.67 -168.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.6 p -78.11 69.75 4.37 Favored 'General case' 0 N--CA 1.506 2.342 0 CA-C-O 124.067 1.889 . . . . 0.0 112.442 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.8 t70 169.15 -51.89 0.01 OUTLIER 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 113.028 -1.896 . . . . 0.0 109.047 -148.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -142.12 -5.48 0.99 Allowed 'General case' 0 CA--C 1.582 2.18 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.4 -40.39 2.94 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 118.501 2.16 . . . . 0.0 118.501 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -60.6 149.69 34.1 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -165.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.12 127.74 32.98 Favored 'General case' 0 CA--C 1.565 1.545 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -169.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.1 tt -119.74 115.29 23.61 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 124.524 1.13 . . . . 0.0 108.296 174.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -101.97 118.23 36.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.037 -1.039 . . . . 0.0 110.902 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.2 m -100.28 111.07 23.32 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 73.9 t -97.72 108.59 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -95.44 129.41 42.61 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.419 0.688 . . . . 0.0 110.791 170.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -145.33 137.42 25.66 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.854 -0.529 . . . . 0.0 111.216 172.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.4 mp -87.6 109.35 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 173.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.253 11.3 tp -92.35 74.14 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 122.221 1.01 . . . . 0.0 110.378 168.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.72 -98.11 0.67 Allowed Glycine 0 N--CA 1.489 2.216 0 O-C-N 121.09 -1.006 . . . . 0.0 115.481 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -87.85 -2.14 58.42 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 174.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -132.2 125.9 32.27 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 119.585 1.084 . . . . 0.0 110.586 -168.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.3 tp -83.13 114.98 21.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.48 -0.763 . . . . 0.0 109.643 168.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.9 m -92.49 105.12 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -101.39 98.96 9.26 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.8 m -102.21 118.15 36.27 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.668 0.787 . . . . 0.0 110.397 -169.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -100.23 107.21 18.99 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.715 0.806 . . . . 0.0 110.888 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.2 t -106.33 107.83 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -118.34 118.94 33.15 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.184 0.593 . . . . 0.0 110.624 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.328 51.9 mt-10 66.2 -81.91 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 124.677 1.191 . . . . 0.0 113.43 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -146.69 45.76 0.77 Allowed Glycine 0 N--CA 1.489 2.21 0 CA-C-O 119.233 -0.76 . . . . 0.0 114.941 158.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.7 t -135.49 117.15 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -100.95 124.12 46.17 Favored 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 123.655 0.782 . . . . 0.0 111.845 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.81 120.01 37.87 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.057 0.543 . . . . 0.0 112.029 170.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -98.63 101.73 13.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.705 -0.622 . . . . 0.0 110.845 -176.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -84.18 111.31 19.24 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 121.072 0.463 . . . . 0.0 110.272 169.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 95.9 mt -90.6 117.45 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -106.57 120.54 42.21 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.4 0.68 . . . . 0.0 109.732 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -84.84 143.32 29.15 Favored 'General case' 0 CA--C 1.566 1.581 0 O-C-N 121.674 -0.641 . . . . 0.0 111.831 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -62.9 105.41 0.67 Allowed 'General case' 0 CA--C 1.572 1.805 0 O-C-N 121.465 -0.772 . . . . 0.0 112.905 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 N--CA 1.493 1.706 0 C-N-CA 124.763 1.225 . . . . 0.0 113.462 -170.95 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 . . . . . 0 N--CA 1.5 2.052 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -152.64 74.01 1.04 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.996 -1.065 . . . . 0.0 112.338 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.0 p -159.1 -179.01 7.63 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.181 0.991 . . . . 0.0 113.416 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.2 m -86.92 119.67 27.38 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.873 0.869 . . . . 0.0 110.131 172.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -120.71 98.22 5.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.654 -0.654 . . . . 0.0 109.961 -173.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -88.58 138.35 31.5 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.333 -0.854 . . . . 0.0 112.168 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.43 125.13 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -95.46 -52.71 4.03 Favored 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 124.647 1.179 . . . . 0.0 112.841 172.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.8 ptt85 -159.7 128.75 5.17 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 120.041 1.291 . . . . 0.0 112.131 -168.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.6 p -97.09 101.82 13.47 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.829 0.852 . . . . 0.0 112.135 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -97.17 112.36 24.18 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.837 -0.54 . . . . 0.0 109.99 -166.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.266 41.9 t30 62.02 24.39 14.51 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -170.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -74.78 -32.97 62.18 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -172.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -53.04 -42.01 65.34 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 164.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -64.17 -47.64 79.08 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 173.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -52.08 -54.04 35.06 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 166.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -34.43 77.7 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 171.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -58.85 -48.53 81.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.272 -1.518 . . . . 0.0 114.559 165.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -55.16 -34.64 63.98 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 166.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.3 mmt -68.31 -37.33 80.49 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 168.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.39 56.4 0.69 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 115.983 1.153 . . . . 0.0 115.983 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 p -124.83 156.31 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-O 122.348 1.07 . . . . 0.0 111.789 173.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -66.09 157.79 30.19 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.288 12.4 tt -58.72 -38.95 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -64.2 -55.38 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.181 0.9 . . . . 0.0 112.708 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -57.76 -30.12 65.37 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 167.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -60.19 -55.73 30.22 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 167.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -61.05 -37.78 83.86 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.7 mt -61.15 -48.52 81.2 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 164.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.36 -41.0 75.44 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 171.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.02 -47.95 74.03 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 164.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -114.99 36.84 3.69 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -79.67 43.82 0.59 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.338 20.0 p30 36.74 37.19 0.06 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 119.956 3.317 . . . . 0.0 119.956 -174.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 tt -75.51 115.22 14.95 Favored 'General case' 0 CA--C 1.558 1.256 0 O-C-N 120.91 -1.119 . . . . 0.0 112.844 -158.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -106.31 110.63 22.92 Favored 'General case' 0 CA--C 1.558 1.26 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.036 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.7 mt -86.65 97.05 10.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 169.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 86.5 m -86.45 92.49 8.86 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.9 mt -87.57 120.88 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 -174.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.9 p -122.95 108.22 12.71 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -84.87 130.55 34.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.542 -0.724 . . . . 0.0 111.652 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -135.88 68.54 1.45 Allowed 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.198 0.599 . . . . 0.0 110.742 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.65 76.31 0.25 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 116.79 1.476 . . . . 0.0 116.79 176.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.321 8.0 m120 73.03 -37.64 0.39 Allowed 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -170.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -67.06 135.07 53.09 Favored 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 119.701 1.137 . . . . 0.0 112.989 162.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -121.51 115.08 22.18 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 168.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.3 m -94.96 103.37 15.22 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 172.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 52.9 t -110.85 110.85 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -171.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -86.1 90.18 8.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.766 -0.583 . . . . 0.0 110.258 176.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -73.14 95.62 2.1 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.034 0.934 . . . . 0.0 110.51 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.1 m -109.3 97.14 6.79 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -161.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.3 p -127.79 163.27 24.73 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.924 0.868 . . . . 0.0 113.255 -170.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.15 -23.23 63.75 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 166.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -77.65 -53.92 6.99 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 119.555 1.071 . . . . 0.0 113.339 165.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -156.0 151.71 27.24 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 119.74 1.155 . . . . 0.0 112.264 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -109.31 108.77 19.46 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.508 0.723 . . . . 0.0 110.357 170.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 pp -135.83 145.25 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-O 121.646 0.736 . . . . 0.0 111.874 -171.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -97.29 115.45 27.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -0.978 . . . . 0.0 111.545 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.83 103.25 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.33 101.47 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 173.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -119.63 136.26 54.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.861 -0.524 . . . . 0.0 112.374 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -92.81 144.02 25.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.692 -0.63 . . . . 0.0 110.716 164.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.94 115.58 3.82 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.77 -15.76 59.81 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 119.698 2.639 . . . . 0.0 119.698 -172.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.8 t -85.25 111.64 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.678 2.239 . . . . 0.0 108.684 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.261 7.4 t -78.78 124.32 28.09 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -165.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -134.4 163.71 29.06 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 124.071 0.949 . . . . 0.0 112.396 -170.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -85.41 109.39 18.4 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 121.865 0.84 . . . . 0.0 112.194 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -93.55 165.97 12.48 Favored 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 124.9 1.28 . . . . 0.0 112.256 172.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.252 0.6 OUTLIER -139.28 155.96 47.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.612 -1.305 . . . . 0.0 113.196 166.096 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.9 mt -86.56 51.35 2.21 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 175.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.285 . . 62.41 -50.51 0.17 Allowed 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 118.472 2.767 . . . . 0.0 118.472 -168.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.9 p30 -78.07 -78.63 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -175.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.4 72.52 0.09 OUTLIER Glycine 0 N--CA 1.481 1.693 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 -170.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.4 m -145.46 105.91 4.08 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.64 112.98 20.02 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-O 121.424 0.63 . . . . 0.0 111.843 -173.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 70.9 mt -118.26 107.74 14.27 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.181 0.592 . . . . 0.0 111.112 -167.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.2 ttm-85 -88.85 121.14 30.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 111.113 174.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.01 -154.57 11.71 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.3 p -144.48 138.06 27.36 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 123.196 0.599 . . . . 0.0 110.627 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -88.0 120.07 28.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.693 -0.629 . . . . 0.0 109.866 163.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.2 t -115.62 124.6 51.34 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.176 0.59 . . . . 0.0 111.109 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.3 tp -84.61 104.92 15.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.471 -0.768 . . . . 0.0 111.586 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -105.16 78.87 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.507 0.67 . . . . 0.0 109.907 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.59 -102.02 1.25 Allowed Glycine 0 N--CA 1.49 2.285 0 O-C-N 121.547 -0.72 . . . . 0.0 114.023 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -112.51 45.39 1.31 Allowed 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 167.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -139.3 115.13 10.11 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.285 -0.884 . . . . 0.0 109.039 173.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.1 mt -86.19 104.64 15.93 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 166.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.0 mt -99.85 110.57 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -172.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.18 94.62 2.01 Favored Glycine 0 N--CA 1.481 1.646 0 C-N-CA 123.47 0.557 . . . . 0.0 112.553 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -86.91 98.86 11.46 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -119.78 142.8 48.25 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.518 0.727 . . . . 0.0 112.337 -168.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -122.71 137.43 54.92 Favored 'General case' 0 CA--C 1.563 1.456 0 O-C-N 121.471 -0.768 . . . . 0.0 109.997 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -64.89 118.05 8.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.192 -0.943 . . . . 0.0 113.182 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.7 p -76.84 67.89 2.96 Favored 'General case' 0 N--CA 1.508 2.439 0 CA-C-O 122.318 1.056 . . . . 0.0 110.623 169.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -178.43 -68.05 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -159.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -98.37 -35.92 10.14 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.075 1.879 . . . . 0.0 116.075 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.72 6.21 76.94 Favored Glycine 0 CA--C 1.558 2.737 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 -150.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -82.74 134.44 35.13 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 119.599 1.699 . . . . 0.0 112.885 -175.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -90.15 133.89 34.61 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -172.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.79 122.18 35.46 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 125.211 1.404 . . . . 0.0 108.878 -176.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -100.31 109.67 21.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.102 -0.999 . . . . 0.0 109.342 172.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.8 m -99.91 99.86 10.7 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 119.353 0.979 . . . . 0.0 109.757 172.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 80.2 t -88.31 105.04 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.019 -1.051 . . . . 0.0 108.549 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -79.48 112.89 17.18 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.339 0.656 . . . . 0.0 110.115 163.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -137.28 147.41 45.67 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.489 0.662 . . . . 0.0 109.935 171.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.77 139.1 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.008 0 O-C-N 120.776 -1.202 . . . . 0.0 109.922 167.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.5 tt -119.36 89.97 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.804 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 162.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 68.68 -99.01 0.56 Allowed Glycine 0 N--CA 1.492 2.391 0 O-C-N 120.948 -1.095 . . . . 0.0 115.529 -176.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -95.21 -3.17 48.18 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 170.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -123.4 129.69 51.64 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 119.464 1.029 . . . . 0.0 111.48 -164.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.4 tp -82.89 114.59 21.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.288 170.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.0 m -82.47 126.06 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 166.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -99.16 101.02 12.22 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 157.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.5 m -90.16 108.31 19.67 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -102.8 99.67 9.63 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.456 0.703 . . . . 0.0 110.855 -170.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 t -99.43 114.17 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -134.63 109.74 8.84 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.041 0.536 . . . . 0.0 110.853 -174.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.287 24.4 mm-40 68.17 -79.52 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 172.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -142.54 58.95 0.55 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 123.212 0.434 . . . . 0.0 113.091 167.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.18 154.79 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 123.756 0.822 . . . . 0.0 109.852 -174.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.255 0.0 OUTLIER -144.47 136.91 26.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.11 -0.994 . . . . 0.0 112.949 161.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.56 145.44 51.72 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.53 0.732 . . . . 0.0 112.204 174.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -120.04 98.22 5.98 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . 0.297 6.1 ptm180 -88.76 123.52 33.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.755 -1.216 . . . . 0.0 110.414 170.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.5 mt -109.82 131.31 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -161.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -119.31 127.1 52.88 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.365 0.666 . . . . 0.0 110.339 -175.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -83.48 144.06 29.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.238 -0.914 . . . . 0.0 112.499 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.6 tttt -69.27 122.11 18.2 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 121.683 0.754 . . . . 0.0 112.464 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.2 t70 . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -162.281 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -83.66 82.59 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.537 -1.352 . . . . 0.0 112.801 -165.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.8 t -162.6 -178.15 6.04 Favored 'General case' 0 CA--C 1.574 1.894 0 CA-C-O 123.004 1.383 . . . . 0.0 112.808 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.9 m -97.21 121.54 39.21 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.968 0.907 . . . . 0.0 109.451 169.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -118.72 112.02 19.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.709 -0.62 . . . . 0.0 110.644 -167.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -98.35 131.23 44.82 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 118.762 0.71 . . . . 0.0 112.167 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 p -66.92 120.9 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.336 -0.852 . . . . 0.0 113.249 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -100.81 -55.97 2.44 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -143.57 122.24 12.57 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 119.61 1.096 . . . . 0.0 112.246 -173.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.9 p -99.77 122.61 43.0 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.804 0.842 . . . . 0.0 111.936 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -76.36 -38.2 56.18 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -172.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -116.06 -78.51 0.58 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 119.269 0.94 . . . . 0.0 109.595 170.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.289 0.5 OUTLIER 47.45 35.11 3.82 Favored 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 118.427 2.751 . . . . 0.0 118.427 -175.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -150.0 -53.5 0.15 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.182 0.993 . . . . 0.0 111.095 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -66.33 -40.76 90.1 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 120.534 1.516 . . . . 0.0 114.095 164.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -45.62 -58.43 3.43 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 157.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.3 mtp -64.16 -38.18 90.13 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -60.45 -42.7 96.69 Favored 'General case' 0 CA--C 1.574 1.893 0 O-C-N 120.16 -1.588 . . . . 0.0 114.951 166.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -66.27 -28.84 69.02 Favored 'General case' 0 CA--C 1.579 2.076 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 168.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 mtm -59.81 -34.66 73.36 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 158.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.02 45.07 1.8 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 115.829 1.092 . . . . 0.0 115.829 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.1 m -127.21 147.65 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 118.837 1.318 . . . . 0.0 112.987 -173.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -72.26 162.41 29.5 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -175.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.256 0.2 OUTLIER -48.21 -44.61 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 168.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.4 t -54.89 -50.66 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 170.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -63.45 -40.78 98.04 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 169.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -57.02 -47.87 79.84 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 169.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.286 0.0 OUTLIER -64.88 -39.59 93.77 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 168.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.79 -53.77 14.16 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 176.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.4 -13.24 60.7 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 175.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.73 -54.58 8.57 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 120.328 1.422 . . . . 0.0 114.367 155.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -85.82 62.81 7.68 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.799 1.181 . . . . 0.0 112.765 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.5 p30 -121.3 9.04 10.31 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 -178.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.347 1.7 p-10 52.66 58.86 4.93 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 177.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.9 tp -75.45 118.97 18.9 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -116.63 114.4 24.04 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.342 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.7 mt -95.08 109.67 21.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.55 -0.719 . . . . 0.0 109.621 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.1 m -90.88 98.57 11.86 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.269 -0.894 . . . . 0.0 108.643 169.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.3 mt -101.47 124.61 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -146.85 135.11 21.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.404 -0.81 . . . . 0.0 112.555 166.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -86.12 145.65 26.94 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 171.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.42 88.05 1.41 Allowed 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 124.818 1.247 . . . . 0.0 109.173 -175.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.81 61.02 4.91 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 117.373 1.709 . . . . 0.0 117.373 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.6 t30 62.82 -4.53 0.24 Allowed 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 118.183 2.66 . . . . 0.0 118.183 -166.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -110.25 130.97 55.45 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.916 1.287 . . . . 0.0 110.113 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -99.63 118.33 35.93 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.507 -0.746 . . . . 0.0 110.491 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.5 m -86.47 114.24 23.06 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 166.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.4 t -122.12 99.4 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -87.12 114.15 23.47 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.317 0.58 . . . . 0.0 110.039 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -107.79 80.92 1.44 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.325 0.583 . . . . 0.0 110.515 -165.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 m -90.46 113.85 25.88 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-O 121.929 0.871 . . . . 0.0 112.205 -172.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.1 p -139.3 167.12 22.79 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.37 1.068 . . . . 0.0 109.305 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.3 57.2 0.24 Allowed 'General case' 0 CA--C 1.578 2.057 0 O-C-N 120.233 -1.542 . . . . 0.0 113.889 159.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -176.68 -57.93 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 125.303 1.441 . . . . 0.0 110.847 -170.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -96.35 -81.33 0.41 Allowed 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 119.974 1.261 . . . . 0.0 112.679 -174.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.284 68.1 m-80 53.59 65.15 1.6 Allowed 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -160.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.2 pt -122.48 121.73 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.871 -0.518 . . . . 0.0 110.031 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.01 94.57 8.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.35 -0.844 . . . . 0.0 111.347 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.2 t -98.46 114.2 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -170.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.46 97.72 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -112.52 137.87 50.11 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.302 0.641 . . . . 0.0 112.507 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -80.48 147.27 30.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.962 . . . . 0.0 112.668 169.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 70.6 mt -66.1 109.18 2.5 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.36 47.33 5.77 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 117.05 1.58 . . . . 0.0 117.05 -173.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.45 138.22 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 118.349 1.075 . . . . 0.0 110.1 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.0 m -84.36 102.8 13.0 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.437 -0.789 . . . . 0.0 109.756 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -127.15 162.53 25.91 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.289 1.042 . . . . 0.0 113.227 -172.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -86.5 121.84 29.6 Favored 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 123.669 0.788 . . . . 0.0 111.658 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -128.21 117.96 22.47 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.551 0.74 . . . . 0.0 110.816 -174.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -98.92 121.25 40.63 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.207 -0.933 . . . . 0.0 111.997 -174.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.7 mt -73.5 166.42 23.26 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.99 52.94 0.57 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 117.522 2.416 . . . . 0.0 117.522 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -163.62 -67.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.427 1.091 . . . . 0.0 109.471 168.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.87 73.59 0.05 OUTLIER Glycine 0 N--CA 1.481 1.677 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.8 m -155.68 121.37 4.98 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.52 -0.988 . . . . 0.0 109.948 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -94.44 125.89 39.37 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 122.457 1.122 . . . . 0.0 111.503 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 50.7 mt -106.55 150.16 26.43 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.299 1.04 . . . . 0.0 112.103 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.8 116.95 20.27 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.31 -161.73 35.11 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 117.551 1.781 . . . . 0.0 117.551 -175.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 71.4 p -124.88 123.67 40.43 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.919 -0.64 . . . . 0.0 111.712 -156.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -83.43 115.41 22.03 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 118.569 0.622 . . . . 0.0 110.158 158.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.8 m -115.47 132.77 56.52 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.243 0.617 . . . . 0.0 111.757 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.0 tp -87.44 109.29 19.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.378 -0.826 . . . . 0.0 112.324 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -101.76 81.34 2.13 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.551 0.691 . . . . 0.0 109.776 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.47 -94.16 0.93 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 114.795 0.678 . . . . 0.0 114.795 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -121.73 52.67 1.24 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.637 0.732 . . . . 0.0 111.485 165.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -146.86 112.4 5.61 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.8 mt -89.64 104.14 16.72 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 171.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.2 tt -94.82 118.19 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.641 -0.662 . . . . 0.0 110.21 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.83 97.85 2.32 Favored Glycine 0 N--CA 1.481 1.636 0 C-N-CA 123.411 0.529 . . . . 0.0 112.348 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -92.58 98.87 11.71 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.312 0.645 . . . . 0.0 109.609 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -123.18 134.28 54.18 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.527 0.731 . . . . 0.0 111.527 -170.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -110.81 157.08 20.21 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.498 1.142 . . . . 0.0 111.241 165.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -107.77 120.22 41.63 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.955 -1.091 . . . . 0.0 112.04 -161.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.5 t -68.0 -11.82 59.62 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 169.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -86.46 -50.68 6.7 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 119.459 1.027 . . . . 0.0 113.3 172.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.87 27.97 2.17 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 120.885 1.675 . . . . 0.0 115.405 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.76 -57.11 2.6 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 118.287 2.075 . . . . 0.0 118.287 176.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -48.46 124.95 8.85 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.833 2.053 . . . . 0.0 114.997 -168.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -67.18 145.47 55.21 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -171.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.3 tp -104.68 115.0 29.57 Favored 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 162.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -94.5 104.0 15.96 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 168.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.8 m -104.63 100.38 10.04 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.758 -0.588 . . . . 0.0 109.79 -177.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.9 t -91.63 104.65 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 120.897 -1.127 . . . . 0.0 108.812 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -82.02 115.78 21.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.883 -0.511 . . . . 0.0 109.852 164.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.79 144.76 34.11 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.037 0.535 . . . . 0.0 111.482 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.72 124.75 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.291 -0.881 . . . . 0.0 111.223 177.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.255 10.9 tp -98.77 79.15 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.151 0.977 . . . . 0.0 108.986 166.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.75 -104.58 1.49 Allowed Glycine 0 N--CA 1.488 2.117 0 O-C-N 121.444 -0.785 . . . . 0.0 114.247 -171.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.26 0.71 57.47 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 117.576 2.435 . . . . 0.0 117.576 172.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -122.41 135.82 54.77 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.192 1.36 . . . . 0.0 110.959 -170.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.0 tp -90.62 119.7 31.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 111.012 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.9 p -102.58 120.34 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.136 -0.978 . . . . 0.0 110.647 172.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.499 ' NE2' ' HH ' ' A' ' 117' ' ' TYR . 21.0 mt-30 -89.99 115.44 27.28 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 122.967 0.507 . . . . 0.0 109.883 166.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.2 m -96.86 100.23 11.77 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.229 0.611 . . . . 0.0 109.626 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.499 ' HH ' ' NE2' ' A' ' 115' ' ' GLN . 45.1 m-85 -88.07 112.4 22.61 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.434 0.694 . . . . 0.0 110.757 -177.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.1 t -113.4 100.35 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -92.92 119.33 32.1 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.285 0.8 OUTLIER 66.07 -85.81 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 119.258 0.936 . . . . 0.0 111.648 -176.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.97 20.71 3.59 Favored Glycine 0 CA--C 1.558 2.749 0 N-CA-C 117.853 1.901 . . . . 0.0 117.853 151.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -92.3 115.79 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 121.496 2.648 . . . . 0.0 111.483 -174.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -89.22 126.23 35.41 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -127.8 106.08 8.88 Favored 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 123.502 0.721 . . . . 0.0 110.781 169.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.73 130.32 37.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 111.147 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -123.69 122.51 38.28 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.5 -0.75 . . . . 0.0 111.934 171.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.5 mt -94.23 124.56 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -174.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -104.55 133.22 49.77 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.392 1.077 . . . . 0.0 110.634 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -88.96 147.75 24.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.055 0.931 . . . . 0.0 112.304 171.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -75.19 118.36 18.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.639 -0.663 . . . . 0.0 111.821 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.1 t70 . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -165.925 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 118.888 -0.577 . . . . 0.0 111.693 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 t70 40.62 51.19 2.98 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 166.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.5 p -165.35 171.0 13.98 Favored 'General case' 0 CA--C 1.569 1.71 0 CA-C-O 122.432 1.111 . . . . 0.0 112.557 -168.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.4 m -89.4 133.92 34.31 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.04 -1.038 . . . . 0.0 111.413 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -138.37 107.82 6.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.801 -0.562 . . . . 0.0 109.927 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -97.26 133.16 42.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.11 -0.994 . . . . 0.0 112.682 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 p -62.41 117.96 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.213 -0.93 . . . . 0.0 113.411 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -102.17 -45.11 5.24 Favored 'General case' 0 CA--C 1.568 1.649 0 C-N-CA 123.961 0.904 . . . . 0.0 113.384 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -152.62 160.46 43.19 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.154 0.982 . . . . 0.0 110.968 -174.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.3 p -146.72 143.72 28.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.37 -1.456 . . . . 0.0 112.871 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -85.83 -51.38 6.44 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -137.93 53.57 1.83 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 119.834 1.197 . . . . 0.0 112.772 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -83.61 63.86 7.63 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 119.628 -1.92 . . . . 0.0 112.205 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -163.85 -57.72 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.529 1.132 . . . . 0.0 110.981 -171.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -81.96 -26.06 34.29 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -51.87 -54.38 29.88 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-N 121.791 2.087 . . . . 0.0 113.778 153.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -51.86 -47.97 64.22 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 169.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -66.02 -38.83 89.42 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 170.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.0 tptp -60.14 -40.39 89.66 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 168.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.5 mtp -62.69 -52.92 61.38 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 165.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.55 59.44 0.06 OUTLIER Glycine 0 N--CA 1.487 2.042 0 CA-C-O 119.522 -0.599 . . . . 0.0 114.338 166.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 m -103.82 147.47 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.857 0.837 . . . . 0.0 111.727 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -74.28 169.03 18.45 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 168.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.267 0.2 OUTLIER -54.61 -44.34 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 176.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.49 -48.65 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-N 119.395 0.998 . . . . 0.0 112.996 172.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -54.38 -39.69 67.46 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 166.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -46.14 91.8 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 167.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -59.62 -48.81 80.21 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 166.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.7 mt -57.4 -39.76 76.81 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 169.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.04 -54.3 46.54 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 168.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.42 -38.14 41.56 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 167.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -95.17 19.9 9.92 Favored 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 172.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.305 28.0 p30 -72.97 -24.53 60.8 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 118.164 2.653 . . . . 0.0 118.164 -173.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 57.2 54.86 6.39 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 173.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.1 tp -79.77 122.52 26.71 Favored 'General case' 0 CA--C 1.563 1.445 0 CA-C-O 121.963 0.887 . . . . 0.0 112.345 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -105.48 106.22 16.62 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.871 169.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.39 100.11 7.47 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.38 0.609 . . . . 0.0 109.583 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.7 m -102.04 96.84 7.28 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -173.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.1 mt -95.38 131.81 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -164.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.2 m -141.04 108.55 5.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.577 -1.327 . . . . 0.0 107.693 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -100.64 139.2 36.66 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.94 0.876 . . . . 0.0 112.485 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -99.78 70.75 1.65 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 122.166 0.984 . . . . 0.0 110.139 164.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.88 -99.99 0.73 Allowed Glycine 0 N--CA 1.488 2.136 0 O-C-N 121.565 -0.71 . . . . 0.0 114.742 -170.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -84.47 -26.84 27.89 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -90.17 117.45 28.94 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.58 1.536 . . . . 0.0 111.101 177.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -99.48 117.33 33.64 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.374 1.07 . . . . 0.0 109.812 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.4 m -90.91 103.19 15.94 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 166.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -99.85 104.06 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -77.43 105.25 8.44 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.935 0.874 . . . . 0.0 109.991 172.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -92.4 91.47 7.67 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.099 0.96 . . . . 0.0 109.303 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.3 t -97.03 111.97 23.95 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.89 0.476 . . . . 0.0 111.336 -173.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.5 p -144.45 165.3 28.35 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -172.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.18 -23.17 67.22 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 117.611 2.449 . . . . 0.0 117.611 165.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -68.7 -52.01 35.54 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 120.367 1.44 . . . . 0.0 113.981 159.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -165.98 152.82 9.7 Favored 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 123.591 0.756 . . . . 0.0 112.144 -167.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -118.28 99.16 6.67 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 pp -136.41 143.19 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 O-C-N 121.747 -0.595 . . . . 0.0 111.994 -171.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -93.82 125.21 38.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.922 -1.111 . . . . 0.0 112.791 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.0 t -102.03 104.87 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.65 108.8 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -133.12 130.85 39.79 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.388 0.613 . . . . 0.0 112.537 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -66.98 140.5 57.73 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 111.835 157.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.8 mt -54.43 123.08 11.9 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 166.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.85 -5.96 83.13 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 119.189 2.436 . . . . 0.0 119.189 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 p -82.75 137.14 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-N 120.616 2.208 . . . . 0.0 112.748 -172.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.8 m -91.45 95.87 10.2 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.41 -0.806 . . . . 0.0 109.934 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -122.18 150.75 41.81 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -170.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -86.03 98.35 10.8 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 124.448 1.099 . . . . 0.0 113.872 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -89.98 118.6 29.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.5 -0.75 . . . . 0.0 110.966 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -72.26 108.47 5.42 Favored 'General case' 0 CA--C 1.569 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 113.114 171.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -78.21 139.79 38.94 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.914 0.886 . . . . 0.0 111.09 177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.32 66.94 0.31 Allowed 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -168.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -166.45 -66.2 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 125.779 1.632 . . . . 0.0 108.505 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.58 68.38 0.05 OUTLIER Glycine 0 N--CA 1.481 1.672 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.6 m -160.65 119.88 2.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.614 -0.933 . . . . 0.0 109.587 -177.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -88.1 113.89 24.18 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.886 0.85 . . . . 0.0 111.081 167.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 70.9 mt -93.78 109.56 21.23 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 124.325 1.05 . . . . 0.0 110.615 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 58.8 ttp85 -88.85 117.18 27.66 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.875 -0.516 . . . . 0.0 110.714 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.41 179.36 48.87 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 118.983 2.353 . . . . 0.0 118.983 -171.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.3 p -122.12 123.11 40.79 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 113.483 -1.358 . . . . 0.0 111.297 -166.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -81.92 107.56 14.74 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 118.476 0.58 . . . . 0.0 110.194 160.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 72.9 m -102.68 131.6 49.37 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.046 0.539 . . . . 0.0 111.101 176.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.9 tp -82.3 106.17 13.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.158 -0.964 . . . . 0.0 110.744 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -82.32 -49.45 10.02 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.07 -95.67 0.21 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 164.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -98.97 59.29 1.17 Allowed 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.869 0.842 . . . . 0.0 110.326 152.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -149.17 116.42 6.09 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.54 103.72 16.34 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 167.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.8 tt -90.08 111.5 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.368 -0.833 . . . . 0.0 110.1 177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.07 98.09 2.34 Favored Glycine 0 N--CA 1.482 1.707 0 C-N-CA 123.843 0.735 . . . . 0.0 113.072 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -93.32 96.34 9.9 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -117.46 147.27 42.87 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.731 0.777 . . . . 0.0 112.533 -168.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -127.0 138.52 53.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.404 -0.81 . . . . 0.0 110.851 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -71.04 115.07 9.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 0.0 113.133 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 73.8 p -80.49 62.96 4.77 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 123.514 1.626 . . . . 0.0 112.384 170.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -174.05 -65.03 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.732 0 C-N-CA 126.236 1.815 . . . . 0.0 107.005 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -94.33 -18.24 21.8 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.05 -15.68 47.24 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 119.148 2.419 . . . . 0.0 119.148 -172.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -84.18 152.76 24.06 Favored 'General case' 0 CA--C 1.566 1.559 0 CA-C-N 118.529 1.165 . . . . 0.0 113.79 -169.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -94.4 130.27 40.8 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-O 122.114 0.959 . . . . 0.0 112.835 -168.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.0 tt -110.66 122.51 47.96 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 124.48 1.112 . . . . 0.0 109.406 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -111.51 111.67 22.86 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.2 m -108.36 100.2 9.52 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 119.441 1.019 . . . . 0.0 110.203 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.8 t -91.38 107.46 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.128 -0.983 . . . . 0.0 108.827 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -103.82 105.3 15.46 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 123.4 0.68 . . . . 0.0 110.598 -173.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -143.48 148.82 36.65 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -169.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.56 120.95 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.17 -1.581 . . . . 0.0 109.672 175.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.5 mm -101.1 88.95 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 167.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.91 -88.14 0.56 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 115.769 1.067 . . . . 0.0 115.769 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -111.0 0.31 16.94 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 173.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -129.67 127.21 40.06 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.953 1.251 . . . . 0.0 110.744 -169.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.1 tp -74.63 115.24 13.98 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.961 0.904 . . . . 0.0 110.519 171.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.0 m -103.72 119.09 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.301 -0.874 . . . . 0.0 109.583 -176.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -88.8 107.38 18.94 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 118.844 0.747 . . . . 0.0 109.842 165.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.7 m -92.35 96.32 10.2 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -87.61 106.48 18.04 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.508 0.723 . . . . 0.0 111.05 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.6 t -106.77 104.35 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -117.48 118.17 31.44 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.885 0.474 . . . . 0.0 109.781 172.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 51.4 49.68 20.47 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.0 -24.79 4.42 Favored Glycine 0 CA--C 1.554 2.507 0 N-CA-C 119.264 2.466 . . . . 0.0 119.264 -169.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.7 t -86.65 105.27 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 120.104 1.952 . . . . 0.0 109.633 -168.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -87.98 124.76 34.05 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 123.314 0.646 . . . . 0.0 112.52 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -124.66 109.85 13.67 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.554 0.742 . . . . 0.0 111.518 173.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.54 108.77 20.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.786 -0.571 . . . . 0.0 110.092 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -111.66 129.44 56.09 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.387 1.089 . . . . 0.0 111.436 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.9 mt -121.66 119.15 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -146.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -112.49 119.79 39.41 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.337 0.655 . . . . 0.0 110.418 -168.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -81.01 147.34 30.24 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 123.507 0.723 . . . . 0.0 112.781 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -58.87 118.94 6.32 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 t70 . . . . . 0 N--CA 1.488 1.464 0 C-N-CA 125.01 1.324 . . . . 0.0 112.444 -172.608 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.364 89.8 m-85 . . . . . 0 N--CA 1.495 1.792 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -77.4 80.13 3.9 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 120.537 1.517 . . . . 0.0 112.669 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.9 t -163.78 178.15 8.08 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 122.443 1.116 . . . . 0.0 112.077 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.9 m -92.2 122.41 34.66 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.459 1.104 . . . . 0.0 110.297 170.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -123.65 108.72 12.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.813 -0.555 . . . . 0.0 109.958 -171.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -97.23 139.59 32.96 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.065 -1.022 . . . . 0.0 112.707 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -60.38 119.7 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -109.19 -51.11 2.92 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.767 0.827 . . . . 0.0 113.099 -173.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -148.57 109.57 4.3 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 119.222 0.919 . . . . 0.0 109.741 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.6 p -109.18 115.01 29.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.381 -0.824 . . . . 0.0 113.056 -174.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -98.69 123.07 42.67 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 123.327 0.651 . . . . 0.0 110.656 -169.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.261 9.4 t30 67.83 18.6 9.67 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -69.74 -43.09 73.0 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -173.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.87 -34.24 75.64 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 169.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -70.79 -47.2 60.79 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -43.1 -53.26 5.02 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 158.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 15.7 mtt -67.3 -25.87 66.25 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 174.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -60.7 -43.24 98.01 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-N 121.345 1.884 . . . . 0.0 114.625 163.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -59.03 -34.63 72.13 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 162.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 76.7 mmm -62.67 -30.31 71.29 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 116.929 2.196 . . . . 0.0 116.929 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.0 53.95 1.07 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 115.157 0.823 . . . . 0.0 115.157 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.31 142.53 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 122.671 1.224 . . . . 0.0 112.063 -175.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -70.24 172.08 8.76 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.275 13.2 tt -60.58 -40.73 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 176.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.6 t -61.61 -52.16 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-N 120.402 1.456 . . . . 0.0 112.913 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -55.3 -43.79 75.16 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 168.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -64.47 -42.22 96.05 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 171.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -58.36 -46.35 86.46 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 120.143 1.338 . . . . 0.0 114.554 167.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.9 mt -60.48 -40.94 93.11 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 165.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.69 95.0 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 172.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.96 -57.41 11.8 Favored 'General case' 0 CA--C 1.566 1.596 0 O-C-N 120.804 -1.185 . . . . 0.0 113.681 164.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -84.3 53.01 2.49 Favored 'General case' 0 CA--C 1.577 2.006 0 CA-C-N 119.716 1.144 . . . . 0.0 113.81 174.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -85.89 -29.51 23.6 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -174.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 62.05 50.22 4.17 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -84.02 121.75 27.83 Favored 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 122.42 1.105 . . . . 0.0 112.014 -175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -111.34 117.29 32.71 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.479 174.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.7 mt -101.44 102.59 13.41 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.0 m -94.46 105.04 17.0 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.309 -0.87 . . . . 0.0 109.649 172.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.6 mt -94.83 131.29 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 85.8 m -145.41 128.46 16.55 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.262 -1.524 . . . . 0.0 110.147 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -111.07 139.89 46.06 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -170.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -138.21 89.97 2.44 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.672 0.789 . . . . 0.0 109.825 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.21 68.18 1.81 Allowed Glycine 0 N--CA 1.497 2.711 0 N-CA-C 116.731 1.452 . . . . 0.0 116.731 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.291 46.7 m-20 67.62 -23.79 0.12 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 118.019 2.6 . . . . 0.0 118.019 -166.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -83.19 100.8 10.8 Favored 'General case' 0 CA--C 1.565 1.552 0 CA-C-N 121.151 1.796 . . . . 0.0 110.901 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -93.36 117.62 30.3 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.029 0.931 . . . . 0.0 109.504 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.0 m -92.75 104.14 16.44 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 p -94.69 109.83 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.699 0.762 . . . . 0.0 109.974 170.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -88.55 111.67 22.13 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -101.93 92.07 4.64 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.441 0.696 . . . . 0.0 110.712 -169.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.1 m -103.37 117.05 33.6 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.106 0.562 . . . . 0.0 111.003 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 p -147.77 -177.3 5.64 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.84 40.73 0.06 Allowed 'General case' 0 CA--C 1.583 2.246 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 166.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -144.2 -62.59 0.38 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 126.519 1.927 . . . . 0.0 108.566 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.64 167.48 28.78 Favored 'General case' 0 CA--C 1.572 1.825 0 C-N-CA 124.122 0.969 . . . . 0.0 111.141 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -121.07 102.8 8.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.328 -0.858 . . . . 0.0 109.46 164.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.33 144.22 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.527 -0.733 . . . . 0.0 112.019 -172.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -94.91 119.65 33.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.339 -0.85 . . . . 0.0 112.58 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.4 t -98.94 104.03 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.8 t -91.87 103.2 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -113.54 123.52 50.18 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.308 0.575 . . . . 0.0 112.006 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -72.28 137.09 46.5 Favored 'General case' 0 CA--C 1.569 1.703 0 O-C-N 121.366 -0.834 . . . . 0.0 110.499 162.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.8 mt -59.62 113.27 2.15 Favored 'General case' 0 CA--C 1.571 1.768 0 O-C-N 121.069 -1.019 . . . . 0.0 113.389 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.29 55.83 3.6 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 116.39 1.316 . . . . 0.0 116.39 -171.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 p -136.46 136.91 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 118.008 0.904 . . . . 0.0 110.125 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 88.0 m -87.41 109.79 19.82 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.505 -0.747 . . . . 0.0 110.156 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -138.56 156.23 47.67 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.168 0.587 . . . . 0.0 112.436 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -84.38 99.04 10.38 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 121.841 0.829 . . . . 0.0 112.126 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -86.64 119.27 26.7 Favored 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 124.449 1.1 . . . . 0.0 111.682 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -83.39 126.68 32.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.099 -1.001 . . . . 0.0 113.208 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.3 mt -80.62 152.67 28.4 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 170.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.93 64.74 2.49 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 175.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -174.31 -66.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 125.465 1.506 . . . . 0.0 110.394 -177.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.3 70.17 0.03 OUTLIER Glycine 0 N--CA 1.487 2.065 0 CA-C-N 119.128 0.876 . . . . 0.0 114.207 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.5 m -167.19 128.34 1.57 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 118.041 0.92 . . . . 0.0 109.015 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -97.34 126.71 42.74 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.172 0.987 . . . . 0.0 110.623 169.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.6 mt -108.91 107.69 18.18 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 124.227 1.011 . . . . 0.0 110.769 -174.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.53 119.15 20.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.048 -1.032 . . . . 0.0 112.068 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.74 -163.88 36.99 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 117.639 1.815 . . . . 0.0 117.639 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.8 p -125.5 120.31 30.59 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.382 -0.909 . . . . 0.0 111.763 -157.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -84.81 121.65 28.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.422 -0.799 . . . . 0.0 110.427 161.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.1 m -126.93 139.3 53.16 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.358 0.663 . . . . 0.0 111.735 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.1 tp -87.72 114.67 24.55 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.679 -1.263 . . . . 0.0 111.642 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -78.07 -37.27 46.95 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 172.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.83 -84.26 0.08 OUTLIER Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -107.93 39.04 2.03 Favored 'General case' 0 CA--C 1.581 2.138 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 158.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -146.19 124.32 12.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.929 -1.107 . . . . 0.0 109.167 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.8 mt -91.4 110.49 21.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.478 -0.764 . . . . 0.0 109.15 166.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.6 tt -97.52 117.59 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.127 -0.983 . . . . 0.0 110.858 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.04 95.7 1.76 Allowed Glycine 0 N--CA 1.482 1.747 0 CA-C-O 119.401 -0.666 . . . . 0.0 113.328 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -84.25 103.8 13.74 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 117.784 0.792 . . . . 0.0 110.017 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -123.16 148.42 45.76 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -171.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -120.96 141.61 50.53 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.782 0.801 . . . . 0.0 110.621 167.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -70.79 137.85 49.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.716 -1.24 . . . . 0.0 112.808 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.286 4.9 t -70.18 -51.78 28.43 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 175.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -75.92 -44.96 37.71 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -80.22 -26.19 39.25 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.7 -38.77 3.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 117.486 1.754 . . . . 0.0 117.486 -166.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -69.22 155.57 40.19 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -162.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.96 140.13 35.43 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 114.18 -1.373 . . . . 0.0 114.679 -175.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.8 tt -135.28 115.59 13.46 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 123.832 0.853 . . . . 0.0 109.114 177.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -94.5 111.72 23.48 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.139 -0.976 . . . . 0.0 109.103 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.9 m -101.34 94.94 6.19 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.0 t -100.91 100.14 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-O 122.516 1.151 . . . . 0.0 109.56 -168.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -93.69 102.35 14.51 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.367 -172.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -131.54 133.12 44.74 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.75 0.82 . . . . 0.0 111.268 -161.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.0 mt -104.0 123.3 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.719 -1.238 . . . . 0.0 110.172 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 45.1 mm -83.55 -47.33 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.98 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.832 167.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -163.09 -89.12 0.07 OUTLIER Glycine 0 N--CA 1.487 2.085 0 CA-C-N 119.058 0.844 . . . . 0.0 112.507 172.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 45.0 p30 -81.62 3.76 24.06 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 174.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -136.97 131.42 32.94 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 119.233 0.924 . . . . 0.0 111.033 -168.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.7 tp -86.14 113.02 21.85 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.446 1.098 . . . . 0.0 109.695 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.6 t -98.98 105.09 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -174.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -96.08 101.74 13.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -0.984 . . . . 0.0 109.997 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.5 m -91.63 103.96 16.49 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.585 0.754 . . . . 0.0 109.207 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -89.26 110.69 21.43 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.338 0.655 . . . . 0.0 110.194 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.1 t -112.79 93.96 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -94.71 114.65 26.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.632 -0.668 . . . . 0.0 111.31 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.317 0.4 OUTLIER 62.07 -62.55 0.1 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 174.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.83 43.41 0.5 Allowed Glycine 0 CA--C 1.551 2.293 0 CA-C-O 118.915 -0.936 . . . . 0.0 114.483 156.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.8 t -139.15 118.61 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 118.982 1.391 . . . . 0.0 107.761 -172.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.2 mp0 -93.68 144.52 25.32 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.81 121.19 10.96 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.208 0.528 . . . . 0.0 112.408 164.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -94.67 107.66 19.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.694 -0.629 . . . . 0.0 111.256 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -89.7 111.61 22.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.722 -0.611 . . . . 0.0 109.601 167.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.2 mt -101.09 114.06 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -172.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -105.81 122.7 46.63 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.673 0.789 . . . . 0.0 109.625 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -83.14 143.27 30.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 112.585 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -65.14 118.44 9.22 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.9 t0 . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -165.67 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.283 93.2 m-85 . . . . . 0 N--CA 1.502 2.137 0 N-CA-C 118.81 2.893 . . . . 0.0 118.81 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -73.77 72.37 1.51 Allowed 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 117.283 2.327 . . . . 0.0 117.283 -160.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.9 p -152.17 -176.36 5.64 Favored 'General case' 0 CA--C 1.572 1.821 0 CA-C-O 121.976 0.893 . . . . 0.0 112.852 178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.1 m -89.37 127.64 35.83 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.013 0.925 . . . . 0.0 110.788 176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -130.02 116.17 18.18 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.178 0.591 . . . . 0.0 109.416 -173.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -99.64 135.77 40.56 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 119.408 1.004 . . . . 0.0 111.944 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p -66.05 116.43 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -96.0 -50.73 4.74 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -144.2 111.25 5.81 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 119.977 1.262 . . . . 0.0 111.054 -172.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.2 m -96.18 101.34 12.98 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.858 0.863 . . . . 0.0 111.317 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -93.5 120.52 33.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.509 -0.744 . . . . 0.0 110.31 -172.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.264 28.5 t30 65.49 20.56 11.72 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -72.51 -40.17 67.04 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.64 -38.07 74.39 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 168.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -67.55 -46.75 71.85 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 119.91 1.232 . . . . 0.0 114.069 171.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -46.55 -56.32 6.2 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 161.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.4 mtp -65.82 -29.84 70.38 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 176.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.63 -50.96 71.43 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 120.241 1.382 . . . . 0.0 114.203 163.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -57.4 -32.1 66.51 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 165.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.0 mmt -64.44 -34.74 78.89 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 168.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.99 51.36 1.93 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 116.072 1.189 . . . . 0.0 116.072 -176.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -114.89 160.23 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-O 122.169 0.985 . . . . 0.0 112.408 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -56.72 145.95 27.32 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 172.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.274 0.1 OUTLIER -54.98 -47.22 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 175.057 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.28 -49.53 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 173.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -58.35 -45.66 87.75 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 170.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -44.27 -55.12 5.13 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 163.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -65.69 -46.66 78.18 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.5 mt -58.48 -47.53 83.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 169.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.24 -21.63 66.35 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 119.062 2.986 . . . . 0.0 119.062 178.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.08 93.64 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 165.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -130.49 68.09 1.47 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 119.577 1.081 . . . . 0.0 111.781 169.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -84.41 44.66 1.05 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 176.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 42.7 40.57 2.08 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -172.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -86.68 116.77 25.0 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.695 -1.253 . . . . 0.0 112.173 -161.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -111.2 118.01 34.77 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.718 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.7 mt -94.28 101.53 13.5 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 172.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 43.8 m -95.14 105.66 17.61 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.883 0.849 . . . . 0.0 108.731 170.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.9 mt -90.57 101.4 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -171.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 87.7 m -99.08 101.48 12.86 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -102.45 127.49 49.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.581 -0.7 . . . . 0.0 112.347 -167.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -79.94 -49.87 11.26 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 161.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.65 -90.92 0.08 OUTLIER Glycine 0 N--CA 1.486 1.97 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -70.12 -29.28 66.19 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 158.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -85.47 126.71 34.03 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-N 119.772 1.169 . . . . 0.0 112.105 169.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -117.83 125.39 50.46 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.482 1.113 . . . . 0.0 108.475 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.0 m -99.52 95.85 7.27 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 168.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.5 t -88.98 105.88 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -89.91 102.07 14.77 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -170.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -93.41 88.09 5.83 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.202 0.601 . . . . 0.0 109.53 -170.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.1 t -98.49 109.26 22.05 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.321 0.648 . . . . 0.0 110.798 -171.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.7 p -134.08 166.15 23.41 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -169.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.55 -26.32 61.25 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 117.838 2.533 . . . . 0.0 117.838 165.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -79.81 -52.34 8.04 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -160.91 163.22 32.07 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-N 119.33 0.968 . . . . 0.0 112.726 -177.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -110.39 118.83 37.35 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.387 0.675 . . . . 0.0 109.53 167.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.2 pt -131.41 133.08 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 CA-C-O 121.785 0.802 . . . . 0.0 111.879 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -98.77 99.24 10.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.605 0.762 . . . . 0.0 109.664 -175.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.35 99.67 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.417 -0.802 . . . . 0.0 109.868 -165.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 56.9 t -85.7 115.8 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 123.458 0.703 . . . . 0.0 109.319 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -134.35 140.68 46.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.829 -0.544 . . . . 0.0 111.769 173.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -92.95 140.06 29.88 Favored 'General case' 0 CA--C 1.565 1.528 0 O-C-N 121.896 -0.502 . . . . 0.0 110.865 163.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -56.92 131.8 50.73 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 176.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.35 -16.68 37.96 Favored Glycine 0 CA--C 1.553 2.437 0 N-CA-C 119.426 2.53 . . . . 0.0 119.426 -172.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.8 t -81.84 132.37 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-N 120.176 1.988 . . . . 0.0 110.408 -175.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.9 m -79.87 104.74 10.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.716 -0.615 . . . . 0.0 110.085 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -124.7 166.85 15.44 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-O 122.106 0.955 . . . . 0.0 112.405 -173.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -91.23 99.01 12.08 Favored 'General case' 0 CA--C 1.571 1.75 0 C-N-CA 123.362 0.665 . . . . 0.0 111.454 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -92.58 104.89 17.14 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.829 0.852 . . . . 0.0 110.174 175.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -95.64 125.86 40.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 112.025 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.7 mt -80.21 150.24 30.17 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.166 0.586 . . . . 0.0 112.425 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.38 44.98 0.16 Allowed 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -149.75 -59.54 0.2 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 124.769 1.228 . . . . 0.0 110.234 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.53 73.37 0.04 OUTLIER Glycine 0 N--CA 1.486 1.977 0 CA-C-N 118.935 0.789 . . . . 0.0 112.678 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 m -167.8 124.77 1.13 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 117.869 0.834 . . . . 0.0 109.959 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -102.08 125.98 48.91 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.852 0.861 . . . . 0.0 111.033 171.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.6 mt -117.83 123.36 45.72 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.607 0.763 . . . . 0.0 110.865 -175.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -102.77 118.79 37.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.102 -0.999 . . . . 0.0 110.85 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.43 -177.71 47.88 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 118.29 2.076 . . . . 0.0 118.29 -172.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.8 p -119.54 124.91 47.57 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 113.812 -1.194 . . . . 0.0 111.215 -167.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -83.46 126.01 32.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.977 -0.452 . . . . 0.0 111.419 163.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.8 m -120.42 135.06 55.16 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.196 0.598 . . . . 0.0 111.026 172.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.6 tp -89.15 106.83 18.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 111.466 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -98.52 -179.08 4.21 Favored 'General case' 0 CA--C 1.575 1.904 0 C-N-CA 123.895 0.878 . . . . 0.0 110.828 168.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.91 106.87 0.88 Allowed Glycine 0 N--CA 1.494 2.537 0 O-C-N 120.265 -1.522 . . . . 0.0 115.894 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.42 9.3 p30 59.4 13.53 3.25 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 119.558 3.17 . . . . 0.0 119.558 -166.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -137.22 125.51 23.25 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 120.293 1.406 . . . . 0.0 111.867 -169.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.9 mt -89.25 109.0 19.93 Favored 'General case' 0 CA--C 1.564 1.484 0 O-C-N 121.098 -1.001 . . . . 0.0 108.379 159.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.6 tt -96.8 115.54 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.526 -0.734 . . . . 0.0 110.103 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.58 104.35 2.58 Favored Glycine 0 N--CA 1.482 1.754 0 C-N-CA 123.875 0.75 . . . . 0.0 112.374 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -92.15 95.45 9.75 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -114.95 148.96 38.05 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.477 1.132 . . . . 0.0 112.876 -168.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -121.87 135.46 54.89 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.713 0.805 . . . . 0.0 109.456 166.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -75.5 104.85 6.24 Favored 'General case' 0 CA--C 1.562 1.414 0 O-C-N 121.084 -1.01 . . . . 0.0 111.845 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 t -61.94 -16.45 51.09 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 118.385 2.735 . . . . 0.0 118.385 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -70.19 -28.99 65.74 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 168.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . 0.25 3.1 p-10 -145.53 7.46 1.13 Allowed 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 119.436 3.125 . . . . 0.0 119.436 -177.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.11 -19.7 47.75 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 119.15 2.42 . . . . 0.0 119.15 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -73.81 139.98 45.51 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -169.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -74.12 141.1 45.64 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 tt -126.77 121.05 30.87 Favored 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 123.589 0.756 . . . . 0.0 109.538 168.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -100.15 110.13 22.4 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.2 m -96.92 131.23 43.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.564 -0.71 . . . . 0.0 110.193 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.8 t -129.45 99.67 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -104.31 105.77 16.02 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.144 0.978 . . . . 0.0 108.606 -172.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -126.4 137.94 53.49 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -162.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.1 mm -88.99 127.19 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.386 -0.821 . . . . 0.0 109.51 167.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 49.2 mm -104.18 -80.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 168.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -165.32 113.19 0.54 Allowed Glycine 0 N--CA 1.487 2.093 0 O-C-N 121.357 -0.839 . . . . 0.0 111.056 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.251 31.3 m-20 60.5 1.31 0.39 Allowed 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 -166.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -136.58 138.69 41.5 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 124.339 1.056 . . . . 0.0 111.071 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.3 tp -94.06 109.77 21.51 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 168.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.2 m -95.07 113.37 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . 0.28 0.1 OUTLIER -124.7 119.44 28.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.82 -1.175 . . . . 0.0 113.315 -175.561 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.4 m -107.65 123.87 49.14 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.166 0.986 . . . . 0.0 109.982 -167.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -105.81 111.74 24.52 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.2 t -108.42 102.45 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -104.61 81.09 1.74 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.305 -0.872 . . . . 0.0 110.602 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 63.63 73.58 0.44 Allowed 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 123.779 0.831 . . . . 0.0 112.624 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.97 -36.9 2.33 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 118.732 2.253 . . . . 0.0 118.732 -173.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.81 99.27 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 119.229 1.515 . . . . 0.0 112.663 -169.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -90.42 112.23 23.77 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 123.375 0.67 . . . . 0.0 112.085 -172.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.36 119.64 37.65 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.077 0.551 . . . . 0.0 112.195 176.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -107.34 105.65 15.69 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.016 0.526 . . . . 0.0 109.962 -174.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -91.02 115.15 27.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.41 -0.806 . . . . 0.0 108.963 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.4 mt -105.01 118.94 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -103.01 152.06 21.77 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.048 0.939 . . . . 0.0 111.421 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -101.72 152.68 20.56 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.715 -1.241 . . . . 0.0 111.723 169.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -66.22 105.44 1.41 Allowed 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 123.758 0.823 . . . . 0.0 112.689 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.6 t0 . . . . . 0 N--CA 1.487 1.397 0 C-N-CA 124.922 1.289 . . . . 0.0 114.251 -178.721 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.33 77.0 m-85 . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -70.55 76.9 0.58 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 120.229 1.377 . . . . 0.0 114.006 -172.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.548 ' HG ' ' NZ ' ' A' ' 130' ' ' LYS . 8.1 t -168.73 173.98 6.9 Favored 'General case' 0 CA--C 1.572 1.821 0 CA-C-O 122.622 1.201 . . . . 0.0 111.93 -165.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.9 m -90.96 133.61 35.14 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.268 -0.895 . . . . 0.0 110.353 171.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -132.2 101.18 5.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.948 -0.47 . . . . 0.0 110.068 -172.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -91.28 135.32 33.88 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.475 -0.766 . . . . 0.0 111.988 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -61.2 121.32 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -99.51 -45.2 5.89 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 117.416 -1.278 . . . . 0.0 114.223 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.57 116.34 1.26 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 120.293 1.406 . . . . 0.0 110.088 -169.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.1 p -100.32 105.41 16.93 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.539 0.736 . . . . 0.0 111.921 -177.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -90.43 126.04 35.77 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.192 0.597 . . . . 0.0 111.635 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.257 45.3 t30 60.1 26.29 15.65 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 117.681 2.474 . . . . 0.0 117.681 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -72.19 -42.84 65.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -60.13 -40.53 90.11 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 117.616 2.451 . . . . 0.0 117.616 171.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.74 -44.18 70.79 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 172.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -44.16 -57.71 3.27 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 158.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.2 mtt -57.0 -42.68 80.73 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 172.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -58.35 -43.92 88.54 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 168.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -59.79 -35.14 74.05 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 168.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 58.0 mtm -66.84 -37.73 85.05 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 170.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.77 59.39 0.45 Allowed Glycine 0 N--CA 1.487 2.089 0 C-N-CA 123.776 0.703 . . . . 0.0 114.745 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.4 p -129.31 136.95 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 122.278 1.037 . . . . 0.0 110.413 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -63.02 143.91 57.36 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.276 13.7 tt -51.03 -42.49 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -176.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.8 t -60.81 -50.36 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 119.59 1.086 . . . . 0.0 113.125 171.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -56.41 -42.33 77.83 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 167.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 57.4 mtm-85 -58.79 -47.05 86.08 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 169.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -59.12 -46.35 88.55 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 170.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.51 -47.75 80.42 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 171.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.09 -25.73 63.65 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.19 76.62 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-N 121.31 1.868 . . . . 0.0 115.043 156.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -78.82 59.42 2.57 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 171.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -97.03 -27.28 14.68 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -175.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.387 1.3 p-10 57.8 55.68 5.28 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -173.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.0 tp -80.17 121.43 25.57 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.419 1.104 . . . . 0.0 113.902 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -106.18 118.33 36.34 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.81 167.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.2 mt -97.4 101.01 12.45 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 51.7 m -94.41 109.5 21.36 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.998 -1.064 . . . . 0.0 109.421 171.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.2 mt -103.79 112.75 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -166.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 87.6 m -103.31 106.3 16.78 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -89.04 108.97 19.88 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.297 0.639 . . . . 0.0 111.948 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.7 70.76 6.71 Favored 'General case' 0 CA--C 1.572 1.809 0 O-C-N 121.587 -0.696 . . . . 0.0 110.486 166.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.99 -96.49 0.22 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 115.515 0.966 . . . . 0.0 115.515 -174.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -87.93 -23.19 23.97 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 169.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -88.85 111.36 21.96 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 121.046 1.748 . . . . 0.0 111.974 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -94.63 117.44 30.14 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.518 0.727 . . . . 0.0 109.181 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.6 m -93.83 97.99 10.77 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.9 t -92.82 105.46 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -86.34 101.79 13.42 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.178 0.591 . . . . 0.0 109.606 -176.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -90.85 97.55 11.25 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.234 0.614 . . . . 0.0 109.837 -172.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -110.54 102.83 11.39 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 122.991 0.516 . . . . 0.0 110.845 -175.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.8 p -140.31 -178.92 5.71 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.028 0.931 . . . . 0.0 111.72 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.86 -29.99 67.38 Favored 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 159.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -97.95 -17.62 19.11 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 174.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -130.07 142.07 50.65 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 121.382 1.901 . . . . 0.0 111.975 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -144.29 74.33 1.42 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.016 -1.052 . . . . 0.0 109.796 162.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.2 pt -143.07 130.16 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.283 -0.886 . . . . 0.0 112.007 -166.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.82 99.84 11.64 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.248 1.019 . . . . 0.0 111.559 172.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.9 t -91.42 98.28 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.174 -0.954 . . . . 0.0 109.19 -169.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.1 t -86.4 119.49 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 123.344 0.658 . . . . 0.0 109.312 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -140.64 133.42 28.97 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.328 0.585 . . . . 0.0 111.532 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -86.45 139.8 30.56 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 121.808 -0.557 . . . . 0.0 111.246 167.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.75 128.43 36.53 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.89 -11.48 59.77 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 119.642 2.617 . . . . 0.0 119.642 -172.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.2 t -85.59 133.01 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 120.43 2.115 . . . . 0.0 110.33 -175.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -77.4 114.11 15.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.508 -0.745 . . . . 0.0 111.466 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -138.56 163.05 33.03 Favored 'General case' 0 CA--C 1.572 1.791 0 C-N-CA 123.264 0.626 . . . . 0.0 112.607 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -85.89 111.17 19.96 Favored 'General case' 0 CA--C 1.57 1.727 0 O-C-N 121.515 -0.741 . . . . 0.0 111.752 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -102.4 156.15 17.78 Favored 'General case' 0 CA--C 1.572 1.796 0 CA-C-O 122.17 0.986 . . . . 0.0 112.678 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -127.18 149.41 49.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.4 -0.812 . . . . 0.0 111.532 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.4 mt -92.97 -113.28 0.1 Allowed 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 118.804 -0.617 . . . . 0.0 110.263 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -146.5 58.91 1.21 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 120.776 1.625 . . . . 0.0 112.718 170.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -159.9 -78.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.116 0.966 . . . . 0.0 108.456 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.18 76.57 0.06 OUTLIER Glycine 0 N--CA 1.481 1.667 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.7 m -147.4 122.22 9.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.731 -0.864 . . . . 0.0 109.212 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -97.96 116.55 30.41 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.403 0.681 . . . . 0.0 110.683 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 70.9 mt -115.48 106.01 13.47 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.46 0.704 . . . . 0.0 110.91 -170.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -82.62 118.73 23.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.41 -0.806 . . . . 0.0 111.743 174.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.56 -167.96 41.06 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 117.741 1.856 . . . . 0.0 117.741 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.8 p -128.22 124.92 37.92 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.675 -0.763 . . . . 0.0 111.534 -163.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -85.92 129.41 34.84 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 118.194 0.452 . . . . 0.0 111.361 161.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.8 t -122.83 137.39 54.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.721 -0.612 . . . . 0.0 111.79 173.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.8 tp -90.93 107.68 19.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.898 -1.126 . . . . 0.0 111.572 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -103.48 75.96 1.38 Allowed 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 121.512 0.672 . . . . 0.0 109.747 171.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.25 -102.54 0.95 Allowed Glycine 0 N--CA 1.491 2.35 0 O-C-N 121.38 -0.825 . . . . 0.0 115.137 -177.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -95.67 22.33 7.31 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -129.84 114.53 16.02 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.713 -1.242 . . . . 0.0 110.03 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.9 mt -84.03 104.68 14.3 Favored 'General case' 0 CA--C 1.564 1.481 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 161.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.1 tt -94.1 114.53 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.466 -0.771 . . . . 0.0 110.231 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -103.07 99.18 1.76 Allowed Glycine 0 N--CA 1.482 1.706 0 C-N-CA 123.689 0.661 . . . . 0.0 113.289 -174.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -90.5 92.75 9.0 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -120.27 134.64 55.22 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.18 0.592 . . . . 0.0 112.503 -168.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -115.68 145.08 43.06 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.514 0.725 . . . . 0.0 109.875 169.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -70.2 123.95 22.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.446 -1.409 . . . . 0.0 112.675 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.281 9.8 t -81.05 59.78 3.97 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 122.625 1.202 . . . . 0.0 113.824 169.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -168.12 -63.31 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.767 0 C-N-CA 125.916 1.686 . . . . 0.0 107.796 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -80.34 -38.72 30.0 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.146 1.535 . . . . 0.0 115.146 171.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.74 -31.17 9.04 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 117.359 1.704 . . . . 0.0 117.359 -158.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -65.86 143.21 57.6 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -165.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -69.13 129.63 40.43 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 175.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.5 tt -121.59 86.06 2.51 Favored 'General case' 0 CA--C 1.563 1.472 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 168.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -83.05 109.06 16.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.987 -1.07 . . . . 0.0 109.735 -167.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 m -111.89 111.38 22.29 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.84 -0.538 . . . . 0.0 110.085 -166.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.0 t -107.1 101.63 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.022 -1.049 . . . . 0.0 109.05 -175.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.4 mtm-85 -84.3 117.32 23.49 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.296 0.639 . . . . 0.0 110.887 174.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -147.76 135.07 20.59 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.816 -1.177 . . . . 0.0 113.347 -173.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 mp -85.14 113.95 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.135 -0.978 . . . . 0.0 108.381 177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.22 84.58 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.29 -84.41 0.73 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 114.728 0.651 . . . . 0.0 114.728 -173.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -103.52 -40.31 6.39 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -101.87 140.34 36.28 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 120.255 1.388 . . . . 0.0 113.096 -169.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.0 tp -76.73 111.34 12.14 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.834 0.853 . . . . 0.0 110.723 172.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 m -99.24 120.04 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -103.32 99.46 9.3 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.542 0.737 . . . . 0.0 109.377 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.4 m -94.18 112.02 23.79 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.301 0.64 . . . . 0.0 110.172 -171.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -90.09 133.3 34.94 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.669 0.788 . . . . 0.0 111.565 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.2 t -119.85 101.61 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 163.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -95.05 94.14 7.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.39 -0.818 . . . . 0.0 109.728 171.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.287 4.6 mm-40 70.35 -69.81 0.17 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -153.13 62.06 0.38 Allowed Glycine 0 N--CA 1.486 2.021 0 CA-C-O 119.784 -0.453 . . . . 0.0 113.683 165.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.5 p -144.58 113.59 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 117.77 0.785 . . . . 0.0 109.05 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -87.56 118.47 27.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.705 -0.622 . . . . 0.0 111.368 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -130.78 131.35 44.63 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 122.839 0.456 . . . . 0.0 111.686 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -115.46 118.02 32.01 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.435 -0.79 . . . . 0.0 111.169 -173.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -93.69 104.62 16.71 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 167.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.76 127.04 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -115.66 130.33 56.82 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.886 0.874 . . . . 0.0 110.264 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -78.61 143.98 35.92 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 121.77 0.795 . . . . 0.0 113.04 176.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.548 ' NZ ' ' HG ' ' A' ' 4' ' ' SER . 53.7 tptt -61.95 115.03 3.72 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 123.927 0.891 . . . . 0.0 112.769 171.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.2 t70 . . . . . 0 N--CA 1.489 1.476 0 C-N-CA 124.93 1.292 . . . . 0.0 112.345 -170.401 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 . . . . . 0 CA--C 1.581 2.149 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.6 90.06 8.23 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 119.799 -1.813 . . . . 0.0 114.03 -157.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.2 m -158.13 -175.22 5.22 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 124.499 1.12 . . . . 0.0 110.808 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.0 m -99.69 113.09 25.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.808 -1.182 . . . . 0.0 109.441 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -117.81 108.16 15.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.912 -0.493 . . . . 0.0 109.84 -170.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -93.26 140.51 29.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.269 -0.895 . . . . 0.0 112.31 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.4 p -63.75 116.52 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -98.66 -59.35 1.76 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.547 0.739 . . . . 0.0 111.798 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.411 ' C ' ' HG ' ' A' ' 11' ' ' SER . 14.9 ptm180 -141.28 166.08 25.76 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.837 0.827 . . . . 0.0 110.846 177.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.411 ' HG ' ' C ' ' A' ' 10' ' ' ARG . 67.4 m -153.71 126.41 8.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 119.236 -2.165 . . . . 0.0 112.142 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -100.8 121.82 42.35 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.741 0.816 . . . . 0.0 109.932 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.267 14.0 t30 65.29 13.57 8.86 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 171.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -63.59 -40.32 96.64 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.21 -27.04 68.71 Favored 'General case' 0 CA--C 1.577 2.014 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 169.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -73.92 -49.44 24.76 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 120.32 1.418 . . . . 0.0 113.8 165.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -46.8 -51.45 16.41 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 166.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -40.73 76.01 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 166.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -59.89 -45.9 91.04 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 168.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -54.59 -38.44 66.74 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 167.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.6 mtm -68.59 -21.7 64.5 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 168.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.12 49.21 1.77 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 116.212 1.245 . . . . 0.0 116.212 175.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.65 151.9 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 118.673 1.236 . . . . 0.0 113.614 -177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -63.08 144.59 56.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.283 13.2 tt -52.66 -45.13 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.3 t -55.5 -52.31 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 124.023 0.929 . . . . 0.0 113.457 168.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -61.56 -46.11 91.27 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 176.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.7 ptt85 -69.68 -28.81 66.17 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 117.975 2.584 . . . . 0.0 117.975 171.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -62.5 -49.1 76.69 Favored 'General case' 0 CA--C 1.572 1.807 0 CA-C-N 120.09 1.314 . . . . 0.0 114.302 161.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.28 -59.89 4.69 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 170.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.08 -16.79 20.94 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 118.915 2.931 . . . . 0.0 118.915 175.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.05 -86.49 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 117.693 -1.146 . . . . 0.0 112.701 159.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -106.4 48.93 0.82 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 121.814 2.097 . . . . 0.0 115.21 -171.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.0 54.27 2.7 Favored 'General case' 0 CA--C 1.576 1.977 0 O-C-N 120.765 -1.209 . . . . 0.0 113.869 166.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 50.7 50.8 18.24 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 117.563 2.431 . . . . 0.0 117.563 171.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -87.0 124.02 32.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.787 -1.196 . . . . 0.0 113.708 -169.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -119.75 121.41 39.11 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.086 0.954 . . . . 0.0 110.406 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.4 mt -91.44 102.19 14.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.553 -0.717 . . . . 0.0 109.301 176.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 87.0 m -95.21 103.5 15.36 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.4 mt -101.67 128.37 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -167.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.3 p -128.99 122.34 29.9 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 171.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -94.33 131.95 39.43 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.823 0.82 . . . . 0.0 111.251 168.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -97.72 36.86 1.45 Allowed 'General case' 0 CA--C 1.582 2.2 0 C-N-CA 124.603 1.161 . . . . 0.0 113.528 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.79 92.06 0.23 Allowed Glycine 0 N--CA 1.492 2.413 0 O-C-N 120.196 -1.565 . . . . 0.0 113.536 -168.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.279 16.8 t-20 71.58 -61.18 0.5 Allowed 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -74.76 133.65 41.95 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -172.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -111.26 134.24 53.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.492 -0.755 . . . . 0.0 112.132 -173.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.2 m -107.16 113.54 27.04 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 161.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.4 t -110.53 104.87 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -81.66 103.9 11.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 110.189 175.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -90.39 96.26 10.57 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.8 t -102.27 117.05 33.92 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.361 0.664 . . . . 0.0 111.274 -170.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.9 p -143.26 164.81 29.2 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.683 0.754 . . . . 0.0 112.903 -173.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.07 -25.51 65.44 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 159.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -73.03 -50.28 23.93 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -162.88 153.87 17.13 Favored 'General case' 0 CA--C 1.572 1.813 0 C-N-CA 124.408 1.083 . . . . 0.0 111.828 -171.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -129.87 104.14 7.21 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.517 -0.74 . . . . 0.0 109.128 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.28 142.13 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.48 -0.762 . . . . 0.0 112.15 -170.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -89.2 114.65 26.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.578 -0.701 . . . . 0.0 112.614 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.9 t -96.82 102.54 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.39 124.48 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 123.065 0.546 . . . . 0.0 109.598 -175.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -146.32 139.1 25.46 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.238 0.615 . . . . 0.0 111.344 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -97.65 142.37 29.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.26 164.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.74 112.36 3.67 Favored 'General case' 0 CA--C 1.566 1.571 0 O-C-N 121.584 -0.697 . . . . 0.0 112.617 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.56 -18.05 58.14 Favored Glycine 0 CA--C 1.558 2.723 0 N-CA-C 119.488 2.555 . . . . 0.0 119.488 -163.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 65.3 t -94.77 112.65 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 120.453 2.127 . . . . 0.0 109.039 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 t -73.07 139.48 46.56 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -131.54 166.81 20.54 Favored 'General case' 0 CA--C 1.574 1.866 0 C-N-CA 124.295 1.038 . . . . 0.0 112.832 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -93.1 120.71 33.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.433 -0.792 . . . . 0.0 110.543 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -119.92 123.27 43.15 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.345 0.658 . . . . 0.0 111.8 -176.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -81.48 127.17 32.53 Favored 'General case' 0 CA--C 1.566 1.584 0 O-C-N 121.329 -0.857 . . . . 0.0 109.703 161.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 57.3 mt -63.36 177.59 0.64 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 168.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.86 35.31 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 118.341 2.719 . . . . 0.0 118.341 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -154.6 -82.7 0.07 Allowed 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.753 1.221 . . . . 0.0 108.951 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.0 74.17 0.09 OUTLIER Glycine 0 N--CA 1.483 1.81 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 55.5 m -152.63 110.36 3.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.91 -0.759 . . . . 0.0 109.301 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -84.84 115.12 22.57 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-O 122.066 0.936 . . . . 0.0 112.224 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.2 mt -107.7 152.24 24.6 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 125.015 1.326 . . . . 0.0 111.442 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -116.26 111.39 20.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.042 -1.036 . . . . 0.0 109.795 174.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.24 -174.99 38.78 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 114.667 0.627 . . . . 0.0 114.667 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.9 m -117.25 -58.5 2.04 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -163.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . 0.272 69.6 m95 76.46 91.3 0.07 Allowed 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.488 1.115 . . . . 0.0 111.284 -153.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.2 m -105.37 127.88 53.2 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.261 0.624 . . . . 0.0 110.731 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.1 tp -78.53 102.64 8.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.0 111.158 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -81.54 -58.06 3.19 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.69 -96.21 1.12 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 160.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -102.34 57.21 0.79 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 117.774 0.787 . . . . 0.0 110.878 154.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -147.53 111.9 5.24 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -173.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.7 mt -86.4 101.86 13.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.582 -0.698 . . . . 0.0 109.746 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.8 tt -88.77 107.28 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.262 1.029 . . . . 0.0 110.638 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.73 93.14 1.72 Allowed Glycine 0 N--CA 1.48 1.592 0 C-N-CA 123.63 0.633 . . . . 0.0 112.954 174.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -86.75 92.44 8.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -112.07 108.31 17.56 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.352 0.661 . . . . 0.0 111.088 -165.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -89.97 129.75 36.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.972 -1.08 . . . . 0.0 110.851 177.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -61.14 135.66 57.83 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.7 p -64.32 -64.0 0.99 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 161.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -86.94 72.67 10.07 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 121.526 -0.734 . . . . 0.0 111.038 171.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 171.11 -39.32 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 126.527 1.931 . . . . 0.0 112.627 168.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 70.38 22.69 77.7 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 118.491 2.156 . . . . 0.0 118.491 -164.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -121.83 157.89 30.09 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.482 1.134 . . . . 0.0 113.394 -169.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -84.97 124.97 32.29 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -166.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.15 111.77 20.72 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.02 0.928 . . . . 0.0 108.717 170.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -103.65 111.99 24.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.301 -0.874 . . . . 0.0 108.883 -173.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.4 m -111.03 104.06 12.59 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 119.771 1.169 . . . . 0.0 110.828 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.7 t -90.25 104.06 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.13 -0.981 . . . . 0.0 108.62 177.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.5 118.86 24.57 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.584 0.754 . . . . 0.0 110.381 171.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -149.4 147.64 28.52 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 119.511 1.051 . . . . 0.0 113.524 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 mp -93.63 123.53 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.969 -1.082 . . . . 0.0 109.261 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 44.4 mm -103.5 92.11 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 170.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.11 -97.58 1.16 Allowed Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.339 -0.851 . . . . 0.0 114.176 -173.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -130.4 49.3 2.31 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 121.897 0.856 . . . . 0.0 111.773 166.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -144.25 116.68 8.56 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 124.015 0.926 . . . . 0.0 108.581 -173.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.8 tp -89.0 115.18 26.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.694 -0.629 . . . . 0.0 110.621 -173.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.4 m -105.56 121.09 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -98.24 108.57 21.3 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.732 0.813 . . . . 0.0 109.914 171.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.4 m -91.0 98.51 11.82 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -90.51 114.07 26.19 Favored 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 124.395 1.078 . . . . 0.0 111.349 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.56 105.91 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-N 119.203 0.91 . . . . 0.0 108.576 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -108.65 114.41 28.2 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 118.917 0.78 . . . . 0.0 109.774 167.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 53.66 50.21 17.63 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.21 -26.41 4.43 Favored Glycine 0 CA--C 1.554 2.472 0 N-CA-C 119.296 2.479 . . . . 0.0 119.296 -168.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.9 t -83.59 104.38 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 120.262 2.031 . . . . 0.0 109.928 -170.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -87.37 132.26 34.02 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -130.9 121.93 26.09 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.671 0.789 . . . . 0.0 111.717 171.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -101.0 106.09 17.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.445 -0.784 . . . . 0.0 110.948 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -93.94 125.52 38.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.794 -0.566 . . . . 0.0 111.47 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.8 mt -116.81 116.84 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -165.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -113.46 130.23 56.37 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.028 0.931 . . . . 0.0 110.445 -172.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -82.77 140.7 32.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.904 . . . . 0.0 112.054 174.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -62.77 107.19 0.92 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.554 -0.716 . . . . 0.0 111.518 162.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -162.487 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.3 92.6 m-85 . . . . . 0 N--CA 1.501 2.097 0 CA-C-O 122.308 1.051 . . . . 0.0 113.154 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.27 17.6 m-20 66.79 50.76 1.09 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.9 t -157.28 -170.02 3.11 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 121.197 -0.94 . . . . 0.0 111.543 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.0 m -97.59 116.85 30.61 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.986 -1.071 . . . . 0.0 109.803 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -116.76 105.34 12.28 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.338 0.655 . . . . 0.0 109.538 -169.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -93.72 132.66 37.86 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.45 0.7 . . . . 0.0 110.86 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 p -57.07 116.56 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.952 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.46 -49.7 5.79 Favored 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 124.411 1.084 . . . . 0.0 112.913 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -149.71 116.62 5.94 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.529 1.059 . . . . 0.0 110.744 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.9 p -97.29 100.67 12.13 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.686 0.794 . . . . 0.0 111.564 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -95.14 125.37 39.74 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.421 0.688 . . . . 0.0 110.665 -169.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.268 42.7 t30 63.56 25.69 14.47 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -73.52 -45.73 52.03 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 115.605 1.705 . . . . 0.0 115.605 -173.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -61.41 -27.8 68.8 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -74.42 -46.28 41.12 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.966 1.257 . . . . 0.0 114.092 165.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -49.48 -52.71 27.42 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 164.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -31.2 72.32 Favored 'General case' 0 CA--C 1.574 1.888 0 N-CA-C 116.313 1.968 . . . . 0.0 116.313 172.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.47 -37.89 86.11 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 121.16 1.8 . . . . 0.0 115.476 163.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -60.05 -39.47 86.07 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 165.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 83.0 mmm -60.68 -45.68 93.25 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 165.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.78 51.42 0.57 Allowed Glycine 0 N--CA 1.484 1.878 0 C-N-CA 124.294 0.95 . . . . 0.0 114.8 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.4 m -108.61 142.4 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.479 1.133 . . . . 0.0 112.776 -178.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -66.5 154.89 39.14 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.305 0.1 OUTLIER -43.77 -56.1 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 -173.373 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.83 -51.55 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 CA-C-N 119.563 1.074 . . . . 0.0 113.082 175.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -55.67 -42.07 74.58 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 170.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.1 ttp85 -60.72 -50.63 72.72 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 169.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -60.53 -43.45 97.13 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 169.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.61 -38.72 88.68 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 167.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.68 -41.5 96.01 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 169.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.26 -51.42 67.79 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 162.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -96.61 58.89 1.74 Allowed 'General case' 0 CA--C 1.572 1.82 0 CA-C-N 119.328 0.967 . . . . 0.0 111.965 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -96.57 -16.33 21.12 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.696 2.109 . . . . 0.0 116.696 -170.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 55.31 57.31 5.55 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 119.878 1.217 . . . . 0.0 114.162 -167.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.4 tp -80.73 117.42 21.39 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 121.969 0.89 . . . . 0.0 111.301 -176.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -122.01 109.52 14.68 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.011 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 84.3 mt -94.89 106.68 18.69 Favored 'General case' 0 CA--C 1.563 1.442 0 C-N-CA 123.31 0.644 . . . . 0.0 110.227 -174.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.0 m -92.11 109.05 20.4 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.268 -0.895 . . . . 0.0 109.894 170.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.4 mt -101.5 133.99 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.739 0 C-N-CA 124.409 1.084 . . . . 0.0 108.53 -170.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t -153.02 125.67 8.27 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.939 -1.101 . . . . 0.0 111.729 171.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -87.29 116.94 25.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.129 -0.982 . . . . 0.0 112.08 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -103.11 75.29 1.36 Allowed 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.413 0.685 . . . . 0.0 110.256 171.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.68 75.29 0.43 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 115.947 1.139 . . . . 0.0 115.947 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.276 10.9 t-20 70.28 -48.67 0.64 Allowed 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -167.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -68.94 114.14 6.97 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 119.313 0.96 . . . . 0.0 113.352 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -88.43 120.48 29.85 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.154 0.582 . . . . 0.0 111.181 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.1 m -89.39 109.34 20.26 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 167.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.0 t -109.71 109.01 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -82.89 106.06 14.4 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -85.57 84.94 7.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.999 0.52 . . . . 0.0 109.906 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 t -85.84 111.06 19.84 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.564 0.345 . . . . 0.0 110.848 -176.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.2 p -142.93 159.85 41.46 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -169.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.34 -27.75 56.86 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 118.321 2.711 . . . . 0.0 118.321 169.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -74.24 -46.86 38.94 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 164.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.7 ptt-85 -167.02 150.76 6.71 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.772 0.829 . . . . 0.0 112.171 -170.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.65 96.62 6.08 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.585 0.754 . . . . 0.0 110.878 171.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.6 pt -119.59 127.47 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.569 -0.707 . . . . 0.0 112.416 -169.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.38 112.13 13.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.542 -0.724 . . . . 0.0 112.166 170.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.5 t -104.75 102.15 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.24 116.79 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -133.14 135.34 45.12 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.438 0.637 . . . . 0.0 111.53 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -80.61 136.27 36.2 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.595 -0.69 . . . . 0.0 111.328 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 57.1 mt -60.06 125.24 22.88 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -176.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.18 -5.7 70.87 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 119.708 2.643 . . . . 0.0 119.708 -172.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.4 t -88.75 133.0 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 120.122 1.961 . . . . 0.0 109.736 -176.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.7 p -72.92 110.26 7.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.65 -0.657 . . . . 0.0 111.947 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -126.83 163.02 24.52 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 124.013 0.925 . . . . 0.0 112.039 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -84.32 106.54 16.01 Favored 'General case' 0 CA--C 1.569 1.689 0 O-C-N 121.297 -0.877 . . . . 0.0 111.586 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -102.44 167.86 9.68 Favored 'General case' 0 CA--C 1.571 1.759 0 C-N-CA 124.749 1.22 . . . . 0.0 112.445 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -146.96 131.53 17.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.705 -1.247 . . . . 0.0 111.575 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.9 mt -84.83 62.77 7.63 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.271 . . 61.46 -36.49 0.11 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 120.409 3.485 . . . . 0.0 120.409 175.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -86.91 -85.89 0.16 Allowed 'General case' 0 CA--C 1.565 1.555 0 CA-C-N 120.052 1.297 . . . . 0.0 110.2 177.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.61 74.5 0.1 OUTLIER Glycine 0 N--CA 1.482 1.747 0 O-C-N 121.587 -0.696 . . . . 0.0 113.536 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.5 m -146.9 123.97 11.42 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.519 -0.989 . . . . 0.0 109.985 162.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -78.42 130.84 36.56 Favored 'General case' 0 CA--C 1.566 1.587 0 CA-C-O 122.155 0.978 . . . . 0.0 112.435 173.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.6 mt -131.61 111.52 11.8 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.242 -165.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -86.61 114.5 23.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.095 -1.003 . . . . 0.0 111.052 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.37 178.63 47.91 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 116.399 1.32 . . . . 0.0 116.399 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.1 p -92.21 165.31 13.19 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.27 1.033 . . . . 0.0 113.494 -174.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -127.23 108.83 11.22 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 143.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.4 m -100.36 137.48 38.72 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.49 0.716 . . . . 0.0 110.949 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.7 tp -85.3 94.75 9.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.215 -0.928 . . . . 0.0 111.398 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -84.49 79.18 9.66 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-O 121.836 0.827 . . . . 0.0 110.866 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.55 -94.58 0.95 Allowed Glycine 0 N--CA 1.489 2.222 0 O-C-N 121.722 -0.612 . . . . 0.0 113.908 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -126.5 63.62 1.27 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.822 0.82 . . . . 0.0 109.695 163.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -152.45 125.19 8.39 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.7 mt -90.74 105.12 17.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.56 -1.338 . . . . 0.0 109.571 171.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.1 tt -105.18 125.68 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 123.743 0.817 . . . . 0.0 110.616 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.65 118.53 1.99 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 115.58 0.992 . . . . 0.0 115.58 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -95.27 99.91 11.79 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.215 0.606 . . . . 0.0 110.229 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -107.62 107.25 17.98 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -167.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -90.48 136.58 32.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.377 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -75.54 124.86 27.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.999 -1.063 . . . . 0.0 113.239 -173.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.5 p -80.8 62.7 4.93 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 122.332 1.063 . . . . 0.0 112.723 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.4 t0 171.85 -41.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 126.732 2.013 . . . . 0.0 110.283 -166.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -121.49 -18.47 7.24 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -175.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.08 -34.91 3.64 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 118.516 2.166 . . . . 0.0 118.516 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -69.89 139.94 53.08 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -166.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -81.79 128.06 33.62 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.8 tt -106.41 85.62 2.21 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.253 8.5 p30 -81.11 110.36 16.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.334 -0.854 . . . . 0.0 110.803 -173.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.9 m -114.18 112.18 22.75 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.916 -164.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.3 t -102.39 103.86 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.1 mtm180 -85.68 120.64 27.34 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.611 -0.681 . . . . 0.0 110.211 164.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.74 157.92 43.77 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.2 mm -94.31 118.14 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.661 -1.274 . . . . 0.0 109.818 -175.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.2 tt -88.76 71.02 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.14 0.971 . . . . 0.0 111.339 171.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.68 -79.22 0.97 Allowed Glycine 0 N--CA 1.491 2.332 0 O-C-N 120.704 -1.248 . . . . 0.0 114.874 -172.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -107.67 -33.64 7.23 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -93.84 146.22 24.05 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 120.482 1.492 . . . . 0.0 112.82 -174.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.3 tp -86.9 115.87 24.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 110.79 174.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 19.6 m -98.03 115.83 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.354 -0.841 . . . . 0.0 109.752 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -97.39 101.73 13.33 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 171.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.1 m -95.03 105.87 17.82 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.216 0.607 . . . . 0.0 109.558 -176.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -92.84 113.83 26.22 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 124.159 0.984 . . . . 0.0 109.505 -177.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.5 t -113.28 112.64 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -123.11 94.42 4.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.691 -0.63 . . . . 0.0 110.059 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 50.9 55.21 9.9 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 103.26 -49.87 0.93 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 117.094 1.598 . . . . 0.0 117.094 -169.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.1 p -76.45 113.4 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 119.211 1.506 . . . . 0.0 113.151 -165.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -92.18 116.89 29.34 Favored 'General case' 0 CA--C 1.563 1.446 0 O-C-N 121.91 -0.494 . . . . 0.0 111.155 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.42 139.76 48.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.914 -0.491 . . . . 0.0 111.734 163.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -120.27 110.31 16.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.886 . . . . 0.0 110.467 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -89.19 108.47 19.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.62 -0.675 . . . . 0.0 110.458 164.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.7 mp -90.22 120.89 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -110.53 131.82 54.72 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 124.05 0.94 . . . . 0.0 110.116 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -90.51 149.02 22.36 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-O 121.864 0.84 . . . . 0.0 111.817 174.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -68.25 106.87 2.59 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 112.035 173.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.046 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -75.36 77.25 2.44 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 -171.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.8 t -148.14 -177.46 5.76 Favored 'General case' 0 CA--C 1.574 1.891 0 CA-C-O 122.389 1.09 . . . . 0.0 111.266 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -95.19 115.87 27.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.126 -0.984 . . . . 0.0 109.667 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -117.37 103.72 10.41 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.97 0.508 . . . . 0.0 110.402 -169.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -86.71 135.69 33.29 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 123.539 0.735 . . . . 0.0 111.998 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.2 p -63.54 119.18 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.338 -0.851 . . . . 0.0 113.228 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -103.77 -53.2 2.81 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 124.021 0.929 . . . . 0.0 113.084 -173.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -149.05 85.54 1.47 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 119.212 0.915 . . . . 0.0 111.095 -172.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.4 p -73.32 120.2 18.61 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 178.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -104.28 115.22 30.02 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 123.544 0.737 . . . . 0.0 109.831 -169.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.1 t30 62.05 17.7 9.31 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 118.116 2.635 . . . . 0.0 118.116 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -75.85 -35.83 59.8 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -168.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.95 -26.17 68.03 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 162.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -71.36 -47.49 56.03 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 119.917 1.235 . . . . 0.0 114.245 166.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -43.9 -50.68 7.97 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 160.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.7 mtt -64.84 -32.98 74.93 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 172.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.42 -43.41 93.05 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 120.897 1.681 . . . . 0.0 115.326 162.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -62.09 -34.73 76.86 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 169.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 22.1 mmt -60.3 -30.28 69.39 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 164.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.94 50.41 3.29 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 115.612 1.005 . . . . 0.0 115.612 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.3 m -89.8 160.63 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 121.984 0.897 . . . . 0.0 113.208 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -70.86 154.75 41.55 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 165.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.269 14.7 tt -59.14 -36.87 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.11 -56.0 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-N 119.558 1.072 . . . . 0.0 112.922 172.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -65.19 -28.78 69.63 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 116.788 2.144 . . . . 0.0 116.788 172.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.5 ttp85 -58.9 -42.23 89.09 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 117.27 2.322 . . . . 0.0 117.27 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.5 OUTLIER -77.36 -48.24 17.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 162.343 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.84 -51.33 62.66 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -175.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.19 -37.04 85.64 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 173.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.71 -51.42 65.05 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 168.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -100.12 47.76 0.93 Allowed 'General case' 0 CA--C 1.574 1.881 0 CA-C-N 118.954 0.797 . . . . 0.0 112.703 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -83.99 16.27 2.96 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -169.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 53.44 50.19 17.94 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.164 -1.585 . . . . 0.0 115.136 -170.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.2 tp -80.23 120.65 24.61 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 121.88 0.847 . . . . 0.0 112.873 -171.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -111.87 121.06 44.0 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.287 172.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.6 mt -101.9 102.54 13.12 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.969 0.508 . . . . 0.0 109.966 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.2 m -89.86 108.82 19.93 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.328 -0.858 . . . . 0.0 109.231 169.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.0 mt -101.57 128.9 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -172.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 t -145.31 133.65 21.78 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.894 -1.129 . . . . 0.0 111.56 171.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -99.95 118.87 37.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.194 -0.942 . . . . 0.0 112.3 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -100.81 71.2 1.44 Allowed 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 123.137 0.575 . . . . 0.0 110.636 169.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 62.39 77.33 0.21 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 116.552 1.381 . . . . 0.0 116.552 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.278 7.1 t30 72.21 -24.72 0.18 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -170.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -90.0 109.62 20.64 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 119.657 1.117 . . . . 0.0 111.901 172.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -83.04 118.01 23.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.516 -0.74 . . . . 0.0 111.161 169.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.6 m -86.23 107.55 17.97 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 164.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.07 112.67 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -87.24 111.36 20.94 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.286 0.634 . . . . 0.0 110.351 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -89.99 89.46 7.72 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.289 0.635 . . . . 0.0 109.467 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.7 m -97.4 107.7 20.27 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.8 p -145.84 174.0 11.62 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.02 0.914 . . . . 0.0 113.23 -171.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.85 -30.32 65.69 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 118.432 2.753 . . . . 0.0 118.432 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.2 -31.64 30.24 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 168.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -159.24 155.27 26.7 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 119.926 1.239 . . . . 0.0 113.357 -159.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -134.64 99.88 4.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.068 -1.02 . . . . 0.0 108.748 165.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.6 pt -132.22 129.75 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.854 -0.529 . . . . 0.0 111.704 -169.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.13 109.66 19.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.203 -0.936 . . . . 0.0 111.762 174.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.8 t -100.43 107.8 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -175.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -92.36 109.99 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -120.26 129.03 53.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.856 -0.528 . . . . 0.0 111.203 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -80.63 130.87 35.36 Favored 'General case' 0 CA--C 1.562 1.425 0 O-C-N 121.666 -0.646 . . . . 0.0 111.117 168.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.3 mt -61.45 124.22 20.03 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.72 -17.45 58.58 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 119.354 2.502 . . . . 0.0 119.354 -166.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.5 t -89.46 134.93 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-N 120.768 2.284 . . . . 0.0 110.41 -176.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -76.87 116.43 17.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.579 -0.701 . . . . 0.0 112.594 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -135.68 159.2 42.38 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 123.651 0.78 . . . . 0.0 111.297 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.03 94.29 7.48 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 121.306 -0.871 . . . . 0.0 112.404 -172.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -89.39 145.76 25.12 Favored 'General case' 0 CA--C 1.569 1.701 0 O-C-N 121.499 -0.751 . . . . 0.0 112.458 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -128.33 126.01 39.89 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.428 -0.795 . . . . 0.0 110.832 -174.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.7 mt -94.65 74.1 3.7 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -173.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.32 . . 65.7 -61.52 0.26 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -67.63 -18.24 64.89 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 119.141 3.015 . . . . 0.0 119.141 174.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.89 31.35 5.73 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 117.515 1.766 . . . . 0.0 117.515 -163.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.1 m -81.45 99.07 8.54 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.129 0.965 . . . . 0.0 109.176 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -85.72 99.39 11.3 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -160.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.6 mt -112.55 113.87 26.24 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.787 0.835 . . . . 0.0 110.832 -167.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -97.22 123.5 41.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.944 . . . . 0.0 111.336 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.71 179.76 46.4 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 118.061 1.984 . . . . 0.0 118.061 -169.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 80.7 p -114.32 134.03 55.25 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.013 -1.093 . . . . 0.0 111.357 -169.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -89.85 119.54 30.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.852 . . . . 0.0 109.974 162.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.6 m -117.17 125.71 51.63 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.175 0.59 . . . . 0.0 110.997 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 tp -91.48 100.22 13.02 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.263 0.625 . . . . 0.0 111.243 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.86 68.79 2.06 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.456 0.703 . . . . 0.0 111.801 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.19 69.23 1.42 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 116.208 1.243 . . . . 0.0 116.208 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.256 1.1 t30 59.46 29.08 18.6 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 -168.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -138.01 111.66 8.2 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.4 mt -95.45 105.1 17.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.488 -0.758 . . . . 0.0 109.72 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.5 tt -95.02 121.12 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.978 0.894 . . . . 0.0 109.807 173.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.8 101.95 2.83 Favored Glycine 0 N--CA 1.479 1.557 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.467 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -91.83 96.44 10.41 Favored 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -121.3 149.45 42.88 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.163 0.982 . . . . 0.0 112.201 -168.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -121.77 139.56 53.44 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 121.857 0.837 . . . . 0.0 109.669 167.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.7 mmm-85 -61.8 115.69 4.21 Favored 'General case' 0 CA--C 1.562 1.427 0 O-C-N 121.451 -0.781 . . . . 0.0 112.889 166.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.8 p -60.22 -55.97 27.22 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 169.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -83.59 55.03 3.05 Favored 'General case' 0 CA--C 1.578 2.036 0 O-C-N 121.58 -0.7 . . . . 0.0 112.375 171.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -175.32 -35.7 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 172.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.81 21.23 77.03 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 118.588 2.195 . . . . 0.0 118.588 -165.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -119.59 145.98 45.92 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.484 1.142 . . . . 0.0 113.154 -168.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.26 135.99 34.11 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -168.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.6 tt -123.8 130.78 53.16 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.612 1.165 . . . . 0.0 110.625 174.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -111.93 116.16 30.16 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.6 m -109.5 102.71 11.55 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 120.649 1.568 . . . . 0.0 110.493 171.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.8 t -102.59 90.91 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -174.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -99.58 137.22 38.38 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.336 1.065 . . . . 0.0 113.071 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -157.89 154.03 27.25 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.89 -174.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.5 mm -93.69 108.74 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.436 -0.79 . . . . 0.0 109.453 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.254 16.4 tt -86.29 71.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 122.152 0.977 . . . . 0.0 111.234 172.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.46 -84.92 0.95 Allowed Glycine 0 N--CA 1.489 2.228 0 O-C-N 121.012 -1.055 . . . . 0.0 114.56 -174.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -129.72 65.1 1.49 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 122.665 0.386 . . . . 0.0 110.044 167.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -164.36 125.37 2.16 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.424 0.69 . . . . 0.0 110.009 170.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.1 tp -83.22 102.81 12.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.609 -0.682 . . . . 0.0 109.197 171.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.4 m -91.7 98.45 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -96.17 95.3 8.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.095 -1.003 . . . . 0.0 110.757 -170.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.496 ' HG1' ' NZ ' ' A' ' 125' ' ' LYS . 38.9 m -89.6 102.58 15.26 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.236 0.614 . . . . 0.0 111.184 -166.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -90.24 119.78 30.84 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.745 0.818 . . . . 0.0 110.85 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.8 t -120.2 104.61 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -113.41 118.27 34.08 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.094 0.557 . . . . 0.0 110.657 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.28 53.0 mt-10 64.9 -79.33 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 123.834 0.854 . . . . 0.0 112.829 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -151.3 58.25 0.43 Allowed Glycine 0 N--CA 1.487 2.051 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.993 157.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.2 p -133.79 112.79 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 118.34 1.07 . . . . 0.0 109.834 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -89.64 124.5 34.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.476 -0.765 . . . . 0.0 111.264 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.24 127.14 20.68 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 170.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.496 ' NZ ' ' HG1' ' A' ' 116' ' ' THR . 41.5 mttp -98.68 121.71 40.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.926 . . . . 0.0 111.535 176.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -85.75 106.98 17.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.319 157.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.7 mt -96.6 115.26 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -176.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -111.3 134.15 53.1 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 122.985 0.514 . . . . 0.0 111.184 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -94.7 147.07 23.7 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-O 121.74 0.781 . . . . 0.0 112.417 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -72.84 116.1 12.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.425 -0.797 . . . . 0.0 112.312 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -172.787 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.264 0 CA-C-O 121.527 0.679 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.302 96.4 m-85 73.82 -54.97 0.68 Allowed 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 174.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -76.84 82.45 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.832 1.197 . . . . 0.0 112.847 -171.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.9 m -170.59 172.85 5.71 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 124.86 1.264 . . . . 0.0 110.832 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.6 m -83.63 113.93 21.19 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.089 -1.007 . . . . 0.0 111.217 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -118.04 113.76 22.11 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.547 0.739 . . . . 0.0 109.914 -175.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -108.33 140.71 41.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.509 -0.745 . . . . 0.0 112.398 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.8 p -62.35 119.19 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -91.35 -54.26 3.99 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 123.765 0.826 . . . . 0.0 112.641 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -148.22 122.85 9.83 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 118.679 0.672 . . . . 0.0 110.226 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.9 m -108.83 115.06 29.36 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.466 0.706 . . . . 0.0 110.843 -172.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -110.99 111.86 23.28 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -161.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.281 12.5 t30 67.07 19.65 10.46 Favored 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 117.573 2.435 . . . . 0.0 117.573 -174.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -72.56 -38.4 67.96 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.48 -29.01 69.7 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 165.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -72.24 -53.3 12.93 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 119.551 1.069 . . . . 0.0 113.595 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -42.82 -53.93 4.38 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 162.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.9 mtt -65.45 -27.13 68.29 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 116.755 2.132 . . . . 0.0 116.755 172.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -64.4 -39.87 94.68 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 166.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -63.17 -32.3 73.66 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 165.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.6 mtm -73.94 -14.35 61.03 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 169.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.11 56.49 2.7 Favored Glycine 0 N--CA 1.487 2.039 0 CA-C-N 120.118 1.327 . . . . 0.0 115.824 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.261 6.0 p -125.35 142.47 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-O 121.795 0.807 . . . . 0.0 112.614 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -62.39 146.2 51.95 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -172.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.288 0.0 OUTLIER -44.26 -46.89 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 176.408 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.8 t -55.53 -61.57 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 C-N-CA 124.204 1.002 . . . . 0.0 113.345 171.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -60.23 -42.65 95.68 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 173.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.8 ttp85 -59.02 -48.21 82.42 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 173.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -66.22 -38.58 88.28 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.9 mt -65.29 -33.24 75.5 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 167.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.13 -32.77 70.93 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 168.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.97 -57.07 14.44 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 154.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -90.05 66.06 6.68 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.56 1.172 . . . . 0.0 112.054 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -101.95 -31.71 10.55 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 116.733 2.123 . . . . 0.0 116.733 -162.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 64.61 50.28 2.17 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 119.781 1.173 . . . . 0.0 113.986 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 tp -89.45 112.13 23.19 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.081 -1.012 . . . . 0.0 111.264 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -103.4 108.67 20.0 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.963 1.305 . . . . 0.0 109.046 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.6 mt -100.21 104.05 15.54 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.607 0.763 . . . . 0.0 109.542 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.2 m -94.9 102.72 14.57 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.557 -0.714 . . . . 0.0 109.448 171.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.9 mt -86.34 121.68 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.776 0.83 . . . . 0.0 108.983 -175.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.4 p -128.34 119.53 25.25 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.618 -0.676 . . . . 0.0 110.429 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -74.84 127.89 34.27 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 122.443 1.115 . . . . 0.0 112.348 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -110.94 -28.3 8.42 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -168.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.05 74.37 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 C-N-CA 124.6 1.095 . . . . 0.0 110.568 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.29 14.7 t-20 66.73 -55.96 0.42 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -150.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -53.59 148.97 8.64 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -113.95 114.8 26.69 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 171.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.1 m -87.17 100.47 12.69 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 170.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.1 t -107.21 113.59 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -171.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -83.39 109.22 17.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.357 0.663 . . . . 0.0 109.52 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -103.82 88.65 3.1 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -170.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.4 m -96.0 120.25 35.95 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.777 0.831 . . . . 0.0 111.142 -171.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.1 p -142.94 169.29 17.84 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.782 1.031 . . . . 0.0 113.782 -172.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.52 -31.27 61.94 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 163.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -79.92 -51.26 9.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 170.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -159.23 148.57 18.54 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -165.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -103.62 102.77 12.65 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 164.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.5 pt -119.05 123.96 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.613 -0.68 . . . . 0.0 111.114 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -90.25 105.4 17.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 0.0 109.935 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.5 105.68 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -170.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.7 t -91.68 99.14 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -110.79 132.63 54.03 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.244 0.545 . . . . 0.0 111.883 178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -84.78 145.7 27.75 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.443 0.64 . . . . 0.0 111.593 168.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.0 mt -63.57 102.13 0.4 Allowed 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.36 -5.16 44.58 Favored Glycine 0 CA--C 1.551 2.342 0 N-CA-C 119.19 2.436 . . . . 0.0 119.19 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.2 p -78.26 139.73 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 120.963 2.381 . . . . 0.0 112.895 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 66.0 m -86.4 105.95 17.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.556 -0.715 . . . . 0.0 109.87 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -132.0 158.37 41.67 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.436 0.694 . . . . 0.0 111.971 -175.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -82.33 95.75 7.71 Favored 'General case' 0 CA--C 1.568 1.652 0 O-C-N 121.647 -0.658 . . . . 0.0 111.202 174.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -83.92 137.81 33.47 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.558 0.694 . . . . 0.0 111.589 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -120.17 133.27 55.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.718 -0.614 . . . . 0.0 109.969 177.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.0 mt -81.72 -132.04 0.03 OUTLIER 'General case' 0 CA--C 1.576 1.958 0 O-C-N 122.093 -0.379 . . . . 0.0 111.31 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.55 -45.57 11.64 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.6 p30 -99.26 -76.38 0.54 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.741 0.816 . . . . 0.0 111.958 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.88 82.05 0.12 Allowed Glycine 0 N--CA 1.482 1.722 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -169.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.0 m -143.1 100.38 3.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.62 113.92 22.9 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.581 0.705 . . . . 0.0 111.516 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.0 mt -118.28 105.84 12.17 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.514 0.726 . . . . 0.0 110.826 -169.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -79.46 119.85 23.04 Favored 'General case' 0 CA--C 1.566 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 111.589 172.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.25 -158.37 30.41 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.8 p -127.17 142.79 51.41 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 123.135 0.574 . . . . 0.0 112.536 -158.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -100.64 116.58 32.9 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.53 -0.731 . . . . 0.0 109.316 158.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 t -122.77 130.29 52.74 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.276 0.631 . . . . 0.0 111.748 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.8 tp -84.06 116.4 22.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.849 -1.157 . . . . 0.0 111.961 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -139.78 100.29 3.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.895 -0.503 . . . . 0.0 110.923 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.27 67.29 2.13 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 116.444 1.337 . . . . 0.0 116.444 174.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.288 21.1 t-20 72.91 -55.55 0.68 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 113.763 1.024 . . . . 0.0 113.763 -157.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -81.77 134.76 35.47 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -152.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.8 mt -85.83 108.32 18.07 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.805 0.812 . . . . 0.0 109.018 170.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.7 mm -96.35 113.02 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -170.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.59 87.87 1.55 Allowed Glycine 0 N--CA 1.48 1.578 0 CA-C-O 119.558 -0.579 . . . . 0.0 112.951 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -86.58 97.68 10.66 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.744 0.783 . . . . 0.0 109.62 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -120.23 161.95 20.22 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-O 123.421 1.581 . . . . 0.0 111.92 -174.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -143.54 149.03 36.86 Favored 'General case' 0 CA--C 1.559 1.325 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.739 164.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -67.46 113.19 5.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.019 -1.051 . . . . 0.0 112.576 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.5 t -65.78 -19.81 66.03 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 165.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.14 -28.58 70.16 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 117.159 2.281 . . . . 0.0 117.159 157.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -130.23 -46.11 1.11 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 -167.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.34 -24.41 24.49 Favored Glycine 0 CA--C 1.554 2.527 0 N-CA-C 117.432 1.733 . . . . 0.0 117.432 -155.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -76.97 139.74 40.22 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 119.842 1.821 . . . . 0.0 114.577 -174.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.04 141.1 49.29 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tt -129.91 120.93 25.68 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.145 0.578 . . . . 0.0 110.061 171.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -109.87 113.9 27.02 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.934 -1.104 . . . . 0.0 109.38 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.1 m -114.35 102.53 10.19 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 119.279 0.945 . . . . 0.0 110.479 -177.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.7 t -90.23 106.13 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 120.809 -1.182 . . . . 0.0 109.595 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -86.03 115.42 23.62 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 123.477 0.711 . . . . 0.0 110.907 170.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -140.45 144.19 35.96 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 123.516 0.727 . . . . 0.0 111.914 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.3 mm -97.76 109.64 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.28 -0.888 . . . . 0.0 109.122 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.252 11.0 tp -93.01 85.02 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-O 121.945 0.878 . . . . 0.0 110.225 169.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.32 -86.89 0.91 Allowed Glycine 0 N--CA 1.49 2.282 0 O-C-N 121.289 -0.882 . . . . 0.0 114.589 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -135.42 53.57 1.96 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.386 0.613 . . . . 0.0 111.995 166.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -146.43 121.25 9.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.126 -0.984 . . . . 0.0 108.359 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.9 tp -82.7 101.23 10.73 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.3 m -101.6 105.47 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.631 -0.668 . . . . 0.0 109.279 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -92.77 109.25 20.67 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.633 -0.667 . . . . 0.0 111.246 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.3 m -91.21 108.62 20.0 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -97.64 119.49 36.31 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 123.977 0.911 . . . . 0.0 109.688 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.6 t -118.29 106.33 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -99.12 116.15 30.67 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 119.038 0.835 . . . . 0.0 109.77 172.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.265 42.0 mt-10 66.12 -79.33 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 123.65 0.78 . . . . 0.0 112.046 -176.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -148.86 42.25 0.83 Allowed Glycine 0 CA--C 1.553 2.455 0 CA-C-O 118.441 -1.199 . . . . 0.0 116.072 157.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -114.41 115.46 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-N 119.729 1.764 . . . . 0.0 110.625 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -81.99 130.34 35.05 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.45 126.13 34.26 Favored 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 123.235 0.614 . . . . 0.0 111.177 163.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -114.64 105.24 12.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.658 -0.651 . . . . 0.0 111.1 -169.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -98.58 117.83 33.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.88 -0.513 . . . . 0.0 111.209 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.9 mt -93.04 115.25 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -103.88 116.86 33.05 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -83.43 157.4 22.49 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 121.611 0.72 . . . . 0.0 111.674 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -66.64 104.27 1.26 Allowed 'General case' 0 CA--C 1.57 1.715 0 O-C-N 120.974 -1.079 . . . . 0.0 112.027 176.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 N--CA 1.491 1.594 0 C-N-CA 124.923 1.289 . . . . 0.0 114.25 -173.761 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.343 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.323 88.9 m-85 72.46 -52.63 0.7 Allowed 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 171.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.25 80.92 1.33 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 120.007 1.276 . . . . 0.0 112.857 -172.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.3 m -174.58 175.69 2.46 Favored 'General case' 0 CA--C 1.572 1.793 0 C-N-CA 125.381 1.473 . . . . 0.0 110.325 -173.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 t -98.62 134.6 41.33 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.906 -1.121 . . . . 0.0 111.462 168.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -126.78 105.01 8.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.431 -0.793 . . . . 0.0 109.15 -166.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -97.02 137.91 35.37 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.493 -0.754 . . . . 0.0 112.513 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -64.3 128.65 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.831 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -170.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -111.12 -49.56 3.01 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.96 135.98 12.82 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 120.295 1.407 . . . . 0.0 111.722 173.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.1 p -107.2 129.64 54.83 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.929 0.892 . . . . 0.0 112.037 174.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -69.68 -66.52 0.58 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -141.92 59.7 1.48 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.158 0.89 . . . . 0.0 111.852 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -82.87 54.68 2.79 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.391 -1.443 . . . . 0.0 112.947 174.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -154.78 -55.79 0.1 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.595 1.558 . . . . 0.0 108.72 -170.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -68.77 -30.41 69.0 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 121.292 1.86 . . . . 0.0 115.67 160.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -52.22 -53.11 47.56 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 121.302 1.865 . . . . 0.0 114.644 156.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -40.27 93.71 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 170.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.27 -32.92 74.45 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 167.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -62.61 -39.08 92.66 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 159.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.1 mmm -63.18 -34.96 78.76 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 116.029 1.862 . . . . 0.0 116.029 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.71 52.81 0.74 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.7 m -130.54 143.67 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 122.127 0.965 . . . . 0.0 112.533 -174.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -65.33 157.82 28.13 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.268 10.8 tp -49.78 -39.48 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 N-CA-C 118.447 2.758 . . . . 0.0 118.447 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.5 t -62.01 -54.04 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-N 119.491 1.041 . . . . 0.0 112.381 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -56.98 -36.69 70.63 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 167.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.4 mtm-85 -62.58 -46.08 89.94 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 121.219 1.827 . . . . 0.0 115.183 169.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -58.07 -49.24 77.6 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 166.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.53 -35.42 70.68 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 116.493 2.034 . . . . 0.0 116.493 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.36 99.07 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 163.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.85 -58.44 8.37 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 162.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -90.24 56.26 3.33 Favored 'General case' 0 CA--C 1.574 1.873 0 CA-C-O 122.316 1.055 . . . . 0.0 113.112 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -88.96 -31.83 17.96 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 71.02 64.11 0.17 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 124.722 1.209 . . . . 0.0 113.409 173.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.6 tp -97.44 125.8 42.31 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.707 0.765 . . . . 0.0 113.042 -167.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -103.36 126.07 50.32 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.891 163.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.9 mt -104.16 103.76 13.59 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 m -91.3 107.88 19.51 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.227 -0.92 . . . . 0.0 108.822 172.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 73.5 mt -100.76 96.95 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -169.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.0 m -98.95 100.49 11.67 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -87.49 121.67 30.22 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 121.6 -0.687 . . . . 0.0 111.813 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -109.36 82.45 1.6 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.18 0.991 . . . . 0.0 109.741 161.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.11 -110.69 3.29 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 114.807 0.683 . . . . 0.0 114.807 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -81.65 -23.6 36.82 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -81.07 115.89 20.74 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 119.871 1.214 . . . . 0.0 111.482 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -101.83 110.37 22.34 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.7 m -91.36 97.39 11.06 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.6 t -95.75 106.27 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -85.21 106.84 16.94 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -94.8 90.4 6.04 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -173.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 m -104.49 115.89 31.14 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.403 0.681 . . . . 0.0 111.018 -173.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.3 p -146.84 -178.5 6.22 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.61 54.22 0.59 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -175.92 -57.29 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.859 0 C-N-CA 125.731 1.612 . . . . 0.0 109.797 -159.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.5 ptp85 -146.33 149.18 33.33 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.175 0.99 . . . . 0.0 111.777 -160.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -135.09 94.27 3.12 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 165.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.8 pt -129.69 124.24 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.323 0.582 . . . . 0.0 111.073 -172.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.42 101.65 14.33 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.982 0.913 . . . . 0.0 111.747 176.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.4 t -91.78 106.4 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.58 106.46 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -122.14 137.07 54.96 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.489 0.662 . . . . 0.0 112.305 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -81.61 140.25 34.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.381 -0.825 . . . . 0.0 111.579 167.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.83 113.59 2.58 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.32 -11.72 56.92 Favored Glycine 0 CA--C 1.55 2.232 0 N-CA-C 118.506 2.162 . . . . 0.0 118.506 -171.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.2 p -78.48 140.27 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-N 120.53 2.165 . . . . 0.0 113.569 -171.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.2 m -84.88 104.18 14.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.728 -0.608 . . . . 0.0 109.539 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -136.99 165.34 26.22 Favored 'General case' 0 CA--C 1.569 1.711 0 CA-C-O 121.675 0.75 . . . . 0.0 112.581 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -87.57 98.9 11.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.559 -0.713 . . . . 0.0 111.791 175.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -86.55 156.37 20.1 Favored 'General case' 0 CA--C 1.567 1.618 0 C-N-CA 123.631 0.772 . . . . 0.0 112.421 173.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -128.75 131.96 47.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.724 -1.235 . . . . 0.0 110.695 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 33.8 mt -86.72 169.97 12.18 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.847 0.832 . . . . 0.0 113.066 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.35 46.9 0.11 Allowed 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 118.773 2.879 . . . . 0.0 118.773 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -138.9 -80.56 0.32 Allowed 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 159.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.19 79.74 0.05 OUTLIER Glycine 0 N--CA 1.48 1.589 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 97.2 m -152.46 128.8 10.57 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.462 -1.022 . . . . 0.0 111.143 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -79.62 131.33 35.96 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.9 mt -124.05 104.32 8.81 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.677 0.791 . . . . 0.0 110.879 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -76.38 114.8 15.48 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.983 0.913 . . . . 0.0 112.095 172.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.94 -164.02 36.78 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 117.083 1.593 . . . . 0.0 117.083 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.9 p -120.57 121.93 39.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -160.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -86.32 112.86 21.82 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 122.906 0.482 . . . . 0.0 110.776 161.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.3 m -119.17 130.2 55.4 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.738 -0.601 . . . . 0.0 112.431 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.8 tp -88.72 130.48 35.32 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.185 -0.947 . . . . 0.0 112.258 177.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -107.45 -79.05 0.58 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 123.512 0.725 . . . . 0.0 110.903 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.15 88.92 0.11 Allowed Glycine 0 N--CA 1.49 2.298 0 CA-C-N 119.803 1.183 . . . . 0.0 111.852 -173.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.26 63.0 m-80 65.4 10.03 6.22 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -156.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -132.99 117.73 17.98 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.374 1.069 . . . . 0.0 109.78 -169.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.37 109.24 20.84 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 168.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.9 tp -91.93 117.67 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.415 -0.803 . . . . 0.0 110.248 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.21 98.21 2.02 Favored Glycine 0 N--CA 1.483 1.795 0 C-N-CA 123.461 0.553 . . . . 0.0 112.424 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -94.84 98.1 10.49 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -124.06 146.48 48.55 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.021 0.915 . . . . 0.0 113.044 -166.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -120.12 148.76 43.21 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.527 0.731 . . . . 0.0 109.693 164.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -73.9 148.55 42.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.148 -1.595 . . . . 0.0 113.433 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.7 p -70.97 -73.59 0.17 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.568 -0.707 . . . . 0.0 111.754 167.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.86 -41.78 97.7 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.844 2.165 . . . . 0.0 116.844 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.31 -14.1 39.13 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 174.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.05 -39.57 2.98 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 118.327 2.091 . . . . 0.0 118.327 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -80.27 162.08 24.79 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -156.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.26 135.66 47.57 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -177.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.5 tt -125.61 130.8 52.36 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 124.185 0.994 . . . . 0.0 109.395 168.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -107.21 129.15 54.9 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.209 -0.932 . . . . 0.0 109.702 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -123.74 108.53 12.63 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.41 -0.806 . . . . 0.0 109.182 171.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.8 t -98.12 110.22 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -87.58 114.99 24.7 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.496 0.718 . . . . 0.0 111.122 172.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -132.19 133.92 44.77 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 119.284 0.947 . . . . 0.0 111.869 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.39 108.77 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.952 -1.093 . . . . 0.0 108.541 173.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.0 pt -97.23 94.03 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 C-N-CA 124.296 1.039 . . . . 0.0 109.028 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.1 -101.67 1.36 Allowed Glycine 0 N--CA 1.492 2.38 0 O-C-N 121.239 -0.913 . . . . 0.0 113.01 -169.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -131.74 53.31 2.0 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.368 0.604 . . . . 0.0 112.009 161.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -134.99 125.37 26.45 Favored 'General case' 0 CA--C 1.563 1.448 0 O-C-N 121.44 -0.787 . . . . 0.0 109.381 167.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.7 tp -78.29 107.67 11.06 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.746 0.818 . . . . 0.0 110.487 175.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -92.38 118.85 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.334 -0.854 . . . . 0.0 110.931 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -95.27 106.89 18.97 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.79 0.836 . . . . 0.0 109.679 172.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.1 m -91.47 104.12 16.66 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.083 0.553 . . . . 0.0 109.864 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -95.61 121.22 37.08 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.181 0.592 . . . . 0.0 111.749 -174.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.6 t -120.63 121.04 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -136.52 98.31 3.78 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.862 -0.524 . . . . 0.0 110.191 168.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 66.19 68.53 0.45 Allowed 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 168.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.68 44.47 57.02 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 118.303 2.081 . . . . 0.0 118.303 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -156.53 150.99 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 118.439 1.12 . . . . 0.0 110.401 -176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.47 126.12 32.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.165 -0.96 . . . . 0.0 110.313 174.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -128.02 105.67 8.55 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.071 0.548 . . . . 0.0 111.286 171.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -85.42 118.47 24.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 110.967 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.4 mtt-85 -99.84 110.32 22.69 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 164.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.7 mt -81.65 133.27 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -120.65 121.78 39.07 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.065 0.946 . . . . 0.0 109.189 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -77.7 142.37 38.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 112.609 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -69.16 111.25 4.99 Favored 'General case' 0 CA--C 1.568 1.655 0 O-C-N 121.451 -0.78 . . . . 0.0 111.785 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 N--CA 1.488 1.468 0 C-N-CA 124.938 1.295 . . . . 0.0 112.587 -170.148 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 1.397 0 CA-C-O 122.144 0.973 . . . . 0.0 113.032 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.328 54.2 m-85 74.99 -49.8 0.66 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 117.712 2.486 . . . . 0.0 117.712 166.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -75.35 76.59 2.44 Favored 'General case' 0 CA--C 1.573 1.838 0 CA-C-N 120.459 1.481 . . . . 0.0 113.979 -170.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.685 ' HG ' ' NZ ' ' A' ' 130' ' ' LYS . 13.0 t -162.71 -178.86 6.44 Favored 'General case' 0 CA--C 1.576 1.974 0 CA-C-O 122.682 1.229 . . . . 0.0 112.367 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.1 m -87.58 129.08 35.23 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.243 1.017 . . . . 0.0 110.42 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -128.01 111.75 13.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.828 -0.545 . . . . 0.0 109.603 -173.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.52 137.54 36.3 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.418 0.687 . . . . 0.0 111.756 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.1 p -64.36 118.14 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -105.75 -59.87 1.71 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.758 0.823 . . . . 0.0 112.076 -174.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -134.24 166.62 22.37 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.55 1.167 . . . . 0.0 111.372 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.6 m -151.51 123.73 8.25 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 119.581 -1.949 . . . . 0.0 109.761 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -82.4 -81.46 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -159.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -108.32 55.97 0.63 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 120.29 1.405 . . . . 0.0 112.435 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -87.38 66.11 8.98 Favored 'General case' 0 CA--C 1.573 1.843 0 CA-C-O 122.63 1.205 . . . . 0.0 111.543 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -158.05 -66.35 0.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.969 0.908 . . . . 0.0 109.961 -167.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -60.67 -47.28 86.96 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 166.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -44.61 -58.69 2.87 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 162.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 37.4 mtp -59.07 -43.32 91.74 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -61.06 -41.74 97.19 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 166.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -62.24 -37.07 84.01 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 168.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 55.7 mtm -65.14 -20.03 66.26 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 164.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.24 47.64 2.78 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.3 m -123.12 142.51 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-N 118.385 1.092 . . . . 0.0 111.504 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -75.24 169.67 17.59 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.27 0.3 OUTLIER -52.91 -42.21 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 176.19 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.3 t -58.36 -48.87 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.027 -1.046 . . . . 0.0 113.357 170.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -61.79 -40.32 94.79 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 168.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 mpp_? -57.15 -34.6 68.59 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 164.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -70.25 -55.79 8.39 Favored 'General case' 0 CA--C 1.572 1.827 0 CA-C-N 120.364 1.438 . . . . 0.0 113.434 164.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.0 mt -66.08 -52.59 47.34 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.74 -4.7 36.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 172.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.36 -57.95 3.51 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 119.692 1.133 . . . . 0.0 113.123 152.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -90.49 52.96 2.32 Favored 'General case' 0 CA--C 1.573 1.841 0 C-N-CA 123.767 0.827 . . . . 0.0 112.903 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -92.98 2.25 56.89 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 55.25 58.45 4.67 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 124.687 1.195 . . . . 0.0 113.957 -175.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.3 tp -92.09 116.47 28.96 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-O 122.065 0.936 . . . . 0.0 111.873 -166.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -115.52 112.1 21.71 Favored 'General case' 0 CA--C 1.561 1.378 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.391 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.0 mt -99.09 100.13 11.24 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.0 m -92.62 108.96 20.37 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.335 -0.853 . . . . 0.0 109.613 174.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -107.96 137.6 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 C-N-CA 124.298 1.039 . . . . 0.0 108.673 -165.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 93.1 m -147.75 122.56 9.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.139 -1.6 . . . . 0.0 110.481 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -86.97 108.97 19.06 Favored 'General case' 0 CA--C 1.565 1.522 0 O-C-N 121.55 -0.719 . . . . 0.0 112.112 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -91.71 76.11 5.7 Favored 'General case' 0 CA--C 1.57 1.725 0 O-C-N 121.477 -0.765 . . . . 0.0 110.054 168.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.69 -98.57 0.54 Allowed Glycine 0 N--CA 1.492 2.404 0 O-C-N 121.443 -0.786 . . . . 0.0 114.778 -174.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -95.74 -11.59 26.77 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 165.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -95.76 101.97 13.71 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 120.791 1.632 . . . . 0.0 110.551 -175.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.49 111.55 18.61 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.379 -0.826 . . . . 0.0 111.135 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.2 m -86.24 105.22 16.46 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.735 0.814 . . . . 0.0 109.069 174.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.5 t -112.52 103.26 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -85.79 107.43 17.63 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.284 0.634 . . . . 0.0 110.722 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -98.49 87.46 3.85 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.1 t -88.35 117.44 27.28 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 122.856 0.462 . . . . 0.0 111.171 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.3 p -146.73 165.04 30.83 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.623 0.725 . . . . 0.0 112.678 -172.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.68 -27.2 62.68 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 118.012 2.597 . . . . 0.0 118.012 165.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -75.42 -51.88 12.04 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 167.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -162.36 151.43 15.37 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.595 0.758 . . . . 0.0 111.727 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -113.88 91.67 3.72 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.801 0.84 . . . . 0.0 110.532 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.6 pt -114.89 125.0 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 121.448 0.642 . . . . 0.0 111.88 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -86.26 101.21 12.85 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.6 0.76 . . . . 0.0 110.971 172.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.69 105.44 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -174.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.3 t -94.58 96.93 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -105.97 128.04 53.55 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.431 0.634 . . . . 0.0 112.077 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -85.23 129.08 34.88 Favored 'General case' 0 CA--C 1.563 1.474 0 O-C-N 121.511 -0.743 . . . . 0.0 111.157 173.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.0 125.92 25.54 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -173.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.79 -16.75 44.6 Favored Glycine 0 CA--C 1.555 2.533 0 N-CA-C 119.106 2.403 . . . . 0.0 119.106 -168.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.3 t -86.26 130.78 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 120.278 2.039 . . . . 0.0 109.938 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.5 t -75.21 121.9 22.84 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -142.7 161.68 37.44 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-O 121.732 0.777 . . . . 0.0 112.201 -172.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -91.63 104.2 16.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.489 -0.757 . . . . 0.0 111.517 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -100.85 142.02 32.91 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 124.164 0.986 . . . . 0.0 111.631 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -134.82 100.94 4.75 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.907 -1.121 . . . . 0.0 110.615 -167.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.0 mt -76.36 93.34 3.45 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -168.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.3 . . 58.07 -64.31 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 119.85 3.278 . . . . 0.0 119.85 170.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -82.98 -83.71 0.13 Allowed 'General case' 0 CA--C 1.57 1.719 0 CA-C-N 118.853 0.752 . . . . 0.0 109.73 164.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.48 55.01 0.2 Allowed Glycine 0 N--CA 1.487 2.057 0 N-CA-C 116.267 1.267 . . . . 0.0 116.267 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.8 m -88.02 101.11 13.46 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 118.068 0.934 . . . . 0.0 108.545 165.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -88.63 112.41 23.05 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 122.794 0.438 . . . . 0.0 111.076 -169.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.8 mt -127.38 112.29 14.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.748 -0.595 . . . . 0.0 111.716 -161.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 51.5 ptt85 -90.94 118.19 30.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.104 -0.997 . . . . 0.0 111.338 172.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.3 -158.94 32.1 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 117.776 1.87 . . . . 0.0 117.776 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.7 p -130.15 129.85 44.01 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -156.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -92.48 132.26 36.95 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.033 -1.042 . . . . 0.0 111.081 164.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.5 m -129.97 127.31 39.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.566 -0.708 . . . . 0.0 111.425 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.6 tp -81.9 125.25 30.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.462 -0.774 . . . . 0.0 111.638 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -130.96 79.59 1.9 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.381 -0.824 . . . . 0.0 109.115 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.47 -109.5 3.02 Favored Glycine 0 N--CA 1.488 2.11 0 O-C-N 121.648 -0.657 . . . . 0.0 113.747 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -111.02 44.22 1.33 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 167.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -144.5 114.06 7.14 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 25.1 mt -89.49 107.49 19.1 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 167.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.9 tt -96.88 119.47 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.296 -0.878 . . . . 0.0 110.409 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -101.95 98.88 1.8 Allowed Glycine 0 N--CA 1.482 1.76 0 C-N-CA 124.1 0.857 . . . . 0.0 113.215 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.17 101.55 13.93 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -121.88 143.11 49.63 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.707 0.765 . . . . 0.0 111.916 -173.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -110.72 138.73 46.74 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.69 0.757 . . . . 0.0 109.384 163.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -62.0 111.34 1.88 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.288 -0.882 . . . . 0.0 112.597 171.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.297 5.8 t -68.66 -14.74 63.22 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 174.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -73.78 -20.46 60.47 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 158.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -133.92 -41.44 0.83 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -166.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.85 -26.94 22.32 Favored Glycine 0 CA--C 1.556 2.643 0 N-CA-C 117.368 1.707 . . . . 0.0 117.368 -153.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -66.06 129.92 41.45 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -167.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.04 129.68 35.54 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -175.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.9 tt -121.7 120.29 34.26 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 124.917 1.287 . . . . 0.0 108.908 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -105.47 113.13 26.51 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.314 -0.866 . . . . 0.0 109.065 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.6 m -101.93 111.48 23.75 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.303 -0.873 . . . . 0.0 110.368 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.34 102.5 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -80.82 115.99 20.58 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.767 0.827 . . . . 0.0 110.194 167.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -143.97 142.24 30.62 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -95.15 106.14 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.899 . . . . 0.0 109.44 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.0 pt -88.75 72.82 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.924 0 O-C-N 121.017 -1.052 . . . . 0.0 111.158 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 85.15 -86.84 1.55 Allowed Glycine 0 N--CA 1.491 2.312 0 O-C-N 120.531 -1.355 . . . . 0.0 113.096 -168.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -139.43 53.81 1.71 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 166.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -144.79 118.19 9.05 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 121.212 -0.93 . . . . 0.0 108.6 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.3 tp -78.53 110.23 13.43 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.107 0.956 . . . . 0.0 110.92 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.5 t -97.77 115.32 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -96.82 93.88 6.93 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.733 0.813 . . . . 0.0 109.778 171.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 48.8 m -84.04 101.97 12.15 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 122.864 0.466 . . . . 0.0 109.784 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -87.09 111.05 20.53 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.128 0.571 . . . . 0.0 110.892 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.3 t -103.1 102.06 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -128.85 109.91 11.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.779 -0.576 . . . . 0.0 109.723 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 53.63 57.59 5.96 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 174.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.35 -33.73 3.16 Favored Glycine 0 CA--C 1.552 2.405 0 N-CA-C 118.758 2.263 . . . . 0.0 118.758 -167.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.4 t -89.87 121.28 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 119.887 1.843 . . . . 0.0 110.708 -166.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -89.4 123.87 33.95 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.229 0.612 . . . . 0.0 111.348 166.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.94 108.47 8.42 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.012 0.525 . . . . 0.0 110.881 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -88.91 114.83 25.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 111.622 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -89.64 121.78 32.15 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 119.275 0.943 . . . . 0.0 109.873 162.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.6 mt -120.54 120.72 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -163.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -118.67 126.57 52.21 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.012 0.925 . . . . 0.0 110.747 -165.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -87.23 152.93 21.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.162 -0.961 . . . . 0.0 113.261 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.685 ' NZ ' ' HG ' ' A' ' 4' ' ' SER . 26.1 tptp -62.18 110.95 1.77 Allowed 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 124.063 0.945 . . . . 0.0 113.309 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.489 1.484 0 C-N-CA 125.175 1.39 . . . . 0.0 113.251 -174.498 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.22 0 CA-C-O 121.703 0.764 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -80.85 63.39 5.22 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.269 -0.895 . . . . 0.0 112.567 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -88.12 88.42 7.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.997 -1.065 . . . . 0.0 111.744 -166.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.1 m -171.6 164.62 6.78 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 122.754 1.264 . . . . 0.0 113.24 -172.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.6 m -89.72 131.08 35.87 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 124.024 0.93 . . . . 0.0 110.9 170.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -131.33 110.12 10.85 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.356 0.662 . . . . 0.0 109.779 -170.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -100.84 135.64 41.98 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.01 -1.056 . . . . 0.0 112.303 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.7 121.88 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -106.53 -49.08 3.4 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -153.17 111.52 3.66 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 118.911 0.778 . . . . 0.0 109.746 -164.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.2 p -102.0 108.62 20.12 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.512 0.725 . . . . 0.0 112.385 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -102.93 115.46 30.65 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.285 38.7 t30 67.93 11.43 8.36 Favored 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 118.458 2.762 . . . . 0.0 118.458 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -64.79 -42.84 94.75 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -61.17 -32.53 72.27 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 170.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -72.99 -42.73 63.0 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 171.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -46.48 -54.31 9.51 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 160.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.7 mtt -61.75 -39.16 90.63 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 172.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -53.35 -48.76 68.27 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 166.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.1 tttp -62.18 -28.63 69.8 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 168.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.5 mmt -65.47 -43.83 89.08 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 168.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.89 63.72 0.36 Allowed Glycine 0 N--CA 1.487 2.099 0 C-N-CA 123.855 0.741 . . . . 0.0 113.742 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 p -138.25 146.49 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.403 1.097 . . . . 0.0 111.638 -176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -59.2 143.92 47.55 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.31 12.9 tt -52.89 -44.15 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.8 t -56.58 -56.55 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.305 0.957 . . . . 0.0 113.197 170.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -63.6 -45.15 91.67 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.2 ptt85 -67.66 -30.61 70.19 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 171.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -68.55 -43.4 76.71 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 120.009 1.277 . . . . 0.0 114.219 165.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.5 mt -62.35 -50.57 71.06 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 169.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.65 -12.53 54.2 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 118.6 2.815 . . . . 0.0 118.6 168.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.76 -59.96 2.55 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 155.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -91.62 53.53 2.27 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 118.765 0.711 . . . . 0.0 112.82 -170.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.6 p30 -102.97 -4.22 24.98 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 118.582 2.808 . . . . 0.0 118.582 -171.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 59.18 56.16 4.02 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-N 121.655 2.025 . . . . 0.0 114.131 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.4 tp -82.63 119.75 24.68 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.981 -1.074 . . . . 0.0 112.1 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -101.55 119.85 39.4 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.199 170.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.8 mt -102.42 107.34 18.29 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.251 88.6 m -88.13 101.09 13.47 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.854 -1.154 . . . . 0.0 108.736 163.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 85.5 mt -94.99 119.45 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.8 t -127.82 131.21 49.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.808 -0.558 . . . . 0.0 111.614 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -79.73 127.21 31.93 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 121.768 0.794 . . . . 0.0 111.472 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -131.96 64.48 1.59 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 124.05 0.94 . . . . 0.0 110.563 -168.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.3 69.25 1.37 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 116.756 1.463 . . . . 0.0 116.756 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.281 14.9 t30 66.82 -15.04 0.15 Allowed 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 -164.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -92.19 154.23 18.8 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 120.684 -1.26 . . . . 0.0 112.231 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -116.4 120.3 38.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.476 -0.765 . . . . 0.0 109.392 165.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.9 m -89.03 107.62 19.14 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 167.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.0 t -104.25 108.01 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -93.18 104.19 16.4 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -86.28 126.3 34.2 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.189 0.595 . . . . 0.0 110.71 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.2 t -135.17 118.73 16.95 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 122.765 0.426 . . . . 0.0 110.255 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 p -147.61 172.83 13.41 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.46 59.08 0.79 Allowed 'General case' 0 CA--C 1.575 1.925 0 O-C-N 120.513 -1.367 . . . . 0.0 113.491 154.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -168.78 -60.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.114 0.966 . . . . 0.0 110.174 -175.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -154.58 143.57 21.01 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 118.588 0.631 . . . . 0.0 111.951 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -115.2 103.11 10.52 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 173.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.6 pt -138.29 141.18 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 121.5 0.667 . . . . 0.0 111.909 -174.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -104.13 105.78 16.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.171 -0.956 . . . . 0.0 109.7 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.32 103.19 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.2 t -97.89 104.11 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -117.78 149.71 40.35 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.125 0.57 . . . . 0.0 112.476 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -94.07 142.41 27.43 Favored 'General case' 0 CA--C 1.568 1.635 0 O-C-N 121.733 -0.604 . . . . 0.0 111.698 171.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.1 mt -71.95 101.91 2.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.004 -1.06 . . . . 0.0 111.699 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.6 -46.15 1.07 Allowed Glycine 0 CA--C 1.549 2.215 0 N-CA-C 116.37 1.308 . . . . 0.0 116.37 -168.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.73 141.46 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.844 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.1 m -92.51 77.86 5.0 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.191 0.996 . . . . 0.0 110.729 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -101.64 166.27 10.79 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -167.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -82.24 93.75 7.17 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-O 121.62 0.724 . . . . 0.0 111.531 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -84.52 164.98 18.44 Favored 'General case' 0 CA--C 1.571 1.756 0 CA-C-O 122.141 0.972 . . . . 0.0 111.498 166.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -153.65 132.75 12.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.325 -1.485 . . . . 0.0 110.801 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.3 mt -75.6 -64.04 1.16 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -164.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -154.36 -70.99 0.13 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 118.926 0.785 . . . . 0.0 111.391 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -83.24 -69.53 0.63 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.958 0.799 . . . . 0.0 112.941 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.74 50.58 0.4 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 116.734 1.454 . . . . 0.0 116.734 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.1 m -112.71 98.33 7.15 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -92.79 140.73 29.21 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 122.439 1.114 . . . . 0.0 112.147 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.8 mt -136.59 119.82 16.72 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 123.78 0.832 . . . . 0.0 110.206 -162.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -90.47 122.91 33.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.964 -1.085 . . . . 0.0 110.034 169.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.75 -173.32 45.46 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 117.633 1.813 . . . . 0.0 117.633 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 75.9 p -115.59 131.47 56.92 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.092 -1.054 . . . . 0.0 111.327 -170.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -87.78 113.92 23.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.195 -0.94 . . . . 0.0 109.621 161.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.6 m -110.94 117.42 33.33 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.419 0.688 . . . . 0.0 110.909 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.9 tp -84.76 99.1 10.64 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.144 -0.972 . . . . 0.0 111.584 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -95.52 85.21 4.14 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.444 0.698 . . . . 0.0 110.687 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.37 -90.59 0.62 Allowed Glycine 0 N--CA 1.491 2.359 0 O-C-N 121.425 -0.797 . . . . 0.0 114.601 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -125.52 53.44 1.55 Allowed 'General case' 0 CA--C 1.575 1.935 0 CA-C-O 121.363 0.601 . . . . 0.0 111.552 162.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -145.0 111.15 5.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.089 -1.007 . . . . 0.0 108.533 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 mt -85.89 102.34 13.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.968 . . . . 0.0 109.075 172.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.6 mt -100.6 108.55 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -172.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.12 101.72 2.75 Favored Glycine 0 N--CA 1.482 1.705 0 C-N-CA 123.235 0.445 . . . . 0.0 113.18 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -95.34 94.28 7.76 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.551 0.74 . . . . 0.0 109.06 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -121.47 138.33 54.33 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -163.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -119.49 138.4 53.17 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.516 0.726 . . . . 0.0 110.085 170.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -70.08 130.21 41.51 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -171.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 36.9 p -81.43 68.69 7.86 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.337 1.065 . . . . 0.0 110.851 170.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -177.7 -62.28 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.774 0 C-N-CA 125.927 1.691 . . . . 0.0 107.417 -164.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -135.37 20.37 3.39 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.4 10.6 36.57 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 121.03 3.172 . . . . 0.0 121.03 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -95.46 138.71 32.76 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 118.121 0.96 . . . . 0.0 112.217 -159.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -80.34 128.25 33.34 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -163.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.86 122.87 39.13 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 124.742 1.217 . . . . 0.0 108.423 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -98.61 114.7 27.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.618 -0.676 . . . . 0.0 109.278 172.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.1 m -108.22 96.85 6.65 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 119.564 1.075 . . . . 0.0 109.701 175.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.3 t -95.65 105.17 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.885 -1.134 . . . . 0.0 108.91 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -88.9 122.02 31.85 Favored 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 123.565 0.746 . . . . 0.0 111.052 169.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -144.87 155.24 43.35 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.281 -0.887 . . . . 0.0 112.38 171.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mp -94.76 118.79 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.649 -1.282 . . . . 0.0 109.657 -176.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.7 mt -95.79 87.55 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 106.941 -1.504 . . . . 0.0 106.941 164.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.0 -94.83 0.38 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 115.742 1.057 . . . . 0.0 115.742 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -101.75 14.56 31.6 Favored 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 169.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -134.38 109.76 8.99 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 119.717 1.144 . . . . 0.0 111.002 -161.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.6 tp -76.46 104.61 7.07 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.918 0.887 . . . . 0.0 110.899 173.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.5 p -88.47 104.77 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 123.05 0.54 . . . . 0.0 110.219 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -90.0 99.85 12.78 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.456 0.646 . . . . 0.0 109.421 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 33.4 m -98.96 104.89 16.97 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.006 -168.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -87.1 125.79 34.36 Favored 'General case' 0 CA--C 1.563 1.476 0 C-N-CA 123.257 0.623 . . . . 0.0 111.048 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.4 t -121.69 109.0 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 168.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -113.87 107.11 15.26 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.265 10.2 mm-40 65.03 -78.68 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 123.914 0.885 . . . . 0.0 112.992 -171.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -152.6 58.32 0.42 Allowed Glycine 0 N--CA 1.486 2.001 0 CA-C-O 119.511 -0.605 . . . . 0.0 114.108 164.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.9 p -129.19 104.21 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -89.43 112.31 23.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.602 -0.687 . . . . 0.0 110.915 -176.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.77 117.34 25.46 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.019 0.527 . . . . 0.0 112.236 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -105.62 102.22 11.69 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.456 0.703 . . . . 0.0 109.704 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . 0.258 15.1 ptm180 -95.92 111.98 23.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.441 -0.787 . . . . 0.0 110.733 168.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.4 mt -97.94 125.01 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -170.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -105.45 116.73 32.44 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.618 0.767 . . . . 0.0 109.068 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -82.78 141.93 31.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.231 -0.918 . . . . 0.0 111.745 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -66.94 124.36 22.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 113.338 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 124.822 1.249 . . . . 0.0 111.88 -170.103 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.305 0 CA-C-O 121.15 0.5 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 64.91 65.03 0.62 Allowed 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -130.55 75.83 1.68 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.952 -1.093 . . . . 0.0 110.701 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.652 ' HG ' ' NZ ' ' A' ' 130' ' ' LYS . 88.1 p -171.15 168.63 6.75 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.795 1.284 . . . . 0.0 113.5 -175.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.7 m -77.23 135.87 38.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.219 -0.926 . . . . 0.0 111.75 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -133.16 101.74 5.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.678 -0.639 . . . . 0.0 109.393 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -97.31 137.84 35.7 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.252 -0.905 . . . . 0.0 112.223 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.266 4.5 p -63.03 115.54 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.81 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -173.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -84.55 -47.4 10.61 Favored 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 123.687 0.795 . . . . 0.0 113.054 170.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -155.15 159.0 39.84 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 122.563 1.173 . . . . 0.0 111.033 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.7 m -147.66 113.03 5.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 119.871 -1.768 . . . . 0.0 109.315 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -83.36 -95.79 0.06 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -162.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -85.06 52.56 2.47 Favored 'General case' 0 CA--C 1.579 2.063 0 CA-C-N 120.635 1.561 . . . . 0.0 113.523 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -82.9 -48.45 10.7 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.526 1.13 . . . . 0.0 114.03 -172.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -58.0 -29.27 65.15 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 169.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 -46.48 34.11 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 169.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -47.64 -51.2 22.28 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 161.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.0 mtm -59.27 -30.77 68.53 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 170.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -65.74 -44.38 86.16 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 166.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -58.63 -37.49 76.01 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 165.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.5 mmm -64.84 -41.57 95.62 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 167.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.43 48.37 0.81 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 115.989 1.156 . . . . 0.0 115.989 174.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.29 10.7 p -113.12 138.84 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 118.534 1.167 . . . . 0.0 112.309 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -62.69 152.39 35.58 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 12.5 tt -48.11 -40.16 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 118.285 2.698 . . . . 0.0 118.285 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.4 t -66.11 -62.28 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-N 119.861 1.209 . . . . 0.0 111.96 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -62.56 -20.03 64.28 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 117.949 2.574 . . . . 0.0 117.949 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.5 ttp85 -76.37 -49.44 16.79 Favored 'General case' 0 CA--C 1.569 1.708 0 C-N-CA 125.292 1.437 . . . . 0.0 114.26 167.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -41.54 98.61 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 169.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.28 -40.63 86.69 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 165.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.72 -31.19 71.69 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 117.729 2.492 . . . . 0.0 117.729 169.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.9 -43.72 69.92 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 157.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -82.41 14.93 2.72 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.313 19.4 p30 -78.36 92.99 4.61 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 121.534 1.97 . . . . 0.0 110.597 170.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -68.8 84.68 0.31 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.767 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.0 tp -86.91 124.75 33.46 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 122.489 1.138 . . . . 0.0 112.731 -167.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -99.48 114.81 27.99 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.57 165.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.2 mt -96.96 95.52 7.88 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.9 m -88.32 98.19 11.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.035 -1.041 . . . . 0.0 108.473 173.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.0 mt -89.76 119.11 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.3 p -121.59 122.14 38.99 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -97.37 130.61 44.5 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -118.02 77.18 1.13 Allowed 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 162.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.61 -106.5 1.08 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 116.404 1.322 . . . . 0.0 116.404 -175.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -84.64 -15.9 43.85 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 169.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -89.03 153.76 20.75 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 119.809 1.186 . . . . 0.0 112.346 168.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -143.51 136.54 27.72 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.606 0.763 . . . . 0.0 109.836 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.9 m -109.82 111.45 22.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.236 -0.915 . . . . 0.0 108.884 164.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.4 p -95.68 120.48 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 121.428 0.632 . . . . 0.0 110.123 168.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -82.4 114.44 20.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 109.484 173.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -93.06 91.25 7.25 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.7 t -112.34 105.42 13.7 Favored 'General case' 0 CA--C 1.562 1.418 0 CA-C-O 121.384 0.611 . . . . 0.0 111.105 -172.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.0 p -143.91 -179.16 6.31 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.393 1.077 . . . . 0.0 111.904 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.11 -25.82 24.11 Favored 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 118.265 2.691 . . . . 0.0 118.265 160.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -96.76 -18.02 19.89 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -148.61 146.43 28.23 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 120.469 1.486 . . . . 0.0 112.155 -171.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -135.19 77.79 1.7 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 156.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.0 pt -126.88 139.88 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 121.216 -0.928 . . . . 0.0 111.953 -167.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.17 105.44 17.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.575 -0.703 . . . . 0.0 109.797 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.3 t -89.69 98.05 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.0 t -89.97 106.85 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -121.63 164.02 18.01 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-O 122.619 1.2 . . . . 0.0 112.752 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -126.5 145.68 50.41 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.452 -0.78 . . . . 0.0 109.683 171.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.75 108.53 1.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.974 . . . . 0.0 113.584 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.65 -23.87 27.03 Favored Glycine 0 CA--C 1.548 2.146 0 N-CA-C 117.985 1.954 . . . . 0.0 117.985 -170.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.8 p -68.67 134.92 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 120.308 2.054 . . . . 0.0 113.588 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -85.38 106.42 16.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.751 -0.593 . . . . 0.0 109.796 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -127.5 158.04 38.48 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.766 0.793 . . . . 0.0 112.151 -176.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -85.72 107.5 17.62 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.549 -0.719 . . . . 0.0 111.413 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -105.54 128.99 53.9 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 124.074 0.95 . . . . 0.0 110.236 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -107.19 125.51 51.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.595 -0.691 . . . . 0.0 111.65 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.9 mt -92.6 78.34 4.91 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.308 . . 63.57 -51.44 0.23 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 120.322 3.453 . . . . 0.0 120.322 162.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -74.22 -81.52 0.07 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 121.39 1.905 . . . . 0.0 109.33 167.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.9 80.88 0.06 OUTLIER Glycine 0 N--CA 1.481 1.692 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.6 m -145.75 109.94 4.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.407 -1.055 . . . . 0.0 108.752 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -84.56 121.84 28.18 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.922 0.867 . . . . 0.0 112.373 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mt -129.65 120.21 24.82 Favored 'General case' 0 CA--C 1.562 1.412 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.515 -168.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -93.08 118.99 31.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.922 . . . . 0.0 111.97 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.51 -170.55 42.06 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 118.069 1.988 . . . . 0.0 118.069 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.0 p -126.24 121.22 32.07 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.49 -0.855 . . . . 0.0 111.679 -163.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -78.29 123.05 26.51 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 119.048 0.84 . . . . 0.0 110.995 160.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.8 m -125.3 137.38 54.07 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.364 0.665 . . . . 0.0 111.721 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 tp -91.25 104.51 17.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 111.586 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -91.46 82.64 5.36 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.63 -0.669 . . . . 0.0 109.55 171.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.44 -94.75 0.66 Allowed Glycine 0 N--CA 1.492 2.373 0 O-C-N 121.545 -0.722 . . . . 0.0 114.382 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -125.23 59.62 1.24 Allowed 'General case' 0 CA--C 1.571 1.788 0 CA-C-O 121.802 0.811 . . . . 0.0 110.926 159.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -140.77 111.49 6.95 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 170.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.5 mt -84.44 100.55 11.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.192 -0.943 . . . . 0.0 109.561 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.6 tt -97.78 128.9 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 123.743 0.817 . . . . 0.0 110.798 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.64 102.77 0.64 Allowed Glycine 0 N--CA 1.481 1.658 0 CA-C-O 119.234 -0.759 . . . . 0.0 114.005 -172.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -90.32 98.55 11.84 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.051 0.925 . . . . 0.0 109.492 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -110.53 106.5 15.82 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.639 0.733 . . . . 0.0 110.576 -171.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -90.99 125.87 35.91 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.224 -0.923 . . . . 0.0 111.772 -168.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.8 ttp85 -66.18 119.66 11.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.132 -0.98 . . . . 0.0 112.432 -174.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.303 5.4 t -59.87 -35.08 74.06 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 117.316 2.339 . . . . 0.0 117.316 -169.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -98.37 42.68 1.09 Allowed 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 168.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -156.62 -50.99 0.08 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.736 -1.228 . . . . 0.0 113.591 173.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.32 8.72 62.54 Favored Glycine 0 CA--C 1.555 2.544 0 N-CA-C 118.471 2.148 . . . . 0.0 118.471 -160.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -89.11 119.78 29.92 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 119.965 1.883 . . . . 0.0 111.389 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -73.07 122.8 22.38 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.6 tt -97.12 108.97 21.8 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -96.23 98.82 10.61 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -165.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.1 m -104.88 108.31 19.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.795 -0.565 . . . . 0.0 109.9 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.7 t -98.72 105.9 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.4 mtm180 -87.58 105.76 17.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.663 -0.648 . . . . 0.0 110.002 167.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.01 162.72 26.15 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.659 0.783 . . . . 0.0 111.729 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.3 mt -127.78 135.61 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.536 -1.352 . . . . 0.0 110.142 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.7 mm -98.15 -76.54 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.74 -112.08 3.44 Favored Glycine 0 N--CA 1.491 2.332 0 CA-C-N 118.687 0.676 . . . . 0.0 111.802 170.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -92.91 47.11 1.26 Allowed 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -146.93 118.78 8.11 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.401 1.08 . . . . 0.0 108.74 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.0 tp -81.91 115.5 21.12 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.482 0.713 . . . . 0.0 109.512 167.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.3 t -100.65 103.53 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -96.81 103.25 15.15 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 123.446 0.698 . . . . 0.0 109.825 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.8 m -99.64 103.25 14.93 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 123.266 0.626 . . . . 0.0 109.835 -173.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -95.0 123.8 38.68 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.775 0.83 . . . . 0.0 111.207 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.02 102.11 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-N 119.307 0.958 . . . . 0.0 108.779 173.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -86.51 102.96 14.59 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.183 -0.948 . . . . 0.0 110.007 167.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.319 0.1 OUTLIER 62.01 -41.42 0.15 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 120.001 3.334 . . . . 0.0 120.001 177.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -173.82 25.42 0.08 OUTLIER Glycine 0 CA--C 1.552 2.369 0 N-CA-C 117.716 1.846 . . . . 0.0 117.716 172.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.0 t -136.57 121.63 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 120.304 2.052 . . . . 0.0 107.532 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.24 140.19 29.8 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -174.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -129.79 125.1 34.98 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.545 0.738 . . . . 0.0 112.045 166.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -99.27 108.88 21.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.704 -0.622 . . . . 0.0 110.601 174.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -96.16 117.99 31.83 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 169.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 76.5 mt -108.55 120.8 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -171.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -117.32 122.77 44.81 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.835 0.854 . . . . 0.0 109.268 -172.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -77.86 148.27 34.73 Favored 'General case' 0 CA--C 1.568 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 112.837 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.652 ' NZ ' ' HG ' ' A' ' 4' ' ' SER . 41.9 tptt -58.9 113.57 2.13 Favored 'General case' 0 CA--C 1.57 1.721 0 C-N-CA 123.906 0.882 . . . . 0.0 113.131 175.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 N--CA 1.489 1.495 0 C-N-CA 124.826 1.251 . . . . 0.0 112.752 -171.328 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.206 0 CA-C-O 121.085 0.469 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.254 91.7 m-85 67.31 -21.58 0.11 Allowed 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 118.99 2.959 . . . . 0.0 118.99 173.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.99 81.63 5.24 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 124.744 1.218 . . . . 0.0 112.897 -164.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.6 m -168.13 173.97 7.56 Favored 'General case' 0 CA--C 1.57 1.738 0 CA-C-O 122.607 1.194 . . . . 0.0 111.703 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.3 m -86.92 131.62 34.05 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.808 0.843 . . . . 0.0 110.804 170.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -132.65 109.36 9.66 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -172.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.24 134.46 48.32 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.281 -0.887 . . . . 0.0 111.716 -175.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -57.7 118.95 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -176.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -114.26 -52.8 2.71 Favored 'General case' 0 CA--C 1.564 1.509 0 C-N-CA 123.592 0.757 . . . . 0.0 113.023 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -144.75 74.17 1.4 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 119.466 1.03 . . . . 0.0 111.918 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.9 p -74.95 127.46 33.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.978 . . . . 0.0 113.454 175.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -79.22 -73.02 0.36 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -166.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -91.97 118.76 31.08 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 156.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -135.34 46.01 2.43 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-O 121.725 0.774 . . . . 0.0 112.406 164.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -146.05 -57.43 0.3 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.166 -0.959 . . . . 0.0 110.551 -173.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -62.39 -33.31 74.5 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 170.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -54.64 -59.77 4.25 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 120.141 1.337 . . . . 0.0 114.144 163.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.51 -47.39 63.31 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 169.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -59.83 -42.95 94.67 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 171.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -56.7 -39.32 73.65 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 165.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 90.5 mtp -64.41 -22.92 67.11 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 172.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.73 39.84 4.85 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 116.712 1.445 . . . . 0.0 116.712 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 m -105.76 138.05 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.631 0.729 . . . . 0.0 110.938 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -63.08 160.73 14.6 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.277 9.8 tp -53.57 -39.59 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.34 -52.85 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-N 119.647 1.112 . . . . 0.0 112.631 169.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -59.24 -34.79 72.63 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 168.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 84.6 mtm-85 -64.3 -47.92 77.61 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 121.428 1.922 . . . . 0.0 114.797 168.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -58.87 -48.96 79.56 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 168.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.4 mt -58.18 -53.36 59.2 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.611 1.338 . . . . 0.0 114.611 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.42 -47.55 78.8 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 116.431 2.012 . . . . 0.0 116.431 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.88 -47.66 67.69 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 168.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -98.69 32.98 2.4 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -85.78 -19.64 30.42 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -168.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 65.5 63.47 0.63 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 120.018 1.281 . . . . 0.0 113.572 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.74 117.28 21.93 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.204 -0.935 . . . . 0.0 111.792 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -103.21 110.8 22.9 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.534 174.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.7 mt -94.48 101.49 13.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 122.992 0.517 . . . . 0.0 109.776 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.9 m -94.94 111.98 23.72 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.36 136.63 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 124.089 0.956 . . . . 0.0 108.703 -168.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.1 m -149.13 124.24 10.1 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 119.903 -1.748 . . . . 0.0 111.235 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -77.34 132.54 38.64 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.374 1.07 . . . . 0.0 112.034 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -130.33 80.96 1.98 Allowed 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 123.524 0.73 . . . . 0.0 109.364 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.39 70.61 0.93 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 117.269 1.667 . . . . 0.0 117.269 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.309 17.3 m120 69.89 -23.49 0.16 Allowed 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -169.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -86.99 152.9 21.99 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 120.037 1.29 . . . . 0.0 112.785 169.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -121.73 133.68 54.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 111.054 173.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.0 m -97.69 117.79 32.77 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.0 t -120.37 112.57 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -83.2 117.21 22.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 0.0 110.85 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -95.32 80.07 3.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.815 -0.553 . . . . 0.0 110.903 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.5 t -97.42 111.36 23.65 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -171.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.5 p -149.93 177.01 10.24 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.77 59.08 0.21 Allowed 'General case' 0 CA--C 1.58 2.126 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 165.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -145.27 -53.84 0.29 Allowed 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 125.746 1.618 . . . . 0.0 110.096 167.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -156.95 -50.57 0.07 Allowed 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -172.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.299 36.6 t-20 76.62 106.13 0.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 120.06 1.3 . . . . 0.0 112.729 -165.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.8 pt -134.7 139.27 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-O 121.294 0.569 . . . . 0.0 111.257 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.73 124.46 30.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.516 -0.74 . . . . 0.0 111.829 168.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.4 t -110.4 101.62 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.9 t -101.04 115.03 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -140.94 151.89 44.57 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -171.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -90.56 139.39 30.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.497 -0.752 . . . . 0.0 111.882 168.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.07 131.46 49.63 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.08 -8.91 59.16 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 119.816 2.686 . . . . 0.0 119.816 -174.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.3 t -89.13 137.02 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-N 120.201 2.001 . . . . 0.0 110.193 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.1 p -76.11 97.85 4.2 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.48 -0.762 . . . . 0.0 111.19 176.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -118.41 164.56 15.06 Favored 'General case' 0 CA--C 1.569 1.689 0 C-N-CA 123.968 0.907 . . . . 0.0 111.879 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -86.31 98.56 11.03 Favored 'General case' 0 CA--C 1.568 1.65 0 O-C-N 121.363 -0.836 . . . . 0.0 111.171 173.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -82.69 114.14 20.85 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 124.074 0.95 . . . . 0.0 110.824 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -96.48 100.09 11.7 Favored 'General case' 0 CA--C 1.566 1.588 0 O-C-N 121.762 -0.586 . . . . 0.0 109.792 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.81 150.08 42.5 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -37.03 -48.9 0.81 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 119.966 3.321 . . . . 0.0 119.966 -176.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -66.26 -23.19 66.36 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 170.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.68 17.99 1.03 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 119.363 2.505 . . . . 0.0 119.363 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.8 m -109.25 126.51 53.4 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 120.477 2.138 . . . . 0.0 112.015 -162.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -96.77 106.86 19.23 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-O 121.486 0.66 . . . . 0.0 111.717 -167.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.3 mt -104.82 116.61 32.3 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.223 1.009 . . . . 0.0 112.256 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 59.7 ttp85 -86.97 117.55 25.76 Favored 'General case' 0 CA--C 1.567 1.618 0 O-C-N 120.834 -1.166 . . . . 0.0 111.27 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 160.6 -165.64 35.12 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.2 p -106.48 138.37 42.77 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.329 -0.512 . . . . 0.0 112.062 -168.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -88.86 106.63 18.51 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 146.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.2 m -106.4 135.9 47.08 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.019 0.527 . . . . 0.0 110.872 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.5 tp -85.01 98.84 10.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.962 -1.086 . . . . 0.0 110.942 175.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.19 79.44 5.72 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.471 0.653 . . . . 0.0 109.347 175.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.2 -99.43 0.32 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -89.7 -10.46 45.66 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -102.04 140.14 36.72 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 121.155 1.798 . . . . 0.0 111.577 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.9 mt -94.84 97.25 9.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.951 -1.093 . . . . 0.0 108.795 161.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.0 tt -90.1 117.38 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 122.15 0.976 . . . . 0.0 110.551 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.71 93.51 1.89 Allowed Glycine 0 N--CA 1.477 1.38 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.425 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -90.2 87.86 7.01 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -117.19 145.96 43.53 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.81 0.814 . . . . 0.0 112.139 -170.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -124.67 131.02 53.49 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.552 0.741 . . . . 0.0 109.001 172.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -76.28 122.78 24.9 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 121.093 -1.005 . . . . 0.0 113.109 -172.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 73.0 p -55.34 -52.4 63.6 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -89.64 65.35 6.87 Favored 'General case' 0 CA--C 1.572 1.797 0 CA-C-N 118.879 0.763 . . . . 0.0 111.824 167.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.54 -47.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 164.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.25 -20.97 47.9 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 118.064 1.986 . . . . 0.0 118.064 -157.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -77.98 147.84 34.71 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.57 1.148 . . . . 0.0 114.007 -172.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.22 133.29 35.42 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.9 tt -117.06 100.09 7.5 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -90.64 110.21 21.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.457 -0.777 . . . . 0.0 109.709 -173.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.3 m -109.97 98.13 7.5 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 119.657 1.117 . . . . 0.0 110.926 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.2 t -93.7 94.92 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.564 -1.335 . . . . 0.0 109.073 -174.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -83.18 127.82 33.95 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.738 0.699 . . . . 0.0 112.242 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -142.43 140.83 32.09 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.326 0.584 . . . . 0.0 112.422 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.4 mm -87.12 119.58 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.426 -0.796 . . . . 0.0 109.12 171.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.9 mt -113.4 88.81 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.84 -107.92 2.2 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 115.728 1.051 . . . . 0.0 115.728 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -90.45 13.78 14.75 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 172.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -138.97 127.62 23.26 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 120.01 1.277 . . . . 0.0 111.192 -172.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.4 tp -78.95 105.87 10.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.453 -0.78 . . . . 0.0 109.159 162.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.5 t -96.08 110.08 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 174.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -113.51 123.28 49.63 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.5 m -96.78 111.4 23.59 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 122.75 0.42 . . . . 0.0 110.001 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -83.7 123.15 29.53 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.987 0.515 . . . . 0.0 110.596 167.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.1 t -117.42 106.14 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 168.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -109.19 101.98 10.96 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.063 0.545 . . . . 0.0 109.639 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 52.24 53.51 12.3 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.15 -31.46 3.44 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 118.722 2.249 . . . . 0.0 118.722 -167.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 98.0 t -78.13 109.54 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 119.869 1.834 . . . . 0.0 110.307 -169.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.48 132.05 39.55 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 123.491 0.716 . . . . 0.0 112.535 -170.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -138.62 112.48 8.43 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.689 0.796 . . . . 0.0 111.427 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -95.19 110.34 22.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.607 -0.683 . . . . 0.0 110.375 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.8 mmm-85 -91.05 116.96 29.21 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.7 mt -104.87 106.4 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -101.53 121.52 42.13 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.908 0.883 . . . . 0.0 110.01 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -82.7 153.32 25.4 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 121.157 -0.964 . . . . 0.0 113.286 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -59.33 105.68 0.37 Allowed 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 178.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.6 t0 . . . . . 0 N--CA 1.489 1.478 0 C-N-CA 125.34 1.456 . . . . 0.0 114.828 178.129 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.563 1.443 0 CA-C-O 122.171 0.986 . . . . 0.0 113.025 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.334 55.7 m-85 65.2 -140.79 0.21 Allowed 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 124.377 1.071 . . . . 0.0 112.407 178.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 38.18 54.09 1.7 Allowed 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 119.214 3.042 . . . . 0.0 119.214 161.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.4 m -175.62 170.6 2.89 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.702 1.201 . . . . 0.0 110.155 -168.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.3 m -79.36 123.42 27.47 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.043 -1.036 . . . . 0.0 110.58 164.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -121.99 118.52 29.02 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -104.68 137.06 43.06 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.417 -0.802 . . . . 0.0 111.417 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.251 4.0 p -66.13 117.96 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.868 0 O-C-N 121.074 -1.016 . . . . 0.0 113.183 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -90.91 -55.76 3.43 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 124.256 1.022 . . . . 0.0 112.715 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.436 ' C ' ' HG ' ' A' ' 11' ' ' SER . 7.7 ptm85 -144.71 174.44 10.97 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-O 122.441 1.115 . . . . 0.0 111.968 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.436 ' HG ' ' C ' ' A' ' 10' ' ' ARG . 67.1 m -156.93 145.29 19.61 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 119.603 -1.935 . . . . 0.0 111.623 -176.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.16 -110.02 0.18 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.951 -174.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -82.13 60.44 4.91 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 122.063 2.21 . . . . 0.0 113.75 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -104.81 67.68 0.81 Allowed 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 122.679 1.228 . . . . 0.0 111.828 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -158.22 -48.44 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.707 1.203 . . . . 0.0 110.039 165.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -57.2 -36.97 71.5 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 164.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -48.72 -51.96 26.07 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 160.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -63.52 -39.76 95.26 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -60.83 -45.03 96.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.447 -1.408 . . . . 0.0 114.644 168.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -55.36 -37.92 68.14 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 165.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.4 mmt -66.47 -16.06 63.83 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 164.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.32 39.51 6.79 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 117.266 1.666 . . . . 0.0 117.266 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.9 m -111.96 143.35 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 118.445 1.123 . . . . 0.0 111.909 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -64.31 157.97 24.67 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -174.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.29 0.1 OUTLIER -52.52 -49.65 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 -177.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.0 t -62.43 -45.43 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-N 119.683 1.128 . . . . 0.0 113.483 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -53.18 -43.75 67.37 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 166.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 82.5 mtm-85 -62.49 -41.35 98.74 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 168.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.78 -45.25 95.11 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 168.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.0 mt -63.13 -44.45 95.58 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.72 -34.6 78.7 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 169.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.42 -55.97 27.94 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 120.159 1.345 . . . . 0.0 114.545 160.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -80.97 58.18 3.34 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 122.581 1.181 . . . . 0.0 113.165 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -86.36 -26.46 24.82 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 117.838 2.532 . . . . 0.0 117.838 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.379 19.7 p30 46.28 47.9 13.44 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 117.799 2.518 . . . . 0.0 117.799 -168.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.7 tp -73.37 124.56 25.99 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 122.113 0.958 . . . . 0.0 113.519 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -118.86 125.55 49.78 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.199 1.0 . . . . 0.0 109.032 175.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.8 mt -106.94 100.89 10.36 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.441 0.696 . . . . 0.0 109.562 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.1 m -93.25 110.14 21.66 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.466 -0.771 . . . . 0.0 108.978 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.1 mt -98.92 112.52 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -168.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.443 ' HG1' ' NZ ' ' A' ' 50' ' ' LYS . 48.5 m -111.02 104.87 13.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -88.92 112.03 22.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.078 -1.014 . . . . 0.0 112.265 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.81 78.94 2.62 Favored 'General case' 0 CA--C 1.568 1.653 0 CA-C-O 121.641 0.734 . . . . 0.0 109.943 163.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.65 -104.15 1.02 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 115.369 0.908 . . . . 0.0 115.369 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -81.03 -27.88 35.62 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 166.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -75.34 109.66 9.05 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.397 1.453 . . . . 0.0 112.173 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -90.85 106.93 18.86 Favored 'General case' 0 CA--C 1.559 1.324 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 169.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.6 m -90.14 95.93 10.43 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.1 t -99.84 108.99 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -171.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.443 ' NZ ' ' HG1' ' A' ' 41' ' ' THR . 74.8 mttt -87.72 100.46 12.85 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.709 0.804 . . . . 0.0 109.166 -173.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -92.77 86.56 5.56 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.022 0.529 . . . . 0.0 110.346 -170.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.4 t -90.53 122.19 33.13 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.01 0.524 . . . . 0.0 111.769 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.7 p -147.92 168.82 21.27 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -167.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.77 38.38 0.03 OUTLIER 'General case' 0 CA--C 1.584 2.271 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 164.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -150.59 -57.12 0.17 Allowed 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 126.533 1.933 . . . . 0.0 108.536 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -155.25 156.85 36.32 Favored 'General case' 0 CA--C 1.566 1.558 0 C-N-CA 124.232 1.013 . . . . 0.0 111.539 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -114.61 106.96 14.86 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.459 0.704 . . . . 0.0 109.336 164.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.7 pt -126.14 128.63 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.668 -0.645 . . . . 0.0 111.217 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -82.47 99.78 9.66 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 121.656 0.741 . . . . 0.0 111.972 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -85.27 100.37 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.48 110.48 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -129.92 127.97 41.2 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.358 0.599 . . . . 0.0 111.652 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.1 mp0 -71.66 141.63 49.9 Favored 'General case' 0 CA--C 1.566 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 110.915 161.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.21 109.11 1.43 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.246 -0.909 . . . . 0.0 113.141 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.84 -0.76 48.44 Favored Glycine 0 CA--C 1.553 2.46 0 N-CA-C 119.026 2.37 . . . . 0.0 119.026 -167.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.0 p -81.24 139.17 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 120.983 2.392 . . . . 0.0 113.223 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.3 m -89.03 109.51 20.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.745 -0.597 . . . . 0.0 109.67 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -138.81 162.04 35.76 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 123.325 0.65 . . . . 0.0 112.34 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -87.57 103.6 15.71 Favored 'General case' 0 CA--C 1.568 1.659 0 O-C-N 121.234 -0.916 . . . . 0.0 111.704 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -89.75 141.23 28.81 Favored 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 123.78 0.832 . . . . 0.0 111.989 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -136.73 107.5 6.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.999 -1.063 . . . . 0.0 110.856 -169.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.7 mt -77.59 88.24 3.9 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -171.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.288 . . 63.41 -53.25 0.21 Allowed 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 119.099 3.0 . . . . 0.0 119.099 174.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -91.59 -76.63 0.44 Allowed 'General case' 0 CA--C 1.572 1.792 0 CA-C-N 119.128 0.876 . . . . 0.0 110.7 170.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.73 56.81 0.1 OUTLIER Glycine 0 N--CA 1.494 2.533 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.3 m -69.76 -36.23 75.59 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.159 2.281 . . . . 0.0 117.159 -173.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 77.32 78.57 0.08 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 124.637 1.175 . . . . 0.0 112.634 164.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.0 mt -127.96 103.44 7.25 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.057 0.543 . . . . 0.0 111.286 -161.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -76.53 120.29 21.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.921 -1.112 . . . . 0.0 112.533 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.51 -169.61 42.44 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 118.098 1.999 . . . . 0.0 118.098 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 p -125.77 135.55 52.16 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 114.136 -1.032 . . . . 0.0 111.774 -164.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -95.11 116.18 28.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.754 -0.591 . . . . 0.0 110.425 164.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.8 t -109.81 132.32 54.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.9 -0.5 . . . . 0.0 111.914 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.5 tp -86.73 106.11 17.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.055 -1.028 . . . . 0.0 112.374 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -84.99 168.84 14.57 Favored 'General case' 0 CA--C 1.577 1.999 0 C-N-CA 123.518 0.727 . . . . 0.0 110.683 157.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -33.32 -63.29 0.35 Allowed Glycine 0 N--CA 1.502 3.052 0 N-CA-C 121.239 3.256 . . . . 0.0 121.239 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -108.16 17.63 22.06 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 165.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -139.37 124.19 18.6 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 121.066 1.757 . . . . 0.0 112.308 -161.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.8 mt -89.29 106.77 18.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.938 -1.101 . . . . 0.0 108.787 162.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.2 113.38 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.794 0.807 . . . . 0.0 109.998 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.99 93.02 1.33 Allowed Glycine 0 N--CA 1.479 1.534 0 C-N-CA 123.844 0.735 . . . . 0.0 112.833 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -89.33 104.29 16.85 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.511 0.672 . . . . 0.0 110.329 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -124.6 149.64 46.84 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.072 0.949 . . . . 0.0 111.972 -168.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -125.02 139.75 53.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.356 -0.84 . . . . 0.0 110.751 169.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -66.69 119.85 12.48 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.0 p -82.86 72.16 9.95 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 122.542 1.163 . . . . 0.0 109.901 167.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 175.91 -64.09 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 126.114 1.766 . . . . 0.0 107.37 -167.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -93.6 -33.31 13.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.68 -35.06 4.2 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 116.865 1.506 . . . . 0.0 116.865 -154.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -53.53 147.61 10.71 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 117.367 2.358 . . . . 0.0 117.367 -173.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -86.21 129.71 34.76 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -175.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.6 tt -113.75 124.11 51.47 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.203 1.001 . . . . 0.0 108.991 169.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -113.7 111.98 22.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.43 -0.793 . . . . 0.0 109.21 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 m -102.5 112.88 25.81 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.767 0.712 . . . . 0.0 110.315 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.4 t -97.88 88.47 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.289 -0.882 . . . . 0.0 108.694 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -79.12 106.43 11.15 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.545 0.738 . . . . 0.0 110.985 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -137.6 140.63 41.07 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -171.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.1 mp -86.65 113.76 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -96.16 91.31 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.2 -89.77 0.7 Allowed Glycine 0 N--CA 1.491 2.345 0 O-C-N 121.016 -1.052 . . . . 0.0 114.745 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -134.4 42.39 2.86 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 166.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -136.66 125.95 24.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.892 -1.13 . . . . 0.0 109.058 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.5 tp -84.23 105.6 15.21 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.88 123.1 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . 0.274 17.9 pt20 -116.85 104.04 10.91 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.373 0.606 . . . . 0.0 112.379 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.0 m -87.13 109.75 19.65 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.727 0.811 . . . . 0.0 109.974 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -87.43 113.59 23.27 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.158 0.583 . . . . 0.0 110.701 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -101.58 98.54 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -115.54 104.14 11.43 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 118.832 0.742 . . . . 0.0 110.106 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 54.64 55.02 8.42 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 174.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.15 -23.46 6.08 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 119.066 2.386 . . . . 0.0 119.066 -167.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.3 t -90.03 111.06 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 120.062 1.931 . . . . 0.0 108.929 -172.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.93 114.65 27.24 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.389 0.675 . . . . 0.0 111.405 174.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -121.12 108.35 13.7 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.319 0.647 . . . . 0.0 111.294 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.24 126.79 40.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 111.787 -176.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.7 mmm-85 -103.66 127.93 51.05 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 167.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.81 120.91 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -175.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -114.26 133.07 55.9 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.857 0.863 . . . . 0.0 111.374 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -95.5 153.69 17.58 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-O 122.155 0.979 . . . . 0.0 112.051 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -65.45 109.18 2.22 Favored 'General case' 0 CA--C 1.571 1.759 0 C-N-CA 124.097 0.959 . . . . 0.0 113.025 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 t70 . . . . . 0 N--CA 1.489 1.5 0 C-N-CA 125.188 1.395 . . . . 0.0 113.96 -178.949 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.231 0 CA-C-O 121.914 0.864 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -83.86 -69.31 0.65 Allowed 'General case' 0 CA--C 1.568 1.644 0 O-C-N 121.884 -0.51 . . . . 0.0 111.581 -170.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.9 t70 48.37 64.09 1.81 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.0 m -167.41 156.65 10.19 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 122.619 1.199 . . . . 0.0 114.147 -163.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.6 m -94.25 127.83 40.34 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.834 0.853 . . . . 0.0 110.963 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -128.03 104.87 8.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.656 -0.652 . . . . 0.0 109.875 -172.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -98.25 138.02 36.14 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.184 -0.948 . . . . 0.0 112.468 -177.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.9 p -62.92 120.97 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -99.65 -57.37 2.16 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 124.188 0.995 . . . . 0.0 112.112 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -152.84 124.43 7.76 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 119.859 1.209 . . . . 0.0 112.367 -176.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.7 p -97.02 103.45 15.38 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.585 0.754 . . . . 0.0 112.663 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -100.51 116.01 31.46 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.915 0.486 . . . . 0.0 110.323 -164.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.278 39.0 t30 65.73 20.29 11.49 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 -169.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -72.08 -36.37 69.49 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -57.33 -32.24 66.5 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.886 2.18 . . . . 0.0 116.886 169.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -71.98 -47.05 54.9 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -50.6 -52.9 34.94 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 163.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.2 mmt -47.65 -57.35 5.6 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 166.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -43.83 -52.13 6.93 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 168.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -56.7 -35.72 68.82 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 171.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 27.5 mtm -73.41 -19.81 60.89 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.37 63.59 0.98 Allowed Glycine 0 N--CA 1.491 2.321 0 CA-C-N 120.367 1.44 . . . . 0.0 114.659 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.7 m -126.91 156.08 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 121.675 0.75 . . . . 0.0 112.437 -169.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -70.28 153.2 43.32 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.857 -1.152 . . . . 0.0 113.733 168.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 11.9 tt -59.21 -38.41 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 172.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.3 t -58.7 -48.16 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 C-N-CA 123.798 0.839 . . . . 0.0 113.253 166.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -55.94 -38.86 70.88 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 167.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -57.58 -52.04 67.02 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 120.587 1.54 . . . . 0.0 115.084 168.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -60.16 -46.46 89.62 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.81 -45.94 90.29 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 171.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.09 92.67 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.84 -57.12 11.28 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 161.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -93.95 52.76 1.69 Allowed 'General case' 0 CA--C 1.575 1.938 0 CA-C-N 119.635 1.107 . . . . 0.0 113.432 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -85.44 -13.35 49.53 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 -173.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 57.93 45.46 18.21 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -174.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.8 tp -82.93 120.57 25.86 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-O 122.06 0.933 . . . . 0.0 112.39 -172.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -104.75 112.05 25.01 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.456 169.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.9 mt -90.17 100.98 13.71 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 m -93.47 92.39 7.59 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.5 mt -94.76 95.84 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -168.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 86.0 m -99.01 126.52 44.73 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.287 0.635 . . . . 0.0 109.769 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -83.18 126.08 32.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.909 . . . . 0.0 112.014 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -131.01 58.58 1.71 Allowed 'General case' 0 CA--C 1.574 1.866 0 C-N-CA 123.669 0.788 . . . . 0.0 111.869 -167.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.23 72.19 0.74 Allowed Glycine 0 N--CA 1.497 2.732 0 N-CA-C 116.591 1.397 . . . . 0.0 116.591 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.294 18.4 t30 68.63 -24.45 0.14 Allowed 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 -164.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -83.79 155.93 22.77 Favored 'General case' 0 CA--C 1.561 1.391 0 O-C-N 120.656 -1.277 . . . . 0.0 113.604 169.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -119.58 121.59 39.69 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 164.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.9 m -93.8 102.8 14.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.36 103.71 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -172.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -81.14 110.4 16.61 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -97.92 83.97 3.24 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.358 0.663 . . . . 0.0 109.733 -175.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.7 t -94.94 115.16 27.1 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.601 0.36 . . . . 0.0 111.936 -170.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.5 p -150.67 168.0 25.66 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.836 0.854 . . . . 0.0 113.134 -166.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.1 -30.03 65.95 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 118.027 2.602 . . . . 0.0 118.027 166.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -73.6 -43.96 58.36 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 167.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.55 154.65 12.07 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.82 0.848 . . . . 0.0 112.428 -165.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -119.66 108.2 14.16 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 161.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.0 pt -129.73 128.37 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.558 -0.714 . . . . 0.0 111.073 -174.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.32 99.62 12.38 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.841 0.857 . . . . 0.0 111.387 173.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.3 t -92.09 102.45 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -176.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.15 93.22 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -106.5 143.49 34.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.716 -0.615 . . . . 0.0 111.78 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -87.73 146.19 25.78 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 121.658 -0.651 . . . . 0.0 112.0 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.6 mt -70.26 109.75 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.095 -1.003 . . . . 0.0 111.839 169.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.42 52.73 2.44 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 116.394 1.318 . . . . 0.0 116.394 -171.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.5 p -143.63 138.48 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 118.327 1.064 . . . . 0.0 109.971 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.3 m -83.74 108.08 16.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.342 -0.849 . . . . 0.0 109.8 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -131.95 165.95 22.77 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-O 121.682 0.753 . . . . 0.0 112.331 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -90.1 108.77 19.94 Favored 'General case' 0 CA--C 1.571 1.779 0 O-C-N 121.619 -0.675 . . . . 0.0 111.506 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -100.5 117.68 35.15 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.742 0.817 . . . . 0.0 110.444 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -98.54 123.66 42.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.119 -0.988 . . . . 0.0 112.919 -175.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.07 158.61 25.0 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.4 69.96 2.93 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 170.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -171.8 -70.36 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 125.292 1.437 . . . . 0.0 108.273 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.45 68.24 0.01 OUTLIER Glycine 0 N--CA 1.483 1.796 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -171.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.3 m -162.14 127.74 3.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.584 -0.951 . . . . 0.0 109.846 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -97.95 126.08 43.18 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.901 0.88 . . . . 0.0 110.439 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.73 111.5 22.51 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.753 -0.592 . . . . 0.0 110.607 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -84.47 123.39 30.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.157 -0.965 . . . . 0.0 111.527 171.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.53 -168.26 39.39 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 117.659 1.824 . . . . 0.0 117.659 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 71.3 p -124.27 123.6 40.58 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.544 -0.828 . . . . 0.0 111.62 -163.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -83.98 114.67 21.87 Favored 'General case' 0 CA--C 1.57 1.735 0 O-C-N 121.992 -0.442 . . . . 0.0 111.433 163.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.532 ' HG ' ' NZ ' ' A' ' 92' ' ' LYS . 50.7 m -114.36 126.54 55.11 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 123.396 0.679 . . . . 0.0 111.071 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.2 tp -94.12 115.56 27.87 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.176 -0.953 . . . . 0.0 112.103 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -100.3 80.94 2.31 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 170.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.88 -87.23 0.55 Allowed Glycine 0 N--CA 1.494 2.515 0 O-C-N 121.052 -1.03 . . . . 0.0 115.083 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -123.39 29.4 6.67 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 166.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -125.06 109.68 13.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.461 -1.399 . . . . 0.0 108.972 177.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.81 106.4 18.44 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.354 0.661 . . . . 0.0 109.524 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.8 tt -96.93 118.67 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.866 -1.146 . . . . 0.0 110.644 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.72 98.06 2.35 Favored Glycine 0 N--CA 1.48 1.605 0 C-N-CA 123.249 0.452 . . . . 0.0 112.098 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.532 ' NZ ' ' HG ' ' A' ' 83' ' ' SER . 20.3 mttt -85.4 93.87 8.84 Favored 'General case' 0 CA--C 1.565 1.552 0 C-N-CA 123.251 0.621 . . . . 0.0 109.354 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -121.79 143.63 49.28 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.298 1.047 . . . . 0.0 113.442 -166.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -119.34 137.8 53.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.391 -0.818 . . . . 0.0 109.146 165.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -69.78 107.34 3.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 0.0 111.664 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.312 13.8 t -74.81 -5.88 45.92 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 118.139 2.644 . . . . 0.0 118.139 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -95.0 -18.1 21.36 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 158.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -123.79 -21.64 5.12 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 117.29 2.329 . . . . 0.0 117.29 -173.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.24 -30.92 7.12 Favored Glycine 0 N--CA 1.496 2.684 0 CA-C-N 121.885 2.129 . . . . 0.0 118.351 -175.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -78.76 151.56 31.96 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 118.45 1.125 . . . . 0.0 113.585 -167.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -98.63 132.62 43.89 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.599 0.714 . . . . 0.0 112.004 -164.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.3 tt -131.11 122.55 26.86 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 124.1 0.96 . . . . 0.0 109.908 -170.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -109.85 116.84 32.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.126 -0.984 . . . . 0.0 109.352 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.7 m -106.52 104.06 13.67 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 119.019 0.827 . . . . 0.0 110.008 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.5 t -92.36 107.8 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.25 -0.906 . . . . 0.0 108.675 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -85.3 103.76 14.53 Favored 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 124.074 0.95 . . . . 0.0 110.433 170.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -127.46 147.35 50.3 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 124.254 1.022 . . . . 0.0 109.534 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . 0.25 5.8 mt -113.72 117.47 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 119.771 -1.83 . . . . 0.0 111.175 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.2 tp -92.35 74.71 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.769 0 CA-C-O 122.124 0.964 . . . . 0.0 110.741 172.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.94 -98.48 0.71 Allowed Glycine 0 N--CA 1.49 2.281 0 O-C-N 121.067 -1.021 . . . . 0.0 115.193 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -80.7 -10.62 59.72 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.892 2.553 . . . . 0.0 117.892 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -128.28 127.64 43.15 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-N 119.736 1.153 . . . . 0.0 112.457 -165.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.9 tp -80.94 124.11 28.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.858 0.863 . . . . 0.0 111.147 170.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.2 m -103.17 116.54 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.524 ' NE2' ' HH ' ' A' ' 117' ' ' TYR . 21.2 mt-30 -91.13 103.49 16.18 Favored 'General case' 0 CA--C 1.558 1.281 0 O-C-N 121.277 -0.889 . . . . 0.0 109.093 167.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.4 m -90.66 104.57 17.14 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.524 ' HH ' ' NE2' ' A' ' 115' ' ' GLN . 70.3 m-85 -92.16 106.92 18.83 Favored 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 123.76 0.824 . . . . 0.0 110.621 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.89 111.39 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -142.04 110.82 6.19 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.988 0.515 . . . . 0.0 110.463 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 54.31 50.52 16.14 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 168.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.69 38.01 44.1 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 118.507 2.163 . . . . 0.0 118.507 -170.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.55 148.15 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 118.812 1.306 . . . . 0.0 110.216 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -130.06 115.82 17.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.729 -0.607 . . . . 0.0 109.981 171.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.22 127.3 54.64 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.009 0.524 . . . . 0.0 112.276 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -108.71 105.09 14.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.595 -0.691 . . . . 0.0 110.099 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -87.85 115.13 25.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.346 -0.847 . . . . 0.0 110.494 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 22.7 mt -99.53 123.16 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -120.99 119.54 32.83 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 124.291 1.036 . . . . 0.0 109.604 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -80.36 142.85 34.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.913 -1.117 . . . . 0.0 113.073 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 52.6 tttt -69.34 113.67 6.87 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.7 t70 . . . . . 0 N--CA 1.49 1.552 0 C-N-CA 124.761 1.224 . . . . 0.0 113.734 172.675 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.349 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 60.03 65.12 1.15 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 172.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -148.99 81.29 1.43 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.659 -0.651 . . . . 0.0 110.431 -176.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.3 m -171.95 170.26 5.45 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.577 1.179 . . . . 0.0 111.763 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.2 m -90.39 130.73 36.44 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.912 -1.117 . . . . 0.0 110.712 170.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -135.39 113.56 11.33 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.576 -0.703 . . . . 0.0 109.762 -171.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -116.13 143.38 45.56 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.651 -1.281 . . . . 0.0 113.649 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.88 115.86 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -168.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.08 -48.75 7.19 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 124.388 1.075 . . . . 0.0 112.86 169.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -136.61 109.73 7.75 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 119.377 0.99 . . . . 0.0 110.225 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.0 p -91.98 101.06 13.61 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.018 -1.051 . . . . 0.0 111.013 167.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -106.96 113.11 26.39 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -165.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.294 13.1 t30 69.67 16.65 7.94 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 117.53 2.419 . . . . 0.0 117.53 -176.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -66.73 -37.92 85.62 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.44 -43.17 83.68 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 167.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -69.29 -43.15 74.44 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 171.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -48.62 -54.34 15.0 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 162.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 mtt -66.7 -24.7 66.29 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 170.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.65 -42.92 81.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.295 -1.503 . . . . 0.0 114.216 164.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -57.47 -33.15 67.69 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 163.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 mmt -64.05 -42.58 96.99 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 164.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.87 56.35 0.96 Allowed Glycine 0 N--CA 1.485 1.951 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -117.44 147.86 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-N 117.983 0.892 . . . . 0.0 112.512 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -56.45 139.72 48.16 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.297 0.0 OUTLIER -47.35 -45.54 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 178.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.4 t -55.07 -60.02 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 C-N-CA 124.288 1.035 . . . . 0.0 113.643 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -63.19 -38.73 92.31 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -58.03 -49.67 76.09 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 170.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -59.18 -47.77 84.08 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 167.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.4 mt -59.0 -41.5 87.8 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 171.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.86 -41.46 87.27 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.84 -52.79 64.02 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 161.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -91.4 35.72 0.94 Allowed 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -77.89 -22.68 49.36 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 66.61 60.6 0.57 Allowed 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 120.472 1.487 . . . . 0.0 113.056 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.4 tp -86.7 120.87 28.46 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 121.415 -0.803 . . . . 0.0 112.979 -171.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -98.4 121.2 40.03 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 124.53 1.132 . . . . 0.0 110.355 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.4 mt -101.76 101.64 12.15 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 123.709 0.804 . . . . 0.0 109.253 174.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.4 m -88.84 95.03 10.13 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.155 -0.966 . . . . 0.0 108.775 172.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 73.6 mt -93.06 118.7 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -173.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -137.01 146.78 45.71 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 123.33 0.652 . . . . 0.0 110.725 171.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -130.53 157.92 41.37 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -127.55 84.23 2.23 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-N 114.482 -1.235 . . . . 0.0 108.706 167.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.73 -82.2 0.84 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 116.206 1.243 . . . . 0.0 116.206 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -116.07 -16.33 11.05 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 168.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -85.79 131.19 34.37 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 121.245 1.839 . . . . 0.0 111.833 173.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -113.61 131.16 56.22 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 124.363 1.065 . . . . 0.0 110.023 177.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 m -103.71 111.87 24.55 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 163.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.7 t -108.99 102.87 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -84.98 109.82 18.45 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -108.16 103.95 13.25 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.896 0.478 . . . . 0.0 110.043 -166.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 t -115.32 118.95 34.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.305 0.642 . . . . 0.0 111.745 -172.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.5 p -138.38 175.5 9.52 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.779 0.8 . . . . 0.0 112.965 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.74 62.26 1.05 Allowed 'General case' 0 CA--C 1.576 1.98 0 O-C-N 120.395 -1.441 . . . . 0.0 113.54 153.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -169.18 -61.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.932 1.293 . . . . 0.0 109.225 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.411 ' HG3' HH11 ' A' ' 56' ' ' ARG . 32.0 ptt85 -142.47 141.49 32.16 Favored 'General case' 0 CA--C 1.567 1.608 0 C-N-CA 124.035 0.934 . . . . 0.0 110.545 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -129.68 92.43 3.33 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.17 153.02 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 CA-C-O 121.91 0.862 . . . . 0.0 111.879 -170.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.38 108.41 18.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.932 . . . . 0.0 110.564 168.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.84 97.77 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.3 t -102.7 125.65 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -173.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -150.77 151.05 31.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.606 -0.684 . . . . 0.0 111.662 -176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -97.3 143.82 27.69 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.285 -0.885 . . . . 0.0 111.004 165.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.8 mt -57.35 122.03 11.59 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.88 -4.77 73.47 Favored Glycine 0 CA--C 1.555 2.537 0 N-CA-C 119.868 2.707 . . . . 0.0 119.868 -170.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -93.64 132.18 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-N 120.489 2.144 . . . . 0.0 109.769 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -74.94 117.98 17.39 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -134.8 161.09 36.16 Favored 'General case' 0 CA--C 1.571 1.753 0 C-N-CA 123.844 0.858 . . . . 0.0 112.013 -176.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -89.41 115.89 27.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.357 -0.84 . . . . 0.0 111.88 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -113.23 129.92 56.38 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 123.868 0.867 . . . . 0.0 111.129 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -98.49 131.32 44.83 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.996 -1.065 . . . . 0.0 110.895 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.6 mt -62.89 -56.1 20.23 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 170.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -154.95 -65.15 0.13 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 119.116 0.871 . . . . 0.0 111.948 177.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -84.16 -76.08 0.31 Allowed 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.396 0.679 . . . . 0.0 111.96 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.66 58.23 0.4 Allowed Glycine 0 N--CA 1.488 2.151 0 CA-C-N 118.795 0.725 . . . . 0.0 114.51 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 m -105.94 90.95 3.53 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -82.59 117.67 22.73 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.936 0.874 . . . . 0.0 112.44 -168.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.8 mt -115.58 108.66 16.71 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.671 0.789 . . . . 0.0 109.393 -171.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -98.1 96.72 8.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.758 -0.589 . . . . 0.0 110.669 -170.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.29 -153.46 10.97 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 116.338 1.295 . . . . 0.0 116.338 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.7 p -129.68 128.8 43.29 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -152.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -91.22 119.51 31.36 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.057 -1.027 . . . . 0.0 109.393 158.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.3 m -122.02 136.04 54.89 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.267 0.556 . . . . 0.0 111.308 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.8 tp -86.12 109.11 18.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.961 -1.087 . . . . 0.0 111.138 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.23 15.08 2.55 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 171.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.09 -80.53 0.27 Allowed Glycine 0 N--CA 1.488 2.148 0 O-C-N 120.827 -1.171 . . . . 0.0 112.087 -170.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -83.89 -28.8 27.67 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -125.45 140.06 53.1 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.781 1.173 . . . . 0.0 111.556 -165.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.5 mt -89.24 104.54 17.08 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 167.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.1 pt -93.97 116.41 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.997 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.82 99.95 2.61 Favored Glycine 0 N--CA 1.482 1.703 0 C-N-CA 123.591 0.615 . . . . 0.0 112.944 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -97.05 98.44 10.06 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -128.61 167.39 17.23 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-O 123.338 1.542 . . . . 0.0 111.657 -170.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.0 154.64 36.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.706 -1.246 . . . . 0.0 110.256 165.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -70.66 109.99 5.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 112.195 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.8 t -66.4 -17.87 65.03 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -84.96 -22.21 29.26 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 165.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -120.12 -22.49 6.63 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.98 -39.4 2.78 Favored Glycine 0 N--CA 1.492 2.37 0 CA-C-N 121.37 1.895 . . . . 0.0 117.258 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -72.05 144.86 48.6 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -165.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.66 140.39 55.46 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -173.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.1 tt -126.16 127.24 45.41 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.549 0.69 . . . . 0.0 111.323 167.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -96.67 149.08 22.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.506 -0.746 . . . . 0.0 110.604 163.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.4 m -145.32 105.54 4.06 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 119.928 -1.732 . . . . 0.0 109.589 162.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.7 t -93.11 114.26 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.094 -1.004 . . . . 0.0 109.03 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.4 mtm-85 -89.05 121.57 31.53 Favored 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 123.787 0.835 . . . . 0.0 111.265 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -143.61 141.48 30.64 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 123.671 0.788 . . . . 0.0 110.424 -177.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.29 126.57 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 120.733 -1.23 . . . . 0.0 109.759 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.1 tp -116.52 91.68 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.754 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 164.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.04 -112.32 4.15 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 120.898 -1.126 . . . . 0.0 114.611 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -99.62 20.31 14.22 Favored 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 167.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -126.14 127.16 45.32 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.788 1.176 . . . . 0.0 111.056 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.5 tp -87.62 114.78 24.54 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.241 1.016 . . . . 0.0 109.982 171.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.4 m -91.35 119.43 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.585 -0.697 . . . . 0.0 109.876 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -99.71 103.68 15.36 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 166.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.5 m -89.81 94.96 10.03 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -81.08 131.45 35.3 Favored 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 123.944 0.898 . . . . 0.0 111.249 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.1 t -134.98 114.37 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 CA-C-N 119.147 0.885 . . . . 0.0 109.274 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -113.94 122.12 45.99 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.31 5.2 mm-40 70.69 -85.47 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 124.23 1.012 . . . . 0.0 112.0 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -151.22 50.49 0.53 Allowed Glycine 0 N--CA 1.487 2.1 0 CA-C-O 119.416 -0.658 . . . . 0.0 114.109 158.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.35 109.08 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -77.81 129.61 35.65 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -124.08 114.3 19.53 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.532 0.682 . . . . 0.0 110.622 163.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -99.7 104.39 16.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.861 -0.525 . . . . 0.0 109.683 -176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 -93.3 112.7 24.7 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.531 0.682 . . . . 0.0 109.612 172.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.8 mt -99.1 114.74 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.555 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -173.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -108.44 111.33 23.17 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.685 0.794 . . . . 0.0 109.891 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -79.97 144.79 32.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.003 -1.061 . . . . 0.0 112.467 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -66.1 120.34 13.02 Favored 'General case' 0 CA--C 1.569 1.692 0 CA-C-O 121.684 0.754 . . . . 0.0 112.961 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.8 t70 . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -158.895 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.347 0 CA-C-O 122.106 0.955 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 55.01 35.03 23.75 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 171.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -146.71 51.82 1.11 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.379 -1.45 . . . . 0.0 113.78 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 p -160.87 176.75 11.1 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.127 -0.983 . . . . 0.0 113.593 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.4 m -78.4 116.58 18.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.72 . . . . 0.0 110.264 160.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -109.73 111.34 22.73 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -95.04 138.65 32.48 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.429 -0.794 . . . . 0.0 111.75 -177.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.02 122.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -110.29 -55.62 2.44 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.581 0.752 . . . . 0.0 112.742 -174.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -158.56 119.8 3.43 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 120.042 1.292 . . . . 0.0 111.064 -171.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.0 p -110.29 124.72 52.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.031 -1.043 . . . . 0.0 113.099 -174.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -78.43 -48.4 15.5 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -170.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -134.83 54.75 1.93 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 119.97 1.259 . . . . 0.0 112.599 168.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -84.45 58.77 5.04 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.018 -1.676 . . . . 0.0 112.419 167.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -151.61 -61.19 0.17 Allowed 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 125.101 1.36 . . . . 0.0 109.43 -176.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -62.02 -48.95 77.97 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 120.846 1.657 . . . . 0.0 114.096 170.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -47.65 -52.8 16.83 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 163.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.8 mtp -55.17 -49.14 72.62 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 171.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -52.84 -46.38 67.78 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 165.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -60.13 -36.22 77.0 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 170.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.7 mtm -72.34 -59.14 2.88 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 119.607 1.094 . . . . 0.0 113.114 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.89 72.14 0.02 OUTLIER Glycine 0 N--CA 1.487 2.047 0 CA-C-N 118.268 0.486 . . . . 0.0 113.779 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 m -118.36 155.44 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-O 122.025 0.917 . . . . 0.0 112.605 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -79.2 153.29 30.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.353 -0.842 . . . . 0.0 110.921 152.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.29 12.9 tt -56.78 -37.61 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 172.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.9 t -58.75 -53.73 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 C-N-CA 124.362 1.065 . . . . 0.0 113.276 166.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -55.34 -36.16 65.98 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 168.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -57.36 -52.08 66.81 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 172.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -64.61 -44.74 89.59 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 166.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -60.98 -58.06 10.02 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.66 -15.9 63.82 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 173.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.96 -52.47 42.41 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 156.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -91.51 -18.31 24.33 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 118.216 2.673 . . . . 0.0 118.216 -172.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -73.32 62.17 0.69 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 50.12 51.58 16.41 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 163.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 tt -91.07 109.55 20.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.116 -0.99 . . . . 0.0 111.588 -170.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -97.75 138.15 35.55 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-O 121.848 0.832 . . . . 0.0 111.937 166.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.2 mt -103.91 97.41 7.41 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 164.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.2 m -88.26 103.43 15.79 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.173 -0.955 . . . . 0.0 108.907 176.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.3 mt -94.01 108.58 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -168.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 m -105.26 111.19 23.84 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -87.34 137.92 31.92 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -135.84 80.36 1.82 Allowed 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 124.123 0.969 . . . . 0.0 109.166 172.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.12 -89.58 0.5 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 116.061 1.184 . . . . 0.0 116.061 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.13 15.33 19.5 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 167.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -134.3 116.13 14.91 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 119.942 1.246 . . . . 0.0 110.259 -166.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -104.8 129.53 53.06 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.715 -0.616 . . . . 0.0 110.847 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.1 m -100.77 104.43 15.69 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 164.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.2 t -101.47 108.39 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -80.21 110.35 15.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 111.003 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -83.73 95.07 8.29 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 t -116.55 114.71 24.53 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.005 0.907 . . . . 0.0 111.31 -170.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.8 t -154.53 175.41 13.65 Favored 'General case' 0 CA--C 1.572 1.8 0 C-N-CA 125.968 1.707 . . . . 0.0 109.087 -171.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.2 -27.11 63.59 Favored 'General case' 0 CA--C 1.581 2.171 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 155.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -85.42 -32.58 22.27 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.1 mmt-85 -137.42 140.41 41.3 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.197 0.908 . . . . 0.0 110.32 -175.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -135.33 76.07 1.6 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 158.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.3 142.6 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 122.026 0.917 . . . . 0.0 111.058 -168.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.4 113.67 26.0 Favored 'General case' 0 CA--C 1.564 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 111.461 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.1 t -90.93 98.35 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.5 t -91.6 119.4 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -136.6 129.78 31.31 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.159 0.504 . . . . 0.0 112.315 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.12 135.82 33.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.801 -0.562 . . . . 0.0 110.5 164.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.43 125.24 22.94 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.75 -16.76 44.37 Favored Glycine 0 CA--C 1.556 2.601 0 N-CA-C 119.447 2.539 . . . . 0.0 119.447 -167.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.0 t -86.21 130.28 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 CA-C-N 120.561 2.18 . . . . 0.0 109.98 -177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.0 t -74.44 121.33 21.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.575 -0.703 . . . . 0.0 112.76 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -142.58 164.72 29.36 Favored 'General case' 0 CA--C 1.573 1.86 0 C-N-CA 123.333 0.653 . . . . 0.0 111.775 -172.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -87.45 116.33 25.49 Favored 'General case' 0 CA--C 1.569 1.696 0 O-C-N 121.339 -0.851 . . . . 0.0 112.909 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -98.99 143.41 29.3 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.876 0.87 . . . . 0.0 111.231 166.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -120.59 132.63 55.24 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.983 0.897 . . . . 0.0 110.682 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.8 mt -84.54 168.19 15.63 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 121.979 0.895 . . . . 0.0 112.9 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.11 -36.67 80.33 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 118.94 2.941 . . . . 0.0 118.94 -173.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.34 -76.48 0.1 Allowed 'General case' 0 CA--C 1.571 1.775 0 CA-C-N 120.113 1.324 . . . . 0.0 111.697 169.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.44 64.0 0.05 OUTLIER Glycine 0 N--CA 1.483 1.806 0 O-C-N 121.841 -0.537 . . . . 0.0 112.543 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.8 m -123.04 107.17 11.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -95.26 128.91 42.47 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-O 122.07 0.938 . . . . 0.0 111.419 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.3 mt -132.69 116.24 16.37 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.076 -156.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -92.47 118.68 31.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.475 -0.765 . . . . 0.0 110.667 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.76 -177.92 42.45 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 117.981 1.953 . . . . 0.0 117.981 -173.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.6 p -126.28 132.13 51.73 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 113.972 -1.114 . . . . 0.0 110.37 -173.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -92.59 122.66 35.23 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.335 -0.853 . . . . 0.0 110.541 169.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.3 m -109.66 118.81 37.53 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.318 0.647 . . . . 0.0 110.831 175.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.5 tp -82.83 103.93 12.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.515 -0.74 . . . . 0.0 111.85 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -105.25 89.78 3.23 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.191 0.52 . . . . 0.0 110.26 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.69 -94.49 0.76 Allowed Glycine 0 N--CA 1.492 2.389 0 O-C-N 121.501 -0.75 . . . . 0.0 113.782 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -127.36 48.4 2.23 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 159.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -129.8 111.87 13.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.089 -1.007 . . . . 0.0 108.49 173.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.4 mt -84.55 108.37 17.28 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.439 -0.788 . . . . 0.0 109.452 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.0 mt -102.22 104.22 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -172.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.51 100.71 2.67 Favored Glycine 0 N--CA 1.483 1.812 0 C-N-CA 123.886 0.755 . . . . 0.0 113.096 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.52 95.92 9.91 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.973 0.509 . . . . 0.0 109.729 -175.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -110.76 147.75 33.78 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.589 0.709 . . . . 0.0 112.868 -171.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -119.04 139.43 51.74 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.644 0.778 . . . . 0.0 109.131 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -69.17 114.9 7.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.928 -1.107 . . . . 0.0 112.885 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 t -66.09 -16.77 64.22 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 117.916 2.562 . . . . 0.0 117.916 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -92.56 -10.65 36.84 Favored 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 165.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -141.15 -16.9 0.83 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 -169.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.94 -42.5 2.76 Favored Glycine 0 N--CA 1.493 2.458 0 CA-C-N 121.949 2.159 . . . . 0.0 117.707 -175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -70.24 147.91 49.19 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -161.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -77.43 132.2 38.36 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -173.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.0 tt -123.61 111.45 16.25 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 124.352 1.061 . . . . 0.0 108.751 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -101.63 113.62 26.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.104 -0.997 . . . . 0.0 109.577 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.0 m -107.2 108.69 20.24 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 119.196 0.907 . . . . 0.0 111.027 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.2 97.86 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.006 -1.059 . . . . 0.0 108.376 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -86.89 117.91 25.93 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.088 0.955 . . . . 0.0 110.899 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -146.97 142.81 27.92 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.326 -0.859 . . . . 0.0 112.864 -178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.2 mp -90.84 110.01 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.0 tp -90.07 80.42 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.119 0.962 . . . . 0.0 110.155 169.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.67 -88.92 0.74 Allowed Glycine 0 N--CA 1.49 2.266 0 O-C-N 121.209 -0.932 . . . . 0.0 114.933 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -117.84 22.05 12.52 Favored 'General case' 0 CA--C 1.581 2.171 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 175.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -137.99 123.6 19.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.53 -1.356 . . . . 0.0 109.858 -175.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.7 tp -78.49 110.03 13.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.524 -0.735 . . . . 0.0 110.127 168.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.89 118.12 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.277 -0.89 . . . . 0.0 108.871 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . 0.269 21.3 pt20 -103.52 104.42 14.49 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.777 0.799 . . . . 0.0 110.724 172.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.0 m -91.56 108.39 19.87 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.755 0.822 . . . . 0.0 109.152 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -94.14 112.13 23.92 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.386 0.674 . . . . 0.0 110.865 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.01 97.39 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -109.6 113.19 25.76 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.152 0.581 . . . . 0.0 109.873 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 54.78 46.14 25.2 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.04 -25.23 4.86 Favored Glycine 0 CA--C 1.556 2.65 0 N-CA-C 119.125 2.41 . . . . 0.0 119.125 -166.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.5 t -83.6 108.61 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 119.989 1.894 . . . . 0.0 110.069 -168.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -86.46 119.47 26.76 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.151 0.58 . . . . 0.0 112.479 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -124.97 117.0 23.06 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.645 0.778 . . . . 0.0 111.888 175.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -106.45 108.68 20.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.537 -0.727 . . . . 0.0 110.174 -170.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -97.43 116.01 28.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.911 -0.493 . . . . 0.0 110.482 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.7 mt -90.48 118.81 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -111.63 123.83 51.05 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.372 1.069 . . . . 0.0 109.221 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -83.92 148.35 26.99 Favored 'General case' 0 CA--C 1.565 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 112.721 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -59.24 113.42 2.13 Favored 'General case' 0 CA--C 1.57 1.735 0 C-N-CA 123.687 0.795 . . . . 0.0 113.05 167.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 N--CA 1.489 1.488 0 C-N-CA 124.949 1.3 . . . . 0.0 113.096 -175.139 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.282 0 CA-C-O 121.231 0.539 . . . . 0.0 111.984 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.327 62.9 m-85 71.43 -49.38 0.68 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.13 93.88 1.09 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 120.259 1.39 . . . . 0.0 112.374 -170.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.4 m -176.76 166.45 2.57 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 122.651 1.215 . . . . 0.0 111.805 -163.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.3 m -94.94 122.79 37.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.485 -0.759 . . . . 0.0 110.326 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -127.14 111.79 14.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.762 -0.586 . . . . 0.0 109.691 -170.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -105.34 133.19 50.51 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.977 -1.077 . . . . 0.0 112.011 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.58 115.79 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -98.47 -54.71 2.96 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 124.483 1.113 . . . . 0.0 111.85 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 56.1 mtm-85 -133.79 106.98 7.62 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.427 1.012 . . . . 0.0 109.458 -177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.5 p -94.34 97.74 10.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.856 -0.527 . . . . 0.0 111.196 174.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.4 127.03 52.76 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.157 0.583 . . . . 0.0 110.06 -159.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.269 37.8 t30 62.76 40.45 9.97 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -169.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -77.99 -49.82 13.32 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -172.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.02 -40.79 77.38 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 171.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -62.76 -47.65 82.6 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.21 1.368 . . . . 0.0 114.629 171.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -53.52 -53.03 57.39 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 166.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.9 mtp -60.83 -41.89 96.65 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -60.02 -42.52 94.51 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 165.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -40.69 73.89 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 166.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 56.6 mtm -61.84 -54.77 37.6 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-N 119.552 1.069 . . . . 0.0 112.763 166.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.99 54.83 0.08 OUTLIER Glycine 0 N--CA 1.487 2.041 0 CA-C-O 119.122 -0.821 . . . . 0.0 113.909 164.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.4 m -126.77 151.18 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 122.651 1.215 . . . . 0.0 112.911 -169.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -72.77 164.48 26.49 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.259 14.0 tt -55.43 -36.86 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 175.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.9 t -65.18 -51.57 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-N 120.09 1.314 . . . . 0.0 112.658 173.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -52.16 -47.08 65.66 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 166.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -57.87 -48.51 79.63 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -60.91 -46.25 91.42 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 171.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.5 mt -60.59 -48.16 83.02 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 171.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.24 -21.14 62.16 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.11 -49.36 15.44 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 120.962 1.71 . . . . 0.0 114.415 167.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -77.91 17.62 0.56 Allowed 'General case' 0 CA--C 1.58 2.124 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 175.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.2 p30 -74.94 -17.91 60.48 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 118.93 2.937 . . . . 0.0 118.93 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 61.53 62.19 1.36 Allowed 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 120.562 1.528 . . . . 0.0 113.484 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 tt -88.56 117.52 27.57 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.418 -0.801 . . . . 0.0 112.257 -164.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -101.21 127.83 47.6 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.54 0.736 . . . . 0.0 110.173 173.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.4 mt -98.48 102.4 14.13 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 166.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.5 m -94.62 107.56 19.55 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.098 -1.002 . . . . 0.0 108.441 171.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.7 mt -104.07 129.01 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -165.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 89.3 m -135.53 123.54 22.8 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.271 -0.893 . . . . 0.0 109.326 174.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.7 tm0? -98.74 132.94 43.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.321 -0.862 . . . . 0.0 112.186 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -127.69 87.6 2.65 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 123.565 0.746 . . . . 0.0 110.947 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.78 -89.5 0.96 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 115.139 0.816 . . . . 0.0 115.139 173.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -108.65 -2.5 18.68 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 166.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -108.99 144.13 37.37 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.34 1.427 . . . . 0.0 112.415 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -110.19 120.42 42.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.4 0.68 . . . . 0.0 109.986 167.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.1 m -86.41 102.72 14.3 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 164.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.3 t -104.6 101.52 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -83.8 107.44 16.21 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.262 -0.899 . . . . 0.0 110.017 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -86.6 92.9 9.05 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.005 0.522 . . . . 0.0 110.066 176.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.3 m -96.24 108.72 21.24 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 120.941 0.4 . . . . 0.0 109.991 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.3 p -143.51 158.02 43.98 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.468 0.651 . . . . 0.0 111.776 -174.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.61 -25.0 64.27 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.429 2.381 . . . . 0.0 117.429 165.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -53.96 15.66 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 165.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.79 152.52 25.19 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-N 119.148 0.886 . . . . 0.0 111.676 174.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -106.08 98.14 7.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.689 -0.632 . . . . 0.0 109.837 166.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.2 pt -122.93 132.85 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 121.989 0.9 . . . . 0.0 111.765 -174.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -94.85 98.46 10.75 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.693 0.797 . . . . 0.0 108.917 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.45 93.3 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -166.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.6 t -94.21 98.42 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -176.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -109.88 141.49 42.52 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.285 0.564 . . . . 0.0 112.116 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.38 138.75 31.16 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.465 0.65 . . . . 0.0 111.292 166.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.66 129.03 39.08 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.95 -7.12 63.95 Favored Glycine 0 CA--C 1.555 2.569 0 N-CA-C 119.969 2.748 . . . . 0.0 119.969 -170.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.9 t -97.78 133.74 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 120.634 2.217 . . . . 0.0 110.414 -170.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.7 p -74.57 104.35 5.23 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.439 0.696 . . . . 0.0 112.626 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -118.07 138.74 52.03 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 123.292 0.637 . . . . 0.0 111.928 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 -74.77 115.37 14.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.581 -0.7 . . . . 0.0 112.244 172.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -111.56 152.02 28.04 Favored 'General case' 0 CA--C 1.569 1.689 0 C-N-CA 124.093 0.957 . . . . 0.0 112.591 -175.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -119.81 136.39 54.48 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.086 0.954 . . . . 0.0 111.633 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.2 mt -105.99 64.12 0.68 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.292 -0.88 . . . . 0.0 113.097 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.32 . . 66.47 -66.76 0.17 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.29 -22.33 41.02 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 119.926 3.306 . . . . 0.0 119.926 176.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.49 21.94 8.93 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 118.229 2.052 . . . . 0.0 118.229 -170.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 83.8 m -82.32 108.01 15.43 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 119.763 1.782 . . . . 0.0 109.334 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -78.33 128.57 33.86 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.267 0.627 . . . . 0.0 112.342 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.0 mt -140.37 105.1 4.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.993 -0.442 . . . . 0.0 110.759 -166.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -81.76 123.79 29.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.654 -1.279 . . . . 0.0 110.896 171.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.22 176.84 40.12 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 118.649 2.22 . . . . 0.0 118.649 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.5 p -126.03 130.2 50.69 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 113.674 -1.263 . . . . 0.0 110.866 -169.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -97.72 123.48 41.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.677 -0.639 . . . . 0.0 111.744 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.2 m -106.07 120.19 41.15 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.408 0.683 . . . . 0.0 110.67 172.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.3 tp -84.22 121.14 27.07 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.336 0.588 . . . . 0.0 111.542 175.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -89.43 -48.21 7.49 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 164.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.56 -87.05 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 CA-C-N 119.177 0.899 . . . . 0.0 110.988 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -82.17 -4.32 56.75 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 156.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.98 138.15 43.69 Favored 'General case' 0 CA--C 1.57 1.714 0 C-N-CA 125.183 1.393 . . . . 0.0 111.69 174.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mt -130.12 124.56 33.0 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 169.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.15 119.4 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.17 -0.956 . . . . 0.0 110.377 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.22 108.78 3.12 Favored Glycine 0 N--CA 1.486 1.99 0 C-N-CA 123.587 0.613 . . . . 0.0 112.972 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.57 94.12 7.57 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.2 0.6 . . . . 0.0 110.652 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.94 142.13 41.73 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -170.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -124.72 138.3 54.29 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.305 1.042 . . . . 0.0 108.194 174.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.79 107.94 9.47 Favored 'General case' 0 CA--C 1.568 1.672 0 O-C-N 120.817 -1.177 . . . . 0.0 113.67 -168.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.6 p -78.11 69.75 4.37 Favored 'General case' 0 N--CA 1.506 2.342 0 CA-C-O 124.067 1.889 . . . . 0.0 112.442 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.8 t70 169.15 -51.89 0.01 OUTLIER 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 113.028 -1.896 . . . . 0.0 109.047 -148.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -142.12 -5.48 0.99 Allowed 'General case' 0 CA--C 1.582 2.18 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.4 -40.39 2.94 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 118.501 2.16 . . . . 0.0 118.501 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -60.6 149.69 34.1 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -165.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.12 127.74 32.98 Favored 'General case' 0 CA--C 1.565 1.545 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -169.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.1 tt -119.74 115.29 23.61 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 124.524 1.13 . . . . 0.0 108.296 174.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -101.97 118.23 36.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.037 -1.039 . . . . 0.0 110.902 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.2 m -100.28 111.07 23.32 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 73.9 t -97.72 108.59 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -95.44 129.41 42.61 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.419 0.688 . . . . 0.0 110.791 170.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -145.33 137.42 25.66 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.854 -0.529 . . . . 0.0 111.216 172.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.4 mp -87.6 109.35 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 173.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.253 11.3 tp -92.35 74.14 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 122.221 1.01 . . . . 0.0 110.378 168.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.72 -98.11 0.67 Allowed Glycine 0 N--CA 1.489 2.216 0 O-C-N 121.09 -1.006 . . . . 0.0 115.481 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -87.85 -2.14 58.42 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 174.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -132.2 125.9 32.27 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 119.585 1.084 . . . . 0.0 110.586 -168.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.3 tp -83.13 114.98 21.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.48 -0.763 . . . . 0.0 109.643 168.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.9 m -92.49 105.12 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -101.39 98.96 9.26 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.8 m -102.21 118.15 36.27 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.668 0.787 . . . . 0.0 110.397 -169.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -100.23 107.21 18.99 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.715 0.806 . . . . 0.0 110.888 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.2 t -106.33 107.83 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -118.34 118.94 33.15 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.184 0.593 . . . . 0.0 110.624 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.328 51.9 mt-10 66.2 -81.91 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 124.677 1.191 . . . . 0.0 113.43 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -146.69 45.76 0.77 Allowed Glycine 0 N--CA 1.489 2.21 0 CA-C-O 119.233 -0.76 . . . . 0.0 114.941 158.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.7 t -135.49 117.15 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -100.95 124.12 46.17 Favored 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 123.655 0.782 . . . . 0.0 111.845 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.81 120.01 37.87 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.057 0.543 . . . . 0.0 112.029 170.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -98.63 101.73 13.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.705 -0.622 . . . . 0.0 110.845 -176.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -84.18 111.31 19.24 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 121.072 0.463 . . . . 0.0 110.272 169.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 95.9 mt -90.6 117.45 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -106.57 120.54 42.21 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.4 0.68 . . . . 0.0 109.732 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -84.84 143.32 29.15 Favored 'General case' 0 CA--C 1.566 1.581 0 O-C-N 121.674 -0.641 . . . . 0.0 111.831 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -62.9 105.41 0.67 Allowed 'General case' 0 CA--C 1.572 1.805 0 O-C-N 121.465 -0.772 . . . . 0.0 112.905 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 N--CA 1.493 1.706 0 C-N-CA 124.763 1.225 . . . . 0.0 113.462 -170.95 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.238 0 CA-C-O 121.063 0.459 . . . . 0.0 111.392 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 66.6 82.25 0.19 Allowed 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 124.398 1.079 . . . . 0.0 112.44 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -152.64 74.01 1.04 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.996 -1.065 . . . . 0.0 112.338 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.0 p -159.1 -179.01 7.63 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.181 0.991 . . . . 0.0 113.416 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.2 m -86.92 119.67 27.38 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.873 0.869 . . . . 0.0 110.131 172.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -120.71 98.22 5.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.654 -0.654 . . . . 0.0 109.961 -173.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -88.58 138.35 31.5 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.333 -0.854 . . . . 0.0 112.168 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.43 125.13 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -95.46 -52.71 4.03 Favored 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 124.647 1.179 . . . . 0.0 112.841 172.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.8 ptt85 -159.7 128.75 5.17 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 120.041 1.291 . . . . 0.0 112.131 -168.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.6 p -97.09 101.82 13.47 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.829 0.852 . . . . 0.0 112.135 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -97.17 112.36 24.18 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.837 -0.54 . . . . 0.0 109.99 -166.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.266 41.9 t30 62.02 24.39 14.51 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -170.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -74.78 -32.97 62.18 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -172.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -53.04 -42.01 65.34 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 164.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -64.17 -47.64 79.08 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 173.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -52.08 -54.04 35.06 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 166.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -34.43 77.7 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 171.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -58.85 -48.53 81.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.272 -1.518 . . . . 0.0 114.559 165.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -55.16 -34.64 63.98 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 166.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.3 mmt -68.31 -37.33 80.49 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 168.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.39 56.4 0.69 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 115.983 1.153 . . . . 0.0 115.983 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 p -124.83 156.31 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-O 122.348 1.07 . . . . 0.0 111.789 173.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -66.09 157.79 30.19 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.288 12.4 tt -58.72 -38.95 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -64.2 -55.38 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.181 0.9 . . . . 0.0 112.708 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -57.76 -30.12 65.37 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 167.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -60.19 -55.73 30.22 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 167.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -61.05 -37.78 83.86 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.7 mt -61.15 -48.52 81.2 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 164.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.36 -41.0 75.44 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 171.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.02 -47.95 74.03 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 164.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -114.99 36.84 3.69 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -79.67 43.82 0.59 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.338 20.0 p30 36.74 37.19 0.06 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 119.956 3.317 . . . . 0.0 119.956 -174.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 tt -75.51 115.22 14.95 Favored 'General case' 0 CA--C 1.558 1.256 0 O-C-N 120.91 -1.119 . . . . 0.0 112.844 -158.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -106.31 110.63 22.92 Favored 'General case' 0 CA--C 1.558 1.26 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.036 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.7 mt -86.65 97.05 10.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 169.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 86.5 m -86.45 92.49 8.86 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.9 mt -87.57 120.88 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 -174.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.9 p -122.95 108.22 12.71 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -84.87 130.55 34.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.542 -0.724 . . . . 0.0 111.652 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -135.88 68.54 1.45 Allowed 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.198 0.599 . . . . 0.0 110.742 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.65 76.31 0.25 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 116.79 1.476 . . . . 0.0 116.79 176.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.321 8.0 m120 73.03 -37.64 0.39 Allowed 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -170.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -67.06 135.07 53.09 Favored 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 119.701 1.137 . . . . 0.0 112.989 162.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -121.51 115.08 22.18 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 168.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.3 m -94.96 103.37 15.22 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 172.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 52.9 t -110.85 110.85 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -171.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -86.1 90.18 8.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.766 -0.583 . . . . 0.0 110.258 176.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -73.14 95.62 2.1 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.034 0.934 . . . . 0.0 110.51 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.1 m -109.3 97.14 6.79 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -161.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.3 p -127.79 163.27 24.73 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.924 0.868 . . . . 0.0 113.255 -170.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.15 -23.23 63.75 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 166.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -77.65 -53.92 6.99 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 119.555 1.071 . . . . 0.0 113.339 165.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -156.0 151.71 27.24 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 119.74 1.155 . . . . 0.0 112.264 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -109.31 108.77 19.46 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.508 0.723 . . . . 0.0 110.357 170.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 pp -135.83 145.25 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-O 121.646 0.736 . . . . 0.0 111.874 -171.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -97.29 115.45 27.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -0.978 . . . . 0.0 111.545 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.83 103.25 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.33 101.47 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 173.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -119.63 136.26 54.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.861 -0.524 . . . . 0.0 112.374 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -92.81 144.02 25.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.692 -0.63 . . . . 0.0 110.716 164.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.94 115.58 3.82 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.77 -15.76 59.81 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 119.698 2.639 . . . . 0.0 119.698 -172.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.8 t -85.25 111.64 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.678 2.239 . . . . 0.0 108.684 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.261 7.4 t -78.78 124.32 28.09 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -165.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -134.4 163.71 29.06 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 124.071 0.949 . . . . 0.0 112.396 -170.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -85.41 109.39 18.4 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 121.865 0.84 . . . . 0.0 112.194 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -93.55 165.97 12.48 Favored 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 124.9 1.28 . . . . 0.0 112.256 172.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.252 0.6 OUTLIER -139.28 155.96 47.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.612 -1.305 . . . . 0.0 113.196 166.096 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.9 mt -86.56 51.35 2.21 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 175.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.285 . . 62.41 -50.51 0.17 Allowed 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 118.472 2.767 . . . . 0.0 118.472 -168.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.9 p30 -78.07 -78.63 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -175.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.4 72.52 0.09 OUTLIER Glycine 0 N--CA 1.481 1.693 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 -170.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.4 m -145.46 105.91 4.08 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.64 112.98 20.02 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-O 121.424 0.63 . . . . 0.0 111.843 -173.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 70.9 mt -118.26 107.74 14.27 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.181 0.592 . . . . 0.0 111.112 -167.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.2 ttm-85 -88.85 121.14 30.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 111.113 174.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.01 -154.57 11.71 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.3 p -144.48 138.06 27.36 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 123.196 0.599 . . . . 0.0 110.627 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -88.0 120.07 28.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.693 -0.629 . . . . 0.0 109.866 163.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.2 t -115.62 124.6 51.34 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.176 0.59 . . . . 0.0 111.109 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.3 tp -84.61 104.92 15.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.471 -0.768 . . . . 0.0 111.586 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -105.16 78.87 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.507 0.67 . . . . 0.0 109.907 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.59 -102.02 1.25 Allowed Glycine 0 N--CA 1.49 2.285 0 O-C-N 121.547 -0.72 . . . . 0.0 114.023 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -112.51 45.39 1.31 Allowed 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 167.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -139.3 115.13 10.11 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.285 -0.884 . . . . 0.0 109.039 173.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.1 mt -86.19 104.64 15.93 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 166.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.0 mt -99.85 110.57 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -172.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.18 94.62 2.01 Favored Glycine 0 N--CA 1.481 1.646 0 C-N-CA 123.47 0.557 . . . . 0.0 112.553 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -86.91 98.86 11.46 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -119.78 142.8 48.25 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.518 0.727 . . . . 0.0 112.337 -168.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -122.71 137.43 54.92 Favored 'General case' 0 CA--C 1.563 1.456 0 O-C-N 121.471 -0.768 . . . . 0.0 109.997 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -64.89 118.05 8.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.192 -0.943 . . . . 0.0 113.182 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.7 p -76.84 67.89 2.96 Favored 'General case' 0 N--CA 1.508 2.439 0 CA-C-O 122.318 1.056 . . . . 0.0 110.623 169.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -178.43 -68.05 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -159.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -98.37 -35.92 10.14 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.075 1.879 . . . . 0.0 116.075 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.72 6.21 76.94 Favored Glycine 0 CA--C 1.558 2.737 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 -150.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -82.74 134.44 35.13 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 119.599 1.699 . . . . 0.0 112.885 -175.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -90.15 133.89 34.61 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -172.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.79 122.18 35.46 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 125.211 1.404 . . . . 0.0 108.878 -176.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -100.31 109.67 21.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.102 -0.999 . . . . 0.0 109.342 172.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.8 m -99.91 99.86 10.7 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 119.353 0.979 . . . . 0.0 109.757 172.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 80.2 t -88.31 105.04 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.019 -1.051 . . . . 0.0 108.549 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -79.48 112.89 17.18 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.339 0.656 . . . . 0.0 110.115 163.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -137.28 147.41 45.67 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.489 0.662 . . . . 0.0 109.935 171.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.77 139.1 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.008 0 O-C-N 120.776 -1.202 . . . . 0.0 109.922 167.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.5 tt -119.36 89.97 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.804 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 162.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 68.68 -99.01 0.56 Allowed Glycine 0 N--CA 1.492 2.391 0 O-C-N 120.948 -1.095 . . . . 0.0 115.529 -176.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -95.21 -3.17 48.18 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 170.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -123.4 129.69 51.64 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 119.464 1.029 . . . . 0.0 111.48 -164.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.4 tp -82.89 114.59 21.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.288 170.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.0 m -82.47 126.06 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 166.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -99.16 101.02 12.22 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 157.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.5 m -90.16 108.31 19.67 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -102.8 99.67 9.63 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.456 0.703 . . . . 0.0 110.855 -170.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 t -99.43 114.17 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -134.63 109.74 8.84 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.041 0.536 . . . . 0.0 110.853 -174.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.287 24.4 mm-40 68.17 -79.52 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 172.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -142.54 58.95 0.55 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 123.212 0.434 . . . . 0.0 113.091 167.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.18 154.79 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 123.756 0.822 . . . . 0.0 109.852 -174.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.255 0.0 OUTLIER -144.47 136.91 26.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.11 -0.994 . . . . 0.0 112.949 161.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.56 145.44 51.72 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.53 0.732 . . . . 0.0 112.204 174.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -120.04 98.22 5.98 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . 0.297 6.1 ptm180 -88.76 123.52 33.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.755 -1.216 . . . . 0.0 110.414 170.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.5 mt -109.82 131.31 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -161.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -119.31 127.1 52.88 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.365 0.666 . . . . 0.0 110.339 -175.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -83.48 144.06 29.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.238 -0.914 . . . . 0.0 112.499 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.6 tttt -69.27 122.11 18.2 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 121.683 0.754 . . . . 0.0 112.464 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.2 t70 . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -162.281 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.291 0 CA-C-O 121.912 0.863 . . . . 0.0 112.396 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -131.1 66.18 1.54 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -171.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -83.66 82.59 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.537 -1.352 . . . . 0.0 112.801 -165.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.8 t -162.6 -178.15 6.04 Favored 'General case' 0 CA--C 1.574 1.894 0 CA-C-O 123.004 1.383 . . . . 0.0 112.808 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.9 m -97.21 121.54 39.21 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.968 0.907 . . . . 0.0 109.451 169.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -118.72 112.02 19.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.709 -0.62 . . . . 0.0 110.644 -167.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -98.35 131.23 44.82 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 118.762 0.71 . . . . 0.0 112.167 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 p -66.92 120.9 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.336 -0.852 . . . . 0.0 113.249 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -100.81 -55.97 2.44 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -143.57 122.24 12.57 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 119.61 1.096 . . . . 0.0 112.246 -173.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.9 p -99.77 122.61 43.0 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.804 0.842 . . . . 0.0 111.936 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -76.36 -38.2 56.18 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -172.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -116.06 -78.51 0.58 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 119.269 0.94 . . . . 0.0 109.595 170.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.289 0.5 OUTLIER 47.45 35.11 3.82 Favored 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 118.427 2.751 . . . . 0.0 118.427 -175.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -150.0 -53.5 0.15 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.182 0.993 . . . . 0.0 111.095 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -66.33 -40.76 90.1 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 120.534 1.516 . . . . 0.0 114.095 164.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -45.62 -58.43 3.43 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 157.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.3 mtp -64.16 -38.18 90.13 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -60.45 -42.7 96.69 Favored 'General case' 0 CA--C 1.574 1.893 0 O-C-N 120.16 -1.588 . . . . 0.0 114.951 166.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -66.27 -28.84 69.02 Favored 'General case' 0 CA--C 1.579 2.076 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 168.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 mtm -59.81 -34.66 73.36 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 158.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.02 45.07 1.8 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 115.829 1.092 . . . . 0.0 115.829 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.1 m -127.21 147.65 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 118.837 1.318 . . . . 0.0 112.987 -173.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -72.26 162.41 29.5 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -175.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.256 0.2 OUTLIER -48.21 -44.61 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 168.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.4 t -54.89 -50.66 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 170.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -63.45 -40.78 98.04 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 169.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -57.02 -47.87 79.84 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 169.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.286 0.0 OUTLIER -64.88 -39.59 93.77 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 168.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.79 -53.77 14.16 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 176.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.4 -13.24 60.7 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 175.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.73 -54.58 8.57 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 120.328 1.422 . . . . 0.0 114.367 155.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -85.82 62.81 7.68 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.799 1.181 . . . . 0.0 112.765 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.5 p30 -121.3 9.04 10.31 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 -178.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.347 1.7 p-10 52.66 58.86 4.93 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 177.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.9 tp -75.45 118.97 18.9 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -116.63 114.4 24.04 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.342 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.7 mt -95.08 109.67 21.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.55 -0.719 . . . . 0.0 109.621 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.1 m -90.88 98.57 11.86 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.269 -0.894 . . . . 0.0 108.643 169.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.3 mt -101.47 124.61 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -146.85 135.11 21.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.404 -0.81 . . . . 0.0 112.555 166.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -86.12 145.65 26.94 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 171.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.42 88.05 1.41 Allowed 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 124.818 1.247 . . . . 0.0 109.173 -175.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.81 61.02 4.91 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 117.373 1.709 . . . . 0.0 117.373 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.6 t30 62.82 -4.53 0.24 Allowed 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 118.183 2.66 . . . . 0.0 118.183 -166.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -110.25 130.97 55.45 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.916 1.287 . . . . 0.0 110.113 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -99.63 118.33 35.93 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.507 -0.746 . . . . 0.0 110.491 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.5 m -86.47 114.24 23.06 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 166.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.4 t -122.12 99.4 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -87.12 114.15 23.47 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.317 0.58 . . . . 0.0 110.039 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -107.79 80.92 1.44 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.325 0.583 . . . . 0.0 110.515 -165.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 m -90.46 113.85 25.88 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-O 121.929 0.871 . . . . 0.0 112.205 -172.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.1 p -139.3 167.12 22.79 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.37 1.068 . . . . 0.0 109.305 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.3 57.2 0.24 Allowed 'General case' 0 CA--C 1.578 2.057 0 O-C-N 120.233 -1.542 . . . . 0.0 113.889 159.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -176.68 -57.93 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 125.303 1.441 . . . . 0.0 110.847 -170.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -96.35 -81.33 0.41 Allowed 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 119.974 1.261 . . . . 0.0 112.679 -174.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.284 68.1 m-80 53.59 65.15 1.6 Allowed 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -160.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.2 pt -122.48 121.73 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.871 -0.518 . . . . 0.0 110.031 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.01 94.57 8.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.35 -0.844 . . . . 0.0 111.347 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.2 t -98.46 114.2 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -170.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.46 97.72 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -112.52 137.87 50.11 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.302 0.641 . . . . 0.0 112.507 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -80.48 147.27 30.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.962 . . . . 0.0 112.668 169.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 70.6 mt -66.1 109.18 2.5 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.36 47.33 5.77 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 117.05 1.58 . . . . 0.0 117.05 -173.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.45 138.22 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 118.349 1.075 . . . . 0.0 110.1 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.0 m -84.36 102.8 13.0 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.437 -0.789 . . . . 0.0 109.756 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -127.15 162.53 25.91 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.289 1.042 . . . . 0.0 113.227 -172.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -86.5 121.84 29.6 Favored 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 123.669 0.788 . . . . 0.0 111.658 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -128.21 117.96 22.47 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.551 0.74 . . . . 0.0 110.816 -174.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -98.92 121.25 40.63 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.207 -0.933 . . . . 0.0 111.997 -174.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.7 mt -73.5 166.42 23.26 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.99 52.94 0.57 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 117.522 2.416 . . . . 0.0 117.522 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -163.62 -67.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.427 1.091 . . . . 0.0 109.471 168.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.87 73.59 0.05 OUTLIER Glycine 0 N--CA 1.481 1.677 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.8 m -155.68 121.37 4.98 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.52 -0.988 . . . . 0.0 109.948 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -94.44 125.89 39.37 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 122.457 1.122 . . . . 0.0 111.503 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 50.7 mt -106.55 150.16 26.43 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.299 1.04 . . . . 0.0 112.103 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.8 116.95 20.27 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.31 -161.73 35.11 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 117.551 1.781 . . . . 0.0 117.551 -175.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 71.4 p -124.88 123.67 40.43 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.919 -0.64 . . . . 0.0 111.712 -156.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -83.43 115.41 22.03 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 118.569 0.622 . . . . 0.0 110.158 158.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.8 m -115.47 132.77 56.52 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.243 0.617 . . . . 0.0 111.757 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.0 tp -87.44 109.29 19.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.378 -0.826 . . . . 0.0 112.324 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -101.76 81.34 2.13 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.551 0.691 . . . . 0.0 109.776 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.47 -94.16 0.93 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 114.795 0.678 . . . . 0.0 114.795 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -121.73 52.67 1.24 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.637 0.732 . . . . 0.0 111.485 165.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -146.86 112.4 5.61 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.8 mt -89.64 104.14 16.72 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 171.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.2 tt -94.82 118.19 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.641 -0.662 . . . . 0.0 110.21 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.83 97.85 2.32 Favored Glycine 0 N--CA 1.481 1.636 0 C-N-CA 123.411 0.529 . . . . 0.0 112.348 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -92.58 98.87 11.71 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.312 0.645 . . . . 0.0 109.609 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -123.18 134.28 54.18 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.527 0.731 . . . . 0.0 111.527 -170.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -110.81 157.08 20.21 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.498 1.142 . . . . 0.0 111.241 165.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -107.77 120.22 41.63 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.955 -1.091 . . . . 0.0 112.04 -161.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.5 t -68.0 -11.82 59.62 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 169.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -86.46 -50.68 6.7 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 119.459 1.027 . . . . 0.0 113.3 172.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.87 27.97 2.17 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 120.885 1.675 . . . . 0.0 115.405 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.76 -57.11 2.6 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 118.287 2.075 . . . . 0.0 118.287 176.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -48.46 124.95 8.85 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.833 2.053 . . . . 0.0 114.997 -168.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -67.18 145.47 55.21 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -171.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.3 tp -104.68 115.0 29.57 Favored 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 162.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -94.5 104.0 15.96 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 168.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.8 m -104.63 100.38 10.04 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.758 -0.588 . . . . 0.0 109.79 -177.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.9 t -91.63 104.65 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 120.897 -1.127 . . . . 0.0 108.812 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -82.02 115.78 21.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.883 -0.511 . . . . 0.0 109.852 164.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.79 144.76 34.11 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.037 0.535 . . . . 0.0 111.482 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.72 124.75 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.291 -0.881 . . . . 0.0 111.223 177.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.255 10.9 tp -98.77 79.15 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.151 0.977 . . . . 0.0 108.986 166.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.75 -104.58 1.49 Allowed Glycine 0 N--CA 1.488 2.117 0 O-C-N 121.444 -0.785 . . . . 0.0 114.247 -171.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.26 0.71 57.47 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 117.576 2.435 . . . . 0.0 117.576 172.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -122.41 135.82 54.77 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.192 1.36 . . . . 0.0 110.959 -170.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.0 tp -90.62 119.7 31.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 111.012 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.9 p -102.58 120.34 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.136 -0.978 . . . . 0.0 110.647 172.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.499 ' NE2' ' HH ' ' A' ' 117' ' ' TYR . 21.0 mt-30 -89.99 115.44 27.28 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 122.967 0.507 . . . . 0.0 109.883 166.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.2 m -96.86 100.23 11.77 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.229 0.611 . . . . 0.0 109.626 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.499 ' HH ' ' NE2' ' A' ' 115' ' ' GLN . 45.1 m-85 -88.07 112.4 22.61 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.434 0.694 . . . . 0.0 110.757 -177.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.1 t -113.4 100.35 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -92.92 119.33 32.1 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.285 0.8 OUTLIER 66.07 -85.81 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 119.258 0.936 . . . . 0.0 111.648 -176.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.97 20.71 3.59 Favored Glycine 0 CA--C 1.558 2.749 0 N-CA-C 117.853 1.901 . . . . 0.0 117.853 151.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -92.3 115.79 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 121.496 2.648 . . . . 0.0 111.483 -174.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -89.22 126.23 35.41 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -127.8 106.08 8.88 Favored 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 123.502 0.721 . . . . 0.0 110.781 169.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.73 130.32 37.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 111.147 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -123.69 122.51 38.28 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.5 -0.75 . . . . 0.0 111.934 171.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.5 mt -94.23 124.56 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -174.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -104.55 133.22 49.77 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.392 1.077 . . . . 0.0 110.634 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -88.96 147.75 24.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.055 0.931 . . . . 0.0 112.304 171.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -75.19 118.36 18.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.639 -0.663 . . . . 0.0 111.821 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.1 t70 . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -165.925 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.563 1.447 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -122.02 -54.9 1.9 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 123.828 0.851 . . . . 0.0 111.693 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 t70 40.62 51.19 2.98 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 166.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.5 p -165.35 171.0 13.98 Favored 'General case' 0 CA--C 1.569 1.71 0 CA-C-O 122.432 1.111 . . . . 0.0 112.557 -168.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.4 m -89.4 133.92 34.31 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.04 -1.038 . . . . 0.0 111.413 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -138.37 107.82 6.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.801 -0.562 . . . . 0.0 109.927 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -97.26 133.16 42.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.11 -0.994 . . . . 0.0 112.682 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 p -62.41 117.96 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.213 -0.93 . . . . 0.0 113.411 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -102.17 -45.11 5.24 Favored 'General case' 0 CA--C 1.568 1.649 0 C-N-CA 123.961 0.904 . . . . 0.0 113.384 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -152.62 160.46 43.19 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.154 0.982 . . . . 0.0 110.968 -174.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.3 p -146.72 143.72 28.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.37 -1.456 . . . . 0.0 112.871 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -85.83 -51.38 6.44 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -137.93 53.57 1.83 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 119.834 1.197 . . . . 0.0 112.772 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -83.61 63.86 7.63 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 119.628 -1.92 . . . . 0.0 112.205 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -163.85 -57.72 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.529 1.132 . . . . 0.0 110.981 -171.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -81.96 -26.06 34.29 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -51.87 -54.38 29.88 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-N 121.791 2.087 . . . . 0.0 113.778 153.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -51.86 -47.97 64.22 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 169.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -66.02 -38.83 89.42 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 170.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.0 tptp -60.14 -40.39 89.66 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 168.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.5 mtp -62.69 -52.92 61.38 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 165.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.55 59.44 0.06 OUTLIER Glycine 0 N--CA 1.487 2.042 0 CA-C-O 119.522 -0.599 . . . . 0.0 114.338 166.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 m -103.82 147.47 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.857 0.837 . . . . 0.0 111.727 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -74.28 169.03 18.45 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 168.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.267 0.2 OUTLIER -54.61 -44.34 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 176.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.49 -48.65 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-N 119.395 0.998 . . . . 0.0 112.996 172.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -54.38 -39.69 67.46 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 166.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -46.14 91.8 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 167.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -59.62 -48.81 80.21 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 166.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.7 mt -57.4 -39.76 76.81 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 169.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.04 -54.3 46.54 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 168.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.42 -38.14 41.56 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 167.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -95.17 19.9 9.92 Favored 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 172.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.305 28.0 p30 -72.97 -24.53 60.8 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 118.164 2.653 . . . . 0.0 118.164 -173.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 57.2 54.86 6.39 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 173.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.1 tp -79.77 122.52 26.71 Favored 'General case' 0 CA--C 1.563 1.445 0 CA-C-O 121.963 0.887 . . . . 0.0 112.345 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -105.48 106.22 16.62 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.871 169.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.39 100.11 7.47 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.38 0.609 . . . . 0.0 109.583 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.7 m -102.04 96.84 7.28 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -173.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.1 mt -95.38 131.81 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -164.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.2 m -141.04 108.55 5.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.577 -1.327 . . . . 0.0 107.693 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -100.64 139.2 36.66 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.94 0.876 . . . . 0.0 112.485 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -99.78 70.75 1.65 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 122.166 0.984 . . . . 0.0 110.139 164.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.88 -99.99 0.73 Allowed Glycine 0 N--CA 1.488 2.136 0 O-C-N 121.565 -0.71 . . . . 0.0 114.742 -170.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -84.47 -26.84 27.89 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -90.17 117.45 28.94 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.58 1.536 . . . . 0.0 111.101 177.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -99.48 117.33 33.64 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.374 1.07 . . . . 0.0 109.812 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.4 m -90.91 103.19 15.94 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 166.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -99.85 104.06 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -77.43 105.25 8.44 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.935 0.874 . . . . 0.0 109.991 172.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -92.4 91.47 7.67 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.099 0.96 . . . . 0.0 109.303 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.3 t -97.03 111.97 23.95 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.89 0.476 . . . . 0.0 111.336 -173.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.5 p -144.45 165.3 28.35 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -172.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.18 -23.17 67.22 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 117.611 2.449 . . . . 0.0 117.611 165.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -68.7 -52.01 35.54 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 120.367 1.44 . . . . 0.0 113.981 159.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -165.98 152.82 9.7 Favored 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 123.591 0.756 . . . . 0.0 112.144 -167.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -118.28 99.16 6.67 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 pp -136.41 143.19 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 O-C-N 121.747 -0.595 . . . . 0.0 111.994 -171.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -93.82 125.21 38.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.922 -1.111 . . . . 0.0 112.791 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.0 t -102.03 104.87 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.65 108.8 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -133.12 130.85 39.79 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.388 0.613 . . . . 0.0 112.537 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -66.98 140.5 57.73 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 111.835 157.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.8 mt -54.43 123.08 11.9 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 166.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.85 -5.96 83.13 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 119.189 2.436 . . . . 0.0 119.189 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 p -82.75 137.14 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-N 120.616 2.208 . . . . 0.0 112.748 -172.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.8 m -91.45 95.87 10.2 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.41 -0.806 . . . . 0.0 109.934 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -122.18 150.75 41.81 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -170.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -86.03 98.35 10.8 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 124.448 1.099 . . . . 0.0 113.872 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -89.98 118.6 29.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.5 -0.75 . . . . 0.0 110.966 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -72.26 108.47 5.42 Favored 'General case' 0 CA--C 1.569 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 113.114 171.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -78.21 139.79 38.94 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.914 0.886 . . . . 0.0 111.09 177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.32 66.94 0.31 Allowed 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -168.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -166.45 -66.2 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 125.779 1.632 . . . . 0.0 108.505 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.58 68.38 0.05 OUTLIER Glycine 0 N--CA 1.481 1.672 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.6 m -160.65 119.88 2.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.614 -0.933 . . . . 0.0 109.587 -177.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -88.1 113.89 24.18 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.886 0.85 . . . . 0.0 111.081 167.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 70.9 mt -93.78 109.56 21.23 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 124.325 1.05 . . . . 0.0 110.615 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 58.8 ttp85 -88.85 117.18 27.66 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.875 -0.516 . . . . 0.0 110.714 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.41 179.36 48.87 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 118.983 2.353 . . . . 0.0 118.983 -171.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.3 p -122.12 123.11 40.79 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 113.483 -1.358 . . . . 0.0 111.297 -166.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -81.92 107.56 14.74 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 118.476 0.58 . . . . 0.0 110.194 160.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 72.9 m -102.68 131.6 49.37 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.046 0.539 . . . . 0.0 111.101 176.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.9 tp -82.3 106.17 13.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.158 -0.964 . . . . 0.0 110.744 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -82.32 -49.45 10.02 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.07 -95.67 0.21 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 164.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -98.97 59.29 1.17 Allowed 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.869 0.842 . . . . 0.0 110.326 152.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -149.17 116.42 6.09 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.54 103.72 16.34 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 167.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.8 tt -90.08 111.5 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.368 -0.833 . . . . 0.0 110.1 177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.07 98.09 2.34 Favored Glycine 0 N--CA 1.482 1.707 0 C-N-CA 123.843 0.735 . . . . 0.0 113.072 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -93.32 96.34 9.9 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -117.46 147.27 42.87 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.731 0.777 . . . . 0.0 112.533 -168.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -127.0 138.52 53.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.404 -0.81 . . . . 0.0 110.851 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -71.04 115.07 9.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 0.0 113.133 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 73.8 p -80.49 62.96 4.77 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 123.514 1.626 . . . . 0.0 112.384 170.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -174.05 -65.03 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.732 0 C-N-CA 126.236 1.815 . . . . 0.0 107.005 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -94.33 -18.24 21.8 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.05 -15.68 47.24 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 119.148 2.419 . . . . 0.0 119.148 -172.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -84.18 152.76 24.06 Favored 'General case' 0 CA--C 1.566 1.559 0 CA-C-N 118.529 1.165 . . . . 0.0 113.79 -169.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -94.4 130.27 40.8 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-O 122.114 0.959 . . . . 0.0 112.835 -168.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.0 tt -110.66 122.51 47.96 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 124.48 1.112 . . . . 0.0 109.406 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -111.51 111.67 22.86 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.2 m -108.36 100.2 9.52 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 119.441 1.019 . . . . 0.0 110.203 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.8 t -91.38 107.46 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.128 -0.983 . . . . 0.0 108.827 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -103.82 105.3 15.46 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 123.4 0.68 . . . . 0.0 110.598 -173.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -143.48 148.82 36.65 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -169.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.56 120.95 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.17 -1.581 . . . . 0.0 109.672 175.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.5 mm -101.1 88.95 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 167.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.91 -88.14 0.56 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 115.769 1.067 . . . . 0.0 115.769 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -111.0 0.31 16.94 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 173.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -129.67 127.21 40.06 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.953 1.251 . . . . 0.0 110.744 -169.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.1 tp -74.63 115.24 13.98 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.961 0.904 . . . . 0.0 110.519 171.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.0 m -103.72 119.09 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.301 -0.874 . . . . 0.0 109.583 -176.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -88.8 107.38 18.94 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 118.844 0.747 . . . . 0.0 109.842 165.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.7 m -92.35 96.32 10.2 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -87.61 106.48 18.04 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.508 0.723 . . . . 0.0 111.05 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.6 t -106.77 104.35 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -117.48 118.17 31.44 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.885 0.474 . . . . 0.0 109.781 172.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 51.4 49.68 20.47 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.0 -24.79 4.42 Favored Glycine 0 CA--C 1.554 2.507 0 N-CA-C 119.264 2.466 . . . . 0.0 119.264 -169.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.7 t -86.65 105.27 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 120.104 1.952 . . . . 0.0 109.633 -168.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -87.98 124.76 34.05 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 123.314 0.646 . . . . 0.0 112.52 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -124.66 109.85 13.67 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.554 0.742 . . . . 0.0 111.518 173.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.54 108.77 20.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.786 -0.571 . . . . 0.0 110.092 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -111.66 129.44 56.09 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.387 1.089 . . . . 0.0 111.436 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.9 mt -121.66 119.15 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -146.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -112.49 119.79 39.41 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.337 0.655 . . . . 0.0 110.418 -168.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -81.01 147.34 30.24 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 123.507 0.723 . . . . 0.0 112.781 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -58.87 118.94 6.32 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 t70 . . . . . 0 N--CA 1.488 1.464 0 C-N-CA 125.01 1.324 . . . . 0.0 112.444 -172.608 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.426 0 CA-C-O 122.178 0.989 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.364 89.8 m-85 69.35 -62.88 0.4 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -77.4 80.13 3.9 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 120.537 1.517 . . . . 0.0 112.669 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.9 t -163.78 178.15 8.08 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 122.443 1.116 . . . . 0.0 112.077 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.9 m -92.2 122.41 34.66 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.459 1.104 . . . . 0.0 110.297 170.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -123.65 108.72 12.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.813 -0.555 . . . . 0.0 109.958 -171.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -97.23 139.59 32.96 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.065 -1.022 . . . . 0.0 112.707 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -60.38 119.7 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -109.19 -51.11 2.92 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.767 0.827 . . . . 0.0 113.099 -173.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -148.57 109.57 4.3 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 119.222 0.919 . . . . 0.0 109.741 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.6 p -109.18 115.01 29.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.381 -0.824 . . . . 0.0 113.056 -174.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -98.69 123.07 42.67 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 123.327 0.651 . . . . 0.0 110.656 -169.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.261 9.4 t30 67.83 18.6 9.67 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -69.74 -43.09 73.0 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -173.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.87 -34.24 75.64 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 169.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -70.79 -47.2 60.79 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -43.1 -53.26 5.02 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 158.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 15.7 mtt -67.3 -25.87 66.25 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 174.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -60.7 -43.24 98.01 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-N 121.345 1.884 . . . . 0.0 114.625 163.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -59.03 -34.63 72.13 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 162.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 76.7 mmm -62.67 -30.31 71.29 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 116.929 2.196 . . . . 0.0 116.929 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.0 53.95 1.07 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 115.157 0.823 . . . . 0.0 115.157 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.31 142.53 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 122.671 1.224 . . . . 0.0 112.063 -175.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -70.24 172.08 8.76 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.275 13.2 tt -60.58 -40.73 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 176.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.6 t -61.61 -52.16 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-N 120.402 1.456 . . . . 0.0 112.913 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -55.3 -43.79 75.16 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 168.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -64.47 -42.22 96.05 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 171.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -58.36 -46.35 86.46 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 120.143 1.338 . . . . 0.0 114.554 167.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.9 mt -60.48 -40.94 93.11 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 165.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.69 95.0 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 172.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.96 -57.41 11.8 Favored 'General case' 0 CA--C 1.566 1.596 0 O-C-N 120.804 -1.185 . . . . 0.0 113.681 164.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -84.3 53.01 2.49 Favored 'General case' 0 CA--C 1.577 2.006 0 CA-C-N 119.716 1.144 . . . . 0.0 113.81 174.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -85.89 -29.51 23.6 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -174.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 62.05 50.22 4.17 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -84.02 121.75 27.83 Favored 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 122.42 1.105 . . . . 0.0 112.014 -175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -111.34 117.29 32.71 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.479 174.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.7 mt -101.44 102.59 13.41 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.0 m -94.46 105.04 17.0 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.309 -0.87 . . . . 0.0 109.649 172.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.6 mt -94.83 131.29 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 85.8 m -145.41 128.46 16.55 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.262 -1.524 . . . . 0.0 110.147 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -111.07 139.89 46.06 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -170.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -138.21 89.97 2.44 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.672 0.789 . . . . 0.0 109.825 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.21 68.18 1.81 Allowed Glycine 0 N--CA 1.497 2.711 0 N-CA-C 116.731 1.452 . . . . 0.0 116.731 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.291 46.7 m-20 67.62 -23.79 0.12 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 118.019 2.6 . . . . 0.0 118.019 -166.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -83.19 100.8 10.8 Favored 'General case' 0 CA--C 1.565 1.552 0 CA-C-N 121.151 1.796 . . . . 0.0 110.901 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -93.36 117.62 30.3 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.029 0.931 . . . . 0.0 109.504 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.0 m -92.75 104.14 16.44 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 p -94.69 109.83 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.699 0.762 . . . . 0.0 109.974 170.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -88.55 111.67 22.13 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -101.93 92.07 4.64 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.441 0.696 . . . . 0.0 110.712 -169.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.1 m -103.37 117.05 33.6 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.106 0.562 . . . . 0.0 111.003 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 p -147.77 -177.3 5.64 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.84 40.73 0.06 Allowed 'General case' 0 CA--C 1.583 2.246 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 166.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -144.2 -62.59 0.38 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 126.519 1.927 . . . . 0.0 108.566 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.64 167.48 28.78 Favored 'General case' 0 CA--C 1.572 1.825 0 C-N-CA 124.122 0.969 . . . . 0.0 111.141 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -121.07 102.8 8.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.328 -0.858 . . . . 0.0 109.46 164.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.33 144.22 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.527 -0.733 . . . . 0.0 112.019 -172.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -94.91 119.65 33.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.339 -0.85 . . . . 0.0 112.58 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.4 t -98.94 104.03 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.8 t -91.87 103.2 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -113.54 123.52 50.18 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.308 0.575 . . . . 0.0 112.006 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -72.28 137.09 46.5 Favored 'General case' 0 CA--C 1.569 1.703 0 O-C-N 121.366 -0.834 . . . . 0.0 110.499 162.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.8 mt -59.62 113.27 2.15 Favored 'General case' 0 CA--C 1.571 1.768 0 O-C-N 121.069 -1.019 . . . . 0.0 113.389 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.29 55.83 3.6 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 116.39 1.316 . . . . 0.0 116.39 -171.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 p -136.46 136.91 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 118.008 0.904 . . . . 0.0 110.125 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 88.0 m -87.41 109.79 19.82 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.505 -0.747 . . . . 0.0 110.156 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -138.56 156.23 47.67 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.168 0.587 . . . . 0.0 112.436 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -84.38 99.04 10.38 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 121.841 0.829 . . . . 0.0 112.126 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -86.64 119.27 26.7 Favored 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 124.449 1.1 . . . . 0.0 111.682 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -83.39 126.68 32.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.099 -1.001 . . . . 0.0 113.208 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.3 mt -80.62 152.67 28.4 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 170.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.93 64.74 2.49 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 175.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -174.31 -66.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 125.465 1.506 . . . . 0.0 110.394 -177.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.3 70.17 0.03 OUTLIER Glycine 0 N--CA 1.487 2.065 0 CA-C-N 119.128 0.876 . . . . 0.0 114.207 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.5 m -167.19 128.34 1.57 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 118.041 0.92 . . . . 0.0 109.015 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -97.34 126.71 42.74 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.172 0.987 . . . . 0.0 110.623 169.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.6 mt -108.91 107.69 18.18 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 124.227 1.011 . . . . 0.0 110.769 -174.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.53 119.15 20.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.048 -1.032 . . . . 0.0 112.068 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.74 -163.88 36.99 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 117.639 1.815 . . . . 0.0 117.639 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.8 p -125.5 120.31 30.59 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.382 -0.909 . . . . 0.0 111.763 -157.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -84.81 121.65 28.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.422 -0.799 . . . . 0.0 110.427 161.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.1 m -126.93 139.3 53.16 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.358 0.663 . . . . 0.0 111.735 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.1 tp -87.72 114.67 24.55 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.679 -1.263 . . . . 0.0 111.642 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -78.07 -37.27 46.95 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 172.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.83 -84.26 0.08 OUTLIER Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -107.93 39.04 2.03 Favored 'General case' 0 CA--C 1.581 2.138 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 158.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -146.19 124.32 12.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.929 -1.107 . . . . 0.0 109.167 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.8 mt -91.4 110.49 21.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.478 -0.764 . . . . 0.0 109.15 166.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.6 tt -97.52 117.59 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.127 -0.983 . . . . 0.0 110.858 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.04 95.7 1.76 Allowed Glycine 0 N--CA 1.482 1.747 0 CA-C-O 119.401 -0.666 . . . . 0.0 113.328 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -84.25 103.8 13.74 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 117.784 0.792 . . . . 0.0 110.017 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -123.16 148.42 45.76 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -171.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -120.96 141.61 50.53 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.782 0.801 . . . . 0.0 110.621 167.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -70.79 137.85 49.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.716 -1.24 . . . . 0.0 112.808 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.286 4.9 t -70.18 -51.78 28.43 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 175.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -75.92 -44.96 37.71 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -80.22 -26.19 39.25 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.7 -38.77 3.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 117.486 1.754 . . . . 0.0 117.486 -166.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -69.22 155.57 40.19 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -162.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.96 140.13 35.43 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 114.18 -1.373 . . . . 0.0 114.679 -175.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.8 tt -135.28 115.59 13.46 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 123.832 0.853 . . . . 0.0 109.114 177.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -94.5 111.72 23.48 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.139 -0.976 . . . . 0.0 109.103 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.9 m -101.34 94.94 6.19 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.0 t -100.91 100.14 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-O 122.516 1.151 . . . . 0.0 109.56 -168.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -93.69 102.35 14.51 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.367 -172.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -131.54 133.12 44.74 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.75 0.82 . . . . 0.0 111.268 -161.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.0 mt -104.0 123.3 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.719 -1.238 . . . . 0.0 110.172 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 45.1 mm -83.55 -47.33 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.98 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.832 167.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -163.09 -89.12 0.07 OUTLIER Glycine 0 N--CA 1.487 2.085 0 CA-C-N 119.058 0.844 . . . . 0.0 112.507 172.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 45.0 p30 -81.62 3.76 24.06 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 174.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -136.97 131.42 32.94 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 119.233 0.924 . . . . 0.0 111.033 -168.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.7 tp -86.14 113.02 21.85 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.446 1.098 . . . . 0.0 109.695 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.6 t -98.98 105.09 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -174.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -96.08 101.74 13.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -0.984 . . . . 0.0 109.997 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.5 m -91.63 103.96 16.49 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.585 0.754 . . . . 0.0 109.207 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -89.26 110.69 21.43 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.338 0.655 . . . . 0.0 110.194 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.1 t -112.79 93.96 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -94.71 114.65 26.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.632 -0.668 . . . . 0.0 111.31 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.317 0.4 OUTLIER 62.07 -62.55 0.1 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 174.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.83 43.41 0.5 Allowed Glycine 0 CA--C 1.551 2.293 0 CA-C-O 118.915 -0.936 . . . . 0.0 114.483 156.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.8 t -139.15 118.61 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 118.982 1.391 . . . . 0.0 107.761 -172.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.2 mp0 -93.68 144.52 25.32 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.81 121.19 10.96 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.208 0.528 . . . . 0.0 112.408 164.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -94.67 107.66 19.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.694 -0.629 . . . . 0.0 111.256 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -89.7 111.61 22.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.722 -0.611 . . . . 0.0 109.601 167.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.2 mt -101.09 114.06 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -172.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -105.81 122.7 46.63 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.673 0.789 . . . . 0.0 109.625 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -83.14 143.27 30.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 112.585 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -65.14 118.44 9.22 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.9 t0 . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -165.67 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.361 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.283 93.2 m-85 73.4 -43.59 0.56 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 118.81 2.893 . . . . 0.0 118.81 170.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -73.77 72.37 1.51 Allowed 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 117.283 2.327 . . . . 0.0 117.283 -160.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.9 p -152.17 -176.36 5.64 Favored 'General case' 0 CA--C 1.572 1.821 0 CA-C-O 121.976 0.893 . . . . 0.0 112.852 178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.1 m -89.37 127.64 35.83 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.013 0.925 . . . . 0.0 110.788 176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -130.02 116.17 18.18 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.178 0.591 . . . . 0.0 109.416 -173.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -99.64 135.77 40.56 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 119.408 1.004 . . . . 0.0 111.944 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p -66.05 116.43 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -96.0 -50.73 4.74 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -144.2 111.25 5.81 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 119.977 1.262 . . . . 0.0 111.054 -172.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.2 m -96.18 101.34 12.98 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.858 0.863 . . . . 0.0 111.317 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -93.5 120.52 33.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.509 -0.744 . . . . 0.0 110.31 -172.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.264 28.5 t30 65.49 20.56 11.72 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -72.51 -40.17 67.04 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.64 -38.07 74.39 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 168.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -67.55 -46.75 71.85 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 119.91 1.232 . . . . 0.0 114.069 171.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -46.55 -56.32 6.2 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 161.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.4 mtp -65.82 -29.84 70.38 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 176.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.63 -50.96 71.43 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 120.241 1.382 . . . . 0.0 114.203 163.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -57.4 -32.1 66.51 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 165.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.0 mmt -64.44 -34.74 78.89 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 168.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.99 51.36 1.93 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 116.072 1.189 . . . . 0.0 116.072 -176.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -114.89 160.23 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-O 122.169 0.985 . . . . 0.0 112.408 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -56.72 145.95 27.32 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 172.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.274 0.1 OUTLIER -54.98 -47.22 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 175.057 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.28 -49.53 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 173.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -58.35 -45.66 87.75 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 170.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -44.27 -55.12 5.13 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 163.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -65.69 -46.66 78.18 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.5 mt -58.48 -47.53 83.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 169.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.24 -21.63 66.35 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 119.062 2.986 . . . . 0.0 119.062 178.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.08 93.64 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 165.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -130.49 68.09 1.47 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 119.577 1.081 . . . . 0.0 111.781 169.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -84.41 44.66 1.05 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 176.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 42.7 40.57 2.08 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -172.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -86.68 116.77 25.0 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.695 -1.253 . . . . 0.0 112.173 -161.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -111.2 118.01 34.77 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.718 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.7 mt -94.28 101.53 13.5 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 172.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 43.8 m -95.14 105.66 17.61 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.883 0.849 . . . . 0.0 108.731 170.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.9 mt -90.57 101.4 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -171.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 87.7 m -99.08 101.48 12.86 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -102.45 127.49 49.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.581 -0.7 . . . . 0.0 112.347 -167.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -79.94 -49.87 11.26 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 161.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.65 -90.92 0.08 OUTLIER Glycine 0 N--CA 1.486 1.97 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -70.12 -29.28 66.19 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 158.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -85.47 126.71 34.03 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-N 119.772 1.169 . . . . 0.0 112.105 169.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -117.83 125.39 50.46 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.482 1.113 . . . . 0.0 108.475 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.0 m -99.52 95.85 7.27 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 168.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.5 t -88.98 105.88 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -89.91 102.07 14.77 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -170.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -93.41 88.09 5.83 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.202 0.601 . . . . 0.0 109.53 -170.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.1 t -98.49 109.26 22.05 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.321 0.648 . . . . 0.0 110.798 -171.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.7 p -134.08 166.15 23.41 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -169.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.55 -26.32 61.25 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 117.838 2.533 . . . . 0.0 117.838 165.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -79.81 -52.34 8.04 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -160.91 163.22 32.07 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-N 119.33 0.968 . . . . 0.0 112.726 -177.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -110.39 118.83 37.35 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.387 0.675 . . . . 0.0 109.53 167.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.2 pt -131.41 133.08 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 CA-C-O 121.785 0.802 . . . . 0.0 111.879 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -98.77 99.24 10.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.605 0.762 . . . . 0.0 109.664 -175.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.35 99.67 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.417 -0.802 . . . . 0.0 109.868 -165.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 56.9 t -85.7 115.8 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 123.458 0.703 . . . . 0.0 109.319 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -134.35 140.68 46.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.829 -0.544 . . . . 0.0 111.769 173.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -92.95 140.06 29.88 Favored 'General case' 0 CA--C 1.565 1.528 0 O-C-N 121.896 -0.502 . . . . 0.0 110.865 163.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -56.92 131.8 50.73 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 176.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.35 -16.68 37.96 Favored Glycine 0 CA--C 1.553 2.437 0 N-CA-C 119.426 2.53 . . . . 0.0 119.426 -172.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.8 t -81.84 132.37 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-N 120.176 1.988 . . . . 0.0 110.408 -175.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.9 m -79.87 104.74 10.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.716 -0.615 . . . . 0.0 110.085 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -124.7 166.85 15.44 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-O 122.106 0.955 . . . . 0.0 112.405 -173.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -91.23 99.01 12.08 Favored 'General case' 0 CA--C 1.571 1.75 0 C-N-CA 123.362 0.665 . . . . 0.0 111.454 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -92.58 104.89 17.14 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.829 0.852 . . . . 0.0 110.174 175.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -95.64 125.86 40.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 112.025 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.7 mt -80.21 150.24 30.17 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.166 0.586 . . . . 0.0 112.425 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.38 44.98 0.16 Allowed 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -149.75 -59.54 0.2 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 124.769 1.228 . . . . 0.0 110.234 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.53 73.37 0.04 OUTLIER Glycine 0 N--CA 1.486 1.977 0 CA-C-N 118.935 0.789 . . . . 0.0 112.678 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 m -167.8 124.77 1.13 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 117.869 0.834 . . . . 0.0 109.959 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -102.08 125.98 48.91 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.852 0.861 . . . . 0.0 111.033 171.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.6 mt -117.83 123.36 45.72 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.607 0.763 . . . . 0.0 110.865 -175.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -102.77 118.79 37.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.102 -0.999 . . . . 0.0 110.85 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.43 -177.71 47.88 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 118.29 2.076 . . . . 0.0 118.29 -172.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.8 p -119.54 124.91 47.57 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 113.812 -1.194 . . . . 0.0 111.215 -167.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -83.46 126.01 32.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.977 -0.452 . . . . 0.0 111.419 163.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.8 m -120.42 135.06 55.16 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.196 0.598 . . . . 0.0 111.026 172.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.6 tp -89.15 106.83 18.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 111.466 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -98.52 -179.08 4.21 Favored 'General case' 0 CA--C 1.575 1.904 0 C-N-CA 123.895 0.878 . . . . 0.0 110.828 168.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.91 106.87 0.88 Allowed Glycine 0 N--CA 1.494 2.537 0 O-C-N 120.265 -1.522 . . . . 0.0 115.894 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.42 9.3 p30 59.4 13.53 3.25 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 119.558 3.17 . . . . 0.0 119.558 -166.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -137.22 125.51 23.25 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 120.293 1.406 . . . . 0.0 111.867 -169.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.9 mt -89.25 109.0 19.93 Favored 'General case' 0 CA--C 1.564 1.484 0 O-C-N 121.098 -1.001 . . . . 0.0 108.379 159.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.6 tt -96.8 115.54 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.526 -0.734 . . . . 0.0 110.103 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.58 104.35 2.58 Favored Glycine 0 N--CA 1.482 1.754 0 C-N-CA 123.875 0.75 . . . . 0.0 112.374 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -92.15 95.45 9.75 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -114.95 148.96 38.05 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.477 1.132 . . . . 0.0 112.876 -168.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -121.87 135.46 54.89 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.713 0.805 . . . . 0.0 109.456 166.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -75.5 104.85 6.24 Favored 'General case' 0 CA--C 1.562 1.414 0 O-C-N 121.084 -1.01 . . . . 0.0 111.845 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 t -61.94 -16.45 51.09 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 118.385 2.735 . . . . 0.0 118.385 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -70.19 -28.99 65.74 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 168.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . 0.25 3.1 p-10 -145.53 7.46 1.13 Allowed 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 119.436 3.125 . . . . 0.0 119.436 -177.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.11 -19.7 47.75 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 119.15 2.42 . . . . 0.0 119.15 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -73.81 139.98 45.51 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -169.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -74.12 141.1 45.64 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 tt -126.77 121.05 30.87 Favored 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 123.589 0.756 . . . . 0.0 109.538 168.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -100.15 110.13 22.4 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.2 m -96.92 131.23 43.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.564 -0.71 . . . . 0.0 110.193 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.8 t -129.45 99.67 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -104.31 105.77 16.02 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.144 0.978 . . . . 0.0 108.606 -172.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -126.4 137.94 53.49 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -162.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.1 mm -88.99 127.19 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.386 -0.821 . . . . 0.0 109.51 167.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 49.2 mm -104.18 -80.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 168.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -165.32 113.19 0.54 Allowed Glycine 0 N--CA 1.487 2.093 0 O-C-N 121.357 -0.839 . . . . 0.0 111.056 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.251 31.3 m-20 60.5 1.31 0.39 Allowed 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 -166.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -136.58 138.69 41.5 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 124.339 1.056 . . . . 0.0 111.071 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.3 tp -94.06 109.77 21.51 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 168.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.2 m -95.07 113.37 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . 0.28 0.1 OUTLIER -124.7 119.44 28.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.82 -1.175 . . . . 0.0 113.315 -175.561 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.4 m -107.65 123.87 49.14 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.166 0.986 . . . . 0.0 109.982 -167.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -105.81 111.74 24.52 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.2 t -108.42 102.45 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -104.61 81.09 1.74 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.305 -0.872 . . . . 0.0 110.602 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 63.63 73.58 0.44 Allowed 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 123.779 0.831 . . . . 0.0 112.624 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.97 -36.9 2.33 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 118.732 2.253 . . . . 0.0 118.732 -173.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.81 99.27 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 119.229 1.515 . . . . 0.0 112.663 -169.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -90.42 112.23 23.77 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 123.375 0.67 . . . . 0.0 112.085 -172.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.36 119.64 37.65 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.077 0.551 . . . . 0.0 112.195 176.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -107.34 105.65 15.69 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.016 0.526 . . . . 0.0 109.962 -174.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -91.02 115.15 27.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.41 -0.806 . . . . 0.0 108.963 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.4 mt -105.01 118.94 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -103.01 152.06 21.77 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.048 0.939 . . . . 0.0 111.421 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -101.72 152.68 20.56 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.715 -1.241 . . . . 0.0 111.723 169.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -66.22 105.44 1.41 Allowed 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 123.758 0.823 . . . . 0.0 112.689 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.6 t0 . . . . . 0 N--CA 1.487 1.397 0 C-N-CA 124.922 1.289 . . . . 0.0 114.251 -178.721 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.357 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.33 77.0 m-85 73.34 -58.1 0.61 Allowed 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 171.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -70.55 76.9 0.58 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 120.229 1.377 . . . . 0.0 114.006 -172.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.548 ' HG ' ' NZ ' ' A' ' 130' ' ' LYS . 8.1 t -168.73 173.98 6.9 Favored 'General case' 0 CA--C 1.572 1.821 0 CA-C-O 122.622 1.201 . . . . 0.0 111.93 -165.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.9 m -90.96 133.61 35.14 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.268 -0.895 . . . . 0.0 110.353 171.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -132.2 101.18 5.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.948 -0.47 . . . . 0.0 110.068 -172.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -91.28 135.32 33.88 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.475 -0.766 . . . . 0.0 111.988 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -61.2 121.32 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -99.51 -45.2 5.89 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 117.416 -1.278 . . . . 0.0 114.223 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.57 116.34 1.26 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 120.293 1.406 . . . . 0.0 110.088 -169.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.1 p -100.32 105.41 16.93 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.539 0.736 . . . . 0.0 111.921 -177.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -90.43 126.04 35.77 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.192 0.597 . . . . 0.0 111.635 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.257 45.3 t30 60.1 26.29 15.65 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 117.681 2.474 . . . . 0.0 117.681 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -72.19 -42.84 65.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -60.13 -40.53 90.11 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 117.616 2.451 . . . . 0.0 117.616 171.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.74 -44.18 70.79 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 172.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -44.16 -57.71 3.27 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 158.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.2 mtt -57.0 -42.68 80.73 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 172.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -58.35 -43.92 88.54 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 168.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -59.79 -35.14 74.05 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 168.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 58.0 mtm -66.84 -37.73 85.05 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 170.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.77 59.39 0.45 Allowed Glycine 0 N--CA 1.487 2.089 0 C-N-CA 123.776 0.703 . . . . 0.0 114.745 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.4 p -129.31 136.95 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 122.278 1.037 . . . . 0.0 110.413 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -63.02 143.91 57.36 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.276 13.7 tt -51.03 -42.49 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -176.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.8 t -60.81 -50.36 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 119.59 1.086 . . . . 0.0 113.125 171.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -56.41 -42.33 77.83 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 167.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 57.4 mtm-85 -58.79 -47.05 86.08 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 169.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -59.12 -46.35 88.55 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 170.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.51 -47.75 80.42 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 171.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.09 -25.73 63.65 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.19 76.62 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-N 121.31 1.868 . . . . 0.0 115.043 156.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -78.82 59.42 2.57 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 171.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -97.03 -27.28 14.68 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -175.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.387 1.3 p-10 57.8 55.68 5.28 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -173.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.0 tp -80.17 121.43 25.57 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.419 1.104 . . . . 0.0 113.902 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -106.18 118.33 36.34 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.81 167.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.2 mt -97.4 101.01 12.45 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 51.7 m -94.41 109.5 21.36 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.998 -1.064 . . . . 0.0 109.421 171.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.2 mt -103.79 112.75 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -166.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 87.6 m -103.31 106.3 16.78 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -89.04 108.97 19.88 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.297 0.639 . . . . 0.0 111.948 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.7 70.76 6.71 Favored 'General case' 0 CA--C 1.572 1.809 0 O-C-N 121.587 -0.696 . . . . 0.0 110.486 166.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.99 -96.49 0.22 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 115.515 0.966 . . . . 0.0 115.515 -174.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -87.93 -23.19 23.97 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 169.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -88.85 111.36 21.96 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 121.046 1.748 . . . . 0.0 111.974 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -94.63 117.44 30.14 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.518 0.727 . . . . 0.0 109.181 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.6 m -93.83 97.99 10.77 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.9 t -92.82 105.46 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -86.34 101.79 13.42 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.178 0.591 . . . . 0.0 109.606 -176.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -90.85 97.55 11.25 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.234 0.614 . . . . 0.0 109.837 -172.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -110.54 102.83 11.39 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 122.991 0.516 . . . . 0.0 110.845 -175.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.8 p -140.31 -178.92 5.71 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.028 0.931 . . . . 0.0 111.72 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.86 -29.99 67.38 Favored 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 159.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -97.95 -17.62 19.11 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 174.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -130.07 142.07 50.65 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 121.382 1.901 . . . . 0.0 111.975 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -144.29 74.33 1.42 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.016 -1.052 . . . . 0.0 109.796 162.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.2 pt -143.07 130.16 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.283 -0.886 . . . . 0.0 112.007 -166.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.82 99.84 11.64 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.248 1.019 . . . . 0.0 111.559 172.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.9 t -91.42 98.28 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.174 -0.954 . . . . 0.0 109.19 -169.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.1 t -86.4 119.49 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 123.344 0.658 . . . . 0.0 109.312 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -140.64 133.42 28.97 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.328 0.585 . . . . 0.0 111.532 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -86.45 139.8 30.56 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 121.808 -0.557 . . . . 0.0 111.246 167.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.75 128.43 36.53 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.89 -11.48 59.77 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 119.642 2.617 . . . . 0.0 119.642 -172.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.2 t -85.59 133.01 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 120.43 2.115 . . . . 0.0 110.33 -175.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -77.4 114.11 15.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.508 -0.745 . . . . 0.0 111.466 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -138.56 163.05 33.03 Favored 'General case' 0 CA--C 1.572 1.791 0 C-N-CA 123.264 0.626 . . . . 0.0 112.607 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -85.89 111.17 19.96 Favored 'General case' 0 CA--C 1.57 1.727 0 O-C-N 121.515 -0.741 . . . . 0.0 111.752 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -102.4 156.15 17.78 Favored 'General case' 0 CA--C 1.572 1.796 0 CA-C-O 122.17 0.986 . . . . 0.0 112.678 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -127.18 149.41 49.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.4 -0.812 . . . . 0.0 111.532 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.4 mt -92.97 -113.28 0.1 Allowed 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 118.804 -0.617 . . . . 0.0 110.263 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -146.5 58.91 1.21 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 120.776 1.625 . . . . 0.0 112.718 170.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -159.9 -78.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.116 0.966 . . . . 0.0 108.456 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.18 76.57 0.06 OUTLIER Glycine 0 N--CA 1.481 1.667 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.7 m -147.4 122.22 9.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.731 -0.864 . . . . 0.0 109.212 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -97.96 116.55 30.41 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.403 0.681 . . . . 0.0 110.683 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 70.9 mt -115.48 106.01 13.47 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.46 0.704 . . . . 0.0 110.91 -170.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -82.62 118.73 23.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.41 -0.806 . . . . 0.0 111.743 174.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.56 -167.96 41.06 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 117.741 1.856 . . . . 0.0 117.741 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.8 p -128.22 124.92 37.92 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.675 -0.763 . . . . 0.0 111.534 -163.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -85.92 129.41 34.84 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 118.194 0.452 . . . . 0.0 111.361 161.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.8 t -122.83 137.39 54.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.721 -0.612 . . . . 0.0 111.79 173.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.8 tp -90.93 107.68 19.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.898 -1.126 . . . . 0.0 111.572 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -103.48 75.96 1.38 Allowed 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 121.512 0.672 . . . . 0.0 109.747 171.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.25 -102.54 0.95 Allowed Glycine 0 N--CA 1.491 2.35 0 O-C-N 121.38 -0.825 . . . . 0.0 115.137 -177.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -95.67 22.33 7.31 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -129.84 114.53 16.02 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.713 -1.242 . . . . 0.0 110.03 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.9 mt -84.03 104.68 14.3 Favored 'General case' 0 CA--C 1.564 1.481 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 161.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.1 tt -94.1 114.53 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.466 -0.771 . . . . 0.0 110.231 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -103.07 99.18 1.76 Allowed Glycine 0 N--CA 1.482 1.706 0 C-N-CA 123.689 0.661 . . . . 0.0 113.289 -174.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -90.5 92.75 9.0 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -120.27 134.64 55.22 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.18 0.592 . . . . 0.0 112.503 -168.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -115.68 145.08 43.06 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.514 0.725 . . . . 0.0 109.875 169.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -70.2 123.95 22.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.446 -1.409 . . . . 0.0 112.675 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.281 9.8 t -81.05 59.78 3.97 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 122.625 1.202 . . . . 0.0 113.824 169.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -168.12 -63.31 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.767 0 C-N-CA 125.916 1.686 . . . . 0.0 107.796 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -80.34 -38.72 30.0 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.146 1.535 . . . . 0.0 115.146 171.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.74 -31.17 9.04 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 117.359 1.704 . . . . 0.0 117.359 -158.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -65.86 143.21 57.6 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -165.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -69.13 129.63 40.43 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 175.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.5 tt -121.59 86.06 2.51 Favored 'General case' 0 CA--C 1.563 1.472 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 168.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -83.05 109.06 16.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.987 -1.07 . . . . 0.0 109.735 -167.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 m -111.89 111.38 22.29 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.84 -0.538 . . . . 0.0 110.085 -166.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.0 t -107.1 101.63 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.022 -1.049 . . . . 0.0 109.05 -175.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.4 mtm-85 -84.3 117.32 23.49 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.296 0.639 . . . . 0.0 110.887 174.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -147.76 135.07 20.59 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.816 -1.177 . . . . 0.0 113.347 -173.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 mp -85.14 113.95 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.135 -0.978 . . . . 0.0 108.381 177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.22 84.58 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.29 -84.41 0.73 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 114.728 0.651 . . . . 0.0 114.728 -173.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -103.52 -40.31 6.39 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -101.87 140.34 36.28 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 120.255 1.388 . . . . 0.0 113.096 -169.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.0 tp -76.73 111.34 12.14 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.834 0.853 . . . . 0.0 110.723 172.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 m -99.24 120.04 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -103.32 99.46 9.3 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.542 0.737 . . . . 0.0 109.377 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.4 m -94.18 112.02 23.79 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.301 0.64 . . . . 0.0 110.172 -171.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -90.09 133.3 34.94 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.669 0.788 . . . . 0.0 111.565 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.2 t -119.85 101.61 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 163.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -95.05 94.14 7.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.39 -0.818 . . . . 0.0 109.728 171.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.287 4.6 mm-40 70.35 -69.81 0.17 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -153.13 62.06 0.38 Allowed Glycine 0 N--CA 1.486 2.021 0 CA-C-O 119.784 -0.453 . . . . 0.0 113.683 165.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.5 p -144.58 113.59 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 117.77 0.785 . . . . 0.0 109.05 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -87.56 118.47 27.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.705 -0.622 . . . . 0.0 111.368 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -130.78 131.35 44.63 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 122.839 0.456 . . . . 0.0 111.686 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -115.46 118.02 32.01 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.435 -0.79 . . . . 0.0 111.169 -173.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -93.69 104.62 16.71 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 167.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.76 127.04 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -115.66 130.33 56.82 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.886 0.874 . . . . 0.0 110.264 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -78.61 143.98 35.92 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 121.77 0.795 . . . . 0.0 113.04 176.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.548 ' NZ ' ' HG ' ' A' ' 4' ' ' SER . 53.7 tptt -61.95 115.03 3.72 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 123.927 0.891 . . . . 0.0 112.769 171.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.2 t70 . . . . . 0 N--CA 1.489 1.476 0 C-N-CA 124.93 1.292 . . . . 0.0 112.345 -170.401 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.293 0 CA-C-O 122.139 0.971 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -81.23 36.38 0.41 Allowed 'General case' 0 CA--C 1.581 2.149 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.6 90.06 8.23 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 119.799 -1.813 . . . . 0.0 114.03 -157.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.2 m -158.13 -175.22 5.22 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 124.499 1.12 . . . . 0.0 110.808 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.0 m -99.69 113.09 25.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.808 -1.182 . . . . 0.0 109.441 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -117.81 108.16 15.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.912 -0.493 . . . . 0.0 109.84 -170.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -93.26 140.51 29.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.269 -0.895 . . . . 0.0 112.31 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.4 p -63.75 116.52 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -98.66 -59.35 1.76 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.547 0.739 . . . . 0.0 111.798 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.411 ' C ' ' HG ' ' A' ' 11' ' ' SER . 14.9 ptm180 -141.28 166.08 25.76 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.837 0.827 . . . . 0.0 110.846 177.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.411 ' HG ' ' C ' ' A' ' 10' ' ' ARG . 67.4 m -153.71 126.41 8.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 119.236 -2.165 . . . . 0.0 112.142 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -100.8 121.82 42.35 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.741 0.816 . . . . 0.0 109.932 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.267 14.0 t30 65.29 13.57 8.86 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 171.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -63.59 -40.32 96.64 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.21 -27.04 68.71 Favored 'General case' 0 CA--C 1.577 2.014 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 169.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -73.92 -49.44 24.76 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 120.32 1.418 . . . . 0.0 113.8 165.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -46.8 -51.45 16.41 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 166.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -40.73 76.01 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 166.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -59.89 -45.9 91.04 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 168.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -54.59 -38.44 66.74 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 167.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.6 mtm -68.59 -21.7 64.5 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 168.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.12 49.21 1.77 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 116.212 1.245 . . . . 0.0 116.212 175.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.65 151.9 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 118.673 1.236 . . . . 0.0 113.614 -177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -63.08 144.59 56.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.283 13.2 tt -52.66 -45.13 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.3 t -55.5 -52.31 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 124.023 0.929 . . . . 0.0 113.457 168.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -61.56 -46.11 91.27 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 176.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.7 ptt85 -69.68 -28.81 66.17 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 117.975 2.584 . . . . 0.0 117.975 171.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -62.5 -49.1 76.69 Favored 'General case' 0 CA--C 1.572 1.807 0 CA-C-N 120.09 1.314 . . . . 0.0 114.302 161.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.28 -59.89 4.69 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 170.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.08 -16.79 20.94 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 118.915 2.931 . . . . 0.0 118.915 175.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.05 -86.49 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 117.693 -1.146 . . . . 0.0 112.701 159.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -106.4 48.93 0.82 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 121.814 2.097 . . . . 0.0 115.21 -171.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.0 54.27 2.7 Favored 'General case' 0 CA--C 1.576 1.977 0 O-C-N 120.765 -1.209 . . . . 0.0 113.869 166.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 50.7 50.8 18.24 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 117.563 2.431 . . . . 0.0 117.563 171.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -87.0 124.02 32.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.787 -1.196 . . . . 0.0 113.708 -169.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -119.75 121.41 39.11 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.086 0.954 . . . . 0.0 110.406 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.4 mt -91.44 102.19 14.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.553 -0.717 . . . . 0.0 109.301 176.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 87.0 m -95.21 103.5 15.36 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.4 mt -101.67 128.37 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -167.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.3 p -128.99 122.34 29.9 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 171.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -94.33 131.95 39.43 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.823 0.82 . . . . 0.0 111.251 168.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -97.72 36.86 1.45 Allowed 'General case' 0 CA--C 1.582 2.2 0 C-N-CA 124.603 1.161 . . . . 0.0 113.528 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.79 92.06 0.23 Allowed Glycine 0 N--CA 1.492 2.413 0 O-C-N 120.196 -1.565 . . . . 0.0 113.536 -168.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.279 16.8 t-20 71.58 -61.18 0.5 Allowed 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -74.76 133.65 41.95 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -172.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -111.26 134.24 53.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.492 -0.755 . . . . 0.0 112.132 -173.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.2 m -107.16 113.54 27.04 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 161.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.4 t -110.53 104.87 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -81.66 103.9 11.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 110.189 175.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -90.39 96.26 10.57 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.8 t -102.27 117.05 33.92 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.361 0.664 . . . . 0.0 111.274 -170.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.9 p -143.26 164.81 29.2 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.683 0.754 . . . . 0.0 112.903 -173.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.07 -25.51 65.44 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 159.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -73.03 -50.28 23.93 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -162.88 153.87 17.13 Favored 'General case' 0 CA--C 1.572 1.813 0 C-N-CA 124.408 1.083 . . . . 0.0 111.828 -171.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -129.87 104.14 7.21 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.517 -0.74 . . . . 0.0 109.128 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.28 142.13 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.48 -0.762 . . . . 0.0 112.15 -170.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -89.2 114.65 26.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.578 -0.701 . . . . 0.0 112.614 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.9 t -96.82 102.54 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.39 124.48 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 123.065 0.546 . . . . 0.0 109.598 -175.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -146.32 139.1 25.46 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.238 0.615 . . . . 0.0 111.344 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -97.65 142.37 29.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.26 164.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.74 112.36 3.67 Favored 'General case' 0 CA--C 1.566 1.571 0 O-C-N 121.584 -0.697 . . . . 0.0 112.617 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.56 -18.05 58.14 Favored Glycine 0 CA--C 1.558 2.723 0 N-CA-C 119.488 2.555 . . . . 0.0 119.488 -163.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 65.3 t -94.77 112.65 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 120.453 2.127 . . . . 0.0 109.039 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 t -73.07 139.48 46.56 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -131.54 166.81 20.54 Favored 'General case' 0 CA--C 1.574 1.866 0 C-N-CA 124.295 1.038 . . . . 0.0 112.832 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -93.1 120.71 33.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.433 -0.792 . . . . 0.0 110.543 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -119.92 123.27 43.15 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.345 0.658 . . . . 0.0 111.8 -176.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -81.48 127.17 32.53 Favored 'General case' 0 CA--C 1.566 1.584 0 O-C-N 121.329 -0.857 . . . . 0.0 109.703 161.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 57.3 mt -63.36 177.59 0.64 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 168.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.86 35.31 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 118.341 2.719 . . . . 0.0 118.341 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -154.6 -82.7 0.07 Allowed 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.753 1.221 . . . . 0.0 108.951 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.0 74.17 0.09 OUTLIER Glycine 0 N--CA 1.483 1.81 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 55.5 m -152.63 110.36 3.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.91 -0.759 . . . . 0.0 109.301 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -84.84 115.12 22.57 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-O 122.066 0.936 . . . . 0.0 112.224 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.2 mt -107.7 152.24 24.6 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 125.015 1.326 . . . . 0.0 111.442 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -116.26 111.39 20.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.042 -1.036 . . . . 0.0 109.795 174.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.24 -174.99 38.78 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 114.667 0.627 . . . . 0.0 114.667 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.9 m -117.25 -58.5 2.04 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -163.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . 0.272 69.6 m95 76.46 91.3 0.07 Allowed 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.488 1.115 . . . . 0.0 111.284 -153.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.2 m -105.37 127.88 53.2 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.261 0.624 . . . . 0.0 110.731 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.1 tp -78.53 102.64 8.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.0 111.158 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -81.54 -58.06 3.19 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.69 -96.21 1.12 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 160.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -102.34 57.21 0.79 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 117.774 0.787 . . . . 0.0 110.878 154.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -147.53 111.9 5.24 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -173.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.7 mt -86.4 101.86 13.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.582 -0.698 . . . . 0.0 109.746 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.8 tt -88.77 107.28 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.262 1.029 . . . . 0.0 110.638 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.73 93.14 1.72 Allowed Glycine 0 N--CA 1.48 1.592 0 C-N-CA 123.63 0.633 . . . . 0.0 112.954 174.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -86.75 92.44 8.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -112.07 108.31 17.56 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.352 0.661 . . . . 0.0 111.088 -165.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -89.97 129.75 36.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.972 -1.08 . . . . 0.0 110.851 177.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -61.14 135.66 57.83 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.7 p -64.32 -64.0 0.99 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 161.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -86.94 72.67 10.07 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 121.526 -0.734 . . . . 0.0 111.038 171.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 171.11 -39.32 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 126.527 1.931 . . . . 0.0 112.627 168.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 70.38 22.69 77.7 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 118.491 2.156 . . . . 0.0 118.491 -164.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -121.83 157.89 30.09 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.482 1.134 . . . . 0.0 113.394 -169.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -84.97 124.97 32.29 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -166.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.15 111.77 20.72 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.02 0.928 . . . . 0.0 108.717 170.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -103.65 111.99 24.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.301 -0.874 . . . . 0.0 108.883 -173.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.4 m -111.03 104.06 12.59 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 119.771 1.169 . . . . 0.0 110.828 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.7 t -90.25 104.06 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.13 -0.981 . . . . 0.0 108.62 177.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.5 118.86 24.57 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.584 0.754 . . . . 0.0 110.381 171.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -149.4 147.64 28.52 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 119.511 1.051 . . . . 0.0 113.524 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 mp -93.63 123.53 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.969 -1.082 . . . . 0.0 109.261 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 44.4 mm -103.5 92.11 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 170.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.11 -97.58 1.16 Allowed Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.339 -0.851 . . . . 0.0 114.176 -173.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -130.4 49.3 2.31 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 121.897 0.856 . . . . 0.0 111.773 166.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -144.25 116.68 8.56 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 124.015 0.926 . . . . 0.0 108.581 -173.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.8 tp -89.0 115.18 26.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.694 -0.629 . . . . 0.0 110.621 -173.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.4 m -105.56 121.09 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -98.24 108.57 21.3 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.732 0.813 . . . . 0.0 109.914 171.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.4 m -91.0 98.51 11.82 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -90.51 114.07 26.19 Favored 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 124.395 1.078 . . . . 0.0 111.349 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.56 105.91 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-N 119.203 0.91 . . . . 0.0 108.576 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -108.65 114.41 28.2 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 118.917 0.78 . . . . 0.0 109.774 167.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 53.66 50.21 17.63 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.21 -26.41 4.43 Favored Glycine 0 CA--C 1.554 2.472 0 N-CA-C 119.296 2.479 . . . . 0.0 119.296 -168.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.9 t -83.59 104.38 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 120.262 2.031 . . . . 0.0 109.928 -170.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -87.37 132.26 34.02 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -130.9 121.93 26.09 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.671 0.789 . . . . 0.0 111.717 171.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -101.0 106.09 17.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.445 -0.784 . . . . 0.0 110.948 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -93.94 125.52 38.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.794 -0.566 . . . . 0.0 111.47 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.8 mt -116.81 116.84 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -165.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -113.46 130.23 56.37 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.028 0.931 . . . . 0.0 110.445 -172.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -82.77 140.7 32.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.904 . . . . 0.0 112.054 174.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -62.77 107.19 0.92 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.554 -0.716 . . . . 0.0 111.518 162.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -162.487 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.57 1.723 0 N-CA-C 117.931 2.567 . . . . 0.0 117.931 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.3 92.6 m-85 72.26 164.39 0.28 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 119.897 1.226 . . . . 0.0 113.154 -163.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.27 17.6 m-20 66.79 50.76 1.09 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.9 t -157.28 -170.02 3.11 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 121.197 -0.94 . . . . 0.0 111.543 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.0 m -97.59 116.85 30.61 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.986 -1.071 . . . . 0.0 109.803 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -116.76 105.34 12.28 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.338 0.655 . . . . 0.0 109.538 -169.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -93.72 132.66 37.86 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.45 0.7 . . . . 0.0 110.86 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 p -57.07 116.56 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.952 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.46 -49.7 5.79 Favored 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 124.411 1.084 . . . . 0.0 112.913 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -149.71 116.62 5.94 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.529 1.059 . . . . 0.0 110.744 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.9 p -97.29 100.67 12.13 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.686 0.794 . . . . 0.0 111.564 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -95.14 125.37 39.74 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.421 0.688 . . . . 0.0 110.665 -169.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.268 42.7 t30 63.56 25.69 14.47 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -73.52 -45.73 52.03 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 115.605 1.705 . . . . 0.0 115.605 -173.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -61.41 -27.8 68.8 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -74.42 -46.28 41.12 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.966 1.257 . . . . 0.0 114.092 165.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -49.48 -52.71 27.42 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 164.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -31.2 72.32 Favored 'General case' 0 CA--C 1.574 1.888 0 N-CA-C 116.313 1.968 . . . . 0.0 116.313 172.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.47 -37.89 86.11 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 121.16 1.8 . . . . 0.0 115.476 163.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -60.05 -39.47 86.07 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 165.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 83.0 mmm -60.68 -45.68 93.25 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 165.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.78 51.42 0.57 Allowed Glycine 0 N--CA 1.484 1.878 0 C-N-CA 124.294 0.95 . . . . 0.0 114.8 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.4 m -108.61 142.4 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.479 1.133 . . . . 0.0 112.776 -178.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -66.5 154.89 39.14 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.305 0.1 OUTLIER -43.77 -56.1 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 -173.373 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.83 -51.55 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 CA-C-N 119.563 1.074 . . . . 0.0 113.082 175.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -55.67 -42.07 74.58 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 170.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.1 ttp85 -60.72 -50.63 72.72 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 169.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -60.53 -43.45 97.13 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 169.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.61 -38.72 88.68 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 167.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.68 -41.5 96.01 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 169.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.26 -51.42 67.79 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 162.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -96.61 58.89 1.74 Allowed 'General case' 0 CA--C 1.572 1.82 0 CA-C-N 119.328 0.967 . . . . 0.0 111.965 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -96.57 -16.33 21.12 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.696 2.109 . . . . 0.0 116.696 -170.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 55.31 57.31 5.55 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 119.878 1.217 . . . . 0.0 114.162 -167.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.4 tp -80.73 117.42 21.39 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 121.969 0.89 . . . . 0.0 111.301 -176.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -122.01 109.52 14.68 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.011 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 84.3 mt -94.89 106.68 18.69 Favored 'General case' 0 CA--C 1.563 1.442 0 C-N-CA 123.31 0.644 . . . . 0.0 110.227 -174.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.0 m -92.11 109.05 20.4 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.268 -0.895 . . . . 0.0 109.894 170.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.4 mt -101.5 133.99 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.739 0 C-N-CA 124.409 1.084 . . . . 0.0 108.53 -170.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t -153.02 125.67 8.27 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.939 -1.101 . . . . 0.0 111.729 171.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -87.29 116.94 25.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.129 -0.982 . . . . 0.0 112.08 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -103.11 75.29 1.36 Allowed 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.413 0.685 . . . . 0.0 110.256 171.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.68 75.29 0.43 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 115.947 1.139 . . . . 0.0 115.947 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.276 10.9 t-20 70.28 -48.67 0.64 Allowed 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -167.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -68.94 114.14 6.97 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 119.313 0.96 . . . . 0.0 113.352 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -88.43 120.48 29.85 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.154 0.582 . . . . 0.0 111.181 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.1 m -89.39 109.34 20.26 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 167.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.0 t -109.71 109.01 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -82.89 106.06 14.4 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -85.57 84.94 7.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.999 0.52 . . . . 0.0 109.906 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 t -85.84 111.06 19.84 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.564 0.345 . . . . 0.0 110.848 -176.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.2 p -142.93 159.85 41.46 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -169.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.34 -27.75 56.86 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 118.321 2.711 . . . . 0.0 118.321 169.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -74.24 -46.86 38.94 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 164.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.7 ptt-85 -167.02 150.76 6.71 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.772 0.829 . . . . 0.0 112.171 -170.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.65 96.62 6.08 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.585 0.754 . . . . 0.0 110.878 171.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.6 pt -119.59 127.47 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.569 -0.707 . . . . 0.0 112.416 -169.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.38 112.13 13.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.542 -0.724 . . . . 0.0 112.166 170.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.5 t -104.75 102.15 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.24 116.79 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -133.14 135.34 45.12 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.438 0.637 . . . . 0.0 111.53 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -80.61 136.27 36.2 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.595 -0.69 . . . . 0.0 111.328 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 57.1 mt -60.06 125.24 22.88 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -176.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.18 -5.7 70.87 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 119.708 2.643 . . . . 0.0 119.708 -172.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.4 t -88.75 133.0 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 120.122 1.961 . . . . 0.0 109.736 -176.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.7 p -72.92 110.26 7.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.65 -0.657 . . . . 0.0 111.947 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -126.83 163.02 24.52 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 124.013 0.925 . . . . 0.0 112.039 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -84.32 106.54 16.01 Favored 'General case' 0 CA--C 1.569 1.689 0 O-C-N 121.297 -0.877 . . . . 0.0 111.586 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -102.44 167.86 9.68 Favored 'General case' 0 CA--C 1.571 1.759 0 C-N-CA 124.749 1.22 . . . . 0.0 112.445 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -146.96 131.53 17.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.705 -1.247 . . . . 0.0 111.575 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.9 mt -84.83 62.77 7.63 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.271 . . 61.46 -36.49 0.11 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 120.409 3.485 . . . . 0.0 120.409 175.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -86.91 -85.89 0.16 Allowed 'General case' 0 CA--C 1.565 1.555 0 CA-C-N 120.052 1.297 . . . . 0.0 110.2 177.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.61 74.5 0.1 OUTLIER Glycine 0 N--CA 1.482 1.747 0 O-C-N 121.587 -0.696 . . . . 0.0 113.536 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.5 m -146.9 123.97 11.42 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.519 -0.989 . . . . 0.0 109.985 162.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -78.42 130.84 36.56 Favored 'General case' 0 CA--C 1.566 1.587 0 CA-C-O 122.155 0.978 . . . . 0.0 112.435 173.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.6 mt -131.61 111.52 11.8 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.242 -165.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -86.61 114.5 23.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.095 -1.003 . . . . 0.0 111.052 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.37 178.63 47.91 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 116.399 1.32 . . . . 0.0 116.399 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.1 p -92.21 165.31 13.19 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.27 1.033 . . . . 0.0 113.494 -174.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -127.23 108.83 11.22 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 143.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.4 m -100.36 137.48 38.72 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.49 0.716 . . . . 0.0 110.949 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.7 tp -85.3 94.75 9.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.215 -0.928 . . . . 0.0 111.398 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -84.49 79.18 9.66 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-O 121.836 0.827 . . . . 0.0 110.866 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.55 -94.58 0.95 Allowed Glycine 0 N--CA 1.489 2.222 0 O-C-N 121.722 -0.612 . . . . 0.0 113.908 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -126.5 63.62 1.27 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.822 0.82 . . . . 0.0 109.695 163.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -152.45 125.19 8.39 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.7 mt -90.74 105.12 17.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.56 -1.338 . . . . 0.0 109.571 171.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.1 tt -105.18 125.68 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 123.743 0.817 . . . . 0.0 110.616 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.65 118.53 1.99 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 115.58 0.992 . . . . 0.0 115.58 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -95.27 99.91 11.79 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.215 0.606 . . . . 0.0 110.229 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -107.62 107.25 17.98 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -167.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -90.48 136.58 32.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.377 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -75.54 124.86 27.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.999 -1.063 . . . . 0.0 113.239 -173.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.5 p -80.8 62.7 4.93 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 122.332 1.063 . . . . 0.0 112.723 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.4 t0 171.85 -41.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 126.732 2.013 . . . . 0.0 110.283 -166.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -121.49 -18.47 7.24 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -175.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.08 -34.91 3.64 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 118.516 2.166 . . . . 0.0 118.516 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -69.89 139.94 53.08 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -166.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -81.79 128.06 33.62 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.8 tt -106.41 85.62 2.21 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.253 8.5 p30 -81.11 110.36 16.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.334 -0.854 . . . . 0.0 110.803 -173.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.9 m -114.18 112.18 22.75 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.916 -164.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.3 t -102.39 103.86 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.1 mtm180 -85.68 120.64 27.34 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.611 -0.681 . . . . 0.0 110.211 164.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.74 157.92 43.77 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.2 mm -94.31 118.14 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.661 -1.274 . . . . 0.0 109.818 -175.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.2 tt -88.76 71.02 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.14 0.971 . . . . 0.0 111.339 171.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.68 -79.22 0.97 Allowed Glycine 0 N--CA 1.491 2.332 0 O-C-N 120.704 -1.248 . . . . 0.0 114.874 -172.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -107.67 -33.64 7.23 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -93.84 146.22 24.05 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 120.482 1.492 . . . . 0.0 112.82 -174.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.3 tp -86.9 115.87 24.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 110.79 174.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 19.6 m -98.03 115.83 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.354 -0.841 . . . . 0.0 109.752 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -97.39 101.73 13.33 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 171.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.1 m -95.03 105.87 17.82 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.216 0.607 . . . . 0.0 109.558 -176.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -92.84 113.83 26.22 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 124.159 0.984 . . . . 0.0 109.505 -177.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.5 t -113.28 112.64 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -123.11 94.42 4.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.691 -0.63 . . . . 0.0 110.059 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 50.9 55.21 9.9 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 103.26 -49.87 0.93 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 117.094 1.598 . . . . 0.0 117.094 -169.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.1 p -76.45 113.4 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 119.211 1.506 . . . . 0.0 113.151 -165.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -92.18 116.89 29.34 Favored 'General case' 0 CA--C 1.563 1.446 0 O-C-N 121.91 -0.494 . . . . 0.0 111.155 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.42 139.76 48.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.914 -0.491 . . . . 0.0 111.734 163.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -120.27 110.31 16.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.886 . . . . 0.0 110.467 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -89.19 108.47 19.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.62 -0.675 . . . . 0.0 110.458 164.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.7 mp -90.22 120.89 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -110.53 131.82 54.72 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 124.05 0.94 . . . . 0.0 110.116 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -90.51 149.02 22.36 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-O 121.864 0.84 . . . . 0.0 111.817 174.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -68.25 106.87 2.59 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 112.035 173.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.046 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.304 0 CA-C-O 121.623 0.725 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -71.08 -34.82 71.54 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -75.36 77.25 2.44 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 -171.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.8 t -148.14 -177.46 5.76 Favored 'General case' 0 CA--C 1.574 1.891 0 CA-C-O 122.389 1.09 . . . . 0.0 111.266 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -95.19 115.87 27.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.126 -0.984 . . . . 0.0 109.667 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -117.37 103.72 10.41 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.97 0.508 . . . . 0.0 110.402 -169.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -86.71 135.69 33.29 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 123.539 0.735 . . . . 0.0 111.998 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.2 p -63.54 119.18 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.338 -0.851 . . . . 0.0 113.228 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -103.77 -53.2 2.81 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 124.021 0.929 . . . . 0.0 113.084 -173.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -149.05 85.54 1.47 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 119.212 0.915 . . . . 0.0 111.095 -172.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.4 p -73.32 120.2 18.61 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 178.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -104.28 115.22 30.02 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 123.544 0.737 . . . . 0.0 109.831 -169.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.1 t30 62.05 17.7 9.31 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 118.116 2.635 . . . . 0.0 118.116 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -75.85 -35.83 59.8 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -168.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.95 -26.17 68.03 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 162.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -71.36 -47.49 56.03 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 119.917 1.235 . . . . 0.0 114.245 166.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -43.9 -50.68 7.97 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 160.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.7 mtt -64.84 -32.98 74.93 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 172.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.42 -43.41 93.05 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 120.897 1.681 . . . . 0.0 115.326 162.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -62.09 -34.73 76.86 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 169.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 22.1 mmt -60.3 -30.28 69.39 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 164.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.94 50.41 3.29 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 115.612 1.005 . . . . 0.0 115.612 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.3 m -89.8 160.63 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 121.984 0.897 . . . . 0.0 113.208 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -70.86 154.75 41.55 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 165.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.269 14.7 tt -59.14 -36.87 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.11 -56.0 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-N 119.558 1.072 . . . . 0.0 112.922 172.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -65.19 -28.78 69.63 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 116.788 2.144 . . . . 0.0 116.788 172.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.5 ttp85 -58.9 -42.23 89.09 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 117.27 2.322 . . . . 0.0 117.27 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.5 OUTLIER -77.36 -48.24 17.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 162.343 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.84 -51.33 62.66 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -175.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.19 -37.04 85.64 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 173.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.71 -51.42 65.05 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 168.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -100.12 47.76 0.93 Allowed 'General case' 0 CA--C 1.574 1.881 0 CA-C-N 118.954 0.797 . . . . 0.0 112.703 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -83.99 16.27 2.96 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -169.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 53.44 50.19 17.94 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.164 -1.585 . . . . 0.0 115.136 -170.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.2 tp -80.23 120.65 24.61 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 121.88 0.847 . . . . 0.0 112.873 -171.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -111.87 121.06 44.0 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.287 172.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.6 mt -101.9 102.54 13.12 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.969 0.508 . . . . 0.0 109.966 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.2 m -89.86 108.82 19.93 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.328 -0.858 . . . . 0.0 109.231 169.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.0 mt -101.57 128.9 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -172.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 t -145.31 133.65 21.78 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.894 -1.129 . . . . 0.0 111.56 171.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -99.95 118.87 37.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.194 -0.942 . . . . 0.0 112.3 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -100.81 71.2 1.44 Allowed 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 123.137 0.575 . . . . 0.0 110.636 169.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 62.39 77.33 0.21 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 116.552 1.381 . . . . 0.0 116.552 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.278 7.1 t30 72.21 -24.72 0.18 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -170.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -90.0 109.62 20.64 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 119.657 1.117 . . . . 0.0 111.901 172.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -83.04 118.01 23.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.516 -0.74 . . . . 0.0 111.161 169.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.6 m -86.23 107.55 17.97 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 164.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.07 112.67 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -87.24 111.36 20.94 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.286 0.634 . . . . 0.0 110.351 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -89.99 89.46 7.72 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.289 0.635 . . . . 0.0 109.467 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.7 m -97.4 107.7 20.27 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.8 p -145.84 174.0 11.62 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.02 0.914 . . . . 0.0 113.23 -171.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.85 -30.32 65.69 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 118.432 2.753 . . . . 0.0 118.432 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.2 -31.64 30.24 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 168.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -159.24 155.27 26.7 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 119.926 1.239 . . . . 0.0 113.357 -159.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -134.64 99.88 4.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.068 -1.02 . . . . 0.0 108.748 165.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.6 pt -132.22 129.75 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.854 -0.529 . . . . 0.0 111.704 -169.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.13 109.66 19.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.203 -0.936 . . . . 0.0 111.762 174.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.8 t -100.43 107.8 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -175.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -92.36 109.99 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -120.26 129.03 53.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.856 -0.528 . . . . 0.0 111.203 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -80.63 130.87 35.36 Favored 'General case' 0 CA--C 1.562 1.425 0 O-C-N 121.666 -0.646 . . . . 0.0 111.117 168.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.3 mt -61.45 124.22 20.03 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.72 -17.45 58.58 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 119.354 2.502 . . . . 0.0 119.354 -166.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.5 t -89.46 134.93 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-N 120.768 2.284 . . . . 0.0 110.41 -176.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -76.87 116.43 17.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.579 -0.701 . . . . 0.0 112.594 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -135.68 159.2 42.38 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 123.651 0.78 . . . . 0.0 111.297 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.03 94.29 7.48 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 121.306 -0.871 . . . . 0.0 112.404 -172.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -89.39 145.76 25.12 Favored 'General case' 0 CA--C 1.569 1.701 0 O-C-N 121.499 -0.751 . . . . 0.0 112.458 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -128.33 126.01 39.89 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.428 -0.795 . . . . 0.0 110.832 -174.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.7 mt -94.65 74.1 3.7 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -173.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.32 . . 65.7 -61.52 0.26 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -67.63 -18.24 64.89 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 119.141 3.015 . . . . 0.0 119.141 174.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.89 31.35 5.73 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 117.515 1.766 . . . . 0.0 117.515 -163.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.1 m -81.45 99.07 8.54 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.129 0.965 . . . . 0.0 109.176 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -85.72 99.39 11.3 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -160.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.6 mt -112.55 113.87 26.24 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.787 0.835 . . . . 0.0 110.832 -167.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -97.22 123.5 41.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.944 . . . . 0.0 111.336 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.71 179.76 46.4 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 118.061 1.984 . . . . 0.0 118.061 -169.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 80.7 p -114.32 134.03 55.25 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.013 -1.093 . . . . 0.0 111.357 -169.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -89.85 119.54 30.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.852 . . . . 0.0 109.974 162.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.6 m -117.17 125.71 51.63 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.175 0.59 . . . . 0.0 110.997 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 tp -91.48 100.22 13.02 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.263 0.625 . . . . 0.0 111.243 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.86 68.79 2.06 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.456 0.703 . . . . 0.0 111.801 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.19 69.23 1.42 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 116.208 1.243 . . . . 0.0 116.208 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.256 1.1 t30 59.46 29.08 18.6 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 -168.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -138.01 111.66 8.2 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.4 mt -95.45 105.1 17.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.488 -0.758 . . . . 0.0 109.72 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.5 tt -95.02 121.12 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.978 0.894 . . . . 0.0 109.807 173.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.8 101.95 2.83 Favored Glycine 0 N--CA 1.479 1.557 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.467 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -91.83 96.44 10.41 Favored 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -121.3 149.45 42.88 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.163 0.982 . . . . 0.0 112.201 -168.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -121.77 139.56 53.44 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 121.857 0.837 . . . . 0.0 109.669 167.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.7 mmm-85 -61.8 115.69 4.21 Favored 'General case' 0 CA--C 1.562 1.427 0 O-C-N 121.451 -0.781 . . . . 0.0 112.889 166.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.8 p -60.22 -55.97 27.22 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 169.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -83.59 55.03 3.05 Favored 'General case' 0 CA--C 1.578 2.036 0 O-C-N 121.58 -0.7 . . . . 0.0 112.375 171.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -175.32 -35.7 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 172.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.81 21.23 77.03 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 118.588 2.195 . . . . 0.0 118.588 -165.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -119.59 145.98 45.92 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.484 1.142 . . . . 0.0 113.154 -168.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.26 135.99 34.11 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -168.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.6 tt -123.8 130.78 53.16 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.612 1.165 . . . . 0.0 110.625 174.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -111.93 116.16 30.16 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.6 m -109.5 102.71 11.55 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 120.649 1.568 . . . . 0.0 110.493 171.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.8 t -102.59 90.91 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -174.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -99.58 137.22 38.38 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.336 1.065 . . . . 0.0 113.071 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -157.89 154.03 27.25 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.89 -174.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.5 mm -93.69 108.74 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.436 -0.79 . . . . 0.0 109.453 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.254 16.4 tt -86.29 71.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 122.152 0.977 . . . . 0.0 111.234 172.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.46 -84.92 0.95 Allowed Glycine 0 N--CA 1.489 2.228 0 O-C-N 121.012 -1.055 . . . . 0.0 114.56 -174.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -129.72 65.1 1.49 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 122.665 0.386 . . . . 0.0 110.044 167.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -164.36 125.37 2.16 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.424 0.69 . . . . 0.0 110.009 170.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.1 tp -83.22 102.81 12.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.609 -0.682 . . . . 0.0 109.197 171.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.4 m -91.7 98.45 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -96.17 95.3 8.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.095 -1.003 . . . . 0.0 110.757 -170.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.496 ' HG1' ' NZ ' ' A' ' 125' ' ' LYS . 38.9 m -89.6 102.58 15.26 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.236 0.614 . . . . 0.0 111.184 -166.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -90.24 119.78 30.84 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.745 0.818 . . . . 0.0 110.85 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.8 t -120.2 104.61 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -113.41 118.27 34.08 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.094 0.557 . . . . 0.0 110.657 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.28 53.0 mt-10 64.9 -79.33 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 123.834 0.854 . . . . 0.0 112.829 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -151.3 58.25 0.43 Allowed Glycine 0 N--CA 1.487 2.051 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.993 157.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.2 p -133.79 112.79 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 118.34 1.07 . . . . 0.0 109.834 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -89.64 124.5 34.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.476 -0.765 . . . . 0.0 111.264 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.24 127.14 20.68 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 170.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.496 ' NZ ' ' HG1' ' A' ' 116' ' ' THR . 41.5 mttp -98.68 121.71 40.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.926 . . . . 0.0 111.535 176.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -85.75 106.98 17.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.319 157.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.7 mt -96.6 115.26 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -176.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -111.3 134.15 53.1 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 122.985 0.514 . . . . 0.0 111.184 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -94.7 147.07 23.7 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-O 121.74 0.781 . . . . 0.0 112.417 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -72.84 116.1 12.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.425 -0.797 . . . . 0.0 112.312 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -172.787 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.302 96.4 m-85 . . . . . 0 N--CA 1.498 1.969 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -76.84 82.45 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.832 1.197 . . . . 0.0 112.847 -171.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.9 m -170.59 172.85 5.71 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 124.86 1.264 . . . . 0.0 110.832 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.6 m -83.63 113.93 21.19 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.089 -1.007 . . . . 0.0 111.217 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -118.04 113.76 22.11 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.547 0.739 . . . . 0.0 109.914 -175.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -108.33 140.71 41.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.509 -0.745 . . . . 0.0 112.398 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.8 p -62.35 119.19 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -91.35 -54.26 3.99 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 123.765 0.826 . . . . 0.0 112.641 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -148.22 122.85 9.83 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 118.679 0.672 . . . . 0.0 110.226 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.9 m -108.83 115.06 29.36 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.466 0.706 . . . . 0.0 110.843 -172.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -110.99 111.86 23.28 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -161.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.281 12.5 t30 67.07 19.65 10.46 Favored 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 117.573 2.435 . . . . 0.0 117.573 -174.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -72.56 -38.4 67.96 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.48 -29.01 69.7 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 165.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -72.24 -53.3 12.93 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 119.551 1.069 . . . . 0.0 113.595 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -42.82 -53.93 4.38 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 162.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.9 mtt -65.45 -27.13 68.29 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 116.755 2.132 . . . . 0.0 116.755 172.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -64.4 -39.87 94.68 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 166.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -63.17 -32.3 73.66 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 165.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.6 mtm -73.94 -14.35 61.03 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 169.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.11 56.49 2.7 Favored Glycine 0 N--CA 1.487 2.039 0 CA-C-N 120.118 1.327 . . . . 0.0 115.824 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.261 6.0 p -125.35 142.47 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-O 121.795 0.807 . . . . 0.0 112.614 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -62.39 146.2 51.95 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -172.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.288 0.0 OUTLIER -44.26 -46.89 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 176.408 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.8 t -55.53 -61.57 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 C-N-CA 124.204 1.002 . . . . 0.0 113.345 171.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -60.23 -42.65 95.68 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 173.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.8 ttp85 -59.02 -48.21 82.42 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 173.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -66.22 -38.58 88.28 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.9 mt -65.29 -33.24 75.5 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 167.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.13 -32.77 70.93 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 168.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.97 -57.07 14.44 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 154.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -90.05 66.06 6.68 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.56 1.172 . . . . 0.0 112.054 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -101.95 -31.71 10.55 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 116.733 2.123 . . . . 0.0 116.733 -162.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 64.61 50.28 2.17 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 119.781 1.173 . . . . 0.0 113.986 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 tp -89.45 112.13 23.19 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.081 -1.012 . . . . 0.0 111.264 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -103.4 108.67 20.0 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.963 1.305 . . . . 0.0 109.046 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.6 mt -100.21 104.05 15.54 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.607 0.763 . . . . 0.0 109.542 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.2 m -94.9 102.72 14.57 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.557 -0.714 . . . . 0.0 109.448 171.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.9 mt -86.34 121.68 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.776 0.83 . . . . 0.0 108.983 -175.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.4 p -128.34 119.53 25.25 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.618 -0.676 . . . . 0.0 110.429 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -74.84 127.89 34.27 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 122.443 1.115 . . . . 0.0 112.348 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -110.94 -28.3 8.42 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -168.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.05 74.37 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 C-N-CA 124.6 1.095 . . . . 0.0 110.568 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.29 14.7 t-20 66.73 -55.96 0.42 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -150.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -53.59 148.97 8.64 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -113.95 114.8 26.69 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 171.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.1 m -87.17 100.47 12.69 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 170.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.1 t -107.21 113.59 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -171.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -83.39 109.22 17.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.357 0.663 . . . . 0.0 109.52 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -103.82 88.65 3.1 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -170.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.4 m -96.0 120.25 35.95 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.777 0.831 . . . . 0.0 111.142 -171.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.1 p -142.94 169.29 17.84 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.782 1.031 . . . . 0.0 113.782 -172.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.52 -31.27 61.94 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 163.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -79.92 -51.26 9.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 170.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -159.23 148.57 18.54 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -165.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -103.62 102.77 12.65 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 164.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.5 pt -119.05 123.96 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.613 -0.68 . . . . 0.0 111.114 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -90.25 105.4 17.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 0.0 109.935 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.5 105.68 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -170.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.7 t -91.68 99.14 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -110.79 132.63 54.03 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.244 0.545 . . . . 0.0 111.883 178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -84.78 145.7 27.75 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.443 0.64 . . . . 0.0 111.593 168.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.0 mt -63.57 102.13 0.4 Allowed 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.36 -5.16 44.58 Favored Glycine 0 CA--C 1.551 2.342 0 N-CA-C 119.19 2.436 . . . . 0.0 119.19 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.2 p -78.26 139.73 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 120.963 2.381 . . . . 0.0 112.895 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 66.0 m -86.4 105.95 17.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.556 -0.715 . . . . 0.0 109.87 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -132.0 158.37 41.67 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.436 0.694 . . . . 0.0 111.971 -175.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -82.33 95.75 7.71 Favored 'General case' 0 CA--C 1.568 1.652 0 O-C-N 121.647 -0.658 . . . . 0.0 111.202 174.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -83.92 137.81 33.47 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.558 0.694 . . . . 0.0 111.589 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -120.17 133.27 55.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.718 -0.614 . . . . 0.0 109.969 177.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.0 mt -81.72 -132.04 0.03 OUTLIER 'General case' 0 CA--C 1.576 1.958 0 O-C-N 122.093 -0.379 . . . . 0.0 111.31 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.55 -45.57 11.64 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.6 p30 -99.26 -76.38 0.54 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.741 0.816 . . . . 0.0 111.958 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.88 82.05 0.12 Allowed Glycine 0 N--CA 1.482 1.722 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -169.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.0 m -143.1 100.38 3.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.62 113.92 22.9 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.581 0.705 . . . . 0.0 111.516 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.0 mt -118.28 105.84 12.17 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.514 0.726 . . . . 0.0 110.826 -169.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -79.46 119.85 23.04 Favored 'General case' 0 CA--C 1.566 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 111.589 172.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.25 -158.37 30.41 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.8 p -127.17 142.79 51.41 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 123.135 0.574 . . . . 0.0 112.536 -158.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -100.64 116.58 32.9 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.53 -0.731 . . . . 0.0 109.316 158.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 t -122.77 130.29 52.74 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.276 0.631 . . . . 0.0 111.748 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.8 tp -84.06 116.4 22.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.849 -1.157 . . . . 0.0 111.961 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -139.78 100.29 3.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.895 -0.503 . . . . 0.0 110.923 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.27 67.29 2.13 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 116.444 1.337 . . . . 0.0 116.444 174.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.288 21.1 t-20 72.91 -55.55 0.68 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 113.763 1.024 . . . . 0.0 113.763 -157.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -81.77 134.76 35.47 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -152.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.8 mt -85.83 108.32 18.07 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.805 0.812 . . . . 0.0 109.018 170.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.7 mm -96.35 113.02 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -170.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.59 87.87 1.55 Allowed Glycine 0 N--CA 1.48 1.578 0 CA-C-O 119.558 -0.579 . . . . 0.0 112.951 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -86.58 97.68 10.66 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.744 0.783 . . . . 0.0 109.62 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -120.23 161.95 20.22 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-O 123.421 1.581 . . . . 0.0 111.92 -174.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -143.54 149.03 36.86 Favored 'General case' 0 CA--C 1.559 1.325 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.739 164.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -67.46 113.19 5.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.019 -1.051 . . . . 0.0 112.576 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.5 t -65.78 -19.81 66.03 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 165.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.14 -28.58 70.16 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 117.159 2.281 . . . . 0.0 117.159 157.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -130.23 -46.11 1.11 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 -167.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.34 -24.41 24.49 Favored Glycine 0 CA--C 1.554 2.527 0 N-CA-C 117.432 1.733 . . . . 0.0 117.432 -155.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -76.97 139.74 40.22 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 119.842 1.821 . . . . 0.0 114.577 -174.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.04 141.1 49.29 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tt -129.91 120.93 25.68 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.145 0.578 . . . . 0.0 110.061 171.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -109.87 113.9 27.02 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.934 -1.104 . . . . 0.0 109.38 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.1 m -114.35 102.53 10.19 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 119.279 0.945 . . . . 0.0 110.479 -177.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.7 t -90.23 106.13 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 120.809 -1.182 . . . . 0.0 109.595 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -86.03 115.42 23.62 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 123.477 0.711 . . . . 0.0 110.907 170.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -140.45 144.19 35.96 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 123.516 0.727 . . . . 0.0 111.914 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.3 mm -97.76 109.64 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.28 -0.888 . . . . 0.0 109.122 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.252 11.0 tp -93.01 85.02 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-O 121.945 0.878 . . . . 0.0 110.225 169.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.32 -86.89 0.91 Allowed Glycine 0 N--CA 1.49 2.282 0 O-C-N 121.289 -0.882 . . . . 0.0 114.589 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -135.42 53.57 1.96 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.386 0.613 . . . . 0.0 111.995 166.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -146.43 121.25 9.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.126 -0.984 . . . . 0.0 108.359 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.9 tp -82.7 101.23 10.73 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.3 m -101.6 105.47 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.631 -0.668 . . . . 0.0 109.279 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -92.77 109.25 20.67 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.633 -0.667 . . . . 0.0 111.246 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.3 m -91.21 108.62 20.0 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -97.64 119.49 36.31 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 123.977 0.911 . . . . 0.0 109.688 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.6 t -118.29 106.33 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -99.12 116.15 30.67 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 119.038 0.835 . . . . 0.0 109.77 172.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.265 42.0 mt-10 66.12 -79.33 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 123.65 0.78 . . . . 0.0 112.046 -176.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -148.86 42.25 0.83 Allowed Glycine 0 CA--C 1.553 2.455 0 CA-C-O 118.441 -1.199 . . . . 0.0 116.072 157.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -114.41 115.46 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-N 119.729 1.764 . . . . 0.0 110.625 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -81.99 130.34 35.05 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.45 126.13 34.26 Favored 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 123.235 0.614 . . . . 0.0 111.177 163.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -114.64 105.24 12.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.658 -0.651 . . . . 0.0 111.1 -169.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -98.58 117.83 33.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.88 -0.513 . . . . 0.0 111.209 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.9 mt -93.04 115.25 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -103.88 116.86 33.05 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -83.43 157.4 22.49 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 121.611 0.72 . . . . 0.0 111.674 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -66.64 104.27 1.26 Allowed 'General case' 0 CA--C 1.57 1.715 0 O-C-N 120.974 -1.079 . . . . 0.0 112.027 176.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 N--CA 1.491 1.594 0 C-N-CA 124.923 1.289 . . . . 0.0 114.25 -173.761 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.323 88.9 m-85 . . . . . 0 N--CA 1.5 2.053 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.25 80.92 1.33 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 120.007 1.276 . . . . 0.0 112.857 -172.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.3 m -174.58 175.69 2.46 Favored 'General case' 0 CA--C 1.572 1.793 0 C-N-CA 125.381 1.473 . . . . 0.0 110.325 -173.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 t -98.62 134.6 41.33 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.906 -1.121 . . . . 0.0 111.462 168.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -126.78 105.01 8.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.431 -0.793 . . . . 0.0 109.15 -166.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -97.02 137.91 35.37 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.493 -0.754 . . . . 0.0 112.513 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -64.3 128.65 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.831 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -170.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -111.12 -49.56 3.01 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.96 135.98 12.82 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 120.295 1.407 . . . . 0.0 111.722 173.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.1 p -107.2 129.64 54.83 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.929 0.892 . . . . 0.0 112.037 174.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -69.68 -66.52 0.58 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -141.92 59.7 1.48 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.158 0.89 . . . . 0.0 111.852 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -82.87 54.68 2.79 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.391 -1.443 . . . . 0.0 112.947 174.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -154.78 -55.79 0.1 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.595 1.558 . . . . 0.0 108.72 -170.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -68.77 -30.41 69.0 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 121.292 1.86 . . . . 0.0 115.67 160.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -52.22 -53.11 47.56 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 121.302 1.865 . . . . 0.0 114.644 156.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -40.27 93.71 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 170.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.27 -32.92 74.45 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 167.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -62.61 -39.08 92.66 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 159.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.1 mmm -63.18 -34.96 78.76 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 116.029 1.862 . . . . 0.0 116.029 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.71 52.81 0.74 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.426 HG23 ' HG2' ' A' ' 28' ' ' ARG . 6.7 m -130.54 143.67 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 122.127 0.965 . . . . 0.0 112.533 -174.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -65.33 157.82 28.13 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.268 10.8 tp -49.78 -39.48 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 N-CA-C 118.447 2.758 . . . . 0.0 118.447 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.5 t -62.01 -54.04 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-N 119.491 1.041 . . . . 0.0 112.381 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -56.98 -36.69 70.63 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 167.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HG2' HG23 ' A' ' 23' ' ' VAL . 76.4 mtm-85 -62.58 -46.08 89.94 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 121.219 1.827 . . . . 0.0 115.183 169.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -58.07 -49.24 77.6 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 166.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.53 -35.42 70.68 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 116.493 2.034 . . . . 0.0 116.493 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.36 99.07 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 163.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.85 -58.44 8.37 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 162.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -90.24 56.26 3.33 Favored 'General case' 0 CA--C 1.574 1.873 0 CA-C-O 122.316 1.055 . . . . 0.0 113.112 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -88.96 -31.83 17.96 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 71.02 64.11 0.17 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 124.722 1.209 . . . . 0.0 113.409 173.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.6 tp -97.44 125.8 42.31 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.707 0.765 . . . . 0.0 113.042 -167.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -103.36 126.07 50.32 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.891 163.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.9 mt -104.16 103.76 13.59 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 m -91.3 107.88 19.51 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.227 -0.92 . . . . 0.0 108.822 172.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 73.5 mt -100.76 96.95 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -169.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.0 m -98.95 100.49 11.67 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -87.49 121.67 30.22 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 121.6 -0.687 . . . . 0.0 111.813 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -109.36 82.45 1.6 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.18 0.991 . . . . 0.0 109.741 161.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.11 -110.69 3.29 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 114.807 0.683 . . . . 0.0 114.807 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -81.65 -23.6 36.82 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -81.07 115.89 20.74 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 119.871 1.214 . . . . 0.0 111.482 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -101.83 110.37 22.34 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.7 m -91.36 97.39 11.06 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.6 t -95.75 106.27 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -85.21 106.84 16.94 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -94.8 90.4 6.04 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -173.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 m -104.49 115.89 31.14 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.403 0.681 . . . . 0.0 111.018 -173.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.3 p -146.84 -178.5 6.22 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.61 54.22 0.59 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -175.92 -57.29 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.859 0 C-N-CA 125.731 1.612 . . . . 0.0 109.797 -159.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.5 ptp85 -146.33 149.18 33.33 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.175 0.99 . . . . 0.0 111.777 -160.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -135.09 94.27 3.12 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 165.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.8 pt -129.69 124.24 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.323 0.582 . . . . 0.0 111.073 -172.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.42 101.65 14.33 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.982 0.913 . . . . 0.0 111.747 176.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.4 t -91.78 106.4 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.58 106.46 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -122.14 137.07 54.96 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.489 0.662 . . . . 0.0 112.305 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -81.61 140.25 34.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.381 -0.825 . . . . 0.0 111.579 167.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.83 113.59 2.58 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.32 -11.72 56.92 Favored Glycine 0 CA--C 1.55 2.232 0 N-CA-C 118.506 2.162 . . . . 0.0 118.506 -171.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.2 p -78.48 140.27 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-N 120.53 2.165 . . . . 0.0 113.569 -171.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.2 m -84.88 104.18 14.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.728 -0.608 . . . . 0.0 109.539 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -136.99 165.34 26.22 Favored 'General case' 0 CA--C 1.569 1.711 0 CA-C-O 121.675 0.75 . . . . 0.0 112.581 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -87.57 98.9 11.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.559 -0.713 . . . . 0.0 111.791 175.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -86.55 156.37 20.1 Favored 'General case' 0 CA--C 1.567 1.618 0 C-N-CA 123.631 0.772 . . . . 0.0 112.421 173.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -128.75 131.96 47.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.724 -1.235 . . . . 0.0 110.695 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 33.8 mt -86.72 169.97 12.18 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.847 0.832 . . . . 0.0 113.066 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.35 46.9 0.11 Allowed 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 118.773 2.879 . . . . 0.0 118.773 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -138.9 -80.56 0.32 Allowed 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 159.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.19 79.74 0.05 OUTLIER Glycine 0 N--CA 1.48 1.589 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 97.2 m -152.46 128.8 10.57 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.462 -1.022 . . . . 0.0 111.143 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -79.62 131.33 35.96 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.9 mt -124.05 104.32 8.81 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.677 0.791 . . . . 0.0 110.879 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -76.38 114.8 15.48 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.983 0.913 . . . . 0.0 112.095 172.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.94 -164.02 36.78 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 117.083 1.593 . . . . 0.0 117.083 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.9 p -120.57 121.93 39.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -160.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -86.32 112.86 21.82 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 122.906 0.482 . . . . 0.0 110.776 161.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.3 m -119.17 130.2 55.4 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.738 -0.601 . . . . 0.0 112.431 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.8 tp -88.72 130.48 35.32 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.185 -0.947 . . . . 0.0 112.258 177.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -107.45 -79.05 0.58 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 123.512 0.725 . . . . 0.0 110.903 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.15 88.92 0.11 Allowed Glycine 0 N--CA 1.49 2.298 0 CA-C-N 119.803 1.183 . . . . 0.0 111.852 -173.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.26 63.0 m-80 65.4 10.03 6.22 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -156.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -132.99 117.73 17.98 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.374 1.069 . . . . 0.0 109.78 -169.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.37 109.24 20.84 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 168.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.9 tp -91.93 117.67 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.415 -0.803 . . . . 0.0 110.248 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.21 98.21 2.02 Favored Glycine 0 N--CA 1.483 1.795 0 C-N-CA 123.461 0.553 . . . . 0.0 112.424 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -94.84 98.1 10.49 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -124.06 146.48 48.55 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.021 0.915 . . . . 0.0 113.044 -166.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -120.12 148.76 43.21 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.527 0.731 . . . . 0.0 109.693 164.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -73.9 148.55 42.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.148 -1.595 . . . . 0.0 113.433 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.7 p -70.97 -73.59 0.17 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.568 -0.707 . . . . 0.0 111.754 167.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.86 -41.78 97.7 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.844 2.165 . . . . 0.0 116.844 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.31 -14.1 39.13 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 174.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.05 -39.57 2.98 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 118.327 2.091 . . . . 0.0 118.327 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -80.27 162.08 24.79 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -156.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.26 135.66 47.57 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -177.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.5 tt -125.61 130.8 52.36 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 124.185 0.994 . . . . 0.0 109.395 168.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -107.21 129.15 54.9 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.209 -0.932 . . . . 0.0 109.702 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -123.74 108.53 12.63 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.41 -0.806 . . . . 0.0 109.182 171.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.8 t -98.12 110.22 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -87.58 114.99 24.7 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.496 0.718 . . . . 0.0 111.122 172.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -132.19 133.92 44.77 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 119.284 0.947 . . . . 0.0 111.869 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.39 108.77 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.952 -1.093 . . . . 0.0 108.541 173.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.0 pt -97.23 94.03 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 C-N-CA 124.296 1.039 . . . . 0.0 109.028 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.1 -101.67 1.36 Allowed Glycine 0 N--CA 1.492 2.38 0 O-C-N 121.239 -0.913 . . . . 0.0 113.01 -169.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -131.74 53.31 2.0 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.368 0.604 . . . . 0.0 112.009 161.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -134.99 125.37 26.45 Favored 'General case' 0 CA--C 1.563 1.448 0 O-C-N 121.44 -0.787 . . . . 0.0 109.381 167.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.7 tp -78.29 107.67 11.06 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.746 0.818 . . . . 0.0 110.487 175.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -92.38 118.85 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.334 -0.854 . . . . 0.0 110.931 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -95.27 106.89 18.97 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.79 0.836 . . . . 0.0 109.679 172.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.1 m -91.47 104.12 16.66 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.083 0.553 . . . . 0.0 109.864 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -95.61 121.22 37.08 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.181 0.592 . . . . 0.0 111.749 -174.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.6 t -120.63 121.04 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -136.52 98.31 3.78 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.862 -0.524 . . . . 0.0 110.191 168.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 66.19 68.53 0.45 Allowed 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 168.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.68 44.47 57.02 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 118.303 2.081 . . . . 0.0 118.303 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -156.53 150.99 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 118.439 1.12 . . . . 0.0 110.401 -176.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.47 126.12 32.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.165 -0.96 . . . . 0.0 110.313 174.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -128.02 105.67 8.55 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.071 0.548 . . . . 0.0 111.286 171.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -85.42 118.47 24.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 110.967 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.4 mtt-85 -99.84 110.32 22.69 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 164.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.7 mt -81.65 133.27 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -120.65 121.78 39.07 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.065 0.946 . . . . 0.0 109.189 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -77.7 142.37 38.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 112.609 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -69.16 111.25 4.99 Favored 'General case' 0 CA--C 1.568 1.655 0 O-C-N 121.451 -0.78 . . . . 0.0 111.785 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 N--CA 1.488 1.468 0 C-N-CA 124.938 1.295 . . . . 0.0 112.587 -170.148 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.328 54.2 m-85 . . . . . 0 N--CA 1.499 1.978 0 N-CA-C 117.712 2.486 . . . . 0.0 117.712 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -75.35 76.59 2.44 Favored 'General case' 0 CA--C 1.573 1.838 0 CA-C-N 120.459 1.481 . . . . 0.0 113.979 -170.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.0 t -162.71 -178.86 6.44 Favored 'General case' 0 CA--C 1.576 1.974 0 CA-C-O 122.682 1.229 . . . . 0.0 112.367 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.1 m -87.58 129.08 35.23 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.243 1.017 . . . . 0.0 110.42 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -128.01 111.75 13.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.828 -0.545 . . . . 0.0 109.603 -173.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.52 137.54 36.3 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.418 0.687 . . . . 0.0 111.756 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.1 p -64.36 118.14 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -105.75 -59.87 1.71 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.758 0.823 . . . . 0.0 112.076 -174.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -134.24 166.62 22.37 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.55 1.167 . . . . 0.0 111.372 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.6 m -151.51 123.73 8.25 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 119.581 -1.949 . . . . 0.0 109.761 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -82.4 -81.46 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -159.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -108.32 55.97 0.63 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 120.29 1.405 . . . . 0.0 112.435 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -87.38 66.11 8.98 Favored 'General case' 0 CA--C 1.573 1.843 0 CA-C-O 122.63 1.205 . . . . 0.0 111.543 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -158.05 -66.35 0.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.969 0.908 . . . . 0.0 109.961 -167.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -60.67 -47.28 86.96 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 166.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -44.61 -58.69 2.87 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 162.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 37.4 mtp -59.07 -43.32 91.74 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -61.06 -41.74 97.19 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 166.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -62.24 -37.07 84.01 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 168.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 55.7 mtm -65.14 -20.03 66.26 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 164.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.24 47.64 2.78 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.3 m -123.12 142.51 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-N 118.385 1.092 . . . . 0.0 111.504 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -75.24 169.67 17.59 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.27 0.3 OUTLIER -52.91 -42.21 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 176.19 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.3 t -58.36 -48.87 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.027 -1.046 . . . . 0.0 113.357 170.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -61.79 -40.32 94.79 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 168.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 mpp_? -57.15 -34.6 68.59 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 164.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -70.25 -55.79 8.39 Favored 'General case' 0 CA--C 1.572 1.827 0 CA-C-N 120.364 1.438 . . . . 0.0 113.434 164.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.0 mt -66.08 -52.59 47.34 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.74 -4.7 36.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 172.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.36 -57.95 3.51 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 119.692 1.133 . . . . 0.0 113.123 152.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -90.49 52.96 2.32 Favored 'General case' 0 CA--C 1.573 1.841 0 C-N-CA 123.767 0.827 . . . . 0.0 112.903 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -92.98 2.25 56.89 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 55.25 58.45 4.67 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 124.687 1.195 . . . . 0.0 113.957 -175.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.3 tp -92.09 116.47 28.96 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-O 122.065 0.936 . . . . 0.0 111.873 -166.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -115.52 112.1 21.71 Favored 'General case' 0 CA--C 1.561 1.378 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.391 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.0 mt -99.09 100.13 11.24 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.0 m -92.62 108.96 20.37 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.335 -0.853 . . . . 0.0 109.613 174.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -107.96 137.6 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 C-N-CA 124.298 1.039 . . . . 0.0 108.673 -165.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 93.1 m -147.75 122.56 9.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.139 -1.6 . . . . 0.0 110.481 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -86.97 108.97 19.06 Favored 'General case' 0 CA--C 1.565 1.522 0 O-C-N 121.55 -0.719 . . . . 0.0 112.112 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -91.71 76.11 5.7 Favored 'General case' 0 CA--C 1.57 1.725 0 O-C-N 121.477 -0.765 . . . . 0.0 110.054 168.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.69 -98.57 0.54 Allowed Glycine 0 N--CA 1.492 2.404 0 O-C-N 121.443 -0.786 . . . . 0.0 114.778 -174.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -95.74 -11.59 26.77 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 165.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -95.76 101.97 13.71 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 120.791 1.632 . . . . 0.0 110.551 -175.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.49 111.55 18.61 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.379 -0.826 . . . . 0.0 111.135 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.2 m -86.24 105.22 16.46 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.735 0.814 . . . . 0.0 109.069 174.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.5 t -112.52 103.26 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -85.79 107.43 17.63 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.284 0.634 . . . . 0.0 110.722 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -98.49 87.46 3.85 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.1 t -88.35 117.44 27.28 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 122.856 0.462 . . . . 0.0 111.171 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.3 p -146.73 165.04 30.83 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.623 0.725 . . . . 0.0 112.678 -172.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.68 -27.2 62.68 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 118.012 2.597 . . . . 0.0 118.012 165.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -75.42 -51.88 12.04 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 167.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -162.36 151.43 15.37 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.595 0.758 . . . . 0.0 111.727 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -113.88 91.67 3.72 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.801 0.84 . . . . 0.0 110.532 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.6 pt -114.89 125.0 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 121.448 0.642 . . . . 0.0 111.88 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -86.26 101.21 12.85 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.6 0.76 . . . . 0.0 110.971 172.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.69 105.44 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -174.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.3 t -94.58 96.93 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -105.97 128.04 53.55 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.431 0.634 . . . . 0.0 112.077 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -85.23 129.08 34.88 Favored 'General case' 0 CA--C 1.563 1.474 0 O-C-N 121.511 -0.743 . . . . 0.0 111.157 173.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.0 125.92 25.54 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -173.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.79 -16.75 44.6 Favored Glycine 0 CA--C 1.555 2.533 0 N-CA-C 119.106 2.403 . . . . 0.0 119.106 -168.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.3 t -86.26 130.78 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 120.278 2.039 . . . . 0.0 109.938 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.5 t -75.21 121.9 22.84 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -142.7 161.68 37.44 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-O 121.732 0.777 . . . . 0.0 112.201 -172.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -91.63 104.2 16.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.489 -0.757 . . . . 0.0 111.517 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -100.85 142.02 32.91 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 124.164 0.986 . . . . 0.0 111.631 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -134.82 100.94 4.75 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.907 -1.121 . . . . 0.0 110.615 -167.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.0 mt -76.36 93.34 3.45 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -168.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.3 . . 58.07 -64.31 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 119.85 3.278 . . . . 0.0 119.85 170.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -82.98 -83.71 0.13 Allowed 'General case' 0 CA--C 1.57 1.719 0 CA-C-N 118.853 0.752 . . . . 0.0 109.73 164.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.48 55.01 0.2 Allowed Glycine 0 N--CA 1.487 2.057 0 N-CA-C 116.267 1.267 . . . . 0.0 116.267 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.8 m -88.02 101.11 13.46 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 118.068 0.934 . . . . 0.0 108.545 165.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -88.63 112.41 23.05 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 122.794 0.438 . . . . 0.0 111.076 -169.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.8 mt -127.38 112.29 14.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.748 -0.595 . . . . 0.0 111.716 -161.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 51.5 ptt85 -90.94 118.19 30.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.104 -0.997 . . . . 0.0 111.338 172.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.3 -158.94 32.1 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 117.776 1.87 . . . . 0.0 117.776 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.7 p -130.15 129.85 44.01 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -156.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -92.48 132.26 36.95 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.033 -1.042 . . . . 0.0 111.081 164.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.5 m -129.97 127.31 39.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.566 -0.708 . . . . 0.0 111.425 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.6 tp -81.9 125.25 30.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.462 -0.774 . . . . 0.0 111.638 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -130.96 79.59 1.9 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.381 -0.824 . . . . 0.0 109.115 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.47 -109.5 3.02 Favored Glycine 0 N--CA 1.488 2.11 0 O-C-N 121.648 -0.657 . . . . 0.0 113.747 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -111.02 44.22 1.33 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 167.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -144.5 114.06 7.14 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 25.1 mt -89.49 107.49 19.1 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 167.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.9 tt -96.88 119.47 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.296 -0.878 . . . . 0.0 110.409 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -101.95 98.88 1.8 Allowed Glycine 0 N--CA 1.482 1.76 0 C-N-CA 124.1 0.857 . . . . 0.0 113.215 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.17 101.55 13.93 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -121.88 143.11 49.63 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.707 0.765 . . . . 0.0 111.916 -173.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -110.72 138.73 46.74 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.69 0.757 . . . . 0.0 109.384 163.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -62.0 111.34 1.88 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.288 -0.882 . . . . 0.0 112.597 171.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.297 5.8 t -68.66 -14.74 63.22 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 174.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -73.78 -20.46 60.47 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 158.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -133.92 -41.44 0.83 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -166.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.85 -26.94 22.32 Favored Glycine 0 CA--C 1.556 2.643 0 N-CA-C 117.368 1.707 . . . . 0.0 117.368 -153.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -66.06 129.92 41.45 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -167.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.04 129.68 35.54 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -175.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.9 tt -121.7 120.29 34.26 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 124.917 1.287 . . . . 0.0 108.908 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -105.47 113.13 26.51 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.314 -0.866 . . . . 0.0 109.065 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.6 m -101.93 111.48 23.75 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.303 -0.873 . . . . 0.0 110.368 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.34 102.5 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -80.82 115.99 20.58 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.767 0.827 . . . . 0.0 110.194 167.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -143.97 142.24 30.62 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -95.15 106.14 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.899 . . . . 0.0 109.44 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.0 pt -88.75 72.82 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.924 0 O-C-N 121.017 -1.052 . . . . 0.0 111.158 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 85.15 -86.84 1.55 Allowed Glycine 0 N--CA 1.491 2.312 0 O-C-N 120.531 -1.355 . . . . 0.0 113.096 -168.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -139.43 53.81 1.71 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 166.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -144.79 118.19 9.05 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 121.212 -0.93 . . . . 0.0 108.6 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.3 tp -78.53 110.23 13.43 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.107 0.956 . . . . 0.0 110.92 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.5 t -97.77 115.32 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -96.82 93.88 6.93 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.733 0.813 . . . . 0.0 109.778 171.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 48.8 m -84.04 101.97 12.15 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 122.864 0.466 . . . . 0.0 109.784 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -87.09 111.05 20.53 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.128 0.571 . . . . 0.0 110.892 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.3 t -103.1 102.06 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -128.85 109.91 11.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.779 -0.576 . . . . 0.0 109.723 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 53.63 57.59 5.96 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 174.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.35 -33.73 3.16 Favored Glycine 0 CA--C 1.552 2.405 0 N-CA-C 118.758 2.263 . . . . 0.0 118.758 -167.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.4 t -89.87 121.28 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 119.887 1.843 . . . . 0.0 110.708 -166.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -89.4 123.87 33.95 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.229 0.612 . . . . 0.0 111.348 166.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.94 108.47 8.42 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.012 0.525 . . . . 0.0 110.881 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -88.91 114.83 25.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 111.622 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -89.64 121.78 32.15 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 119.275 0.943 . . . . 0.0 109.873 162.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.6 mt -120.54 120.72 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -163.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -118.67 126.57 52.21 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.012 0.925 . . . . 0.0 110.747 -165.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -87.23 152.93 21.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.162 -0.961 . . . . 0.0 113.261 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -62.18 110.95 1.77 Allowed 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 124.063 0.945 . . . . 0.0 113.309 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.489 1.484 0 C-N-CA 125.175 1.39 . . . . 0.0 113.251 -174.498 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 . . . . . 0 N--CA 1.497 1.879 0 CA-C-O 121.377 0.608 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -88.12 88.42 7.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.997 -1.065 . . . . 0.0 111.744 -166.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.1 m -171.6 164.62 6.78 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 122.754 1.264 . . . . 0.0 113.24 -172.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.6 m -89.72 131.08 35.87 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 124.024 0.93 . . . . 0.0 110.9 170.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -131.33 110.12 10.85 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.356 0.662 . . . . 0.0 109.779 -170.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -100.84 135.64 41.98 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.01 -1.056 . . . . 0.0 112.303 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.7 121.88 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -106.53 -49.08 3.4 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -153.17 111.52 3.66 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 118.911 0.778 . . . . 0.0 109.746 -164.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.2 p -102.0 108.62 20.12 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.512 0.725 . . . . 0.0 112.385 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -102.93 115.46 30.65 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.285 38.7 t30 67.93 11.43 8.36 Favored 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 118.458 2.762 . . . . 0.0 118.458 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -64.79 -42.84 94.75 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -61.17 -32.53 72.27 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 170.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -72.99 -42.73 63.0 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 171.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -46.48 -54.31 9.51 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 160.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.7 mtt -61.75 -39.16 90.63 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 172.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -53.35 -48.76 68.27 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 166.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.1 tttp -62.18 -28.63 69.8 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 168.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.5 mmt -65.47 -43.83 89.08 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 168.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.89 63.72 0.36 Allowed Glycine 0 N--CA 1.487 2.099 0 C-N-CA 123.855 0.741 . . . . 0.0 113.742 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 p -138.25 146.49 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.403 1.097 . . . . 0.0 111.638 -176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -59.2 143.92 47.55 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.31 12.9 tt -52.89 -44.15 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.8 t -56.58 -56.55 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.305 0.957 . . . . 0.0 113.197 170.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -63.6 -45.15 91.67 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.2 ptt85 -67.66 -30.61 70.19 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 171.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -68.55 -43.4 76.71 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 120.009 1.277 . . . . 0.0 114.219 165.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.5 mt -62.35 -50.57 71.06 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 169.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.65 -12.53 54.2 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 118.6 2.815 . . . . 0.0 118.6 168.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.76 -59.96 2.55 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 155.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -91.62 53.53 2.27 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 118.765 0.711 . . . . 0.0 112.82 -170.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.6 p30 -102.97 -4.22 24.98 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 118.582 2.808 . . . . 0.0 118.582 -171.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 59.18 56.16 4.02 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-N 121.655 2.025 . . . . 0.0 114.131 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.4 tp -82.63 119.75 24.68 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.981 -1.074 . . . . 0.0 112.1 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -101.55 119.85 39.4 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.199 170.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.8 mt -102.42 107.34 18.29 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.251 88.6 m -88.13 101.09 13.47 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.854 -1.154 . . . . 0.0 108.736 163.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 85.5 mt -94.99 119.45 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.8 t -127.82 131.21 49.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.808 -0.558 . . . . 0.0 111.614 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -79.73 127.21 31.93 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 121.768 0.794 . . . . 0.0 111.472 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -131.96 64.48 1.59 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 124.05 0.94 . . . . 0.0 110.563 -168.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.3 69.25 1.37 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 116.756 1.463 . . . . 0.0 116.756 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.281 14.9 t30 66.82 -15.04 0.15 Allowed 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 -164.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -92.19 154.23 18.8 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 120.684 -1.26 . . . . 0.0 112.231 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -116.4 120.3 38.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.476 -0.765 . . . . 0.0 109.392 165.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.9 m -89.03 107.62 19.14 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 167.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.0 t -104.25 108.01 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -93.18 104.19 16.4 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -86.28 126.3 34.2 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.189 0.595 . . . . 0.0 110.71 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.2 t -135.17 118.73 16.95 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 122.765 0.426 . . . . 0.0 110.255 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 p -147.61 172.83 13.41 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.46 59.08 0.79 Allowed 'General case' 0 CA--C 1.575 1.925 0 O-C-N 120.513 -1.367 . . . . 0.0 113.491 154.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -168.78 -60.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.114 0.966 . . . . 0.0 110.174 -175.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -154.58 143.57 21.01 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 118.588 0.631 . . . . 0.0 111.951 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -115.2 103.11 10.52 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 173.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.6 pt -138.29 141.18 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 121.5 0.667 . . . . 0.0 111.909 -174.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -104.13 105.78 16.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.171 -0.956 . . . . 0.0 109.7 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.32 103.19 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.2 t -97.89 104.11 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -117.78 149.71 40.35 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.125 0.57 . . . . 0.0 112.476 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -94.07 142.41 27.43 Favored 'General case' 0 CA--C 1.568 1.635 0 O-C-N 121.733 -0.604 . . . . 0.0 111.698 171.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.1 mt -71.95 101.91 2.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.004 -1.06 . . . . 0.0 111.699 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.6 -46.15 1.07 Allowed Glycine 0 CA--C 1.549 2.215 0 N-CA-C 116.37 1.308 . . . . 0.0 116.37 -168.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.73 141.46 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.844 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.1 m -92.51 77.86 5.0 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.191 0.996 . . . . 0.0 110.729 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -101.64 166.27 10.79 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -167.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -82.24 93.75 7.17 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-O 121.62 0.724 . . . . 0.0 111.531 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -84.52 164.98 18.44 Favored 'General case' 0 CA--C 1.571 1.756 0 CA-C-O 122.141 0.972 . . . . 0.0 111.498 166.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -153.65 132.75 12.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.325 -1.485 . . . . 0.0 110.801 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.3 mt -75.6 -64.04 1.16 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -164.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -154.36 -70.99 0.13 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 118.926 0.785 . . . . 0.0 111.391 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -83.24 -69.53 0.63 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.958 0.799 . . . . 0.0 112.941 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.74 50.58 0.4 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 116.734 1.454 . . . . 0.0 116.734 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.1 m -112.71 98.33 7.15 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -92.79 140.73 29.21 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 122.439 1.114 . . . . 0.0 112.147 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.8 mt -136.59 119.82 16.72 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 123.78 0.832 . . . . 0.0 110.206 -162.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -90.47 122.91 33.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.964 -1.085 . . . . 0.0 110.034 169.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.75 -173.32 45.46 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 117.633 1.813 . . . . 0.0 117.633 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 75.9 p -115.59 131.47 56.92 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.092 -1.054 . . . . 0.0 111.327 -170.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -87.78 113.92 23.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.195 -0.94 . . . . 0.0 109.621 161.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.6 m -110.94 117.42 33.33 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.419 0.688 . . . . 0.0 110.909 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.9 tp -84.76 99.1 10.64 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.144 -0.972 . . . . 0.0 111.584 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -95.52 85.21 4.14 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.444 0.698 . . . . 0.0 110.687 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.37 -90.59 0.62 Allowed Glycine 0 N--CA 1.491 2.359 0 O-C-N 121.425 -0.797 . . . . 0.0 114.601 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -125.52 53.44 1.55 Allowed 'General case' 0 CA--C 1.575 1.935 0 CA-C-O 121.363 0.601 . . . . 0.0 111.552 162.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -145.0 111.15 5.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.089 -1.007 . . . . 0.0 108.533 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 mt -85.89 102.34 13.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.968 . . . . 0.0 109.075 172.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.6 mt -100.6 108.55 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -172.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.12 101.72 2.75 Favored Glycine 0 N--CA 1.482 1.705 0 C-N-CA 123.235 0.445 . . . . 0.0 113.18 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -95.34 94.28 7.76 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.551 0.74 . . . . 0.0 109.06 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -121.47 138.33 54.33 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -163.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -119.49 138.4 53.17 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.516 0.726 . . . . 0.0 110.085 170.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -70.08 130.21 41.51 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -171.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 36.9 p -81.43 68.69 7.86 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.337 1.065 . . . . 0.0 110.851 170.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -177.7 -62.28 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.774 0 C-N-CA 125.927 1.691 . . . . 0.0 107.417 -164.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -135.37 20.37 3.39 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.4 10.6 36.57 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 121.03 3.172 . . . . 0.0 121.03 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -95.46 138.71 32.76 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 118.121 0.96 . . . . 0.0 112.217 -159.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -80.34 128.25 33.34 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -163.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.86 122.87 39.13 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 124.742 1.217 . . . . 0.0 108.423 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -98.61 114.7 27.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.618 -0.676 . . . . 0.0 109.278 172.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.1 m -108.22 96.85 6.65 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 119.564 1.075 . . . . 0.0 109.701 175.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.3 t -95.65 105.17 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.885 -1.134 . . . . 0.0 108.91 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -88.9 122.02 31.85 Favored 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 123.565 0.746 . . . . 0.0 111.052 169.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -144.87 155.24 43.35 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.281 -0.887 . . . . 0.0 112.38 171.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mp -94.76 118.79 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.649 -1.282 . . . . 0.0 109.657 -176.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.7 mt -95.79 87.55 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 106.941 -1.504 . . . . 0.0 106.941 164.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.0 -94.83 0.38 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 115.742 1.057 . . . . 0.0 115.742 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -101.75 14.56 31.6 Favored 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 169.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -134.38 109.76 8.99 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 119.717 1.144 . . . . 0.0 111.002 -161.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.6 tp -76.46 104.61 7.07 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.918 0.887 . . . . 0.0 110.899 173.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.5 p -88.47 104.77 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 123.05 0.54 . . . . 0.0 110.219 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -90.0 99.85 12.78 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.456 0.646 . . . . 0.0 109.421 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 33.4 m -98.96 104.89 16.97 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.006 -168.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -87.1 125.79 34.36 Favored 'General case' 0 CA--C 1.563 1.476 0 C-N-CA 123.257 0.623 . . . . 0.0 111.048 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.4 t -121.69 109.0 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 168.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -113.87 107.11 15.26 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.265 10.2 mm-40 65.03 -78.68 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 123.914 0.885 . . . . 0.0 112.992 -171.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -152.6 58.32 0.42 Allowed Glycine 0 N--CA 1.486 2.001 0 CA-C-O 119.511 -0.605 . . . . 0.0 114.108 164.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.9 p -129.19 104.21 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -89.43 112.31 23.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.602 -0.687 . . . . 0.0 110.915 -176.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.77 117.34 25.46 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.019 0.527 . . . . 0.0 112.236 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -105.62 102.22 11.69 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.456 0.703 . . . . 0.0 109.704 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . 0.258 15.1 ptm180 -95.92 111.98 23.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.441 -0.787 . . . . 0.0 110.733 168.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.4 mt -97.94 125.01 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -170.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -105.45 116.73 32.44 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.618 0.767 . . . . 0.0 109.068 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -82.78 141.93 31.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.231 -0.918 . . . . 0.0 111.745 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -66.94 124.36 22.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 113.338 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 124.822 1.249 . . . . 0.0 111.88 -170.103 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 . . . . . 0 N--CA 1.502 2.16 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -130.55 75.83 1.68 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.952 -1.093 . . . . 0.0 110.701 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.1 p -171.15 168.63 6.75 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.795 1.284 . . . . 0.0 113.5 -175.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.7 m -77.23 135.87 38.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.219 -0.926 . . . . 0.0 111.75 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -133.16 101.74 5.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.678 -0.639 . . . . 0.0 109.393 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -97.31 137.84 35.7 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.252 -0.905 . . . . 0.0 112.223 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.266 4.5 p -63.03 115.54 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.81 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -173.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -84.55 -47.4 10.61 Favored 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 123.687 0.795 . . . . 0.0 113.054 170.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -155.15 159.0 39.84 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 122.563 1.173 . . . . 0.0 111.033 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.7 m -147.66 113.03 5.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 119.871 -1.768 . . . . 0.0 109.315 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -83.36 -95.79 0.06 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -162.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -85.06 52.56 2.47 Favored 'General case' 0 CA--C 1.579 2.063 0 CA-C-N 120.635 1.561 . . . . 0.0 113.523 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -82.9 -48.45 10.7 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.526 1.13 . . . . 0.0 114.03 -172.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -58.0 -29.27 65.15 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 169.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 -46.48 34.11 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 169.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -47.64 -51.2 22.28 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 161.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.0 mtm -59.27 -30.77 68.53 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 170.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -65.74 -44.38 86.16 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 166.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -58.63 -37.49 76.01 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 165.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.5 mmm -64.84 -41.57 95.62 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 167.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.43 48.37 0.81 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 115.989 1.156 . . . . 0.0 115.989 174.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.29 10.7 p -113.12 138.84 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 118.534 1.167 . . . . 0.0 112.309 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -62.69 152.39 35.58 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 12.5 tt -48.11 -40.16 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 118.285 2.698 . . . . 0.0 118.285 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.4 t -66.11 -62.28 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-N 119.861 1.209 . . . . 0.0 111.96 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -62.56 -20.03 64.28 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 117.949 2.574 . . . . 0.0 117.949 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.5 ttp85 -76.37 -49.44 16.79 Favored 'General case' 0 CA--C 1.569 1.708 0 C-N-CA 125.292 1.437 . . . . 0.0 114.26 167.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -41.54 98.61 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 169.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.28 -40.63 86.69 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 165.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.72 -31.19 71.69 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 117.729 2.492 . . . . 0.0 117.729 169.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.9 -43.72 69.92 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 157.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -82.41 14.93 2.72 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.313 19.4 p30 -78.36 92.99 4.61 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 121.534 1.97 . . . . 0.0 110.597 170.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -68.8 84.68 0.31 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.767 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.0 tp -86.91 124.75 33.46 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 122.489 1.138 . . . . 0.0 112.731 -167.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -99.48 114.81 27.99 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.57 165.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.2 mt -96.96 95.52 7.88 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.9 m -88.32 98.19 11.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.035 -1.041 . . . . 0.0 108.473 173.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.0 mt -89.76 119.11 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.3 p -121.59 122.14 38.99 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -97.37 130.61 44.5 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -118.02 77.18 1.13 Allowed 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 162.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.61 -106.5 1.08 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 116.404 1.322 . . . . 0.0 116.404 -175.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -84.64 -15.9 43.85 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 169.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -89.03 153.76 20.75 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 119.809 1.186 . . . . 0.0 112.346 168.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -143.51 136.54 27.72 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.606 0.763 . . . . 0.0 109.836 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.9 m -109.82 111.45 22.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.236 -0.915 . . . . 0.0 108.884 164.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.4 p -95.68 120.48 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 121.428 0.632 . . . . 0.0 110.123 168.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -82.4 114.44 20.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 109.484 173.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -93.06 91.25 7.25 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.7 t -112.34 105.42 13.7 Favored 'General case' 0 CA--C 1.562 1.418 0 CA-C-O 121.384 0.611 . . . . 0.0 111.105 -172.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.0 p -143.91 -179.16 6.31 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.393 1.077 . . . . 0.0 111.904 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.11 -25.82 24.11 Favored 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 118.265 2.691 . . . . 0.0 118.265 160.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -96.76 -18.02 19.89 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -148.61 146.43 28.23 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 120.469 1.486 . . . . 0.0 112.155 -171.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -135.19 77.79 1.7 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 156.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.0 pt -126.88 139.88 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 121.216 -0.928 . . . . 0.0 111.953 -167.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.17 105.44 17.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.575 -0.703 . . . . 0.0 109.797 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.3 t -89.69 98.05 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.0 t -89.97 106.85 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -121.63 164.02 18.01 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-O 122.619 1.2 . . . . 0.0 112.752 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -126.5 145.68 50.41 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.452 -0.78 . . . . 0.0 109.683 171.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.75 108.53 1.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.974 . . . . 0.0 113.584 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.65 -23.87 27.03 Favored Glycine 0 CA--C 1.548 2.146 0 N-CA-C 117.985 1.954 . . . . 0.0 117.985 -170.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.8 p -68.67 134.92 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 120.308 2.054 . . . . 0.0 113.588 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -85.38 106.42 16.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.751 -0.593 . . . . 0.0 109.796 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -127.5 158.04 38.48 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.766 0.793 . . . . 0.0 112.151 -176.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -85.72 107.5 17.62 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.549 -0.719 . . . . 0.0 111.413 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -105.54 128.99 53.9 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 124.074 0.95 . . . . 0.0 110.236 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -107.19 125.51 51.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.595 -0.691 . . . . 0.0 111.65 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.9 mt -92.6 78.34 4.91 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.308 . . 63.57 -51.44 0.23 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 120.322 3.453 . . . . 0.0 120.322 162.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -74.22 -81.52 0.07 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 121.39 1.905 . . . . 0.0 109.33 167.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.9 80.88 0.06 OUTLIER Glycine 0 N--CA 1.481 1.692 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.6 m -145.75 109.94 4.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.407 -1.055 . . . . 0.0 108.752 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -84.56 121.84 28.18 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.922 0.867 . . . . 0.0 112.373 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mt -129.65 120.21 24.82 Favored 'General case' 0 CA--C 1.562 1.412 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.515 -168.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -93.08 118.99 31.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.922 . . . . 0.0 111.97 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.51 -170.55 42.06 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 118.069 1.988 . . . . 0.0 118.069 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.0 p -126.24 121.22 32.07 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.49 -0.855 . . . . 0.0 111.679 -163.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -78.29 123.05 26.51 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 119.048 0.84 . . . . 0.0 110.995 160.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.8 m -125.3 137.38 54.07 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.364 0.665 . . . . 0.0 111.721 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 tp -91.25 104.51 17.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 111.586 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -91.46 82.64 5.36 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.63 -0.669 . . . . 0.0 109.55 171.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.44 -94.75 0.66 Allowed Glycine 0 N--CA 1.492 2.373 0 O-C-N 121.545 -0.722 . . . . 0.0 114.382 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -125.23 59.62 1.24 Allowed 'General case' 0 CA--C 1.571 1.788 0 CA-C-O 121.802 0.811 . . . . 0.0 110.926 159.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -140.77 111.49 6.95 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 170.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.5 mt -84.44 100.55 11.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.192 -0.943 . . . . 0.0 109.561 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.6 tt -97.78 128.9 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 123.743 0.817 . . . . 0.0 110.798 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.64 102.77 0.64 Allowed Glycine 0 N--CA 1.481 1.658 0 CA-C-O 119.234 -0.759 . . . . 0.0 114.005 -172.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -90.32 98.55 11.84 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.051 0.925 . . . . 0.0 109.492 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -110.53 106.5 15.82 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.639 0.733 . . . . 0.0 110.576 -171.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -90.99 125.87 35.91 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.224 -0.923 . . . . 0.0 111.772 -168.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.8 ttp85 -66.18 119.66 11.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.132 -0.98 . . . . 0.0 112.432 -174.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.303 5.4 t -59.87 -35.08 74.06 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 117.316 2.339 . . . . 0.0 117.316 -169.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -98.37 42.68 1.09 Allowed 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 168.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -156.62 -50.99 0.08 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.736 -1.228 . . . . 0.0 113.591 173.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.32 8.72 62.54 Favored Glycine 0 CA--C 1.555 2.544 0 N-CA-C 118.471 2.148 . . . . 0.0 118.471 -160.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -89.11 119.78 29.92 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 119.965 1.883 . . . . 0.0 111.389 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -73.07 122.8 22.38 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.6 tt -97.12 108.97 21.8 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -96.23 98.82 10.61 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -165.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.1 m -104.88 108.31 19.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.795 -0.565 . . . . 0.0 109.9 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.7 t -98.72 105.9 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.4 mtm180 -87.58 105.76 17.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.663 -0.648 . . . . 0.0 110.002 167.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.01 162.72 26.15 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.659 0.783 . . . . 0.0 111.729 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.3 mt -127.78 135.61 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.536 -1.352 . . . . 0.0 110.142 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.7 mm -98.15 -76.54 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.74 -112.08 3.44 Favored Glycine 0 N--CA 1.491 2.332 0 CA-C-N 118.687 0.676 . . . . 0.0 111.802 170.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -92.91 47.11 1.26 Allowed 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -146.93 118.78 8.11 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.401 1.08 . . . . 0.0 108.74 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.0 tp -81.91 115.5 21.12 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.482 0.713 . . . . 0.0 109.512 167.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.3 t -100.65 103.53 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -96.81 103.25 15.15 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 123.446 0.698 . . . . 0.0 109.825 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.8 m -99.64 103.25 14.93 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 123.266 0.626 . . . . 0.0 109.835 -173.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -95.0 123.8 38.68 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.775 0.83 . . . . 0.0 111.207 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.02 102.11 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-N 119.307 0.958 . . . . 0.0 108.779 173.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -86.51 102.96 14.59 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.183 -0.948 . . . . 0.0 110.007 167.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.319 0.1 OUTLIER 62.01 -41.42 0.15 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 120.001 3.334 . . . . 0.0 120.001 177.639 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -173.82 25.42 0.08 OUTLIER Glycine 0 CA--C 1.552 2.369 0 N-CA-C 117.716 1.846 . . . . 0.0 117.716 172.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.0 t -136.57 121.63 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 120.304 2.052 . . . . 0.0 107.532 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.24 140.19 29.8 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -174.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -129.79 125.1 34.98 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.545 0.738 . . . . 0.0 112.045 166.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -99.27 108.88 21.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.704 -0.622 . . . . 0.0 110.601 174.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -96.16 117.99 31.83 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 169.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 76.5 mt -108.55 120.8 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -171.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -117.32 122.77 44.81 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.835 0.854 . . . . 0.0 109.268 -172.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -77.86 148.27 34.73 Favored 'General case' 0 CA--C 1.568 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 112.837 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -58.9 113.57 2.13 Favored 'General case' 0 CA--C 1.57 1.721 0 C-N-CA 123.906 0.882 . . . . 0.0 113.131 175.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 N--CA 1.489 1.495 0 C-N-CA 124.826 1.251 . . . . 0.0 112.752 -171.328 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.254 91.7 m-85 . . . . . 0 N--CA 1.507 2.398 0 N-CA-C 118.99 2.959 . . . . 0.0 118.99 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.99 81.63 5.24 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 124.744 1.218 . . . . 0.0 112.897 -164.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.6 m -168.13 173.97 7.56 Favored 'General case' 0 CA--C 1.57 1.738 0 CA-C-O 122.607 1.194 . . . . 0.0 111.703 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.3 m -86.92 131.62 34.05 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.808 0.843 . . . . 0.0 110.804 170.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -132.65 109.36 9.66 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -172.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.24 134.46 48.32 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.281 -0.887 . . . . 0.0 111.716 -175.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -57.7 118.95 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -176.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -114.26 -52.8 2.71 Favored 'General case' 0 CA--C 1.564 1.509 0 C-N-CA 123.592 0.757 . . . . 0.0 113.023 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -144.75 74.17 1.4 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 119.466 1.03 . . . . 0.0 111.918 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.9 p -74.95 127.46 33.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.978 . . . . 0.0 113.454 175.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -79.22 -73.02 0.36 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -166.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -91.97 118.76 31.08 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 156.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -135.34 46.01 2.43 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-O 121.725 0.774 . . . . 0.0 112.406 164.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -146.05 -57.43 0.3 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.166 -0.959 . . . . 0.0 110.551 -173.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -62.39 -33.31 74.5 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 170.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -54.64 -59.77 4.25 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 120.141 1.337 . . . . 0.0 114.144 163.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.51 -47.39 63.31 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 169.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -59.83 -42.95 94.67 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 171.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -56.7 -39.32 73.65 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 165.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 90.5 mtp -64.41 -22.92 67.11 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 172.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.73 39.84 4.85 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 116.712 1.445 . . . . 0.0 116.712 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.446 HG23 ' HG2' ' A' ' 28' ' ' ARG . 6.2 m -105.76 138.05 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.631 0.729 . . . . 0.0 110.938 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -63.08 160.73 14.6 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.277 9.8 tp -53.57 -39.59 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.34 -52.85 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-N 119.647 1.112 . . . . 0.0 112.631 169.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -59.24 -34.79 72.63 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 168.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.446 ' HG2' HG23 ' A' ' 23' ' ' VAL . 84.6 mtm-85 -64.3 -47.92 77.61 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 121.428 1.922 . . . . 0.0 114.797 168.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -58.87 -48.96 79.56 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 168.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.4 mt -58.18 -53.36 59.2 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.611 1.338 . . . . 0.0 114.611 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.42 -47.55 78.8 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 116.431 2.012 . . . . 0.0 116.431 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.88 -47.66 67.69 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 168.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -98.69 32.98 2.4 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -85.78 -19.64 30.42 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -168.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 65.5 63.47 0.63 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 120.018 1.281 . . . . 0.0 113.572 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.74 117.28 21.93 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.204 -0.935 . . . . 0.0 111.792 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -103.21 110.8 22.9 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.534 174.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.7 mt -94.48 101.49 13.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 122.992 0.517 . . . . 0.0 109.776 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.9 m -94.94 111.98 23.72 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.36 136.63 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 124.089 0.956 . . . . 0.0 108.703 -168.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.1 m -149.13 124.24 10.1 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 119.903 -1.748 . . . . 0.0 111.235 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -77.34 132.54 38.64 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.374 1.07 . . . . 0.0 112.034 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -130.33 80.96 1.98 Allowed 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 123.524 0.73 . . . . 0.0 109.364 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.39 70.61 0.93 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 117.269 1.667 . . . . 0.0 117.269 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.309 17.3 m120 69.89 -23.49 0.16 Allowed 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -169.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -86.99 152.9 21.99 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 120.037 1.29 . . . . 0.0 112.785 169.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -121.73 133.68 54.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 111.054 173.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.0 m -97.69 117.79 32.77 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.0 t -120.37 112.57 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -83.2 117.21 22.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 0.0 110.85 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -95.32 80.07 3.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.815 -0.553 . . . . 0.0 110.903 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.5 t -97.42 111.36 23.65 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -171.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.5 p -149.93 177.01 10.24 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.77 59.08 0.21 Allowed 'General case' 0 CA--C 1.58 2.126 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 165.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -145.27 -53.84 0.29 Allowed 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 125.746 1.618 . . . . 0.0 110.096 167.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -156.95 -50.57 0.07 Allowed 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -172.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.299 36.6 t-20 76.62 106.13 0.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 120.06 1.3 . . . . 0.0 112.729 -165.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.8 pt -134.7 139.27 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-O 121.294 0.569 . . . . 0.0 111.257 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.73 124.46 30.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.516 -0.74 . . . . 0.0 111.829 168.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.4 t -110.4 101.62 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.9 t -101.04 115.03 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -140.94 151.89 44.57 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -171.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -90.56 139.39 30.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.497 -0.752 . . . . 0.0 111.882 168.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.07 131.46 49.63 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.08 -8.91 59.16 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 119.816 2.686 . . . . 0.0 119.816 -174.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.3 t -89.13 137.02 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-N 120.201 2.001 . . . . 0.0 110.193 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.1 p -76.11 97.85 4.2 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.48 -0.762 . . . . 0.0 111.19 176.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -118.41 164.56 15.06 Favored 'General case' 0 CA--C 1.569 1.689 0 C-N-CA 123.968 0.907 . . . . 0.0 111.879 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -86.31 98.56 11.03 Favored 'General case' 0 CA--C 1.568 1.65 0 O-C-N 121.363 -0.836 . . . . 0.0 111.171 173.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -82.69 114.14 20.85 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 124.074 0.95 . . . . 0.0 110.824 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -96.48 100.09 11.7 Favored 'General case' 0 CA--C 1.566 1.588 0 O-C-N 121.762 -0.586 . . . . 0.0 109.792 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.81 150.08 42.5 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -37.03 -48.9 0.81 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 119.966 3.321 . . . . 0.0 119.966 -176.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -66.26 -23.19 66.36 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 170.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.68 17.99 1.03 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 119.363 2.505 . . . . 0.0 119.363 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.8 m -109.25 126.51 53.4 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 120.477 2.138 . . . . 0.0 112.015 -162.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -96.77 106.86 19.23 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-O 121.486 0.66 . . . . 0.0 111.717 -167.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.3 mt -104.82 116.61 32.3 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.223 1.009 . . . . 0.0 112.256 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 59.7 ttp85 -86.97 117.55 25.76 Favored 'General case' 0 CA--C 1.567 1.618 0 O-C-N 120.834 -1.166 . . . . 0.0 111.27 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 160.6 -165.64 35.12 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.2 p -106.48 138.37 42.77 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.329 -0.512 . . . . 0.0 112.062 -168.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -88.86 106.63 18.51 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 146.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.2 m -106.4 135.9 47.08 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.019 0.527 . . . . 0.0 110.872 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.5 tp -85.01 98.84 10.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.962 -1.086 . . . . 0.0 110.942 175.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.19 79.44 5.72 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.471 0.653 . . . . 0.0 109.347 175.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.2 -99.43 0.32 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -89.7 -10.46 45.66 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -102.04 140.14 36.72 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 121.155 1.798 . . . . 0.0 111.577 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.9 mt -94.84 97.25 9.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.951 -1.093 . . . . 0.0 108.795 161.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.0 tt -90.1 117.38 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 122.15 0.976 . . . . 0.0 110.551 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.71 93.51 1.89 Allowed Glycine 0 N--CA 1.477 1.38 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.425 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -90.2 87.86 7.01 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -117.19 145.96 43.53 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.81 0.814 . . . . 0.0 112.139 -170.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -124.67 131.02 53.49 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.552 0.741 . . . . 0.0 109.001 172.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -76.28 122.78 24.9 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 121.093 -1.005 . . . . 0.0 113.109 -172.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 73.0 p -55.34 -52.4 63.6 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -89.64 65.35 6.87 Favored 'General case' 0 CA--C 1.572 1.797 0 CA-C-N 118.879 0.763 . . . . 0.0 111.824 167.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.54 -47.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 164.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.25 -20.97 47.9 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 118.064 1.986 . . . . 0.0 118.064 -157.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -77.98 147.84 34.71 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.57 1.148 . . . . 0.0 114.007 -172.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.22 133.29 35.42 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.9 tt -117.06 100.09 7.5 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -90.64 110.21 21.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.457 -0.777 . . . . 0.0 109.709 -173.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.3 m -109.97 98.13 7.5 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 119.657 1.117 . . . . 0.0 110.926 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.2 t -93.7 94.92 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.564 -1.335 . . . . 0.0 109.073 -174.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -83.18 127.82 33.95 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.738 0.699 . . . . 0.0 112.242 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -142.43 140.83 32.09 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.326 0.584 . . . . 0.0 112.422 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.4 mm -87.12 119.58 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.426 -0.796 . . . . 0.0 109.12 171.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.9 mt -113.4 88.81 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.84 -107.92 2.2 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 115.728 1.051 . . . . 0.0 115.728 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -90.45 13.78 14.75 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 172.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -138.97 127.62 23.26 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 120.01 1.277 . . . . 0.0 111.192 -172.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.4 tp -78.95 105.87 10.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.453 -0.78 . . . . 0.0 109.159 162.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.5 t -96.08 110.08 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 174.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -113.51 123.28 49.63 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.5 m -96.78 111.4 23.59 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 122.75 0.42 . . . . 0.0 110.001 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -83.7 123.15 29.53 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.987 0.515 . . . . 0.0 110.596 167.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.1 t -117.42 106.14 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 168.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -109.19 101.98 10.96 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.063 0.545 . . . . 0.0 109.639 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 52.24 53.51 12.3 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.15 -31.46 3.44 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 118.722 2.249 . . . . 0.0 118.722 -167.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 98.0 t -78.13 109.54 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 119.869 1.834 . . . . 0.0 110.307 -169.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.48 132.05 39.55 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 123.491 0.716 . . . . 0.0 112.535 -170.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -138.62 112.48 8.43 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.689 0.796 . . . . 0.0 111.427 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -95.19 110.34 22.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.607 -0.683 . . . . 0.0 110.375 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.8 mmm-85 -91.05 116.96 29.21 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.7 mt -104.87 106.4 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -101.53 121.52 42.13 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.908 0.883 . . . . 0.0 110.01 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -82.7 153.32 25.4 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 121.157 -0.964 . . . . 0.0 113.286 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -59.33 105.68 0.37 Allowed 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 178.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.6 t0 . . . . . 0 N--CA 1.489 1.478 0 C-N-CA 125.34 1.456 . . . . 0.0 114.828 178.129 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.334 55.7 m-85 . . . . . 0 N--CA 1.498 1.969 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 38.18 54.09 1.7 Allowed 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 119.214 3.042 . . . . 0.0 119.214 161.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.4 m -175.62 170.6 2.89 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.702 1.201 . . . . 0.0 110.155 -168.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.3 m -79.36 123.42 27.47 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.043 -1.036 . . . . 0.0 110.58 164.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -121.99 118.52 29.02 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -104.68 137.06 43.06 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.417 -0.802 . . . . 0.0 111.417 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.251 4.0 p -66.13 117.96 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.868 0 O-C-N 121.074 -1.016 . . . . 0.0 113.183 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -90.91 -55.76 3.43 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 124.256 1.022 . . . . 0.0 112.715 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.7 ptm85 -144.71 174.44 10.97 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-O 122.441 1.115 . . . . 0.0 111.968 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.1 m -156.93 145.29 19.61 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 119.603 -1.935 . . . . 0.0 111.623 -176.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.16 -110.02 0.18 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.951 -174.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -82.13 60.44 4.91 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 122.063 2.21 . . . . 0.0 113.75 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -104.81 67.68 0.81 Allowed 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 122.679 1.228 . . . . 0.0 111.828 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -158.22 -48.44 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.707 1.203 . . . . 0.0 110.039 165.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -57.2 -36.97 71.5 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 164.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -48.72 -51.96 26.07 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 160.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -63.52 -39.76 95.26 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -60.83 -45.03 96.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.447 -1.408 . . . . 0.0 114.644 168.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -55.36 -37.92 68.14 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 165.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.4 mmt -66.47 -16.06 63.83 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 164.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.32 39.51 6.79 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 117.266 1.666 . . . . 0.0 117.266 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.426 HG23 ' HG2' ' A' ' 28' ' ' ARG . 17.9 m -111.96 143.35 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 118.445 1.123 . . . . 0.0 111.909 -177.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -64.31 157.97 24.67 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -174.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.29 0.1 OUTLIER -52.52 -49.65 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 -177.689 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.0 t -62.43 -45.43 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-N 119.683 1.128 . . . . 0.0 113.483 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -53.18 -43.75 67.37 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 166.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HG2' HG23 ' A' ' 23' ' ' VAL . 82.5 mtm-85 -62.49 -41.35 98.74 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 168.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.78 -45.25 95.11 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 168.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.0 mt -63.13 -44.45 95.58 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.72 -34.6 78.7 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 169.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.42 -55.97 27.94 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 120.159 1.345 . . . . 0.0 114.545 160.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -80.97 58.18 3.34 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 122.581 1.181 . . . . 0.0 113.165 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -86.36 -26.46 24.82 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 117.838 2.532 . . . . 0.0 117.838 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.379 19.7 p30 46.28 47.9 13.44 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 117.799 2.518 . . . . 0.0 117.799 -168.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.7 tp -73.37 124.56 25.99 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 122.113 0.958 . . . . 0.0 113.519 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -118.86 125.55 49.78 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.199 1.0 . . . . 0.0 109.032 175.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.8 mt -106.94 100.89 10.36 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.441 0.696 . . . . 0.0 109.562 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.1 m -93.25 110.14 21.66 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.466 -0.771 . . . . 0.0 108.978 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.1 mt -98.92 112.52 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -168.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.5 m -111.02 104.87 13.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -88.92 112.03 22.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.078 -1.014 . . . . 0.0 112.265 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.81 78.94 2.62 Favored 'General case' 0 CA--C 1.568 1.653 0 CA-C-O 121.641 0.734 . . . . 0.0 109.943 163.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.65 -104.15 1.02 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 115.369 0.908 . . . . 0.0 115.369 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -81.03 -27.88 35.62 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 166.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -75.34 109.66 9.05 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.397 1.453 . . . . 0.0 112.173 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -90.85 106.93 18.86 Favored 'General case' 0 CA--C 1.559 1.324 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 169.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.6 m -90.14 95.93 10.43 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.1 t -99.84 108.99 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -171.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -87.72 100.46 12.85 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.709 0.804 . . . . 0.0 109.166 -173.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -92.77 86.56 5.56 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.022 0.529 . . . . 0.0 110.346 -170.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.4 t -90.53 122.19 33.13 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.01 0.524 . . . . 0.0 111.769 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.7 p -147.92 168.82 21.27 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -167.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.77 38.38 0.03 OUTLIER 'General case' 0 CA--C 1.584 2.271 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 164.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -150.59 -57.12 0.17 Allowed 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 126.533 1.933 . . . . 0.0 108.536 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -155.25 156.85 36.32 Favored 'General case' 0 CA--C 1.566 1.558 0 C-N-CA 124.232 1.013 . . . . 0.0 111.539 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -114.61 106.96 14.86 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.459 0.704 . . . . 0.0 109.336 164.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.7 pt -126.14 128.63 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.668 -0.645 . . . . 0.0 111.217 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -82.47 99.78 9.66 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 121.656 0.741 . . . . 0.0 111.972 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -85.27 100.37 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.48 110.48 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -129.92 127.97 41.2 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.358 0.599 . . . . 0.0 111.652 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.1 mp0 -71.66 141.63 49.9 Favored 'General case' 0 CA--C 1.566 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 110.915 161.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.21 109.11 1.43 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.246 -0.909 . . . . 0.0 113.141 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.84 -0.76 48.44 Favored Glycine 0 CA--C 1.553 2.46 0 N-CA-C 119.026 2.37 . . . . 0.0 119.026 -167.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.0 p -81.24 139.17 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 120.983 2.392 . . . . 0.0 113.223 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.3 m -89.03 109.51 20.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.745 -0.597 . . . . 0.0 109.67 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -138.81 162.04 35.76 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 123.325 0.65 . . . . 0.0 112.34 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -87.57 103.6 15.71 Favored 'General case' 0 CA--C 1.568 1.659 0 O-C-N 121.234 -0.916 . . . . 0.0 111.704 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -89.75 141.23 28.81 Favored 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 123.78 0.832 . . . . 0.0 111.989 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -136.73 107.5 6.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.999 -1.063 . . . . 0.0 110.856 -169.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.7 mt -77.59 88.24 3.9 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -171.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.288 . . 63.41 -53.25 0.21 Allowed 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 119.099 3.0 . . . . 0.0 119.099 174.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -91.59 -76.63 0.44 Allowed 'General case' 0 CA--C 1.572 1.792 0 CA-C-N 119.128 0.876 . . . . 0.0 110.7 170.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.73 56.81 0.1 OUTLIER Glycine 0 N--CA 1.494 2.533 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.3 m -69.76 -36.23 75.59 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.159 2.281 . . . . 0.0 117.159 -173.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 77.32 78.57 0.08 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 124.637 1.175 . . . . 0.0 112.634 164.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.0 mt -127.96 103.44 7.25 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.057 0.543 . . . . 0.0 111.286 -161.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -76.53 120.29 21.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.921 -1.112 . . . . 0.0 112.533 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.51 -169.61 42.44 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 118.098 1.999 . . . . 0.0 118.098 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 p -125.77 135.55 52.16 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 114.136 -1.032 . . . . 0.0 111.774 -164.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -95.11 116.18 28.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.754 -0.591 . . . . 0.0 110.425 164.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.8 t -109.81 132.32 54.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.9 -0.5 . . . . 0.0 111.914 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.5 tp -86.73 106.11 17.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.055 -1.028 . . . . 0.0 112.374 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -84.99 168.84 14.57 Favored 'General case' 0 CA--C 1.577 1.999 0 C-N-CA 123.518 0.727 . . . . 0.0 110.683 157.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -33.32 -63.29 0.35 Allowed Glycine 0 N--CA 1.502 3.052 0 N-CA-C 121.239 3.256 . . . . 0.0 121.239 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -108.16 17.63 22.06 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 165.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -139.37 124.19 18.6 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 121.066 1.757 . . . . 0.0 112.308 -161.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.8 mt -89.29 106.77 18.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.938 -1.101 . . . . 0.0 108.787 162.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.2 113.38 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.794 0.807 . . . . 0.0 109.998 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.99 93.02 1.33 Allowed Glycine 0 N--CA 1.479 1.534 0 C-N-CA 123.844 0.735 . . . . 0.0 112.833 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -89.33 104.29 16.85 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.511 0.672 . . . . 0.0 110.329 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -124.6 149.64 46.84 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.072 0.949 . . . . 0.0 111.972 -168.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -125.02 139.75 53.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.356 -0.84 . . . . 0.0 110.751 169.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -66.69 119.85 12.48 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.0 p -82.86 72.16 9.95 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 122.542 1.163 . . . . 0.0 109.901 167.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 175.91 -64.09 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 126.114 1.766 . . . . 0.0 107.37 -167.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -93.6 -33.31 13.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.68 -35.06 4.2 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 116.865 1.506 . . . . 0.0 116.865 -154.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -53.53 147.61 10.71 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 117.367 2.358 . . . . 0.0 117.367 -173.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -86.21 129.71 34.76 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -175.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.6 tt -113.75 124.11 51.47 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.203 1.001 . . . . 0.0 108.991 169.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -113.7 111.98 22.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.43 -0.793 . . . . 0.0 109.21 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 m -102.5 112.88 25.81 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.767 0.712 . . . . 0.0 110.315 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.4 t -97.88 88.47 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.289 -0.882 . . . . 0.0 108.694 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -79.12 106.43 11.15 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.545 0.738 . . . . 0.0 110.985 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -137.6 140.63 41.07 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -171.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.1 mp -86.65 113.76 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -96.16 91.31 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.2 -89.77 0.7 Allowed Glycine 0 N--CA 1.491 2.345 0 O-C-N 121.016 -1.052 . . . . 0.0 114.745 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -134.4 42.39 2.86 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 166.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -136.66 125.95 24.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.892 -1.13 . . . . 0.0 109.058 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.5 tp -84.23 105.6 15.21 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.88 123.1 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . 0.274 17.9 pt20 -116.85 104.04 10.91 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.373 0.606 . . . . 0.0 112.379 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.0 m -87.13 109.75 19.65 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.727 0.811 . . . . 0.0 109.974 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -87.43 113.59 23.27 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.158 0.583 . . . . 0.0 110.701 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -101.58 98.54 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -115.54 104.14 11.43 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 118.832 0.742 . . . . 0.0 110.106 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 54.64 55.02 8.42 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 174.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.15 -23.46 6.08 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 119.066 2.386 . . . . 0.0 119.066 -167.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.3 t -90.03 111.06 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 120.062 1.931 . . . . 0.0 108.929 -172.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.93 114.65 27.24 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.389 0.675 . . . . 0.0 111.405 174.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -121.12 108.35 13.7 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.319 0.647 . . . . 0.0 111.294 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.24 126.79 40.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 111.787 -176.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.7 mmm-85 -103.66 127.93 51.05 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 167.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.81 120.91 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -175.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -114.26 133.07 55.9 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.857 0.863 . . . . 0.0 111.374 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -95.5 153.69 17.58 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-O 122.155 0.979 . . . . 0.0 112.051 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -65.45 109.18 2.22 Favored 'General case' 0 CA--C 1.571 1.759 0 C-N-CA 124.097 0.959 . . . . 0.0 113.025 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 t70 . . . . . 0 N--CA 1.489 1.5 0 C-N-CA 125.188 1.395 . . . . 0.0 113.96 -178.949 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 . . . . . 0 CA--C 1.568 1.644 0 CA-C-O 119.277 -0.392 . . . . 0.0 111.581 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.9 t70 48.37 64.09 1.81 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.0 m -167.41 156.65 10.19 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 122.619 1.199 . . . . 0.0 114.147 -163.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.6 m -94.25 127.83 40.34 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.834 0.853 . . . . 0.0 110.963 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -128.03 104.87 8.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.656 -0.652 . . . . 0.0 109.875 -172.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -98.25 138.02 36.14 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.184 -0.948 . . . . 0.0 112.468 -177.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.9 p -62.92 120.97 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -99.65 -57.37 2.16 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 124.188 0.995 . . . . 0.0 112.112 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -152.84 124.43 7.76 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 119.859 1.209 . . . . 0.0 112.367 -176.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.7 p -97.02 103.45 15.38 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.585 0.754 . . . . 0.0 112.663 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -100.51 116.01 31.46 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.915 0.486 . . . . 0.0 110.323 -164.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.278 39.0 t30 65.73 20.29 11.49 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 -169.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -72.08 -36.37 69.49 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -57.33 -32.24 66.5 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.886 2.18 . . . . 0.0 116.886 169.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -71.98 -47.05 54.9 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -50.6 -52.9 34.94 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 163.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.2 mmt -47.65 -57.35 5.6 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 166.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -43.83 -52.13 6.93 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 168.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -56.7 -35.72 68.82 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 171.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 27.5 mtm -73.41 -19.81 60.89 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.37 63.59 0.98 Allowed Glycine 0 N--CA 1.491 2.321 0 CA-C-N 120.367 1.44 . . . . 0.0 114.659 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.7 m -126.91 156.08 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 121.675 0.75 . . . . 0.0 112.437 -169.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -70.28 153.2 43.32 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.857 -1.152 . . . . 0.0 113.733 168.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 11.9 tt -59.21 -38.41 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 172.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.3 t -58.7 -48.16 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 C-N-CA 123.798 0.839 . . . . 0.0 113.253 166.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -55.94 -38.86 70.88 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 167.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -57.58 -52.04 67.02 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 120.587 1.54 . . . . 0.0 115.084 168.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -60.16 -46.46 89.62 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.81 -45.94 90.29 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 171.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.09 92.67 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.84 -57.12 11.28 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 161.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -93.95 52.76 1.69 Allowed 'General case' 0 CA--C 1.575 1.938 0 CA-C-N 119.635 1.107 . . . . 0.0 113.432 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -85.44 -13.35 49.53 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 -173.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 57.93 45.46 18.21 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -174.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.8 tp -82.93 120.57 25.86 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-O 122.06 0.933 . . . . 0.0 112.39 -172.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -104.75 112.05 25.01 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.456 169.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.9 mt -90.17 100.98 13.71 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 m -93.47 92.39 7.59 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.5 mt -94.76 95.84 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -168.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 86.0 m -99.01 126.52 44.73 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.287 0.635 . . . . 0.0 109.769 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -83.18 126.08 32.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.909 . . . . 0.0 112.014 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -131.01 58.58 1.71 Allowed 'General case' 0 CA--C 1.574 1.866 0 C-N-CA 123.669 0.788 . . . . 0.0 111.869 -167.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.23 72.19 0.74 Allowed Glycine 0 N--CA 1.497 2.732 0 N-CA-C 116.591 1.397 . . . . 0.0 116.591 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.294 18.4 t30 68.63 -24.45 0.14 Allowed 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 -164.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -83.79 155.93 22.77 Favored 'General case' 0 CA--C 1.561 1.391 0 O-C-N 120.656 -1.277 . . . . 0.0 113.604 169.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -119.58 121.59 39.69 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 164.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.9 m -93.8 102.8 14.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.36 103.71 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -172.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -81.14 110.4 16.61 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -97.92 83.97 3.24 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.358 0.663 . . . . 0.0 109.733 -175.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.7 t -94.94 115.16 27.1 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.601 0.36 . . . . 0.0 111.936 -170.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.5 p -150.67 168.0 25.66 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.836 0.854 . . . . 0.0 113.134 -166.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.1 -30.03 65.95 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 118.027 2.602 . . . . 0.0 118.027 166.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -73.6 -43.96 58.36 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 167.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.55 154.65 12.07 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.82 0.848 . . . . 0.0 112.428 -165.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -119.66 108.2 14.16 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 161.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.0 pt -129.73 128.37 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.558 -0.714 . . . . 0.0 111.073 -174.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.32 99.62 12.38 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.841 0.857 . . . . 0.0 111.387 173.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.3 t -92.09 102.45 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -176.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.15 93.22 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -106.5 143.49 34.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.716 -0.615 . . . . 0.0 111.78 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -87.73 146.19 25.78 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 121.658 -0.651 . . . . 0.0 112.0 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.6 mt -70.26 109.75 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.095 -1.003 . . . . 0.0 111.839 169.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.42 52.73 2.44 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 116.394 1.318 . . . . 0.0 116.394 -171.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.5 p -143.63 138.48 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 118.327 1.064 . . . . 0.0 109.971 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.3 m -83.74 108.08 16.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.342 -0.849 . . . . 0.0 109.8 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -131.95 165.95 22.77 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-O 121.682 0.753 . . . . 0.0 112.331 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -90.1 108.77 19.94 Favored 'General case' 0 CA--C 1.571 1.779 0 O-C-N 121.619 -0.675 . . . . 0.0 111.506 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -100.5 117.68 35.15 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.742 0.817 . . . . 0.0 110.444 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -98.54 123.66 42.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.119 -0.988 . . . . 0.0 112.919 -175.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.07 158.61 25.0 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.4 69.96 2.93 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 170.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -171.8 -70.36 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 125.292 1.437 . . . . 0.0 108.273 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.45 68.24 0.01 OUTLIER Glycine 0 N--CA 1.483 1.796 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -171.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.3 m -162.14 127.74 3.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.584 -0.951 . . . . 0.0 109.846 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -97.95 126.08 43.18 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.901 0.88 . . . . 0.0 110.439 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.73 111.5 22.51 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.753 -0.592 . . . . 0.0 110.607 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -84.47 123.39 30.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.157 -0.965 . . . . 0.0 111.527 171.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.53 -168.26 39.39 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 117.659 1.824 . . . . 0.0 117.659 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 71.3 p -124.27 123.6 40.58 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.544 -0.828 . . . . 0.0 111.62 -163.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -83.98 114.67 21.87 Favored 'General case' 0 CA--C 1.57 1.735 0 O-C-N 121.992 -0.442 . . . . 0.0 111.433 163.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.7 m -114.36 126.54 55.11 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 123.396 0.679 . . . . 0.0 111.071 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.2 tp -94.12 115.56 27.87 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.176 -0.953 . . . . 0.0 112.103 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -100.3 80.94 2.31 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 170.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.88 -87.23 0.55 Allowed Glycine 0 N--CA 1.494 2.515 0 O-C-N 121.052 -1.03 . . . . 0.0 115.083 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -123.39 29.4 6.67 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 166.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -125.06 109.68 13.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.461 -1.399 . . . . 0.0 108.972 177.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.81 106.4 18.44 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.354 0.661 . . . . 0.0 109.524 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.8 tt -96.93 118.67 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.866 -1.146 . . . . 0.0 110.644 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.72 98.06 2.35 Favored Glycine 0 N--CA 1.48 1.605 0 C-N-CA 123.249 0.452 . . . . 0.0 112.098 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -85.4 93.87 8.84 Favored 'General case' 0 CA--C 1.565 1.552 0 C-N-CA 123.251 0.621 . . . . 0.0 109.354 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -121.79 143.63 49.28 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.298 1.047 . . . . 0.0 113.442 -166.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -119.34 137.8 53.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.391 -0.818 . . . . 0.0 109.146 165.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -69.78 107.34 3.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 0.0 111.664 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.312 13.8 t -74.81 -5.88 45.92 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 118.139 2.644 . . . . 0.0 118.139 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -95.0 -18.1 21.36 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 158.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -123.79 -21.64 5.12 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 117.29 2.329 . . . . 0.0 117.29 -173.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.24 -30.92 7.12 Favored Glycine 0 N--CA 1.496 2.684 0 CA-C-N 121.885 2.129 . . . . 0.0 118.351 -175.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -78.76 151.56 31.96 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 118.45 1.125 . . . . 0.0 113.585 -167.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -98.63 132.62 43.89 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.599 0.714 . . . . 0.0 112.004 -164.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.3 tt -131.11 122.55 26.86 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 124.1 0.96 . . . . 0.0 109.908 -170.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -109.85 116.84 32.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.126 -0.984 . . . . 0.0 109.352 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.7 m -106.52 104.06 13.67 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 119.019 0.827 . . . . 0.0 110.008 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.5 t -92.36 107.8 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.25 -0.906 . . . . 0.0 108.675 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -85.3 103.76 14.53 Favored 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 124.074 0.95 . . . . 0.0 110.433 170.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -127.46 147.35 50.3 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 124.254 1.022 . . . . 0.0 109.534 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . 0.25 5.8 mt -113.72 117.47 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 119.771 -1.83 . . . . 0.0 111.175 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.2 tp -92.35 74.71 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.769 0 CA-C-O 122.124 0.964 . . . . 0.0 110.741 172.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.94 -98.48 0.71 Allowed Glycine 0 N--CA 1.49 2.281 0 O-C-N 121.067 -1.021 . . . . 0.0 115.193 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -80.7 -10.62 59.72 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.892 2.553 . . . . 0.0 117.892 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -128.28 127.64 43.15 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-N 119.736 1.153 . . . . 0.0 112.457 -165.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.9 tp -80.94 124.11 28.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.858 0.863 . . . . 0.0 111.147 170.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.2 m -103.17 116.54 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -91.13 103.49 16.18 Favored 'General case' 0 CA--C 1.558 1.281 0 O-C-N 121.277 -0.889 . . . . 0.0 109.093 167.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.4 m -90.66 104.57 17.14 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -92.16 106.92 18.83 Favored 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 123.76 0.824 . . . . 0.0 110.621 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.89 111.39 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.403 ' O ' HG12 ' A' ' 122' ' ' VAL . 91.7 t80 -142.04 110.82 6.19 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.988 0.515 . . . . 0.0 110.463 -175.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 54.31 50.52 16.14 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 168.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.69 38.01 44.1 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 118.507 2.163 . . . . 0.0 118.507 -170.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 119' ' ' TYR . 0.5 OUTLIER -146.55 148.15 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 118.812 1.306 . . . . 0.0 110.216 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -130.06 115.82 17.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.729 -0.607 . . . . 0.0 109.981 171.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.22 127.3 54.64 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.009 0.524 . . . . 0.0 112.276 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -108.71 105.09 14.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.595 -0.691 . . . . 0.0 110.099 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -87.85 115.13 25.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.346 -0.847 . . . . 0.0 110.494 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 22.7 mt -99.53 123.16 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -120.99 119.54 32.83 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 124.291 1.036 . . . . 0.0 109.604 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -80.36 142.85 34.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.913 -1.117 . . . . 0.0 113.073 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 52.6 tttt -69.34 113.67 6.87 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.7 t70 . . . . . 0 N--CA 1.49 1.552 0 C-N-CA 124.761 1.224 . . . . 0.0 113.734 172.675 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 N--CA 1.5 2.067 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -148.99 81.29 1.43 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.659 -0.651 . . . . 0.0 110.431 -176.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.3 m -171.95 170.26 5.45 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.577 1.179 . . . . 0.0 111.763 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.2 m -90.39 130.73 36.44 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.912 -1.117 . . . . 0.0 110.712 170.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -135.39 113.56 11.33 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.576 -0.703 . . . . 0.0 109.762 -171.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -116.13 143.38 45.56 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.651 -1.281 . . . . 0.0 113.649 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.88 115.86 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -168.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.08 -48.75 7.19 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 124.388 1.075 . . . . 0.0 112.86 169.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -136.61 109.73 7.75 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 119.377 0.99 . . . . 0.0 110.225 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.0 p -91.98 101.06 13.61 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.018 -1.051 . . . . 0.0 111.013 167.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -106.96 113.11 26.39 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -165.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.294 13.1 t30 69.67 16.65 7.94 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 117.53 2.419 . . . . 0.0 117.53 -176.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -66.73 -37.92 85.62 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.44 -43.17 83.68 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 167.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -69.29 -43.15 74.44 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 171.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -48.62 -54.34 15.0 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 162.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 mtt -66.7 -24.7 66.29 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 170.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.65 -42.92 81.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.295 -1.503 . . . . 0.0 114.216 164.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -57.47 -33.15 67.69 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 163.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 mmt -64.05 -42.58 96.99 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 164.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.87 56.35 0.96 Allowed Glycine 0 N--CA 1.485 1.951 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -117.44 147.86 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-N 117.983 0.892 . . . . 0.0 112.512 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -56.45 139.72 48.16 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.297 0.0 OUTLIER -47.35 -45.54 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 178.598 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.4 t -55.07 -60.02 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 C-N-CA 124.288 1.035 . . . . 0.0 113.643 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -63.19 -38.73 92.31 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -58.03 -49.67 76.09 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 170.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -59.18 -47.77 84.08 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 167.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.4 mt -59.0 -41.5 87.8 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 171.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.86 -41.46 87.27 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.84 -52.79 64.02 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 161.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -91.4 35.72 0.94 Allowed 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -77.89 -22.68 49.36 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 66.61 60.6 0.57 Allowed 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 120.472 1.487 . . . . 0.0 113.056 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.4 tp -86.7 120.87 28.46 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 121.415 -0.803 . . . . 0.0 112.979 -171.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -98.4 121.2 40.03 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 124.53 1.132 . . . . 0.0 110.355 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.4 mt -101.76 101.64 12.15 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 123.709 0.804 . . . . 0.0 109.253 174.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.4 m -88.84 95.03 10.13 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.155 -0.966 . . . . 0.0 108.775 172.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 73.6 mt -93.06 118.7 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -173.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -137.01 146.78 45.71 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 123.33 0.652 . . . . 0.0 110.725 171.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -130.53 157.92 41.37 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -127.55 84.23 2.23 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-N 114.482 -1.235 . . . . 0.0 108.706 167.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.73 -82.2 0.84 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 116.206 1.243 . . . . 0.0 116.206 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -116.07 -16.33 11.05 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 168.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -85.79 131.19 34.37 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 121.245 1.839 . . . . 0.0 111.833 173.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -113.61 131.16 56.22 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 124.363 1.065 . . . . 0.0 110.023 177.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 m -103.71 111.87 24.55 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 163.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.7 t -108.99 102.87 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -84.98 109.82 18.45 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -108.16 103.95 13.25 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.896 0.478 . . . . 0.0 110.043 -166.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 t -115.32 118.95 34.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.305 0.642 . . . . 0.0 111.745 -172.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.5 p -138.38 175.5 9.52 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.779 0.8 . . . . 0.0 112.965 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.74 62.26 1.05 Allowed 'General case' 0 CA--C 1.576 1.98 0 O-C-N 120.395 -1.441 . . . . 0.0 113.54 153.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -169.18 -61.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.932 1.293 . . . . 0.0 109.225 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.402 ' HG3' HH11 ' A' ' 56' ' ' ARG . 32.0 ptt85 -142.47 141.49 32.16 Favored 'General case' 0 CA--C 1.567 1.608 0 C-N-CA 124.035 0.934 . . . . 0.0 110.545 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -129.68 92.43 3.33 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.17 153.02 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 CA-C-O 121.91 0.862 . . . . 0.0 111.879 -170.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.38 108.41 18.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.932 . . . . 0.0 110.564 168.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.84 97.77 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.3 t -102.7 125.65 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -173.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -150.77 151.05 31.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.606 -0.684 . . . . 0.0 111.662 -176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -97.3 143.82 27.69 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.285 -0.885 . . . . 0.0 111.004 165.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.8 mt -57.35 122.03 11.59 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.88 -4.77 73.47 Favored Glycine 0 CA--C 1.555 2.537 0 N-CA-C 119.868 2.707 . . . . 0.0 119.868 -170.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -93.64 132.18 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-N 120.489 2.144 . . . . 0.0 109.769 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -74.94 117.98 17.39 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -134.8 161.09 36.16 Favored 'General case' 0 CA--C 1.571 1.753 0 C-N-CA 123.844 0.858 . . . . 0.0 112.013 -176.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -89.41 115.89 27.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.357 -0.84 . . . . 0.0 111.88 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -113.23 129.92 56.38 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 123.868 0.867 . . . . 0.0 111.129 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -98.49 131.32 44.83 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.996 -1.065 . . . . 0.0 110.895 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.6 mt -62.89 -56.1 20.23 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 170.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -154.95 -65.15 0.13 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 119.116 0.871 . . . . 0.0 111.948 177.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -84.16 -76.08 0.31 Allowed 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.396 0.679 . . . . 0.0 111.96 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.66 58.23 0.4 Allowed Glycine 0 N--CA 1.488 2.151 0 CA-C-N 118.795 0.725 . . . . 0.0 114.51 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 m -105.94 90.95 3.53 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -82.59 117.67 22.73 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.936 0.874 . . . . 0.0 112.44 -168.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.8 mt -115.58 108.66 16.71 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.671 0.789 . . . . 0.0 109.393 -171.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -98.1 96.72 8.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.758 -0.589 . . . . 0.0 110.669 -170.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.29 -153.46 10.97 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 116.338 1.295 . . . . 0.0 116.338 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.7 p -129.68 128.8 43.29 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -152.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -91.22 119.51 31.36 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.057 -1.027 . . . . 0.0 109.393 158.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.3 m -122.02 136.04 54.89 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.267 0.556 . . . . 0.0 111.308 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.8 tp -86.12 109.11 18.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.961 -1.087 . . . . 0.0 111.138 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.23 15.08 2.55 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 171.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.09 -80.53 0.27 Allowed Glycine 0 N--CA 1.488 2.148 0 O-C-N 120.827 -1.171 . . . . 0.0 112.087 -170.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -83.89 -28.8 27.67 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -125.45 140.06 53.1 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.781 1.173 . . . . 0.0 111.556 -165.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.5 mt -89.24 104.54 17.08 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 167.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.1 pt -93.97 116.41 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.997 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.82 99.95 2.61 Favored Glycine 0 N--CA 1.482 1.703 0 C-N-CA 123.591 0.615 . . . . 0.0 112.944 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -97.05 98.44 10.06 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -128.61 167.39 17.23 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-O 123.338 1.542 . . . . 0.0 111.657 -170.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.0 154.64 36.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.706 -1.246 . . . . 0.0 110.256 165.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -70.66 109.99 5.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 112.195 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.8 t -66.4 -17.87 65.03 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -84.96 -22.21 29.26 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 165.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -120.12 -22.49 6.63 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.98 -39.4 2.78 Favored Glycine 0 N--CA 1.492 2.37 0 CA-C-N 121.37 1.895 . . . . 0.0 117.258 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -72.05 144.86 48.6 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -165.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.66 140.39 55.46 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -173.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.1 tt -126.16 127.24 45.41 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.549 0.69 . . . . 0.0 111.323 167.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -96.67 149.08 22.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.506 -0.746 . . . . 0.0 110.604 163.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.4 m -145.32 105.54 4.06 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 119.928 -1.732 . . . . 0.0 109.589 162.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.7 t -93.11 114.26 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.094 -1.004 . . . . 0.0 109.03 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.4 mtm-85 -89.05 121.57 31.53 Favored 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 123.787 0.835 . . . . 0.0 111.265 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -143.61 141.48 30.64 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 123.671 0.788 . . . . 0.0 110.424 -177.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.29 126.57 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 120.733 -1.23 . . . . 0.0 109.759 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.1 tp -116.52 91.68 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.754 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 164.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.04 -112.32 4.15 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 120.898 -1.126 . . . . 0.0 114.611 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -99.62 20.31 14.22 Favored 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 167.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -126.14 127.16 45.32 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.788 1.176 . . . . 0.0 111.056 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.5 tp -87.62 114.78 24.54 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.241 1.016 . . . . 0.0 109.982 171.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.4 m -91.35 119.43 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.585 -0.697 . . . . 0.0 109.876 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -99.71 103.68 15.36 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 166.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.5 m -89.81 94.96 10.03 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -81.08 131.45 35.3 Favored 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 123.944 0.898 . . . . 0.0 111.249 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.1 t -134.98 114.37 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 CA-C-N 119.147 0.885 . . . . 0.0 109.274 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -113.94 122.12 45.99 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.31 5.2 mm-40 70.69 -85.47 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 124.23 1.012 . . . . 0.0 112.0 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -151.22 50.49 0.53 Allowed Glycine 0 N--CA 1.487 2.1 0 CA-C-O 119.416 -0.658 . . . . 0.0 114.109 158.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.35 109.08 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -77.81 129.61 35.65 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -124.08 114.3 19.53 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.532 0.682 . . . . 0.0 110.622 163.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -99.7 104.39 16.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.861 -0.525 . . . . 0.0 109.683 -176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 -93.3 112.7 24.7 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.531 0.682 . . . . 0.0 109.612 172.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.8 mt -99.1 114.74 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.555 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -173.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -108.44 111.33 23.17 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.685 0.794 . . . . 0.0 109.891 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -79.97 144.79 32.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.003 -1.061 . . . . 0.0 112.467 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -66.1 120.34 13.02 Favored 'General case' 0 CA--C 1.569 1.692 0 CA-C-O 121.684 0.754 . . . . 0.0 112.961 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.8 t70 . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -158.895 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 . . . . . 0 N--CA 1.502 2.156 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -146.71 51.82 1.11 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.379 -1.45 . . . . 0.0 113.78 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 p -160.87 176.75 11.1 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.127 -0.983 . . . . 0.0 113.593 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.4 m -78.4 116.58 18.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.72 . . . . 0.0 110.264 160.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -109.73 111.34 22.73 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -95.04 138.65 32.48 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.429 -0.794 . . . . 0.0 111.75 -177.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.02 122.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -110.29 -55.62 2.44 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.581 0.752 . . . . 0.0 112.742 -174.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -158.56 119.8 3.43 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 120.042 1.292 . . . . 0.0 111.064 -171.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.0 p -110.29 124.72 52.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.031 -1.043 . . . . 0.0 113.099 -174.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -78.43 -48.4 15.5 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -170.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -134.83 54.75 1.93 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 119.97 1.259 . . . . 0.0 112.599 168.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -84.45 58.77 5.04 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.018 -1.676 . . . . 0.0 112.419 167.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -151.61 -61.19 0.17 Allowed 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 125.101 1.36 . . . . 0.0 109.43 -176.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -62.02 -48.95 77.97 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 120.846 1.657 . . . . 0.0 114.096 170.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -47.65 -52.8 16.83 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 163.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.8 mtp -55.17 -49.14 72.62 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 171.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -52.84 -46.38 67.78 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 165.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -60.13 -36.22 77.0 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 170.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.7 mtm -72.34 -59.14 2.88 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 119.607 1.094 . . . . 0.0 113.114 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.89 72.14 0.02 OUTLIER Glycine 0 N--CA 1.487 2.047 0 CA-C-N 118.268 0.486 . . . . 0.0 113.779 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 m -118.36 155.44 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-O 122.025 0.917 . . . . 0.0 112.605 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -79.2 153.29 30.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.353 -0.842 . . . . 0.0 110.921 152.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.29 12.9 tt -56.78 -37.61 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 172.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.9 t -58.75 -53.73 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 C-N-CA 124.362 1.065 . . . . 0.0 113.276 166.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -55.34 -36.16 65.98 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 168.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -57.36 -52.08 66.81 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 172.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -64.61 -44.74 89.59 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 166.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -60.98 -58.06 10.02 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.66 -15.9 63.82 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 173.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.96 -52.47 42.41 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 156.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -91.51 -18.31 24.33 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 118.216 2.673 . . . . 0.0 118.216 -172.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -73.32 62.17 0.69 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 50.12 51.58 16.41 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 163.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 tt -91.07 109.55 20.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.116 -0.99 . . . . 0.0 111.588 -170.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -97.75 138.15 35.55 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-O 121.848 0.832 . . . . 0.0 111.937 166.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.2 mt -103.91 97.41 7.41 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 164.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.2 m -88.26 103.43 15.79 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.173 -0.955 . . . . 0.0 108.907 176.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.3 mt -94.01 108.58 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -168.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 m -105.26 111.19 23.84 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -87.34 137.92 31.92 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -135.84 80.36 1.82 Allowed 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 124.123 0.969 . . . . 0.0 109.166 172.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.12 -89.58 0.5 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 116.061 1.184 . . . . 0.0 116.061 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.13 15.33 19.5 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 167.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -134.3 116.13 14.91 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 119.942 1.246 . . . . 0.0 110.259 -166.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -104.8 129.53 53.06 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.715 -0.616 . . . . 0.0 110.847 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.1 m -100.77 104.43 15.69 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 164.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.2 t -101.47 108.39 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -80.21 110.35 15.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 111.003 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -83.73 95.07 8.29 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 t -116.55 114.71 24.53 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.005 0.907 . . . . 0.0 111.31 -170.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.8 t -154.53 175.41 13.65 Favored 'General case' 0 CA--C 1.572 1.8 0 C-N-CA 125.968 1.707 . . . . 0.0 109.087 -171.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.2 -27.11 63.59 Favored 'General case' 0 CA--C 1.581 2.171 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 155.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -85.42 -32.58 22.27 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.1 mmt-85 -137.42 140.41 41.3 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.197 0.908 . . . . 0.0 110.32 -175.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -135.33 76.07 1.6 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 158.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.3 142.6 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 122.026 0.917 . . . . 0.0 111.058 -168.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.4 113.67 26.0 Favored 'General case' 0 CA--C 1.564 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 111.461 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.1 t -90.93 98.35 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.5 t -91.6 119.4 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -136.6 129.78 31.31 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.159 0.504 . . . . 0.0 112.315 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.12 135.82 33.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.801 -0.562 . . . . 0.0 110.5 164.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.43 125.24 22.94 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.75 -16.76 44.37 Favored Glycine 0 CA--C 1.556 2.601 0 N-CA-C 119.447 2.539 . . . . 0.0 119.447 -167.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.0 t -86.21 130.28 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 CA-C-N 120.561 2.18 . . . . 0.0 109.98 -177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.0 t -74.44 121.33 21.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.575 -0.703 . . . . 0.0 112.76 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -142.58 164.72 29.36 Favored 'General case' 0 CA--C 1.573 1.86 0 C-N-CA 123.333 0.653 . . . . 0.0 111.775 -172.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -87.45 116.33 25.49 Favored 'General case' 0 CA--C 1.569 1.696 0 O-C-N 121.339 -0.851 . . . . 0.0 112.909 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -98.99 143.41 29.3 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.876 0.87 . . . . 0.0 111.231 166.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -120.59 132.63 55.24 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.983 0.897 . . . . 0.0 110.682 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.8 mt -84.54 168.19 15.63 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 121.979 0.895 . . . . 0.0 112.9 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.11 -36.67 80.33 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 118.94 2.941 . . . . 0.0 118.94 -173.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.34 -76.48 0.1 Allowed 'General case' 0 CA--C 1.571 1.775 0 CA-C-N 120.113 1.324 . . . . 0.0 111.697 169.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.44 64.0 0.05 OUTLIER Glycine 0 N--CA 1.483 1.806 0 O-C-N 121.841 -0.537 . . . . 0.0 112.543 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.8 m -123.04 107.17 11.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -95.26 128.91 42.47 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-O 122.07 0.938 . . . . 0.0 111.419 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.3 mt -132.69 116.24 16.37 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.076 -156.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -92.47 118.68 31.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.475 -0.765 . . . . 0.0 110.667 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.76 -177.92 42.45 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 117.981 1.953 . . . . 0.0 117.981 -173.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.6 p -126.28 132.13 51.73 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 113.972 -1.114 . . . . 0.0 110.37 -173.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -92.59 122.66 35.23 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.335 -0.853 . . . . 0.0 110.541 169.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.3 m -109.66 118.81 37.53 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.318 0.647 . . . . 0.0 110.831 175.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.5 tp -82.83 103.93 12.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.515 -0.74 . . . . 0.0 111.85 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -105.25 89.78 3.23 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.191 0.52 . . . . 0.0 110.26 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.69 -94.49 0.76 Allowed Glycine 0 N--CA 1.492 2.389 0 O-C-N 121.501 -0.75 . . . . 0.0 113.782 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -127.36 48.4 2.23 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 159.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -129.8 111.87 13.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.089 -1.007 . . . . 0.0 108.49 173.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.4 mt -84.55 108.37 17.28 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.439 -0.788 . . . . 0.0 109.452 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.0 mt -102.22 104.22 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -172.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.51 100.71 2.67 Favored Glycine 0 N--CA 1.483 1.812 0 C-N-CA 123.886 0.755 . . . . 0.0 113.096 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.52 95.92 9.91 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.973 0.509 . . . . 0.0 109.729 -175.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -110.76 147.75 33.78 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.589 0.709 . . . . 0.0 112.868 -171.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -119.04 139.43 51.74 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.644 0.778 . . . . 0.0 109.131 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -69.17 114.9 7.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.928 -1.107 . . . . 0.0 112.885 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 t -66.09 -16.77 64.22 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 117.916 2.562 . . . . 0.0 117.916 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -92.56 -10.65 36.84 Favored 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 165.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -141.15 -16.9 0.83 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 -169.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.94 -42.5 2.76 Favored Glycine 0 N--CA 1.493 2.458 0 CA-C-N 121.949 2.159 . . . . 0.0 117.707 -175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -70.24 147.91 49.19 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -161.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -77.43 132.2 38.36 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -173.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.0 tt -123.61 111.45 16.25 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 124.352 1.061 . . . . 0.0 108.751 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -101.63 113.62 26.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.104 -0.997 . . . . 0.0 109.577 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.0 m -107.2 108.69 20.24 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 119.196 0.907 . . . . 0.0 111.027 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.2 97.86 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.006 -1.059 . . . . 0.0 108.376 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -86.89 117.91 25.93 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.088 0.955 . . . . 0.0 110.899 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -146.97 142.81 27.92 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.326 -0.859 . . . . 0.0 112.864 -178.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.2 mp -90.84 110.01 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.0 tp -90.07 80.42 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.119 0.962 . . . . 0.0 110.155 169.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.67 -88.92 0.74 Allowed Glycine 0 N--CA 1.49 2.266 0 O-C-N 121.209 -0.932 . . . . 0.0 114.933 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -117.84 22.05 12.52 Favored 'General case' 0 CA--C 1.581 2.171 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 175.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -137.99 123.6 19.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.53 -1.356 . . . . 0.0 109.858 -175.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.7 tp -78.49 110.03 13.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.524 -0.735 . . . . 0.0 110.127 168.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.89 118.12 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.277 -0.89 . . . . 0.0 108.871 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . 0.269 21.3 pt20 -103.52 104.42 14.49 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.777 0.799 . . . . 0.0 110.724 172.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.0 m -91.56 108.39 19.87 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.755 0.822 . . . . 0.0 109.152 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -94.14 112.13 23.92 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.386 0.674 . . . . 0.0 110.865 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.01 97.39 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -109.6 113.19 25.76 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.152 0.581 . . . . 0.0 109.873 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 54.78 46.14 25.2 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.04 -25.23 4.86 Favored Glycine 0 CA--C 1.556 2.65 0 N-CA-C 119.125 2.41 . . . . 0.0 119.125 -166.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.5 t -83.6 108.61 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 119.989 1.894 . . . . 0.0 110.069 -168.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -86.46 119.47 26.76 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.151 0.58 . . . . 0.0 112.479 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -124.97 117.0 23.06 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.645 0.778 . . . . 0.0 111.888 175.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -106.45 108.68 20.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.537 -0.727 . . . . 0.0 110.174 -170.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -97.43 116.01 28.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.911 -0.493 . . . . 0.0 110.482 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.7 mt -90.48 118.81 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -111.63 123.83 51.05 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.372 1.069 . . . . 0.0 109.221 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -83.92 148.35 26.99 Favored 'General case' 0 CA--C 1.565 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 112.721 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -59.24 113.42 2.13 Favored 'General case' 0 CA--C 1.57 1.735 0 C-N-CA 123.687 0.795 . . . . 0.0 113.05 167.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 N--CA 1.489 1.488 0 C-N-CA 124.949 1.3 . . . . 0.0 113.096 -175.139 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.327 62.9 m-85 . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.13 93.88 1.09 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 120.259 1.39 . . . . 0.0 112.374 -170.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.4 m -176.76 166.45 2.57 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 122.651 1.215 . . . . 0.0 111.805 -163.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.3 m -94.94 122.79 37.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.485 -0.759 . . . . 0.0 110.326 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -127.14 111.79 14.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.762 -0.586 . . . . 0.0 109.691 -170.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -105.34 133.19 50.51 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.977 -1.077 . . . . 0.0 112.011 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.58 115.79 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -98.47 -54.71 2.96 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 124.483 1.113 . . . . 0.0 111.85 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 56.1 mtm-85 -133.79 106.98 7.62 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.427 1.012 . . . . 0.0 109.458 -177.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.5 p -94.34 97.74 10.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.856 -0.527 . . . . 0.0 111.196 174.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.4 127.03 52.76 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.157 0.583 . . . . 0.0 110.06 -159.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.269 37.8 t30 62.76 40.45 9.97 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -169.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -77.99 -49.82 13.32 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -172.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.02 -40.79 77.38 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 171.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -62.76 -47.65 82.6 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.21 1.368 . . . . 0.0 114.629 171.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -53.52 -53.03 57.39 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 166.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.9 mtp -60.83 -41.89 96.65 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -60.02 -42.52 94.51 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 165.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -40.69 73.89 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 166.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 56.6 mtm -61.84 -54.77 37.6 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-N 119.552 1.069 . . . . 0.0 112.763 166.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.99 54.83 0.08 OUTLIER Glycine 0 N--CA 1.487 2.041 0 CA-C-O 119.122 -0.821 . . . . 0.0 113.909 164.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.4 m -126.77 151.18 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 122.651 1.215 . . . . 0.0 112.911 -169.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -72.77 164.48 26.49 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.259 14.0 tt -55.43 -36.86 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 175.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.9 t -65.18 -51.57 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-N 120.09 1.314 . . . . 0.0 112.658 173.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -52.16 -47.08 65.66 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 166.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -57.87 -48.51 79.63 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -60.91 -46.25 91.42 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 171.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.5 mt -60.59 -48.16 83.02 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 171.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.24 -21.14 62.16 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.11 -49.36 15.44 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 120.962 1.71 . . . . 0.0 114.415 167.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -77.91 17.62 0.56 Allowed 'General case' 0 CA--C 1.58 2.124 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 175.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.2 p30 -74.94 -17.91 60.48 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 118.93 2.937 . . . . 0.0 118.93 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 61.53 62.19 1.36 Allowed 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 120.562 1.528 . . . . 0.0 113.484 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 tt -88.56 117.52 27.57 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.418 -0.801 . . . . 0.0 112.257 -164.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -101.21 127.83 47.6 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.54 0.736 . . . . 0.0 110.173 173.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.4 mt -98.48 102.4 14.13 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 166.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.5 m -94.62 107.56 19.55 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.098 -1.002 . . . . 0.0 108.441 171.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.7 mt -104.07 129.01 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -165.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 89.3 m -135.53 123.54 22.8 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.271 -0.893 . . . . 0.0 109.326 174.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.7 tm0? -98.74 132.94 43.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.321 -0.862 . . . . 0.0 112.186 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -127.69 87.6 2.65 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 123.565 0.746 . . . . 0.0 110.947 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.78 -89.5 0.96 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 115.139 0.816 . . . . 0.0 115.139 173.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -108.65 -2.5 18.68 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 166.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -108.99 144.13 37.37 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.34 1.427 . . . . 0.0 112.415 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -110.19 120.42 42.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.4 0.68 . . . . 0.0 109.986 167.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.1 m -86.41 102.72 14.3 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 164.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.3 t -104.6 101.52 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -83.8 107.44 16.21 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.262 -0.899 . . . . 0.0 110.017 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -86.6 92.9 9.05 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.005 0.522 . . . . 0.0 110.066 176.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.3 m -96.24 108.72 21.24 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 120.941 0.4 . . . . 0.0 109.991 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.3 p -143.51 158.02 43.98 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.468 0.651 . . . . 0.0 111.776 -174.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.61 -25.0 64.27 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.429 2.381 . . . . 0.0 117.429 165.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -53.96 15.66 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 165.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.79 152.52 25.19 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-N 119.148 0.886 . . . . 0.0 111.676 174.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -106.08 98.14 7.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.689 -0.632 . . . . 0.0 109.837 166.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.2 pt -122.93 132.85 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 121.989 0.9 . . . . 0.0 111.765 -174.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -94.85 98.46 10.75 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.693 0.797 . . . . 0.0 108.917 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.45 93.3 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -166.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.6 t -94.21 98.42 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -176.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -109.88 141.49 42.52 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.285 0.564 . . . . 0.0 112.116 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.38 138.75 31.16 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.465 0.65 . . . . 0.0 111.292 166.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.66 129.03 39.08 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.95 -7.12 63.95 Favored Glycine 0 CA--C 1.555 2.569 0 N-CA-C 119.969 2.748 . . . . 0.0 119.969 -170.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.9 t -97.78 133.74 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 120.634 2.217 . . . . 0.0 110.414 -170.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.7 p -74.57 104.35 5.23 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.439 0.696 . . . . 0.0 112.626 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -118.07 138.74 52.03 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 123.292 0.637 . . . . 0.0 111.928 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 -74.77 115.37 14.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.581 -0.7 . . . . 0.0 112.244 172.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -111.56 152.02 28.04 Favored 'General case' 0 CA--C 1.569 1.689 0 C-N-CA 124.093 0.957 . . . . 0.0 112.591 -175.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -119.81 136.39 54.48 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.086 0.954 . . . . 0.0 111.633 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.2 mt -105.99 64.12 0.68 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.292 -0.88 . . . . 0.0 113.097 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.32 . . 66.47 -66.76 0.17 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.29 -22.33 41.02 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 119.926 3.306 . . . . 0.0 119.926 176.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.49 21.94 8.93 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 118.229 2.052 . . . . 0.0 118.229 -170.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 83.8 m -82.32 108.01 15.43 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 119.763 1.782 . . . . 0.0 109.334 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -78.33 128.57 33.86 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.267 0.627 . . . . 0.0 112.342 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.0 mt -140.37 105.1 4.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.993 -0.442 . . . . 0.0 110.759 -166.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -81.76 123.79 29.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.654 -1.279 . . . . 0.0 110.896 171.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.22 176.84 40.12 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 118.649 2.22 . . . . 0.0 118.649 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.5 p -126.03 130.2 50.69 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 113.674 -1.263 . . . . 0.0 110.866 -169.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -97.72 123.48 41.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.677 -0.639 . . . . 0.0 111.744 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.2 m -106.07 120.19 41.15 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.408 0.683 . . . . 0.0 110.67 172.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.3 tp -84.22 121.14 27.07 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.336 0.588 . . . . 0.0 111.542 175.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -89.43 -48.21 7.49 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 164.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.56 -87.05 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 CA-C-N 119.177 0.899 . . . . 0.0 110.988 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -82.17 -4.32 56.75 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 156.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.98 138.15 43.69 Favored 'General case' 0 CA--C 1.57 1.714 0 C-N-CA 125.183 1.393 . . . . 0.0 111.69 174.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mt -130.12 124.56 33.0 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 169.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.15 119.4 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.17 -0.956 . . . . 0.0 110.377 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.22 108.78 3.12 Favored Glycine 0 N--CA 1.486 1.99 0 C-N-CA 123.587 0.613 . . . . 0.0 112.972 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.57 94.12 7.57 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.2 0.6 . . . . 0.0 110.652 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.94 142.13 41.73 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -170.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -124.72 138.3 54.29 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.305 1.042 . . . . 0.0 108.194 174.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.79 107.94 9.47 Favored 'General case' 0 CA--C 1.568 1.672 0 O-C-N 120.817 -1.177 . . . . 0.0 113.67 -168.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.6 p -78.11 69.75 4.37 Favored 'General case' 0 N--CA 1.506 2.342 0 CA-C-O 124.067 1.889 . . . . 0.0 112.442 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.8 t70 169.15 -51.89 0.01 OUTLIER 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 113.028 -1.896 . . . . 0.0 109.047 -148.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -142.12 -5.48 0.99 Allowed 'General case' 0 CA--C 1.582 2.18 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.4 -40.39 2.94 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 118.501 2.16 . . . . 0.0 118.501 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -60.6 149.69 34.1 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -165.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.12 127.74 32.98 Favored 'General case' 0 CA--C 1.565 1.545 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -169.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.1 tt -119.74 115.29 23.61 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 124.524 1.13 . . . . 0.0 108.296 174.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -101.97 118.23 36.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.037 -1.039 . . . . 0.0 110.902 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.2 m -100.28 111.07 23.32 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 73.9 t -97.72 108.59 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -95.44 129.41 42.61 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.419 0.688 . . . . 0.0 110.791 170.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -145.33 137.42 25.66 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.854 -0.529 . . . . 0.0 111.216 172.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.4 mp -87.6 109.35 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 173.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.253 11.3 tp -92.35 74.14 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 122.221 1.01 . . . . 0.0 110.378 168.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.72 -98.11 0.67 Allowed Glycine 0 N--CA 1.489 2.216 0 O-C-N 121.09 -1.006 . . . . 0.0 115.481 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -87.85 -2.14 58.42 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 174.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -132.2 125.9 32.27 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 119.585 1.084 . . . . 0.0 110.586 -168.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.3 tp -83.13 114.98 21.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.48 -0.763 . . . . 0.0 109.643 168.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.9 m -92.49 105.12 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -101.39 98.96 9.26 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.8 m -102.21 118.15 36.27 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.668 0.787 . . . . 0.0 110.397 -169.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -100.23 107.21 18.99 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.715 0.806 . . . . 0.0 110.888 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.2 t -106.33 107.83 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -118.34 118.94 33.15 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.184 0.593 . . . . 0.0 110.624 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.328 51.9 mt-10 66.2 -81.91 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 124.677 1.191 . . . . 0.0 113.43 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -146.69 45.76 0.77 Allowed Glycine 0 N--CA 1.489 2.21 0 CA-C-O 119.233 -0.76 . . . . 0.0 114.941 158.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.7 t -135.49 117.15 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -100.95 124.12 46.17 Favored 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 123.655 0.782 . . . . 0.0 111.845 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.81 120.01 37.87 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.057 0.543 . . . . 0.0 112.029 170.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -98.63 101.73 13.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.705 -0.622 . . . . 0.0 110.845 -176.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -84.18 111.31 19.24 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 121.072 0.463 . . . . 0.0 110.272 169.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 95.9 mt -90.6 117.45 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -106.57 120.54 42.21 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.4 0.68 . . . . 0.0 109.732 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -84.84 143.32 29.15 Favored 'General case' 0 CA--C 1.566 1.581 0 O-C-N 121.674 -0.641 . . . . 0.0 111.831 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -62.9 105.41 0.67 Allowed 'General case' 0 CA--C 1.572 1.805 0 O-C-N 121.465 -0.772 . . . . 0.0 112.905 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 N--CA 1.493 1.706 0 C-N-CA 124.763 1.225 . . . . 0.0 113.462 -170.95 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 . . . . . 0 N--CA 1.5 2.052 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -152.64 74.01 1.04 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.996 -1.065 . . . . 0.0 112.338 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.0 p -159.1 -179.01 7.63 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.181 0.991 . . . . 0.0 113.416 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.2 m -86.92 119.67 27.38 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.873 0.869 . . . . 0.0 110.131 172.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -120.71 98.22 5.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.654 -0.654 . . . . 0.0 109.961 -173.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -88.58 138.35 31.5 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.333 -0.854 . . . . 0.0 112.168 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.43 125.13 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -95.46 -52.71 4.03 Favored 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 124.647 1.179 . . . . 0.0 112.841 172.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.8 ptt85 -159.7 128.75 5.17 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 120.041 1.291 . . . . 0.0 112.131 -168.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.6 p -97.09 101.82 13.47 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.829 0.852 . . . . 0.0 112.135 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -97.17 112.36 24.18 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.837 -0.54 . . . . 0.0 109.99 -166.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.266 41.9 t30 62.02 24.39 14.51 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -170.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -74.78 -32.97 62.18 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -172.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -53.04 -42.01 65.34 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 164.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -64.17 -47.64 79.08 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 173.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -52.08 -54.04 35.06 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 166.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.45 ' HB3' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -63.36 -34.43 77.7 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 171.059 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -58.85 -48.53 81.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.272 -1.518 . . . . 0.0 114.559 165.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -55.16 -34.64 63.98 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 166.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.3 mmt -68.31 -37.33 80.49 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 168.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.39 56.4 0.69 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 115.983 1.153 . . . . 0.0 115.983 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 p -124.83 156.31 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-O 122.348 1.07 . . . . 0.0 111.789 173.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -66.09 157.79 30.19 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.288 12.4 tt -58.72 -38.95 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -64.2 -55.38 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.181 0.9 . . . . 0.0 112.708 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -57.76 -30.12 65.37 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 167.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.45 ' HG3' ' HB3' ' A' ' 18' ' ' MET . 6.3 mtp180 -60.19 -55.73 30.22 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 167.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -61.05 -37.78 83.86 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.7 mt -61.15 -48.52 81.2 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 164.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.36 -41.0 75.44 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 171.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.02 -47.95 74.03 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 164.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -114.99 36.84 3.69 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -79.67 43.82 0.59 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.338 20.0 p30 36.74 37.19 0.06 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 119.956 3.317 . . . . 0.0 119.956 -174.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 tt -75.51 115.22 14.95 Favored 'General case' 0 CA--C 1.558 1.256 0 O-C-N 120.91 -1.119 . . . . 0.0 112.844 -158.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -106.31 110.63 22.92 Favored 'General case' 0 CA--C 1.558 1.26 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.036 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.7 mt -86.65 97.05 10.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 169.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 86.5 m -86.45 92.49 8.86 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.9 mt -87.57 120.88 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 -174.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.9 p -122.95 108.22 12.71 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -84.87 130.55 34.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.542 -0.724 . . . . 0.0 111.652 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -135.88 68.54 1.45 Allowed 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.198 0.599 . . . . 0.0 110.742 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.65 76.31 0.25 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 116.79 1.476 . . . . 0.0 116.79 176.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.321 8.0 m120 73.03 -37.64 0.39 Allowed 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -170.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -67.06 135.07 53.09 Favored 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 119.701 1.137 . . . . 0.0 112.989 162.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -121.51 115.08 22.18 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 168.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.3 m -94.96 103.37 15.22 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 172.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 52.9 t -110.85 110.85 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -171.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -86.1 90.18 8.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.766 -0.583 . . . . 0.0 110.258 176.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -73.14 95.62 2.1 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.034 0.934 . . . . 0.0 110.51 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.1 m -109.3 97.14 6.79 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -161.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.3 p -127.79 163.27 24.73 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.924 0.868 . . . . 0.0 113.255 -170.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.15 -23.23 63.75 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 166.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -77.65 -53.92 6.99 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 119.555 1.071 . . . . 0.0 113.339 165.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -156.0 151.71 27.24 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 119.74 1.155 . . . . 0.0 112.264 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -109.31 108.77 19.46 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.508 0.723 . . . . 0.0 110.357 170.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 pp -135.83 145.25 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-O 121.646 0.736 . . . . 0.0 111.874 -171.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -97.29 115.45 27.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -0.978 . . . . 0.0 111.545 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.83 103.25 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.33 101.47 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 173.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -119.63 136.26 54.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.861 -0.524 . . . . 0.0 112.374 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -92.81 144.02 25.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.692 -0.63 . . . . 0.0 110.716 164.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.94 115.58 3.82 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.77 -15.76 59.81 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 119.698 2.639 . . . . 0.0 119.698 -172.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.8 t -85.25 111.64 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.678 2.239 . . . . 0.0 108.684 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.261 7.4 t -78.78 124.32 28.09 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -165.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -134.4 163.71 29.06 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 124.071 0.949 . . . . 0.0 112.396 -170.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -85.41 109.39 18.4 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 121.865 0.84 . . . . 0.0 112.194 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -93.55 165.97 12.48 Favored 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 124.9 1.28 . . . . 0.0 112.256 172.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.252 0.6 OUTLIER -139.28 155.96 47.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.612 -1.305 . . . . 0.0 113.196 166.096 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.9 mt -86.56 51.35 2.21 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 175.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.285 . . 62.41 -50.51 0.17 Allowed 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 118.472 2.767 . . . . 0.0 118.472 -168.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.9 p30 -78.07 -78.63 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -175.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.4 72.52 0.09 OUTLIER Glycine 0 N--CA 1.481 1.693 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 -170.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.4 m -145.46 105.91 4.08 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.64 112.98 20.02 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-O 121.424 0.63 . . . . 0.0 111.843 -173.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 70.9 mt -118.26 107.74 14.27 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.181 0.592 . . . . 0.0 111.112 -167.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.2 ttm-85 -88.85 121.14 30.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 111.113 174.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.01 -154.57 11.71 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.3 p -144.48 138.06 27.36 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 123.196 0.599 . . . . 0.0 110.627 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -88.0 120.07 28.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.693 -0.629 . . . . 0.0 109.866 163.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.2 t -115.62 124.6 51.34 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.176 0.59 . . . . 0.0 111.109 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.3 tp -84.61 104.92 15.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.471 -0.768 . . . . 0.0 111.586 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -105.16 78.87 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.507 0.67 . . . . 0.0 109.907 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.59 -102.02 1.25 Allowed Glycine 0 N--CA 1.49 2.285 0 O-C-N 121.547 -0.72 . . . . 0.0 114.023 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -112.51 45.39 1.31 Allowed 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 167.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -139.3 115.13 10.11 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.285 -0.884 . . . . 0.0 109.039 173.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.1 mt -86.19 104.64 15.93 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 166.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.0 mt -99.85 110.57 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -172.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.18 94.62 2.01 Favored Glycine 0 N--CA 1.481 1.646 0 C-N-CA 123.47 0.557 . . . . 0.0 112.553 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -86.91 98.86 11.46 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -119.78 142.8 48.25 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.518 0.727 . . . . 0.0 112.337 -168.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -122.71 137.43 54.92 Favored 'General case' 0 CA--C 1.563 1.456 0 O-C-N 121.471 -0.768 . . . . 0.0 109.997 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -64.89 118.05 8.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.192 -0.943 . . . . 0.0 113.182 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.7 p -76.84 67.89 2.96 Favored 'General case' 0 N--CA 1.508 2.439 0 CA-C-O 122.318 1.056 . . . . 0.0 110.623 169.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -178.43 -68.05 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -159.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -98.37 -35.92 10.14 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.075 1.879 . . . . 0.0 116.075 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.72 6.21 76.94 Favored Glycine 0 CA--C 1.558 2.737 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 -150.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -82.74 134.44 35.13 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 119.599 1.699 . . . . 0.0 112.885 -175.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -90.15 133.89 34.61 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -172.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.79 122.18 35.46 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 125.211 1.404 . . . . 0.0 108.878 -176.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -100.31 109.67 21.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.102 -0.999 . . . . 0.0 109.342 172.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.8 m -99.91 99.86 10.7 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 119.353 0.979 . . . . 0.0 109.757 172.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 80.2 t -88.31 105.04 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.019 -1.051 . . . . 0.0 108.549 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -79.48 112.89 17.18 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.339 0.656 . . . . 0.0 110.115 163.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -137.28 147.41 45.67 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.489 0.662 . . . . 0.0 109.935 171.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.77 139.1 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.008 0 O-C-N 120.776 -1.202 . . . . 0.0 109.922 167.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.5 tt -119.36 89.97 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.804 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 162.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 68.68 -99.01 0.56 Allowed Glycine 0 N--CA 1.492 2.391 0 O-C-N 120.948 -1.095 . . . . 0.0 115.529 -176.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -95.21 -3.17 48.18 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 170.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -123.4 129.69 51.64 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 119.464 1.029 . . . . 0.0 111.48 -164.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.4 tp -82.89 114.59 21.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.288 170.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.0 m -82.47 126.06 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 166.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -99.16 101.02 12.22 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 157.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.5 m -90.16 108.31 19.67 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -102.8 99.67 9.63 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.456 0.703 . . . . 0.0 110.855 -170.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 t -99.43 114.17 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -134.63 109.74 8.84 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.041 0.536 . . . . 0.0 110.853 -174.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.287 24.4 mm-40 68.17 -79.52 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 172.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -142.54 58.95 0.55 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 123.212 0.434 . . . . 0.0 113.091 167.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.18 154.79 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 123.756 0.822 . . . . 0.0 109.852 -174.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.255 0.0 OUTLIER -144.47 136.91 26.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.11 -0.994 . . . . 0.0 112.949 161.72 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.56 145.44 51.72 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.53 0.732 . . . . 0.0 112.204 174.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -120.04 98.22 5.98 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . 0.297 6.1 ptm180 -88.76 123.52 33.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.755 -1.216 . . . . 0.0 110.414 170.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.5 mt -109.82 131.31 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -161.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -119.31 127.1 52.88 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.365 0.666 . . . . 0.0 110.339 -175.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -83.48 144.06 29.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.238 -0.914 . . . . 0.0 112.499 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.6 tttt -69.27 122.11 18.2 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 121.683 0.754 . . . . 0.0 112.464 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.2 t70 . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -162.281 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -83.66 82.59 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.537 -1.352 . . . . 0.0 112.801 -165.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.8 t -162.6 -178.15 6.04 Favored 'General case' 0 CA--C 1.574 1.894 0 CA-C-O 123.004 1.383 . . . . 0.0 112.808 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.9 m -97.21 121.54 39.21 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.968 0.907 . . . . 0.0 109.451 169.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.461 ' CH2' HD11 ' A' ' 108' ' ' ILE . 98.9 m95 -118.72 112.02 19.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.709 -0.62 . . . . 0.0 110.644 -167.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -98.35 131.23 44.82 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 118.762 0.71 . . . . 0.0 112.167 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 p -66.92 120.9 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.336 -0.852 . . . . 0.0 113.249 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -100.81 -55.97 2.44 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -143.57 122.24 12.57 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 119.61 1.096 . . . . 0.0 112.246 -173.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.9 p -99.77 122.61 43.0 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.804 0.842 . . . . 0.0 111.936 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -76.36 -38.2 56.18 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -172.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -116.06 -78.51 0.58 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 119.269 0.94 . . . . 0.0 109.595 170.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.289 0.5 OUTLIER 47.45 35.11 3.82 Favored 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 118.427 2.751 . . . . 0.0 118.427 -175.745 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -150.0 -53.5 0.15 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.182 0.993 . . . . 0.0 111.095 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -66.33 -40.76 90.1 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 120.534 1.516 . . . . 0.0 114.095 164.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -45.62 -58.43 3.43 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 157.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.3 mtp -64.16 -38.18 90.13 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -60.45 -42.7 96.69 Favored 'General case' 0 CA--C 1.574 1.893 0 O-C-N 120.16 -1.588 . . . . 0.0 114.951 166.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -66.27 -28.84 69.02 Favored 'General case' 0 CA--C 1.579 2.076 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 168.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 mtm -59.81 -34.66 73.36 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 158.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.02 45.07 1.8 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 115.829 1.092 . . . . 0.0 115.829 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.1 m -127.21 147.65 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 118.837 1.318 . . . . 0.0 112.987 -173.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -72.26 162.41 29.5 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -175.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.256 0.2 OUTLIER -48.21 -44.61 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 168.818 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.4 t -54.89 -50.66 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 170.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -63.45 -40.78 98.04 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 169.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -57.02 -47.87 79.84 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 169.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.286 0.0 OUTLIER -64.88 -39.59 93.77 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 168.784 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.79 -53.77 14.16 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 176.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.4 -13.24 60.7 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 175.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.73 -54.58 8.57 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 120.328 1.422 . . . . 0.0 114.367 155.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -85.82 62.81 7.68 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.799 1.181 . . . . 0.0 112.765 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.5 p30 -121.3 9.04 10.31 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 -178.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.347 1.7 p-10 52.66 58.86 4.93 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 177.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.9 tp -75.45 118.97 18.9 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -116.63 114.4 24.04 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.342 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.7 mt -95.08 109.67 21.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.55 -0.719 . . . . 0.0 109.621 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.1 m -90.88 98.57 11.86 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.269 -0.894 . . . . 0.0 108.643 169.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.3 mt -101.47 124.61 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -146.85 135.11 21.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.404 -0.81 . . . . 0.0 112.555 166.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -86.12 145.65 26.94 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 171.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.42 88.05 1.41 Allowed 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 124.818 1.247 . . . . 0.0 109.173 -175.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.81 61.02 4.91 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 117.373 1.709 . . . . 0.0 117.373 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.6 t30 62.82 -4.53 0.24 Allowed 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 118.183 2.66 . . . . 0.0 118.183 -166.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -110.25 130.97 55.45 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.916 1.287 . . . . 0.0 110.113 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -99.63 118.33 35.93 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.507 -0.746 . . . . 0.0 110.491 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.5 m -86.47 114.24 23.06 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 166.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.4 t -122.12 99.4 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -87.12 114.15 23.47 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.317 0.58 . . . . 0.0 110.039 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -107.79 80.92 1.44 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.325 0.583 . . . . 0.0 110.515 -165.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 m -90.46 113.85 25.88 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-O 121.929 0.871 . . . . 0.0 112.205 -172.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.1 p -139.3 167.12 22.79 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.37 1.068 . . . . 0.0 109.305 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.3 57.2 0.24 Allowed 'General case' 0 CA--C 1.578 2.057 0 O-C-N 120.233 -1.542 . . . . 0.0 113.889 159.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -176.68 -57.93 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 125.303 1.441 . . . . 0.0 110.847 -170.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -96.35 -81.33 0.41 Allowed 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 119.974 1.261 . . . . 0.0 112.679 -174.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.284 68.1 m-80 53.59 65.15 1.6 Allowed 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -160.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.2 pt -122.48 121.73 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.871 -0.518 . . . . 0.0 110.031 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.01 94.57 8.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.35 -0.844 . . . . 0.0 111.347 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.2 t -98.46 114.2 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -170.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.46 97.72 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -112.52 137.87 50.11 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.302 0.641 . . . . 0.0 112.507 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -80.48 147.27 30.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.962 . . . . 0.0 112.668 169.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 70.6 mt -66.1 109.18 2.5 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.36 47.33 5.77 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 117.05 1.58 . . . . 0.0 117.05 -173.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.45 138.22 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 118.349 1.075 . . . . 0.0 110.1 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.0 m -84.36 102.8 13.0 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.437 -0.789 . . . . 0.0 109.756 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -127.15 162.53 25.91 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.289 1.042 . . . . 0.0 113.227 -172.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -86.5 121.84 29.6 Favored 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 123.669 0.788 . . . . 0.0 111.658 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -128.21 117.96 22.47 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.551 0.74 . . . . 0.0 110.816 -174.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -98.92 121.25 40.63 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.207 -0.933 . . . . 0.0 111.997 -174.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.7 mt -73.5 166.42 23.26 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.99 52.94 0.57 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 117.522 2.416 . . . . 0.0 117.522 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -163.62 -67.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.427 1.091 . . . . 0.0 109.471 168.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.87 73.59 0.05 OUTLIER Glycine 0 N--CA 1.481 1.677 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.8 m -155.68 121.37 4.98 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.52 -0.988 . . . . 0.0 109.948 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -94.44 125.89 39.37 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 122.457 1.122 . . . . 0.0 111.503 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 50.7 mt -106.55 150.16 26.43 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.299 1.04 . . . . 0.0 112.103 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.8 116.95 20.27 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.31 -161.73 35.11 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 117.551 1.781 . . . . 0.0 117.551 -175.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 71.4 p -124.88 123.67 40.43 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.919 -0.64 . . . . 0.0 111.712 -156.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -83.43 115.41 22.03 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 118.569 0.622 . . . . 0.0 110.158 158.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.8 m -115.47 132.77 56.52 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.243 0.617 . . . . 0.0 111.757 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.0 tp -87.44 109.29 19.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.378 -0.826 . . . . 0.0 112.324 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -101.76 81.34 2.13 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.551 0.691 . . . . 0.0 109.776 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.47 -94.16 0.93 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 114.795 0.678 . . . . 0.0 114.795 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -121.73 52.67 1.24 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.637 0.732 . . . . 0.0 111.485 165.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -146.86 112.4 5.61 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.8 mt -89.64 104.14 16.72 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 171.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.2 tt -94.82 118.19 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.641 -0.662 . . . . 0.0 110.21 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.83 97.85 2.32 Favored Glycine 0 N--CA 1.481 1.636 0 C-N-CA 123.411 0.529 . . . . 0.0 112.348 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -92.58 98.87 11.71 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.312 0.645 . . . . 0.0 109.609 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -123.18 134.28 54.18 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.527 0.731 . . . . 0.0 111.527 -170.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -110.81 157.08 20.21 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.498 1.142 . . . . 0.0 111.241 165.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -107.77 120.22 41.63 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.955 -1.091 . . . . 0.0 112.04 -161.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.5 t -68.0 -11.82 59.62 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 169.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -86.46 -50.68 6.7 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 119.459 1.027 . . . . 0.0 113.3 172.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.87 27.97 2.17 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 120.885 1.675 . . . . 0.0 115.405 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.76 -57.11 2.6 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 118.287 2.075 . . . . 0.0 118.287 176.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -48.46 124.95 8.85 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.833 2.053 . . . . 0.0 114.997 -168.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -67.18 145.47 55.21 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -171.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.3 tp -104.68 115.0 29.57 Favored 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 162.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -94.5 104.0 15.96 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 168.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.8 m -104.63 100.38 10.04 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.758 -0.588 . . . . 0.0 109.79 -177.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.9 t -91.63 104.65 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 120.897 -1.127 . . . . 0.0 108.812 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -82.02 115.78 21.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.883 -0.511 . . . . 0.0 109.852 164.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.79 144.76 34.11 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.037 0.535 . . . . 0.0 111.482 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.461 HD11 ' CH2' ' A' ' 6' ' ' TRP . 1.0 OUTLIER -85.72 124.75 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.291 -0.881 . . . . 0.0 111.223 177.857 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.255 10.9 tp -98.77 79.15 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.151 0.977 . . . . 0.0 108.986 166.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.75 -104.58 1.49 Allowed Glycine 0 N--CA 1.488 2.117 0 O-C-N 121.444 -0.785 . . . . 0.0 114.247 -171.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.26 0.71 57.47 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 117.576 2.435 . . . . 0.0 117.576 172.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -122.41 135.82 54.77 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.192 1.36 . . . . 0.0 110.959 -170.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.0 tp -90.62 119.7 31.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 111.012 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.9 p -102.58 120.34 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.136 -0.978 . . . . 0.0 110.647 172.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -89.99 115.44 27.28 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 122.967 0.507 . . . . 0.0 109.883 166.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.2 m -96.86 100.23 11.77 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.229 0.611 . . . . 0.0 109.626 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -88.07 112.4 22.61 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.434 0.694 . . . . 0.0 110.757 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.1 t -113.4 100.35 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -92.92 119.33 32.1 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.285 0.8 OUTLIER 66.07 -85.81 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 119.258 0.936 . . . . 0.0 111.648 -176.83 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.97 20.71 3.59 Favored Glycine 0 CA--C 1.558 2.749 0 N-CA-C 117.853 1.901 . . . . 0.0 117.853 151.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -92.3 115.79 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 121.496 2.648 . . . . 0.0 111.483 -174.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -89.22 126.23 35.41 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -127.8 106.08 8.88 Favored 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 123.502 0.721 . . . . 0.0 110.781 169.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.73 130.32 37.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 111.147 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -123.69 122.51 38.28 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.5 -0.75 . . . . 0.0 111.934 171.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.5 mt -94.23 124.56 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -174.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -104.55 133.22 49.77 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.392 1.077 . . . . 0.0 110.634 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -88.96 147.75 24.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.055 0.931 . . . . 0.0 112.304 171.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -75.19 118.36 18.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.639 -0.663 . . . . 0.0 111.821 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.1 t70 . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -165.925 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 118.888 -0.577 . . . . 0.0 111.693 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 t70 40.62 51.19 2.98 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 166.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.5 p -165.35 171.0 13.98 Favored 'General case' 0 CA--C 1.569 1.71 0 CA-C-O 122.432 1.111 . . . . 0.0 112.557 -168.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.4 m -89.4 133.92 34.31 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.04 -1.038 . . . . 0.0 111.413 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -138.37 107.82 6.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.801 -0.562 . . . . 0.0 109.927 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -97.26 133.16 42.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.11 -0.994 . . . . 0.0 112.682 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 p -62.41 117.96 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.213 -0.93 . . . . 0.0 113.411 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -102.17 -45.11 5.24 Favored 'General case' 0 CA--C 1.568 1.649 0 C-N-CA 123.961 0.904 . . . . 0.0 113.384 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -152.62 160.46 43.19 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.154 0.982 . . . . 0.0 110.968 -174.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.3 p -146.72 143.72 28.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.37 -1.456 . . . . 0.0 112.871 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -85.83 -51.38 6.44 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -137.93 53.57 1.83 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 119.834 1.197 . . . . 0.0 112.772 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -83.61 63.86 7.63 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 119.628 -1.92 . . . . 0.0 112.205 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -163.85 -57.72 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.529 1.132 . . . . 0.0 110.981 -171.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -81.96 -26.06 34.29 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -51.87 -54.38 29.88 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-N 121.791 2.087 . . . . 0.0 113.778 153.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.702 ' SD ' HG11 ' A' ' 23' ' ' VAL . 0.8 OUTLIER -51.86 -47.97 64.22 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 169.019 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -66.02 -38.83 89.42 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 170.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.0 tptp -60.14 -40.39 89.66 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 168.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.5 mtp -62.69 -52.92 61.38 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 165.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.55 59.44 0.06 OUTLIER Glycine 0 N--CA 1.487 2.042 0 CA-C-O 119.522 -0.599 . . . . 0.0 114.338 166.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.702 HG11 ' SD ' ' A' ' 18' ' ' MET . 2.8 m -103.82 147.47 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.857 0.837 . . . . 0.0 111.727 -177.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -74.28 169.03 18.45 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 168.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.267 0.2 OUTLIER -54.61 -44.34 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 176.521 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.49 -48.65 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-N 119.395 0.998 . . . . 0.0 112.996 172.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -54.38 -39.69 67.46 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 166.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -46.14 91.8 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 167.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -59.62 -48.81 80.21 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 166.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.7 mt -57.4 -39.76 76.81 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 169.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.04 -54.3 46.54 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 168.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.42 -38.14 41.56 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 167.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -95.17 19.9 9.92 Favored 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 172.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.305 28.0 p30 -72.97 -24.53 60.8 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 118.164 2.653 . . . . 0.0 118.164 -173.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 57.2 54.86 6.39 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 173.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.1 tp -79.77 122.52 26.71 Favored 'General case' 0 CA--C 1.563 1.445 0 CA-C-O 121.963 0.887 . . . . 0.0 112.345 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -105.48 106.22 16.62 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.871 169.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.39 100.11 7.47 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.38 0.609 . . . . 0.0 109.583 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.7 m -102.04 96.84 7.28 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -173.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.1 mt -95.38 131.81 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -164.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.2 m -141.04 108.55 5.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.577 -1.327 . . . . 0.0 107.693 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -100.64 139.2 36.66 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.94 0.876 . . . . 0.0 112.485 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -99.78 70.75 1.65 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 122.166 0.984 . . . . 0.0 110.139 164.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.88 -99.99 0.73 Allowed Glycine 0 N--CA 1.488 2.136 0 O-C-N 121.565 -0.71 . . . . 0.0 114.742 -170.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -84.47 -26.84 27.89 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -90.17 117.45 28.94 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.58 1.536 . . . . 0.0 111.101 177.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -99.48 117.33 33.64 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.374 1.07 . . . . 0.0 109.812 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.4 m -90.91 103.19 15.94 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 166.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -99.85 104.06 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -77.43 105.25 8.44 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.935 0.874 . . . . 0.0 109.991 172.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -92.4 91.47 7.67 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.099 0.96 . . . . 0.0 109.303 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.3 t -97.03 111.97 23.95 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.89 0.476 . . . . 0.0 111.336 -173.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.5 p -144.45 165.3 28.35 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -172.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.18 -23.17 67.22 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 117.611 2.449 . . . . 0.0 117.611 165.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -68.7 -52.01 35.54 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 120.367 1.44 . . . . 0.0 113.981 159.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -165.98 152.82 9.7 Favored 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 123.591 0.756 . . . . 0.0 112.144 -167.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -118.28 99.16 6.67 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 pp -136.41 143.19 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 O-C-N 121.747 -0.595 . . . . 0.0 111.994 -171.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -93.82 125.21 38.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.922 -1.111 . . . . 0.0 112.791 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.0 t -102.03 104.87 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.65 108.8 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -133.12 130.85 39.79 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.388 0.613 . . . . 0.0 112.537 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -66.98 140.5 57.73 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 111.835 157.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.8 mt -54.43 123.08 11.9 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 166.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.85 -5.96 83.13 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 119.189 2.436 . . . . 0.0 119.189 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 p -82.75 137.14 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-N 120.616 2.208 . . . . 0.0 112.748 -172.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.8 m -91.45 95.87 10.2 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.41 -0.806 . . . . 0.0 109.934 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -122.18 150.75 41.81 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -170.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -86.03 98.35 10.8 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 124.448 1.099 . . . . 0.0 113.872 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -89.98 118.6 29.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.5 -0.75 . . . . 0.0 110.966 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -72.26 108.47 5.42 Favored 'General case' 0 CA--C 1.569 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 113.114 171.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -78.21 139.79 38.94 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.914 0.886 . . . . 0.0 111.09 177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.32 66.94 0.31 Allowed 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -168.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -166.45 -66.2 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 125.779 1.632 . . . . 0.0 108.505 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.58 68.38 0.05 OUTLIER Glycine 0 N--CA 1.481 1.672 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.6 m -160.65 119.88 2.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.614 -0.933 . . . . 0.0 109.587 -177.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -88.1 113.89 24.18 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.886 0.85 . . . . 0.0 111.081 167.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 70.9 mt -93.78 109.56 21.23 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 124.325 1.05 . . . . 0.0 110.615 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 58.8 ttp85 -88.85 117.18 27.66 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.875 -0.516 . . . . 0.0 110.714 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.41 179.36 48.87 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 118.983 2.353 . . . . 0.0 118.983 -171.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.3 p -122.12 123.11 40.79 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 113.483 -1.358 . . . . 0.0 111.297 -166.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -81.92 107.56 14.74 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 118.476 0.58 . . . . 0.0 110.194 160.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 72.9 m -102.68 131.6 49.37 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.046 0.539 . . . . 0.0 111.101 176.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.9 tp -82.3 106.17 13.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.158 -0.964 . . . . 0.0 110.744 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -82.32 -49.45 10.02 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.07 -95.67 0.21 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 164.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -98.97 59.29 1.17 Allowed 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.869 0.842 . . . . 0.0 110.326 152.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -149.17 116.42 6.09 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.54 103.72 16.34 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 167.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.8 tt -90.08 111.5 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.368 -0.833 . . . . 0.0 110.1 177.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.07 98.09 2.34 Favored Glycine 0 N--CA 1.482 1.707 0 C-N-CA 123.843 0.735 . . . . 0.0 113.072 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -93.32 96.34 9.9 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -117.46 147.27 42.87 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.731 0.777 . . . . 0.0 112.533 -168.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -127.0 138.52 53.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.404 -0.81 . . . . 0.0 110.851 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -71.04 115.07 9.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 0.0 113.133 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 73.8 p -80.49 62.96 4.77 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 123.514 1.626 . . . . 0.0 112.384 170.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -174.05 -65.03 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.732 0 C-N-CA 126.236 1.815 . . . . 0.0 107.005 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -94.33 -18.24 21.8 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.05 -15.68 47.24 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 119.148 2.419 . . . . 0.0 119.148 -172.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -84.18 152.76 24.06 Favored 'General case' 0 CA--C 1.566 1.559 0 CA-C-N 118.529 1.165 . . . . 0.0 113.79 -169.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -94.4 130.27 40.8 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-O 122.114 0.959 . . . . 0.0 112.835 -168.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.0 tt -110.66 122.51 47.96 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 124.48 1.112 . . . . 0.0 109.406 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -111.51 111.67 22.86 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.2 m -108.36 100.2 9.52 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 119.441 1.019 . . . . 0.0 110.203 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.8 t -91.38 107.46 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.128 -0.983 . . . . 0.0 108.827 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -103.82 105.3 15.46 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 123.4 0.68 . . . . 0.0 110.598 -173.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -143.48 148.82 36.65 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -169.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.56 120.95 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.17 -1.581 . . . . 0.0 109.672 175.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.5 mm -101.1 88.95 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 167.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.91 -88.14 0.56 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 115.769 1.067 . . . . 0.0 115.769 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -111.0 0.31 16.94 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 173.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -129.67 127.21 40.06 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.953 1.251 . . . . 0.0 110.744 -169.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.1 tp -74.63 115.24 13.98 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.961 0.904 . . . . 0.0 110.519 171.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.0 m -103.72 119.09 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.301 -0.874 . . . . 0.0 109.583 -176.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -88.8 107.38 18.94 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 118.844 0.747 . . . . 0.0 109.842 165.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.7 m -92.35 96.32 10.2 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -87.61 106.48 18.04 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.508 0.723 . . . . 0.0 111.05 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.6 t -106.77 104.35 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -117.48 118.17 31.44 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.885 0.474 . . . . 0.0 109.781 172.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 51.4 49.68 20.47 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.0 -24.79 4.42 Favored Glycine 0 CA--C 1.554 2.507 0 N-CA-C 119.264 2.466 . . . . 0.0 119.264 -169.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.7 t -86.65 105.27 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 120.104 1.952 . . . . 0.0 109.633 -168.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -87.98 124.76 34.05 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 123.314 0.646 . . . . 0.0 112.52 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -124.66 109.85 13.67 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.554 0.742 . . . . 0.0 111.518 173.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.54 108.77 20.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.786 -0.571 . . . . 0.0 110.092 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -111.66 129.44 56.09 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.387 1.089 . . . . 0.0 111.436 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.9 mt -121.66 119.15 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -146.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -112.49 119.79 39.41 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.337 0.655 . . . . 0.0 110.418 -168.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -81.01 147.34 30.24 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 123.507 0.723 . . . . 0.0 112.781 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -58.87 118.94 6.32 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 t70 . . . . . 0 N--CA 1.488 1.464 0 C-N-CA 125.01 1.324 . . . . 0.0 112.444 -172.608 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.364 89.8 m-85 . . . . . 0 N--CA 1.495 1.792 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -77.4 80.13 3.9 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 120.537 1.517 . . . . 0.0 112.669 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.9 t -163.78 178.15 8.08 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 122.443 1.116 . . . . 0.0 112.077 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.9 m -92.2 122.41 34.66 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.459 1.104 . . . . 0.0 110.297 170.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -123.65 108.72 12.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.813 -0.555 . . . . 0.0 109.958 -171.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -97.23 139.59 32.96 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.065 -1.022 . . . . 0.0 112.707 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -60.38 119.7 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -109.19 -51.11 2.92 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.767 0.827 . . . . 0.0 113.099 -173.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -148.57 109.57 4.3 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 119.222 0.919 . . . . 0.0 109.741 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.6 p -109.18 115.01 29.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.381 -0.824 . . . . 0.0 113.056 -174.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -98.69 123.07 42.67 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 123.327 0.651 . . . . 0.0 110.656 -169.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.261 9.4 t30 67.83 18.6 9.67 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -69.74 -43.09 73.0 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -173.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.87 -34.24 75.64 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 169.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -70.79 -47.2 60.79 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -43.1 -53.26 5.02 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 158.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 15.7 mtt -67.3 -25.87 66.25 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 174.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -60.7 -43.24 98.01 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-N 121.345 1.884 . . . . 0.0 114.625 163.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -59.03 -34.63 72.13 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 162.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 76.7 mmm -62.67 -30.31 71.29 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 116.929 2.196 . . . . 0.0 116.929 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.0 53.95 1.07 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 115.157 0.823 . . . . 0.0 115.157 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.31 142.53 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 122.671 1.224 . . . . 0.0 112.063 -175.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -70.24 172.08 8.76 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.275 13.2 tt -60.58 -40.73 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 176.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.6 t -61.61 -52.16 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-N 120.402 1.456 . . . . 0.0 112.913 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -55.3 -43.79 75.16 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 168.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -64.47 -42.22 96.05 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 171.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -58.36 -46.35 86.46 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 120.143 1.338 . . . . 0.0 114.554 167.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.9 mt -60.48 -40.94 93.11 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 165.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.69 95.0 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 172.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.96 -57.41 11.8 Favored 'General case' 0 CA--C 1.566 1.596 0 O-C-N 120.804 -1.185 . . . . 0.0 113.681 164.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -84.3 53.01 2.49 Favored 'General case' 0 CA--C 1.577 2.006 0 CA-C-N 119.716 1.144 . . . . 0.0 113.81 174.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -85.89 -29.51 23.6 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -174.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 62.05 50.22 4.17 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -84.02 121.75 27.83 Favored 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 122.42 1.105 . . . . 0.0 112.014 -175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -111.34 117.29 32.71 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.479 174.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.7 mt -101.44 102.59 13.41 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.0 m -94.46 105.04 17.0 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.309 -0.87 . . . . 0.0 109.649 172.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.6 mt -94.83 131.29 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 85.8 m -145.41 128.46 16.55 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.262 -1.524 . . . . 0.0 110.147 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -111.07 139.89 46.06 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -170.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -138.21 89.97 2.44 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.672 0.789 . . . . 0.0 109.825 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.21 68.18 1.81 Allowed Glycine 0 N--CA 1.497 2.711 0 N-CA-C 116.731 1.452 . . . . 0.0 116.731 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.291 46.7 m-20 67.62 -23.79 0.12 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 118.019 2.6 . . . . 0.0 118.019 -166.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -83.19 100.8 10.8 Favored 'General case' 0 CA--C 1.565 1.552 0 CA-C-N 121.151 1.796 . . . . 0.0 110.901 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -93.36 117.62 30.3 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.029 0.931 . . . . 0.0 109.504 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.0 m -92.75 104.14 16.44 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 p -94.69 109.83 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.699 0.762 . . . . 0.0 109.974 170.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -88.55 111.67 22.13 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -101.93 92.07 4.64 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.441 0.696 . . . . 0.0 110.712 -169.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.1 m -103.37 117.05 33.6 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.106 0.562 . . . . 0.0 111.003 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 p -147.77 -177.3 5.64 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.84 40.73 0.06 Allowed 'General case' 0 CA--C 1.583 2.246 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 166.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -144.2 -62.59 0.38 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 126.519 1.927 . . . . 0.0 108.566 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.64 167.48 28.78 Favored 'General case' 0 CA--C 1.572 1.825 0 C-N-CA 124.122 0.969 . . . . 0.0 111.141 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -121.07 102.8 8.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.328 -0.858 . . . . 0.0 109.46 164.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.33 144.22 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.527 -0.733 . . . . 0.0 112.019 -172.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -94.91 119.65 33.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.339 -0.85 . . . . 0.0 112.58 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.4 t -98.94 104.03 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.8 t -91.87 103.2 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -113.54 123.52 50.18 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.308 0.575 . . . . 0.0 112.006 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -72.28 137.09 46.5 Favored 'General case' 0 CA--C 1.569 1.703 0 O-C-N 121.366 -0.834 . . . . 0.0 110.499 162.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.8 mt -59.62 113.27 2.15 Favored 'General case' 0 CA--C 1.571 1.768 0 O-C-N 121.069 -1.019 . . . . 0.0 113.389 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.29 55.83 3.6 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 116.39 1.316 . . . . 0.0 116.39 -171.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 p -136.46 136.91 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 118.008 0.904 . . . . 0.0 110.125 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 88.0 m -87.41 109.79 19.82 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.505 -0.747 . . . . 0.0 110.156 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -138.56 156.23 47.67 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.168 0.587 . . . . 0.0 112.436 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -84.38 99.04 10.38 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 121.841 0.829 . . . . 0.0 112.126 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -86.64 119.27 26.7 Favored 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 124.449 1.1 . . . . 0.0 111.682 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -83.39 126.68 32.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.099 -1.001 . . . . 0.0 113.208 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.3 mt -80.62 152.67 28.4 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 170.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.93 64.74 2.49 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 175.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -174.31 -66.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 125.465 1.506 . . . . 0.0 110.394 -177.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.3 70.17 0.03 OUTLIER Glycine 0 N--CA 1.487 2.065 0 CA-C-N 119.128 0.876 . . . . 0.0 114.207 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.5 m -167.19 128.34 1.57 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 118.041 0.92 . . . . 0.0 109.015 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -97.34 126.71 42.74 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.172 0.987 . . . . 0.0 110.623 169.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.6 mt -108.91 107.69 18.18 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 124.227 1.011 . . . . 0.0 110.769 -174.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.53 119.15 20.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.048 -1.032 . . . . 0.0 112.068 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.74 -163.88 36.99 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 117.639 1.815 . . . . 0.0 117.639 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.8 p -125.5 120.31 30.59 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.382 -0.909 . . . . 0.0 111.763 -157.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -84.81 121.65 28.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.422 -0.799 . . . . 0.0 110.427 161.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.1 m -126.93 139.3 53.16 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.358 0.663 . . . . 0.0 111.735 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.1 tp -87.72 114.67 24.55 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.679 -1.263 . . . . 0.0 111.642 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -78.07 -37.27 46.95 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 172.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.83 -84.26 0.08 OUTLIER Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -107.93 39.04 2.03 Favored 'General case' 0 CA--C 1.581 2.138 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 158.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -146.19 124.32 12.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.929 -1.107 . . . . 0.0 109.167 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.8 mt -91.4 110.49 21.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.478 -0.764 . . . . 0.0 109.15 166.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.6 tt -97.52 117.59 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.127 -0.983 . . . . 0.0 110.858 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.04 95.7 1.76 Allowed Glycine 0 N--CA 1.482 1.747 0 CA-C-O 119.401 -0.666 . . . . 0.0 113.328 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -84.25 103.8 13.74 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 117.784 0.792 . . . . 0.0 110.017 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -123.16 148.42 45.76 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -171.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -120.96 141.61 50.53 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.782 0.801 . . . . 0.0 110.621 167.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -70.79 137.85 49.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.716 -1.24 . . . . 0.0 112.808 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.286 4.9 t -70.18 -51.78 28.43 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 175.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -75.92 -44.96 37.71 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -80.22 -26.19 39.25 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.7 -38.77 3.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 117.486 1.754 . . . . 0.0 117.486 -166.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -69.22 155.57 40.19 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -162.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.96 140.13 35.43 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 114.18 -1.373 . . . . 0.0 114.679 -175.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.8 tt -135.28 115.59 13.46 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 123.832 0.853 . . . . 0.0 109.114 177.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -94.5 111.72 23.48 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.139 -0.976 . . . . 0.0 109.103 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.9 m -101.34 94.94 6.19 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.0 t -100.91 100.14 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-O 122.516 1.151 . . . . 0.0 109.56 -168.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -93.69 102.35 14.51 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.367 -172.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -131.54 133.12 44.74 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.75 0.82 . . . . 0.0 111.268 -161.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.0 mt -104.0 123.3 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.719 -1.238 . . . . 0.0 110.172 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 45.1 mm -83.55 -47.33 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.98 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.832 167.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -163.09 -89.12 0.07 OUTLIER Glycine 0 N--CA 1.487 2.085 0 CA-C-N 119.058 0.844 . . . . 0.0 112.507 172.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 45.0 p30 -81.62 3.76 24.06 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 174.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -136.97 131.42 32.94 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 119.233 0.924 . . . . 0.0 111.033 -168.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.7 tp -86.14 113.02 21.85 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.446 1.098 . . . . 0.0 109.695 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.6 t -98.98 105.09 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -174.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -96.08 101.74 13.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -0.984 . . . . 0.0 109.997 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.5 m -91.63 103.96 16.49 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.585 0.754 . . . . 0.0 109.207 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -89.26 110.69 21.43 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.338 0.655 . . . . 0.0 110.194 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.1 t -112.79 93.96 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -94.71 114.65 26.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.632 -0.668 . . . . 0.0 111.31 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.317 0.4 OUTLIER 62.07 -62.55 0.1 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 174.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.83 43.41 0.5 Allowed Glycine 0 CA--C 1.551 2.293 0 CA-C-O 118.915 -0.936 . . . . 0.0 114.483 156.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.8 t -139.15 118.61 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 118.982 1.391 . . . . 0.0 107.761 -172.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.2 mp0 -93.68 144.52 25.32 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.81 121.19 10.96 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.208 0.528 . . . . 0.0 112.408 164.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -94.67 107.66 19.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.694 -0.629 . . . . 0.0 111.256 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -89.7 111.61 22.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.722 -0.611 . . . . 0.0 109.601 167.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.2 mt -101.09 114.06 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -172.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -105.81 122.7 46.63 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.673 0.789 . . . . 0.0 109.625 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -83.14 143.27 30.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 112.585 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -65.14 118.44 9.22 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.9 t0 . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -165.67 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.283 93.2 m-85 . . . . . 0 N--CA 1.502 2.137 0 N-CA-C 118.81 2.893 . . . . 0.0 118.81 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -73.77 72.37 1.51 Allowed 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 117.283 2.327 . . . . 0.0 117.283 -160.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.9 p -152.17 -176.36 5.64 Favored 'General case' 0 CA--C 1.572 1.821 0 CA-C-O 121.976 0.893 . . . . 0.0 112.852 178.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.1 m -89.37 127.64 35.83 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.013 0.925 . . . . 0.0 110.788 176.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -130.02 116.17 18.18 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.178 0.591 . . . . 0.0 109.416 -173.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -99.64 135.77 40.56 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 119.408 1.004 . . . . 0.0 111.944 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p -66.05 116.43 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -96.0 -50.73 4.74 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -144.2 111.25 5.81 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 119.977 1.262 . . . . 0.0 111.054 -172.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.2 m -96.18 101.34 12.98 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.858 0.863 . . . . 0.0 111.317 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -93.5 120.52 33.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.509 -0.744 . . . . 0.0 110.31 -172.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.264 28.5 t30 65.49 20.56 11.72 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -72.51 -40.17 67.04 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.64 -38.07 74.39 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 168.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -67.55 -46.75 71.85 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 119.91 1.232 . . . . 0.0 114.069 171.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -46.55 -56.32 6.2 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 161.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.4 mtp -65.82 -29.84 70.38 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 176.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.63 -50.96 71.43 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 120.241 1.382 . . . . 0.0 114.203 163.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -57.4 -32.1 66.51 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 165.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.0 mmt -64.44 -34.74 78.89 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 168.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.99 51.36 1.93 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 116.072 1.189 . . . . 0.0 116.072 -176.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -114.89 160.23 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-O 122.169 0.985 . . . . 0.0 112.408 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -56.72 145.95 27.32 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 172.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.274 0.1 OUTLIER -54.98 -47.22 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 175.057 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.28 -49.53 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 173.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -58.35 -45.66 87.75 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 170.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -44.27 -55.12 5.13 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 163.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -65.69 -46.66 78.18 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.5 mt -58.48 -47.53 83.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 169.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.24 -21.63 66.35 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 119.062 2.986 . . . . 0.0 119.062 178.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.08 93.64 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 165.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -130.49 68.09 1.47 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 119.577 1.081 . . . . 0.0 111.781 169.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -84.41 44.66 1.05 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 176.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 42.7 40.57 2.08 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -172.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -86.68 116.77 25.0 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.695 -1.253 . . . . 0.0 112.173 -161.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -111.2 118.01 34.77 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.718 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.7 mt -94.28 101.53 13.5 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 172.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 43.8 m -95.14 105.66 17.61 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.883 0.849 . . . . 0.0 108.731 170.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.9 mt -90.57 101.4 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -171.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 87.7 m -99.08 101.48 12.86 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -102.45 127.49 49.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.581 -0.7 . . . . 0.0 112.347 -167.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -79.94 -49.87 11.26 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 161.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.65 -90.92 0.08 OUTLIER Glycine 0 N--CA 1.486 1.97 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -70.12 -29.28 66.19 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 158.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -85.47 126.71 34.03 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-N 119.772 1.169 . . . . 0.0 112.105 169.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -117.83 125.39 50.46 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.482 1.113 . . . . 0.0 108.475 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.0 m -99.52 95.85 7.27 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 168.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.5 t -88.98 105.88 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -89.91 102.07 14.77 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -170.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -93.41 88.09 5.83 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.202 0.601 . . . . 0.0 109.53 -170.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.1 t -98.49 109.26 22.05 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.321 0.648 . . . . 0.0 110.798 -171.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.7 p -134.08 166.15 23.41 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -169.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.55 -26.32 61.25 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 117.838 2.533 . . . . 0.0 117.838 165.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -79.81 -52.34 8.04 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -160.91 163.22 32.07 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-N 119.33 0.968 . . . . 0.0 112.726 -177.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -110.39 118.83 37.35 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.387 0.675 . . . . 0.0 109.53 167.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.2 pt -131.41 133.08 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 CA-C-O 121.785 0.802 . . . . 0.0 111.879 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -98.77 99.24 10.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.605 0.762 . . . . 0.0 109.664 -175.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.35 99.67 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.417 -0.802 . . . . 0.0 109.868 -165.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 56.9 t -85.7 115.8 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 123.458 0.703 . . . . 0.0 109.319 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -134.35 140.68 46.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.829 -0.544 . . . . 0.0 111.769 173.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -92.95 140.06 29.88 Favored 'General case' 0 CA--C 1.565 1.528 0 O-C-N 121.896 -0.502 . . . . 0.0 110.865 163.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -56.92 131.8 50.73 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 176.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.35 -16.68 37.96 Favored Glycine 0 CA--C 1.553 2.437 0 N-CA-C 119.426 2.53 . . . . 0.0 119.426 -172.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.8 t -81.84 132.37 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-N 120.176 1.988 . . . . 0.0 110.408 -175.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.9 m -79.87 104.74 10.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.716 -0.615 . . . . 0.0 110.085 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -124.7 166.85 15.44 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-O 122.106 0.955 . . . . 0.0 112.405 -173.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -91.23 99.01 12.08 Favored 'General case' 0 CA--C 1.571 1.75 0 C-N-CA 123.362 0.665 . . . . 0.0 111.454 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -92.58 104.89 17.14 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.829 0.852 . . . . 0.0 110.174 175.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -95.64 125.86 40.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 112.025 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.7 mt -80.21 150.24 30.17 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.166 0.586 . . . . 0.0 112.425 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.38 44.98 0.16 Allowed 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -149.75 -59.54 0.2 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 124.769 1.228 . . . . 0.0 110.234 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.53 73.37 0.04 OUTLIER Glycine 0 N--CA 1.486 1.977 0 CA-C-N 118.935 0.789 . . . . 0.0 112.678 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 m -167.8 124.77 1.13 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 117.869 0.834 . . . . 0.0 109.959 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -102.08 125.98 48.91 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.852 0.861 . . . . 0.0 111.033 171.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.6 mt -117.83 123.36 45.72 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.607 0.763 . . . . 0.0 110.865 -175.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -102.77 118.79 37.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.102 -0.999 . . . . 0.0 110.85 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.43 -177.71 47.88 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 118.29 2.076 . . . . 0.0 118.29 -172.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.8 p -119.54 124.91 47.57 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 113.812 -1.194 . . . . 0.0 111.215 -167.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -83.46 126.01 32.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.977 -0.452 . . . . 0.0 111.419 163.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.8 m -120.42 135.06 55.16 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.196 0.598 . . . . 0.0 111.026 172.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.6 tp -89.15 106.83 18.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 111.466 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -98.52 -179.08 4.21 Favored 'General case' 0 CA--C 1.575 1.904 0 C-N-CA 123.895 0.878 . . . . 0.0 110.828 168.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.91 106.87 0.88 Allowed Glycine 0 N--CA 1.494 2.537 0 O-C-N 120.265 -1.522 . . . . 0.0 115.894 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.42 9.3 p30 59.4 13.53 3.25 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 119.558 3.17 . . . . 0.0 119.558 -166.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -137.22 125.51 23.25 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 120.293 1.406 . . . . 0.0 111.867 -169.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.9 mt -89.25 109.0 19.93 Favored 'General case' 0 CA--C 1.564 1.484 0 O-C-N 121.098 -1.001 . . . . 0.0 108.379 159.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.6 tt -96.8 115.54 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.526 -0.734 . . . . 0.0 110.103 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.58 104.35 2.58 Favored Glycine 0 N--CA 1.482 1.754 0 C-N-CA 123.875 0.75 . . . . 0.0 112.374 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -92.15 95.45 9.75 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -114.95 148.96 38.05 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.477 1.132 . . . . 0.0 112.876 -168.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -121.87 135.46 54.89 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.713 0.805 . . . . 0.0 109.456 166.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -75.5 104.85 6.24 Favored 'General case' 0 CA--C 1.562 1.414 0 O-C-N 121.084 -1.01 . . . . 0.0 111.845 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 t -61.94 -16.45 51.09 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 118.385 2.735 . . . . 0.0 118.385 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -70.19 -28.99 65.74 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 168.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . 0.25 3.1 p-10 -145.53 7.46 1.13 Allowed 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 119.436 3.125 . . . . 0.0 119.436 -177.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.11 -19.7 47.75 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 119.15 2.42 . . . . 0.0 119.15 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -73.81 139.98 45.51 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -169.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -74.12 141.1 45.64 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 tt -126.77 121.05 30.87 Favored 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 123.589 0.756 . . . . 0.0 109.538 168.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -100.15 110.13 22.4 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.2 m -96.92 131.23 43.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.564 -0.71 . . . . 0.0 110.193 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.8 t -129.45 99.67 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -104.31 105.77 16.02 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.144 0.978 . . . . 0.0 108.606 -172.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -126.4 137.94 53.49 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -162.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.1 mm -88.99 127.19 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.386 -0.821 . . . . 0.0 109.51 167.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 49.2 mm -104.18 -80.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 168.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -165.32 113.19 0.54 Allowed Glycine 0 N--CA 1.487 2.093 0 O-C-N 121.357 -0.839 . . . . 0.0 111.056 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.251 31.3 m-20 60.5 1.31 0.39 Allowed 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 -166.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -136.58 138.69 41.5 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 124.339 1.056 . . . . 0.0 111.071 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.3 tp -94.06 109.77 21.51 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 168.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.2 m -95.07 113.37 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . 0.28 0.1 OUTLIER -124.7 119.44 28.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.82 -1.175 . . . . 0.0 113.315 -175.561 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.4 m -107.65 123.87 49.14 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.166 0.986 . . . . 0.0 109.982 -167.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -105.81 111.74 24.52 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.2 t -108.42 102.45 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -104.61 81.09 1.74 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.305 -0.872 . . . . 0.0 110.602 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 63.63 73.58 0.44 Allowed 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 123.779 0.831 . . . . 0.0 112.624 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.97 -36.9 2.33 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 118.732 2.253 . . . . 0.0 118.732 -173.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.81 99.27 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 119.229 1.515 . . . . 0.0 112.663 -169.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -90.42 112.23 23.77 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 123.375 0.67 . . . . 0.0 112.085 -172.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.36 119.64 37.65 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.077 0.551 . . . . 0.0 112.195 176.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -107.34 105.65 15.69 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.016 0.526 . . . . 0.0 109.962 -174.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -91.02 115.15 27.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.41 -0.806 . . . . 0.0 108.963 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.4 mt -105.01 118.94 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -103.01 152.06 21.77 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.048 0.939 . . . . 0.0 111.421 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -101.72 152.68 20.56 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.715 -1.241 . . . . 0.0 111.723 169.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -66.22 105.44 1.41 Allowed 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 123.758 0.823 . . . . 0.0 112.689 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.6 t0 . . . . . 0 N--CA 1.487 1.397 0 C-N-CA 124.922 1.289 . . . . 0.0 114.251 -178.721 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.33 77.0 m-85 . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -70.55 76.9 0.58 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 120.229 1.377 . . . . 0.0 114.006 -172.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.1 t -168.73 173.98 6.9 Favored 'General case' 0 CA--C 1.572 1.821 0 CA-C-O 122.622 1.201 . . . . 0.0 111.93 -165.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.9 m -90.96 133.61 35.14 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.268 -0.895 . . . . 0.0 110.353 171.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -132.2 101.18 5.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.948 -0.47 . . . . 0.0 110.068 -172.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -91.28 135.32 33.88 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.475 -0.766 . . . . 0.0 111.988 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -61.2 121.32 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -99.51 -45.2 5.89 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 117.416 -1.278 . . . . 0.0 114.223 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.57 116.34 1.26 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 120.293 1.406 . . . . 0.0 110.088 -169.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.1 p -100.32 105.41 16.93 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.539 0.736 . . . . 0.0 111.921 -177.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -90.43 126.04 35.77 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.192 0.597 . . . . 0.0 111.635 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.257 45.3 t30 60.1 26.29 15.65 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 117.681 2.474 . . . . 0.0 117.681 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -72.19 -42.84 65.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -60.13 -40.53 90.11 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 117.616 2.451 . . . . 0.0 117.616 171.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.74 -44.18 70.79 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 172.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -44.16 -57.71 3.27 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 158.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.2 mtt -57.0 -42.68 80.73 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 172.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -58.35 -43.92 88.54 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 168.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -59.79 -35.14 74.05 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 168.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 58.0 mtm -66.84 -37.73 85.05 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 170.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.77 59.39 0.45 Allowed Glycine 0 N--CA 1.487 2.089 0 C-N-CA 123.776 0.703 . . . . 0.0 114.745 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.426 HG13 ' HG2' ' A' ' 28' ' ' ARG . 2.4 p -129.31 136.95 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 122.278 1.037 . . . . 0.0 110.413 177.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -63.02 143.91 57.36 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.276 13.7 tt -51.03 -42.49 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -176.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.8 t -60.81 -50.36 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 119.59 1.086 . . . . 0.0 113.125 171.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -56.41 -42.33 77.83 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 167.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HG2' HG13 ' A' ' 23' ' ' VAL . 57.4 mtm-85 -58.79 -47.05 86.08 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 169.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -59.12 -46.35 88.55 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 170.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.51 -47.75 80.42 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 171.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.09 -25.73 63.65 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.19 76.62 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-N 121.31 1.868 . . . . 0.0 115.043 156.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -78.82 59.42 2.57 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 171.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -97.03 -27.28 14.68 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -175.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.387 1.3 p-10 57.8 55.68 5.28 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -173.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.0 tp -80.17 121.43 25.57 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.419 1.104 . . . . 0.0 113.902 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -106.18 118.33 36.34 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.81 167.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.2 mt -97.4 101.01 12.45 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 51.7 m -94.41 109.5 21.36 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.998 -1.064 . . . . 0.0 109.421 171.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.2 mt -103.79 112.75 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -166.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 87.6 m -103.31 106.3 16.78 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -89.04 108.97 19.88 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.297 0.639 . . . . 0.0 111.948 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.7 70.76 6.71 Favored 'General case' 0 CA--C 1.572 1.809 0 O-C-N 121.587 -0.696 . . . . 0.0 110.486 166.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.99 -96.49 0.22 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 115.515 0.966 . . . . 0.0 115.515 -174.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -87.93 -23.19 23.97 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 169.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -88.85 111.36 21.96 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 121.046 1.748 . . . . 0.0 111.974 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -94.63 117.44 30.14 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.518 0.727 . . . . 0.0 109.181 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.6 m -93.83 97.99 10.77 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.9 t -92.82 105.46 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -86.34 101.79 13.42 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.178 0.591 . . . . 0.0 109.606 -176.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -90.85 97.55 11.25 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.234 0.614 . . . . 0.0 109.837 -172.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -110.54 102.83 11.39 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 122.991 0.516 . . . . 0.0 110.845 -175.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.8 p -140.31 -178.92 5.71 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.028 0.931 . . . . 0.0 111.72 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.86 -29.99 67.38 Favored 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 159.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -97.95 -17.62 19.11 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 174.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -130.07 142.07 50.65 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 121.382 1.901 . . . . 0.0 111.975 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -144.29 74.33 1.42 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.016 -1.052 . . . . 0.0 109.796 162.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.2 pt -143.07 130.16 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.283 -0.886 . . . . 0.0 112.007 -166.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.82 99.84 11.64 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.248 1.019 . . . . 0.0 111.559 172.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.9 t -91.42 98.28 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.174 -0.954 . . . . 0.0 109.19 -169.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.1 t -86.4 119.49 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 123.344 0.658 . . . . 0.0 109.312 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -140.64 133.42 28.97 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.328 0.585 . . . . 0.0 111.532 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -86.45 139.8 30.56 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 121.808 -0.557 . . . . 0.0 111.246 167.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.75 128.43 36.53 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.89 -11.48 59.77 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 119.642 2.617 . . . . 0.0 119.642 -172.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.2 t -85.59 133.01 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 120.43 2.115 . . . . 0.0 110.33 -175.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -77.4 114.11 15.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.508 -0.745 . . . . 0.0 111.466 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -138.56 163.05 33.03 Favored 'General case' 0 CA--C 1.572 1.791 0 C-N-CA 123.264 0.626 . . . . 0.0 112.607 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -85.89 111.17 19.96 Favored 'General case' 0 CA--C 1.57 1.727 0 O-C-N 121.515 -0.741 . . . . 0.0 111.752 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -102.4 156.15 17.78 Favored 'General case' 0 CA--C 1.572 1.796 0 CA-C-O 122.17 0.986 . . . . 0.0 112.678 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -127.18 149.41 49.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.4 -0.812 . . . . 0.0 111.532 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.4 mt -92.97 -113.28 0.1 Allowed 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 118.804 -0.617 . . . . 0.0 110.263 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -146.5 58.91 1.21 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 120.776 1.625 . . . . 0.0 112.718 170.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -159.9 -78.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.116 0.966 . . . . 0.0 108.456 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.18 76.57 0.06 OUTLIER Glycine 0 N--CA 1.481 1.667 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.7 m -147.4 122.22 9.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.731 -0.864 . . . . 0.0 109.212 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -97.96 116.55 30.41 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.403 0.681 . . . . 0.0 110.683 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 70.9 mt -115.48 106.01 13.47 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.46 0.704 . . . . 0.0 110.91 -170.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -82.62 118.73 23.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.41 -0.806 . . . . 0.0 111.743 174.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.56 -167.96 41.06 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 117.741 1.856 . . . . 0.0 117.741 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.8 p -128.22 124.92 37.92 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.675 -0.763 . . . . 0.0 111.534 -163.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -85.92 129.41 34.84 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 118.194 0.452 . . . . 0.0 111.361 161.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.8 t -122.83 137.39 54.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.721 -0.612 . . . . 0.0 111.79 173.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.8 tp -90.93 107.68 19.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.898 -1.126 . . . . 0.0 111.572 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -103.48 75.96 1.38 Allowed 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 121.512 0.672 . . . . 0.0 109.747 171.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.25 -102.54 0.95 Allowed Glycine 0 N--CA 1.491 2.35 0 O-C-N 121.38 -0.825 . . . . 0.0 115.137 -177.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -95.67 22.33 7.31 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -129.84 114.53 16.02 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.713 -1.242 . . . . 0.0 110.03 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.9 mt -84.03 104.68 14.3 Favored 'General case' 0 CA--C 1.564 1.481 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 161.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.1 tt -94.1 114.53 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.466 -0.771 . . . . 0.0 110.231 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -103.07 99.18 1.76 Allowed Glycine 0 N--CA 1.482 1.706 0 C-N-CA 123.689 0.661 . . . . 0.0 113.289 -174.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -90.5 92.75 9.0 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -120.27 134.64 55.22 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.18 0.592 . . . . 0.0 112.503 -168.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -115.68 145.08 43.06 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.514 0.725 . . . . 0.0 109.875 169.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -70.2 123.95 22.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.446 -1.409 . . . . 0.0 112.675 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.281 9.8 t -81.05 59.78 3.97 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 122.625 1.202 . . . . 0.0 113.824 169.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -168.12 -63.31 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.767 0 C-N-CA 125.916 1.686 . . . . 0.0 107.796 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -80.34 -38.72 30.0 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.146 1.535 . . . . 0.0 115.146 171.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.74 -31.17 9.04 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 117.359 1.704 . . . . 0.0 117.359 -158.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -65.86 143.21 57.6 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -165.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -69.13 129.63 40.43 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 175.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.5 tt -121.59 86.06 2.51 Favored 'General case' 0 CA--C 1.563 1.472 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 168.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -83.05 109.06 16.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.987 -1.07 . . . . 0.0 109.735 -167.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 m -111.89 111.38 22.29 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.84 -0.538 . . . . 0.0 110.085 -166.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.0 t -107.1 101.63 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.022 -1.049 . . . . 0.0 109.05 -175.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.4 mtm-85 -84.3 117.32 23.49 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.296 0.639 . . . . 0.0 110.887 174.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -147.76 135.07 20.59 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.816 -1.177 . . . . 0.0 113.347 -173.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 mp -85.14 113.95 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.135 -0.978 . . . . 0.0 108.381 177.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.22 84.58 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.29 -84.41 0.73 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 114.728 0.651 . . . . 0.0 114.728 -173.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -103.52 -40.31 6.39 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -101.87 140.34 36.28 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 120.255 1.388 . . . . 0.0 113.096 -169.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.0 tp -76.73 111.34 12.14 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.834 0.853 . . . . 0.0 110.723 172.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 m -99.24 120.04 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -103.32 99.46 9.3 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.542 0.737 . . . . 0.0 109.377 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.4 m -94.18 112.02 23.79 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.301 0.64 . . . . 0.0 110.172 -171.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -90.09 133.3 34.94 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.669 0.788 . . . . 0.0 111.565 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.2 t -119.85 101.61 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 163.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -95.05 94.14 7.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.39 -0.818 . . . . 0.0 109.728 171.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.287 4.6 mm-40 70.35 -69.81 0.17 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -153.13 62.06 0.38 Allowed Glycine 0 N--CA 1.486 2.021 0 CA-C-O 119.784 -0.453 . . . . 0.0 113.683 165.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.5 p -144.58 113.59 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 117.77 0.785 . . . . 0.0 109.05 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -87.56 118.47 27.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.705 -0.622 . . . . 0.0 111.368 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -130.78 131.35 44.63 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 122.839 0.456 . . . . 0.0 111.686 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -115.46 118.02 32.01 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.435 -0.79 . . . . 0.0 111.169 -173.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -93.69 104.62 16.71 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 167.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.76 127.04 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -115.66 130.33 56.82 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.886 0.874 . . . . 0.0 110.264 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -78.61 143.98 35.92 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 121.77 0.795 . . . . 0.0 113.04 176.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -61.95 115.03 3.72 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 123.927 0.891 . . . . 0.0 112.769 171.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.2 t70 . . . . . 0 N--CA 1.489 1.476 0 C-N-CA 124.93 1.292 . . . . 0.0 112.345 -170.401 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 . . . . . 0 CA--C 1.581 2.149 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.6 90.06 8.23 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 119.799 -1.813 . . . . 0.0 114.03 -157.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.2 m -158.13 -175.22 5.22 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 124.499 1.12 . . . . 0.0 110.808 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.0 m -99.69 113.09 25.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.808 -1.182 . . . . 0.0 109.441 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -117.81 108.16 15.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.912 -0.493 . . . . 0.0 109.84 -170.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -93.26 140.51 29.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.269 -0.895 . . . . 0.0 112.31 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.4 p -63.75 116.52 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -98.66 -59.35 1.76 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.547 0.739 . . . . 0.0 111.798 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -141.28 166.08 25.76 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.837 0.827 . . . . 0.0 110.846 177.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.4 m -153.71 126.41 8.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 119.236 -2.165 . . . . 0.0 112.142 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -100.8 121.82 42.35 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.741 0.816 . . . . 0.0 109.932 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.267 14.0 t30 65.29 13.57 8.86 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 171.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -63.59 -40.32 96.64 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.21 -27.04 68.71 Favored 'General case' 0 CA--C 1.577 2.014 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 169.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -73.92 -49.44 24.76 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 120.32 1.418 . . . . 0.0 113.8 165.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -46.8 -51.45 16.41 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 166.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -40.73 76.01 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 166.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -59.89 -45.9 91.04 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 168.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -54.59 -38.44 66.74 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 167.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.6 mtm -68.59 -21.7 64.5 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 168.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.12 49.21 1.77 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 116.212 1.245 . . . . 0.0 116.212 175.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.65 151.9 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 118.673 1.236 . . . . 0.0 113.614 -177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -63.08 144.59 56.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.283 13.2 tt -52.66 -45.13 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.3 t -55.5 -52.31 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 124.023 0.929 . . . . 0.0 113.457 168.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -61.56 -46.11 91.27 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 176.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.7 ptt85 -69.68 -28.81 66.17 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 117.975 2.584 . . . . 0.0 117.975 171.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -62.5 -49.1 76.69 Favored 'General case' 0 CA--C 1.572 1.807 0 CA-C-N 120.09 1.314 . . . . 0.0 114.302 161.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.28 -59.89 4.69 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 170.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.08 -16.79 20.94 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 118.915 2.931 . . . . 0.0 118.915 175.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.05 -86.49 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 117.693 -1.146 . . . . 0.0 112.701 159.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -106.4 48.93 0.82 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 121.814 2.097 . . . . 0.0 115.21 -171.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.0 54.27 2.7 Favored 'General case' 0 CA--C 1.576 1.977 0 O-C-N 120.765 -1.209 . . . . 0.0 113.869 166.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 50.7 50.8 18.24 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 117.563 2.431 . . . . 0.0 117.563 171.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -87.0 124.02 32.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.787 -1.196 . . . . 0.0 113.708 -169.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -119.75 121.41 39.11 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.086 0.954 . . . . 0.0 110.406 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.4 mt -91.44 102.19 14.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.553 -0.717 . . . . 0.0 109.301 176.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 87.0 m -95.21 103.5 15.36 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.4 mt -101.67 128.37 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -167.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.3 p -128.99 122.34 29.9 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 171.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -94.33 131.95 39.43 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.823 0.82 . . . . 0.0 111.251 168.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -97.72 36.86 1.45 Allowed 'General case' 0 CA--C 1.582 2.2 0 C-N-CA 124.603 1.161 . . . . 0.0 113.528 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.79 92.06 0.23 Allowed Glycine 0 N--CA 1.492 2.413 0 O-C-N 120.196 -1.565 . . . . 0.0 113.536 -168.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.279 16.8 t-20 71.58 -61.18 0.5 Allowed 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -74.76 133.65 41.95 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -172.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -111.26 134.24 53.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.492 -0.755 . . . . 0.0 112.132 -173.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.2 m -107.16 113.54 27.04 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 161.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.4 t -110.53 104.87 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -81.66 103.9 11.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 110.189 175.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -90.39 96.26 10.57 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.8 t -102.27 117.05 33.92 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.361 0.664 . . . . 0.0 111.274 -170.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.9 p -143.26 164.81 29.2 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.683 0.754 . . . . 0.0 112.903 -173.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.07 -25.51 65.44 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 159.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -73.03 -50.28 23.93 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -162.88 153.87 17.13 Favored 'General case' 0 CA--C 1.572 1.813 0 C-N-CA 124.408 1.083 . . . . 0.0 111.828 -171.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -129.87 104.14 7.21 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.517 -0.74 . . . . 0.0 109.128 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.28 142.13 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.48 -0.762 . . . . 0.0 112.15 -170.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -89.2 114.65 26.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.578 -0.701 . . . . 0.0 112.614 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.9 t -96.82 102.54 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.39 124.48 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 123.065 0.546 . . . . 0.0 109.598 -175.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -146.32 139.1 25.46 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.238 0.615 . . . . 0.0 111.344 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -97.65 142.37 29.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.26 164.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.74 112.36 3.67 Favored 'General case' 0 CA--C 1.566 1.571 0 O-C-N 121.584 -0.697 . . . . 0.0 112.617 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.56 -18.05 58.14 Favored Glycine 0 CA--C 1.558 2.723 0 N-CA-C 119.488 2.555 . . . . 0.0 119.488 -163.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 65.3 t -94.77 112.65 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 120.453 2.127 . . . . 0.0 109.039 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 t -73.07 139.48 46.56 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -131.54 166.81 20.54 Favored 'General case' 0 CA--C 1.574 1.866 0 C-N-CA 124.295 1.038 . . . . 0.0 112.832 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -93.1 120.71 33.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.433 -0.792 . . . . 0.0 110.543 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -119.92 123.27 43.15 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.345 0.658 . . . . 0.0 111.8 -176.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -81.48 127.17 32.53 Favored 'General case' 0 CA--C 1.566 1.584 0 O-C-N 121.329 -0.857 . . . . 0.0 109.703 161.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 57.3 mt -63.36 177.59 0.64 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 168.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.86 35.31 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 118.341 2.719 . . . . 0.0 118.341 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -154.6 -82.7 0.07 Allowed 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.753 1.221 . . . . 0.0 108.951 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.0 74.17 0.09 OUTLIER Glycine 0 N--CA 1.483 1.81 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 55.5 m -152.63 110.36 3.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.91 -0.759 . . . . 0.0 109.301 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -84.84 115.12 22.57 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-O 122.066 0.936 . . . . 0.0 112.224 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.2 mt -107.7 152.24 24.6 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 125.015 1.326 . . . . 0.0 111.442 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -116.26 111.39 20.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.042 -1.036 . . . . 0.0 109.795 174.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.24 -174.99 38.78 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 114.667 0.627 . . . . 0.0 114.667 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.9 m -117.25 -58.5 2.04 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -163.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . 0.272 69.6 m95 76.46 91.3 0.07 Allowed 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.488 1.115 . . . . 0.0 111.284 -153.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.2 m -105.37 127.88 53.2 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.261 0.624 . . . . 0.0 110.731 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.1 tp -78.53 102.64 8.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.0 111.158 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -81.54 -58.06 3.19 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.69 -96.21 1.12 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 160.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -102.34 57.21 0.79 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 117.774 0.787 . . . . 0.0 110.878 154.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -147.53 111.9 5.24 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -173.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.7 mt -86.4 101.86 13.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.582 -0.698 . . . . 0.0 109.746 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.8 tt -88.77 107.28 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.262 1.029 . . . . 0.0 110.638 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.73 93.14 1.72 Allowed Glycine 0 N--CA 1.48 1.592 0 C-N-CA 123.63 0.633 . . . . 0.0 112.954 174.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -86.75 92.44 8.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -112.07 108.31 17.56 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.352 0.661 . . . . 0.0 111.088 -165.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -89.97 129.75 36.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.972 -1.08 . . . . 0.0 110.851 177.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -61.14 135.66 57.83 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.7 p -64.32 -64.0 0.99 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 161.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -86.94 72.67 10.07 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 121.526 -0.734 . . . . 0.0 111.038 171.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 171.11 -39.32 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 126.527 1.931 . . . . 0.0 112.627 168.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 70.38 22.69 77.7 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 118.491 2.156 . . . . 0.0 118.491 -164.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -121.83 157.89 30.09 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.482 1.134 . . . . 0.0 113.394 -169.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -84.97 124.97 32.29 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -166.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.15 111.77 20.72 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.02 0.928 . . . . 0.0 108.717 170.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -103.65 111.99 24.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.301 -0.874 . . . . 0.0 108.883 -173.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.4 m -111.03 104.06 12.59 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 119.771 1.169 . . . . 0.0 110.828 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.7 t -90.25 104.06 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.13 -0.981 . . . . 0.0 108.62 177.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.5 118.86 24.57 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.584 0.754 . . . . 0.0 110.381 171.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -149.4 147.64 28.52 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 119.511 1.051 . . . . 0.0 113.524 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 mp -93.63 123.53 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.969 -1.082 . . . . 0.0 109.261 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 44.4 mm -103.5 92.11 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 170.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.11 -97.58 1.16 Allowed Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.339 -0.851 . . . . 0.0 114.176 -173.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -130.4 49.3 2.31 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 121.897 0.856 . . . . 0.0 111.773 166.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -144.25 116.68 8.56 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 124.015 0.926 . . . . 0.0 108.581 -173.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.8 tp -89.0 115.18 26.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.694 -0.629 . . . . 0.0 110.621 -173.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.4 m -105.56 121.09 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -98.24 108.57 21.3 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.732 0.813 . . . . 0.0 109.914 171.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.4 m -91.0 98.51 11.82 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -90.51 114.07 26.19 Favored 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 124.395 1.078 . . . . 0.0 111.349 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.56 105.91 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-N 119.203 0.91 . . . . 0.0 108.576 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -108.65 114.41 28.2 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 118.917 0.78 . . . . 0.0 109.774 167.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 53.66 50.21 17.63 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.21 -26.41 4.43 Favored Glycine 0 CA--C 1.554 2.472 0 N-CA-C 119.296 2.479 . . . . 0.0 119.296 -168.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.9 t -83.59 104.38 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 120.262 2.031 . . . . 0.0 109.928 -170.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -87.37 132.26 34.02 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -130.9 121.93 26.09 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.671 0.789 . . . . 0.0 111.717 171.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -101.0 106.09 17.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.445 -0.784 . . . . 0.0 110.948 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -93.94 125.52 38.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.794 -0.566 . . . . 0.0 111.47 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.8 mt -116.81 116.84 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -165.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -113.46 130.23 56.37 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.028 0.931 . . . . 0.0 110.445 -172.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -82.77 140.7 32.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.904 . . . . 0.0 112.054 174.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -62.77 107.19 0.92 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.554 -0.716 . . . . 0.0 111.518 162.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -162.487 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.3 92.6 m-85 . . . . . 0 N--CA 1.501 2.097 0 CA-C-O 122.308 1.051 . . . . 0.0 113.154 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.27 17.6 m-20 66.79 50.76 1.09 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.043 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.9 t -157.28 -170.02 3.11 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 121.197 -0.94 . . . . 0.0 111.543 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.0 m -97.59 116.85 30.61 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.986 -1.071 . . . . 0.0 109.803 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -116.76 105.34 12.28 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.338 0.655 . . . . 0.0 109.538 -169.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -93.72 132.66 37.86 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.45 0.7 . . . . 0.0 110.86 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 p -57.07 116.56 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.952 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.46 -49.7 5.79 Favored 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 124.411 1.084 . . . . 0.0 112.913 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -149.71 116.62 5.94 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.529 1.059 . . . . 0.0 110.744 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.9 p -97.29 100.67 12.13 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.686 0.794 . . . . 0.0 111.564 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -95.14 125.37 39.74 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.421 0.688 . . . . 0.0 110.665 -169.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.268 42.7 t30 63.56 25.69 14.47 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -73.52 -45.73 52.03 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 115.605 1.705 . . . . 0.0 115.605 -173.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -61.41 -27.8 68.8 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -74.42 -46.28 41.12 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.966 1.257 . . . . 0.0 114.092 165.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -49.48 -52.71 27.42 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 164.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -31.2 72.32 Favored 'General case' 0 CA--C 1.574 1.888 0 N-CA-C 116.313 1.968 . . . . 0.0 116.313 172.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.47 -37.89 86.11 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 121.16 1.8 . . . . 0.0 115.476 163.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -60.05 -39.47 86.07 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 165.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 83.0 mmm -60.68 -45.68 93.25 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 165.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.78 51.42 0.57 Allowed Glycine 0 N--CA 1.484 1.878 0 C-N-CA 124.294 0.95 . . . . 0.0 114.8 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.4 m -108.61 142.4 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.479 1.133 . . . . 0.0 112.776 -178.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -66.5 154.89 39.14 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.305 0.1 OUTLIER -43.77 -56.1 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 -173.373 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.83 -51.55 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 CA-C-N 119.563 1.074 . . . . 0.0 113.082 175.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -55.67 -42.07 74.58 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 170.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.1 ttp85 -60.72 -50.63 72.72 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 169.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -60.53 -43.45 97.13 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 169.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.61 -38.72 88.68 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 167.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.68 -41.5 96.01 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 169.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.26 -51.42 67.79 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 162.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -96.61 58.89 1.74 Allowed 'General case' 0 CA--C 1.572 1.82 0 CA-C-N 119.328 0.967 . . . . 0.0 111.965 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -96.57 -16.33 21.12 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.696 2.109 . . . . 0.0 116.696 -170.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 55.31 57.31 5.55 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 119.878 1.217 . . . . 0.0 114.162 -167.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.4 tp -80.73 117.42 21.39 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 121.969 0.89 . . . . 0.0 111.301 -176.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -122.01 109.52 14.68 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.011 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 84.3 mt -94.89 106.68 18.69 Favored 'General case' 0 CA--C 1.563 1.442 0 C-N-CA 123.31 0.644 . . . . 0.0 110.227 -174.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.0 m -92.11 109.05 20.4 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.268 -0.895 . . . . 0.0 109.894 170.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.4 mt -101.5 133.99 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.739 0 C-N-CA 124.409 1.084 . . . . 0.0 108.53 -170.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t -153.02 125.67 8.27 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.939 -1.101 . . . . 0.0 111.729 171.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -87.29 116.94 25.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.129 -0.982 . . . . 0.0 112.08 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -103.11 75.29 1.36 Allowed 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.413 0.685 . . . . 0.0 110.256 171.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.68 75.29 0.43 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 115.947 1.139 . . . . 0.0 115.947 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.276 10.9 t-20 70.28 -48.67 0.64 Allowed 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -167.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -68.94 114.14 6.97 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 119.313 0.96 . . . . 0.0 113.352 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -88.43 120.48 29.85 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.154 0.582 . . . . 0.0 111.181 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.1 m -89.39 109.34 20.26 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 167.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.0 t -109.71 109.01 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -82.89 106.06 14.4 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -85.57 84.94 7.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.999 0.52 . . . . 0.0 109.906 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 t -85.84 111.06 19.84 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.564 0.345 . . . . 0.0 110.848 -176.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.2 p -142.93 159.85 41.46 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -169.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.34 -27.75 56.86 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 118.321 2.711 . . . . 0.0 118.321 169.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -74.24 -46.86 38.94 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 164.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.7 ptt-85 -167.02 150.76 6.71 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.772 0.829 . . . . 0.0 112.171 -170.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.65 96.62 6.08 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.585 0.754 . . . . 0.0 110.878 171.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.6 pt -119.59 127.47 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.569 -0.707 . . . . 0.0 112.416 -169.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.38 112.13 13.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.542 -0.724 . . . . 0.0 112.166 170.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.5 t -104.75 102.15 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.24 116.79 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -133.14 135.34 45.12 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.438 0.637 . . . . 0.0 111.53 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -80.61 136.27 36.2 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.595 -0.69 . . . . 0.0 111.328 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 57.1 mt -60.06 125.24 22.88 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -176.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.18 -5.7 70.87 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 119.708 2.643 . . . . 0.0 119.708 -172.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.4 t -88.75 133.0 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 120.122 1.961 . . . . 0.0 109.736 -176.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.7 p -72.92 110.26 7.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.65 -0.657 . . . . 0.0 111.947 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -126.83 163.02 24.52 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 124.013 0.925 . . . . 0.0 112.039 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -84.32 106.54 16.01 Favored 'General case' 0 CA--C 1.569 1.689 0 O-C-N 121.297 -0.877 . . . . 0.0 111.586 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -102.44 167.86 9.68 Favored 'General case' 0 CA--C 1.571 1.759 0 C-N-CA 124.749 1.22 . . . . 0.0 112.445 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -146.96 131.53 17.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.705 -1.247 . . . . 0.0 111.575 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.9 mt -84.83 62.77 7.63 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.271 . . 61.46 -36.49 0.11 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 120.409 3.485 . . . . 0.0 120.409 175.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -86.91 -85.89 0.16 Allowed 'General case' 0 CA--C 1.565 1.555 0 CA-C-N 120.052 1.297 . . . . 0.0 110.2 177.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.61 74.5 0.1 OUTLIER Glycine 0 N--CA 1.482 1.747 0 O-C-N 121.587 -0.696 . . . . 0.0 113.536 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.5 m -146.9 123.97 11.42 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.519 -0.989 . . . . 0.0 109.985 162.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -78.42 130.84 36.56 Favored 'General case' 0 CA--C 1.566 1.587 0 CA-C-O 122.155 0.978 . . . . 0.0 112.435 173.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.6 mt -131.61 111.52 11.8 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.242 -165.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -86.61 114.5 23.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.095 -1.003 . . . . 0.0 111.052 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.37 178.63 47.91 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 116.399 1.32 . . . . 0.0 116.399 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.1 p -92.21 165.31 13.19 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.27 1.033 . . . . 0.0 113.494 -174.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -127.23 108.83 11.22 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 143.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.4 m -100.36 137.48 38.72 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.49 0.716 . . . . 0.0 110.949 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.7 tp -85.3 94.75 9.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.215 -0.928 . . . . 0.0 111.398 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -84.49 79.18 9.66 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-O 121.836 0.827 . . . . 0.0 110.866 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.55 -94.58 0.95 Allowed Glycine 0 N--CA 1.489 2.222 0 O-C-N 121.722 -0.612 . . . . 0.0 113.908 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -126.5 63.62 1.27 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.822 0.82 . . . . 0.0 109.695 163.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -152.45 125.19 8.39 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.7 mt -90.74 105.12 17.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.56 -1.338 . . . . 0.0 109.571 171.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.1 tt -105.18 125.68 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 123.743 0.817 . . . . 0.0 110.616 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.65 118.53 1.99 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 115.58 0.992 . . . . 0.0 115.58 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -95.27 99.91 11.79 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.215 0.606 . . . . 0.0 110.229 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -107.62 107.25 17.98 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -167.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -90.48 136.58 32.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.377 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -75.54 124.86 27.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.999 -1.063 . . . . 0.0 113.239 -173.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.5 p -80.8 62.7 4.93 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 122.332 1.063 . . . . 0.0 112.723 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.4 t0 171.85 -41.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 126.732 2.013 . . . . 0.0 110.283 -166.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -121.49 -18.47 7.24 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -175.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.08 -34.91 3.64 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 118.516 2.166 . . . . 0.0 118.516 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -69.89 139.94 53.08 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -166.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -81.79 128.06 33.62 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.8 tt -106.41 85.62 2.21 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.253 8.5 p30 -81.11 110.36 16.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.334 -0.854 . . . . 0.0 110.803 -173.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.9 m -114.18 112.18 22.75 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.916 -164.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.3 t -102.39 103.86 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.1 mtm180 -85.68 120.64 27.34 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.611 -0.681 . . . . 0.0 110.211 164.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.74 157.92 43.77 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.2 mm -94.31 118.14 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.661 -1.274 . . . . 0.0 109.818 -175.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.2 tt -88.76 71.02 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.14 0.971 . . . . 0.0 111.339 171.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.68 -79.22 0.97 Allowed Glycine 0 N--CA 1.491 2.332 0 O-C-N 120.704 -1.248 . . . . 0.0 114.874 -172.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -107.67 -33.64 7.23 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -93.84 146.22 24.05 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 120.482 1.492 . . . . 0.0 112.82 -174.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.3 tp -86.9 115.87 24.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 110.79 174.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 19.6 m -98.03 115.83 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.354 -0.841 . . . . 0.0 109.752 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -97.39 101.73 13.33 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 171.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.1 m -95.03 105.87 17.82 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.216 0.607 . . . . 0.0 109.558 -176.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -92.84 113.83 26.22 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 124.159 0.984 . . . . 0.0 109.505 -177.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.5 t -113.28 112.64 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -123.11 94.42 4.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.691 -0.63 . . . . 0.0 110.059 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 50.9 55.21 9.9 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 103.26 -49.87 0.93 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 117.094 1.598 . . . . 0.0 117.094 -169.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.1 p -76.45 113.4 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 119.211 1.506 . . . . 0.0 113.151 -165.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -92.18 116.89 29.34 Favored 'General case' 0 CA--C 1.563 1.446 0 O-C-N 121.91 -0.494 . . . . 0.0 111.155 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.42 139.76 48.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.914 -0.491 . . . . 0.0 111.734 163.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -120.27 110.31 16.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.886 . . . . 0.0 110.467 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -89.19 108.47 19.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.62 -0.675 . . . . 0.0 110.458 164.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.7 mp -90.22 120.89 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -110.53 131.82 54.72 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 124.05 0.94 . . . . 0.0 110.116 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -90.51 149.02 22.36 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-O 121.864 0.84 . . . . 0.0 111.817 174.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -68.25 106.87 2.59 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 112.035 173.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.046 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -75.36 77.25 2.44 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 -171.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.8 t -148.14 -177.46 5.76 Favored 'General case' 0 CA--C 1.574 1.891 0 CA-C-O 122.389 1.09 . . . . 0.0 111.266 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -95.19 115.87 27.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.126 -0.984 . . . . 0.0 109.667 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -117.37 103.72 10.41 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.97 0.508 . . . . 0.0 110.402 -169.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -86.71 135.69 33.29 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 123.539 0.735 . . . . 0.0 111.998 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.2 p -63.54 119.18 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.338 -0.851 . . . . 0.0 113.228 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -103.77 -53.2 2.81 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 124.021 0.929 . . . . 0.0 113.084 -173.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -149.05 85.54 1.47 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 119.212 0.915 . . . . 0.0 111.095 -172.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.4 p -73.32 120.2 18.61 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 178.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -104.28 115.22 30.02 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 123.544 0.737 . . . . 0.0 109.831 -169.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.1 t30 62.05 17.7 9.31 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 118.116 2.635 . . . . 0.0 118.116 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -75.85 -35.83 59.8 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -168.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.95 -26.17 68.03 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 162.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -71.36 -47.49 56.03 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 119.917 1.235 . . . . 0.0 114.245 166.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -43.9 -50.68 7.97 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 160.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.7 mtt -64.84 -32.98 74.93 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 172.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.42 -43.41 93.05 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 120.897 1.681 . . . . 0.0 115.326 162.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -62.09 -34.73 76.86 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 169.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 22.1 mmt -60.3 -30.28 69.39 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 164.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.94 50.41 3.29 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 115.612 1.005 . . . . 0.0 115.612 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.3 m -89.8 160.63 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 121.984 0.897 . . . . 0.0 113.208 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -70.86 154.75 41.55 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 165.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.269 14.7 tt -59.14 -36.87 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.11 -56.0 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-N 119.558 1.072 . . . . 0.0 112.922 172.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -65.19 -28.78 69.63 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 116.788 2.144 . . . . 0.0 116.788 172.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.5 ttp85 -58.9 -42.23 89.09 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 117.27 2.322 . . . . 0.0 117.27 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.5 OUTLIER -77.36 -48.24 17.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 162.343 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.84 -51.33 62.66 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -175.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.19 -37.04 85.64 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 173.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.71 -51.42 65.05 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 168.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -100.12 47.76 0.93 Allowed 'General case' 0 CA--C 1.574 1.881 0 CA-C-N 118.954 0.797 . . . . 0.0 112.703 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -83.99 16.27 2.96 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -169.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 53.44 50.19 17.94 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.164 -1.585 . . . . 0.0 115.136 -170.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.2 tp -80.23 120.65 24.61 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 121.88 0.847 . . . . 0.0 112.873 -171.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -111.87 121.06 44.0 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.287 172.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.6 mt -101.9 102.54 13.12 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.969 0.508 . . . . 0.0 109.966 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.2 m -89.86 108.82 19.93 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.328 -0.858 . . . . 0.0 109.231 169.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.0 mt -101.57 128.9 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -172.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 t -145.31 133.65 21.78 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.894 -1.129 . . . . 0.0 111.56 171.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -99.95 118.87 37.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.194 -0.942 . . . . 0.0 112.3 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -100.81 71.2 1.44 Allowed 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 123.137 0.575 . . . . 0.0 110.636 169.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 62.39 77.33 0.21 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 116.552 1.381 . . . . 0.0 116.552 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.278 7.1 t30 72.21 -24.72 0.18 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -170.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -90.0 109.62 20.64 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 119.657 1.117 . . . . 0.0 111.901 172.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -83.04 118.01 23.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.516 -0.74 . . . . 0.0 111.161 169.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.6 m -86.23 107.55 17.97 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 164.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.07 112.67 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -87.24 111.36 20.94 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.286 0.634 . . . . 0.0 110.351 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -89.99 89.46 7.72 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.289 0.635 . . . . 0.0 109.467 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.7 m -97.4 107.7 20.27 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.8 p -145.84 174.0 11.62 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.02 0.914 . . . . 0.0 113.23 -171.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.85 -30.32 65.69 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 118.432 2.753 . . . . 0.0 118.432 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.2 -31.64 30.24 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 168.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -159.24 155.27 26.7 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 119.926 1.239 . . . . 0.0 113.357 -159.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -134.64 99.88 4.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.068 -1.02 . . . . 0.0 108.748 165.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.6 pt -132.22 129.75 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.854 -0.529 . . . . 0.0 111.704 -169.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.13 109.66 19.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.203 -0.936 . . . . 0.0 111.762 174.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.8 t -100.43 107.8 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -175.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -92.36 109.99 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -120.26 129.03 53.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.856 -0.528 . . . . 0.0 111.203 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -80.63 130.87 35.36 Favored 'General case' 0 CA--C 1.562 1.425 0 O-C-N 121.666 -0.646 . . . . 0.0 111.117 168.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.3 mt -61.45 124.22 20.03 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.72 -17.45 58.58 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 119.354 2.502 . . . . 0.0 119.354 -166.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.5 t -89.46 134.93 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-N 120.768 2.284 . . . . 0.0 110.41 -176.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -76.87 116.43 17.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.579 -0.701 . . . . 0.0 112.594 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -135.68 159.2 42.38 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 123.651 0.78 . . . . 0.0 111.297 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.03 94.29 7.48 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 121.306 -0.871 . . . . 0.0 112.404 -172.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -89.39 145.76 25.12 Favored 'General case' 0 CA--C 1.569 1.701 0 O-C-N 121.499 -0.751 . . . . 0.0 112.458 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -128.33 126.01 39.89 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.428 -0.795 . . . . 0.0 110.832 -174.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.7 mt -94.65 74.1 3.7 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -173.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.32 . . 65.7 -61.52 0.26 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -67.63 -18.24 64.89 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 119.141 3.015 . . . . 0.0 119.141 174.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.89 31.35 5.73 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 117.515 1.766 . . . . 0.0 117.515 -163.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.1 m -81.45 99.07 8.54 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.129 0.965 . . . . 0.0 109.176 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -85.72 99.39 11.3 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -160.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.6 mt -112.55 113.87 26.24 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.787 0.835 . . . . 0.0 110.832 -167.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -97.22 123.5 41.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.944 . . . . 0.0 111.336 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.71 179.76 46.4 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 118.061 1.984 . . . . 0.0 118.061 -169.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 80.7 p -114.32 134.03 55.25 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.013 -1.093 . . . . 0.0 111.357 -169.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -89.85 119.54 30.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.852 . . . . 0.0 109.974 162.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.6 m -117.17 125.71 51.63 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.175 0.59 . . . . 0.0 110.997 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 tp -91.48 100.22 13.02 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.263 0.625 . . . . 0.0 111.243 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.86 68.79 2.06 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.456 0.703 . . . . 0.0 111.801 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.19 69.23 1.42 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 116.208 1.243 . . . . 0.0 116.208 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.256 1.1 t30 59.46 29.08 18.6 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 -168.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -138.01 111.66 8.2 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.4 mt -95.45 105.1 17.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.488 -0.758 . . . . 0.0 109.72 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.5 tt -95.02 121.12 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.978 0.894 . . . . 0.0 109.807 173.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.8 101.95 2.83 Favored Glycine 0 N--CA 1.479 1.557 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.467 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -91.83 96.44 10.41 Favored 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -121.3 149.45 42.88 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.163 0.982 . . . . 0.0 112.201 -168.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -121.77 139.56 53.44 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 121.857 0.837 . . . . 0.0 109.669 167.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.7 mmm-85 -61.8 115.69 4.21 Favored 'General case' 0 CA--C 1.562 1.427 0 O-C-N 121.451 -0.781 . . . . 0.0 112.889 166.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.8 p -60.22 -55.97 27.22 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 169.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -83.59 55.03 3.05 Favored 'General case' 0 CA--C 1.578 2.036 0 O-C-N 121.58 -0.7 . . . . 0.0 112.375 171.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -175.32 -35.7 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 172.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.81 21.23 77.03 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 118.588 2.195 . . . . 0.0 118.588 -165.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -119.59 145.98 45.92 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.484 1.142 . . . . 0.0 113.154 -168.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.26 135.99 34.11 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -168.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.6 tt -123.8 130.78 53.16 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.612 1.165 . . . . 0.0 110.625 174.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -111.93 116.16 30.16 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.6 m -109.5 102.71 11.55 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 120.649 1.568 . . . . 0.0 110.493 171.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.8 t -102.59 90.91 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -174.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -99.58 137.22 38.38 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.336 1.065 . . . . 0.0 113.071 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -157.89 154.03 27.25 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.89 -174.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.5 mm -93.69 108.74 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.436 -0.79 . . . . 0.0 109.453 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.254 16.4 tt -86.29 71.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 122.152 0.977 . . . . 0.0 111.234 172.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.46 -84.92 0.95 Allowed Glycine 0 N--CA 1.489 2.228 0 O-C-N 121.012 -1.055 . . . . 0.0 114.56 -174.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -129.72 65.1 1.49 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 122.665 0.386 . . . . 0.0 110.044 167.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -164.36 125.37 2.16 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.424 0.69 . . . . 0.0 110.009 170.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.1 tp -83.22 102.81 12.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.609 -0.682 . . . . 0.0 109.197 171.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.4 m -91.7 98.45 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -96.17 95.3 8.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.095 -1.003 . . . . 0.0 110.757 -170.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.9 m -89.6 102.58 15.26 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.236 0.614 . . . . 0.0 111.184 -166.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -90.24 119.78 30.84 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.745 0.818 . . . . 0.0 110.85 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.8 t -120.2 104.61 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -113.41 118.27 34.08 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.094 0.557 . . . . 0.0 110.657 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.28 53.0 mt-10 64.9 -79.33 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 123.834 0.854 . . . . 0.0 112.829 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -151.3 58.25 0.43 Allowed Glycine 0 N--CA 1.487 2.051 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.993 157.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.2 p -133.79 112.79 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 118.34 1.07 . . . . 0.0 109.834 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -89.64 124.5 34.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.476 -0.765 . . . . 0.0 111.264 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.24 127.14 20.68 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 170.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -98.68 121.71 40.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.926 . . . . 0.0 111.535 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -85.75 106.98 17.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.319 157.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.7 mt -96.6 115.26 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -176.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -111.3 134.15 53.1 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 122.985 0.514 . . . . 0.0 111.184 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -94.7 147.07 23.7 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-O 121.74 0.781 . . . . 0.0 112.417 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -72.84 116.1 12.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.425 -0.797 . . . . 0.0 112.312 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -172.787 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.264 0 CA-C-O 121.527 0.679 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.302 96.4 m-85 73.82 -54.97 0.68 Allowed 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 174.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -76.84 82.45 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.832 1.197 . . . . 0.0 112.847 -171.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.9 m -170.59 172.85 5.71 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 124.86 1.264 . . . . 0.0 110.832 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.6 m -83.63 113.93 21.19 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.089 -1.007 . . . . 0.0 111.217 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -118.04 113.76 22.11 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.547 0.739 . . . . 0.0 109.914 -175.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -108.33 140.71 41.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.509 -0.745 . . . . 0.0 112.398 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.8 p -62.35 119.19 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -91.35 -54.26 3.99 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 123.765 0.826 . . . . 0.0 112.641 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -148.22 122.85 9.83 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 118.679 0.672 . . . . 0.0 110.226 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.9 m -108.83 115.06 29.36 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.466 0.706 . . . . 0.0 110.843 -172.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -110.99 111.86 23.28 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -161.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.281 12.5 t30 67.07 19.65 10.46 Favored 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 117.573 2.435 . . . . 0.0 117.573 -174.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -72.56 -38.4 67.96 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.48 -29.01 69.7 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 165.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -72.24 -53.3 12.93 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 119.551 1.069 . . . . 0.0 113.595 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -42.82 -53.93 4.38 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 162.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.9 mtt -65.45 -27.13 68.29 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 116.755 2.132 . . . . 0.0 116.755 172.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -64.4 -39.87 94.68 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 166.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -63.17 -32.3 73.66 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 165.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.6 mtm -73.94 -14.35 61.03 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 169.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.11 56.49 2.7 Favored Glycine 0 N--CA 1.487 2.039 0 CA-C-N 120.118 1.327 . . . . 0.0 115.824 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.261 6.0 p -125.35 142.47 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-O 121.795 0.807 . . . . 0.0 112.614 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -62.39 146.2 51.95 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -172.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.288 0.0 OUTLIER -44.26 -46.89 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 176.408 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.8 t -55.53 -61.57 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 C-N-CA 124.204 1.002 . . . . 0.0 113.345 171.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -60.23 -42.65 95.68 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 173.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.8 ttp85 -59.02 -48.21 82.42 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 173.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -66.22 -38.58 88.28 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.9 mt -65.29 -33.24 75.5 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 167.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.13 -32.77 70.93 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 168.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.97 -57.07 14.44 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 154.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -90.05 66.06 6.68 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.56 1.172 . . . . 0.0 112.054 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -101.95 -31.71 10.55 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 116.733 2.123 . . . . 0.0 116.733 -162.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 64.61 50.28 2.17 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 119.781 1.173 . . . . 0.0 113.986 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 tp -89.45 112.13 23.19 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.081 -1.012 . . . . 0.0 111.264 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -103.4 108.67 20.0 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.963 1.305 . . . . 0.0 109.046 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.6 mt -100.21 104.05 15.54 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.607 0.763 . . . . 0.0 109.542 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.2 m -94.9 102.72 14.57 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.557 -0.714 . . . . 0.0 109.448 171.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.9 mt -86.34 121.68 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.776 0.83 . . . . 0.0 108.983 -175.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.4 p -128.34 119.53 25.25 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.618 -0.676 . . . . 0.0 110.429 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -74.84 127.89 34.27 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 122.443 1.115 . . . . 0.0 112.348 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -110.94 -28.3 8.42 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -168.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.05 74.37 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 C-N-CA 124.6 1.095 . . . . 0.0 110.568 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.29 14.7 t-20 66.73 -55.96 0.42 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -150.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -53.59 148.97 8.64 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -113.95 114.8 26.69 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 171.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.1 m -87.17 100.47 12.69 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 170.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.1 t -107.21 113.59 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -171.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -83.39 109.22 17.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.357 0.663 . . . . 0.0 109.52 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -103.82 88.65 3.1 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -170.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.4 m -96.0 120.25 35.95 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.777 0.831 . . . . 0.0 111.142 -171.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.1 p -142.94 169.29 17.84 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.782 1.031 . . . . 0.0 113.782 -172.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.52 -31.27 61.94 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 163.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -79.92 -51.26 9.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 170.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -159.23 148.57 18.54 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -165.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -103.62 102.77 12.65 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 164.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.5 pt -119.05 123.96 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.613 -0.68 . . . . 0.0 111.114 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -90.25 105.4 17.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 0.0 109.935 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.5 105.68 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -170.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.7 t -91.68 99.14 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -110.79 132.63 54.03 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.244 0.545 . . . . 0.0 111.883 178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -84.78 145.7 27.75 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.443 0.64 . . . . 0.0 111.593 168.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.0 mt -63.57 102.13 0.4 Allowed 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.36 -5.16 44.58 Favored Glycine 0 CA--C 1.551 2.342 0 N-CA-C 119.19 2.436 . . . . 0.0 119.19 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.2 p -78.26 139.73 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 120.963 2.381 . . . . 0.0 112.895 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 66.0 m -86.4 105.95 17.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.556 -0.715 . . . . 0.0 109.87 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -132.0 158.37 41.67 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.436 0.694 . . . . 0.0 111.971 -175.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -82.33 95.75 7.71 Favored 'General case' 0 CA--C 1.568 1.652 0 O-C-N 121.647 -0.658 . . . . 0.0 111.202 174.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -83.92 137.81 33.47 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.558 0.694 . . . . 0.0 111.589 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -120.17 133.27 55.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.718 -0.614 . . . . 0.0 109.969 177.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.0 mt -81.72 -132.04 0.03 OUTLIER 'General case' 0 CA--C 1.576 1.958 0 O-C-N 122.093 -0.379 . . . . 0.0 111.31 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.55 -45.57 11.64 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.6 p30 -99.26 -76.38 0.54 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.741 0.816 . . . . 0.0 111.958 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.88 82.05 0.12 Allowed Glycine 0 N--CA 1.482 1.722 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -169.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.0 m -143.1 100.38 3.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.62 113.92 22.9 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.581 0.705 . . . . 0.0 111.516 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.0 mt -118.28 105.84 12.17 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.514 0.726 . . . . 0.0 110.826 -169.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -79.46 119.85 23.04 Favored 'General case' 0 CA--C 1.566 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 111.589 172.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.25 -158.37 30.41 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.8 p -127.17 142.79 51.41 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 123.135 0.574 . . . . 0.0 112.536 -158.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -100.64 116.58 32.9 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.53 -0.731 . . . . 0.0 109.316 158.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 t -122.77 130.29 52.74 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.276 0.631 . . . . 0.0 111.748 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.8 tp -84.06 116.4 22.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.849 -1.157 . . . . 0.0 111.961 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -139.78 100.29 3.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.895 -0.503 . . . . 0.0 110.923 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.27 67.29 2.13 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 116.444 1.337 . . . . 0.0 116.444 174.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.288 21.1 t-20 72.91 -55.55 0.68 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 113.763 1.024 . . . . 0.0 113.763 -157.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -81.77 134.76 35.47 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -152.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.8 mt -85.83 108.32 18.07 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.805 0.812 . . . . 0.0 109.018 170.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.7 mm -96.35 113.02 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -170.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.59 87.87 1.55 Allowed Glycine 0 N--CA 1.48 1.578 0 CA-C-O 119.558 -0.579 . . . . 0.0 112.951 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -86.58 97.68 10.66 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.744 0.783 . . . . 0.0 109.62 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -120.23 161.95 20.22 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-O 123.421 1.581 . . . . 0.0 111.92 -174.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -143.54 149.03 36.86 Favored 'General case' 0 CA--C 1.559 1.325 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.739 164.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -67.46 113.19 5.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.019 -1.051 . . . . 0.0 112.576 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.5 t -65.78 -19.81 66.03 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 165.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.14 -28.58 70.16 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 117.159 2.281 . . . . 0.0 117.159 157.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -130.23 -46.11 1.11 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 -167.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.34 -24.41 24.49 Favored Glycine 0 CA--C 1.554 2.527 0 N-CA-C 117.432 1.733 . . . . 0.0 117.432 -155.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -76.97 139.74 40.22 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 119.842 1.821 . . . . 0.0 114.577 -174.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.04 141.1 49.29 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tt -129.91 120.93 25.68 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.145 0.578 . . . . 0.0 110.061 171.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -109.87 113.9 27.02 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.934 -1.104 . . . . 0.0 109.38 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.1 m -114.35 102.53 10.19 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 119.279 0.945 . . . . 0.0 110.479 -177.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.7 t -90.23 106.13 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 120.809 -1.182 . . . . 0.0 109.595 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -86.03 115.42 23.62 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 123.477 0.711 . . . . 0.0 110.907 170.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -140.45 144.19 35.96 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 123.516 0.727 . . . . 0.0 111.914 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.3 mm -97.76 109.64 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.28 -0.888 . . . . 0.0 109.122 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.252 11.0 tp -93.01 85.02 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-O 121.945 0.878 . . . . 0.0 110.225 169.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.32 -86.89 0.91 Allowed Glycine 0 N--CA 1.49 2.282 0 O-C-N 121.289 -0.882 . . . . 0.0 114.589 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -135.42 53.57 1.96 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.386 0.613 . . . . 0.0 111.995 166.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -146.43 121.25 9.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.126 -0.984 . . . . 0.0 108.359 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.9 tp -82.7 101.23 10.73 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.3 m -101.6 105.47 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.631 -0.668 . . . . 0.0 109.279 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -92.77 109.25 20.67 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.633 -0.667 . . . . 0.0 111.246 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.3 m -91.21 108.62 20.0 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -97.64 119.49 36.31 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 123.977 0.911 . . . . 0.0 109.688 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.6 t -118.29 106.33 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -99.12 116.15 30.67 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 119.038 0.835 . . . . 0.0 109.77 172.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.265 42.0 mt-10 66.12 -79.33 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 123.65 0.78 . . . . 0.0 112.046 -176.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -148.86 42.25 0.83 Allowed Glycine 0 CA--C 1.553 2.455 0 CA-C-O 118.441 -1.199 . . . . 0.0 116.072 157.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -114.41 115.46 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-N 119.729 1.764 . . . . 0.0 110.625 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -81.99 130.34 35.05 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.45 126.13 34.26 Favored 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 123.235 0.614 . . . . 0.0 111.177 163.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -114.64 105.24 12.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.658 -0.651 . . . . 0.0 111.1 -169.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -98.58 117.83 33.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.88 -0.513 . . . . 0.0 111.209 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.9 mt -93.04 115.25 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -103.88 116.86 33.05 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -83.43 157.4 22.49 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 121.611 0.72 . . . . 0.0 111.674 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -66.64 104.27 1.26 Allowed 'General case' 0 CA--C 1.57 1.715 0 O-C-N 120.974 -1.079 . . . . 0.0 112.027 176.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 N--CA 1.491 1.594 0 C-N-CA 124.923 1.289 . . . . 0.0 114.25 -173.761 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.343 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.323 88.9 m-85 72.46 -52.63 0.7 Allowed 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 171.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.25 80.92 1.33 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 120.007 1.276 . . . . 0.0 112.857 -172.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.3 m -174.58 175.69 2.46 Favored 'General case' 0 CA--C 1.572 1.793 0 C-N-CA 125.381 1.473 . . . . 0.0 110.325 -173.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 t -98.62 134.6 41.33 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.906 -1.121 . . . . 0.0 111.462 168.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -126.78 105.01 8.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.431 -0.793 . . . . 0.0 109.15 -166.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -97.02 137.91 35.37 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.493 -0.754 . . . . 0.0 112.513 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -64.3 128.65 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.831 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -170.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -111.12 -49.56 3.01 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.96 135.98 12.82 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 120.295 1.407 . . . . 0.0 111.722 173.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.1 p -107.2 129.64 54.83 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.929 0.892 . . . . 0.0 112.037 174.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -69.68 -66.52 0.58 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -141.92 59.7 1.48 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.158 0.89 . . . . 0.0 111.852 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -82.87 54.68 2.79 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.391 -1.443 . . . . 0.0 112.947 174.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -154.78 -55.79 0.1 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.595 1.558 . . . . 0.0 108.72 -170.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -68.77 -30.41 69.0 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 121.292 1.86 . . . . 0.0 115.67 160.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -52.22 -53.11 47.56 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 121.302 1.865 . . . . 0.0 114.644 156.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -40.27 93.71 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 170.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.27 -32.92 74.45 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 167.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -62.61 -39.08 92.66 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 159.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.1 mmm -63.18 -34.96 78.76 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 116.029 1.862 . . . . 0.0 116.029 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.71 52.81 0.74 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.426 HG23 ' HG2' ' A' ' 28' ' ' ARG . 6.7 m -130.54 143.67 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 122.127 0.965 . . . . 0.0 112.533 -174.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -65.33 157.82 28.13 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.268 10.8 tp -49.78 -39.48 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 N-CA-C 118.447 2.758 . . . . 0.0 118.447 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.5 t -62.01 -54.04 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-N 119.491 1.041 . . . . 0.0 112.381 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -56.98 -36.69 70.63 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 167.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HG2' HG23 ' A' ' 23' ' ' VAL . 76.4 mtm-85 -62.58 -46.08 89.94 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 121.219 1.827 . . . . 0.0 115.183 169.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -58.07 -49.24 77.6 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 166.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.53 -35.42 70.68 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 116.493 2.034 . . . . 0.0 116.493 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.36 99.07 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 163.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.85 -58.44 8.37 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 162.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -90.24 56.26 3.33 Favored 'General case' 0 CA--C 1.574 1.873 0 CA-C-O 122.316 1.055 . . . . 0.0 113.112 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -88.96 -31.83 17.96 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 71.02 64.11 0.17 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 124.722 1.209 . . . . 0.0 113.409 173.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.6 tp -97.44 125.8 42.31 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.707 0.765 . . . . 0.0 113.042 -167.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -103.36 126.07 50.32 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.891 163.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.9 mt -104.16 103.76 13.59 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 m -91.3 107.88 19.51 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.227 -0.92 . . . . 0.0 108.822 172.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 73.5 mt -100.76 96.95 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -169.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.0 m -98.95 100.49 11.67 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -87.49 121.67 30.22 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 121.6 -0.687 . . . . 0.0 111.813 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -109.36 82.45 1.6 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.18 0.991 . . . . 0.0 109.741 161.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.11 -110.69 3.29 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 114.807 0.683 . . . . 0.0 114.807 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -81.65 -23.6 36.82 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -81.07 115.89 20.74 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 119.871 1.214 . . . . 0.0 111.482 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -101.83 110.37 22.34 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.7 m -91.36 97.39 11.06 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.6 t -95.75 106.27 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -85.21 106.84 16.94 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -94.8 90.4 6.04 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -173.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 m -104.49 115.89 31.14 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.403 0.681 . . . . 0.0 111.018 -173.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.3 p -146.84 -178.5 6.22 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.61 54.22 0.59 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -175.92 -57.29 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.859 0 C-N-CA 125.731 1.612 . . . . 0.0 109.797 -159.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.5 ptp85 -146.33 149.18 33.33 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.175 0.99 . . . . 0.0 111.777 -160.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -135.09 94.27 3.12 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 165.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.8 pt -129.69 124.24 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.323 0.582 . . . . 0.0 111.073 -172.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.42 101.65 14.33 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.982 0.913 . . . . 0.0 111.747 176.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.4 t -91.78 106.4 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.58 106.46 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -122.14 137.07 54.96 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.489 0.662 . . . . 0.0 112.305 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -81.61 140.25 34.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.381 -0.825 . . . . 0.0 111.579 167.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.83 113.59 2.58 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.32 -11.72 56.92 Favored Glycine 0 CA--C 1.55 2.232 0 N-CA-C 118.506 2.162 . . . . 0.0 118.506 -171.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.2 p -78.48 140.27 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-N 120.53 2.165 . . . . 0.0 113.569 -171.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.2 m -84.88 104.18 14.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.728 -0.608 . . . . 0.0 109.539 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -136.99 165.34 26.22 Favored 'General case' 0 CA--C 1.569 1.711 0 CA-C-O 121.675 0.75 . . . . 0.0 112.581 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -87.57 98.9 11.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.559 -0.713 . . . . 0.0 111.791 175.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -86.55 156.37 20.1 Favored 'General case' 0 CA--C 1.567 1.618 0 C-N-CA 123.631 0.772 . . . . 0.0 112.421 173.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -128.75 131.96 47.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.724 -1.235 . . . . 0.0 110.695 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 33.8 mt -86.72 169.97 12.18 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.847 0.832 . . . . 0.0 113.066 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.35 46.9 0.11 Allowed 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 118.773 2.879 . . . . 0.0 118.773 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -138.9 -80.56 0.32 Allowed 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 159.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.19 79.74 0.05 OUTLIER Glycine 0 N--CA 1.48 1.589 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 97.2 m -152.46 128.8 10.57 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.462 -1.022 . . . . 0.0 111.143 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -79.62 131.33 35.96 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.9 mt -124.05 104.32 8.81 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.677 0.791 . . . . 0.0 110.879 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -76.38 114.8 15.48 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.983 0.913 . . . . 0.0 112.095 172.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.94 -164.02 36.78 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 117.083 1.593 . . . . 0.0 117.083 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.9 p -120.57 121.93 39.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -160.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -86.32 112.86 21.82 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 122.906 0.482 . . . . 0.0 110.776 161.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.3 m -119.17 130.2 55.4 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.738 -0.601 . . . . 0.0 112.431 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.8 tp -88.72 130.48 35.32 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.185 -0.947 . . . . 0.0 112.258 177.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -107.45 -79.05 0.58 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 123.512 0.725 . . . . 0.0 110.903 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.15 88.92 0.11 Allowed Glycine 0 N--CA 1.49 2.298 0 CA-C-N 119.803 1.183 . . . . 0.0 111.852 -173.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.26 63.0 m-80 65.4 10.03 6.22 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -156.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -132.99 117.73 17.98 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.374 1.069 . . . . 0.0 109.78 -169.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.37 109.24 20.84 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 168.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.9 tp -91.93 117.67 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.415 -0.803 . . . . 0.0 110.248 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.21 98.21 2.02 Favored Glycine 0 N--CA 1.483 1.795 0 C-N-CA 123.461 0.553 . . . . 0.0 112.424 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -94.84 98.1 10.49 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -124.06 146.48 48.55 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.021 0.915 . . . . 0.0 113.044 -166.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -120.12 148.76 43.21 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.527 0.731 . . . . 0.0 109.693 164.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -73.9 148.55 42.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.148 -1.595 . . . . 0.0 113.433 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.7 p -70.97 -73.59 0.17 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.568 -0.707 . . . . 0.0 111.754 167.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.86 -41.78 97.7 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.844 2.165 . . . . 0.0 116.844 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.31 -14.1 39.13 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 174.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.05 -39.57 2.98 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 118.327 2.091 . . . . 0.0 118.327 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -80.27 162.08 24.79 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -156.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.26 135.66 47.57 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -177.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.5 tt -125.61 130.8 52.36 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 124.185 0.994 . . . . 0.0 109.395 168.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -107.21 129.15 54.9 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.209 -0.932 . . . . 0.0 109.702 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -123.74 108.53 12.63 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.41 -0.806 . . . . 0.0 109.182 171.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.8 t -98.12 110.22 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -87.58 114.99 24.7 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.496 0.718 . . . . 0.0 111.122 172.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -132.19 133.92 44.77 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 119.284 0.947 . . . . 0.0 111.869 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.39 108.77 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.952 -1.093 . . . . 0.0 108.541 173.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.0 pt -97.23 94.03 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 C-N-CA 124.296 1.039 . . . . 0.0 109.028 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.1 -101.67 1.36 Allowed Glycine 0 N--CA 1.492 2.38 0 O-C-N 121.239 -0.913 . . . . 0.0 113.01 -169.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -131.74 53.31 2.0 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.368 0.604 . . . . 0.0 112.009 161.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -134.99 125.37 26.45 Favored 'General case' 0 CA--C 1.563 1.448 0 O-C-N 121.44 -0.787 . . . . 0.0 109.381 167.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.7 tp -78.29 107.67 11.06 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.746 0.818 . . . . 0.0 110.487 175.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -92.38 118.85 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.334 -0.854 . . . . 0.0 110.931 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -95.27 106.89 18.97 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.79 0.836 . . . . 0.0 109.679 172.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.1 m -91.47 104.12 16.66 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.083 0.553 . . . . 0.0 109.864 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -95.61 121.22 37.08 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.181 0.592 . . . . 0.0 111.749 -174.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.6 t -120.63 121.04 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -136.52 98.31 3.78 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.862 -0.524 . . . . 0.0 110.191 168.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 66.19 68.53 0.45 Allowed 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 168.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.68 44.47 57.02 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 118.303 2.081 . . . . 0.0 118.303 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -156.53 150.99 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 118.439 1.12 . . . . 0.0 110.401 -176.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.47 126.12 32.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.165 -0.96 . . . . 0.0 110.313 174.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -128.02 105.67 8.55 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.071 0.548 . . . . 0.0 111.286 171.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -85.42 118.47 24.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 110.967 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.4 mtt-85 -99.84 110.32 22.69 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 164.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.7 mt -81.65 133.27 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -120.65 121.78 39.07 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.065 0.946 . . . . 0.0 109.189 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -77.7 142.37 38.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 112.609 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -69.16 111.25 4.99 Favored 'General case' 0 CA--C 1.568 1.655 0 O-C-N 121.451 -0.78 . . . . 0.0 111.785 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 N--CA 1.488 1.468 0 C-N-CA 124.938 1.295 . . . . 0.0 112.587 -170.148 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 1.397 0 CA-C-O 122.144 0.973 . . . . 0.0 113.032 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.328 54.2 m-85 74.99 -49.8 0.66 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 117.712 2.486 . . . . 0.0 117.712 166.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -75.35 76.59 2.44 Favored 'General case' 0 CA--C 1.573 1.838 0 CA-C-N 120.459 1.481 . . . . 0.0 113.979 -170.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.0 t -162.71 -178.86 6.44 Favored 'General case' 0 CA--C 1.576 1.974 0 CA-C-O 122.682 1.229 . . . . 0.0 112.367 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.1 m -87.58 129.08 35.23 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.243 1.017 . . . . 0.0 110.42 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -128.01 111.75 13.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.828 -0.545 . . . . 0.0 109.603 -173.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.52 137.54 36.3 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.418 0.687 . . . . 0.0 111.756 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.1 p -64.36 118.14 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -105.75 -59.87 1.71 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.758 0.823 . . . . 0.0 112.076 -174.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -134.24 166.62 22.37 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.55 1.167 . . . . 0.0 111.372 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.6 m -151.51 123.73 8.25 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 119.581 -1.949 . . . . 0.0 109.761 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -82.4 -81.46 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -159.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -108.32 55.97 0.63 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 120.29 1.405 . . . . 0.0 112.435 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -87.38 66.11 8.98 Favored 'General case' 0 CA--C 1.573 1.843 0 CA-C-O 122.63 1.205 . . . . 0.0 111.543 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -158.05 -66.35 0.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.969 0.908 . . . . 0.0 109.961 -167.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -60.67 -47.28 86.96 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 166.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -44.61 -58.69 2.87 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 162.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 37.4 mtp -59.07 -43.32 91.74 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -61.06 -41.74 97.19 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 166.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -62.24 -37.07 84.01 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 168.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 55.7 mtm -65.14 -20.03 66.26 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 164.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.24 47.64 2.78 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.3 m -123.12 142.51 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-N 118.385 1.092 . . . . 0.0 111.504 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -75.24 169.67 17.59 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.27 0.3 OUTLIER -52.91 -42.21 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 176.19 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.3 t -58.36 -48.87 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.027 -1.046 . . . . 0.0 113.357 170.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -61.79 -40.32 94.79 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 168.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 mpp_? -57.15 -34.6 68.59 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 164.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -70.25 -55.79 8.39 Favored 'General case' 0 CA--C 1.572 1.827 0 CA-C-N 120.364 1.438 . . . . 0.0 113.434 164.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.0 mt -66.08 -52.59 47.34 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.74 -4.7 36.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 172.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.36 -57.95 3.51 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 119.692 1.133 . . . . 0.0 113.123 152.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -90.49 52.96 2.32 Favored 'General case' 0 CA--C 1.573 1.841 0 C-N-CA 123.767 0.827 . . . . 0.0 112.903 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -92.98 2.25 56.89 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 55.25 58.45 4.67 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 124.687 1.195 . . . . 0.0 113.957 -175.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.3 tp -92.09 116.47 28.96 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-O 122.065 0.936 . . . . 0.0 111.873 -166.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -115.52 112.1 21.71 Favored 'General case' 0 CA--C 1.561 1.378 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.391 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.0 mt -99.09 100.13 11.24 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.0 m -92.62 108.96 20.37 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.335 -0.853 . . . . 0.0 109.613 174.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -107.96 137.6 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 C-N-CA 124.298 1.039 . . . . 0.0 108.673 -165.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 93.1 m -147.75 122.56 9.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.139 -1.6 . . . . 0.0 110.481 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -86.97 108.97 19.06 Favored 'General case' 0 CA--C 1.565 1.522 0 O-C-N 121.55 -0.719 . . . . 0.0 112.112 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -91.71 76.11 5.7 Favored 'General case' 0 CA--C 1.57 1.725 0 O-C-N 121.477 -0.765 . . . . 0.0 110.054 168.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.69 -98.57 0.54 Allowed Glycine 0 N--CA 1.492 2.404 0 O-C-N 121.443 -0.786 . . . . 0.0 114.778 -174.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -95.74 -11.59 26.77 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 165.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -95.76 101.97 13.71 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 120.791 1.632 . . . . 0.0 110.551 -175.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.49 111.55 18.61 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.379 -0.826 . . . . 0.0 111.135 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.2 m -86.24 105.22 16.46 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.735 0.814 . . . . 0.0 109.069 174.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.5 t -112.52 103.26 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -85.79 107.43 17.63 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.284 0.634 . . . . 0.0 110.722 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -98.49 87.46 3.85 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.1 t -88.35 117.44 27.28 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 122.856 0.462 . . . . 0.0 111.171 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.3 p -146.73 165.04 30.83 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.623 0.725 . . . . 0.0 112.678 -172.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.68 -27.2 62.68 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 118.012 2.597 . . . . 0.0 118.012 165.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -75.42 -51.88 12.04 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 167.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -162.36 151.43 15.37 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.595 0.758 . . . . 0.0 111.727 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -113.88 91.67 3.72 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.801 0.84 . . . . 0.0 110.532 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.6 pt -114.89 125.0 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 121.448 0.642 . . . . 0.0 111.88 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -86.26 101.21 12.85 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.6 0.76 . . . . 0.0 110.971 172.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.69 105.44 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -174.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.3 t -94.58 96.93 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -105.97 128.04 53.55 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.431 0.634 . . . . 0.0 112.077 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -85.23 129.08 34.88 Favored 'General case' 0 CA--C 1.563 1.474 0 O-C-N 121.511 -0.743 . . . . 0.0 111.157 173.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.0 125.92 25.54 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -173.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.79 -16.75 44.6 Favored Glycine 0 CA--C 1.555 2.533 0 N-CA-C 119.106 2.403 . . . . 0.0 119.106 -168.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.3 t -86.26 130.78 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 120.278 2.039 . . . . 0.0 109.938 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.5 t -75.21 121.9 22.84 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -142.7 161.68 37.44 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-O 121.732 0.777 . . . . 0.0 112.201 -172.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -91.63 104.2 16.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.489 -0.757 . . . . 0.0 111.517 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -100.85 142.02 32.91 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 124.164 0.986 . . . . 0.0 111.631 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -134.82 100.94 4.75 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.907 -1.121 . . . . 0.0 110.615 -167.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.0 mt -76.36 93.34 3.45 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -168.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.3 . . 58.07 -64.31 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 119.85 3.278 . . . . 0.0 119.85 170.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -82.98 -83.71 0.13 Allowed 'General case' 0 CA--C 1.57 1.719 0 CA-C-N 118.853 0.752 . . . . 0.0 109.73 164.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.48 55.01 0.2 Allowed Glycine 0 N--CA 1.487 2.057 0 N-CA-C 116.267 1.267 . . . . 0.0 116.267 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.8 m -88.02 101.11 13.46 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 118.068 0.934 . . . . 0.0 108.545 165.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -88.63 112.41 23.05 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 122.794 0.438 . . . . 0.0 111.076 -169.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.8 mt -127.38 112.29 14.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.748 -0.595 . . . . 0.0 111.716 -161.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 51.5 ptt85 -90.94 118.19 30.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.104 -0.997 . . . . 0.0 111.338 172.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.3 -158.94 32.1 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 117.776 1.87 . . . . 0.0 117.776 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.7 p -130.15 129.85 44.01 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -156.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -92.48 132.26 36.95 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.033 -1.042 . . . . 0.0 111.081 164.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.5 m -129.97 127.31 39.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.566 -0.708 . . . . 0.0 111.425 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.6 tp -81.9 125.25 30.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.462 -0.774 . . . . 0.0 111.638 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -130.96 79.59 1.9 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.381 -0.824 . . . . 0.0 109.115 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.47 -109.5 3.02 Favored Glycine 0 N--CA 1.488 2.11 0 O-C-N 121.648 -0.657 . . . . 0.0 113.747 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -111.02 44.22 1.33 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 167.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -144.5 114.06 7.14 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 25.1 mt -89.49 107.49 19.1 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 167.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.9 tt -96.88 119.47 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.296 -0.878 . . . . 0.0 110.409 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -101.95 98.88 1.8 Allowed Glycine 0 N--CA 1.482 1.76 0 C-N-CA 124.1 0.857 . . . . 0.0 113.215 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.17 101.55 13.93 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -121.88 143.11 49.63 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.707 0.765 . . . . 0.0 111.916 -173.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -110.72 138.73 46.74 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.69 0.757 . . . . 0.0 109.384 163.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -62.0 111.34 1.88 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.288 -0.882 . . . . 0.0 112.597 171.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.297 5.8 t -68.66 -14.74 63.22 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 174.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -73.78 -20.46 60.47 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 158.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -133.92 -41.44 0.83 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -166.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.85 -26.94 22.32 Favored Glycine 0 CA--C 1.556 2.643 0 N-CA-C 117.368 1.707 . . . . 0.0 117.368 -153.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -66.06 129.92 41.45 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -167.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.04 129.68 35.54 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -175.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.9 tt -121.7 120.29 34.26 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 124.917 1.287 . . . . 0.0 108.908 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -105.47 113.13 26.51 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.314 -0.866 . . . . 0.0 109.065 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.6 m -101.93 111.48 23.75 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.303 -0.873 . . . . 0.0 110.368 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.34 102.5 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -80.82 115.99 20.58 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.767 0.827 . . . . 0.0 110.194 167.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -143.97 142.24 30.62 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -95.15 106.14 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.899 . . . . 0.0 109.44 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.0 pt -88.75 72.82 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.924 0 O-C-N 121.017 -1.052 . . . . 0.0 111.158 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 85.15 -86.84 1.55 Allowed Glycine 0 N--CA 1.491 2.312 0 O-C-N 120.531 -1.355 . . . . 0.0 113.096 -168.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -139.43 53.81 1.71 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 166.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -144.79 118.19 9.05 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 121.212 -0.93 . . . . 0.0 108.6 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.3 tp -78.53 110.23 13.43 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.107 0.956 . . . . 0.0 110.92 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.5 t -97.77 115.32 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -96.82 93.88 6.93 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.733 0.813 . . . . 0.0 109.778 171.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 48.8 m -84.04 101.97 12.15 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 122.864 0.466 . . . . 0.0 109.784 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -87.09 111.05 20.53 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.128 0.571 . . . . 0.0 110.892 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.3 t -103.1 102.06 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -128.85 109.91 11.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.779 -0.576 . . . . 0.0 109.723 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 53.63 57.59 5.96 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 174.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.35 -33.73 3.16 Favored Glycine 0 CA--C 1.552 2.405 0 N-CA-C 118.758 2.263 . . . . 0.0 118.758 -167.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.4 t -89.87 121.28 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 119.887 1.843 . . . . 0.0 110.708 -166.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -89.4 123.87 33.95 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.229 0.612 . . . . 0.0 111.348 166.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.94 108.47 8.42 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.012 0.525 . . . . 0.0 110.881 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -88.91 114.83 25.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 111.622 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -89.64 121.78 32.15 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 119.275 0.943 . . . . 0.0 109.873 162.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.6 mt -120.54 120.72 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -163.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -118.67 126.57 52.21 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.012 0.925 . . . . 0.0 110.747 -165.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -87.23 152.93 21.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.162 -0.961 . . . . 0.0 113.261 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -62.18 110.95 1.77 Allowed 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 124.063 0.945 . . . . 0.0 113.309 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.489 1.484 0 C-N-CA 125.175 1.39 . . . . 0.0 113.251 -174.498 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.22 0 CA-C-O 121.703 0.764 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -80.85 63.39 5.22 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.269 -0.895 . . . . 0.0 112.567 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -88.12 88.42 7.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.997 -1.065 . . . . 0.0 111.744 -166.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.1 m -171.6 164.62 6.78 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 122.754 1.264 . . . . 0.0 113.24 -172.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.6 m -89.72 131.08 35.87 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 124.024 0.93 . . . . 0.0 110.9 170.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -131.33 110.12 10.85 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.356 0.662 . . . . 0.0 109.779 -170.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -100.84 135.64 41.98 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.01 -1.056 . . . . 0.0 112.303 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.7 121.88 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -106.53 -49.08 3.4 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -153.17 111.52 3.66 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 118.911 0.778 . . . . 0.0 109.746 -164.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.2 p -102.0 108.62 20.12 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.512 0.725 . . . . 0.0 112.385 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -102.93 115.46 30.65 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.285 38.7 t30 67.93 11.43 8.36 Favored 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 118.458 2.762 . . . . 0.0 118.458 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -64.79 -42.84 94.75 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -61.17 -32.53 72.27 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 170.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -72.99 -42.73 63.0 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 171.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -46.48 -54.31 9.51 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 160.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.7 mtt -61.75 -39.16 90.63 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 172.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -53.35 -48.76 68.27 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 166.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.1 tttp -62.18 -28.63 69.8 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 168.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.5 mmt -65.47 -43.83 89.08 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 168.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.89 63.72 0.36 Allowed Glycine 0 N--CA 1.487 2.099 0 C-N-CA 123.855 0.741 . . . . 0.0 113.742 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 p -138.25 146.49 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.403 1.097 . . . . 0.0 111.638 -176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -59.2 143.92 47.55 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.31 12.9 tt -52.89 -44.15 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.8 t -56.58 -56.55 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.305 0.957 . . . . 0.0 113.197 170.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -63.6 -45.15 91.67 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.2 ptt85 -67.66 -30.61 70.19 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 171.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -68.55 -43.4 76.71 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 120.009 1.277 . . . . 0.0 114.219 165.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.5 mt -62.35 -50.57 71.06 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 169.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.65 -12.53 54.2 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 118.6 2.815 . . . . 0.0 118.6 168.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.76 -59.96 2.55 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 155.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -91.62 53.53 2.27 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 118.765 0.711 . . . . 0.0 112.82 -170.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.6 p30 -102.97 -4.22 24.98 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 118.582 2.808 . . . . 0.0 118.582 -171.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 59.18 56.16 4.02 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-N 121.655 2.025 . . . . 0.0 114.131 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.4 tp -82.63 119.75 24.68 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.981 -1.074 . . . . 0.0 112.1 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -101.55 119.85 39.4 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.199 170.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.8 mt -102.42 107.34 18.29 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.251 88.6 m -88.13 101.09 13.47 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.854 -1.154 . . . . 0.0 108.736 163.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 85.5 mt -94.99 119.45 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.8 t -127.82 131.21 49.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.808 -0.558 . . . . 0.0 111.614 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -79.73 127.21 31.93 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 121.768 0.794 . . . . 0.0 111.472 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -131.96 64.48 1.59 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 124.05 0.94 . . . . 0.0 110.563 -168.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.3 69.25 1.37 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 116.756 1.463 . . . . 0.0 116.756 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.281 14.9 t30 66.82 -15.04 0.15 Allowed 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 -164.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -92.19 154.23 18.8 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 120.684 -1.26 . . . . 0.0 112.231 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -116.4 120.3 38.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.476 -0.765 . . . . 0.0 109.392 165.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.9 m -89.03 107.62 19.14 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 167.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.0 t -104.25 108.01 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -93.18 104.19 16.4 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -86.28 126.3 34.2 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.189 0.595 . . . . 0.0 110.71 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.2 t -135.17 118.73 16.95 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 122.765 0.426 . . . . 0.0 110.255 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 p -147.61 172.83 13.41 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.46 59.08 0.79 Allowed 'General case' 0 CA--C 1.575 1.925 0 O-C-N 120.513 -1.367 . . . . 0.0 113.491 154.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -168.78 -60.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.114 0.966 . . . . 0.0 110.174 -175.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -154.58 143.57 21.01 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 118.588 0.631 . . . . 0.0 111.951 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -115.2 103.11 10.52 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 173.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.6 pt -138.29 141.18 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 121.5 0.667 . . . . 0.0 111.909 -174.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -104.13 105.78 16.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.171 -0.956 . . . . 0.0 109.7 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.32 103.19 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.2 t -97.89 104.11 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -117.78 149.71 40.35 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.125 0.57 . . . . 0.0 112.476 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -94.07 142.41 27.43 Favored 'General case' 0 CA--C 1.568 1.635 0 O-C-N 121.733 -0.604 . . . . 0.0 111.698 171.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.1 mt -71.95 101.91 2.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.004 -1.06 . . . . 0.0 111.699 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.6 -46.15 1.07 Allowed Glycine 0 CA--C 1.549 2.215 0 N-CA-C 116.37 1.308 . . . . 0.0 116.37 -168.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.73 141.46 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.844 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.1 m -92.51 77.86 5.0 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.191 0.996 . . . . 0.0 110.729 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -101.64 166.27 10.79 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -167.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -82.24 93.75 7.17 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-O 121.62 0.724 . . . . 0.0 111.531 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -84.52 164.98 18.44 Favored 'General case' 0 CA--C 1.571 1.756 0 CA-C-O 122.141 0.972 . . . . 0.0 111.498 166.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -153.65 132.75 12.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.325 -1.485 . . . . 0.0 110.801 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.3 mt -75.6 -64.04 1.16 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -164.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -154.36 -70.99 0.13 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 118.926 0.785 . . . . 0.0 111.391 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -83.24 -69.53 0.63 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.958 0.799 . . . . 0.0 112.941 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.74 50.58 0.4 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 116.734 1.454 . . . . 0.0 116.734 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.1 m -112.71 98.33 7.15 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -92.79 140.73 29.21 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 122.439 1.114 . . . . 0.0 112.147 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.8 mt -136.59 119.82 16.72 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 123.78 0.832 . . . . 0.0 110.206 -162.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -90.47 122.91 33.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.964 -1.085 . . . . 0.0 110.034 169.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.75 -173.32 45.46 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 117.633 1.813 . . . . 0.0 117.633 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 75.9 p -115.59 131.47 56.92 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.092 -1.054 . . . . 0.0 111.327 -170.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -87.78 113.92 23.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.195 -0.94 . . . . 0.0 109.621 161.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.6 m -110.94 117.42 33.33 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.419 0.688 . . . . 0.0 110.909 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.9 tp -84.76 99.1 10.64 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.144 -0.972 . . . . 0.0 111.584 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -95.52 85.21 4.14 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.444 0.698 . . . . 0.0 110.687 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.37 -90.59 0.62 Allowed Glycine 0 N--CA 1.491 2.359 0 O-C-N 121.425 -0.797 . . . . 0.0 114.601 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -125.52 53.44 1.55 Allowed 'General case' 0 CA--C 1.575 1.935 0 CA-C-O 121.363 0.601 . . . . 0.0 111.552 162.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -145.0 111.15 5.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.089 -1.007 . . . . 0.0 108.533 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 mt -85.89 102.34 13.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.968 . . . . 0.0 109.075 172.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.6 mt -100.6 108.55 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -172.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.12 101.72 2.75 Favored Glycine 0 N--CA 1.482 1.705 0 C-N-CA 123.235 0.445 . . . . 0.0 113.18 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -95.34 94.28 7.76 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.551 0.74 . . . . 0.0 109.06 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -121.47 138.33 54.33 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -163.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -119.49 138.4 53.17 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.516 0.726 . . . . 0.0 110.085 170.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -70.08 130.21 41.51 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -171.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 36.9 p -81.43 68.69 7.86 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.337 1.065 . . . . 0.0 110.851 170.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -177.7 -62.28 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.774 0 C-N-CA 125.927 1.691 . . . . 0.0 107.417 -164.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -135.37 20.37 3.39 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.4 10.6 36.57 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 121.03 3.172 . . . . 0.0 121.03 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -95.46 138.71 32.76 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 118.121 0.96 . . . . 0.0 112.217 -159.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -80.34 128.25 33.34 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -163.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.86 122.87 39.13 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 124.742 1.217 . . . . 0.0 108.423 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -98.61 114.7 27.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.618 -0.676 . . . . 0.0 109.278 172.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.1 m -108.22 96.85 6.65 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 119.564 1.075 . . . . 0.0 109.701 175.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.3 t -95.65 105.17 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.885 -1.134 . . . . 0.0 108.91 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -88.9 122.02 31.85 Favored 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 123.565 0.746 . . . . 0.0 111.052 169.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -144.87 155.24 43.35 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.281 -0.887 . . . . 0.0 112.38 171.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mp -94.76 118.79 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.649 -1.282 . . . . 0.0 109.657 -176.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.7 mt -95.79 87.55 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 106.941 -1.504 . . . . 0.0 106.941 164.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.0 -94.83 0.38 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 115.742 1.057 . . . . 0.0 115.742 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -101.75 14.56 31.6 Favored 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 169.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -134.38 109.76 8.99 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 119.717 1.144 . . . . 0.0 111.002 -161.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.6 tp -76.46 104.61 7.07 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.918 0.887 . . . . 0.0 110.899 173.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.5 p -88.47 104.77 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 123.05 0.54 . . . . 0.0 110.219 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -90.0 99.85 12.78 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.456 0.646 . . . . 0.0 109.421 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 33.4 m -98.96 104.89 16.97 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.006 -168.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -87.1 125.79 34.36 Favored 'General case' 0 CA--C 1.563 1.476 0 C-N-CA 123.257 0.623 . . . . 0.0 111.048 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.4 t -121.69 109.0 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 168.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -113.87 107.11 15.26 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.265 10.2 mm-40 65.03 -78.68 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 123.914 0.885 . . . . 0.0 112.992 -171.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -152.6 58.32 0.42 Allowed Glycine 0 N--CA 1.486 2.001 0 CA-C-O 119.511 -0.605 . . . . 0.0 114.108 164.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.9 p -129.19 104.21 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -89.43 112.31 23.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.602 -0.687 . . . . 0.0 110.915 -176.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.77 117.34 25.46 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.019 0.527 . . . . 0.0 112.236 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -105.62 102.22 11.69 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.456 0.703 . . . . 0.0 109.704 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . 0.258 15.1 ptm180 -95.92 111.98 23.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.441 -0.787 . . . . 0.0 110.733 168.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.4 mt -97.94 125.01 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -170.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -105.45 116.73 32.44 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.618 0.767 . . . . 0.0 109.068 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -82.78 141.93 31.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.231 -0.918 . . . . 0.0 111.745 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -66.94 124.36 22.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 113.338 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 124.822 1.249 . . . . 0.0 111.88 -170.103 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.305 0 CA-C-O 121.15 0.5 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 64.91 65.03 0.62 Allowed 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -130.55 75.83 1.68 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.952 -1.093 . . . . 0.0 110.701 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.1 p -171.15 168.63 6.75 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.795 1.284 . . . . 0.0 113.5 -175.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.7 m -77.23 135.87 38.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.219 -0.926 . . . . 0.0 111.75 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -133.16 101.74 5.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.678 -0.639 . . . . 0.0 109.393 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -97.31 137.84 35.7 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.252 -0.905 . . . . 0.0 112.223 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.266 4.5 p -63.03 115.54 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.81 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -173.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -84.55 -47.4 10.61 Favored 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 123.687 0.795 . . . . 0.0 113.054 170.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -155.15 159.0 39.84 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 122.563 1.173 . . . . 0.0 111.033 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.7 m -147.66 113.03 5.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 119.871 -1.768 . . . . 0.0 109.315 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -83.36 -95.79 0.06 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -162.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -85.06 52.56 2.47 Favored 'General case' 0 CA--C 1.579 2.063 0 CA-C-N 120.635 1.561 . . . . 0.0 113.523 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -82.9 -48.45 10.7 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.526 1.13 . . . . 0.0 114.03 -172.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -58.0 -29.27 65.15 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 169.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 -46.48 34.11 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 169.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -47.64 -51.2 22.28 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 161.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.0 mtm -59.27 -30.77 68.53 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 170.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -65.74 -44.38 86.16 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 166.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -58.63 -37.49 76.01 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 165.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.5 mmm -64.84 -41.57 95.62 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 167.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.43 48.37 0.81 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 115.989 1.156 . . . . 0.0 115.989 174.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.29 10.7 p -113.12 138.84 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 118.534 1.167 . . . . 0.0 112.309 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -62.69 152.39 35.58 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 12.5 tt -48.11 -40.16 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 118.285 2.698 . . . . 0.0 118.285 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.4 t -66.11 -62.28 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-N 119.861 1.209 . . . . 0.0 111.96 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -62.56 -20.03 64.28 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 117.949 2.574 . . . . 0.0 117.949 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.5 ttp85 -76.37 -49.44 16.79 Favored 'General case' 0 CA--C 1.569 1.708 0 C-N-CA 125.292 1.437 . . . . 0.0 114.26 167.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -41.54 98.61 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 169.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.28 -40.63 86.69 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 165.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.72 -31.19 71.69 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 117.729 2.492 . . . . 0.0 117.729 169.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.9 -43.72 69.92 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 157.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -82.41 14.93 2.72 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.313 19.4 p30 -78.36 92.99 4.61 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 121.534 1.97 . . . . 0.0 110.597 170.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -68.8 84.68 0.31 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.767 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.0 tp -86.91 124.75 33.46 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 122.489 1.138 . . . . 0.0 112.731 -167.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -99.48 114.81 27.99 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.57 165.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.2 mt -96.96 95.52 7.88 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.9 m -88.32 98.19 11.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.035 -1.041 . . . . 0.0 108.473 173.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.0 mt -89.76 119.11 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.3 p -121.59 122.14 38.99 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -97.37 130.61 44.5 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -118.02 77.18 1.13 Allowed 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 162.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.61 -106.5 1.08 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 116.404 1.322 . . . . 0.0 116.404 -175.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -84.64 -15.9 43.85 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 169.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -89.03 153.76 20.75 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 119.809 1.186 . . . . 0.0 112.346 168.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -143.51 136.54 27.72 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.606 0.763 . . . . 0.0 109.836 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.9 m -109.82 111.45 22.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.236 -0.915 . . . . 0.0 108.884 164.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.4 p -95.68 120.48 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 121.428 0.632 . . . . 0.0 110.123 168.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -82.4 114.44 20.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 109.484 173.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -93.06 91.25 7.25 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.7 t -112.34 105.42 13.7 Favored 'General case' 0 CA--C 1.562 1.418 0 CA-C-O 121.384 0.611 . . . . 0.0 111.105 -172.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.0 p -143.91 -179.16 6.31 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.393 1.077 . . . . 0.0 111.904 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.11 -25.82 24.11 Favored 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 118.265 2.691 . . . . 0.0 118.265 160.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -96.76 -18.02 19.89 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -148.61 146.43 28.23 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 120.469 1.486 . . . . 0.0 112.155 -171.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -135.19 77.79 1.7 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 156.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.0 pt -126.88 139.88 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 121.216 -0.928 . . . . 0.0 111.953 -167.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.17 105.44 17.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.575 -0.703 . . . . 0.0 109.797 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.3 t -89.69 98.05 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.0 t -89.97 106.85 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -121.63 164.02 18.01 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-O 122.619 1.2 . . . . 0.0 112.752 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -126.5 145.68 50.41 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.452 -0.78 . . . . 0.0 109.683 171.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.75 108.53 1.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.974 . . . . 0.0 113.584 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.65 -23.87 27.03 Favored Glycine 0 CA--C 1.548 2.146 0 N-CA-C 117.985 1.954 . . . . 0.0 117.985 -170.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.8 p -68.67 134.92 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 120.308 2.054 . . . . 0.0 113.588 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -85.38 106.42 16.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.751 -0.593 . . . . 0.0 109.796 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -127.5 158.04 38.48 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.766 0.793 . . . . 0.0 112.151 -176.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -85.72 107.5 17.62 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.549 -0.719 . . . . 0.0 111.413 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -105.54 128.99 53.9 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 124.074 0.95 . . . . 0.0 110.236 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -107.19 125.51 51.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.595 -0.691 . . . . 0.0 111.65 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.9 mt -92.6 78.34 4.91 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.308 . . 63.57 -51.44 0.23 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 120.322 3.453 . . . . 0.0 120.322 162.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -74.22 -81.52 0.07 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 121.39 1.905 . . . . 0.0 109.33 167.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.9 80.88 0.06 OUTLIER Glycine 0 N--CA 1.481 1.692 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.6 m -145.75 109.94 4.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.407 -1.055 . . . . 0.0 108.752 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -84.56 121.84 28.18 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.922 0.867 . . . . 0.0 112.373 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mt -129.65 120.21 24.82 Favored 'General case' 0 CA--C 1.562 1.412 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.515 -168.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -93.08 118.99 31.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.922 . . . . 0.0 111.97 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.51 -170.55 42.06 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 118.069 1.988 . . . . 0.0 118.069 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.0 p -126.24 121.22 32.07 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.49 -0.855 . . . . 0.0 111.679 -163.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -78.29 123.05 26.51 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 119.048 0.84 . . . . 0.0 110.995 160.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.8 m -125.3 137.38 54.07 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.364 0.665 . . . . 0.0 111.721 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 tp -91.25 104.51 17.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 111.586 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -91.46 82.64 5.36 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.63 -0.669 . . . . 0.0 109.55 171.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.44 -94.75 0.66 Allowed Glycine 0 N--CA 1.492 2.373 0 O-C-N 121.545 -0.722 . . . . 0.0 114.382 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -125.23 59.62 1.24 Allowed 'General case' 0 CA--C 1.571 1.788 0 CA-C-O 121.802 0.811 . . . . 0.0 110.926 159.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -140.77 111.49 6.95 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 170.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.5 mt -84.44 100.55 11.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.192 -0.943 . . . . 0.0 109.561 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.6 tt -97.78 128.9 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 123.743 0.817 . . . . 0.0 110.798 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.64 102.77 0.64 Allowed Glycine 0 N--CA 1.481 1.658 0 CA-C-O 119.234 -0.759 . . . . 0.0 114.005 -172.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -90.32 98.55 11.84 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.051 0.925 . . . . 0.0 109.492 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -110.53 106.5 15.82 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.639 0.733 . . . . 0.0 110.576 -171.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -90.99 125.87 35.91 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.224 -0.923 . . . . 0.0 111.772 -168.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.8 ttp85 -66.18 119.66 11.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.132 -0.98 . . . . 0.0 112.432 -174.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.303 5.4 t -59.87 -35.08 74.06 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 117.316 2.339 . . . . 0.0 117.316 -169.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -98.37 42.68 1.09 Allowed 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 168.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -156.62 -50.99 0.08 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.736 -1.228 . . . . 0.0 113.591 173.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.32 8.72 62.54 Favored Glycine 0 CA--C 1.555 2.544 0 N-CA-C 118.471 2.148 . . . . 0.0 118.471 -160.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -89.11 119.78 29.92 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 119.965 1.883 . . . . 0.0 111.389 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -73.07 122.8 22.38 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.6 tt -97.12 108.97 21.8 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -96.23 98.82 10.61 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -165.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.1 m -104.88 108.31 19.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.795 -0.565 . . . . 0.0 109.9 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.7 t -98.72 105.9 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.4 mtm180 -87.58 105.76 17.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.663 -0.648 . . . . 0.0 110.002 167.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.01 162.72 26.15 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.659 0.783 . . . . 0.0 111.729 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.3 mt -127.78 135.61 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.536 -1.352 . . . . 0.0 110.142 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.7 mm -98.15 -76.54 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.74 -112.08 3.44 Favored Glycine 0 N--CA 1.491 2.332 0 CA-C-N 118.687 0.676 . . . . 0.0 111.802 170.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -92.91 47.11 1.26 Allowed 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -146.93 118.78 8.11 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.401 1.08 . . . . 0.0 108.74 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.0 tp -81.91 115.5 21.12 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.482 0.713 . . . . 0.0 109.512 167.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.3 t -100.65 103.53 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -96.81 103.25 15.15 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 123.446 0.698 . . . . 0.0 109.825 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.8 m -99.64 103.25 14.93 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 123.266 0.626 . . . . 0.0 109.835 -173.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -95.0 123.8 38.68 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.775 0.83 . . . . 0.0 111.207 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.02 102.11 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-N 119.307 0.958 . . . . 0.0 108.779 173.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -86.51 102.96 14.59 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.183 -0.948 . . . . 0.0 110.007 167.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.319 0.1 OUTLIER 62.01 -41.42 0.15 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 120.001 3.334 . . . . 0.0 120.001 177.639 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -173.82 25.42 0.08 OUTLIER Glycine 0 CA--C 1.552 2.369 0 N-CA-C 117.716 1.846 . . . . 0.0 117.716 172.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.0 t -136.57 121.63 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 120.304 2.052 . . . . 0.0 107.532 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.24 140.19 29.8 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -174.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -129.79 125.1 34.98 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.545 0.738 . . . . 0.0 112.045 166.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -99.27 108.88 21.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.704 -0.622 . . . . 0.0 110.601 174.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -96.16 117.99 31.83 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 169.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 76.5 mt -108.55 120.8 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -171.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -117.32 122.77 44.81 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.835 0.854 . . . . 0.0 109.268 -172.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -77.86 148.27 34.73 Favored 'General case' 0 CA--C 1.568 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 112.837 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -58.9 113.57 2.13 Favored 'General case' 0 CA--C 1.57 1.721 0 C-N-CA 123.906 0.882 . . . . 0.0 113.131 175.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 N--CA 1.489 1.495 0 C-N-CA 124.826 1.251 . . . . 0.0 112.752 -171.328 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.206 0 CA-C-O 121.085 0.469 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.254 91.7 m-85 67.31 -21.58 0.11 Allowed 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 118.99 2.959 . . . . 0.0 118.99 173.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.99 81.63 5.24 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 124.744 1.218 . . . . 0.0 112.897 -164.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.6 m -168.13 173.97 7.56 Favored 'General case' 0 CA--C 1.57 1.738 0 CA-C-O 122.607 1.194 . . . . 0.0 111.703 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.3 m -86.92 131.62 34.05 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.808 0.843 . . . . 0.0 110.804 170.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -132.65 109.36 9.66 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -172.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.24 134.46 48.32 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.281 -0.887 . . . . 0.0 111.716 -175.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -57.7 118.95 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -176.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -114.26 -52.8 2.71 Favored 'General case' 0 CA--C 1.564 1.509 0 C-N-CA 123.592 0.757 . . . . 0.0 113.023 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -144.75 74.17 1.4 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 119.466 1.03 . . . . 0.0 111.918 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.9 p -74.95 127.46 33.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.978 . . . . 0.0 113.454 175.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -79.22 -73.02 0.36 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -166.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -91.97 118.76 31.08 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 156.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -135.34 46.01 2.43 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-O 121.725 0.774 . . . . 0.0 112.406 164.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -146.05 -57.43 0.3 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.166 -0.959 . . . . 0.0 110.551 -173.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -62.39 -33.31 74.5 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 170.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -54.64 -59.77 4.25 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 120.141 1.337 . . . . 0.0 114.144 163.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.51 -47.39 63.31 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 169.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -59.83 -42.95 94.67 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 171.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -56.7 -39.32 73.65 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 165.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 90.5 mtp -64.41 -22.92 67.11 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 172.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.73 39.84 4.85 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 116.712 1.445 . . . . 0.0 116.712 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.446 HG23 ' HG2' ' A' ' 28' ' ' ARG . 6.2 m -105.76 138.05 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.631 0.729 . . . . 0.0 110.938 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -63.08 160.73 14.6 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.277 9.8 tp -53.57 -39.59 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.34 -52.85 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-N 119.647 1.112 . . . . 0.0 112.631 169.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -59.24 -34.79 72.63 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 168.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.446 ' HG2' HG23 ' A' ' 23' ' ' VAL . 84.6 mtm-85 -64.3 -47.92 77.61 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 121.428 1.922 . . . . 0.0 114.797 168.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -58.87 -48.96 79.56 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 168.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.4 mt -58.18 -53.36 59.2 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.611 1.338 . . . . 0.0 114.611 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.42 -47.55 78.8 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 116.431 2.012 . . . . 0.0 116.431 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.88 -47.66 67.69 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 168.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -98.69 32.98 2.4 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -85.78 -19.64 30.42 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -168.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 65.5 63.47 0.63 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 120.018 1.281 . . . . 0.0 113.572 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.74 117.28 21.93 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.204 -0.935 . . . . 0.0 111.792 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -103.21 110.8 22.9 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.534 174.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.7 mt -94.48 101.49 13.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 122.992 0.517 . . . . 0.0 109.776 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.9 m -94.94 111.98 23.72 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.36 136.63 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 124.089 0.956 . . . . 0.0 108.703 -168.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.1 m -149.13 124.24 10.1 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 119.903 -1.748 . . . . 0.0 111.235 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -77.34 132.54 38.64 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.374 1.07 . . . . 0.0 112.034 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -130.33 80.96 1.98 Allowed 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 123.524 0.73 . . . . 0.0 109.364 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.39 70.61 0.93 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 117.269 1.667 . . . . 0.0 117.269 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.309 17.3 m120 69.89 -23.49 0.16 Allowed 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -169.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -86.99 152.9 21.99 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 120.037 1.29 . . . . 0.0 112.785 169.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -121.73 133.68 54.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 111.054 173.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.0 m -97.69 117.79 32.77 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.0 t -120.37 112.57 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -83.2 117.21 22.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 0.0 110.85 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -95.32 80.07 3.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.815 -0.553 . . . . 0.0 110.903 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.5 t -97.42 111.36 23.65 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -171.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.5 p -149.93 177.01 10.24 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.77 59.08 0.21 Allowed 'General case' 0 CA--C 1.58 2.126 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 165.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -145.27 -53.84 0.29 Allowed 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 125.746 1.618 . . . . 0.0 110.096 167.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -156.95 -50.57 0.07 Allowed 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -172.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.299 36.6 t-20 76.62 106.13 0.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 120.06 1.3 . . . . 0.0 112.729 -165.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.8 pt -134.7 139.27 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-O 121.294 0.569 . . . . 0.0 111.257 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.73 124.46 30.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.516 -0.74 . . . . 0.0 111.829 168.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.4 t -110.4 101.62 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.9 t -101.04 115.03 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -140.94 151.89 44.57 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -171.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -90.56 139.39 30.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.497 -0.752 . . . . 0.0 111.882 168.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.07 131.46 49.63 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.08 -8.91 59.16 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 119.816 2.686 . . . . 0.0 119.816 -174.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.3 t -89.13 137.02 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-N 120.201 2.001 . . . . 0.0 110.193 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.1 p -76.11 97.85 4.2 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.48 -0.762 . . . . 0.0 111.19 176.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -118.41 164.56 15.06 Favored 'General case' 0 CA--C 1.569 1.689 0 C-N-CA 123.968 0.907 . . . . 0.0 111.879 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -86.31 98.56 11.03 Favored 'General case' 0 CA--C 1.568 1.65 0 O-C-N 121.363 -0.836 . . . . 0.0 111.171 173.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -82.69 114.14 20.85 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 124.074 0.95 . . . . 0.0 110.824 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -96.48 100.09 11.7 Favored 'General case' 0 CA--C 1.566 1.588 0 O-C-N 121.762 -0.586 . . . . 0.0 109.792 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.81 150.08 42.5 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -37.03 -48.9 0.81 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 119.966 3.321 . . . . 0.0 119.966 -176.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -66.26 -23.19 66.36 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 170.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.68 17.99 1.03 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 119.363 2.505 . . . . 0.0 119.363 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.8 m -109.25 126.51 53.4 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 120.477 2.138 . . . . 0.0 112.015 -162.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -96.77 106.86 19.23 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-O 121.486 0.66 . . . . 0.0 111.717 -167.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.3 mt -104.82 116.61 32.3 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.223 1.009 . . . . 0.0 112.256 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 59.7 ttp85 -86.97 117.55 25.76 Favored 'General case' 0 CA--C 1.567 1.618 0 O-C-N 120.834 -1.166 . . . . 0.0 111.27 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 160.6 -165.64 35.12 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.2 p -106.48 138.37 42.77 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.329 -0.512 . . . . 0.0 112.062 -168.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -88.86 106.63 18.51 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 146.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.2 m -106.4 135.9 47.08 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.019 0.527 . . . . 0.0 110.872 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.5 tp -85.01 98.84 10.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.962 -1.086 . . . . 0.0 110.942 175.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.19 79.44 5.72 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.471 0.653 . . . . 0.0 109.347 175.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.2 -99.43 0.32 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -89.7 -10.46 45.66 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -102.04 140.14 36.72 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 121.155 1.798 . . . . 0.0 111.577 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.9 mt -94.84 97.25 9.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.951 -1.093 . . . . 0.0 108.795 161.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.0 tt -90.1 117.38 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 122.15 0.976 . . . . 0.0 110.551 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.71 93.51 1.89 Allowed Glycine 0 N--CA 1.477 1.38 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.425 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -90.2 87.86 7.01 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -117.19 145.96 43.53 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.81 0.814 . . . . 0.0 112.139 -170.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -124.67 131.02 53.49 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.552 0.741 . . . . 0.0 109.001 172.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -76.28 122.78 24.9 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 121.093 -1.005 . . . . 0.0 113.109 -172.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 73.0 p -55.34 -52.4 63.6 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -89.64 65.35 6.87 Favored 'General case' 0 CA--C 1.572 1.797 0 CA-C-N 118.879 0.763 . . . . 0.0 111.824 167.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.54 -47.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 164.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.25 -20.97 47.9 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 118.064 1.986 . . . . 0.0 118.064 -157.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -77.98 147.84 34.71 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.57 1.148 . . . . 0.0 114.007 -172.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.22 133.29 35.42 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.9 tt -117.06 100.09 7.5 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -90.64 110.21 21.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.457 -0.777 . . . . 0.0 109.709 -173.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.3 m -109.97 98.13 7.5 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 119.657 1.117 . . . . 0.0 110.926 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.2 t -93.7 94.92 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.564 -1.335 . . . . 0.0 109.073 -174.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -83.18 127.82 33.95 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.738 0.699 . . . . 0.0 112.242 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -142.43 140.83 32.09 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.326 0.584 . . . . 0.0 112.422 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.4 mm -87.12 119.58 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.426 -0.796 . . . . 0.0 109.12 171.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.9 mt -113.4 88.81 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.84 -107.92 2.2 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 115.728 1.051 . . . . 0.0 115.728 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -90.45 13.78 14.75 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 172.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -138.97 127.62 23.26 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 120.01 1.277 . . . . 0.0 111.192 -172.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.4 tp -78.95 105.87 10.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.453 -0.78 . . . . 0.0 109.159 162.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.5 t -96.08 110.08 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 174.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -113.51 123.28 49.63 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.5 m -96.78 111.4 23.59 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 122.75 0.42 . . . . 0.0 110.001 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -83.7 123.15 29.53 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.987 0.515 . . . . 0.0 110.596 167.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.1 t -117.42 106.14 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 168.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -109.19 101.98 10.96 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.063 0.545 . . . . 0.0 109.639 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 52.24 53.51 12.3 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.15 -31.46 3.44 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 118.722 2.249 . . . . 0.0 118.722 -167.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 98.0 t -78.13 109.54 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 119.869 1.834 . . . . 0.0 110.307 -169.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.48 132.05 39.55 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 123.491 0.716 . . . . 0.0 112.535 -170.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -138.62 112.48 8.43 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.689 0.796 . . . . 0.0 111.427 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -95.19 110.34 22.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.607 -0.683 . . . . 0.0 110.375 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.8 mmm-85 -91.05 116.96 29.21 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.7 mt -104.87 106.4 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -101.53 121.52 42.13 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.908 0.883 . . . . 0.0 110.01 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -82.7 153.32 25.4 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 121.157 -0.964 . . . . 0.0 113.286 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -59.33 105.68 0.37 Allowed 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 178.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.6 t0 . . . . . 0 N--CA 1.489 1.478 0 C-N-CA 125.34 1.456 . . . . 0.0 114.828 178.129 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.563 1.443 0 CA-C-O 122.171 0.986 . . . . 0.0 113.025 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.334 55.7 m-85 65.2 -140.79 0.21 Allowed 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 124.377 1.071 . . . . 0.0 112.407 178.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 38.18 54.09 1.7 Allowed 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 119.214 3.042 . . . . 0.0 119.214 161.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.4 m -175.62 170.6 2.89 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.702 1.201 . . . . 0.0 110.155 -168.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.3 m -79.36 123.42 27.47 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.043 -1.036 . . . . 0.0 110.58 164.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -121.99 118.52 29.02 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -104.68 137.06 43.06 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.417 -0.802 . . . . 0.0 111.417 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.251 4.0 p -66.13 117.96 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.868 0 O-C-N 121.074 -1.016 . . . . 0.0 113.183 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -90.91 -55.76 3.43 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 124.256 1.022 . . . . 0.0 112.715 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.7 ptm85 -144.71 174.44 10.97 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-O 122.441 1.115 . . . . 0.0 111.968 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.1 m -156.93 145.29 19.61 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 119.603 -1.935 . . . . 0.0 111.623 -176.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.16 -110.02 0.18 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.951 -174.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -82.13 60.44 4.91 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 122.063 2.21 . . . . 0.0 113.75 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -104.81 67.68 0.81 Allowed 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 122.679 1.228 . . . . 0.0 111.828 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -158.22 -48.44 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.707 1.203 . . . . 0.0 110.039 165.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -57.2 -36.97 71.5 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 164.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -48.72 -51.96 26.07 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 160.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -63.52 -39.76 95.26 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -60.83 -45.03 96.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.447 -1.408 . . . . 0.0 114.644 168.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -55.36 -37.92 68.14 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 165.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.4 mmt -66.47 -16.06 63.83 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 164.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.32 39.51 6.79 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 117.266 1.666 . . . . 0.0 117.266 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.426 HG23 ' HG2' ' A' ' 28' ' ' ARG . 17.9 m -111.96 143.35 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 118.445 1.123 . . . . 0.0 111.909 -177.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -64.31 157.97 24.67 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -174.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.29 0.1 OUTLIER -52.52 -49.65 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 -177.689 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.0 t -62.43 -45.43 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-N 119.683 1.128 . . . . 0.0 113.483 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -53.18 -43.75 67.37 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 166.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HG2' HG23 ' A' ' 23' ' ' VAL . 82.5 mtm-85 -62.49 -41.35 98.74 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 168.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.78 -45.25 95.11 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 168.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.0 mt -63.13 -44.45 95.58 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.72 -34.6 78.7 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 169.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.42 -55.97 27.94 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 120.159 1.345 . . . . 0.0 114.545 160.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -80.97 58.18 3.34 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 122.581 1.181 . . . . 0.0 113.165 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -86.36 -26.46 24.82 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 117.838 2.532 . . . . 0.0 117.838 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.379 19.7 p30 46.28 47.9 13.44 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 117.799 2.518 . . . . 0.0 117.799 -168.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.7 tp -73.37 124.56 25.99 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 122.113 0.958 . . . . 0.0 113.519 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -118.86 125.55 49.78 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.199 1.0 . . . . 0.0 109.032 175.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.8 mt -106.94 100.89 10.36 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.441 0.696 . . . . 0.0 109.562 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.1 m -93.25 110.14 21.66 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.466 -0.771 . . . . 0.0 108.978 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.1 mt -98.92 112.52 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -168.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.5 m -111.02 104.87 13.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -88.92 112.03 22.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.078 -1.014 . . . . 0.0 112.265 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.81 78.94 2.62 Favored 'General case' 0 CA--C 1.568 1.653 0 CA-C-O 121.641 0.734 . . . . 0.0 109.943 163.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.65 -104.15 1.02 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 115.369 0.908 . . . . 0.0 115.369 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -81.03 -27.88 35.62 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 166.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -75.34 109.66 9.05 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.397 1.453 . . . . 0.0 112.173 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -90.85 106.93 18.86 Favored 'General case' 0 CA--C 1.559 1.324 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 169.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.6 m -90.14 95.93 10.43 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.1 t -99.84 108.99 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -171.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -87.72 100.46 12.85 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.709 0.804 . . . . 0.0 109.166 -173.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -92.77 86.56 5.56 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.022 0.529 . . . . 0.0 110.346 -170.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.4 t -90.53 122.19 33.13 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.01 0.524 . . . . 0.0 111.769 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.7 p -147.92 168.82 21.27 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -167.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.77 38.38 0.03 OUTLIER 'General case' 0 CA--C 1.584 2.271 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 164.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -150.59 -57.12 0.17 Allowed 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 126.533 1.933 . . . . 0.0 108.536 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -155.25 156.85 36.32 Favored 'General case' 0 CA--C 1.566 1.558 0 C-N-CA 124.232 1.013 . . . . 0.0 111.539 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -114.61 106.96 14.86 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.459 0.704 . . . . 0.0 109.336 164.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.7 pt -126.14 128.63 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.668 -0.645 . . . . 0.0 111.217 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -82.47 99.78 9.66 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 121.656 0.741 . . . . 0.0 111.972 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -85.27 100.37 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.48 110.48 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -129.92 127.97 41.2 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.358 0.599 . . . . 0.0 111.652 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.1 mp0 -71.66 141.63 49.9 Favored 'General case' 0 CA--C 1.566 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 110.915 161.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.21 109.11 1.43 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.246 -0.909 . . . . 0.0 113.141 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.84 -0.76 48.44 Favored Glycine 0 CA--C 1.553 2.46 0 N-CA-C 119.026 2.37 . . . . 0.0 119.026 -167.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.0 p -81.24 139.17 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 120.983 2.392 . . . . 0.0 113.223 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.3 m -89.03 109.51 20.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.745 -0.597 . . . . 0.0 109.67 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -138.81 162.04 35.76 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 123.325 0.65 . . . . 0.0 112.34 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -87.57 103.6 15.71 Favored 'General case' 0 CA--C 1.568 1.659 0 O-C-N 121.234 -0.916 . . . . 0.0 111.704 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -89.75 141.23 28.81 Favored 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 123.78 0.832 . . . . 0.0 111.989 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -136.73 107.5 6.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.999 -1.063 . . . . 0.0 110.856 -169.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.7 mt -77.59 88.24 3.9 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -171.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.288 . . 63.41 -53.25 0.21 Allowed 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 119.099 3.0 . . . . 0.0 119.099 174.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -91.59 -76.63 0.44 Allowed 'General case' 0 CA--C 1.572 1.792 0 CA-C-N 119.128 0.876 . . . . 0.0 110.7 170.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.73 56.81 0.1 OUTLIER Glycine 0 N--CA 1.494 2.533 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.3 m -69.76 -36.23 75.59 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.159 2.281 . . . . 0.0 117.159 -173.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 77.32 78.57 0.08 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 124.637 1.175 . . . . 0.0 112.634 164.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.0 mt -127.96 103.44 7.25 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.057 0.543 . . . . 0.0 111.286 -161.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -76.53 120.29 21.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.921 -1.112 . . . . 0.0 112.533 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.51 -169.61 42.44 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 118.098 1.999 . . . . 0.0 118.098 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 p -125.77 135.55 52.16 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 114.136 -1.032 . . . . 0.0 111.774 -164.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -95.11 116.18 28.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.754 -0.591 . . . . 0.0 110.425 164.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.8 t -109.81 132.32 54.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.9 -0.5 . . . . 0.0 111.914 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.5 tp -86.73 106.11 17.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.055 -1.028 . . . . 0.0 112.374 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -84.99 168.84 14.57 Favored 'General case' 0 CA--C 1.577 1.999 0 C-N-CA 123.518 0.727 . . . . 0.0 110.683 157.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -33.32 -63.29 0.35 Allowed Glycine 0 N--CA 1.502 3.052 0 N-CA-C 121.239 3.256 . . . . 0.0 121.239 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -108.16 17.63 22.06 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 165.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -139.37 124.19 18.6 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 121.066 1.757 . . . . 0.0 112.308 -161.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.8 mt -89.29 106.77 18.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.938 -1.101 . . . . 0.0 108.787 162.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.2 113.38 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.794 0.807 . . . . 0.0 109.998 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.99 93.02 1.33 Allowed Glycine 0 N--CA 1.479 1.534 0 C-N-CA 123.844 0.735 . . . . 0.0 112.833 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -89.33 104.29 16.85 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.511 0.672 . . . . 0.0 110.329 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -124.6 149.64 46.84 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.072 0.949 . . . . 0.0 111.972 -168.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -125.02 139.75 53.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.356 -0.84 . . . . 0.0 110.751 169.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -66.69 119.85 12.48 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.0 p -82.86 72.16 9.95 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 122.542 1.163 . . . . 0.0 109.901 167.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 175.91 -64.09 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 126.114 1.766 . . . . 0.0 107.37 -167.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -93.6 -33.31 13.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.68 -35.06 4.2 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 116.865 1.506 . . . . 0.0 116.865 -154.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -53.53 147.61 10.71 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 117.367 2.358 . . . . 0.0 117.367 -173.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -86.21 129.71 34.76 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -175.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.6 tt -113.75 124.11 51.47 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.203 1.001 . . . . 0.0 108.991 169.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -113.7 111.98 22.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.43 -0.793 . . . . 0.0 109.21 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 m -102.5 112.88 25.81 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.767 0.712 . . . . 0.0 110.315 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.4 t -97.88 88.47 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.289 -0.882 . . . . 0.0 108.694 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -79.12 106.43 11.15 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.545 0.738 . . . . 0.0 110.985 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -137.6 140.63 41.07 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -171.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.1 mp -86.65 113.76 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -96.16 91.31 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.2 -89.77 0.7 Allowed Glycine 0 N--CA 1.491 2.345 0 O-C-N 121.016 -1.052 . . . . 0.0 114.745 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -134.4 42.39 2.86 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 166.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -136.66 125.95 24.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.892 -1.13 . . . . 0.0 109.058 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.5 tp -84.23 105.6 15.21 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.88 123.1 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . 0.274 17.9 pt20 -116.85 104.04 10.91 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.373 0.606 . . . . 0.0 112.379 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.0 m -87.13 109.75 19.65 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.727 0.811 . . . . 0.0 109.974 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -87.43 113.59 23.27 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.158 0.583 . . . . 0.0 110.701 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -101.58 98.54 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -115.54 104.14 11.43 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 118.832 0.742 . . . . 0.0 110.106 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 54.64 55.02 8.42 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 174.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.15 -23.46 6.08 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 119.066 2.386 . . . . 0.0 119.066 -167.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.3 t -90.03 111.06 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 120.062 1.931 . . . . 0.0 108.929 -172.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.93 114.65 27.24 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.389 0.675 . . . . 0.0 111.405 174.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -121.12 108.35 13.7 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.319 0.647 . . . . 0.0 111.294 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.24 126.79 40.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 111.787 -176.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.7 mmm-85 -103.66 127.93 51.05 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 167.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.81 120.91 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -175.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -114.26 133.07 55.9 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.857 0.863 . . . . 0.0 111.374 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -95.5 153.69 17.58 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-O 122.155 0.979 . . . . 0.0 112.051 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -65.45 109.18 2.22 Favored 'General case' 0 CA--C 1.571 1.759 0 C-N-CA 124.097 0.959 . . . . 0.0 113.025 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 t70 . . . . . 0 N--CA 1.489 1.5 0 C-N-CA 125.188 1.395 . . . . 0.0 113.96 -178.949 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.231 0 CA-C-O 121.914 0.864 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -83.86 -69.31 0.65 Allowed 'General case' 0 CA--C 1.568 1.644 0 O-C-N 121.884 -0.51 . . . . 0.0 111.581 -170.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.9 t70 48.37 64.09 1.81 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.0 m -167.41 156.65 10.19 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 122.619 1.199 . . . . 0.0 114.147 -163.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.6 m -94.25 127.83 40.34 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.834 0.853 . . . . 0.0 110.963 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -128.03 104.87 8.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.656 -0.652 . . . . 0.0 109.875 -172.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -98.25 138.02 36.14 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.184 -0.948 . . . . 0.0 112.468 -177.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.9 p -62.92 120.97 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -99.65 -57.37 2.16 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 124.188 0.995 . . . . 0.0 112.112 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -152.84 124.43 7.76 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 119.859 1.209 . . . . 0.0 112.367 -176.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.7 p -97.02 103.45 15.38 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.585 0.754 . . . . 0.0 112.663 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -100.51 116.01 31.46 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.915 0.486 . . . . 0.0 110.323 -164.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.278 39.0 t30 65.73 20.29 11.49 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 -169.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -72.08 -36.37 69.49 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -57.33 -32.24 66.5 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.886 2.18 . . . . 0.0 116.886 169.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -71.98 -47.05 54.9 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -50.6 -52.9 34.94 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 163.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.2 mmt -47.65 -57.35 5.6 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 166.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -43.83 -52.13 6.93 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 168.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -56.7 -35.72 68.82 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 171.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 27.5 mtm -73.41 -19.81 60.89 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.37 63.59 0.98 Allowed Glycine 0 N--CA 1.491 2.321 0 CA-C-N 120.367 1.44 . . . . 0.0 114.659 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.7 m -126.91 156.08 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 121.675 0.75 . . . . 0.0 112.437 -169.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -70.28 153.2 43.32 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.857 -1.152 . . . . 0.0 113.733 168.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 11.9 tt -59.21 -38.41 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 172.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.3 t -58.7 -48.16 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 C-N-CA 123.798 0.839 . . . . 0.0 113.253 166.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -55.94 -38.86 70.88 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 167.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -57.58 -52.04 67.02 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 120.587 1.54 . . . . 0.0 115.084 168.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -60.16 -46.46 89.62 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.81 -45.94 90.29 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 171.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.09 92.67 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.84 -57.12 11.28 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 161.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -93.95 52.76 1.69 Allowed 'General case' 0 CA--C 1.575 1.938 0 CA-C-N 119.635 1.107 . . . . 0.0 113.432 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -85.44 -13.35 49.53 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 -173.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 57.93 45.46 18.21 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -174.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.8 tp -82.93 120.57 25.86 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-O 122.06 0.933 . . . . 0.0 112.39 -172.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -104.75 112.05 25.01 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.456 169.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.9 mt -90.17 100.98 13.71 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 m -93.47 92.39 7.59 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.5 mt -94.76 95.84 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -168.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 86.0 m -99.01 126.52 44.73 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.287 0.635 . . . . 0.0 109.769 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -83.18 126.08 32.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.909 . . . . 0.0 112.014 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -131.01 58.58 1.71 Allowed 'General case' 0 CA--C 1.574 1.866 0 C-N-CA 123.669 0.788 . . . . 0.0 111.869 -167.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.23 72.19 0.74 Allowed Glycine 0 N--CA 1.497 2.732 0 N-CA-C 116.591 1.397 . . . . 0.0 116.591 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.294 18.4 t30 68.63 -24.45 0.14 Allowed 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 -164.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -83.79 155.93 22.77 Favored 'General case' 0 CA--C 1.561 1.391 0 O-C-N 120.656 -1.277 . . . . 0.0 113.604 169.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -119.58 121.59 39.69 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 164.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.9 m -93.8 102.8 14.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.36 103.71 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -172.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -81.14 110.4 16.61 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -97.92 83.97 3.24 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.358 0.663 . . . . 0.0 109.733 -175.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.7 t -94.94 115.16 27.1 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.601 0.36 . . . . 0.0 111.936 -170.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.5 p -150.67 168.0 25.66 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.836 0.854 . . . . 0.0 113.134 -166.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.1 -30.03 65.95 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 118.027 2.602 . . . . 0.0 118.027 166.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -73.6 -43.96 58.36 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 167.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.55 154.65 12.07 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.82 0.848 . . . . 0.0 112.428 -165.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -119.66 108.2 14.16 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 161.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.0 pt -129.73 128.37 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.558 -0.714 . . . . 0.0 111.073 -174.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.32 99.62 12.38 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.841 0.857 . . . . 0.0 111.387 173.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.3 t -92.09 102.45 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -176.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.15 93.22 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -106.5 143.49 34.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.716 -0.615 . . . . 0.0 111.78 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -87.73 146.19 25.78 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 121.658 -0.651 . . . . 0.0 112.0 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.6 mt -70.26 109.75 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.095 -1.003 . . . . 0.0 111.839 169.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.42 52.73 2.44 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 116.394 1.318 . . . . 0.0 116.394 -171.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.5 p -143.63 138.48 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 118.327 1.064 . . . . 0.0 109.971 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.3 m -83.74 108.08 16.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.342 -0.849 . . . . 0.0 109.8 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -131.95 165.95 22.77 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-O 121.682 0.753 . . . . 0.0 112.331 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -90.1 108.77 19.94 Favored 'General case' 0 CA--C 1.571 1.779 0 O-C-N 121.619 -0.675 . . . . 0.0 111.506 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -100.5 117.68 35.15 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.742 0.817 . . . . 0.0 110.444 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -98.54 123.66 42.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.119 -0.988 . . . . 0.0 112.919 -175.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.07 158.61 25.0 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.4 69.96 2.93 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 170.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -171.8 -70.36 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 125.292 1.437 . . . . 0.0 108.273 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.45 68.24 0.01 OUTLIER Glycine 0 N--CA 1.483 1.796 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -171.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.3 m -162.14 127.74 3.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.584 -0.951 . . . . 0.0 109.846 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -97.95 126.08 43.18 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.901 0.88 . . . . 0.0 110.439 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.73 111.5 22.51 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.753 -0.592 . . . . 0.0 110.607 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -84.47 123.39 30.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.157 -0.965 . . . . 0.0 111.527 171.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.53 -168.26 39.39 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 117.659 1.824 . . . . 0.0 117.659 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 71.3 p -124.27 123.6 40.58 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.544 -0.828 . . . . 0.0 111.62 -163.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -83.98 114.67 21.87 Favored 'General case' 0 CA--C 1.57 1.735 0 O-C-N 121.992 -0.442 . . . . 0.0 111.433 163.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.7 m -114.36 126.54 55.11 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 123.396 0.679 . . . . 0.0 111.071 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.2 tp -94.12 115.56 27.87 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.176 -0.953 . . . . 0.0 112.103 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -100.3 80.94 2.31 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 170.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.88 -87.23 0.55 Allowed Glycine 0 N--CA 1.494 2.515 0 O-C-N 121.052 -1.03 . . . . 0.0 115.083 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -123.39 29.4 6.67 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 166.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -125.06 109.68 13.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.461 -1.399 . . . . 0.0 108.972 177.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.81 106.4 18.44 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.354 0.661 . . . . 0.0 109.524 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.8 tt -96.93 118.67 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.866 -1.146 . . . . 0.0 110.644 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.72 98.06 2.35 Favored Glycine 0 N--CA 1.48 1.605 0 C-N-CA 123.249 0.452 . . . . 0.0 112.098 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -85.4 93.87 8.84 Favored 'General case' 0 CA--C 1.565 1.552 0 C-N-CA 123.251 0.621 . . . . 0.0 109.354 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -121.79 143.63 49.28 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.298 1.047 . . . . 0.0 113.442 -166.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -119.34 137.8 53.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.391 -0.818 . . . . 0.0 109.146 165.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -69.78 107.34 3.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 0.0 111.664 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.312 13.8 t -74.81 -5.88 45.92 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 118.139 2.644 . . . . 0.0 118.139 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -95.0 -18.1 21.36 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 158.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -123.79 -21.64 5.12 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 117.29 2.329 . . . . 0.0 117.29 -173.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.24 -30.92 7.12 Favored Glycine 0 N--CA 1.496 2.684 0 CA-C-N 121.885 2.129 . . . . 0.0 118.351 -175.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -78.76 151.56 31.96 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 118.45 1.125 . . . . 0.0 113.585 -167.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -98.63 132.62 43.89 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.599 0.714 . . . . 0.0 112.004 -164.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.3 tt -131.11 122.55 26.86 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 124.1 0.96 . . . . 0.0 109.908 -170.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -109.85 116.84 32.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.126 -0.984 . . . . 0.0 109.352 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.7 m -106.52 104.06 13.67 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 119.019 0.827 . . . . 0.0 110.008 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.5 t -92.36 107.8 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.25 -0.906 . . . . 0.0 108.675 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -85.3 103.76 14.53 Favored 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 124.074 0.95 . . . . 0.0 110.433 170.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -127.46 147.35 50.3 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 124.254 1.022 . . . . 0.0 109.534 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . 0.25 5.8 mt -113.72 117.47 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 119.771 -1.83 . . . . 0.0 111.175 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.2 tp -92.35 74.71 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.769 0 CA-C-O 122.124 0.964 . . . . 0.0 110.741 172.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.94 -98.48 0.71 Allowed Glycine 0 N--CA 1.49 2.281 0 O-C-N 121.067 -1.021 . . . . 0.0 115.193 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -80.7 -10.62 59.72 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.892 2.553 . . . . 0.0 117.892 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -128.28 127.64 43.15 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-N 119.736 1.153 . . . . 0.0 112.457 -165.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.9 tp -80.94 124.11 28.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.858 0.863 . . . . 0.0 111.147 170.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.2 m -103.17 116.54 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -91.13 103.49 16.18 Favored 'General case' 0 CA--C 1.558 1.281 0 O-C-N 121.277 -0.889 . . . . 0.0 109.093 167.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.4 m -90.66 104.57 17.14 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -92.16 106.92 18.83 Favored 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 123.76 0.824 . . . . 0.0 110.621 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.89 111.39 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.403 ' O ' HG12 ' A' ' 122' ' ' VAL . 91.7 t80 -142.04 110.82 6.19 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.988 0.515 . . . . 0.0 110.463 -175.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 54.31 50.52 16.14 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 168.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.69 38.01 44.1 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 118.507 2.163 . . . . 0.0 118.507 -170.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 119' ' ' TYR . 0.5 OUTLIER -146.55 148.15 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 118.812 1.306 . . . . 0.0 110.216 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -130.06 115.82 17.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.729 -0.607 . . . . 0.0 109.981 171.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.22 127.3 54.64 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.009 0.524 . . . . 0.0 112.276 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -108.71 105.09 14.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.595 -0.691 . . . . 0.0 110.099 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -87.85 115.13 25.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.346 -0.847 . . . . 0.0 110.494 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 22.7 mt -99.53 123.16 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -120.99 119.54 32.83 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 124.291 1.036 . . . . 0.0 109.604 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -80.36 142.85 34.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.913 -1.117 . . . . 0.0 113.073 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 52.6 tttt -69.34 113.67 6.87 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.7 t70 . . . . . 0 N--CA 1.49 1.552 0 C-N-CA 124.761 1.224 . . . . 0.0 113.734 172.675 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.349 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 60.03 65.12 1.15 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 172.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -148.99 81.29 1.43 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.659 -0.651 . . . . 0.0 110.431 -176.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.3 m -171.95 170.26 5.45 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.577 1.179 . . . . 0.0 111.763 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.2 m -90.39 130.73 36.44 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.912 -1.117 . . . . 0.0 110.712 170.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -135.39 113.56 11.33 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.576 -0.703 . . . . 0.0 109.762 -171.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -116.13 143.38 45.56 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.651 -1.281 . . . . 0.0 113.649 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.88 115.86 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -168.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.08 -48.75 7.19 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 124.388 1.075 . . . . 0.0 112.86 169.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -136.61 109.73 7.75 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 119.377 0.99 . . . . 0.0 110.225 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.0 p -91.98 101.06 13.61 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.018 -1.051 . . . . 0.0 111.013 167.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -106.96 113.11 26.39 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -165.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.294 13.1 t30 69.67 16.65 7.94 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 117.53 2.419 . . . . 0.0 117.53 -176.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -66.73 -37.92 85.62 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.44 -43.17 83.68 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 167.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -69.29 -43.15 74.44 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 171.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -48.62 -54.34 15.0 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 162.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 mtt -66.7 -24.7 66.29 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 170.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.65 -42.92 81.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.295 -1.503 . . . . 0.0 114.216 164.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -57.47 -33.15 67.69 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 163.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 mmt -64.05 -42.58 96.99 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 164.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.87 56.35 0.96 Allowed Glycine 0 N--CA 1.485 1.951 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -117.44 147.86 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-N 117.983 0.892 . . . . 0.0 112.512 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -56.45 139.72 48.16 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.297 0.0 OUTLIER -47.35 -45.54 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 178.598 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.4 t -55.07 -60.02 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 C-N-CA 124.288 1.035 . . . . 0.0 113.643 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -63.19 -38.73 92.31 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -58.03 -49.67 76.09 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 170.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -59.18 -47.77 84.08 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 167.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.4 mt -59.0 -41.5 87.8 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 171.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.86 -41.46 87.27 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.84 -52.79 64.02 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 161.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -91.4 35.72 0.94 Allowed 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -77.89 -22.68 49.36 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 66.61 60.6 0.57 Allowed 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 120.472 1.487 . . . . 0.0 113.056 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.4 tp -86.7 120.87 28.46 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 121.415 -0.803 . . . . 0.0 112.979 -171.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -98.4 121.2 40.03 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 124.53 1.132 . . . . 0.0 110.355 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.4 mt -101.76 101.64 12.15 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 123.709 0.804 . . . . 0.0 109.253 174.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.4 m -88.84 95.03 10.13 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.155 -0.966 . . . . 0.0 108.775 172.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 73.6 mt -93.06 118.7 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -173.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -137.01 146.78 45.71 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 123.33 0.652 . . . . 0.0 110.725 171.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -130.53 157.92 41.37 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -127.55 84.23 2.23 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-N 114.482 -1.235 . . . . 0.0 108.706 167.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.73 -82.2 0.84 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 116.206 1.243 . . . . 0.0 116.206 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -116.07 -16.33 11.05 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 168.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -85.79 131.19 34.37 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 121.245 1.839 . . . . 0.0 111.833 173.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -113.61 131.16 56.22 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 124.363 1.065 . . . . 0.0 110.023 177.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 m -103.71 111.87 24.55 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 163.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.7 t -108.99 102.87 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -84.98 109.82 18.45 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -108.16 103.95 13.25 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.896 0.478 . . . . 0.0 110.043 -166.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 t -115.32 118.95 34.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.305 0.642 . . . . 0.0 111.745 -172.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.5 p -138.38 175.5 9.52 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.779 0.8 . . . . 0.0 112.965 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.74 62.26 1.05 Allowed 'General case' 0 CA--C 1.576 1.98 0 O-C-N 120.395 -1.441 . . . . 0.0 113.54 153.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -169.18 -61.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.932 1.293 . . . . 0.0 109.225 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.402 ' HG3' HH11 ' A' ' 56' ' ' ARG . 32.0 ptt85 -142.47 141.49 32.16 Favored 'General case' 0 CA--C 1.567 1.608 0 C-N-CA 124.035 0.934 . . . . 0.0 110.545 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -129.68 92.43 3.33 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.17 153.02 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 CA-C-O 121.91 0.862 . . . . 0.0 111.879 -170.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.38 108.41 18.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.932 . . . . 0.0 110.564 168.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.84 97.77 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.3 t -102.7 125.65 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -173.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -150.77 151.05 31.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.606 -0.684 . . . . 0.0 111.662 -176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -97.3 143.82 27.69 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.285 -0.885 . . . . 0.0 111.004 165.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.8 mt -57.35 122.03 11.59 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.88 -4.77 73.47 Favored Glycine 0 CA--C 1.555 2.537 0 N-CA-C 119.868 2.707 . . . . 0.0 119.868 -170.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -93.64 132.18 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-N 120.489 2.144 . . . . 0.0 109.769 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -74.94 117.98 17.39 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -134.8 161.09 36.16 Favored 'General case' 0 CA--C 1.571 1.753 0 C-N-CA 123.844 0.858 . . . . 0.0 112.013 -176.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -89.41 115.89 27.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.357 -0.84 . . . . 0.0 111.88 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -113.23 129.92 56.38 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 123.868 0.867 . . . . 0.0 111.129 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -98.49 131.32 44.83 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.996 -1.065 . . . . 0.0 110.895 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.6 mt -62.89 -56.1 20.23 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 170.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -154.95 -65.15 0.13 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 119.116 0.871 . . . . 0.0 111.948 177.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -84.16 -76.08 0.31 Allowed 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.396 0.679 . . . . 0.0 111.96 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.66 58.23 0.4 Allowed Glycine 0 N--CA 1.488 2.151 0 CA-C-N 118.795 0.725 . . . . 0.0 114.51 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 m -105.94 90.95 3.53 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -82.59 117.67 22.73 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.936 0.874 . . . . 0.0 112.44 -168.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.8 mt -115.58 108.66 16.71 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.671 0.789 . . . . 0.0 109.393 -171.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -98.1 96.72 8.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.758 -0.589 . . . . 0.0 110.669 -170.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.29 -153.46 10.97 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 116.338 1.295 . . . . 0.0 116.338 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.7 p -129.68 128.8 43.29 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -152.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -91.22 119.51 31.36 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.057 -1.027 . . . . 0.0 109.393 158.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.3 m -122.02 136.04 54.89 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.267 0.556 . . . . 0.0 111.308 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.8 tp -86.12 109.11 18.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.961 -1.087 . . . . 0.0 111.138 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.23 15.08 2.55 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 171.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.09 -80.53 0.27 Allowed Glycine 0 N--CA 1.488 2.148 0 O-C-N 120.827 -1.171 . . . . 0.0 112.087 -170.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -83.89 -28.8 27.67 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -125.45 140.06 53.1 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.781 1.173 . . . . 0.0 111.556 -165.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.5 mt -89.24 104.54 17.08 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 167.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.1 pt -93.97 116.41 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.997 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.82 99.95 2.61 Favored Glycine 0 N--CA 1.482 1.703 0 C-N-CA 123.591 0.615 . . . . 0.0 112.944 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -97.05 98.44 10.06 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -128.61 167.39 17.23 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-O 123.338 1.542 . . . . 0.0 111.657 -170.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.0 154.64 36.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.706 -1.246 . . . . 0.0 110.256 165.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -70.66 109.99 5.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 112.195 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.8 t -66.4 -17.87 65.03 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -84.96 -22.21 29.26 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 165.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -120.12 -22.49 6.63 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.98 -39.4 2.78 Favored Glycine 0 N--CA 1.492 2.37 0 CA-C-N 121.37 1.895 . . . . 0.0 117.258 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -72.05 144.86 48.6 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -165.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.66 140.39 55.46 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -173.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.1 tt -126.16 127.24 45.41 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.549 0.69 . . . . 0.0 111.323 167.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -96.67 149.08 22.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.506 -0.746 . . . . 0.0 110.604 163.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.4 m -145.32 105.54 4.06 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 119.928 -1.732 . . . . 0.0 109.589 162.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.7 t -93.11 114.26 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.094 -1.004 . . . . 0.0 109.03 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.4 mtm-85 -89.05 121.57 31.53 Favored 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 123.787 0.835 . . . . 0.0 111.265 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -143.61 141.48 30.64 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 123.671 0.788 . . . . 0.0 110.424 -177.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.29 126.57 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 120.733 -1.23 . . . . 0.0 109.759 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.1 tp -116.52 91.68 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.754 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 164.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.04 -112.32 4.15 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 120.898 -1.126 . . . . 0.0 114.611 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -99.62 20.31 14.22 Favored 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 167.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -126.14 127.16 45.32 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.788 1.176 . . . . 0.0 111.056 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.5 tp -87.62 114.78 24.54 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.241 1.016 . . . . 0.0 109.982 171.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.4 m -91.35 119.43 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.585 -0.697 . . . . 0.0 109.876 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -99.71 103.68 15.36 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 166.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.5 m -89.81 94.96 10.03 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -81.08 131.45 35.3 Favored 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 123.944 0.898 . . . . 0.0 111.249 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.1 t -134.98 114.37 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 CA-C-N 119.147 0.885 . . . . 0.0 109.274 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -113.94 122.12 45.99 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.31 5.2 mm-40 70.69 -85.47 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 124.23 1.012 . . . . 0.0 112.0 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -151.22 50.49 0.53 Allowed Glycine 0 N--CA 1.487 2.1 0 CA-C-O 119.416 -0.658 . . . . 0.0 114.109 158.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.35 109.08 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -77.81 129.61 35.65 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -124.08 114.3 19.53 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.532 0.682 . . . . 0.0 110.622 163.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -99.7 104.39 16.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.861 -0.525 . . . . 0.0 109.683 -176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 -93.3 112.7 24.7 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.531 0.682 . . . . 0.0 109.612 172.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.8 mt -99.1 114.74 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.555 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -173.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -108.44 111.33 23.17 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.685 0.794 . . . . 0.0 109.891 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -79.97 144.79 32.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.003 -1.061 . . . . 0.0 112.467 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -66.1 120.34 13.02 Favored 'General case' 0 CA--C 1.569 1.692 0 CA-C-O 121.684 0.754 . . . . 0.0 112.961 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.8 t70 . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -158.895 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.347 0 CA-C-O 122.106 0.955 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 55.01 35.03 23.75 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 171.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -146.71 51.82 1.11 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.379 -1.45 . . . . 0.0 113.78 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 p -160.87 176.75 11.1 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.127 -0.983 . . . . 0.0 113.593 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.4 m -78.4 116.58 18.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.72 . . . . 0.0 110.264 160.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -109.73 111.34 22.73 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -95.04 138.65 32.48 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.429 -0.794 . . . . 0.0 111.75 -177.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.02 122.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -110.29 -55.62 2.44 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.581 0.752 . . . . 0.0 112.742 -174.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -158.56 119.8 3.43 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 120.042 1.292 . . . . 0.0 111.064 -171.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.0 p -110.29 124.72 52.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.031 -1.043 . . . . 0.0 113.099 -174.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -78.43 -48.4 15.5 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -170.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -134.83 54.75 1.93 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 119.97 1.259 . . . . 0.0 112.599 168.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -84.45 58.77 5.04 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.018 -1.676 . . . . 0.0 112.419 167.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -151.61 -61.19 0.17 Allowed 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 125.101 1.36 . . . . 0.0 109.43 -176.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -62.02 -48.95 77.97 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 120.846 1.657 . . . . 0.0 114.096 170.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -47.65 -52.8 16.83 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 163.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.8 mtp -55.17 -49.14 72.62 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 171.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -52.84 -46.38 67.78 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 165.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -60.13 -36.22 77.0 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 170.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.7 mtm -72.34 -59.14 2.88 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 119.607 1.094 . . . . 0.0 113.114 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.89 72.14 0.02 OUTLIER Glycine 0 N--CA 1.487 2.047 0 CA-C-N 118.268 0.486 . . . . 0.0 113.779 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 m -118.36 155.44 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-O 122.025 0.917 . . . . 0.0 112.605 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -79.2 153.29 30.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.353 -0.842 . . . . 0.0 110.921 152.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.29 12.9 tt -56.78 -37.61 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 172.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.9 t -58.75 -53.73 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 C-N-CA 124.362 1.065 . . . . 0.0 113.276 166.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -55.34 -36.16 65.98 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 168.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -57.36 -52.08 66.81 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 172.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -64.61 -44.74 89.59 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 166.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -60.98 -58.06 10.02 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.66 -15.9 63.82 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 173.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.96 -52.47 42.41 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 156.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -91.51 -18.31 24.33 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 118.216 2.673 . . . . 0.0 118.216 -172.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -73.32 62.17 0.69 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 50.12 51.58 16.41 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 163.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 tt -91.07 109.55 20.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.116 -0.99 . . . . 0.0 111.588 -170.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -97.75 138.15 35.55 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-O 121.848 0.832 . . . . 0.0 111.937 166.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.2 mt -103.91 97.41 7.41 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 164.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.2 m -88.26 103.43 15.79 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.173 -0.955 . . . . 0.0 108.907 176.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.3 mt -94.01 108.58 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -168.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 m -105.26 111.19 23.84 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -87.34 137.92 31.92 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -135.84 80.36 1.82 Allowed 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 124.123 0.969 . . . . 0.0 109.166 172.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.12 -89.58 0.5 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 116.061 1.184 . . . . 0.0 116.061 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.13 15.33 19.5 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 167.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -134.3 116.13 14.91 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 119.942 1.246 . . . . 0.0 110.259 -166.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -104.8 129.53 53.06 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.715 -0.616 . . . . 0.0 110.847 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.1 m -100.77 104.43 15.69 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 164.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.2 t -101.47 108.39 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -80.21 110.35 15.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 111.003 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -83.73 95.07 8.29 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 t -116.55 114.71 24.53 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.005 0.907 . . . . 0.0 111.31 -170.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.8 t -154.53 175.41 13.65 Favored 'General case' 0 CA--C 1.572 1.8 0 C-N-CA 125.968 1.707 . . . . 0.0 109.087 -171.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.2 -27.11 63.59 Favored 'General case' 0 CA--C 1.581 2.171 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 155.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -85.42 -32.58 22.27 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.1 mmt-85 -137.42 140.41 41.3 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.197 0.908 . . . . 0.0 110.32 -175.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -135.33 76.07 1.6 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 158.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.3 142.6 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 122.026 0.917 . . . . 0.0 111.058 -168.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.4 113.67 26.0 Favored 'General case' 0 CA--C 1.564 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 111.461 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.1 t -90.93 98.35 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.5 t -91.6 119.4 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -136.6 129.78 31.31 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.159 0.504 . . . . 0.0 112.315 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.12 135.82 33.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.801 -0.562 . . . . 0.0 110.5 164.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.43 125.24 22.94 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.75 -16.76 44.37 Favored Glycine 0 CA--C 1.556 2.601 0 N-CA-C 119.447 2.539 . . . . 0.0 119.447 -167.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.0 t -86.21 130.28 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 CA-C-N 120.561 2.18 . . . . 0.0 109.98 -177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.0 t -74.44 121.33 21.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.575 -0.703 . . . . 0.0 112.76 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -142.58 164.72 29.36 Favored 'General case' 0 CA--C 1.573 1.86 0 C-N-CA 123.333 0.653 . . . . 0.0 111.775 -172.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -87.45 116.33 25.49 Favored 'General case' 0 CA--C 1.569 1.696 0 O-C-N 121.339 -0.851 . . . . 0.0 112.909 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -98.99 143.41 29.3 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.876 0.87 . . . . 0.0 111.231 166.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -120.59 132.63 55.24 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.983 0.897 . . . . 0.0 110.682 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.8 mt -84.54 168.19 15.63 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 121.979 0.895 . . . . 0.0 112.9 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.11 -36.67 80.33 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 118.94 2.941 . . . . 0.0 118.94 -173.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.34 -76.48 0.1 Allowed 'General case' 0 CA--C 1.571 1.775 0 CA-C-N 120.113 1.324 . . . . 0.0 111.697 169.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.44 64.0 0.05 OUTLIER Glycine 0 N--CA 1.483 1.806 0 O-C-N 121.841 -0.537 . . . . 0.0 112.543 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.8 m -123.04 107.17 11.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -95.26 128.91 42.47 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-O 122.07 0.938 . . . . 0.0 111.419 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.3 mt -132.69 116.24 16.37 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.076 -156.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -92.47 118.68 31.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.475 -0.765 . . . . 0.0 110.667 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.76 -177.92 42.45 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 117.981 1.953 . . . . 0.0 117.981 -173.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.6 p -126.28 132.13 51.73 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 113.972 -1.114 . . . . 0.0 110.37 -173.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -92.59 122.66 35.23 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.335 -0.853 . . . . 0.0 110.541 169.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.3 m -109.66 118.81 37.53 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.318 0.647 . . . . 0.0 110.831 175.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.5 tp -82.83 103.93 12.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.515 -0.74 . . . . 0.0 111.85 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -105.25 89.78 3.23 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.191 0.52 . . . . 0.0 110.26 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.69 -94.49 0.76 Allowed Glycine 0 N--CA 1.492 2.389 0 O-C-N 121.501 -0.75 . . . . 0.0 113.782 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -127.36 48.4 2.23 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 159.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -129.8 111.87 13.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.089 -1.007 . . . . 0.0 108.49 173.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.4 mt -84.55 108.37 17.28 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.439 -0.788 . . . . 0.0 109.452 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.0 mt -102.22 104.22 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -172.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.51 100.71 2.67 Favored Glycine 0 N--CA 1.483 1.812 0 C-N-CA 123.886 0.755 . . . . 0.0 113.096 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.52 95.92 9.91 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.973 0.509 . . . . 0.0 109.729 -175.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -110.76 147.75 33.78 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.589 0.709 . . . . 0.0 112.868 -171.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -119.04 139.43 51.74 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.644 0.778 . . . . 0.0 109.131 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -69.17 114.9 7.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.928 -1.107 . . . . 0.0 112.885 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 t -66.09 -16.77 64.22 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 117.916 2.562 . . . . 0.0 117.916 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -92.56 -10.65 36.84 Favored 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 165.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -141.15 -16.9 0.83 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 -169.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.94 -42.5 2.76 Favored Glycine 0 N--CA 1.493 2.458 0 CA-C-N 121.949 2.159 . . . . 0.0 117.707 -175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -70.24 147.91 49.19 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -161.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -77.43 132.2 38.36 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -173.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.0 tt -123.61 111.45 16.25 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 124.352 1.061 . . . . 0.0 108.751 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -101.63 113.62 26.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.104 -0.997 . . . . 0.0 109.577 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.0 m -107.2 108.69 20.24 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 119.196 0.907 . . . . 0.0 111.027 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.2 97.86 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.006 -1.059 . . . . 0.0 108.376 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -86.89 117.91 25.93 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.088 0.955 . . . . 0.0 110.899 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -146.97 142.81 27.92 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.326 -0.859 . . . . 0.0 112.864 -178.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.2 mp -90.84 110.01 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.0 tp -90.07 80.42 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.119 0.962 . . . . 0.0 110.155 169.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.67 -88.92 0.74 Allowed Glycine 0 N--CA 1.49 2.266 0 O-C-N 121.209 -0.932 . . . . 0.0 114.933 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -117.84 22.05 12.52 Favored 'General case' 0 CA--C 1.581 2.171 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 175.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -137.99 123.6 19.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.53 -1.356 . . . . 0.0 109.858 -175.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.7 tp -78.49 110.03 13.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.524 -0.735 . . . . 0.0 110.127 168.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.89 118.12 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.277 -0.89 . . . . 0.0 108.871 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . 0.269 21.3 pt20 -103.52 104.42 14.49 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.777 0.799 . . . . 0.0 110.724 172.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.0 m -91.56 108.39 19.87 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.755 0.822 . . . . 0.0 109.152 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -94.14 112.13 23.92 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.386 0.674 . . . . 0.0 110.865 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.01 97.39 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -109.6 113.19 25.76 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.152 0.581 . . . . 0.0 109.873 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 54.78 46.14 25.2 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.04 -25.23 4.86 Favored Glycine 0 CA--C 1.556 2.65 0 N-CA-C 119.125 2.41 . . . . 0.0 119.125 -166.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.5 t -83.6 108.61 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 119.989 1.894 . . . . 0.0 110.069 -168.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -86.46 119.47 26.76 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.151 0.58 . . . . 0.0 112.479 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -124.97 117.0 23.06 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.645 0.778 . . . . 0.0 111.888 175.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -106.45 108.68 20.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.537 -0.727 . . . . 0.0 110.174 -170.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -97.43 116.01 28.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.911 -0.493 . . . . 0.0 110.482 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.7 mt -90.48 118.81 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -111.63 123.83 51.05 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.372 1.069 . . . . 0.0 109.221 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -83.92 148.35 26.99 Favored 'General case' 0 CA--C 1.565 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 112.721 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -59.24 113.42 2.13 Favored 'General case' 0 CA--C 1.57 1.735 0 C-N-CA 123.687 0.795 . . . . 0.0 113.05 167.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 N--CA 1.489 1.488 0 C-N-CA 124.949 1.3 . . . . 0.0 113.096 -175.139 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.282 0 CA-C-O 121.231 0.539 . . . . 0.0 111.984 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.327 62.9 m-85 71.43 -49.38 0.68 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.13 93.88 1.09 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 120.259 1.39 . . . . 0.0 112.374 -170.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.4 m -176.76 166.45 2.57 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 122.651 1.215 . . . . 0.0 111.805 -163.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.3 m -94.94 122.79 37.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.485 -0.759 . . . . 0.0 110.326 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -127.14 111.79 14.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.762 -0.586 . . . . 0.0 109.691 -170.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -105.34 133.19 50.51 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.977 -1.077 . . . . 0.0 112.011 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.58 115.79 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -98.47 -54.71 2.96 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 124.483 1.113 . . . . 0.0 111.85 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 56.1 mtm-85 -133.79 106.98 7.62 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.427 1.012 . . . . 0.0 109.458 -177.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.5 p -94.34 97.74 10.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.856 -0.527 . . . . 0.0 111.196 174.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.4 127.03 52.76 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.157 0.583 . . . . 0.0 110.06 -159.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.269 37.8 t30 62.76 40.45 9.97 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -169.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -77.99 -49.82 13.32 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -172.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.02 -40.79 77.38 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 171.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -62.76 -47.65 82.6 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.21 1.368 . . . . 0.0 114.629 171.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -53.52 -53.03 57.39 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 166.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.9 mtp -60.83 -41.89 96.65 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -60.02 -42.52 94.51 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 165.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -40.69 73.89 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 166.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 56.6 mtm -61.84 -54.77 37.6 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-N 119.552 1.069 . . . . 0.0 112.763 166.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.99 54.83 0.08 OUTLIER Glycine 0 N--CA 1.487 2.041 0 CA-C-O 119.122 -0.821 . . . . 0.0 113.909 164.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.4 m -126.77 151.18 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 122.651 1.215 . . . . 0.0 112.911 -169.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -72.77 164.48 26.49 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.259 14.0 tt -55.43 -36.86 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 175.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.9 t -65.18 -51.57 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-N 120.09 1.314 . . . . 0.0 112.658 173.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -52.16 -47.08 65.66 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 166.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -57.87 -48.51 79.63 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -60.91 -46.25 91.42 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 171.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.5 mt -60.59 -48.16 83.02 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 171.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.24 -21.14 62.16 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.11 -49.36 15.44 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 120.962 1.71 . . . . 0.0 114.415 167.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -77.91 17.62 0.56 Allowed 'General case' 0 CA--C 1.58 2.124 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 175.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.2 p30 -74.94 -17.91 60.48 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 118.93 2.937 . . . . 0.0 118.93 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 61.53 62.19 1.36 Allowed 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 120.562 1.528 . . . . 0.0 113.484 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 tt -88.56 117.52 27.57 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.418 -0.801 . . . . 0.0 112.257 -164.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -101.21 127.83 47.6 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.54 0.736 . . . . 0.0 110.173 173.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.4 mt -98.48 102.4 14.13 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 166.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.5 m -94.62 107.56 19.55 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.098 -1.002 . . . . 0.0 108.441 171.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.7 mt -104.07 129.01 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -165.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 89.3 m -135.53 123.54 22.8 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.271 -0.893 . . . . 0.0 109.326 174.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.7 tm0? -98.74 132.94 43.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.321 -0.862 . . . . 0.0 112.186 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -127.69 87.6 2.65 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 123.565 0.746 . . . . 0.0 110.947 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.78 -89.5 0.96 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 115.139 0.816 . . . . 0.0 115.139 173.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -108.65 -2.5 18.68 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 166.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -108.99 144.13 37.37 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.34 1.427 . . . . 0.0 112.415 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -110.19 120.42 42.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.4 0.68 . . . . 0.0 109.986 167.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.1 m -86.41 102.72 14.3 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 164.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.3 t -104.6 101.52 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -83.8 107.44 16.21 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.262 -0.899 . . . . 0.0 110.017 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -86.6 92.9 9.05 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.005 0.522 . . . . 0.0 110.066 176.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.3 m -96.24 108.72 21.24 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 120.941 0.4 . . . . 0.0 109.991 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.3 p -143.51 158.02 43.98 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.468 0.651 . . . . 0.0 111.776 -174.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.61 -25.0 64.27 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.429 2.381 . . . . 0.0 117.429 165.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -53.96 15.66 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 165.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.79 152.52 25.19 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-N 119.148 0.886 . . . . 0.0 111.676 174.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -106.08 98.14 7.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.689 -0.632 . . . . 0.0 109.837 166.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.2 pt -122.93 132.85 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 121.989 0.9 . . . . 0.0 111.765 -174.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -94.85 98.46 10.75 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.693 0.797 . . . . 0.0 108.917 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.45 93.3 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -166.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.6 t -94.21 98.42 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -176.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -109.88 141.49 42.52 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.285 0.564 . . . . 0.0 112.116 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.38 138.75 31.16 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.465 0.65 . . . . 0.0 111.292 166.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.66 129.03 39.08 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.95 -7.12 63.95 Favored Glycine 0 CA--C 1.555 2.569 0 N-CA-C 119.969 2.748 . . . . 0.0 119.969 -170.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.9 t -97.78 133.74 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 120.634 2.217 . . . . 0.0 110.414 -170.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.7 p -74.57 104.35 5.23 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.439 0.696 . . . . 0.0 112.626 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -118.07 138.74 52.03 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 123.292 0.637 . . . . 0.0 111.928 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 -74.77 115.37 14.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.581 -0.7 . . . . 0.0 112.244 172.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -111.56 152.02 28.04 Favored 'General case' 0 CA--C 1.569 1.689 0 C-N-CA 124.093 0.957 . . . . 0.0 112.591 -175.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -119.81 136.39 54.48 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.086 0.954 . . . . 0.0 111.633 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.2 mt -105.99 64.12 0.68 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.292 -0.88 . . . . 0.0 113.097 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.32 . . 66.47 -66.76 0.17 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.29 -22.33 41.02 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 119.926 3.306 . . . . 0.0 119.926 176.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.49 21.94 8.93 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 118.229 2.052 . . . . 0.0 118.229 -170.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 83.8 m -82.32 108.01 15.43 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 119.763 1.782 . . . . 0.0 109.334 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -78.33 128.57 33.86 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.267 0.627 . . . . 0.0 112.342 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.0 mt -140.37 105.1 4.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.993 -0.442 . . . . 0.0 110.759 -166.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -81.76 123.79 29.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.654 -1.279 . . . . 0.0 110.896 171.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.22 176.84 40.12 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 118.649 2.22 . . . . 0.0 118.649 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.5 p -126.03 130.2 50.69 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 113.674 -1.263 . . . . 0.0 110.866 -169.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -97.72 123.48 41.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.677 -0.639 . . . . 0.0 111.744 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.2 m -106.07 120.19 41.15 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.408 0.683 . . . . 0.0 110.67 172.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.3 tp -84.22 121.14 27.07 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.336 0.588 . . . . 0.0 111.542 175.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -89.43 -48.21 7.49 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 164.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.56 -87.05 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 CA-C-N 119.177 0.899 . . . . 0.0 110.988 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -82.17 -4.32 56.75 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 156.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.98 138.15 43.69 Favored 'General case' 0 CA--C 1.57 1.714 0 C-N-CA 125.183 1.393 . . . . 0.0 111.69 174.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mt -130.12 124.56 33.0 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 169.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.15 119.4 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.17 -0.956 . . . . 0.0 110.377 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.22 108.78 3.12 Favored Glycine 0 N--CA 1.486 1.99 0 C-N-CA 123.587 0.613 . . . . 0.0 112.972 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.57 94.12 7.57 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.2 0.6 . . . . 0.0 110.652 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.94 142.13 41.73 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -170.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -124.72 138.3 54.29 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.305 1.042 . . . . 0.0 108.194 174.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.79 107.94 9.47 Favored 'General case' 0 CA--C 1.568 1.672 0 O-C-N 120.817 -1.177 . . . . 0.0 113.67 -168.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.6 p -78.11 69.75 4.37 Favored 'General case' 0 N--CA 1.506 2.342 0 CA-C-O 124.067 1.889 . . . . 0.0 112.442 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.8 t70 169.15 -51.89 0.01 OUTLIER 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 113.028 -1.896 . . . . 0.0 109.047 -148.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -142.12 -5.48 0.99 Allowed 'General case' 0 CA--C 1.582 2.18 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.4 -40.39 2.94 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 118.501 2.16 . . . . 0.0 118.501 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -60.6 149.69 34.1 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -165.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.12 127.74 32.98 Favored 'General case' 0 CA--C 1.565 1.545 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -169.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.1 tt -119.74 115.29 23.61 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 124.524 1.13 . . . . 0.0 108.296 174.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -101.97 118.23 36.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.037 -1.039 . . . . 0.0 110.902 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.2 m -100.28 111.07 23.32 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 73.9 t -97.72 108.59 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -95.44 129.41 42.61 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.419 0.688 . . . . 0.0 110.791 170.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -145.33 137.42 25.66 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.854 -0.529 . . . . 0.0 111.216 172.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.4 mp -87.6 109.35 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 173.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.253 11.3 tp -92.35 74.14 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 122.221 1.01 . . . . 0.0 110.378 168.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.72 -98.11 0.67 Allowed Glycine 0 N--CA 1.489 2.216 0 O-C-N 121.09 -1.006 . . . . 0.0 115.481 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -87.85 -2.14 58.42 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 174.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -132.2 125.9 32.27 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 119.585 1.084 . . . . 0.0 110.586 -168.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.3 tp -83.13 114.98 21.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.48 -0.763 . . . . 0.0 109.643 168.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.9 m -92.49 105.12 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -101.39 98.96 9.26 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.8 m -102.21 118.15 36.27 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.668 0.787 . . . . 0.0 110.397 -169.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -100.23 107.21 18.99 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.715 0.806 . . . . 0.0 110.888 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.2 t -106.33 107.83 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -118.34 118.94 33.15 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.184 0.593 . . . . 0.0 110.624 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.328 51.9 mt-10 66.2 -81.91 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 124.677 1.191 . . . . 0.0 113.43 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -146.69 45.76 0.77 Allowed Glycine 0 N--CA 1.489 2.21 0 CA-C-O 119.233 -0.76 . . . . 0.0 114.941 158.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.7 t -135.49 117.15 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -100.95 124.12 46.17 Favored 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 123.655 0.782 . . . . 0.0 111.845 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.81 120.01 37.87 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.057 0.543 . . . . 0.0 112.029 170.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -98.63 101.73 13.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.705 -0.622 . . . . 0.0 110.845 -176.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -84.18 111.31 19.24 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 121.072 0.463 . . . . 0.0 110.272 169.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 95.9 mt -90.6 117.45 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -106.57 120.54 42.21 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.4 0.68 . . . . 0.0 109.732 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -84.84 143.32 29.15 Favored 'General case' 0 CA--C 1.566 1.581 0 O-C-N 121.674 -0.641 . . . . 0.0 111.831 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -62.9 105.41 0.67 Allowed 'General case' 0 CA--C 1.572 1.805 0 O-C-N 121.465 -0.772 . . . . 0.0 112.905 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 N--CA 1.493 1.706 0 C-N-CA 124.763 1.225 . . . . 0.0 113.462 -170.95 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.238 0 CA-C-O 121.063 0.459 . . . . 0.0 111.392 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 66.6 82.25 0.19 Allowed 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 124.398 1.079 . . . . 0.0 112.44 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -152.64 74.01 1.04 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.996 -1.065 . . . . 0.0 112.338 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.0 p -159.1 -179.01 7.63 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.181 0.991 . . . . 0.0 113.416 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.2 m -86.92 119.67 27.38 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.873 0.869 . . . . 0.0 110.131 172.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -120.71 98.22 5.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.654 -0.654 . . . . 0.0 109.961 -173.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -88.58 138.35 31.5 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.333 -0.854 . . . . 0.0 112.168 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.43 125.13 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -95.46 -52.71 4.03 Favored 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 124.647 1.179 . . . . 0.0 112.841 172.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.8 ptt85 -159.7 128.75 5.17 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 120.041 1.291 . . . . 0.0 112.131 -168.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.6 p -97.09 101.82 13.47 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.829 0.852 . . . . 0.0 112.135 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -97.17 112.36 24.18 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.837 -0.54 . . . . 0.0 109.99 -166.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.266 41.9 t30 62.02 24.39 14.51 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -170.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -74.78 -32.97 62.18 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -172.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -53.04 -42.01 65.34 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 164.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -64.17 -47.64 79.08 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 173.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -52.08 -54.04 35.06 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 166.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.45 ' HB3' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -63.36 -34.43 77.7 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 171.059 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -58.85 -48.53 81.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.272 -1.518 . . . . 0.0 114.559 165.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -55.16 -34.64 63.98 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 166.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.3 mmt -68.31 -37.33 80.49 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 168.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.39 56.4 0.69 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 115.983 1.153 . . . . 0.0 115.983 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 p -124.83 156.31 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-O 122.348 1.07 . . . . 0.0 111.789 173.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -66.09 157.79 30.19 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.288 12.4 tt -58.72 -38.95 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -64.2 -55.38 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.181 0.9 . . . . 0.0 112.708 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -57.76 -30.12 65.37 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 167.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.45 ' HG3' ' HB3' ' A' ' 18' ' ' MET . 6.3 mtp180 -60.19 -55.73 30.22 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 167.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -61.05 -37.78 83.86 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.7 mt -61.15 -48.52 81.2 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 164.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.36 -41.0 75.44 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 171.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.02 -47.95 74.03 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 164.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -114.99 36.84 3.69 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -79.67 43.82 0.59 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.338 20.0 p30 36.74 37.19 0.06 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 119.956 3.317 . . . . 0.0 119.956 -174.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 tt -75.51 115.22 14.95 Favored 'General case' 0 CA--C 1.558 1.256 0 O-C-N 120.91 -1.119 . . . . 0.0 112.844 -158.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -106.31 110.63 22.92 Favored 'General case' 0 CA--C 1.558 1.26 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.036 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.7 mt -86.65 97.05 10.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 169.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 86.5 m -86.45 92.49 8.86 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.9 mt -87.57 120.88 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 -174.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.9 p -122.95 108.22 12.71 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -84.87 130.55 34.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.542 -0.724 . . . . 0.0 111.652 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -135.88 68.54 1.45 Allowed 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.198 0.599 . . . . 0.0 110.742 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.65 76.31 0.25 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 116.79 1.476 . . . . 0.0 116.79 176.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.321 8.0 m120 73.03 -37.64 0.39 Allowed 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -170.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -67.06 135.07 53.09 Favored 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 119.701 1.137 . . . . 0.0 112.989 162.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -121.51 115.08 22.18 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 168.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.3 m -94.96 103.37 15.22 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 172.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 52.9 t -110.85 110.85 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -171.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -86.1 90.18 8.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.766 -0.583 . . . . 0.0 110.258 176.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -73.14 95.62 2.1 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.034 0.934 . . . . 0.0 110.51 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.1 m -109.3 97.14 6.79 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -161.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.3 p -127.79 163.27 24.73 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.924 0.868 . . . . 0.0 113.255 -170.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.15 -23.23 63.75 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 166.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -77.65 -53.92 6.99 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 119.555 1.071 . . . . 0.0 113.339 165.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -156.0 151.71 27.24 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 119.74 1.155 . . . . 0.0 112.264 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -109.31 108.77 19.46 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.508 0.723 . . . . 0.0 110.357 170.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 pp -135.83 145.25 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-O 121.646 0.736 . . . . 0.0 111.874 -171.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -97.29 115.45 27.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -0.978 . . . . 0.0 111.545 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.83 103.25 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.33 101.47 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 173.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -119.63 136.26 54.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.861 -0.524 . . . . 0.0 112.374 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -92.81 144.02 25.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.692 -0.63 . . . . 0.0 110.716 164.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.94 115.58 3.82 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.77 -15.76 59.81 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 119.698 2.639 . . . . 0.0 119.698 -172.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.8 t -85.25 111.64 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.678 2.239 . . . . 0.0 108.684 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.261 7.4 t -78.78 124.32 28.09 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -165.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -134.4 163.71 29.06 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 124.071 0.949 . . . . 0.0 112.396 -170.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -85.41 109.39 18.4 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 121.865 0.84 . . . . 0.0 112.194 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -93.55 165.97 12.48 Favored 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 124.9 1.28 . . . . 0.0 112.256 172.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.252 0.6 OUTLIER -139.28 155.96 47.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.612 -1.305 . . . . 0.0 113.196 166.096 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.9 mt -86.56 51.35 2.21 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 175.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.285 . . 62.41 -50.51 0.17 Allowed 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 118.472 2.767 . . . . 0.0 118.472 -168.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.9 p30 -78.07 -78.63 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -175.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.4 72.52 0.09 OUTLIER Glycine 0 N--CA 1.481 1.693 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 -170.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.4 m -145.46 105.91 4.08 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.64 112.98 20.02 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-O 121.424 0.63 . . . . 0.0 111.843 -173.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 70.9 mt -118.26 107.74 14.27 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.181 0.592 . . . . 0.0 111.112 -167.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.2 ttm-85 -88.85 121.14 30.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 111.113 174.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.01 -154.57 11.71 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.3 p -144.48 138.06 27.36 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 123.196 0.599 . . . . 0.0 110.627 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -88.0 120.07 28.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.693 -0.629 . . . . 0.0 109.866 163.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.2 t -115.62 124.6 51.34 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.176 0.59 . . . . 0.0 111.109 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.3 tp -84.61 104.92 15.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.471 -0.768 . . . . 0.0 111.586 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -105.16 78.87 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.507 0.67 . . . . 0.0 109.907 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.59 -102.02 1.25 Allowed Glycine 0 N--CA 1.49 2.285 0 O-C-N 121.547 -0.72 . . . . 0.0 114.023 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -112.51 45.39 1.31 Allowed 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 167.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -139.3 115.13 10.11 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.285 -0.884 . . . . 0.0 109.039 173.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.1 mt -86.19 104.64 15.93 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 166.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.0 mt -99.85 110.57 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -172.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.18 94.62 2.01 Favored Glycine 0 N--CA 1.481 1.646 0 C-N-CA 123.47 0.557 . . . . 0.0 112.553 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -86.91 98.86 11.46 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -119.78 142.8 48.25 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.518 0.727 . . . . 0.0 112.337 -168.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -122.71 137.43 54.92 Favored 'General case' 0 CA--C 1.563 1.456 0 O-C-N 121.471 -0.768 . . . . 0.0 109.997 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -64.89 118.05 8.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.192 -0.943 . . . . 0.0 113.182 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.7 p -76.84 67.89 2.96 Favored 'General case' 0 N--CA 1.508 2.439 0 CA-C-O 122.318 1.056 . . . . 0.0 110.623 169.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -178.43 -68.05 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -159.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -98.37 -35.92 10.14 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.075 1.879 . . . . 0.0 116.075 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.72 6.21 76.94 Favored Glycine 0 CA--C 1.558 2.737 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 -150.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -82.74 134.44 35.13 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 119.599 1.699 . . . . 0.0 112.885 -175.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -90.15 133.89 34.61 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -172.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.79 122.18 35.46 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 125.211 1.404 . . . . 0.0 108.878 -176.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -100.31 109.67 21.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.102 -0.999 . . . . 0.0 109.342 172.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.8 m -99.91 99.86 10.7 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 119.353 0.979 . . . . 0.0 109.757 172.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 80.2 t -88.31 105.04 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.019 -1.051 . . . . 0.0 108.549 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -79.48 112.89 17.18 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.339 0.656 . . . . 0.0 110.115 163.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -137.28 147.41 45.67 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.489 0.662 . . . . 0.0 109.935 171.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.77 139.1 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.008 0 O-C-N 120.776 -1.202 . . . . 0.0 109.922 167.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.5 tt -119.36 89.97 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.804 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 162.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 68.68 -99.01 0.56 Allowed Glycine 0 N--CA 1.492 2.391 0 O-C-N 120.948 -1.095 . . . . 0.0 115.529 -176.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -95.21 -3.17 48.18 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 170.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -123.4 129.69 51.64 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 119.464 1.029 . . . . 0.0 111.48 -164.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.4 tp -82.89 114.59 21.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.288 170.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.0 m -82.47 126.06 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 166.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -99.16 101.02 12.22 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 157.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.5 m -90.16 108.31 19.67 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -102.8 99.67 9.63 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.456 0.703 . . . . 0.0 110.855 -170.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 t -99.43 114.17 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -134.63 109.74 8.84 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.041 0.536 . . . . 0.0 110.853 -174.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.287 24.4 mm-40 68.17 -79.52 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 172.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -142.54 58.95 0.55 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 123.212 0.434 . . . . 0.0 113.091 167.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.18 154.79 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 123.756 0.822 . . . . 0.0 109.852 -174.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.255 0.0 OUTLIER -144.47 136.91 26.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.11 -0.994 . . . . 0.0 112.949 161.72 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.56 145.44 51.72 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.53 0.732 . . . . 0.0 112.204 174.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -120.04 98.22 5.98 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . 0.297 6.1 ptm180 -88.76 123.52 33.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.755 -1.216 . . . . 0.0 110.414 170.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.5 mt -109.82 131.31 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -161.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -119.31 127.1 52.88 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.365 0.666 . . . . 0.0 110.339 -175.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -83.48 144.06 29.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.238 -0.914 . . . . 0.0 112.499 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.6 tttt -69.27 122.11 18.2 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 121.683 0.754 . . . . 0.0 112.464 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.2 t70 . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -162.281 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.291 0 CA-C-O 121.912 0.863 . . . . 0.0 112.396 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -131.1 66.18 1.54 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -171.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -83.66 82.59 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.537 -1.352 . . . . 0.0 112.801 -165.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.8 t -162.6 -178.15 6.04 Favored 'General case' 0 CA--C 1.574 1.894 0 CA-C-O 123.004 1.383 . . . . 0.0 112.808 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.9 m -97.21 121.54 39.21 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.968 0.907 . . . . 0.0 109.451 169.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.461 ' CH2' HD11 ' A' ' 108' ' ' ILE . 98.9 m95 -118.72 112.02 19.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.709 -0.62 . . . . 0.0 110.644 -167.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -98.35 131.23 44.82 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 118.762 0.71 . . . . 0.0 112.167 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 p -66.92 120.9 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.336 -0.852 . . . . 0.0 113.249 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -100.81 -55.97 2.44 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -143.57 122.24 12.57 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 119.61 1.096 . . . . 0.0 112.246 -173.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.9 p -99.77 122.61 43.0 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.804 0.842 . . . . 0.0 111.936 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -76.36 -38.2 56.18 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -172.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -116.06 -78.51 0.58 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 119.269 0.94 . . . . 0.0 109.595 170.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.289 0.5 OUTLIER 47.45 35.11 3.82 Favored 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 118.427 2.751 . . . . 0.0 118.427 -175.745 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -150.0 -53.5 0.15 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.182 0.993 . . . . 0.0 111.095 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -66.33 -40.76 90.1 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 120.534 1.516 . . . . 0.0 114.095 164.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -45.62 -58.43 3.43 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 157.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.3 mtp -64.16 -38.18 90.13 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -60.45 -42.7 96.69 Favored 'General case' 0 CA--C 1.574 1.893 0 O-C-N 120.16 -1.588 . . . . 0.0 114.951 166.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -66.27 -28.84 69.02 Favored 'General case' 0 CA--C 1.579 2.076 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 168.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 mtm -59.81 -34.66 73.36 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 158.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.02 45.07 1.8 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 115.829 1.092 . . . . 0.0 115.829 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.1 m -127.21 147.65 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 118.837 1.318 . . . . 0.0 112.987 -173.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -72.26 162.41 29.5 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -175.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.256 0.2 OUTLIER -48.21 -44.61 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 168.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.4 t -54.89 -50.66 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 170.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -63.45 -40.78 98.04 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 169.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -57.02 -47.87 79.84 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 169.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.286 0.0 OUTLIER -64.88 -39.59 93.77 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 168.784 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.79 -53.77 14.16 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 176.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.4 -13.24 60.7 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 175.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.73 -54.58 8.57 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 120.328 1.422 . . . . 0.0 114.367 155.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -85.82 62.81 7.68 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.799 1.181 . . . . 0.0 112.765 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.5 p30 -121.3 9.04 10.31 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 -178.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.347 1.7 p-10 52.66 58.86 4.93 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 177.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.9 tp -75.45 118.97 18.9 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -116.63 114.4 24.04 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.342 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.7 mt -95.08 109.67 21.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.55 -0.719 . . . . 0.0 109.621 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.1 m -90.88 98.57 11.86 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.269 -0.894 . . . . 0.0 108.643 169.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.3 mt -101.47 124.61 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -146.85 135.11 21.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.404 -0.81 . . . . 0.0 112.555 166.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -86.12 145.65 26.94 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 171.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.42 88.05 1.41 Allowed 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 124.818 1.247 . . . . 0.0 109.173 -175.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.81 61.02 4.91 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 117.373 1.709 . . . . 0.0 117.373 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.6 t30 62.82 -4.53 0.24 Allowed 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 118.183 2.66 . . . . 0.0 118.183 -166.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -110.25 130.97 55.45 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.916 1.287 . . . . 0.0 110.113 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -99.63 118.33 35.93 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.507 -0.746 . . . . 0.0 110.491 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.5 m -86.47 114.24 23.06 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 166.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.4 t -122.12 99.4 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -87.12 114.15 23.47 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.317 0.58 . . . . 0.0 110.039 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -107.79 80.92 1.44 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.325 0.583 . . . . 0.0 110.515 -165.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 m -90.46 113.85 25.88 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-O 121.929 0.871 . . . . 0.0 112.205 -172.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.1 p -139.3 167.12 22.79 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.37 1.068 . . . . 0.0 109.305 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.3 57.2 0.24 Allowed 'General case' 0 CA--C 1.578 2.057 0 O-C-N 120.233 -1.542 . . . . 0.0 113.889 159.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -176.68 -57.93 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 125.303 1.441 . . . . 0.0 110.847 -170.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -96.35 -81.33 0.41 Allowed 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 119.974 1.261 . . . . 0.0 112.679 -174.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.284 68.1 m-80 53.59 65.15 1.6 Allowed 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -160.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.2 pt -122.48 121.73 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.871 -0.518 . . . . 0.0 110.031 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.01 94.57 8.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.35 -0.844 . . . . 0.0 111.347 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.2 t -98.46 114.2 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -170.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.46 97.72 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -112.52 137.87 50.11 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.302 0.641 . . . . 0.0 112.507 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -80.48 147.27 30.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.962 . . . . 0.0 112.668 169.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 70.6 mt -66.1 109.18 2.5 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.36 47.33 5.77 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 117.05 1.58 . . . . 0.0 117.05 -173.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.45 138.22 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 118.349 1.075 . . . . 0.0 110.1 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.0 m -84.36 102.8 13.0 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.437 -0.789 . . . . 0.0 109.756 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -127.15 162.53 25.91 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.289 1.042 . . . . 0.0 113.227 -172.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -86.5 121.84 29.6 Favored 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 123.669 0.788 . . . . 0.0 111.658 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -128.21 117.96 22.47 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.551 0.74 . . . . 0.0 110.816 -174.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -98.92 121.25 40.63 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.207 -0.933 . . . . 0.0 111.997 -174.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.7 mt -73.5 166.42 23.26 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.99 52.94 0.57 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 117.522 2.416 . . . . 0.0 117.522 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -163.62 -67.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.427 1.091 . . . . 0.0 109.471 168.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.87 73.59 0.05 OUTLIER Glycine 0 N--CA 1.481 1.677 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.8 m -155.68 121.37 4.98 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.52 -0.988 . . . . 0.0 109.948 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -94.44 125.89 39.37 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 122.457 1.122 . . . . 0.0 111.503 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 50.7 mt -106.55 150.16 26.43 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.299 1.04 . . . . 0.0 112.103 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.8 116.95 20.27 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.31 -161.73 35.11 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 117.551 1.781 . . . . 0.0 117.551 -175.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 71.4 p -124.88 123.67 40.43 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.919 -0.64 . . . . 0.0 111.712 -156.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -83.43 115.41 22.03 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 118.569 0.622 . . . . 0.0 110.158 158.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.8 m -115.47 132.77 56.52 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.243 0.617 . . . . 0.0 111.757 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.0 tp -87.44 109.29 19.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.378 -0.826 . . . . 0.0 112.324 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -101.76 81.34 2.13 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.551 0.691 . . . . 0.0 109.776 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.47 -94.16 0.93 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 114.795 0.678 . . . . 0.0 114.795 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -121.73 52.67 1.24 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.637 0.732 . . . . 0.0 111.485 165.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -146.86 112.4 5.61 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.8 mt -89.64 104.14 16.72 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 171.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.2 tt -94.82 118.19 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.641 -0.662 . . . . 0.0 110.21 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.83 97.85 2.32 Favored Glycine 0 N--CA 1.481 1.636 0 C-N-CA 123.411 0.529 . . . . 0.0 112.348 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -92.58 98.87 11.71 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.312 0.645 . . . . 0.0 109.609 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -123.18 134.28 54.18 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.527 0.731 . . . . 0.0 111.527 -170.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -110.81 157.08 20.21 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.498 1.142 . . . . 0.0 111.241 165.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -107.77 120.22 41.63 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.955 -1.091 . . . . 0.0 112.04 -161.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.5 t -68.0 -11.82 59.62 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 169.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -86.46 -50.68 6.7 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 119.459 1.027 . . . . 0.0 113.3 172.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.87 27.97 2.17 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 120.885 1.675 . . . . 0.0 115.405 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.76 -57.11 2.6 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 118.287 2.075 . . . . 0.0 118.287 176.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -48.46 124.95 8.85 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.833 2.053 . . . . 0.0 114.997 -168.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -67.18 145.47 55.21 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -171.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.3 tp -104.68 115.0 29.57 Favored 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 162.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -94.5 104.0 15.96 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 168.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.8 m -104.63 100.38 10.04 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.758 -0.588 . . . . 0.0 109.79 -177.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.9 t -91.63 104.65 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 120.897 -1.127 . . . . 0.0 108.812 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -82.02 115.78 21.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.883 -0.511 . . . . 0.0 109.852 164.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.79 144.76 34.11 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.037 0.535 . . . . 0.0 111.482 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.461 HD11 ' CH2' ' A' ' 6' ' ' TRP . 1.0 OUTLIER -85.72 124.75 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.291 -0.881 . . . . 0.0 111.223 177.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.255 10.9 tp -98.77 79.15 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.151 0.977 . . . . 0.0 108.986 166.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.75 -104.58 1.49 Allowed Glycine 0 N--CA 1.488 2.117 0 O-C-N 121.444 -0.785 . . . . 0.0 114.247 -171.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.26 0.71 57.47 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 117.576 2.435 . . . . 0.0 117.576 172.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -122.41 135.82 54.77 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.192 1.36 . . . . 0.0 110.959 -170.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.0 tp -90.62 119.7 31.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 111.012 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.9 p -102.58 120.34 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.136 -0.978 . . . . 0.0 110.647 172.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -89.99 115.44 27.28 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 122.967 0.507 . . . . 0.0 109.883 166.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.2 m -96.86 100.23 11.77 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.229 0.611 . . . . 0.0 109.626 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -88.07 112.4 22.61 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.434 0.694 . . . . 0.0 110.757 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.1 t -113.4 100.35 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -92.92 119.33 32.1 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.285 0.8 OUTLIER 66.07 -85.81 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 119.258 0.936 . . . . 0.0 111.648 -176.83 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.97 20.71 3.59 Favored Glycine 0 CA--C 1.558 2.749 0 N-CA-C 117.853 1.901 . . . . 0.0 117.853 151.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -92.3 115.79 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 121.496 2.648 . . . . 0.0 111.483 -174.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -89.22 126.23 35.41 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -127.8 106.08 8.88 Favored 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 123.502 0.721 . . . . 0.0 110.781 169.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.73 130.32 37.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 111.147 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -123.69 122.51 38.28 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.5 -0.75 . . . . 0.0 111.934 171.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.5 mt -94.23 124.56 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -174.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -104.55 133.22 49.77 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.392 1.077 . . . . 0.0 110.634 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -88.96 147.75 24.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.055 0.931 . . . . 0.0 112.304 171.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -75.19 118.36 18.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.639 -0.663 . . . . 0.0 111.821 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.1 t70 . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -165.925 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.563 1.447 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -122.02 -54.9 1.9 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 123.828 0.851 . . . . 0.0 111.693 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 t70 40.62 51.19 2.98 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 166.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.5 p -165.35 171.0 13.98 Favored 'General case' 0 CA--C 1.569 1.71 0 CA-C-O 122.432 1.111 . . . . 0.0 112.557 -168.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.4 m -89.4 133.92 34.31 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.04 -1.038 . . . . 0.0 111.413 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -138.37 107.82 6.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.801 -0.562 . . . . 0.0 109.927 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -97.26 133.16 42.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.11 -0.994 . . . . 0.0 112.682 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 p -62.41 117.96 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.213 -0.93 . . . . 0.0 113.411 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -102.17 -45.11 5.24 Favored 'General case' 0 CA--C 1.568 1.649 0 C-N-CA 123.961 0.904 . . . . 0.0 113.384 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -152.62 160.46 43.19 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.154 0.982 . . . . 0.0 110.968 -174.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.3 p -146.72 143.72 28.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.37 -1.456 . . . . 0.0 112.871 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -85.83 -51.38 6.44 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -137.93 53.57 1.83 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 119.834 1.197 . . . . 0.0 112.772 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -83.61 63.86 7.63 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 119.628 -1.92 . . . . 0.0 112.205 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -163.85 -57.72 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.529 1.132 . . . . 0.0 110.981 -171.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -81.96 -26.06 34.29 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -51.87 -54.38 29.88 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-N 121.791 2.087 . . . . 0.0 113.778 153.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.702 ' SD ' HG11 ' A' ' 23' ' ' VAL . 0.8 OUTLIER -51.86 -47.97 64.22 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 169.019 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -66.02 -38.83 89.42 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 170.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.0 tptp -60.14 -40.39 89.66 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 168.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.5 mtp -62.69 -52.92 61.38 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 165.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.55 59.44 0.06 OUTLIER Glycine 0 N--CA 1.487 2.042 0 CA-C-O 119.522 -0.599 . . . . 0.0 114.338 166.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.702 HG11 ' SD ' ' A' ' 18' ' ' MET . 2.8 m -103.82 147.47 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.857 0.837 . . . . 0.0 111.727 -177.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -74.28 169.03 18.45 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 168.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.267 0.2 OUTLIER -54.61 -44.34 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 176.521 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.49 -48.65 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-N 119.395 0.998 . . . . 0.0 112.996 172.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -54.38 -39.69 67.46 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 166.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -46.14 91.8 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 167.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -59.62 -48.81 80.21 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 166.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.7 mt -57.4 -39.76 76.81 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 169.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.04 -54.3 46.54 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 168.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.42 -38.14 41.56 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 167.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -95.17 19.9 9.92 Favored 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 172.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.305 28.0 p30 -72.97 -24.53 60.8 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 118.164 2.653 . . . . 0.0 118.164 -173.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 57.2 54.86 6.39 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 173.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.1 tp -79.77 122.52 26.71 Favored 'General case' 0 CA--C 1.563 1.445 0 CA-C-O 121.963 0.887 . . . . 0.0 112.345 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -105.48 106.22 16.62 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.871 169.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.39 100.11 7.47 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.38 0.609 . . . . 0.0 109.583 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.7 m -102.04 96.84 7.28 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -173.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.1 mt -95.38 131.81 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -164.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.2 m -141.04 108.55 5.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.577 -1.327 . . . . 0.0 107.693 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -100.64 139.2 36.66 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.94 0.876 . . . . 0.0 112.485 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -99.78 70.75 1.65 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 122.166 0.984 . . . . 0.0 110.139 164.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.88 -99.99 0.73 Allowed Glycine 0 N--CA 1.488 2.136 0 O-C-N 121.565 -0.71 . . . . 0.0 114.742 -170.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -84.47 -26.84 27.89 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -90.17 117.45 28.94 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.58 1.536 . . . . 0.0 111.101 177.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -99.48 117.33 33.64 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.374 1.07 . . . . 0.0 109.812 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.4 m -90.91 103.19 15.94 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 166.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -99.85 104.06 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -77.43 105.25 8.44 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.935 0.874 . . . . 0.0 109.991 172.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -92.4 91.47 7.67 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.099 0.96 . . . . 0.0 109.303 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.3 t -97.03 111.97 23.95 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.89 0.476 . . . . 0.0 111.336 -173.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.5 p -144.45 165.3 28.35 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -172.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.18 -23.17 67.22 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 117.611 2.449 . . . . 0.0 117.611 165.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -68.7 -52.01 35.54 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 120.367 1.44 . . . . 0.0 113.981 159.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -165.98 152.82 9.7 Favored 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 123.591 0.756 . . . . 0.0 112.144 -167.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -118.28 99.16 6.67 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 pp -136.41 143.19 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 O-C-N 121.747 -0.595 . . . . 0.0 111.994 -171.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -93.82 125.21 38.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.922 -1.111 . . . . 0.0 112.791 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.0 t -102.03 104.87 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.65 108.8 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -133.12 130.85 39.79 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.388 0.613 . . . . 0.0 112.537 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -66.98 140.5 57.73 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 111.835 157.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.8 mt -54.43 123.08 11.9 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 166.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.85 -5.96 83.13 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 119.189 2.436 . . . . 0.0 119.189 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 p -82.75 137.14 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-N 120.616 2.208 . . . . 0.0 112.748 -172.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.8 m -91.45 95.87 10.2 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.41 -0.806 . . . . 0.0 109.934 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -122.18 150.75 41.81 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -170.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -86.03 98.35 10.8 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 124.448 1.099 . . . . 0.0 113.872 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -89.98 118.6 29.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.5 -0.75 . . . . 0.0 110.966 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -72.26 108.47 5.42 Favored 'General case' 0 CA--C 1.569 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 113.114 171.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -78.21 139.79 38.94 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.914 0.886 . . . . 0.0 111.09 177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.32 66.94 0.31 Allowed 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -168.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -166.45 -66.2 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 125.779 1.632 . . . . 0.0 108.505 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.58 68.38 0.05 OUTLIER Glycine 0 N--CA 1.481 1.672 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.6 m -160.65 119.88 2.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.614 -0.933 . . . . 0.0 109.587 -177.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -88.1 113.89 24.18 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.886 0.85 . . . . 0.0 111.081 167.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 70.9 mt -93.78 109.56 21.23 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 124.325 1.05 . . . . 0.0 110.615 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 58.8 ttp85 -88.85 117.18 27.66 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.875 -0.516 . . . . 0.0 110.714 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.41 179.36 48.87 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 118.983 2.353 . . . . 0.0 118.983 -171.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.3 p -122.12 123.11 40.79 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 113.483 -1.358 . . . . 0.0 111.297 -166.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -81.92 107.56 14.74 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 118.476 0.58 . . . . 0.0 110.194 160.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 72.9 m -102.68 131.6 49.37 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.046 0.539 . . . . 0.0 111.101 176.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.9 tp -82.3 106.17 13.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.158 -0.964 . . . . 0.0 110.744 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -82.32 -49.45 10.02 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.07 -95.67 0.21 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 164.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -98.97 59.29 1.17 Allowed 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.869 0.842 . . . . 0.0 110.326 152.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -149.17 116.42 6.09 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.54 103.72 16.34 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 167.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.8 tt -90.08 111.5 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.368 -0.833 . . . . 0.0 110.1 177.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.07 98.09 2.34 Favored Glycine 0 N--CA 1.482 1.707 0 C-N-CA 123.843 0.735 . . . . 0.0 113.072 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -93.32 96.34 9.9 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -117.46 147.27 42.87 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.731 0.777 . . . . 0.0 112.533 -168.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -127.0 138.52 53.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.404 -0.81 . . . . 0.0 110.851 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -71.04 115.07 9.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 0.0 113.133 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 73.8 p -80.49 62.96 4.77 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 123.514 1.626 . . . . 0.0 112.384 170.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -174.05 -65.03 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.732 0 C-N-CA 126.236 1.815 . . . . 0.0 107.005 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -94.33 -18.24 21.8 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.05 -15.68 47.24 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 119.148 2.419 . . . . 0.0 119.148 -172.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -84.18 152.76 24.06 Favored 'General case' 0 CA--C 1.566 1.559 0 CA-C-N 118.529 1.165 . . . . 0.0 113.79 -169.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -94.4 130.27 40.8 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-O 122.114 0.959 . . . . 0.0 112.835 -168.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.0 tt -110.66 122.51 47.96 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 124.48 1.112 . . . . 0.0 109.406 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -111.51 111.67 22.86 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.2 m -108.36 100.2 9.52 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 119.441 1.019 . . . . 0.0 110.203 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.8 t -91.38 107.46 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.128 -0.983 . . . . 0.0 108.827 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -103.82 105.3 15.46 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 123.4 0.68 . . . . 0.0 110.598 -173.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -143.48 148.82 36.65 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -169.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.56 120.95 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.17 -1.581 . . . . 0.0 109.672 175.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.5 mm -101.1 88.95 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 167.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.91 -88.14 0.56 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 115.769 1.067 . . . . 0.0 115.769 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -111.0 0.31 16.94 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 173.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -129.67 127.21 40.06 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.953 1.251 . . . . 0.0 110.744 -169.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.1 tp -74.63 115.24 13.98 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.961 0.904 . . . . 0.0 110.519 171.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.0 m -103.72 119.09 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.301 -0.874 . . . . 0.0 109.583 -176.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -88.8 107.38 18.94 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 118.844 0.747 . . . . 0.0 109.842 165.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.7 m -92.35 96.32 10.2 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -87.61 106.48 18.04 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.508 0.723 . . . . 0.0 111.05 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.6 t -106.77 104.35 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -117.48 118.17 31.44 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.885 0.474 . . . . 0.0 109.781 172.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 51.4 49.68 20.47 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.0 -24.79 4.42 Favored Glycine 0 CA--C 1.554 2.507 0 N-CA-C 119.264 2.466 . . . . 0.0 119.264 -169.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.7 t -86.65 105.27 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 120.104 1.952 . . . . 0.0 109.633 -168.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -87.98 124.76 34.05 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 123.314 0.646 . . . . 0.0 112.52 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -124.66 109.85 13.67 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.554 0.742 . . . . 0.0 111.518 173.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.54 108.77 20.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.786 -0.571 . . . . 0.0 110.092 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -111.66 129.44 56.09 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.387 1.089 . . . . 0.0 111.436 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.9 mt -121.66 119.15 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -146.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -112.49 119.79 39.41 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.337 0.655 . . . . 0.0 110.418 -168.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -81.01 147.34 30.24 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 123.507 0.723 . . . . 0.0 112.781 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -58.87 118.94 6.32 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 t70 . . . . . 0 N--CA 1.488 1.464 0 C-N-CA 125.01 1.324 . . . . 0.0 112.444 -172.608 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.426 0 CA-C-O 122.178 0.989 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.364 89.8 m-85 69.35 -62.88 0.4 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -77.4 80.13 3.9 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 120.537 1.517 . . . . 0.0 112.669 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.9 t -163.78 178.15 8.08 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 122.443 1.116 . . . . 0.0 112.077 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.9 m -92.2 122.41 34.66 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.459 1.104 . . . . 0.0 110.297 170.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -123.65 108.72 12.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.813 -0.555 . . . . 0.0 109.958 -171.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -97.23 139.59 32.96 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.065 -1.022 . . . . 0.0 112.707 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -60.38 119.7 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -109.19 -51.11 2.92 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.767 0.827 . . . . 0.0 113.099 -173.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -148.57 109.57 4.3 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 119.222 0.919 . . . . 0.0 109.741 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.6 p -109.18 115.01 29.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.381 -0.824 . . . . 0.0 113.056 -174.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -98.69 123.07 42.67 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 123.327 0.651 . . . . 0.0 110.656 -169.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.261 9.4 t30 67.83 18.6 9.67 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -69.74 -43.09 73.0 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -173.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.87 -34.24 75.64 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 169.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -70.79 -47.2 60.79 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -43.1 -53.26 5.02 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 158.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 15.7 mtt -67.3 -25.87 66.25 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 174.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -60.7 -43.24 98.01 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-N 121.345 1.884 . . . . 0.0 114.625 163.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -59.03 -34.63 72.13 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 162.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 76.7 mmm -62.67 -30.31 71.29 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 116.929 2.196 . . . . 0.0 116.929 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.0 53.95 1.07 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 115.157 0.823 . . . . 0.0 115.157 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.31 142.53 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 122.671 1.224 . . . . 0.0 112.063 -175.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -70.24 172.08 8.76 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.275 13.2 tt -60.58 -40.73 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 176.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.6 t -61.61 -52.16 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-N 120.402 1.456 . . . . 0.0 112.913 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -55.3 -43.79 75.16 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 168.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -64.47 -42.22 96.05 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 171.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -58.36 -46.35 86.46 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 120.143 1.338 . . . . 0.0 114.554 167.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.9 mt -60.48 -40.94 93.11 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 165.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.69 95.0 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 172.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.96 -57.41 11.8 Favored 'General case' 0 CA--C 1.566 1.596 0 O-C-N 120.804 -1.185 . . . . 0.0 113.681 164.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -84.3 53.01 2.49 Favored 'General case' 0 CA--C 1.577 2.006 0 CA-C-N 119.716 1.144 . . . . 0.0 113.81 174.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -85.89 -29.51 23.6 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -174.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 62.05 50.22 4.17 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -84.02 121.75 27.83 Favored 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 122.42 1.105 . . . . 0.0 112.014 -175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -111.34 117.29 32.71 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.479 174.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.7 mt -101.44 102.59 13.41 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.0 m -94.46 105.04 17.0 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.309 -0.87 . . . . 0.0 109.649 172.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.6 mt -94.83 131.29 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 85.8 m -145.41 128.46 16.55 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.262 -1.524 . . . . 0.0 110.147 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -111.07 139.89 46.06 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -170.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -138.21 89.97 2.44 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.672 0.789 . . . . 0.0 109.825 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.21 68.18 1.81 Allowed Glycine 0 N--CA 1.497 2.711 0 N-CA-C 116.731 1.452 . . . . 0.0 116.731 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.291 46.7 m-20 67.62 -23.79 0.12 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 118.019 2.6 . . . . 0.0 118.019 -166.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -83.19 100.8 10.8 Favored 'General case' 0 CA--C 1.565 1.552 0 CA-C-N 121.151 1.796 . . . . 0.0 110.901 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -93.36 117.62 30.3 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.029 0.931 . . . . 0.0 109.504 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.0 m -92.75 104.14 16.44 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 p -94.69 109.83 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.699 0.762 . . . . 0.0 109.974 170.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -88.55 111.67 22.13 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -101.93 92.07 4.64 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.441 0.696 . . . . 0.0 110.712 -169.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.1 m -103.37 117.05 33.6 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.106 0.562 . . . . 0.0 111.003 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 p -147.77 -177.3 5.64 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.84 40.73 0.06 Allowed 'General case' 0 CA--C 1.583 2.246 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 166.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -144.2 -62.59 0.38 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 126.519 1.927 . . . . 0.0 108.566 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.64 167.48 28.78 Favored 'General case' 0 CA--C 1.572 1.825 0 C-N-CA 124.122 0.969 . . . . 0.0 111.141 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -121.07 102.8 8.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.328 -0.858 . . . . 0.0 109.46 164.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.33 144.22 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.527 -0.733 . . . . 0.0 112.019 -172.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -94.91 119.65 33.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.339 -0.85 . . . . 0.0 112.58 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.4 t -98.94 104.03 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.8 t -91.87 103.2 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -113.54 123.52 50.18 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.308 0.575 . . . . 0.0 112.006 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -72.28 137.09 46.5 Favored 'General case' 0 CA--C 1.569 1.703 0 O-C-N 121.366 -0.834 . . . . 0.0 110.499 162.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.8 mt -59.62 113.27 2.15 Favored 'General case' 0 CA--C 1.571 1.768 0 O-C-N 121.069 -1.019 . . . . 0.0 113.389 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.29 55.83 3.6 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 116.39 1.316 . . . . 0.0 116.39 -171.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 p -136.46 136.91 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 118.008 0.904 . . . . 0.0 110.125 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 88.0 m -87.41 109.79 19.82 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.505 -0.747 . . . . 0.0 110.156 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -138.56 156.23 47.67 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.168 0.587 . . . . 0.0 112.436 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -84.38 99.04 10.38 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 121.841 0.829 . . . . 0.0 112.126 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -86.64 119.27 26.7 Favored 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 124.449 1.1 . . . . 0.0 111.682 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -83.39 126.68 32.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.099 -1.001 . . . . 0.0 113.208 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.3 mt -80.62 152.67 28.4 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 170.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.93 64.74 2.49 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 175.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -174.31 -66.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 125.465 1.506 . . . . 0.0 110.394 -177.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.3 70.17 0.03 OUTLIER Glycine 0 N--CA 1.487 2.065 0 CA-C-N 119.128 0.876 . . . . 0.0 114.207 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.5 m -167.19 128.34 1.57 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 118.041 0.92 . . . . 0.0 109.015 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -97.34 126.71 42.74 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.172 0.987 . . . . 0.0 110.623 169.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.6 mt -108.91 107.69 18.18 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 124.227 1.011 . . . . 0.0 110.769 -174.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.53 119.15 20.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.048 -1.032 . . . . 0.0 112.068 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.74 -163.88 36.99 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 117.639 1.815 . . . . 0.0 117.639 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.8 p -125.5 120.31 30.59 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.382 -0.909 . . . . 0.0 111.763 -157.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -84.81 121.65 28.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.422 -0.799 . . . . 0.0 110.427 161.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.1 m -126.93 139.3 53.16 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.358 0.663 . . . . 0.0 111.735 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.1 tp -87.72 114.67 24.55 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.679 -1.263 . . . . 0.0 111.642 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -78.07 -37.27 46.95 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 172.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.83 -84.26 0.08 OUTLIER Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -107.93 39.04 2.03 Favored 'General case' 0 CA--C 1.581 2.138 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 158.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -146.19 124.32 12.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.929 -1.107 . . . . 0.0 109.167 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.8 mt -91.4 110.49 21.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.478 -0.764 . . . . 0.0 109.15 166.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.6 tt -97.52 117.59 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.127 -0.983 . . . . 0.0 110.858 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.04 95.7 1.76 Allowed Glycine 0 N--CA 1.482 1.747 0 CA-C-O 119.401 -0.666 . . . . 0.0 113.328 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -84.25 103.8 13.74 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 117.784 0.792 . . . . 0.0 110.017 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -123.16 148.42 45.76 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -171.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -120.96 141.61 50.53 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.782 0.801 . . . . 0.0 110.621 167.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -70.79 137.85 49.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.716 -1.24 . . . . 0.0 112.808 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.286 4.9 t -70.18 -51.78 28.43 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 175.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -75.92 -44.96 37.71 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -80.22 -26.19 39.25 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.7 -38.77 3.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 117.486 1.754 . . . . 0.0 117.486 -166.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -69.22 155.57 40.19 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -162.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.96 140.13 35.43 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 114.18 -1.373 . . . . 0.0 114.679 -175.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.8 tt -135.28 115.59 13.46 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 123.832 0.853 . . . . 0.0 109.114 177.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -94.5 111.72 23.48 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.139 -0.976 . . . . 0.0 109.103 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.9 m -101.34 94.94 6.19 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.0 t -100.91 100.14 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-O 122.516 1.151 . . . . 0.0 109.56 -168.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -93.69 102.35 14.51 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.367 -172.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -131.54 133.12 44.74 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.75 0.82 . . . . 0.0 111.268 -161.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.0 mt -104.0 123.3 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.719 -1.238 . . . . 0.0 110.172 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 45.1 mm -83.55 -47.33 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.98 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.832 167.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -163.09 -89.12 0.07 OUTLIER Glycine 0 N--CA 1.487 2.085 0 CA-C-N 119.058 0.844 . . . . 0.0 112.507 172.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 45.0 p30 -81.62 3.76 24.06 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 174.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -136.97 131.42 32.94 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 119.233 0.924 . . . . 0.0 111.033 -168.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.7 tp -86.14 113.02 21.85 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.446 1.098 . . . . 0.0 109.695 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.6 t -98.98 105.09 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -174.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -96.08 101.74 13.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -0.984 . . . . 0.0 109.997 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.5 m -91.63 103.96 16.49 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.585 0.754 . . . . 0.0 109.207 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -89.26 110.69 21.43 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.338 0.655 . . . . 0.0 110.194 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.1 t -112.79 93.96 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -94.71 114.65 26.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.632 -0.668 . . . . 0.0 111.31 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.317 0.4 OUTLIER 62.07 -62.55 0.1 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 174.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.83 43.41 0.5 Allowed Glycine 0 CA--C 1.551 2.293 0 CA-C-O 118.915 -0.936 . . . . 0.0 114.483 156.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.8 t -139.15 118.61 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 118.982 1.391 . . . . 0.0 107.761 -172.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.2 mp0 -93.68 144.52 25.32 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.81 121.19 10.96 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.208 0.528 . . . . 0.0 112.408 164.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -94.67 107.66 19.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.694 -0.629 . . . . 0.0 111.256 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -89.7 111.61 22.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.722 -0.611 . . . . 0.0 109.601 167.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.2 mt -101.09 114.06 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -172.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -105.81 122.7 46.63 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.673 0.789 . . . . 0.0 109.625 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -83.14 143.27 30.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 112.585 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -65.14 118.44 9.22 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.9 t0 . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -165.67 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.361 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.283 93.2 m-85 73.4 -43.59 0.56 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 118.81 2.893 . . . . 0.0 118.81 170.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -73.77 72.37 1.51 Allowed 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 117.283 2.327 . . . . 0.0 117.283 -160.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.9 p -152.17 -176.36 5.64 Favored 'General case' 0 CA--C 1.572 1.821 0 CA-C-O 121.976 0.893 . . . . 0.0 112.852 178.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.1 m -89.37 127.64 35.83 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.013 0.925 . . . . 0.0 110.788 176.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -130.02 116.17 18.18 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.178 0.591 . . . . 0.0 109.416 -173.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -99.64 135.77 40.56 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 119.408 1.004 . . . . 0.0 111.944 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p -66.05 116.43 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -96.0 -50.73 4.74 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -144.2 111.25 5.81 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 119.977 1.262 . . . . 0.0 111.054 -172.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.2 m -96.18 101.34 12.98 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.858 0.863 . . . . 0.0 111.317 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -93.5 120.52 33.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.509 -0.744 . . . . 0.0 110.31 -172.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.264 28.5 t30 65.49 20.56 11.72 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -72.51 -40.17 67.04 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.64 -38.07 74.39 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 168.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -67.55 -46.75 71.85 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 119.91 1.232 . . . . 0.0 114.069 171.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -46.55 -56.32 6.2 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 161.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.4 mtp -65.82 -29.84 70.38 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 176.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.63 -50.96 71.43 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 120.241 1.382 . . . . 0.0 114.203 163.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -57.4 -32.1 66.51 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 165.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.0 mmt -64.44 -34.74 78.89 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 168.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.99 51.36 1.93 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 116.072 1.189 . . . . 0.0 116.072 -176.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -114.89 160.23 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-O 122.169 0.985 . . . . 0.0 112.408 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -56.72 145.95 27.32 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 172.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.274 0.1 OUTLIER -54.98 -47.22 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 175.057 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.28 -49.53 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 173.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -58.35 -45.66 87.75 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 170.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -44.27 -55.12 5.13 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 163.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -65.69 -46.66 78.18 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.5 mt -58.48 -47.53 83.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 169.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.24 -21.63 66.35 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 119.062 2.986 . . . . 0.0 119.062 178.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.08 93.64 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 165.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -130.49 68.09 1.47 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 119.577 1.081 . . . . 0.0 111.781 169.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -84.41 44.66 1.05 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 176.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 42.7 40.57 2.08 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -172.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -86.68 116.77 25.0 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.695 -1.253 . . . . 0.0 112.173 -161.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -111.2 118.01 34.77 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.718 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.7 mt -94.28 101.53 13.5 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 172.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 43.8 m -95.14 105.66 17.61 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.883 0.849 . . . . 0.0 108.731 170.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.9 mt -90.57 101.4 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -171.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 87.7 m -99.08 101.48 12.86 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -102.45 127.49 49.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.581 -0.7 . . . . 0.0 112.347 -167.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -79.94 -49.87 11.26 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 161.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.65 -90.92 0.08 OUTLIER Glycine 0 N--CA 1.486 1.97 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -70.12 -29.28 66.19 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 158.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -85.47 126.71 34.03 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-N 119.772 1.169 . . . . 0.0 112.105 169.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -117.83 125.39 50.46 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.482 1.113 . . . . 0.0 108.475 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.0 m -99.52 95.85 7.27 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 168.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.5 t -88.98 105.88 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -89.91 102.07 14.77 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -170.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -93.41 88.09 5.83 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.202 0.601 . . . . 0.0 109.53 -170.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.1 t -98.49 109.26 22.05 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.321 0.648 . . . . 0.0 110.798 -171.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.7 p -134.08 166.15 23.41 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -169.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.55 -26.32 61.25 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 117.838 2.533 . . . . 0.0 117.838 165.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -79.81 -52.34 8.04 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -160.91 163.22 32.07 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-N 119.33 0.968 . . . . 0.0 112.726 -177.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -110.39 118.83 37.35 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.387 0.675 . . . . 0.0 109.53 167.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.2 pt -131.41 133.08 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 CA-C-O 121.785 0.802 . . . . 0.0 111.879 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -98.77 99.24 10.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.605 0.762 . . . . 0.0 109.664 -175.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.35 99.67 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.417 -0.802 . . . . 0.0 109.868 -165.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 56.9 t -85.7 115.8 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 123.458 0.703 . . . . 0.0 109.319 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -134.35 140.68 46.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.829 -0.544 . . . . 0.0 111.769 173.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -92.95 140.06 29.88 Favored 'General case' 0 CA--C 1.565 1.528 0 O-C-N 121.896 -0.502 . . . . 0.0 110.865 163.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -56.92 131.8 50.73 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 176.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.35 -16.68 37.96 Favored Glycine 0 CA--C 1.553 2.437 0 N-CA-C 119.426 2.53 . . . . 0.0 119.426 -172.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.8 t -81.84 132.37 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-N 120.176 1.988 . . . . 0.0 110.408 -175.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.9 m -79.87 104.74 10.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.716 -0.615 . . . . 0.0 110.085 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -124.7 166.85 15.44 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-O 122.106 0.955 . . . . 0.0 112.405 -173.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -91.23 99.01 12.08 Favored 'General case' 0 CA--C 1.571 1.75 0 C-N-CA 123.362 0.665 . . . . 0.0 111.454 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -92.58 104.89 17.14 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.829 0.852 . . . . 0.0 110.174 175.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -95.64 125.86 40.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 112.025 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.7 mt -80.21 150.24 30.17 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.166 0.586 . . . . 0.0 112.425 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.38 44.98 0.16 Allowed 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -149.75 -59.54 0.2 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 124.769 1.228 . . . . 0.0 110.234 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.53 73.37 0.04 OUTLIER Glycine 0 N--CA 1.486 1.977 0 CA-C-N 118.935 0.789 . . . . 0.0 112.678 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 m -167.8 124.77 1.13 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 117.869 0.834 . . . . 0.0 109.959 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -102.08 125.98 48.91 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.852 0.861 . . . . 0.0 111.033 171.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.6 mt -117.83 123.36 45.72 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.607 0.763 . . . . 0.0 110.865 -175.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -102.77 118.79 37.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.102 -0.999 . . . . 0.0 110.85 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.43 -177.71 47.88 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 118.29 2.076 . . . . 0.0 118.29 -172.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.8 p -119.54 124.91 47.57 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 113.812 -1.194 . . . . 0.0 111.215 -167.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -83.46 126.01 32.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.977 -0.452 . . . . 0.0 111.419 163.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.8 m -120.42 135.06 55.16 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.196 0.598 . . . . 0.0 111.026 172.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.6 tp -89.15 106.83 18.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 111.466 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -98.52 -179.08 4.21 Favored 'General case' 0 CA--C 1.575 1.904 0 C-N-CA 123.895 0.878 . . . . 0.0 110.828 168.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.91 106.87 0.88 Allowed Glycine 0 N--CA 1.494 2.537 0 O-C-N 120.265 -1.522 . . . . 0.0 115.894 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.42 9.3 p30 59.4 13.53 3.25 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 119.558 3.17 . . . . 0.0 119.558 -166.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -137.22 125.51 23.25 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 120.293 1.406 . . . . 0.0 111.867 -169.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.9 mt -89.25 109.0 19.93 Favored 'General case' 0 CA--C 1.564 1.484 0 O-C-N 121.098 -1.001 . . . . 0.0 108.379 159.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.6 tt -96.8 115.54 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.526 -0.734 . . . . 0.0 110.103 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.58 104.35 2.58 Favored Glycine 0 N--CA 1.482 1.754 0 C-N-CA 123.875 0.75 . . . . 0.0 112.374 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -92.15 95.45 9.75 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -114.95 148.96 38.05 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.477 1.132 . . . . 0.0 112.876 -168.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -121.87 135.46 54.89 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.713 0.805 . . . . 0.0 109.456 166.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -75.5 104.85 6.24 Favored 'General case' 0 CA--C 1.562 1.414 0 O-C-N 121.084 -1.01 . . . . 0.0 111.845 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 t -61.94 -16.45 51.09 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 118.385 2.735 . . . . 0.0 118.385 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -70.19 -28.99 65.74 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 168.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . 0.25 3.1 p-10 -145.53 7.46 1.13 Allowed 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 119.436 3.125 . . . . 0.0 119.436 -177.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.11 -19.7 47.75 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 119.15 2.42 . . . . 0.0 119.15 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -73.81 139.98 45.51 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -169.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -74.12 141.1 45.64 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 tt -126.77 121.05 30.87 Favored 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 123.589 0.756 . . . . 0.0 109.538 168.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -100.15 110.13 22.4 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.2 m -96.92 131.23 43.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.564 -0.71 . . . . 0.0 110.193 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.8 t -129.45 99.67 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -104.31 105.77 16.02 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.144 0.978 . . . . 0.0 108.606 -172.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -126.4 137.94 53.49 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -162.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.1 mm -88.99 127.19 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.386 -0.821 . . . . 0.0 109.51 167.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 49.2 mm -104.18 -80.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 168.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -165.32 113.19 0.54 Allowed Glycine 0 N--CA 1.487 2.093 0 O-C-N 121.357 -0.839 . . . . 0.0 111.056 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.251 31.3 m-20 60.5 1.31 0.39 Allowed 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 -166.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -136.58 138.69 41.5 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 124.339 1.056 . . . . 0.0 111.071 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.3 tp -94.06 109.77 21.51 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 168.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.2 m -95.07 113.37 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . 0.28 0.1 OUTLIER -124.7 119.44 28.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.82 -1.175 . . . . 0.0 113.315 -175.561 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.4 m -107.65 123.87 49.14 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.166 0.986 . . . . 0.0 109.982 -167.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -105.81 111.74 24.52 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.2 t -108.42 102.45 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -104.61 81.09 1.74 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.305 -0.872 . . . . 0.0 110.602 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 63.63 73.58 0.44 Allowed 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 123.779 0.831 . . . . 0.0 112.624 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.97 -36.9 2.33 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 118.732 2.253 . . . . 0.0 118.732 -173.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.81 99.27 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 119.229 1.515 . . . . 0.0 112.663 -169.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -90.42 112.23 23.77 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 123.375 0.67 . . . . 0.0 112.085 -172.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.36 119.64 37.65 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.077 0.551 . . . . 0.0 112.195 176.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -107.34 105.65 15.69 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.016 0.526 . . . . 0.0 109.962 -174.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -91.02 115.15 27.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.41 -0.806 . . . . 0.0 108.963 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.4 mt -105.01 118.94 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -103.01 152.06 21.77 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.048 0.939 . . . . 0.0 111.421 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -101.72 152.68 20.56 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.715 -1.241 . . . . 0.0 111.723 169.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -66.22 105.44 1.41 Allowed 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 123.758 0.823 . . . . 0.0 112.689 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.6 t0 . . . . . 0 N--CA 1.487 1.397 0 C-N-CA 124.922 1.289 . . . . 0.0 114.251 -178.721 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.357 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.33 77.0 m-85 73.34 -58.1 0.61 Allowed 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 171.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -70.55 76.9 0.58 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 120.229 1.377 . . . . 0.0 114.006 -172.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.1 t -168.73 173.98 6.9 Favored 'General case' 0 CA--C 1.572 1.821 0 CA-C-O 122.622 1.201 . . . . 0.0 111.93 -165.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.9 m -90.96 133.61 35.14 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.268 -0.895 . . . . 0.0 110.353 171.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -132.2 101.18 5.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.948 -0.47 . . . . 0.0 110.068 -172.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -91.28 135.32 33.88 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.475 -0.766 . . . . 0.0 111.988 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -61.2 121.32 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -99.51 -45.2 5.89 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 117.416 -1.278 . . . . 0.0 114.223 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.57 116.34 1.26 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 120.293 1.406 . . . . 0.0 110.088 -169.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.1 p -100.32 105.41 16.93 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.539 0.736 . . . . 0.0 111.921 -177.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -90.43 126.04 35.77 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.192 0.597 . . . . 0.0 111.635 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.257 45.3 t30 60.1 26.29 15.65 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 117.681 2.474 . . . . 0.0 117.681 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -72.19 -42.84 65.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -60.13 -40.53 90.11 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 117.616 2.451 . . . . 0.0 117.616 171.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.74 -44.18 70.79 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 172.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -44.16 -57.71 3.27 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 158.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.2 mtt -57.0 -42.68 80.73 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 172.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -58.35 -43.92 88.54 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 168.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -59.79 -35.14 74.05 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 168.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 58.0 mtm -66.84 -37.73 85.05 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 170.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.77 59.39 0.45 Allowed Glycine 0 N--CA 1.487 2.089 0 C-N-CA 123.776 0.703 . . . . 0.0 114.745 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.426 HG13 ' HG2' ' A' ' 28' ' ' ARG . 2.4 p -129.31 136.95 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 122.278 1.037 . . . . 0.0 110.413 177.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -63.02 143.91 57.36 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.276 13.7 tt -51.03 -42.49 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -176.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.8 t -60.81 -50.36 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 119.59 1.086 . . . . 0.0 113.125 171.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -56.41 -42.33 77.83 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 167.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HG2' HG13 ' A' ' 23' ' ' VAL . 57.4 mtm-85 -58.79 -47.05 86.08 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 169.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -59.12 -46.35 88.55 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 170.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.51 -47.75 80.42 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 171.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.09 -25.73 63.65 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.19 76.62 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-N 121.31 1.868 . . . . 0.0 115.043 156.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -78.82 59.42 2.57 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 171.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -97.03 -27.28 14.68 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -175.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.387 1.3 p-10 57.8 55.68 5.28 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -173.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.0 tp -80.17 121.43 25.57 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.419 1.104 . . . . 0.0 113.902 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -106.18 118.33 36.34 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.81 167.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.2 mt -97.4 101.01 12.45 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 51.7 m -94.41 109.5 21.36 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.998 -1.064 . . . . 0.0 109.421 171.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.2 mt -103.79 112.75 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -166.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 87.6 m -103.31 106.3 16.78 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -89.04 108.97 19.88 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.297 0.639 . . . . 0.0 111.948 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.7 70.76 6.71 Favored 'General case' 0 CA--C 1.572 1.809 0 O-C-N 121.587 -0.696 . . . . 0.0 110.486 166.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.99 -96.49 0.22 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 115.515 0.966 . . . . 0.0 115.515 -174.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -87.93 -23.19 23.97 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 169.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -88.85 111.36 21.96 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 121.046 1.748 . . . . 0.0 111.974 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -94.63 117.44 30.14 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.518 0.727 . . . . 0.0 109.181 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.6 m -93.83 97.99 10.77 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.9 t -92.82 105.46 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -86.34 101.79 13.42 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.178 0.591 . . . . 0.0 109.606 -176.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -90.85 97.55 11.25 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.234 0.614 . . . . 0.0 109.837 -172.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -110.54 102.83 11.39 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 122.991 0.516 . . . . 0.0 110.845 -175.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.8 p -140.31 -178.92 5.71 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.028 0.931 . . . . 0.0 111.72 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.86 -29.99 67.38 Favored 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 159.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -97.95 -17.62 19.11 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 174.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -130.07 142.07 50.65 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 121.382 1.901 . . . . 0.0 111.975 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -144.29 74.33 1.42 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.016 -1.052 . . . . 0.0 109.796 162.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.2 pt -143.07 130.16 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.283 -0.886 . . . . 0.0 112.007 -166.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.82 99.84 11.64 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.248 1.019 . . . . 0.0 111.559 172.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.9 t -91.42 98.28 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.174 -0.954 . . . . 0.0 109.19 -169.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.1 t -86.4 119.49 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 123.344 0.658 . . . . 0.0 109.312 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -140.64 133.42 28.97 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.328 0.585 . . . . 0.0 111.532 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -86.45 139.8 30.56 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 121.808 -0.557 . . . . 0.0 111.246 167.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.75 128.43 36.53 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.89 -11.48 59.77 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 119.642 2.617 . . . . 0.0 119.642 -172.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.2 t -85.59 133.01 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 120.43 2.115 . . . . 0.0 110.33 -175.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -77.4 114.11 15.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.508 -0.745 . . . . 0.0 111.466 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -138.56 163.05 33.03 Favored 'General case' 0 CA--C 1.572 1.791 0 C-N-CA 123.264 0.626 . . . . 0.0 112.607 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -85.89 111.17 19.96 Favored 'General case' 0 CA--C 1.57 1.727 0 O-C-N 121.515 -0.741 . . . . 0.0 111.752 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -102.4 156.15 17.78 Favored 'General case' 0 CA--C 1.572 1.796 0 CA-C-O 122.17 0.986 . . . . 0.0 112.678 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -127.18 149.41 49.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.4 -0.812 . . . . 0.0 111.532 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.4 mt -92.97 -113.28 0.1 Allowed 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 118.804 -0.617 . . . . 0.0 110.263 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -146.5 58.91 1.21 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 120.776 1.625 . . . . 0.0 112.718 170.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -159.9 -78.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.116 0.966 . . . . 0.0 108.456 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.18 76.57 0.06 OUTLIER Glycine 0 N--CA 1.481 1.667 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.7 m -147.4 122.22 9.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.731 -0.864 . . . . 0.0 109.212 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -97.96 116.55 30.41 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.403 0.681 . . . . 0.0 110.683 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 70.9 mt -115.48 106.01 13.47 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.46 0.704 . . . . 0.0 110.91 -170.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -82.62 118.73 23.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.41 -0.806 . . . . 0.0 111.743 174.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.56 -167.96 41.06 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 117.741 1.856 . . . . 0.0 117.741 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.8 p -128.22 124.92 37.92 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.675 -0.763 . . . . 0.0 111.534 -163.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -85.92 129.41 34.84 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 118.194 0.452 . . . . 0.0 111.361 161.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.8 t -122.83 137.39 54.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.721 -0.612 . . . . 0.0 111.79 173.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.8 tp -90.93 107.68 19.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.898 -1.126 . . . . 0.0 111.572 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -103.48 75.96 1.38 Allowed 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 121.512 0.672 . . . . 0.0 109.747 171.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.25 -102.54 0.95 Allowed Glycine 0 N--CA 1.491 2.35 0 O-C-N 121.38 -0.825 . . . . 0.0 115.137 -177.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -95.67 22.33 7.31 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -129.84 114.53 16.02 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.713 -1.242 . . . . 0.0 110.03 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.9 mt -84.03 104.68 14.3 Favored 'General case' 0 CA--C 1.564 1.481 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 161.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.1 tt -94.1 114.53 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.466 -0.771 . . . . 0.0 110.231 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -103.07 99.18 1.76 Allowed Glycine 0 N--CA 1.482 1.706 0 C-N-CA 123.689 0.661 . . . . 0.0 113.289 -174.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -90.5 92.75 9.0 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -120.27 134.64 55.22 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.18 0.592 . . . . 0.0 112.503 -168.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -115.68 145.08 43.06 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.514 0.725 . . . . 0.0 109.875 169.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -70.2 123.95 22.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.446 -1.409 . . . . 0.0 112.675 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.281 9.8 t -81.05 59.78 3.97 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 122.625 1.202 . . . . 0.0 113.824 169.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -168.12 -63.31 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.767 0 C-N-CA 125.916 1.686 . . . . 0.0 107.796 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -80.34 -38.72 30.0 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.146 1.535 . . . . 0.0 115.146 171.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.74 -31.17 9.04 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 117.359 1.704 . . . . 0.0 117.359 -158.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -65.86 143.21 57.6 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -165.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -69.13 129.63 40.43 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 175.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.5 tt -121.59 86.06 2.51 Favored 'General case' 0 CA--C 1.563 1.472 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 168.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -83.05 109.06 16.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.987 -1.07 . . . . 0.0 109.735 -167.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 m -111.89 111.38 22.29 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.84 -0.538 . . . . 0.0 110.085 -166.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.0 t -107.1 101.63 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.022 -1.049 . . . . 0.0 109.05 -175.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.4 mtm-85 -84.3 117.32 23.49 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.296 0.639 . . . . 0.0 110.887 174.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -147.76 135.07 20.59 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.816 -1.177 . . . . 0.0 113.347 -173.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 mp -85.14 113.95 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.135 -0.978 . . . . 0.0 108.381 177.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.22 84.58 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.29 -84.41 0.73 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 114.728 0.651 . . . . 0.0 114.728 -173.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -103.52 -40.31 6.39 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -101.87 140.34 36.28 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 120.255 1.388 . . . . 0.0 113.096 -169.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.0 tp -76.73 111.34 12.14 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.834 0.853 . . . . 0.0 110.723 172.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 m -99.24 120.04 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -103.32 99.46 9.3 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.542 0.737 . . . . 0.0 109.377 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.4 m -94.18 112.02 23.79 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.301 0.64 . . . . 0.0 110.172 -171.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -90.09 133.3 34.94 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.669 0.788 . . . . 0.0 111.565 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.2 t -119.85 101.61 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 163.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -95.05 94.14 7.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.39 -0.818 . . . . 0.0 109.728 171.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.287 4.6 mm-40 70.35 -69.81 0.17 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -153.13 62.06 0.38 Allowed Glycine 0 N--CA 1.486 2.021 0 CA-C-O 119.784 -0.453 . . . . 0.0 113.683 165.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.5 p -144.58 113.59 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 117.77 0.785 . . . . 0.0 109.05 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -87.56 118.47 27.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.705 -0.622 . . . . 0.0 111.368 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -130.78 131.35 44.63 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 122.839 0.456 . . . . 0.0 111.686 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -115.46 118.02 32.01 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.435 -0.79 . . . . 0.0 111.169 -173.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -93.69 104.62 16.71 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 167.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.76 127.04 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -115.66 130.33 56.82 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.886 0.874 . . . . 0.0 110.264 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -78.61 143.98 35.92 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 121.77 0.795 . . . . 0.0 113.04 176.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -61.95 115.03 3.72 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 123.927 0.891 . . . . 0.0 112.769 171.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.2 t70 . . . . . 0 N--CA 1.489 1.476 0 C-N-CA 124.93 1.292 . . . . 0.0 112.345 -170.401 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.293 0 CA-C-O 122.139 0.971 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -81.23 36.38 0.41 Allowed 'General case' 0 CA--C 1.581 2.149 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.6 90.06 8.23 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 119.799 -1.813 . . . . 0.0 114.03 -157.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.2 m -158.13 -175.22 5.22 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 124.499 1.12 . . . . 0.0 110.808 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.0 m -99.69 113.09 25.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.808 -1.182 . . . . 0.0 109.441 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -117.81 108.16 15.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.912 -0.493 . . . . 0.0 109.84 -170.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -93.26 140.51 29.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.269 -0.895 . . . . 0.0 112.31 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.4 p -63.75 116.52 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -98.66 -59.35 1.76 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.547 0.739 . . . . 0.0 111.798 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -141.28 166.08 25.76 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.837 0.827 . . . . 0.0 110.846 177.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.4 m -153.71 126.41 8.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 119.236 -2.165 . . . . 0.0 112.142 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -100.8 121.82 42.35 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.741 0.816 . . . . 0.0 109.932 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.267 14.0 t30 65.29 13.57 8.86 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 171.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -63.59 -40.32 96.64 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.21 -27.04 68.71 Favored 'General case' 0 CA--C 1.577 2.014 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 169.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -73.92 -49.44 24.76 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 120.32 1.418 . . . . 0.0 113.8 165.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -46.8 -51.45 16.41 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 166.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -40.73 76.01 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 166.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -59.89 -45.9 91.04 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 168.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -54.59 -38.44 66.74 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 167.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.6 mtm -68.59 -21.7 64.5 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 168.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.12 49.21 1.77 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 116.212 1.245 . . . . 0.0 116.212 175.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.65 151.9 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 118.673 1.236 . . . . 0.0 113.614 -177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -63.08 144.59 56.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.283 13.2 tt -52.66 -45.13 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.3 t -55.5 -52.31 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 124.023 0.929 . . . . 0.0 113.457 168.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -61.56 -46.11 91.27 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 176.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.7 ptt85 -69.68 -28.81 66.17 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 117.975 2.584 . . . . 0.0 117.975 171.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -62.5 -49.1 76.69 Favored 'General case' 0 CA--C 1.572 1.807 0 CA-C-N 120.09 1.314 . . . . 0.0 114.302 161.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.28 -59.89 4.69 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 170.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.08 -16.79 20.94 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 118.915 2.931 . . . . 0.0 118.915 175.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.05 -86.49 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 117.693 -1.146 . . . . 0.0 112.701 159.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -106.4 48.93 0.82 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 121.814 2.097 . . . . 0.0 115.21 -171.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.0 54.27 2.7 Favored 'General case' 0 CA--C 1.576 1.977 0 O-C-N 120.765 -1.209 . . . . 0.0 113.869 166.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 50.7 50.8 18.24 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 117.563 2.431 . . . . 0.0 117.563 171.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -87.0 124.02 32.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.787 -1.196 . . . . 0.0 113.708 -169.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -119.75 121.41 39.11 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.086 0.954 . . . . 0.0 110.406 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.4 mt -91.44 102.19 14.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.553 -0.717 . . . . 0.0 109.301 176.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 87.0 m -95.21 103.5 15.36 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.4 mt -101.67 128.37 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -167.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.3 p -128.99 122.34 29.9 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 171.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -94.33 131.95 39.43 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.823 0.82 . . . . 0.0 111.251 168.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -97.72 36.86 1.45 Allowed 'General case' 0 CA--C 1.582 2.2 0 C-N-CA 124.603 1.161 . . . . 0.0 113.528 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.79 92.06 0.23 Allowed Glycine 0 N--CA 1.492 2.413 0 O-C-N 120.196 -1.565 . . . . 0.0 113.536 -168.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.279 16.8 t-20 71.58 -61.18 0.5 Allowed 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -74.76 133.65 41.95 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -172.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -111.26 134.24 53.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.492 -0.755 . . . . 0.0 112.132 -173.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.2 m -107.16 113.54 27.04 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 161.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.4 t -110.53 104.87 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -81.66 103.9 11.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 110.189 175.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -90.39 96.26 10.57 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.8 t -102.27 117.05 33.92 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.361 0.664 . . . . 0.0 111.274 -170.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.9 p -143.26 164.81 29.2 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.683 0.754 . . . . 0.0 112.903 -173.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.07 -25.51 65.44 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 159.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -73.03 -50.28 23.93 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -162.88 153.87 17.13 Favored 'General case' 0 CA--C 1.572 1.813 0 C-N-CA 124.408 1.083 . . . . 0.0 111.828 -171.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -129.87 104.14 7.21 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.517 -0.74 . . . . 0.0 109.128 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.28 142.13 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.48 -0.762 . . . . 0.0 112.15 -170.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -89.2 114.65 26.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.578 -0.701 . . . . 0.0 112.614 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.9 t -96.82 102.54 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.39 124.48 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 123.065 0.546 . . . . 0.0 109.598 -175.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -146.32 139.1 25.46 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.238 0.615 . . . . 0.0 111.344 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -97.65 142.37 29.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.26 164.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.74 112.36 3.67 Favored 'General case' 0 CA--C 1.566 1.571 0 O-C-N 121.584 -0.697 . . . . 0.0 112.617 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.56 -18.05 58.14 Favored Glycine 0 CA--C 1.558 2.723 0 N-CA-C 119.488 2.555 . . . . 0.0 119.488 -163.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 65.3 t -94.77 112.65 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 120.453 2.127 . . . . 0.0 109.039 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 t -73.07 139.48 46.56 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -131.54 166.81 20.54 Favored 'General case' 0 CA--C 1.574 1.866 0 C-N-CA 124.295 1.038 . . . . 0.0 112.832 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -93.1 120.71 33.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.433 -0.792 . . . . 0.0 110.543 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -119.92 123.27 43.15 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.345 0.658 . . . . 0.0 111.8 -176.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -81.48 127.17 32.53 Favored 'General case' 0 CA--C 1.566 1.584 0 O-C-N 121.329 -0.857 . . . . 0.0 109.703 161.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 57.3 mt -63.36 177.59 0.64 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 168.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.86 35.31 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 118.341 2.719 . . . . 0.0 118.341 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -154.6 -82.7 0.07 Allowed 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.753 1.221 . . . . 0.0 108.951 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.0 74.17 0.09 OUTLIER Glycine 0 N--CA 1.483 1.81 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 55.5 m -152.63 110.36 3.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.91 -0.759 . . . . 0.0 109.301 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -84.84 115.12 22.57 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-O 122.066 0.936 . . . . 0.0 112.224 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.2 mt -107.7 152.24 24.6 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 125.015 1.326 . . . . 0.0 111.442 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -116.26 111.39 20.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.042 -1.036 . . . . 0.0 109.795 174.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.24 -174.99 38.78 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 114.667 0.627 . . . . 0.0 114.667 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.9 m -117.25 -58.5 2.04 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -163.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . 0.272 69.6 m95 76.46 91.3 0.07 Allowed 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.488 1.115 . . . . 0.0 111.284 -153.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.2 m -105.37 127.88 53.2 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.261 0.624 . . . . 0.0 110.731 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.1 tp -78.53 102.64 8.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.0 111.158 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -81.54 -58.06 3.19 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.69 -96.21 1.12 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 160.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -102.34 57.21 0.79 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 117.774 0.787 . . . . 0.0 110.878 154.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -147.53 111.9 5.24 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -173.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.7 mt -86.4 101.86 13.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.582 -0.698 . . . . 0.0 109.746 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.8 tt -88.77 107.28 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.262 1.029 . . . . 0.0 110.638 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.73 93.14 1.72 Allowed Glycine 0 N--CA 1.48 1.592 0 C-N-CA 123.63 0.633 . . . . 0.0 112.954 174.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -86.75 92.44 8.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -112.07 108.31 17.56 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.352 0.661 . . . . 0.0 111.088 -165.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -89.97 129.75 36.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.972 -1.08 . . . . 0.0 110.851 177.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -61.14 135.66 57.83 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.7 p -64.32 -64.0 0.99 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 161.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -86.94 72.67 10.07 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 121.526 -0.734 . . . . 0.0 111.038 171.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 171.11 -39.32 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 126.527 1.931 . . . . 0.0 112.627 168.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 70.38 22.69 77.7 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 118.491 2.156 . . . . 0.0 118.491 -164.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -121.83 157.89 30.09 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.482 1.134 . . . . 0.0 113.394 -169.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -84.97 124.97 32.29 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -166.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.15 111.77 20.72 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.02 0.928 . . . . 0.0 108.717 170.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -103.65 111.99 24.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.301 -0.874 . . . . 0.0 108.883 -173.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.4 m -111.03 104.06 12.59 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 119.771 1.169 . . . . 0.0 110.828 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.7 t -90.25 104.06 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.13 -0.981 . . . . 0.0 108.62 177.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.5 118.86 24.57 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.584 0.754 . . . . 0.0 110.381 171.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -149.4 147.64 28.52 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 119.511 1.051 . . . . 0.0 113.524 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 mp -93.63 123.53 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.969 -1.082 . . . . 0.0 109.261 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 44.4 mm -103.5 92.11 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 170.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.11 -97.58 1.16 Allowed Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.339 -0.851 . . . . 0.0 114.176 -173.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -130.4 49.3 2.31 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 121.897 0.856 . . . . 0.0 111.773 166.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -144.25 116.68 8.56 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 124.015 0.926 . . . . 0.0 108.581 -173.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.8 tp -89.0 115.18 26.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.694 -0.629 . . . . 0.0 110.621 -173.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.4 m -105.56 121.09 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -98.24 108.57 21.3 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.732 0.813 . . . . 0.0 109.914 171.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.4 m -91.0 98.51 11.82 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -90.51 114.07 26.19 Favored 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 124.395 1.078 . . . . 0.0 111.349 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.56 105.91 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-N 119.203 0.91 . . . . 0.0 108.576 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -108.65 114.41 28.2 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 118.917 0.78 . . . . 0.0 109.774 167.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 53.66 50.21 17.63 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.21 -26.41 4.43 Favored Glycine 0 CA--C 1.554 2.472 0 N-CA-C 119.296 2.479 . . . . 0.0 119.296 -168.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.9 t -83.59 104.38 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 120.262 2.031 . . . . 0.0 109.928 -170.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -87.37 132.26 34.02 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -130.9 121.93 26.09 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.671 0.789 . . . . 0.0 111.717 171.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -101.0 106.09 17.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.445 -0.784 . . . . 0.0 110.948 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -93.94 125.52 38.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.794 -0.566 . . . . 0.0 111.47 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.8 mt -116.81 116.84 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -165.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -113.46 130.23 56.37 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.028 0.931 . . . . 0.0 110.445 -172.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -82.77 140.7 32.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.904 . . . . 0.0 112.054 174.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -62.77 107.19 0.92 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.554 -0.716 . . . . 0.0 111.518 162.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -162.487 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.57 1.723 0 N-CA-C 117.931 2.567 . . . . 0.0 117.931 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.3 92.6 m-85 72.26 164.39 0.28 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 119.897 1.226 . . . . 0.0 113.154 -163.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.27 17.6 m-20 66.79 50.76 1.09 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.9 t -157.28 -170.02 3.11 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 121.197 -0.94 . . . . 0.0 111.543 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.0 m -97.59 116.85 30.61 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.986 -1.071 . . . . 0.0 109.803 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -116.76 105.34 12.28 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.338 0.655 . . . . 0.0 109.538 -169.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -93.72 132.66 37.86 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.45 0.7 . . . . 0.0 110.86 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 p -57.07 116.56 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.952 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.46 -49.7 5.79 Favored 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 124.411 1.084 . . . . 0.0 112.913 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -149.71 116.62 5.94 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.529 1.059 . . . . 0.0 110.744 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.9 p -97.29 100.67 12.13 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.686 0.794 . . . . 0.0 111.564 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -95.14 125.37 39.74 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.421 0.688 . . . . 0.0 110.665 -169.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.268 42.7 t30 63.56 25.69 14.47 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -73.52 -45.73 52.03 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 115.605 1.705 . . . . 0.0 115.605 -173.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -61.41 -27.8 68.8 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -74.42 -46.28 41.12 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.966 1.257 . . . . 0.0 114.092 165.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -49.48 -52.71 27.42 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 164.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -31.2 72.32 Favored 'General case' 0 CA--C 1.574 1.888 0 N-CA-C 116.313 1.968 . . . . 0.0 116.313 172.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.47 -37.89 86.11 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 121.16 1.8 . . . . 0.0 115.476 163.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -60.05 -39.47 86.07 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 165.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 83.0 mmm -60.68 -45.68 93.25 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 165.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.78 51.42 0.57 Allowed Glycine 0 N--CA 1.484 1.878 0 C-N-CA 124.294 0.95 . . . . 0.0 114.8 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.4 m -108.61 142.4 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.479 1.133 . . . . 0.0 112.776 -178.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -66.5 154.89 39.14 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.305 0.1 OUTLIER -43.77 -56.1 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 -173.373 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.83 -51.55 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 CA-C-N 119.563 1.074 . . . . 0.0 113.082 175.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -55.67 -42.07 74.58 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 170.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.1 ttp85 -60.72 -50.63 72.72 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 169.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -60.53 -43.45 97.13 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 169.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.61 -38.72 88.68 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 167.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.68 -41.5 96.01 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 169.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.26 -51.42 67.79 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 162.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -96.61 58.89 1.74 Allowed 'General case' 0 CA--C 1.572 1.82 0 CA-C-N 119.328 0.967 . . . . 0.0 111.965 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -96.57 -16.33 21.12 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.696 2.109 . . . . 0.0 116.696 -170.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 55.31 57.31 5.55 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 119.878 1.217 . . . . 0.0 114.162 -167.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.4 tp -80.73 117.42 21.39 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 121.969 0.89 . . . . 0.0 111.301 -176.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -122.01 109.52 14.68 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.011 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 84.3 mt -94.89 106.68 18.69 Favored 'General case' 0 CA--C 1.563 1.442 0 C-N-CA 123.31 0.644 . . . . 0.0 110.227 -174.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.0 m -92.11 109.05 20.4 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.268 -0.895 . . . . 0.0 109.894 170.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.4 mt -101.5 133.99 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.739 0 C-N-CA 124.409 1.084 . . . . 0.0 108.53 -170.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t -153.02 125.67 8.27 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.939 -1.101 . . . . 0.0 111.729 171.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -87.29 116.94 25.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.129 -0.982 . . . . 0.0 112.08 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -103.11 75.29 1.36 Allowed 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.413 0.685 . . . . 0.0 110.256 171.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.68 75.29 0.43 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 115.947 1.139 . . . . 0.0 115.947 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.276 10.9 t-20 70.28 -48.67 0.64 Allowed 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -167.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -68.94 114.14 6.97 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 119.313 0.96 . . . . 0.0 113.352 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -88.43 120.48 29.85 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.154 0.582 . . . . 0.0 111.181 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.1 m -89.39 109.34 20.26 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 167.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.0 t -109.71 109.01 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -82.89 106.06 14.4 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -85.57 84.94 7.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.999 0.52 . . . . 0.0 109.906 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 t -85.84 111.06 19.84 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.564 0.345 . . . . 0.0 110.848 -176.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.2 p -142.93 159.85 41.46 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -169.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.34 -27.75 56.86 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 118.321 2.711 . . . . 0.0 118.321 169.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -74.24 -46.86 38.94 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 164.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.7 ptt-85 -167.02 150.76 6.71 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.772 0.829 . . . . 0.0 112.171 -170.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.65 96.62 6.08 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.585 0.754 . . . . 0.0 110.878 171.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.6 pt -119.59 127.47 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.569 -0.707 . . . . 0.0 112.416 -169.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.38 112.13 13.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.542 -0.724 . . . . 0.0 112.166 170.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.5 t -104.75 102.15 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.24 116.79 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -133.14 135.34 45.12 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.438 0.637 . . . . 0.0 111.53 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -80.61 136.27 36.2 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.595 -0.69 . . . . 0.0 111.328 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 57.1 mt -60.06 125.24 22.88 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -176.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.18 -5.7 70.87 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 119.708 2.643 . . . . 0.0 119.708 -172.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.4 t -88.75 133.0 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 120.122 1.961 . . . . 0.0 109.736 -176.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.7 p -72.92 110.26 7.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.65 -0.657 . . . . 0.0 111.947 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -126.83 163.02 24.52 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 124.013 0.925 . . . . 0.0 112.039 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -84.32 106.54 16.01 Favored 'General case' 0 CA--C 1.569 1.689 0 O-C-N 121.297 -0.877 . . . . 0.0 111.586 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -102.44 167.86 9.68 Favored 'General case' 0 CA--C 1.571 1.759 0 C-N-CA 124.749 1.22 . . . . 0.0 112.445 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -146.96 131.53 17.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.705 -1.247 . . . . 0.0 111.575 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.9 mt -84.83 62.77 7.63 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.271 . . 61.46 -36.49 0.11 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 120.409 3.485 . . . . 0.0 120.409 175.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -86.91 -85.89 0.16 Allowed 'General case' 0 CA--C 1.565 1.555 0 CA-C-N 120.052 1.297 . . . . 0.0 110.2 177.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.61 74.5 0.1 OUTLIER Glycine 0 N--CA 1.482 1.747 0 O-C-N 121.587 -0.696 . . . . 0.0 113.536 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.5 m -146.9 123.97 11.42 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.519 -0.989 . . . . 0.0 109.985 162.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -78.42 130.84 36.56 Favored 'General case' 0 CA--C 1.566 1.587 0 CA-C-O 122.155 0.978 . . . . 0.0 112.435 173.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.6 mt -131.61 111.52 11.8 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.242 -165.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -86.61 114.5 23.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.095 -1.003 . . . . 0.0 111.052 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.37 178.63 47.91 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 116.399 1.32 . . . . 0.0 116.399 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.1 p -92.21 165.31 13.19 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.27 1.033 . . . . 0.0 113.494 -174.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -127.23 108.83 11.22 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 143.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.4 m -100.36 137.48 38.72 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.49 0.716 . . . . 0.0 110.949 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.7 tp -85.3 94.75 9.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.215 -0.928 . . . . 0.0 111.398 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -84.49 79.18 9.66 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-O 121.836 0.827 . . . . 0.0 110.866 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.55 -94.58 0.95 Allowed Glycine 0 N--CA 1.489 2.222 0 O-C-N 121.722 -0.612 . . . . 0.0 113.908 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -126.5 63.62 1.27 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.822 0.82 . . . . 0.0 109.695 163.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -152.45 125.19 8.39 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.7 mt -90.74 105.12 17.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.56 -1.338 . . . . 0.0 109.571 171.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.1 tt -105.18 125.68 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 123.743 0.817 . . . . 0.0 110.616 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.65 118.53 1.99 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 115.58 0.992 . . . . 0.0 115.58 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -95.27 99.91 11.79 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.215 0.606 . . . . 0.0 110.229 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -107.62 107.25 17.98 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -167.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -90.48 136.58 32.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.377 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -75.54 124.86 27.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.999 -1.063 . . . . 0.0 113.239 -173.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.5 p -80.8 62.7 4.93 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 122.332 1.063 . . . . 0.0 112.723 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.4 t0 171.85 -41.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 126.732 2.013 . . . . 0.0 110.283 -166.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -121.49 -18.47 7.24 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -175.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.08 -34.91 3.64 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 118.516 2.166 . . . . 0.0 118.516 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -69.89 139.94 53.08 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -166.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -81.79 128.06 33.62 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.8 tt -106.41 85.62 2.21 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.253 8.5 p30 -81.11 110.36 16.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.334 -0.854 . . . . 0.0 110.803 -173.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.9 m -114.18 112.18 22.75 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.916 -164.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.3 t -102.39 103.86 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.1 mtm180 -85.68 120.64 27.34 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.611 -0.681 . . . . 0.0 110.211 164.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.74 157.92 43.77 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.2 mm -94.31 118.14 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.661 -1.274 . . . . 0.0 109.818 -175.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.2 tt -88.76 71.02 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.14 0.971 . . . . 0.0 111.339 171.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.68 -79.22 0.97 Allowed Glycine 0 N--CA 1.491 2.332 0 O-C-N 120.704 -1.248 . . . . 0.0 114.874 -172.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -107.67 -33.64 7.23 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -93.84 146.22 24.05 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 120.482 1.492 . . . . 0.0 112.82 -174.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.3 tp -86.9 115.87 24.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 110.79 174.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 19.6 m -98.03 115.83 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.354 -0.841 . . . . 0.0 109.752 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -97.39 101.73 13.33 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 171.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.1 m -95.03 105.87 17.82 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.216 0.607 . . . . 0.0 109.558 -176.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -92.84 113.83 26.22 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 124.159 0.984 . . . . 0.0 109.505 -177.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.5 t -113.28 112.64 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -123.11 94.42 4.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.691 -0.63 . . . . 0.0 110.059 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 50.9 55.21 9.9 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 103.26 -49.87 0.93 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 117.094 1.598 . . . . 0.0 117.094 -169.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.1 p -76.45 113.4 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 119.211 1.506 . . . . 0.0 113.151 -165.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -92.18 116.89 29.34 Favored 'General case' 0 CA--C 1.563 1.446 0 O-C-N 121.91 -0.494 . . . . 0.0 111.155 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.42 139.76 48.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.914 -0.491 . . . . 0.0 111.734 163.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -120.27 110.31 16.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.886 . . . . 0.0 110.467 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -89.19 108.47 19.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.62 -0.675 . . . . 0.0 110.458 164.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.7 mp -90.22 120.89 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -110.53 131.82 54.72 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 124.05 0.94 . . . . 0.0 110.116 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -90.51 149.02 22.36 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-O 121.864 0.84 . . . . 0.0 111.817 174.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -68.25 106.87 2.59 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 112.035 173.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.046 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.304 0 CA-C-O 121.623 0.725 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -71.08 -34.82 71.54 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -75.36 77.25 2.44 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 -171.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.8 t -148.14 -177.46 5.76 Favored 'General case' 0 CA--C 1.574 1.891 0 CA-C-O 122.389 1.09 . . . . 0.0 111.266 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -95.19 115.87 27.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.126 -0.984 . . . . 0.0 109.667 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -117.37 103.72 10.41 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.97 0.508 . . . . 0.0 110.402 -169.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -86.71 135.69 33.29 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 123.539 0.735 . . . . 0.0 111.998 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.2 p -63.54 119.18 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.338 -0.851 . . . . 0.0 113.228 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -103.77 -53.2 2.81 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 124.021 0.929 . . . . 0.0 113.084 -173.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -149.05 85.54 1.47 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 119.212 0.915 . . . . 0.0 111.095 -172.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.4 p -73.32 120.2 18.61 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 178.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -104.28 115.22 30.02 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 123.544 0.737 . . . . 0.0 109.831 -169.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.1 t30 62.05 17.7 9.31 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 118.116 2.635 . . . . 0.0 118.116 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -75.85 -35.83 59.8 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -168.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.95 -26.17 68.03 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 162.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -71.36 -47.49 56.03 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 119.917 1.235 . . . . 0.0 114.245 166.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -43.9 -50.68 7.97 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 160.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.7 mtt -64.84 -32.98 74.93 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 172.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.42 -43.41 93.05 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 120.897 1.681 . . . . 0.0 115.326 162.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -62.09 -34.73 76.86 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 169.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 22.1 mmt -60.3 -30.28 69.39 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 164.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.94 50.41 3.29 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 115.612 1.005 . . . . 0.0 115.612 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.3 m -89.8 160.63 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 121.984 0.897 . . . . 0.0 113.208 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -70.86 154.75 41.55 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 165.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.269 14.7 tt -59.14 -36.87 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.11 -56.0 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-N 119.558 1.072 . . . . 0.0 112.922 172.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -65.19 -28.78 69.63 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 116.788 2.144 . . . . 0.0 116.788 172.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.5 ttp85 -58.9 -42.23 89.09 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 117.27 2.322 . . . . 0.0 117.27 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.5 OUTLIER -77.36 -48.24 17.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 162.343 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.84 -51.33 62.66 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -175.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.19 -37.04 85.64 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 173.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.71 -51.42 65.05 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 168.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -100.12 47.76 0.93 Allowed 'General case' 0 CA--C 1.574 1.881 0 CA-C-N 118.954 0.797 . . . . 0.0 112.703 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -83.99 16.27 2.96 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -169.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 53.44 50.19 17.94 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.164 -1.585 . . . . 0.0 115.136 -170.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.2 tp -80.23 120.65 24.61 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 121.88 0.847 . . . . 0.0 112.873 -171.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -111.87 121.06 44.0 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.287 172.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.6 mt -101.9 102.54 13.12 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.969 0.508 . . . . 0.0 109.966 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.2 m -89.86 108.82 19.93 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.328 -0.858 . . . . 0.0 109.231 169.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.0 mt -101.57 128.9 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -172.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 t -145.31 133.65 21.78 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.894 -1.129 . . . . 0.0 111.56 171.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -99.95 118.87 37.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.194 -0.942 . . . . 0.0 112.3 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -100.81 71.2 1.44 Allowed 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 123.137 0.575 . . . . 0.0 110.636 169.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 62.39 77.33 0.21 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 116.552 1.381 . . . . 0.0 116.552 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.278 7.1 t30 72.21 -24.72 0.18 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -170.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -90.0 109.62 20.64 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 119.657 1.117 . . . . 0.0 111.901 172.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -83.04 118.01 23.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.516 -0.74 . . . . 0.0 111.161 169.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.6 m -86.23 107.55 17.97 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 164.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.07 112.67 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -87.24 111.36 20.94 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.286 0.634 . . . . 0.0 110.351 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -89.99 89.46 7.72 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.289 0.635 . . . . 0.0 109.467 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.7 m -97.4 107.7 20.27 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.8 p -145.84 174.0 11.62 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.02 0.914 . . . . 0.0 113.23 -171.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.85 -30.32 65.69 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 118.432 2.753 . . . . 0.0 118.432 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.2 -31.64 30.24 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 168.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -159.24 155.27 26.7 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 119.926 1.239 . . . . 0.0 113.357 -159.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -134.64 99.88 4.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.068 -1.02 . . . . 0.0 108.748 165.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.6 pt -132.22 129.75 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.854 -0.529 . . . . 0.0 111.704 -169.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.13 109.66 19.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.203 -0.936 . . . . 0.0 111.762 174.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.8 t -100.43 107.8 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -175.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -92.36 109.99 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -120.26 129.03 53.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.856 -0.528 . . . . 0.0 111.203 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -80.63 130.87 35.36 Favored 'General case' 0 CA--C 1.562 1.425 0 O-C-N 121.666 -0.646 . . . . 0.0 111.117 168.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.3 mt -61.45 124.22 20.03 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.72 -17.45 58.58 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 119.354 2.502 . . . . 0.0 119.354 -166.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.5 t -89.46 134.93 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-N 120.768 2.284 . . . . 0.0 110.41 -176.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -76.87 116.43 17.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.579 -0.701 . . . . 0.0 112.594 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -135.68 159.2 42.38 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 123.651 0.78 . . . . 0.0 111.297 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.03 94.29 7.48 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 121.306 -0.871 . . . . 0.0 112.404 -172.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -89.39 145.76 25.12 Favored 'General case' 0 CA--C 1.569 1.701 0 O-C-N 121.499 -0.751 . . . . 0.0 112.458 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -128.33 126.01 39.89 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.428 -0.795 . . . . 0.0 110.832 -174.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.7 mt -94.65 74.1 3.7 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -173.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.32 . . 65.7 -61.52 0.26 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -67.63 -18.24 64.89 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 119.141 3.015 . . . . 0.0 119.141 174.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.89 31.35 5.73 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 117.515 1.766 . . . . 0.0 117.515 -163.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.1 m -81.45 99.07 8.54 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.129 0.965 . . . . 0.0 109.176 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -85.72 99.39 11.3 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -160.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.6 mt -112.55 113.87 26.24 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.787 0.835 . . . . 0.0 110.832 -167.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -97.22 123.5 41.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.944 . . . . 0.0 111.336 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.71 179.76 46.4 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 118.061 1.984 . . . . 0.0 118.061 -169.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 80.7 p -114.32 134.03 55.25 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.013 -1.093 . . . . 0.0 111.357 -169.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -89.85 119.54 30.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.852 . . . . 0.0 109.974 162.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.6 m -117.17 125.71 51.63 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.175 0.59 . . . . 0.0 110.997 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 tp -91.48 100.22 13.02 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.263 0.625 . . . . 0.0 111.243 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.86 68.79 2.06 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.456 0.703 . . . . 0.0 111.801 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.19 69.23 1.42 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 116.208 1.243 . . . . 0.0 116.208 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.256 1.5 t-20 59.46 29.08 18.6 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 -168.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -138.01 111.66 8.2 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.4 mt -95.45 105.1 17.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.488 -0.758 . . . . 0.0 109.72 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.5 tt -95.02 121.12 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.978 0.894 . . . . 0.0 109.807 173.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.8 101.95 2.83 Favored Glycine 0 N--CA 1.479 1.557 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.467 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -91.83 96.44 10.41 Favored 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -121.3 149.45 42.88 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.163 0.982 . . . . 0.0 112.201 -168.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -121.77 139.56 53.44 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 121.857 0.837 . . . . 0.0 109.669 167.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.7 mmm-85 -61.8 115.69 4.21 Favored 'General case' 0 CA--C 1.562 1.427 0 O-C-N 121.451 -0.781 . . . . 0.0 112.889 166.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.8 p -60.22 -55.97 27.22 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 169.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -83.59 55.03 3.05 Favored 'General case' 0 CA--C 1.578 2.036 0 O-C-N 121.58 -0.7 . . . . 0.0 112.375 171.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -175.32 -35.7 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 172.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.81 21.23 77.03 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 118.588 2.195 . . . . 0.0 118.588 -165.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -119.59 145.98 45.92 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.484 1.142 . . . . 0.0 113.154 -168.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.26 135.99 34.11 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -168.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.6 tt -123.8 130.78 53.16 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.612 1.165 . . . . 0.0 110.625 174.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -111.93 116.16 30.16 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.6 m -109.5 102.71 11.55 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 120.649 1.568 . . . . 0.0 110.493 171.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.8 t -102.59 90.91 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -174.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -99.58 137.22 38.38 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.336 1.065 . . . . 0.0 113.071 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -157.89 154.03 27.25 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.89 -174.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.5 mm -93.69 108.74 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.436 -0.79 . . . . 0.0 109.453 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.254 16.4 tt -86.29 71.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 122.152 0.977 . . . . 0.0 111.234 172.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.46 -84.92 0.95 Allowed Glycine 0 N--CA 1.489 2.228 0 O-C-N 121.012 -1.055 . . . . 0.0 114.56 -174.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -129.72 65.1 1.49 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 122.665 0.386 . . . . 0.0 110.044 167.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -164.36 125.37 2.16 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.424 0.69 . . . . 0.0 110.009 170.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.1 tp -83.22 102.81 12.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.609 -0.682 . . . . 0.0 109.197 171.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.4 m -91.7 98.45 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -96.17 95.3 8.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.095 -1.003 . . . . 0.0 110.757 -170.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.9 m -89.6 102.58 15.26 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.236 0.614 . . . . 0.0 111.184 -166.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -90.24 119.78 30.84 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.745 0.818 . . . . 0.0 110.85 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.8 t -120.2 104.61 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -113.41 118.27 34.08 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.094 0.557 . . . . 0.0 110.657 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.28 53.0 mt-10 64.9 -79.33 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 123.834 0.854 . . . . 0.0 112.829 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -151.3 58.25 0.43 Allowed Glycine 0 N--CA 1.487 2.051 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.993 157.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.2 p -133.79 112.79 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 118.34 1.07 . . . . 0.0 109.834 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -89.64 124.5 34.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.476 -0.765 . . . . 0.0 111.264 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.24 127.14 20.68 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 170.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -98.68 121.71 40.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.926 . . . . 0.0 111.535 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -85.75 106.98 17.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.319 157.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.7 mt -96.6 115.26 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -176.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -111.3 134.15 53.1 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 122.985 0.514 . . . . 0.0 111.184 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -94.7 147.07 23.7 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-O 121.74 0.781 . . . . 0.0 112.417 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -72.84 116.1 12.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.425 -0.797 . . . . 0.0 112.312 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -172.787 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.302 96.4 m-85 . . . . . 0 N--CA 1.498 1.969 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -76.84 82.45 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.832 1.197 . . . . 0.0 112.847 -171.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.9 m -170.59 172.85 5.71 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 124.86 1.264 . . . . 0.0 110.832 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.6 m -83.63 113.93 21.19 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.089 -1.007 . . . . 0.0 111.217 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -118.04 113.76 22.11 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.547 0.739 . . . . 0.0 109.914 -175.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -108.33 140.71 41.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.509 -0.745 . . . . 0.0 112.398 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.8 p -62.35 119.19 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -91.35 -54.26 3.99 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 123.765 0.826 . . . . 0.0 112.641 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -148.22 122.85 9.83 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 118.679 0.672 . . . . 0.0 110.226 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.9 m -108.83 115.06 29.36 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.466 0.706 . . . . 0.0 110.843 -172.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -110.99 111.86 23.28 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -161.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.281 12.5 t30 67.07 19.65 10.46 Favored 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 117.573 2.435 . . . . 0.0 117.573 -174.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -72.56 -38.4 67.96 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.48 -29.01 69.7 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 165.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -72.24 -53.3 12.93 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 119.551 1.069 . . . . 0.0 113.595 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -42.82 -53.93 4.38 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 162.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.9 mtt -65.45 -27.13 68.29 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 116.755 2.132 . . . . 0.0 116.755 172.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -64.4 -39.87 94.68 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 166.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -63.17 -32.3 73.66 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 165.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.6 mtm -73.94 -14.35 61.03 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 169.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.11 56.49 2.7 Favored Glycine 0 N--CA 1.487 2.039 0 CA-C-N 120.118 1.327 . . . . 0.0 115.824 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.261 6.0 p -125.35 142.47 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-O 121.795 0.807 . . . . 0.0 112.614 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -62.39 146.2 51.95 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -172.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.288 0.0 OUTLIER -44.26 -46.89 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 176.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.8 t -55.53 -61.57 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 C-N-CA 124.204 1.002 . . . . 0.0 113.345 171.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -60.23 -42.65 95.68 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 173.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.8 ttp85 -59.02 -48.21 82.42 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 173.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -66.22 -38.58 88.28 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.9 mt -65.29 -33.24 75.5 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 167.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.13 -32.77 70.93 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 168.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.97 -57.07 14.44 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 154.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -90.05 66.06 6.68 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.56 1.172 . . . . 0.0 112.054 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -101.95 -31.71 10.55 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 116.733 2.123 . . . . 0.0 116.733 -162.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 64.61 50.28 2.17 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 119.781 1.173 . . . . 0.0 113.986 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 tp -89.45 112.13 23.19 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.081 -1.012 . . . . 0.0 111.264 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -103.4 108.67 20.0 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.963 1.305 . . . . 0.0 109.046 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.6 mt -100.21 104.05 15.54 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.607 0.763 . . . . 0.0 109.542 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.2 m -94.9 102.72 14.57 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.557 -0.714 . . . . 0.0 109.448 171.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.9 mt -86.34 121.68 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.776 0.83 . . . . 0.0 108.983 -175.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.4 p -128.34 119.53 25.25 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.618 -0.676 . . . . 0.0 110.429 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -74.84 127.89 34.27 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 122.443 1.115 . . . . 0.0 112.348 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -110.94 -28.3 8.42 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -168.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.05 74.37 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 C-N-CA 124.6 1.095 . . . . 0.0 110.568 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.29 14.7 t-20 66.73 -55.96 0.42 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -150.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -53.59 148.97 8.64 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -113.95 114.8 26.69 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 171.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.1 m -87.17 100.47 12.69 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 170.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.1 t -107.21 113.59 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -171.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -83.39 109.22 17.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.357 0.663 . . . . 0.0 109.52 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -103.82 88.65 3.1 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -170.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.4 m -96.0 120.25 35.95 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.777 0.831 . . . . 0.0 111.142 -171.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.1 p -142.94 169.29 17.84 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.782 1.031 . . . . 0.0 113.782 -172.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.52 -31.27 61.94 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 163.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -79.92 -51.26 9.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 170.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -159.23 148.57 18.54 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -165.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -103.62 102.77 12.65 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 164.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.5 pt -119.05 123.96 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.613 -0.68 . . . . 0.0 111.114 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -90.25 105.4 17.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 0.0 109.935 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.5 105.68 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -170.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.7 t -91.68 99.14 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -110.79 132.63 54.03 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.244 0.545 . . . . 0.0 111.883 178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -84.78 145.7 27.75 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.443 0.64 . . . . 0.0 111.593 168.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.0 mt -63.57 102.13 0.4 Allowed 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.36 -5.16 44.58 Favored Glycine 0 CA--C 1.551 2.342 0 N-CA-C 119.19 2.436 . . . . 0.0 119.19 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.2 p -78.26 139.73 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 120.963 2.381 . . . . 0.0 112.895 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 66.0 m -86.4 105.95 17.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.556 -0.715 . . . . 0.0 109.87 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -132.0 158.37 41.67 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.436 0.694 . . . . 0.0 111.971 -175.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -82.33 95.75 7.71 Favored 'General case' 0 CA--C 1.568 1.652 0 O-C-N 121.647 -0.658 . . . . 0.0 111.202 174.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -83.92 137.81 33.47 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.558 0.694 . . . . 0.0 111.589 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -120.17 133.27 55.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.718 -0.614 . . . . 0.0 109.969 177.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.0 mt -81.72 -132.04 0.03 OUTLIER 'General case' 0 CA--C 1.576 1.958 0 O-C-N 122.093 -0.379 . . . . 0.0 111.31 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.55 -45.57 11.64 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.6 p30 -99.26 -76.38 0.54 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.741 0.816 . . . . 0.0 111.958 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.88 82.05 0.12 Allowed Glycine 0 N--CA 1.482 1.722 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -169.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.0 m -143.1 100.38 3.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.62 113.92 22.9 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.581 0.705 . . . . 0.0 111.516 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.0 mt -118.28 105.84 12.17 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.514 0.726 . . . . 0.0 110.826 -169.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -79.46 119.85 23.04 Favored 'General case' 0 CA--C 1.566 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 111.589 172.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.25 -158.37 30.41 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.8 p -127.17 142.79 51.41 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 123.135 0.574 . . . . 0.0 112.536 -158.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -100.64 116.58 32.9 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.53 -0.731 . . . . 0.0 109.316 158.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 t -122.77 130.29 52.74 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.276 0.631 . . . . 0.0 111.748 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.8 tp -84.06 116.4 22.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.849 -1.157 . . . . 0.0 111.961 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -139.78 100.29 3.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.895 -0.503 . . . . 0.0 110.923 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.27 67.29 2.13 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 116.444 1.337 . . . . 0.0 116.444 174.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.288 21.1 t-20 72.91 -55.55 0.68 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 113.763 1.024 . . . . 0.0 113.763 -157.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -81.77 134.76 35.47 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -152.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.8 mt -85.83 108.32 18.07 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.805 0.812 . . . . 0.0 109.018 170.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.7 mm -96.35 113.02 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -170.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.59 87.87 1.55 Allowed Glycine 0 N--CA 1.48 1.578 0 CA-C-O 119.558 -0.579 . . . . 0.0 112.951 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -86.58 97.68 10.66 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.744 0.783 . . . . 0.0 109.62 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -120.23 161.95 20.22 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-O 123.421 1.581 . . . . 0.0 111.92 -174.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -143.54 149.03 36.86 Favored 'General case' 0 CA--C 1.559 1.325 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.739 164.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -67.46 113.19 5.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.019 -1.051 . . . . 0.0 112.576 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.5 t -65.78 -19.81 66.03 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 165.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.14 -28.58 70.16 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 117.159 2.281 . . . . 0.0 117.159 157.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -130.23 -46.11 1.11 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 -167.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.34 -24.41 24.49 Favored Glycine 0 CA--C 1.554 2.527 0 N-CA-C 117.432 1.733 . . . . 0.0 117.432 -155.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -76.97 139.74 40.22 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 119.842 1.821 . . . . 0.0 114.577 -174.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.04 141.1 49.29 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tt -129.91 120.93 25.68 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.145 0.578 . . . . 0.0 110.061 171.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -109.87 113.9 27.02 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.934 -1.104 . . . . 0.0 109.38 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.1 m -114.35 102.53 10.19 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 119.279 0.945 . . . . 0.0 110.479 -177.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.7 t -90.23 106.13 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 120.809 -1.182 . . . . 0.0 109.595 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -86.03 115.42 23.62 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 123.477 0.711 . . . . 0.0 110.907 170.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -140.45 144.19 35.96 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 123.516 0.727 . . . . 0.0 111.914 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.3 mm -97.76 109.64 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.28 -0.888 . . . . 0.0 109.122 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.252 11.0 tp -93.01 85.02 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-O 121.945 0.878 . . . . 0.0 110.225 169.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.32 -86.89 0.91 Allowed Glycine 0 N--CA 1.49 2.282 0 O-C-N 121.289 -0.882 . . . . 0.0 114.589 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -135.42 53.57 1.96 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.386 0.613 . . . . 0.0 111.995 166.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -146.43 121.25 9.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.126 -0.984 . . . . 0.0 108.359 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.9 tp -82.7 101.23 10.73 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.3 m -101.6 105.47 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.631 -0.668 . . . . 0.0 109.279 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -92.77 109.25 20.67 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.633 -0.667 . . . . 0.0 111.246 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.3 m -91.21 108.62 20.0 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -97.64 119.49 36.31 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 123.977 0.911 . . . . 0.0 109.688 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.6 t -118.29 106.33 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -99.12 116.15 30.67 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 119.038 0.835 . . . . 0.0 109.77 172.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.265 42.0 mt-10 66.12 -79.33 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 123.65 0.78 . . . . 0.0 112.046 -176.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -148.86 42.25 0.83 Allowed Glycine 0 CA--C 1.553 2.455 0 CA-C-O 118.441 -1.199 . . . . 0.0 116.072 157.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -114.41 115.46 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-N 119.729 1.764 . . . . 0.0 110.625 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -81.99 130.34 35.05 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.45 126.13 34.26 Favored 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 123.235 0.614 . . . . 0.0 111.177 163.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -114.64 105.24 12.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.658 -0.651 . . . . 0.0 111.1 -169.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -98.58 117.83 33.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.88 -0.513 . . . . 0.0 111.209 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.9 mt -93.04 115.25 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -103.88 116.86 33.05 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -83.43 157.4 22.49 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 121.611 0.72 . . . . 0.0 111.674 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -66.64 104.27 1.26 Allowed 'General case' 0 CA--C 1.57 1.715 0 O-C-N 120.974 -1.079 . . . . 0.0 112.027 176.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 N--CA 1.491 1.594 0 C-N-CA 124.923 1.289 . . . . 0.0 114.25 -173.761 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.323 88.9 m-85 . . . . . 0 N--CA 1.5 2.053 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.25 80.92 1.33 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 120.007 1.276 . . . . 0.0 112.857 -172.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.3 m -174.58 175.69 2.46 Favored 'General case' 0 CA--C 1.572 1.793 0 C-N-CA 125.381 1.473 . . . . 0.0 110.325 -173.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 t -98.62 134.6 41.33 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.906 -1.121 . . . . 0.0 111.462 168.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -126.78 105.01 8.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.431 -0.793 . . . . 0.0 109.15 -166.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -97.02 137.91 35.37 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.493 -0.754 . . . . 0.0 112.513 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -64.3 128.65 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.831 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -170.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -111.12 -49.56 3.01 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.96 135.98 12.82 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 120.295 1.407 . . . . 0.0 111.722 173.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.1 p -107.2 129.64 54.83 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.929 0.892 . . . . 0.0 112.037 174.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -69.68 -66.52 0.58 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -141.92 59.7 1.48 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.158 0.89 . . . . 0.0 111.852 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -82.87 54.68 2.79 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.391 -1.443 . . . . 0.0 112.947 174.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -154.78 -55.79 0.1 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.595 1.558 . . . . 0.0 108.72 -170.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -68.77 -30.41 69.0 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 121.292 1.86 . . . . 0.0 115.67 160.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -52.22 -53.11 47.56 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 121.302 1.865 . . . . 0.0 114.644 156.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -40.27 93.71 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 170.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.27 -32.92 74.45 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 167.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -62.61 -39.08 92.66 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 159.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.1 mmm -63.18 -34.96 78.76 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 116.029 1.862 . . . . 0.0 116.029 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.71 52.81 0.74 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.426 HG23 ' HG2' ' A' ' 28' ' ' ARG . 6.7 m -130.54 143.67 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 122.127 0.965 . . . . 0.0 112.533 -174.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -65.33 157.82 28.13 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.268 10.8 tp -49.78 -39.48 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 N-CA-C 118.447 2.758 . . . . 0.0 118.447 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.5 t -62.01 -54.04 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-N 119.491 1.041 . . . . 0.0 112.381 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -56.98 -36.69 70.63 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 167.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HG2' HG23 ' A' ' 23' ' ' VAL . 76.4 mtm-85 -62.58 -46.08 89.94 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 121.219 1.827 . . . . 0.0 115.183 169.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -58.07 -49.24 77.6 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 166.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.53 -35.42 70.68 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 116.493 2.034 . . . . 0.0 116.493 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.36 99.07 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 163.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.85 -58.44 8.37 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 162.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -90.24 56.26 3.33 Favored 'General case' 0 CA--C 1.574 1.873 0 CA-C-O 122.316 1.055 . . . . 0.0 113.112 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -88.96 -31.83 17.96 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 71.02 64.11 0.17 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 124.722 1.209 . . . . 0.0 113.409 173.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.6 tp -97.44 125.8 42.31 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.707 0.765 . . . . 0.0 113.042 -167.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -103.36 126.07 50.32 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.891 163.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.9 mt -104.16 103.76 13.59 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 m -91.3 107.88 19.51 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.227 -0.92 . . . . 0.0 108.822 172.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 73.5 mt -100.76 96.95 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -169.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.0 m -98.95 100.49 11.67 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -87.49 121.67 30.22 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 121.6 -0.687 . . . . 0.0 111.813 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -109.36 82.45 1.6 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.18 0.991 . . . . 0.0 109.741 161.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.11 -110.69 3.29 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 114.807 0.683 . . . . 0.0 114.807 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -81.65 -23.6 36.82 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -81.07 115.89 20.74 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 119.871 1.214 . . . . 0.0 111.482 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -101.83 110.37 22.34 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.7 m -91.36 97.39 11.06 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.6 t -95.75 106.27 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -85.21 106.84 16.94 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -94.8 90.4 6.04 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -173.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 m -104.49 115.89 31.14 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.403 0.681 . . . . 0.0 111.018 -173.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.3 p -146.84 -178.5 6.22 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.61 54.22 0.59 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -175.92 -57.29 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.859 0 C-N-CA 125.731 1.612 . . . . 0.0 109.797 -159.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.5 ptp85 -146.33 149.18 33.33 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.175 0.99 . . . . 0.0 111.777 -160.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -135.09 94.27 3.12 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 165.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.8 pt -129.69 124.24 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.323 0.582 . . . . 0.0 111.073 -172.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.42 101.65 14.33 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.982 0.913 . . . . 0.0 111.747 176.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.4 t -91.78 106.4 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.58 106.46 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -122.14 137.07 54.96 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.489 0.662 . . . . 0.0 112.305 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -81.61 140.25 34.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.381 -0.825 . . . . 0.0 111.579 167.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.83 113.59 2.58 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.32 -11.72 56.92 Favored Glycine 0 CA--C 1.55 2.232 0 N-CA-C 118.506 2.162 . . . . 0.0 118.506 -171.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.2 p -78.48 140.27 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-N 120.53 2.165 . . . . 0.0 113.569 -171.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.2 m -84.88 104.18 14.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.728 -0.608 . . . . 0.0 109.539 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -136.99 165.34 26.22 Favored 'General case' 0 CA--C 1.569 1.711 0 CA-C-O 121.675 0.75 . . . . 0.0 112.581 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -87.57 98.9 11.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.559 -0.713 . . . . 0.0 111.791 175.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -86.55 156.37 20.1 Favored 'General case' 0 CA--C 1.567 1.618 0 C-N-CA 123.631 0.772 . . . . 0.0 112.421 173.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -128.75 131.96 47.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.724 -1.235 . . . . 0.0 110.695 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 33.8 mt -86.72 169.97 12.18 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.847 0.832 . . . . 0.0 113.066 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.35 46.9 0.11 Allowed 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 118.773 2.879 . . . . 0.0 118.773 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -138.9 -80.56 0.32 Allowed 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 159.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.19 79.74 0.05 OUTLIER Glycine 0 N--CA 1.48 1.589 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 97.2 m -152.46 128.8 10.57 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.462 -1.022 . . . . 0.0 111.143 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -79.62 131.33 35.96 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.9 mt -124.05 104.32 8.81 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.677 0.791 . . . . 0.0 110.879 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -76.38 114.8 15.48 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.983 0.913 . . . . 0.0 112.095 172.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.94 -164.02 36.78 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 117.083 1.593 . . . . 0.0 117.083 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.9 p -120.57 121.93 39.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -160.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -86.32 112.86 21.82 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 122.906 0.482 . . . . 0.0 110.776 161.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.3 m -119.17 130.2 55.4 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.738 -0.601 . . . . 0.0 112.431 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.8 tp -88.72 130.48 35.32 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.185 -0.947 . . . . 0.0 112.258 177.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -107.45 -79.05 0.58 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 123.512 0.725 . . . . 0.0 110.903 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.15 88.92 0.11 Allowed Glycine 0 N--CA 1.49 2.298 0 CA-C-N 119.803 1.183 . . . . 0.0 111.852 -173.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.26 63.0 m-80 65.4 10.03 6.22 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -156.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -132.99 117.73 17.98 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.374 1.069 . . . . 0.0 109.78 -169.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.37 109.24 20.84 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 168.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.9 tp -91.93 117.67 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.415 -0.803 . . . . 0.0 110.248 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.21 98.21 2.02 Favored Glycine 0 N--CA 1.483 1.795 0 C-N-CA 123.461 0.553 . . . . 0.0 112.424 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -94.84 98.1 10.49 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -124.06 146.48 48.55 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.021 0.915 . . . . 0.0 113.044 -166.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -120.12 148.76 43.21 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.527 0.731 . . . . 0.0 109.693 164.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -73.9 148.55 42.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.148 -1.595 . . . . 0.0 113.433 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.7 p -70.97 -73.59 0.17 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.568 -0.707 . . . . 0.0 111.754 167.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.86 -41.78 97.7 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.844 2.165 . . . . 0.0 116.844 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.31 -14.1 39.13 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 174.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.05 -39.57 2.98 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 118.327 2.091 . . . . 0.0 118.327 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -80.27 162.08 24.79 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -156.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.26 135.66 47.57 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -177.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.5 tt -125.61 130.8 52.36 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 124.185 0.994 . . . . 0.0 109.395 168.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -107.21 129.15 54.9 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.209 -0.932 . . . . 0.0 109.702 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -123.74 108.53 12.63 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.41 -0.806 . . . . 0.0 109.182 171.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.8 t -98.12 110.22 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -87.58 114.99 24.7 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.496 0.718 . . . . 0.0 111.122 172.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -132.19 133.92 44.77 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 119.284 0.947 . . . . 0.0 111.869 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.39 108.77 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.952 -1.093 . . . . 0.0 108.541 173.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.0 pt -97.23 94.03 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 C-N-CA 124.296 1.039 . . . . 0.0 109.028 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.1 -101.67 1.36 Allowed Glycine 0 N--CA 1.492 2.38 0 O-C-N 121.239 -0.913 . . . . 0.0 113.01 -169.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -131.74 53.31 2.0 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.368 0.604 . . . . 0.0 112.009 161.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -134.99 125.37 26.45 Favored 'General case' 0 CA--C 1.563 1.448 0 O-C-N 121.44 -0.787 . . . . 0.0 109.381 167.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.7 tp -78.29 107.67 11.06 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.746 0.818 . . . . 0.0 110.487 175.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -92.38 118.85 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.334 -0.854 . . . . 0.0 110.931 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -95.27 106.89 18.97 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.79 0.836 . . . . 0.0 109.679 172.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.1 m -91.47 104.12 16.66 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.083 0.553 . . . . 0.0 109.864 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -95.61 121.22 37.08 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.181 0.592 . . . . 0.0 111.749 -174.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.6 t -120.63 121.04 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -136.52 98.31 3.78 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.862 -0.524 . . . . 0.0 110.191 168.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 66.19 68.53 0.45 Allowed 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 168.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.68 44.47 57.02 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 118.303 2.081 . . . . 0.0 118.303 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -156.53 150.99 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 118.439 1.12 . . . . 0.0 110.401 -176.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.47 126.12 32.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.165 -0.96 . . . . 0.0 110.313 174.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -128.02 105.67 8.55 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.071 0.548 . . . . 0.0 111.286 171.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -85.42 118.47 24.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 110.967 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.4 mtt-85 -99.84 110.32 22.69 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 164.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.7 mt -81.65 133.27 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -120.65 121.78 39.07 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.065 0.946 . . . . 0.0 109.189 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -77.7 142.37 38.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 112.609 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -69.16 111.25 4.99 Favored 'General case' 0 CA--C 1.568 1.655 0 O-C-N 121.451 -0.78 . . . . 0.0 111.785 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 N--CA 1.488 1.468 0 C-N-CA 124.938 1.295 . . . . 0.0 112.587 -170.148 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.328 54.2 m-85 . . . . . 0 N--CA 1.499 1.978 0 N-CA-C 117.712 2.486 . . . . 0.0 117.712 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -75.35 76.59 2.44 Favored 'General case' 0 CA--C 1.573 1.838 0 CA-C-N 120.459 1.481 . . . . 0.0 113.979 -170.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.0 t -162.71 -178.86 6.44 Favored 'General case' 0 CA--C 1.576 1.974 0 CA-C-O 122.682 1.229 . . . . 0.0 112.367 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.1 m -87.58 129.08 35.23 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.243 1.017 . . . . 0.0 110.42 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -128.01 111.75 13.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.828 -0.545 . . . . 0.0 109.603 -173.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.52 137.54 36.3 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.418 0.687 . . . . 0.0 111.756 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.1 p -64.36 118.14 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -105.75 -59.87 1.71 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.758 0.823 . . . . 0.0 112.076 -174.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -134.24 166.62 22.37 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.55 1.167 . . . . 0.0 111.372 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.6 m -151.51 123.73 8.25 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 119.581 -1.949 . . . . 0.0 109.761 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -82.4 -81.46 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -159.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -108.32 55.97 0.63 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 120.29 1.405 . . . . 0.0 112.435 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -87.38 66.11 8.98 Favored 'General case' 0 CA--C 1.573 1.843 0 CA-C-O 122.63 1.205 . . . . 0.0 111.543 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -158.05 -66.35 0.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.969 0.908 . . . . 0.0 109.961 -167.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -60.67 -47.28 86.96 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 166.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -44.61 -58.69 2.87 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 162.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 37.4 mtp -59.07 -43.32 91.74 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -61.06 -41.74 97.19 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 166.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -62.24 -37.07 84.01 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 168.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 55.7 mtm -65.14 -20.03 66.26 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 164.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.24 47.64 2.78 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.3 m -123.12 142.51 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-N 118.385 1.092 . . . . 0.0 111.504 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -75.24 169.67 17.59 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.27 0.3 OUTLIER -52.91 -42.21 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 176.19 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.3 t -58.36 -48.87 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.027 -1.046 . . . . 0.0 113.357 170.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -61.79 -40.32 94.79 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 168.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 mpp_? -57.15 -34.6 68.59 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 164.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -70.25 -55.79 8.39 Favored 'General case' 0 CA--C 1.572 1.827 0 CA-C-N 120.364 1.438 . . . . 0.0 113.434 164.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.0 mt -66.08 -52.59 47.34 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.74 -4.7 36.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 172.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.36 -57.95 3.51 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 119.692 1.133 . . . . 0.0 113.123 152.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -90.49 52.96 2.32 Favored 'General case' 0 CA--C 1.573 1.841 0 C-N-CA 123.767 0.827 . . . . 0.0 112.903 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -92.98 2.25 56.89 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 55.25 58.45 4.67 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 124.687 1.195 . . . . 0.0 113.957 -175.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.3 tp -92.09 116.47 28.96 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-O 122.065 0.936 . . . . 0.0 111.873 -166.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -115.52 112.1 21.71 Favored 'General case' 0 CA--C 1.561 1.378 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.391 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.0 mt -99.09 100.13 11.24 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.0 m -92.62 108.96 20.37 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.335 -0.853 . . . . 0.0 109.613 174.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -107.96 137.6 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 C-N-CA 124.298 1.039 . . . . 0.0 108.673 -165.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 93.1 m -147.75 122.56 9.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.139 -1.6 . . . . 0.0 110.481 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -86.97 108.97 19.06 Favored 'General case' 0 CA--C 1.565 1.522 0 O-C-N 121.55 -0.719 . . . . 0.0 112.112 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -91.71 76.11 5.7 Favored 'General case' 0 CA--C 1.57 1.725 0 O-C-N 121.477 -0.765 . . . . 0.0 110.054 168.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.69 -98.57 0.54 Allowed Glycine 0 N--CA 1.492 2.404 0 O-C-N 121.443 -0.786 . . . . 0.0 114.778 -174.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -95.74 -11.59 26.77 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 165.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -95.76 101.97 13.71 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 120.791 1.632 . . . . 0.0 110.551 -175.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.49 111.55 18.61 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.379 -0.826 . . . . 0.0 111.135 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.2 m -86.24 105.22 16.46 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.735 0.814 . . . . 0.0 109.069 174.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.5 t -112.52 103.26 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -85.79 107.43 17.63 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.284 0.634 . . . . 0.0 110.722 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -98.49 87.46 3.85 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.1 t -88.35 117.44 27.28 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 122.856 0.462 . . . . 0.0 111.171 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.3 p -146.73 165.04 30.83 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.623 0.725 . . . . 0.0 112.678 -172.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.68 -27.2 62.68 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 118.012 2.597 . . . . 0.0 118.012 165.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -75.42 -51.88 12.04 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 167.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -162.36 151.43 15.37 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.595 0.758 . . . . 0.0 111.727 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -113.88 91.67 3.72 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.801 0.84 . . . . 0.0 110.532 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.6 pt -114.89 125.0 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 121.448 0.642 . . . . 0.0 111.88 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -86.26 101.21 12.85 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.6 0.76 . . . . 0.0 110.971 172.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.69 105.44 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -174.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.3 t -94.58 96.93 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -105.97 128.04 53.55 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.431 0.634 . . . . 0.0 112.077 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -85.23 129.08 34.88 Favored 'General case' 0 CA--C 1.563 1.474 0 O-C-N 121.511 -0.743 . . . . 0.0 111.157 173.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.0 125.92 25.54 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -173.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.79 -16.75 44.6 Favored Glycine 0 CA--C 1.555 2.533 0 N-CA-C 119.106 2.403 . . . . 0.0 119.106 -168.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.3 t -86.26 130.78 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 120.278 2.039 . . . . 0.0 109.938 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.5 t -75.21 121.9 22.84 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -142.7 161.68 37.44 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-O 121.732 0.777 . . . . 0.0 112.201 -172.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -91.63 104.2 16.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.489 -0.757 . . . . 0.0 111.517 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -100.85 142.02 32.91 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 124.164 0.986 . . . . 0.0 111.631 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -134.82 100.94 4.75 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.907 -1.121 . . . . 0.0 110.615 -167.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.0 mt -76.36 93.34 3.45 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -168.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.3 . . 58.07 -64.31 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 119.85 3.278 . . . . 0.0 119.85 170.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -82.98 -83.71 0.13 Allowed 'General case' 0 CA--C 1.57 1.719 0 CA-C-N 118.853 0.752 . . . . 0.0 109.73 164.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.48 55.01 0.2 Allowed Glycine 0 N--CA 1.487 2.057 0 N-CA-C 116.267 1.267 . . . . 0.0 116.267 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.8 m -88.02 101.11 13.46 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 118.068 0.934 . . . . 0.0 108.545 165.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -88.63 112.41 23.05 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 122.794 0.438 . . . . 0.0 111.076 -169.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.8 mt -127.38 112.29 14.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.748 -0.595 . . . . 0.0 111.716 -161.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 51.5 ptt85 -90.94 118.19 30.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.104 -0.997 . . . . 0.0 111.338 172.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.3 -158.94 32.1 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 117.776 1.87 . . . . 0.0 117.776 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.7 p -130.15 129.85 44.01 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -156.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -92.48 132.26 36.95 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.033 -1.042 . . . . 0.0 111.081 164.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.5 m -129.97 127.31 39.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.566 -0.708 . . . . 0.0 111.425 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.6 tp -81.9 125.25 30.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.462 -0.774 . . . . 0.0 111.638 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -130.96 79.59 1.9 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.381 -0.824 . . . . 0.0 109.115 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.47 -109.5 3.02 Favored Glycine 0 N--CA 1.488 2.11 0 O-C-N 121.648 -0.657 . . . . 0.0 113.747 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -111.02 44.22 1.33 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 167.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -144.5 114.06 7.14 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 25.1 mt -89.49 107.49 19.1 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 167.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.9 tt -96.88 119.47 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.296 -0.878 . . . . 0.0 110.409 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -101.95 98.88 1.8 Allowed Glycine 0 N--CA 1.482 1.76 0 C-N-CA 124.1 0.857 . . . . 0.0 113.215 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.17 101.55 13.93 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -121.88 143.11 49.63 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.707 0.765 . . . . 0.0 111.916 -173.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -110.72 138.73 46.74 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.69 0.757 . . . . 0.0 109.384 163.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -62.0 111.34 1.88 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.288 -0.882 . . . . 0.0 112.597 171.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.297 5.8 t -68.66 -14.74 63.22 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 174.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -73.78 -20.46 60.47 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 158.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -133.92 -41.44 0.83 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -166.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.85 -26.94 22.32 Favored Glycine 0 CA--C 1.556 2.643 0 N-CA-C 117.368 1.707 . . . . 0.0 117.368 -153.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -66.06 129.92 41.45 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -167.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.04 129.68 35.54 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -175.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.9 tt -121.7 120.29 34.26 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 124.917 1.287 . . . . 0.0 108.908 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -105.47 113.13 26.51 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.314 -0.866 . . . . 0.0 109.065 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.6 m -101.93 111.48 23.75 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.303 -0.873 . . . . 0.0 110.368 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.34 102.5 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -80.82 115.99 20.58 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.767 0.827 . . . . 0.0 110.194 167.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -143.97 142.24 30.62 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -95.15 106.14 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.899 . . . . 0.0 109.44 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.0 pt -88.75 72.82 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.924 0 O-C-N 121.017 -1.052 . . . . 0.0 111.158 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 85.15 -86.84 1.55 Allowed Glycine 0 N--CA 1.491 2.312 0 O-C-N 120.531 -1.355 . . . . 0.0 113.096 -168.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -139.43 53.81 1.71 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 166.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -144.79 118.19 9.05 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 121.212 -0.93 . . . . 0.0 108.6 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.3 tp -78.53 110.23 13.43 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.107 0.956 . . . . 0.0 110.92 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.5 t -97.77 115.32 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -96.82 93.88 6.93 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.733 0.813 . . . . 0.0 109.778 171.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 48.8 m -84.04 101.97 12.15 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 122.864 0.466 . . . . 0.0 109.784 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -87.09 111.05 20.53 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.128 0.571 . . . . 0.0 110.892 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.3 t -103.1 102.06 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -128.85 109.91 11.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.779 -0.576 . . . . 0.0 109.723 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 53.63 57.59 5.96 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 174.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.35 -33.73 3.16 Favored Glycine 0 CA--C 1.552 2.405 0 N-CA-C 118.758 2.263 . . . . 0.0 118.758 -167.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.4 t -89.87 121.28 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 119.887 1.843 . . . . 0.0 110.708 -166.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -89.4 123.87 33.95 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.229 0.612 . . . . 0.0 111.348 166.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.94 108.47 8.42 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.012 0.525 . . . . 0.0 110.881 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -88.91 114.83 25.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 111.622 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -89.64 121.78 32.15 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 119.275 0.943 . . . . 0.0 109.873 162.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.6 mt -120.54 120.72 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -163.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -118.67 126.57 52.21 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.012 0.925 . . . . 0.0 110.747 -165.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -87.23 152.93 21.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.162 -0.961 . . . . 0.0 113.261 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -62.18 110.95 1.77 Allowed 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 124.063 0.945 . . . . 0.0 113.309 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.489 1.484 0 C-N-CA 125.175 1.39 . . . . 0.0 113.251 -174.498 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 . . . . . 0 N--CA 1.497 1.879 0 CA-C-O 121.377 0.608 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -88.12 88.42 7.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.997 -1.065 . . . . 0.0 111.744 -166.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.1 m -171.6 164.62 6.78 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 122.754 1.264 . . . . 0.0 113.24 -172.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.6 m -89.72 131.08 35.87 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 124.024 0.93 . . . . 0.0 110.9 170.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -131.33 110.12 10.85 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.356 0.662 . . . . 0.0 109.779 -170.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -100.84 135.64 41.98 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.01 -1.056 . . . . 0.0 112.303 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.7 121.88 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -106.53 -49.08 3.4 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -153.17 111.52 3.66 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 118.911 0.778 . . . . 0.0 109.746 -164.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.2 p -102.0 108.62 20.12 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.512 0.725 . . . . 0.0 112.385 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -102.93 115.46 30.65 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.285 38.7 t30 67.93 11.43 8.36 Favored 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 118.458 2.762 . . . . 0.0 118.458 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -64.79 -42.84 94.75 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -61.17 -32.53 72.27 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 170.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -72.99 -42.73 63.0 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 171.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -46.48 -54.31 9.51 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 160.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.7 mtt -61.75 -39.16 90.63 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 172.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -53.35 -48.76 68.27 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 166.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.1 tttp -62.18 -28.63 69.8 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 168.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.5 mmt -65.47 -43.83 89.08 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 168.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.89 63.72 0.36 Allowed Glycine 0 N--CA 1.487 2.099 0 C-N-CA 123.855 0.741 . . . . 0.0 113.742 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 p -138.25 146.49 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.403 1.097 . . . . 0.0 111.638 -176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -59.2 143.92 47.55 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.31 12.9 tt -52.89 -44.15 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.8 t -56.58 -56.55 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.305 0.957 . . . . 0.0 113.197 170.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -63.6 -45.15 91.67 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.2 ptt85 -67.66 -30.61 70.19 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 171.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -68.55 -43.4 76.71 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 120.009 1.277 . . . . 0.0 114.219 165.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.5 mt -62.35 -50.57 71.06 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 169.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.65 -12.53 54.2 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 118.6 2.815 . . . . 0.0 118.6 168.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.76 -59.96 2.55 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 155.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -91.62 53.53 2.27 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 118.765 0.711 . . . . 0.0 112.82 -170.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.6 p30 -102.97 -4.22 24.98 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 118.582 2.808 . . . . 0.0 118.582 -171.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 59.18 56.16 4.02 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-N 121.655 2.025 . . . . 0.0 114.131 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.4 tp -82.63 119.75 24.68 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.981 -1.074 . . . . 0.0 112.1 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -101.55 119.85 39.4 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.199 170.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.8 mt -102.42 107.34 18.29 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.251 88.6 m -88.13 101.09 13.47 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.854 -1.154 . . . . 0.0 108.736 163.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 85.5 mt -94.99 119.45 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.8 t -127.82 131.21 49.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.808 -0.558 . . . . 0.0 111.614 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -79.73 127.21 31.93 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 121.768 0.794 . . . . 0.0 111.472 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -131.96 64.48 1.59 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 124.05 0.94 . . . . 0.0 110.563 -168.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.3 69.25 1.37 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 116.756 1.463 . . . . 0.0 116.756 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.281 14.9 t30 66.82 -15.04 0.15 Allowed 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 -164.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -92.19 154.23 18.8 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 120.684 -1.26 . . . . 0.0 112.231 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -116.4 120.3 38.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.476 -0.765 . . . . 0.0 109.392 165.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.9 m -89.03 107.62 19.14 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 167.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.0 t -104.25 108.01 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -93.18 104.19 16.4 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -86.28 126.3 34.2 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.189 0.595 . . . . 0.0 110.71 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.2 t -135.17 118.73 16.95 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 122.765 0.426 . . . . 0.0 110.255 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 p -147.61 172.83 13.41 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.46 59.08 0.79 Allowed 'General case' 0 CA--C 1.575 1.925 0 O-C-N 120.513 -1.367 . . . . 0.0 113.491 154.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -168.78 -60.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.114 0.966 . . . . 0.0 110.174 -175.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -154.58 143.57 21.01 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 118.588 0.631 . . . . 0.0 111.951 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -115.2 103.11 10.52 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 173.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.6 pt -138.29 141.18 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 121.5 0.667 . . . . 0.0 111.909 -174.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -104.13 105.78 16.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.171 -0.956 . . . . 0.0 109.7 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.32 103.19 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.2 t -97.89 104.11 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -117.78 149.71 40.35 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.125 0.57 . . . . 0.0 112.476 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -94.07 142.41 27.43 Favored 'General case' 0 CA--C 1.568 1.635 0 O-C-N 121.733 -0.604 . . . . 0.0 111.698 171.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.1 mt -71.95 101.91 2.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.004 -1.06 . . . . 0.0 111.699 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.6 -46.15 1.07 Allowed Glycine 0 CA--C 1.549 2.215 0 N-CA-C 116.37 1.308 . . . . 0.0 116.37 -168.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.73 141.46 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.844 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.1 m -92.51 77.86 5.0 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.191 0.996 . . . . 0.0 110.729 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -101.64 166.27 10.79 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -167.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -82.24 93.75 7.17 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-O 121.62 0.724 . . . . 0.0 111.531 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -84.52 164.98 18.44 Favored 'General case' 0 CA--C 1.571 1.756 0 CA-C-O 122.141 0.972 . . . . 0.0 111.498 166.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -153.65 132.75 12.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.325 -1.485 . . . . 0.0 110.801 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.3 mt -75.6 -64.04 1.16 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -164.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -154.36 -70.99 0.13 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 118.926 0.785 . . . . 0.0 111.391 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -83.24 -69.53 0.63 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.958 0.799 . . . . 0.0 112.941 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.74 50.58 0.4 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 116.734 1.454 . . . . 0.0 116.734 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.1 m -112.71 98.33 7.15 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -92.79 140.73 29.21 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 122.439 1.114 . . . . 0.0 112.147 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.8 mt -136.59 119.82 16.72 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 123.78 0.832 . . . . 0.0 110.206 -162.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -90.47 122.91 33.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.964 -1.085 . . . . 0.0 110.034 169.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.75 -173.32 45.46 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 117.633 1.813 . . . . 0.0 117.633 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 75.9 p -115.59 131.47 56.92 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.092 -1.054 . . . . 0.0 111.327 -170.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -87.78 113.92 23.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.195 -0.94 . . . . 0.0 109.621 161.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.6 m -110.94 117.42 33.33 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.419 0.688 . . . . 0.0 110.909 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.9 tp -84.76 99.1 10.64 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.144 -0.972 . . . . 0.0 111.584 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -95.52 85.21 4.14 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.444 0.698 . . . . 0.0 110.687 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.37 -90.59 0.62 Allowed Glycine 0 N--CA 1.491 2.359 0 O-C-N 121.425 -0.797 . . . . 0.0 114.601 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -125.52 53.44 1.55 Allowed 'General case' 0 CA--C 1.575 1.935 0 CA-C-O 121.363 0.601 . . . . 0.0 111.552 162.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -145.0 111.15 5.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.089 -1.007 . . . . 0.0 108.533 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 mt -85.89 102.34 13.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.968 . . . . 0.0 109.075 172.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.6 mt -100.6 108.55 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -172.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.12 101.72 2.75 Favored Glycine 0 N--CA 1.482 1.705 0 C-N-CA 123.235 0.445 . . . . 0.0 113.18 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -95.34 94.28 7.76 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.551 0.74 . . . . 0.0 109.06 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -121.47 138.33 54.33 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -163.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -119.49 138.4 53.17 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.516 0.726 . . . . 0.0 110.085 170.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -70.08 130.21 41.51 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -171.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 36.9 p -81.43 68.69 7.86 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.337 1.065 . . . . 0.0 110.851 170.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -177.7 -62.28 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.774 0 C-N-CA 125.927 1.691 . . . . 0.0 107.417 -164.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -135.37 20.37 3.39 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.4 10.6 36.57 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 121.03 3.172 . . . . 0.0 121.03 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -95.46 138.71 32.76 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 118.121 0.96 . . . . 0.0 112.217 -159.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -80.34 128.25 33.34 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -163.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.86 122.87 39.13 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 124.742 1.217 . . . . 0.0 108.423 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -98.61 114.7 27.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.618 -0.676 . . . . 0.0 109.278 172.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.1 m -108.22 96.85 6.65 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 119.564 1.075 . . . . 0.0 109.701 175.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.3 t -95.65 105.17 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.885 -1.134 . . . . 0.0 108.91 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -88.9 122.02 31.85 Favored 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 123.565 0.746 . . . . 0.0 111.052 169.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -144.87 155.24 43.35 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.281 -0.887 . . . . 0.0 112.38 171.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mp -94.76 118.79 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.649 -1.282 . . . . 0.0 109.657 -176.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.7 mt -95.79 87.55 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 106.941 -1.504 . . . . 0.0 106.941 164.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.0 -94.83 0.38 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 115.742 1.057 . . . . 0.0 115.742 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -101.75 14.56 31.6 Favored 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 169.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -134.38 109.76 8.99 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 119.717 1.144 . . . . 0.0 111.002 -161.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.6 tp -76.46 104.61 7.07 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.918 0.887 . . . . 0.0 110.899 173.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.5 p -88.47 104.77 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 123.05 0.54 . . . . 0.0 110.219 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -90.0 99.85 12.78 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.456 0.646 . . . . 0.0 109.421 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 33.4 m -98.96 104.89 16.97 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.006 -168.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -87.1 125.79 34.36 Favored 'General case' 0 CA--C 1.563 1.476 0 C-N-CA 123.257 0.623 . . . . 0.0 111.048 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.4 t -121.69 109.0 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 168.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -113.87 107.11 15.26 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.265 10.2 mm-40 65.03 -78.68 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 123.914 0.885 . . . . 0.0 112.992 -171.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -152.6 58.32 0.42 Allowed Glycine 0 N--CA 1.486 2.001 0 CA-C-O 119.511 -0.605 . . . . 0.0 114.108 164.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.9 p -129.19 104.21 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -89.43 112.31 23.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.602 -0.687 . . . . 0.0 110.915 -176.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.77 117.34 25.46 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.019 0.527 . . . . 0.0 112.236 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -105.62 102.22 11.69 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.456 0.703 . . . . 0.0 109.704 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . 0.258 15.1 ptm180 -95.92 111.98 23.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.441 -0.787 . . . . 0.0 110.733 168.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.4 mt -97.94 125.01 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -170.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -105.45 116.73 32.44 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.618 0.767 . . . . 0.0 109.068 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -82.78 141.93 31.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.231 -0.918 . . . . 0.0 111.745 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -66.94 124.36 22.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 113.338 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 124.822 1.249 . . . . 0.0 111.88 -170.103 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 . . . . . 0 N--CA 1.502 2.16 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -130.55 75.83 1.68 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.952 -1.093 . . . . 0.0 110.701 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.1 p -171.15 168.63 6.75 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.795 1.284 . . . . 0.0 113.5 -175.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.7 m -77.23 135.87 38.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.219 -0.926 . . . . 0.0 111.75 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -133.16 101.74 5.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.678 -0.639 . . . . 0.0 109.393 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -97.31 137.84 35.7 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.252 -0.905 . . . . 0.0 112.223 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.266 4.5 p -63.03 115.54 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.81 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -173.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -84.55 -47.4 10.61 Favored 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 123.687 0.795 . . . . 0.0 113.054 170.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -155.15 159.0 39.84 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 122.563 1.173 . . . . 0.0 111.033 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.7 m -147.66 113.03 5.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 119.871 -1.768 . . . . 0.0 109.315 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -83.36 -95.79 0.06 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -162.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -85.06 52.56 2.47 Favored 'General case' 0 CA--C 1.579 2.063 0 CA-C-N 120.635 1.561 . . . . 0.0 113.523 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -82.9 -48.45 10.7 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.526 1.13 . . . . 0.0 114.03 -172.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -58.0 -29.27 65.15 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 169.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 -46.48 34.11 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 169.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -47.64 -51.2 22.28 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 161.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.0 mtm -59.27 -30.77 68.53 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 170.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -65.74 -44.38 86.16 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 166.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -58.63 -37.49 76.01 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 165.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.5 mmm -64.84 -41.57 95.62 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 167.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.43 48.37 0.81 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 115.989 1.156 . . . . 0.0 115.989 174.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.29 10.7 p -113.12 138.84 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 118.534 1.167 . . . . 0.0 112.309 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -62.69 152.39 35.58 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 12.5 tt -48.11 -40.16 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 118.285 2.698 . . . . 0.0 118.285 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.4 t -66.11 -62.28 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-N 119.861 1.209 . . . . 0.0 111.96 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -62.56 -20.03 64.28 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 117.949 2.574 . . . . 0.0 117.949 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.5 ttp85 -76.37 -49.44 16.79 Favored 'General case' 0 CA--C 1.569 1.708 0 C-N-CA 125.292 1.437 . . . . 0.0 114.26 167.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -41.54 98.61 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 169.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.28 -40.63 86.69 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 165.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.72 -31.19 71.69 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 117.729 2.492 . . . . 0.0 117.729 169.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.9 -43.72 69.92 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 157.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -82.41 14.93 2.72 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.313 19.4 p30 -78.36 92.99 4.61 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 121.534 1.97 . . . . 0.0 110.597 170.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -68.8 84.68 0.31 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.767 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.0 tp -86.91 124.75 33.46 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 122.489 1.138 . . . . 0.0 112.731 -167.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -99.48 114.81 27.99 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.57 165.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.2 mt -96.96 95.52 7.88 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.9 m -88.32 98.19 11.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.035 -1.041 . . . . 0.0 108.473 173.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.0 mt -89.76 119.11 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.3 p -121.59 122.14 38.99 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -97.37 130.61 44.5 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -118.02 77.18 1.13 Allowed 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 162.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.61 -106.5 1.08 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 116.404 1.322 . . . . 0.0 116.404 -175.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -84.64 -15.9 43.85 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 169.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -89.03 153.76 20.75 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 119.809 1.186 . . . . 0.0 112.346 168.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -143.51 136.54 27.72 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.606 0.763 . . . . 0.0 109.836 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.9 m -109.82 111.45 22.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.236 -0.915 . . . . 0.0 108.884 164.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.4 p -95.68 120.48 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 121.428 0.632 . . . . 0.0 110.123 168.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -82.4 114.44 20.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 109.484 173.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -93.06 91.25 7.25 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.7 t -112.34 105.42 13.7 Favored 'General case' 0 CA--C 1.562 1.418 0 CA-C-O 121.384 0.611 . . . . 0.0 111.105 -172.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.0 p -143.91 -179.16 6.31 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.393 1.077 . . . . 0.0 111.904 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.11 -25.82 24.11 Favored 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 118.265 2.691 . . . . 0.0 118.265 160.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -96.76 -18.02 19.89 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -148.61 146.43 28.23 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 120.469 1.486 . . . . 0.0 112.155 -171.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -135.19 77.79 1.7 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 156.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.0 pt -126.88 139.88 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 121.216 -0.928 . . . . 0.0 111.953 -167.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.17 105.44 17.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.575 -0.703 . . . . 0.0 109.797 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.3 t -89.69 98.05 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.0 t -89.97 106.85 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -121.63 164.02 18.01 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-O 122.619 1.2 . . . . 0.0 112.752 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -126.5 145.68 50.41 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.452 -0.78 . . . . 0.0 109.683 171.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.75 108.53 1.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.974 . . . . 0.0 113.584 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.65 -23.87 27.03 Favored Glycine 0 CA--C 1.548 2.146 0 N-CA-C 117.985 1.954 . . . . 0.0 117.985 -170.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.8 p -68.67 134.92 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 120.308 2.054 . . . . 0.0 113.588 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -85.38 106.42 16.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.751 -0.593 . . . . 0.0 109.796 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -127.5 158.04 38.48 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.766 0.793 . . . . 0.0 112.151 -176.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -85.72 107.5 17.62 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.549 -0.719 . . . . 0.0 111.413 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -105.54 128.99 53.9 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 124.074 0.95 . . . . 0.0 110.236 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -107.19 125.51 51.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.595 -0.691 . . . . 0.0 111.65 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.9 mt -92.6 78.34 4.91 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.308 . . 63.57 -51.44 0.23 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 120.322 3.453 . . . . 0.0 120.322 162.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -74.22 -81.52 0.07 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 121.39 1.905 . . . . 0.0 109.33 167.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.9 80.88 0.06 OUTLIER Glycine 0 N--CA 1.481 1.692 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.6 m -145.75 109.94 4.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.407 -1.055 . . . . 0.0 108.752 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -84.56 121.84 28.18 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.922 0.867 . . . . 0.0 112.373 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mt -129.65 120.21 24.82 Favored 'General case' 0 CA--C 1.562 1.412 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.515 -168.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -93.08 118.99 31.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.922 . . . . 0.0 111.97 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.51 -170.55 42.06 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 118.069 1.988 . . . . 0.0 118.069 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.0 p -126.24 121.22 32.07 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.49 -0.855 . . . . 0.0 111.679 -163.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -78.29 123.05 26.51 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 119.048 0.84 . . . . 0.0 110.995 160.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.8 m -125.3 137.38 54.07 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.364 0.665 . . . . 0.0 111.721 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 tp -91.25 104.51 17.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 111.586 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -91.46 82.64 5.36 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.63 -0.669 . . . . 0.0 109.55 171.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.44 -94.75 0.66 Allowed Glycine 0 N--CA 1.492 2.373 0 O-C-N 121.545 -0.722 . . . . 0.0 114.382 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -125.23 59.62 1.24 Allowed 'General case' 0 CA--C 1.571 1.788 0 CA-C-O 121.802 0.811 . . . . 0.0 110.926 159.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -140.77 111.49 6.95 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 170.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.5 mt -84.44 100.55 11.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.192 -0.943 . . . . 0.0 109.561 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.6 tt -97.78 128.9 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 123.743 0.817 . . . . 0.0 110.798 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.64 102.77 0.64 Allowed Glycine 0 N--CA 1.481 1.658 0 CA-C-O 119.234 -0.759 . . . . 0.0 114.005 -172.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -90.32 98.55 11.84 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.051 0.925 . . . . 0.0 109.492 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -110.53 106.5 15.82 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.639 0.733 . . . . 0.0 110.576 -171.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -90.99 125.87 35.91 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.224 -0.923 . . . . 0.0 111.772 -168.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.8 ttp85 -66.18 119.66 11.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.132 -0.98 . . . . 0.0 112.432 -174.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.303 5.4 t -59.87 -35.08 74.06 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 117.316 2.339 . . . . 0.0 117.316 -169.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -98.37 42.68 1.09 Allowed 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 168.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -156.62 -50.99 0.08 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.736 -1.228 . . . . 0.0 113.591 173.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.32 8.72 62.54 Favored Glycine 0 CA--C 1.555 2.544 0 N-CA-C 118.471 2.148 . . . . 0.0 118.471 -160.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -89.11 119.78 29.92 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 119.965 1.883 . . . . 0.0 111.389 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -73.07 122.8 22.38 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.6 tt -97.12 108.97 21.8 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -96.23 98.82 10.61 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -165.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.1 m -104.88 108.31 19.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.795 -0.565 . . . . 0.0 109.9 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.7 t -98.72 105.9 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.4 mtm180 -87.58 105.76 17.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.663 -0.648 . . . . 0.0 110.002 167.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.01 162.72 26.15 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.659 0.783 . . . . 0.0 111.729 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.3 mt -127.78 135.61 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.536 -1.352 . . . . 0.0 110.142 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.7 mm -98.15 -76.54 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.74 -112.08 3.44 Favored Glycine 0 N--CA 1.491 2.332 0 CA-C-N 118.687 0.676 . . . . 0.0 111.802 170.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -92.91 47.11 1.26 Allowed 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -146.93 118.78 8.11 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.401 1.08 . . . . 0.0 108.74 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.0 tp -81.91 115.5 21.12 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.482 0.713 . . . . 0.0 109.512 167.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.3 t -100.65 103.53 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -96.81 103.25 15.15 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 123.446 0.698 . . . . 0.0 109.825 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.8 m -99.64 103.25 14.93 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 123.266 0.626 . . . . 0.0 109.835 -173.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -95.0 123.8 38.68 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.775 0.83 . . . . 0.0 111.207 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.02 102.11 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-N 119.307 0.958 . . . . 0.0 108.779 173.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -86.51 102.96 14.59 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.183 -0.948 . . . . 0.0 110.007 167.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.319 0.1 OUTLIER 62.01 -41.42 0.15 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 120.001 3.334 . . . . 0.0 120.001 177.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -173.82 25.42 0.08 OUTLIER Glycine 0 CA--C 1.552 2.369 0 N-CA-C 117.716 1.846 . . . . 0.0 117.716 172.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.0 t -136.57 121.63 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 120.304 2.052 . . . . 0.0 107.532 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.24 140.19 29.8 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -174.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -129.79 125.1 34.98 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.545 0.738 . . . . 0.0 112.045 166.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -99.27 108.88 21.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.704 -0.622 . . . . 0.0 110.601 174.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -96.16 117.99 31.83 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 169.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 76.5 mt -108.55 120.8 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -171.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -117.32 122.77 44.81 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.835 0.854 . . . . 0.0 109.268 -172.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -77.86 148.27 34.73 Favored 'General case' 0 CA--C 1.568 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 112.837 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -58.9 113.57 2.13 Favored 'General case' 0 CA--C 1.57 1.721 0 C-N-CA 123.906 0.882 . . . . 0.0 113.131 175.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 N--CA 1.489 1.495 0 C-N-CA 124.826 1.251 . . . . 0.0 112.752 -171.328 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.254 91.7 m-85 . . . . . 0 N--CA 1.507 2.398 0 N-CA-C 118.99 2.959 . . . . 0.0 118.99 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.99 81.63 5.24 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 124.744 1.218 . . . . 0.0 112.897 -164.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.6 m -168.13 173.97 7.56 Favored 'General case' 0 CA--C 1.57 1.738 0 CA-C-O 122.607 1.194 . . . . 0.0 111.703 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.3 m -86.92 131.62 34.05 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.808 0.843 . . . . 0.0 110.804 170.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -132.65 109.36 9.66 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -172.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.24 134.46 48.32 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.281 -0.887 . . . . 0.0 111.716 -175.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -57.7 118.95 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -176.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -114.26 -52.8 2.71 Favored 'General case' 0 CA--C 1.564 1.509 0 C-N-CA 123.592 0.757 . . . . 0.0 113.023 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -144.75 74.17 1.4 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 119.466 1.03 . . . . 0.0 111.918 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.9 p -74.95 127.46 33.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.978 . . . . 0.0 113.454 175.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -79.22 -73.02 0.36 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -166.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -91.97 118.76 31.08 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 156.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -135.34 46.01 2.43 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-O 121.725 0.774 . . . . 0.0 112.406 164.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -146.05 -57.43 0.3 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.166 -0.959 . . . . 0.0 110.551 -173.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -62.39 -33.31 74.5 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 170.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -54.64 -59.77 4.25 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 120.141 1.337 . . . . 0.0 114.144 163.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.51 -47.39 63.31 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 169.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -59.83 -42.95 94.67 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 171.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -56.7 -39.32 73.65 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 165.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 90.5 mtp -64.41 -22.92 67.11 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 172.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.73 39.84 4.85 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 116.712 1.445 . . . . 0.0 116.712 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.446 HG23 ' HG2' ' A' ' 28' ' ' ARG . 6.2 m -105.76 138.05 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.631 0.729 . . . . 0.0 110.938 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -63.08 160.73 14.6 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.277 9.8 tp -53.57 -39.59 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.34 -52.85 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-N 119.647 1.112 . . . . 0.0 112.631 169.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -59.24 -34.79 72.63 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 168.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.446 ' HG2' HG23 ' A' ' 23' ' ' VAL . 84.6 mtm-85 -64.3 -47.92 77.61 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 121.428 1.922 . . . . 0.0 114.797 168.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -58.87 -48.96 79.56 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 168.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.4 mt -58.18 -53.36 59.2 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.611 1.338 . . . . 0.0 114.611 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.42 -47.55 78.8 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 116.431 2.012 . . . . 0.0 116.431 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.88 -47.66 67.69 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 168.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -98.69 32.98 2.4 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -85.78 -19.64 30.42 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -168.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 65.5 63.47 0.63 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 120.018 1.281 . . . . 0.0 113.572 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.74 117.28 21.93 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.204 -0.935 . . . . 0.0 111.792 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -103.21 110.8 22.9 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.534 174.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.7 mt -94.48 101.49 13.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 122.992 0.517 . . . . 0.0 109.776 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.9 m -94.94 111.98 23.72 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.36 136.63 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 124.089 0.956 . . . . 0.0 108.703 -168.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.1 m -149.13 124.24 10.1 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 119.903 -1.748 . . . . 0.0 111.235 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -77.34 132.54 38.64 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.374 1.07 . . . . 0.0 112.034 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -130.33 80.96 1.98 Allowed 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 123.524 0.73 . . . . 0.0 109.364 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.39 70.61 0.93 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 117.269 1.667 . . . . 0.0 117.269 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.309 17.3 m120 69.89 -23.49 0.16 Allowed 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -169.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -86.99 152.9 21.99 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 120.037 1.29 . . . . 0.0 112.785 169.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -121.73 133.68 54.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 111.054 173.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.0 m -97.69 117.79 32.77 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.0 t -120.37 112.57 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -83.2 117.21 22.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 0.0 110.85 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -95.32 80.07 3.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.815 -0.553 . . . . 0.0 110.903 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.5 t -97.42 111.36 23.65 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -171.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.5 p -149.93 177.01 10.24 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.77 59.08 0.21 Allowed 'General case' 0 CA--C 1.58 2.126 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 165.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -145.27 -53.84 0.29 Allowed 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 125.746 1.618 . . . . 0.0 110.096 167.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -156.95 -50.57 0.07 Allowed 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -172.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.299 36.6 t-20 76.62 106.13 0.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 120.06 1.3 . . . . 0.0 112.729 -165.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.8 pt -134.7 139.27 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-O 121.294 0.569 . . . . 0.0 111.257 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.73 124.46 30.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.516 -0.74 . . . . 0.0 111.829 168.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.4 t -110.4 101.62 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.9 t -101.04 115.03 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -140.94 151.89 44.57 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -171.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -90.56 139.39 30.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.497 -0.752 . . . . 0.0 111.882 168.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.07 131.46 49.63 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.08 -8.91 59.16 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 119.816 2.686 . . . . 0.0 119.816 -174.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.3 t -89.13 137.02 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-N 120.201 2.001 . . . . 0.0 110.193 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.1 p -76.11 97.85 4.2 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.48 -0.762 . . . . 0.0 111.19 176.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -118.41 164.56 15.06 Favored 'General case' 0 CA--C 1.569 1.689 0 C-N-CA 123.968 0.907 . . . . 0.0 111.879 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -86.31 98.56 11.03 Favored 'General case' 0 CA--C 1.568 1.65 0 O-C-N 121.363 -0.836 . . . . 0.0 111.171 173.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -82.69 114.14 20.85 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 124.074 0.95 . . . . 0.0 110.824 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -96.48 100.09 11.7 Favored 'General case' 0 CA--C 1.566 1.588 0 O-C-N 121.762 -0.586 . . . . 0.0 109.792 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.81 150.08 42.5 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -37.03 -48.9 0.81 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 119.966 3.321 . . . . 0.0 119.966 -176.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -66.26 -23.19 66.36 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 170.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.68 17.99 1.03 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 119.363 2.505 . . . . 0.0 119.363 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.8 m -109.25 126.51 53.4 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 120.477 2.138 . . . . 0.0 112.015 -162.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -96.77 106.86 19.23 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-O 121.486 0.66 . . . . 0.0 111.717 -167.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.3 mt -104.82 116.61 32.3 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.223 1.009 . . . . 0.0 112.256 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 59.7 ttp85 -86.97 117.55 25.76 Favored 'General case' 0 CA--C 1.567 1.618 0 O-C-N 120.834 -1.166 . . . . 0.0 111.27 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 160.6 -165.64 35.12 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.2 p -106.48 138.37 42.77 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.329 -0.512 . . . . 0.0 112.062 -168.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -88.86 106.63 18.51 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 146.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.2 m -106.4 135.9 47.08 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.019 0.527 . . . . 0.0 110.872 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.5 tp -85.01 98.84 10.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.962 -1.086 . . . . 0.0 110.942 175.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.19 79.44 5.72 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.471 0.653 . . . . 0.0 109.347 175.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.2 -99.43 0.32 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -89.7 -10.46 45.66 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -102.04 140.14 36.72 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 121.155 1.798 . . . . 0.0 111.577 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.9 mt -94.84 97.25 9.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.951 -1.093 . . . . 0.0 108.795 161.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.0 tt -90.1 117.38 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 122.15 0.976 . . . . 0.0 110.551 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.71 93.51 1.89 Allowed Glycine 0 N--CA 1.477 1.38 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.425 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -90.2 87.86 7.01 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -117.19 145.96 43.53 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.81 0.814 . . . . 0.0 112.139 -170.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -124.67 131.02 53.49 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.552 0.741 . . . . 0.0 109.001 172.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -76.28 122.78 24.9 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 121.093 -1.005 . . . . 0.0 113.109 -172.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 73.0 p -55.34 -52.4 63.6 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -89.64 65.35 6.87 Favored 'General case' 0 CA--C 1.572 1.797 0 CA-C-N 118.879 0.763 . . . . 0.0 111.824 167.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.54 -47.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 164.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.25 -20.97 47.9 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 118.064 1.986 . . . . 0.0 118.064 -157.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -77.98 147.84 34.71 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.57 1.148 . . . . 0.0 114.007 -172.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.22 133.29 35.42 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.9 tt -117.06 100.09 7.5 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -90.64 110.21 21.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.457 -0.777 . . . . 0.0 109.709 -173.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.3 m -109.97 98.13 7.5 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 119.657 1.117 . . . . 0.0 110.926 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.2 t -93.7 94.92 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.564 -1.335 . . . . 0.0 109.073 -174.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -83.18 127.82 33.95 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.738 0.699 . . . . 0.0 112.242 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -142.43 140.83 32.09 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.326 0.584 . . . . 0.0 112.422 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.4 mm -87.12 119.58 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.426 -0.796 . . . . 0.0 109.12 171.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.9 mt -113.4 88.81 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.84 -107.92 2.2 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 115.728 1.051 . . . . 0.0 115.728 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -90.45 13.78 14.75 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 172.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -138.97 127.62 23.26 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 120.01 1.277 . . . . 0.0 111.192 -172.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.4 tp -78.95 105.87 10.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.453 -0.78 . . . . 0.0 109.159 162.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.5 t -96.08 110.08 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 174.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -113.51 123.28 49.63 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.5 m -96.78 111.4 23.59 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 122.75 0.42 . . . . 0.0 110.001 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -83.7 123.15 29.53 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.987 0.515 . . . . 0.0 110.596 167.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.1 t -117.42 106.14 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 168.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -109.19 101.98 10.96 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.063 0.545 . . . . 0.0 109.639 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 52.24 53.51 12.3 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.15 -31.46 3.44 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 118.722 2.249 . . . . 0.0 118.722 -167.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 98.0 t -78.13 109.54 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 119.869 1.834 . . . . 0.0 110.307 -169.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.48 132.05 39.55 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 123.491 0.716 . . . . 0.0 112.535 -170.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -138.62 112.48 8.43 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.689 0.796 . . . . 0.0 111.427 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -95.19 110.34 22.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.607 -0.683 . . . . 0.0 110.375 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.8 mmm-85 -91.05 116.96 29.21 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.7 mt -104.87 106.4 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -101.53 121.52 42.13 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.908 0.883 . . . . 0.0 110.01 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -82.7 153.32 25.4 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 121.157 -0.964 . . . . 0.0 113.286 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -59.33 105.68 0.37 Allowed 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 178.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.6 t0 . . . . . 0 N--CA 1.489 1.478 0 C-N-CA 125.34 1.456 . . . . 0.0 114.828 178.129 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.334 55.7 m-85 . . . . . 0 N--CA 1.498 1.969 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 38.18 54.09 1.7 Allowed 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 119.214 3.042 . . . . 0.0 119.214 161.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.4 m -175.62 170.6 2.89 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.702 1.201 . . . . 0.0 110.155 -168.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.3 m -79.36 123.42 27.47 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.043 -1.036 . . . . 0.0 110.58 164.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -121.99 118.52 29.02 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -104.68 137.06 43.06 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.417 -0.802 . . . . 0.0 111.417 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.251 4.0 p -66.13 117.96 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.868 0 O-C-N 121.074 -1.016 . . . . 0.0 113.183 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -90.91 -55.76 3.43 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 124.256 1.022 . . . . 0.0 112.715 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.7 ptm85 -144.71 174.44 10.97 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-O 122.441 1.115 . . . . 0.0 111.968 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.1 m -156.93 145.29 19.61 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 119.603 -1.935 . . . . 0.0 111.623 -176.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.16 -110.02 0.18 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.951 -174.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -82.13 60.44 4.91 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 122.063 2.21 . . . . 0.0 113.75 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -104.81 67.68 0.81 Allowed 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 122.679 1.228 . . . . 0.0 111.828 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -158.22 -48.44 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.707 1.203 . . . . 0.0 110.039 165.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -57.2 -36.97 71.5 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 164.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -48.72 -51.96 26.07 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 160.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -63.52 -39.76 95.26 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -60.83 -45.03 96.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.447 -1.408 . . . . 0.0 114.644 168.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -55.36 -37.92 68.14 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 165.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.4 mmt -66.47 -16.06 63.83 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 164.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.32 39.51 6.79 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 117.266 1.666 . . . . 0.0 117.266 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.426 HG23 ' HG2' ' A' ' 28' ' ' ARG . 17.9 m -111.96 143.35 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 118.445 1.123 . . . . 0.0 111.909 -177.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -64.31 157.97 24.67 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -174.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.29 0.1 OUTLIER -52.52 -49.65 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 -177.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.0 t -62.43 -45.43 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-N 119.683 1.128 . . . . 0.0 113.483 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -53.18 -43.75 67.37 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 166.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HG2' HG23 ' A' ' 23' ' ' VAL . 82.5 mtm-85 -62.49 -41.35 98.74 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 168.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.78 -45.25 95.11 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 168.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.0 mt -63.13 -44.45 95.58 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.72 -34.6 78.7 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 169.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.42 -55.97 27.94 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 120.159 1.345 . . . . 0.0 114.545 160.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -80.97 58.18 3.34 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 122.581 1.181 . . . . 0.0 113.165 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -86.36 -26.46 24.82 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 117.838 2.532 . . . . 0.0 117.838 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.379 19.7 p30 46.28 47.9 13.44 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 117.799 2.518 . . . . 0.0 117.799 -168.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.7 tp -73.37 124.56 25.99 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 122.113 0.958 . . . . 0.0 113.519 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -118.86 125.55 49.78 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.199 1.0 . . . . 0.0 109.032 175.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.8 mt -106.94 100.89 10.36 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.441 0.696 . . . . 0.0 109.562 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.1 m -93.25 110.14 21.66 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.466 -0.771 . . . . 0.0 108.978 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.1 mt -98.92 112.52 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -168.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.5 m -111.02 104.87 13.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -88.92 112.03 22.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.078 -1.014 . . . . 0.0 112.265 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.81 78.94 2.62 Favored 'General case' 0 CA--C 1.568 1.653 0 CA-C-O 121.641 0.734 . . . . 0.0 109.943 163.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.65 -104.15 1.02 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 115.369 0.908 . . . . 0.0 115.369 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -81.03 -27.88 35.62 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 166.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -75.34 109.66 9.05 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.397 1.453 . . . . 0.0 112.173 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -90.85 106.93 18.86 Favored 'General case' 0 CA--C 1.559 1.324 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 169.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.6 m -90.14 95.93 10.43 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.1 t -99.84 108.99 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -171.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -87.72 100.46 12.85 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.709 0.804 . . . . 0.0 109.166 -173.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -92.77 86.56 5.56 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.022 0.529 . . . . 0.0 110.346 -170.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.4 t -90.53 122.19 33.13 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.01 0.524 . . . . 0.0 111.769 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.7 p -147.92 168.82 21.27 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -167.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.77 38.38 0.03 OUTLIER 'General case' 0 CA--C 1.584 2.271 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 164.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -150.59 -57.12 0.17 Allowed 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 126.533 1.933 . . . . 0.0 108.536 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -155.25 156.85 36.32 Favored 'General case' 0 CA--C 1.566 1.558 0 C-N-CA 124.232 1.013 . . . . 0.0 111.539 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -114.61 106.96 14.86 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.459 0.704 . . . . 0.0 109.336 164.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.7 pt -126.14 128.63 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.668 -0.645 . . . . 0.0 111.217 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -82.47 99.78 9.66 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 121.656 0.741 . . . . 0.0 111.972 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -85.27 100.37 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.48 110.48 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -129.92 127.97 41.2 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.358 0.599 . . . . 0.0 111.652 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.1 mp0 -71.66 141.63 49.9 Favored 'General case' 0 CA--C 1.566 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 110.915 161.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.21 109.11 1.43 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.246 -0.909 . . . . 0.0 113.141 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.84 -0.76 48.44 Favored Glycine 0 CA--C 1.553 2.46 0 N-CA-C 119.026 2.37 . . . . 0.0 119.026 -167.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.0 p -81.24 139.17 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 120.983 2.392 . . . . 0.0 113.223 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.3 m -89.03 109.51 20.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.745 -0.597 . . . . 0.0 109.67 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -138.81 162.04 35.76 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 123.325 0.65 . . . . 0.0 112.34 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -87.57 103.6 15.71 Favored 'General case' 0 CA--C 1.568 1.659 0 O-C-N 121.234 -0.916 . . . . 0.0 111.704 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -89.75 141.23 28.81 Favored 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 123.78 0.832 . . . . 0.0 111.989 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -136.73 107.5 6.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.999 -1.063 . . . . 0.0 110.856 -169.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.7 mt -77.59 88.24 3.9 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -171.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.288 . . 63.41 -53.25 0.21 Allowed 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 119.099 3.0 . . . . 0.0 119.099 174.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -91.59 -76.63 0.44 Allowed 'General case' 0 CA--C 1.572 1.792 0 CA-C-N 119.128 0.876 . . . . 0.0 110.7 170.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.73 56.81 0.1 OUTLIER Glycine 0 N--CA 1.494 2.533 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.3 m -69.76 -36.23 75.59 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.159 2.281 . . . . 0.0 117.159 -173.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 77.32 78.57 0.08 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 124.637 1.175 . . . . 0.0 112.634 164.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.0 mt -127.96 103.44 7.25 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.057 0.543 . . . . 0.0 111.286 -161.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -76.53 120.29 21.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.921 -1.112 . . . . 0.0 112.533 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.51 -169.61 42.44 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 118.098 1.999 . . . . 0.0 118.098 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 p -125.77 135.55 52.16 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 114.136 -1.032 . . . . 0.0 111.774 -164.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -95.11 116.18 28.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.754 -0.591 . . . . 0.0 110.425 164.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.8 t -109.81 132.32 54.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.9 -0.5 . . . . 0.0 111.914 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.5 tp -86.73 106.11 17.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.055 -1.028 . . . . 0.0 112.374 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -84.99 168.84 14.57 Favored 'General case' 0 CA--C 1.577 1.999 0 C-N-CA 123.518 0.727 . . . . 0.0 110.683 157.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -33.32 -63.29 0.35 Allowed Glycine 0 N--CA 1.502 3.052 0 N-CA-C 121.239 3.256 . . . . 0.0 121.239 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -108.16 17.63 22.06 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 165.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -139.37 124.19 18.6 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 121.066 1.757 . . . . 0.0 112.308 -161.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.8 mt -89.29 106.77 18.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.938 -1.101 . . . . 0.0 108.787 162.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.2 113.38 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.794 0.807 . . . . 0.0 109.998 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.99 93.02 1.33 Allowed Glycine 0 N--CA 1.479 1.534 0 C-N-CA 123.844 0.735 . . . . 0.0 112.833 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -89.33 104.29 16.85 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.511 0.672 . . . . 0.0 110.329 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -124.6 149.64 46.84 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.072 0.949 . . . . 0.0 111.972 -168.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -125.02 139.75 53.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.356 -0.84 . . . . 0.0 110.751 169.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -66.69 119.85 12.48 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.0 p -82.86 72.16 9.95 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 122.542 1.163 . . . . 0.0 109.901 167.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 175.91 -64.09 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 126.114 1.766 . . . . 0.0 107.37 -167.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -93.6 -33.31 13.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.68 -35.06 4.2 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 116.865 1.506 . . . . 0.0 116.865 -154.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -53.53 147.61 10.71 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 117.367 2.358 . . . . 0.0 117.367 -173.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -86.21 129.71 34.76 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -175.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.6 tt -113.75 124.11 51.47 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.203 1.001 . . . . 0.0 108.991 169.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -113.7 111.98 22.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.43 -0.793 . . . . 0.0 109.21 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 m -102.5 112.88 25.81 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.767 0.712 . . . . 0.0 110.315 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.4 t -97.88 88.47 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.289 -0.882 . . . . 0.0 108.694 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -79.12 106.43 11.15 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.545 0.738 . . . . 0.0 110.985 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -137.6 140.63 41.07 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -171.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.1 mp -86.65 113.76 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -96.16 91.31 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.2 -89.77 0.7 Allowed Glycine 0 N--CA 1.491 2.345 0 O-C-N 121.016 -1.052 . . . . 0.0 114.745 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -134.4 42.39 2.86 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 166.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -136.66 125.95 24.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.892 -1.13 . . . . 0.0 109.058 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.5 tp -84.23 105.6 15.21 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.88 123.1 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . 0.274 17.9 pt20 -116.85 104.04 10.91 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.373 0.606 . . . . 0.0 112.379 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.0 m -87.13 109.75 19.65 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.727 0.811 . . . . 0.0 109.974 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -87.43 113.59 23.27 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.158 0.583 . . . . 0.0 110.701 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -101.58 98.54 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -115.54 104.14 11.43 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 118.832 0.742 . . . . 0.0 110.106 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 54.64 55.02 8.42 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 174.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.15 -23.46 6.08 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 119.066 2.386 . . . . 0.0 119.066 -167.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.3 t -90.03 111.06 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 120.062 1.931 . . . . 0.0 108.929 -172.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.93 114.65 27.24 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.389 0.675 . . . . 0.0 111.405 174.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -121.12 108.35 13.7 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.319 0.647 . . . . 0.0 111.294 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.24 126.79 40.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 111.787 -176.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.7 mmm-85 -103.66 127.93 51.05 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 167.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.81 120.91 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -175.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -114.26 133.07 55.9 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.857 0.863 . . . . 0.0 111.374 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -95.5 153.69 17.58 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-O 122.155 0.979 . . . . 0.0 112.051 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -65.45 109.18 2.22 Favored 'General case' 0 CA--C 1.571 1.759 0 C-N-CA 124.097 0.959 . . . . 0.0 113.025 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 t70 . . . . . 0 N--CA 1.489 1.5 0 C-N-CA 125.188 1.395 . . . . 0.0 113.96 -178.949 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 . . . . . 0 CA--C 1.568 1.644 0 CA-C-O 119.277 -0.392 . . . . 0.0 111.581 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.9 t70 48.37 64.09 1.81 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.0 m -167.41 156.65 10.19 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 122.619 1.199 . . . . 0.0 114.147 -163.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.6 m -94.25 127.83 40.34 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.834 0.853 . . . . 0.0 110.963 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -128.03 104.87 8.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.656 -0.652 . . . . 0.0 109.875 -172.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -98.25 138.02 36.14 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.184 -0.948 . . . . 0.0 112.468 -177.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.9 p -62.92 120.97 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -99.65 -57.37 2.16 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 124.188 0.995 . . . . 0.0 112.112 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -152.84 124.43 7.76 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 119.859 1.209 . . . . 0.0 112.367 -176.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.7 p -97.02 103.45 15.38 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.585 0.754 . . . . 0.0 112.663 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -100.51 116.01 31.46 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.915 0.486 . . . . 0.0 110.323 -164.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.278 39.0 t30 65.73 20.29 11.49 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 -169.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -72.08 -36.37 69.49 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -57.33 -32.24 66.5 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.886 2.18 . . . . 0.0 116.886 169.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -71.98 -47.05 54.9 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -50.6 -52.9 34.94 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 163.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.2 mmt -47.65 -57.35 5.6 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 166.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -43.83 -52.13 6.93 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 168.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -56.7 -35.72 68.82 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 171.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 27.5 mtm -73.41 -19.81 60.89 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.37 63.59 0.98 Allowed Glycine 0 N--CA 1.491 2.321 0 CA-C-N 120.367 1.44 . . . . 0.0 114.659 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.7 m -126.91 156.08 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 121.675 0.75 . . . . 0.0 112.437 -169.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -70.28 153.2 43.32 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.857 -1.152 . . . . 0.0 113.733 168.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 11.9 tt -59.21 -38.41 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 172.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.3 t -58.7 -48.16 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 C-N-CA 123.798 0.839 . . . . 0.0 113.253 166.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -55.94 -38.86 70.88 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 167.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -57.58 -52.04 67.02 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 120.587 1.54 . . . . 0.0 115.084 168.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -60.16 -46.46 89.62 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.81 -45.94 90.29 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 171.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.09 92.67 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.84 -57.12 11.28 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 161.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -93.95 52.76 1.69 Allowed 'General case' 0 CA--C 1.575 1.938 0 CA-C-N 119.635 1.107 . . . . 0.0 113.432 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -85.44 -13.35 49.53 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 -173.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 57.93 45.46 18.21 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -174.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.8 tp -82.93 120.57 25.86 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-O 122.06 0.933 . . . . 0.0 112.39 -172.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -104.75 112.05 25.01 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.456 169.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.9 mt -90.17 100.98 13.71 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 m -93.47 92.39 7.59 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.5 mt -94.76 95.84 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -168.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 86.0 m -99.01 126.52 44.73 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.287 0.635 . . . . 0.0 109.769 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -83.18 126.08 32.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.909 . . . . 0.0 112.014 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -131.01 58.58 1.71 Allowed 'General case' 0 CA--C 1.574 1.866 0 C-N-CA 123.669 0.788 . . . . 0.0 111.869 -167.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.23 72.19 0.74 Allowed Glycine 0 N--CA 1.497 2.732 0 N-CA-C 116.591 1.397 . . . . 0.0 116.591 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.294 18.4 t30 68.63 -24.45 0.14 Allowed 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 -164.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -83.79 155.93 22.77 Favored 'General case' 0 CA--C 1.561 1.391 0 O-C-N 120.656 -1.277 . . . . 0.0 113.604 169.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -119.58 121.59 39.69 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 164.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.9 m -93.8 102.8 14.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.36 103.71 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -172.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -81.14 110.4 16.61 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -97.92 83.97 3.24 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.358 0.663 . . . . 0.0 109.733 -175.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.7 t -94.94 115.16 27.1 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.601 0.36 . . . . 0.0 111.936 -170.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.5 p -150.67 168.0 25.66 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.836 0.854 . . . . 0.0 113.134 -166.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.1 -30.03 65.95 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 118.027 2.602 . . . . 0.0 118.027 166.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -73.6 -43.96 58.36 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 167.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.55 154.65 12.07 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.82 0.848 . . . . 0.0 112.428 -165.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -119.66 108.2 14.16 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 161.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.0 pt -129.73 128.37 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.558 -0.714 . . . . 0.0 111.073 -174.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.32 99.62 12.38 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.841 0.857 . . . . 0.0 111.387 173.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.3 t -92.09 102.45 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -176.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.15 93.22 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -106.5 143.49 34.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.716 -0.615 . . . . 0.0 111.78 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -87.73 146.19 25.78 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 121.658 -0.651 . . . . 0.0 112.0 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.6 mt -70.26 109.75 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.095 -1.003 . . . . 0.0 111.839 169.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.42 52.73 2.44 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 116.394 1.318 . . . . 0.0 116.394 -171.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.5 p -143.63 138.48 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 118.327 1.064 . . . . 0.0 109.971 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.3 m -83.74 108.08 16.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.342 -0.849 . . . . 0.0 109.8 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -131.95 165.95 22.77 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-O 121.682 0.753 . . . . 0.0 112.331 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -90.1 108.77 19.94 Favored 'General case' 0 CA--C 1.571 1.779 0 O-C-N 121.619 -0.675 . . . . 0.0 111.506 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -100.5 117.68 35.15 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.742 0.817 . . . . 0.0 110.444 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -98.54 123.66 42.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.119 -0.988 . . . . 0.0 112.919 -175.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.07 158.61 25.0 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.4 69.96 2.93 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 170.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -171.8 -70.36 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 125.292 1.437 . . . . 0.0 108.273 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.45 68.24 0.01 OUTLIER Glycine 0 N--CA 1.483 1.796 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -171.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.3 m -162.14 127.74 3.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.584 -0.951 . . . . 0.0 109.846 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -97.95 126.08 43.18 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.901 0.88 . . . . 0.0 110.439 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.73 111.5 22.51 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.753 -0.592 . . . . 0.0 110.607 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -84.47 123.39 30.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.157 -0.965 . . . . 0.0 111.527 171.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.53 -168.26 39.39 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 117.659 1.824 . . . . 0.0 117.659 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 71.3 p -124.27 123.6 40.58 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.544 -0.828 . . . . 0.0 111.62 -163.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -83.98 114.67 21.87 Favored 'General case' 0 CA--C 1.57 1.735 0 O-C-N 121.992 -0.442 . . . . 0.0 111.433 163.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.7 m -114.36 126.54 55.11 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 123.396 0.679 . . . . 0.0 111.071 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.2 tp -94.12 115.56 27.87 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.176 -0.953 . . . . 0.0 112.103 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -100.3 80.94 2.31 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 170.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.88 -87.23 0.55 Allowed Glycine 0 N--CA 1.494 2.515 0 O-C-N 121.052 -1.03 . . . . 0.0 115.083 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -123.39 29.4 6.67 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 166.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -125.06 109.68 13.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.461 -1.399 . . . . 0.0 108.972 177.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.81 106.4 18.44 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.354 0.661 . . . . 0.0 109.524 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.8 tt -96.93 118.67 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.866 -1.146 . . . . 0.0 110.644 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.72 98.06 2.35 Favored Glycine 0 N--CA 1.48 1.605 0 C-N-CA 123.249 0.452 . . . . 0.0 112.098 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -85.4 93.87 8.84 Favored 'General case' 0 CA--C 1.565 1.552 0 C-N-CA 123.251 0.621 . . . . 0.0 109.354 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -121.79 143.63 49.28 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.298 1.047 . . . . 0.0 113.442 -166.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -119.34 137.8 53.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.391 -0.818 . . . . 0.0 109.146 165.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -69.78 107.34 3.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 0.0 111.664 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.312 13.8 t -74.81 -5.88 45.92 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 118.139 2.644 . . . . 0.0 118.139 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -95.0 -18.1 21.36 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 158.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -123.79 -21.64 5.12 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 117.29 2.329 . . . . 0.0 117.29 -173.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.24 -30.92 7.12 Favored Glycine 0 N--CA 1.496 2.684 0 CA-C-N 121.885 2.129 . . . . 0.0 118.351 -175.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -78.76 151.56 31.96 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 118.45 1.125 . . . . 0.0 113.585 -167.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -98.63 132.62 43.89 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.599 0.714 . . . . 0.0 112.004 -164.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.3 tt -131.11 122.55 26.86 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 124.1 0.96 . . . . 0.0 109.908 -170.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -109.85 116.84 32.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.126 -0.984 . . . . 0.0 109.352 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.7 m -106.52 104.06 13.67 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 119.019 0.827 . . . . 0.0 110.008 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.5 t -92.36 107.8 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.25 -0.906 . . . . 0.0 108.675 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -85.3 103.76 14.53 Favored 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 124.074 0.95 . . . . 0.0 110.433 170.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -127.46 147.35 50.3 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 124.254 1.022 . . . . 0.0 109.534 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . 0.25 5.8 mt -113.72 117.47 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 119.771 -1.83 . . . . 0.0 111.175 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.2 tp -92.35 74.71 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.769 0 CA-C-O 122.124 0.964 . . . . 0.0 110.741 172.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.94 -98.48 0.71 Allowed Glycine 0 N--CA 1.49 2.281 0 O-C-N 121.067 -1.021 . . . . 0.0 115.193 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -80.7 -10.62 59.72 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.892 2.553 . . . . 0.0 117.892 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -128.28 127.64 43.15 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-N 119.736 1.153 . . . . 0.0 112.457 -165.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.9 tp -80.94 124.11 28.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.858 0.863 . . . . 0.0 111.147 170.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.2 m -103.17 116.54 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -91.13 103.49 16.18 Favored 'General case' 0 CA--C 1.558 1.281 0 O-C-N 121.277 -0.889 . . . . 0.0 109.093 167.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.4 m -90.66 104.57 17.14 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -92.16 106.92 18.83 Favored 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 123.76 0.824 . . . . 0.0 110.621 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.89 111.39 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.403 ' O ' HG12 ' A' ' 122' ' ' VAL . 91.7 t80 -142.04 110.82 6.19 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.988 0.515 . . . . 0.0 110.463 -175.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 54.31 50.52 16.14 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 168.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.69 38.01 44.1 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 118.507 2.163 . . . . 0.0 118.507 -170.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 119' ' ' TYR . 0.5 OUTLIER -146.55 148.15 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 118.812 1.306 . . . . 0.0 110.216 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -130.06 115.82 17.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.729 -0.607 . . . . 0.0 109.981 171.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.22 127.3 54.64 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.009 0.524 . . . . 0.0 112.276 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -108.71 105.09 14.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.595 -0.691 . . . . 0.0 110.099 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -87.85 115.13 25.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.346 -0.847 . . . . 0.0 110.494 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 22.7 mt -99.53 123.16 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -120.99 119.54 32.83 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 124.291 1.036 . . . . 0.0 109.604 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -80.36 142.85 34.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.913 -1.117 . . . . 0.0 113.073 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 52.6 tttt -69.34 113.67 6.87 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.7 t70 . . . . . 0 N--CA 1.49 1.552 0 C-N-CA 124.761 1.224 . . . . 0.0 113.734 172.675 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 N--CA 1.5 2.067 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -148.99 81.29 1.43 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.659 -0.651 . . . . 0.0 110.431 -176.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.3 m -171.95 170.26 5.45 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.577 1.179 . . . . 0.0 111.763 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.2 m -90.39 130.73 36.44 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.912 -1.117 . . . . 0.0 110.712 170.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -135.39 113.56 11.33 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.576 -0.703 . . . . 0.0 109.762 -171.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -116.13 143.38 45.56 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.651 -1.281 . . . . 0.0 113.649 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.88 115.86 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -168.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.08 -48.75 7.19 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 124.388 1.075 . . . . 0.0 112.86 169.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -136.61 109.73 7.75 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 119.377 0.99 . . . . 0.0 110.225 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.0 p -91.98 101.06 13.61 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.018 -1.051 . . . . 0.0 111.013 167.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -106.96 113.11 26.39 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -165.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.294 13.1 t30 69.67 16.65 7.94 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 117.53 2.419 . . . . 0.0 117.53 -176.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -66.73 -37.92 85.62 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.44 -43.17 83.68 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 167.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -69.29 -43.15 74.44 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 171.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -48.62 -54.34 15.0 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 162.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 mtt -66.7 -24.7 66.29 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 170.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.65 -42.92 81.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.295 -1.503 . . . . 0.0 114.216 164.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -57.47 -33.15 67.69 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 163.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 mmt -64.05 -42.58 96.99 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 164.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.87 56.35 0.96 Allowed Glycine 0 N--CA 1.485 1.951 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -117.44 147.86 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-N 117.983 0.892 . . . . 0.0 112.512 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -56.45 139.72 48.16 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.297 0.0 OUTLIER -47.35 -45.54 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 178.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.4 t -55.07 -60.02 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 C-N-CA 124.288 1.035 . . . . 0.0 113.643 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -63.19 -38.73 92.31 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -58.03 -49.67 76.09 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 170.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -59.18 -47.77 84.08 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 167.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.4 mt -59.0 -41.5 87.8 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 171.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.86 -41.46 87.27 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.84 -52.79 64.02 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 161.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -91.4 35.72 0.94 Allowed 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -77.89 -22.68 49.36 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 66.61 60.6 0.57 Allowed 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 120.472 1.487 . . . . 0.0 113.056 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.4 tp -86.7 120.87 28.46 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 121.415 -0.803 . . . . 0.0 112.979 -171.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -98.4 121.2 40.03 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 124.53 1.132 . . . . 0.0 110.355 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.4 mt -101.76 101.64 12.15 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 123.709 0.804 . . . . 0.0 109.253 174.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.4 m -88.84 95.03 10.13 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.155 -0.966 . . . . 0.0 108.775 172.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 73.6 mt -93.06 118.7 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -173.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -137.01 146.78 45.71 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 123.33 0.652 . . . . 0.0 110.725 171.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -130.53 157.92 41.37 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -127.55 84.23 2.23 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-N 114.482 -1.235 . . . . 0.0 108.706 167.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.73 -82.2 0.84 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 116.206 1.243 . . . . 0.0 116.206 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -116.07 -16.33 11.05 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 168.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -85.79 131.19 34.37 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 121.245 1.839 . . . . 0.0 111.833 173.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -113.61 131.16 56.22 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 124.363 1.065 . . . . 0.0 110.023 177.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 m -103.71 111.87 24.55 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 163.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.7 t -108.99 102.87 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -84.98 109.82 18.45 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -108.16 103.95 13.25 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.896 0.478 . . . . 0.0 110.043 -166.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 t -115.32 118.95 34.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.305 0.642 . . . . 0.0 111.745 -172.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.5 p -138.38 175.5 9.52 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.779 0.8 . . . . 0.0 112.965 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.74 62.26 1.05 Allowed 'General case' 0 CA--C 1.576 1.98 0 O-C-N 120.395 -1.441 . . . . 0.0 113.54 153.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -169.18 -61.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.932 1.293 . . . . 0.0 109.225 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.402 ' HG3' HH11 ' A' ' 56' ' ' ARG . 32.0 ptt85 -142.47 141.49 32.16 Favored 'General case' 0 CA--C 1.567 1.608 0 C-N-CA 124.035 0.934 . . . . 0.0 110.545 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -129.68 92.43 3.33 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.17 153.02 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 CA-C-O 121.91 0.862 . . . . 0.0 111.879 -170.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.38 108.41 18.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.932 . . . . 0.0 110.564 168.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.84 97.77 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.3 t -102.7 125.65 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -173.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -150.77 151.05 31.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.606 -0.684 . . . . 0.0 111.662 -176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -97.3 143.82 27.69 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.285 -0.885 . . . . 0.0 111.004 165.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.8 mt -57.35 122.03 11.59 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.88 -4.77 73.47 Favored Glycine 0 CA--C 1.555 2.537 0 N-CA-C 119.868 2.707 . . . . 0.0 119.868 -170.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -93.64 132.18 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-N 120.489 2.144 . . . . 0.0 109.769 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -74.94 117.98 17.39 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -134.8 161.09 36.16 Favored 'General case' 0 CA--C 1.571 1.753 0 C-N-CA 123.844 0.858 . . . . 0.0 112.013 -176.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -89.41 115.89 27.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.357 -0.84 . . . . 0.0 111.88 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -113.23 129.92 56.38 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 123.868 0.867 . . . . 0.0 111.129 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -98.49 131.32 44.83 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.996 -1.065 . . . . 0.0 110.895 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.6 mt -62.89 -56.1 20.23 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 170.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -154.95 -65.15 0.13 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 119.116 0.871 . . . . 0.0 111.948 177.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -84.16 -76.08 0.31 Allowed 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.396 0.679 . . . . 0.0 111.96 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.66 58.23 0.4 Allowed Glycine 0 N--CA 1.488 2.151 0 CA-C-N 118.795 0.725 . . . . 0.0 114.51 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 m -105.94 90.95 3.53 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -82.59 117.67 22.73 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.936 0.874 . . . . 0.0 112.44 -168.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.8 mt -115.58 108.66 16.71 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.671 0.789 . . . . 0.0 109.393 -171.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -98.1 96.72 8.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.758 -0.589 . . . . 0.0 110.669 -170.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.29 -153.46 10.97 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 116.338 1.295 . . . . 0.0 116.338 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.7 p -129.68 128.8 43.29 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -152.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -91.22 119.51 31.36 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.057 -1.027 . . . . 0.0 109.393 158.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.3 m -122.02 136.04 54.89 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.267 0.556 . . . . 0.0 111.308 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.8 tp -86.12 109.11 18.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.961 -1.087 . . . . 0.0 111.138 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.23 15.08 2.55 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 171.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.09 -80.53 0.27 Allowed Glycine 0 N--CA 1.488 2.148 0 O-C-N 120.827 -1.171 . . . . 0.0 112.087 -170.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -83.89 -28.8 27.67 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -125.45 140.06 53.1 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.781 1.173 . . . . 0.0 111.556 -165.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.5 mt -89.24 104.54 17.08 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 167.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.1 pt -93.97 116.41 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.997 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.82 99.95 2.61 Favored Glycine 0 N--CA 1.482 1.703 0 C-N-CA 123.591 0.615 . . . . 0.0 112.944 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -97.05 98.44 10.06 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -128.61 167.39 17.23 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-O 123.338 1.542 . . . . 0.0 111.657 -170.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.0 154.64 36.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.706 -1.246 . . . . 0.0 110.256 165.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -70.66 109.99 5.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 112.195 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.8 t -66.4 -17.87 65.03 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -84.96 -22.21 29.26 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 165.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -120.12 -22.49 6.63 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.98 -39.4 2.78 Favored Glycine 0 N--CA 1.492 2.37 0 CA-C-N 121.37 1.895 . . . . 0.0 117.258 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -72.05 144.86 48.6 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -165.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.66 140.39 55.46 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -173.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.1 tt -126.16 127.24 45.41 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.549 0.69 . . . . 0.0 111.323 167.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -96.67 149.08 22.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.506 -0.746 . . . . 0.0 110.604 163.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.4 m -145.32 105.54 4.06 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 119.928 -1.732 . . . . 0.0 109.589 162.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.7 t -93.11 114.26 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.094 -1.004 . . . . 0.0 109.03 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.4 mtm-85 -89.05 121.57 31.53 Favored 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 123.787 0.835 . . . . 0.0 111.265 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -143.61 141.48 30.64 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 123.671 0.788 . . . . 0.0 110.424 -177.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.29 126.57 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 120.733 -1.23 . . . . 0.0 109.759 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.1 tp -116.52 91.68 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.754 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 164.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.04 -112.32 4.15 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 120.898 -1.126 . . . . 0.0 114.611 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -99.62 20.31 14.22 Favored 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 167.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -126.14 127.16 45.32 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.788 1.176 . . . . 0.0 111.056 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.5 tp -87.62 114.78 24.54 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.241 1.016 . . . . 0.0 109.982 171.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.4 m -91.35 119.43 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.585 -0.697 . . . . 0.0 109.876 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -99.71 103.68 15.36 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 166.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.5 m -89.81 94.96 10.03 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -81.08 131.45 35.3 Favored 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 123.944 0.898 . . . . 0.0 111.249 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.1 t -134.98 114.37 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 CA-C-N 119.147 0.885 . . . . 0.0 109.274 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -113.94 122.12 45.99 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.31 5.2 mm-40 70.69 -85.47 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 124.23 1.012 . . . . 0.0 112.0 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -151.22 50.49 0.53 Allowed Glycine 0 N--CA 1.487 2.1 0 CA-C-O 119.416 -0.658 . . . . 0.0 114.109 158.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.35 109.08 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -77.81 129.61 35.65 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -124.08 114.3 19.53 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.532 0.682 . . . . 0.0 110.622 163.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -99.7 104.39 16.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.861 -0.525 . . . . 0.0 109.683 -176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 -93.3 112.7 24.7 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.531 0.682 . . . . 0.0 109.612 172.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.8 mt -99.1 114.74 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.555 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -173.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -108.44 111.33 23.17 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.685 0.794 . . . . 0.0 109.891 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -79.97 144.79 32.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.003 -1.061 . . . . 0.0 112.467 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -66.1 120.34 13.02 Favored 'General case' 0 CA--C 1.569 1.692 0 CA-C-O 121.684 0.754 . . . . 0.0 112.961 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.8 t70 . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -158.895 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 . . . . . 0 N--CA 1.502 2.156 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -146.71 51.82 1.11 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.379 -1.45 . . . . 0.0 113.78 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 p -160.87 176.75 11.1 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.127 -0.983 . . . . 0.0 113.593 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.4 m -78.4 116.58 18.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.72 . . . . 0.0 110.264 160.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -109.73 111.34 22.73 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -95.04 138.65 32.48 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.429 -0.794 . . . . 0.0 111.75 -177.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.02 122.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -110.29 -55.62 2.44 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.581 0.752 . . . . 0.0 112.742 -174.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -158.56 119.8 3.43 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 120.042 1.292 . . . . 0.0 111.064 -171.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.0 p -110.29 124.72 52.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.031 -1.043 . . . . 0.0 113.099 -174.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -78.43 -48.4 15.5 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -170.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -134.83 54.75 1.93 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 119.97 1.259 . . . . 0.0 112.599 168.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -84.45 58.77 5.04 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.018 -1.676 . . . . 0.0 112.419 167.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -151.61 -61.19 0.17 Allowed 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 125.101 1.36 . . . . 0.0 109.43 -176.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -62.02 -48.95 77.97 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 120.846 1.657 . . . . 0.0 114.096 170.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -47.65 -52.8 16.83 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 163.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.8 mtp -55.17 -49.14 72.62 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 171.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -52.84 -46.38 67.78 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 165.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -60.13 -36.22 77.0 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 170.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.7 mtm -72.34 -59.14 2.88 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 119.607 1.094 . . . . 0.0 113.114 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.89 72.14 0.02 OUTLIER Glycine 0 N--CA 1.487 2.047 0 CA-C-N 118.268 0.486 . . . . 0.0 113.779 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 m -118.36 155.44 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-O 122.025 0.917 . . . . 0.0 112.605 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -79.2 153.29 30.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.353 -0.842 . . . . 0.0 110.921 152.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.29 12.9 tt -56.78 -37.61 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 172.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.9 t -58.75 -53.73 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 C-N-CA 124.362 1.065 . . . . 0.0 113.276 166.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -55.34 -36.16 65.98 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 168.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -57.36 -52.08 66.81 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 172.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -64.61 -44.74 89.59 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 166.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -60.98 -58.06 10.02 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.66 -15.9 63.82 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 173.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.96 -52.47 42.41 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 156.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -91.51 -18.31 24.33 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 118.216 2.673 . . . . 0.0 118.216 -172.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -73.32 62.17 0.69 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 50.12 51.58 16.41 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 163.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 tt -91.07 109.55 20.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.116 -0.99 . . . . 0.0 111.588 -170.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -97.75 138.15 35.55 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-O 121.848 0.832 . . . . 0.0 111.937 166.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.2 mt -103.91 97.41 7.41 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 164.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.2 m -88.26 103.43 15.79 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.173 -0.955 . . . . 0.0 108.907 176.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.3 mt -94.01 108.58 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -168.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 m -105.26 111.19 23.84 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -87.34 137.92 31.92 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -135.84 80.36 1.82 Allowed 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 124.123 0.969 . . . . 0.0 109.166 172.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.12 -89.58 0.5 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 116.061 1.184 . . . . 0.0 116.061 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.13 15.33 19.5 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 167.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -134.3 116.13 14.91 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 119.942 1.246 . . . . 0.0 110.259 -166.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -104.8 129.53 53.06 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.715 -0.616 . . . . 0.0 110.847 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.1 m -100.77 104.43 15.69 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 164.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.2 t -101.47 108.39 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -80.21 110.35 15.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 111.003 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -83.73 95.07 8.29 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 t -116.55 114.71 24.53 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.005 0.907 . . . . 0.0 111.31 -170.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.8 t -154.53 175.41 13.65 Favored 'General case' 0 CA--C 1.572 1.8 0 C-N-CA 125.968 1.707 . . . . 0.0 109.087 -171.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.2 -27.11 63.59 Favored 'General case' 0 CA--C 1.581 2.171 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 155.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -85.42 -32.58 22.27 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.1 mmt-85 -137.42 140.41 41.3 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.197 0.908 . . . . 0.0 110.32 -175.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -135.33 76.07 1.6 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 158.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.3 142.6 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 122.026 0.917 . . . . 0.0 111.058 -168.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.4 113.67 26.0 Favored 'General case' 0 CA--C 1.564 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 111.461 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.1 t -90.93 98.35 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.5 t -91.6 119.4 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -136.6 129.78 31.31 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.159 0.504 . . . . 0.0 112.315 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.12 135.82 33.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.801 -0.562 . . . . 0.0 110.5 164.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.43 125.24 22.94 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.75 -16.76 44.37 Favored Glycine 0 CA--C 1.556 2.601 0 N-CA-C 119.447 2.539 . . . . 0.0 119.447 -167.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.0 t -86.21 130.28 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 CA-C-N 120.561 2.18 . . . . 0.0 109.98 -177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.0 t -74.44 121.33 21.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.575 -0.703 . . . . 0.0 112.76 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -142.58 164.72 29.36 Favored 'General case' 0 CA--C 1.573 1.86 0 C-N-CA 123.333 0.653 . . . . 0.0 111.775 -172.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -87.45 116.33 25.49 Favored 'General case' 0 CA--C 1.569 1.696 0 O-C-N 121.339 -0.851 . . . . 0.0 112.909 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -98.99 143.41 29.3 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.876 0.87 . . . . 0.0 111.231 166.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -120.59 132.63 55.24 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.983 0.897 . . . . 0.0 110.682 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.8 mt -84.54 168.19 15.63 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 121.979 0.895 . . . . 0.0 112.9 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.11 -36.67 80.33 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 118.94 2.941 . . . . 0.0 118.94 -173.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.34 -76.48 0.1 Allowed 'General case' 0 CA--C 1.571 1.775 0 CA-C-N 120.113 1.324 . . . . 0.0 111.697 169.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.44 64.0 0.05 OUTLIER Glycine 0 N--CA 1.483 1.806 0 O-C-N 121.841 -0.537 . . . . 0.0 112.543 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.8 m -123.04 107.17 11.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -95.26 128.91 42.47 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-O 122.07 0.938 . . . . 0.0 111.419 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.3 mt -132.69 116.24 16.37 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.076 -156.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -92.47 118.68 31.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.475 -0.765 . . . . 0.0 110.667 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.76 -177.92 42.45 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 117.981 1.953 . . . . 0.0 117.981 -173.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.6 p -126.28 132.13 51.73 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 113.972 -1.114 . . . . 0.0 110.37 -173.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -92.59 122.66 35.23 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.335 -0.853 . . . . 0.0 110.541 169.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.3 m -109.66 118.81 37.53 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.318 0.647 . . . . 0.0 110.831 175.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.5 tp -82.83 103.93 12.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.515 -0.74 . . . . 0.0 111.85 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -105.25 89.78 3.23 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.191 0.52 . . . . 0.0 110.26 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.69 -94.49 0.76 Allowed Glycine 0 N--CA 1.492 2.389 0 O-C-N 121.501 -0.75 . . . . 0.0 113.782 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -127.36 48.4 2.23 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 159.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -129.8 111.87 13.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.089 -1.007 . . . . 0.0 108.49 173.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.4 mt -84.55 108.37 17.28 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.439 -0.788 . . . . 0.0 109.452 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.0 mt -102.22 104.22 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -172.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.51 100.71 2.67 Favored Glycine 0 N--CA 1.483 1.812 0 C-N-CA 123.886 0.755 . . . . 0.0 113.096 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.52 95.92 9.91 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.973 0.509 . . . . 0.0 109.729 -175.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -110.76 147.75 33.78 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.589 0.709 . . . . 0.0 112.868 -171.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -119.04 139.43 51.74 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.644 0.778 . . . . 0.0 109.131 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -69.17 114.9 7.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.928 -1.107 . . . . 0.0 112.885 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 t -66.09 -16.77 64.22 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 117.916 2.562 . . . . 0.0 117.916 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -92.56 -10.65 36.84 Favored 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 165.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -141.15 -16.9 0.83 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 -169.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.94 -42.5 2.76 Favored Glycine 0 N--CA 1.493 2.458 0 CA-C-N 121.949 2.159 . . . . 0.0 117.707 -175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -70.24 147.91 49.19 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -161.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -77.43 132.2 38.36 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -173.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.0 tt -123.61 111.45 16.25 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 124.352 1.061 . . . . 0.0 108.751 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -101.63 113.62 26.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.104 -0.997 . . . . 0.0 109.577 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.0 m -107.2 108.69 20.24 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 119.196 0.907 . . . . 0.0 111.027 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.2 97.86 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.006 -1.059 . . . . 0.0 108.376 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -86.89 117.91 25.93 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.088 0.955 . . . . 0.0 110.899 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -146.97 142.81 27.92 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.326 -0.859 . . . . 0.0 112.864 -178.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.2 mp -90.84 110.01 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.0 tp -90.07 80.42 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.119 0.962 . . . . 0.0 110.155 169.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.67 -88.92 0.74 Allowed Glycine 0 N--CA 1.49 2.266 0 O-C-N 121.209 -0.932 . . . . 0.0 114.933 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -117.84 22.05 12.52 Favored 'General case' 0 CA--C 1.581 2.171 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 175.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -137.99 123.6 19.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.53 -1.356 . . . . 0.0 109.858 -175.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.7 tp -78.49 110.03 13.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.524 -0.735 . . . . 0.0 110.127 168.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.89 118.12 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.277 -0.89 . . . . 0.0 108.871 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . 0.269 21.3 pt20 -103.52 104.42 14.49 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.777 0.799 . . . . 0.0 110.724 172.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.0 m -91.56 108.39 19.87 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.755 0.822 . . . . 0.0 109.152 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -94.14 112.13 23.92 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.386 0.674 . . . . 0.0 110.865 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.01 97.39 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -109.6 113.19 25.76 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.152 0.581 . . . . 0.0 109.873 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 54.78 46.14 25.2 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.04 -25.23 4.86 Favored Glycine 0 CA--C 1.556 2.65 0 N-CA-C 119.125 2.41 . . . . 0.0 119.125 -166.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.5 t -83.6 108.61 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 119.989 1.894 . . . . 0.0 110.069 -168.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -86.46 119.47 26.76 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.151 0.58 . . . . 0.0 112.479 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -124.97 117.0 23.06 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.645 0.778 . . . . 0.0 111.888 175.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -106.45 108.68 20.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.537 -0.727 . . . . 0.0 110.174 -170.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -97.43 116.01 28.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.911 -0.493 . . . . 0.0 110.482 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.7 mt -90.48 118.81 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -111.63 123.83 51.05 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.372 1.069 . . . . 0.0 109.221 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -83.92 148.35 26.99 Favored 'General case' 0 CA--C 1.565 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 112.721 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -59.24 113.42 2.13 Favored 'General case' 0 CA--C 1.57 1.735 0 C-N-CA 123.687 0.795 . . . . 0.0 113.05 167.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 N--CA 1.489 1.488 0 C-N-CA 124.949 1.3 . . . . 0.0 113.096 -175.139 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.327 62.9 m-85 . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.13 93.88 1.09 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 120.259 1.39 . . . . 0.0 112.374 -170.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.4 m -176.76 166.45 2.57 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 122.651 1.215 . . . . 0.0 111.805 -163.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.3 m -94.94 122.79 37.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.485 -0.759 . . . . 0.0 110.326 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -127.14 111.79 14.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.762 -0.586 . . . . 0.0 109.691 -170.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -105.34 133.19 50.51 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.977 -1.077 . . . . 0.0 112.011 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.58 115.79 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -98.47 -54.71 2.96 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 124.483 1.113 . . . . 0.0 111.85 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 56.1 mtm-85 -133.79 106.98 7.62 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.427 1.012 . . . . 0.0 109.458 -177.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.5 p -94.34 97.74 10.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.856 -0.527 . . . . 0.0 111.196 174.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.4 127.03 52.76 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.157 0.583 . . . . 0.0 110.06 -159.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.269 37.8 t30 62.76 40.45 9.97 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -169.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -77.99 -49.82 13.32 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -172.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.02 -40.79 77.38 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 171.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -62.76 -47.65 82.6 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.21 1.368 . . . . 0.0 114.629 171.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -53.52 -53.03 57.39 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 166.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.9 mtp -60.83 -41.89 96.65 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -60.02 -42.52 94.51 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 165.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -40.69 73.89 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 166.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 56.6 mtm -61.84 -54.77 37.6 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-N 119.552 1.069 . . . . 0.0 112.763 166.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.99 54.83 0.08 OUTLIER Glycine 0 N--CA 1.487 2.041 0 CA-C-O 119.122 -0.821 . . . . 0.0 113.909 164.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.4 m -126.77 151.18 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 122.651 1.215 . . . . 0.0 112.911 -169.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -72.77 164.48 26.49 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.259 14.0 tt -55.43 -36.86 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 175.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.9 t -65.18 -51.57 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-N 120.09 1.314 . . . . 0.0 112.658 173.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -52.16 -47.08 65.66 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 166.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -57.87 -48.51 79.63 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -60.91 -46.25 91.42 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 171.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.5 mt -60.59 -48.16 83.02 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 171.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.24 -21.14 62.16 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.11 -49.36 15.44 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 120.962 1.71 . . . . 0.0 114.415 167.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -77.91 17.62 0.56 Allowed 'General case' 0 CA--C 1.58 2.124 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 175.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.2 p30 -74.94 -17.91 60.48 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 118.93 2.937 . . . . 0.0 118.93 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 61.53 62.19 1.36 Allowed 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 120.562 1.528 . . . . 0.0 113.484 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 tt -88.56 117.52 27.57 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.418 -0.801 . . . . 0.0 112.257 -164.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -101.21 127.83 47.6 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.54 0.736 . . . . 0.0 110.173 173.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.4 mt -98.48 102.4 14.13 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 166.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.5 m -94.62 107.56 19.55 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.098 -1.002 . . . . 0.0 108.441 171.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.7 mt -104.07 129.01 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -165.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 89.3 m -135.53 123.54 22.8 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.271 -0.893 . . . . 0.0 109.326 174.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.7 tm0? -98.74 132.94 43.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.321 -0.862 . . . . 0.0 112.186 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -127.69 87.6 2.65 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 123.565 0.746 . . . . 0.0 110.947 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.78 -89.5 0.96 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 115.139 0.816 . . . . 0.0 115.139 173.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -108.65 -2.5 18.68 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 166.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -108.99 144.13 37.37 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.34 1.427 . . . . 0.0 112.415 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -110.19 120.42 42.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.4 0.68 . . . . 0.0 109.986 167.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.1 m -86.41 102.72 14.3 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 164.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.3 t -104.6 101.52 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -83.8 107.44 16.21 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.262 -0.899 . . . . 0.0 110.017 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -86.6 92.9 9.05 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.005 0.522 . . . . 0.0 110.066 176.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.3 m -96.24 108.72 21.24 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 120.941 0.4 . . . . 0.0 109.991 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.3 p -143.51 158.02 43.98 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.468 0.651 . . . . 0.0 111.776 -174.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.61 -25.0 64.27 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.429 2.381 . . . . 0.0 117.429 165.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -53.96 15.66 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 165.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.79 152.52 25.19 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-N 119.148 0.886 . . . . 0.0 111.676 174.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -106.08 98.14 7.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.689 -0.632 . . . . 0.0 109.837 166.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.2 pt -122.93 132.85 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 121.989 0.9 . . . . 0.0 111.765 -174.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -94.85 98.46 10.75 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.693 0.797 . . . . 0.0 108.917 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.45 93.3 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -166.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.6 t -94.21 98.42 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -176.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -109.88 141.49 42.52 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.285 0.564 . . . . 0.0 112.116 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.38 138.75 31.16 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.465 0.65 . . . . 0.0 111.292 166.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.66 129.03 39.08 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.95 -7.12 63.95 Favored Glycine 0 CA--C 1.555 2.569 0 N-CA-C 119.969 2.748 . . . . 0.0 119.969 -170.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.9 t -97.78 133.74 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 120.634 2.217 . . . . 0.0 110.414 -170.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.7 p -74.57 104.35 5.23 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.439 0.696 . . . . 0.0 112.626 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -118.07 138.74 52.03 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 123.292 0.637 . . . . 0.0 111.928 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 -74.77 115.37 14.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.581 -0.7 . . . . 0.0 112.244 172.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -111.56 152.02 28.04 Favored 'General case' 0 CA--C 1.569 1.689 0 C-N-CA 124.093 0.957 . . . . 0.0 112.591 -175.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -119.81 136.39 54.48 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.086 0.954 . . . . 0.0 111.633 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.2 mt -105.99 64.12 0.68 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.292 -0.88 . . . . 0.0 113.097 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.32 . . 66.47 -66.76 0.17 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.29 -22.33 41.02 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 119.926 3.306 . . . . 0.0 119.926 176.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.49 21.94 8.93 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 118.229 2.052 . . . . 0.0 118.229 -170.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 83.8 m -82.32 108.01 15.43 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 119.763 1.782 . . . . 0.0 109.334 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -78.33 128.57 33.86 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.267 0.627 . . . . 0.0 112.342 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.0 mt -140.37 105.1 4.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.993 -0.442 . . . . 0.0 110.759 -166.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -81.76 123.79 29.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.654 -1.279 . . . . 0.0 110.896 171.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.22 176.84 40.12 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 118.649 2.22 . . . . 0.0 118.649 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.5 p -126.03 130.2 50.69 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 113.674 -1.263 . . . . 0.0 110.866 -169.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -97.72 123.48 41.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.677 -0.639 . . . . 0.0 111.744 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.2 m -106.07 120.19 41.15 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.408 0.683 . . . . 0.0 110.67 172.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.3 tp -84.22 121.14 27.07 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.336 0.588 . . . . 0.0 111.542 175.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -89.43 -48.21 7.49 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 164.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.56 -87.05 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 CA-C-N 119.177 0.899 . . . . 0.0 110.988 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -82.17 -4.32 56.75 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 156.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.98 138.15 43.69 Favored 'General case' 0 CA--C 1.57 1.714 0 C-N-CA 125.183 1.393 . . . . 0.0 111.69 174.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mt -130.12 124.56 33.0 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 169.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.15 119.4 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.17 -0.956 . . . . 0.0 110.377 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.22 108.78 3.12 Favored Glycine 0 N--CA 1.486 1.99 0 C-N-CA 123.587 0.613 . . . . 0.0 112.972 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.57 94.12 7.57 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.2 0.6 . . . . 0.0 110.652 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.94 142.13 41.73 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -170.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -124.72 138.3 54.29 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.305 1.042 . . . . 0.0 108.194 174.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.79 107.94 9.47 Favored 'General case' 0 CA--C 1.568 1.672 0 O-C-N 120.817 -1.177 . . . . 0.0 113.67 -168.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.6 p -78.11 69.75 4.37 Favored 'General case' 0 N--CA 1.506 2.342 0 CA-C-O 124.067 1.889 . . . . 0.0 112.442 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.8 t70 169.15 -51.89 0.01 OUTLIER 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 113.028 -1.896 . . . . 0.0 109.047 -148.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -142.12 -5.48 0.99 Allowed 'General case' 0 CA--C 1.582 2.18 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.4 -40.39 2.94 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 118.501 2.16 . . . . 0.0 118.501 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -60.6 149.69 34.1 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -165.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.12 127.74 32.98 Favored 'General case' 0 CA--C 1.565 1.545 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -169.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.1 tt -119.74 115.29 23.61 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 124.524 1.13 . . . . 0.0 108.296 174.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -101.97 118.23 36.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.037 -1.039 . . . . 0.0 110.902 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.2 m -100.28 111.07 23.32 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 73.9 t -97.72 108.59 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -95.44 129.41 42.61 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.419 0.688 . . . . 0.0 110.791 170.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -145.33 137.42 25.66 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.854 -0.529 . . . . 0.0 111.216 172.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.4 mp -87.6 109.35 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 173.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.253 11.3 tp -92.35 74.14 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 122.221 1.01 . . . . 0.0 110.378 168.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.72 -98.11 0.67 Allowed Glycine 0 N--CA 1.489 2.216 0 O-C-N 121.09 -1.006 . . . . 0.0 115.481 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -87.85 -2.14 58.42 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 174.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -132.2 125.9 32.27 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 119.585 1.084 . . . . 0.0 110.586 -168.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.3 tp -83.13 114.98 21.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.48 -0.763 . . . . 0.0 109.643 168.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.9 m -92.49 105.12 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -101.39 98.96 9.26 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.8 m -102.21 118.15 36.27 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.668 0.787 . . . . 0.0 110.397 -169.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -100.23 107.21 18.99 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.715 0.806 . . . . 0.0 110.888 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.2 t -106.33 107.83 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -118.34 118.94 33.15 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.184 0.593 . . . . 0.0 110.624 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.328 51.9 mt-10 66.2 -81.91 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 124.677 1.191 . . . . 0.0 113.43 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -146.69 45.76 0.77 Allowed Glycine 0 N--CA 1.489 2.21 0 CA-C-O 119.233 -0.76 . . . . 0.0 114.941 158.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.7 t -135.49 117.15 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -100.95 124.12 46.17 Favored 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 123.655 0.782 . . . . 0.0 111.845 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.81 120.01 37.87 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.057 0.543 . . . . 0.0 112.029 170.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -98.63 101.73 13.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.705 -0.622 . . . . 0.0 110.845 -176.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -84.18 111.31 19.24 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 121.072 0.463 . . . . 0.0 110.272 169.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 95.9 mt -90.6 117.45 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -106.57 120.54 42.21 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.4 0.68 . . . . 0.0 109.732 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -84.84 143.32 29.15 Favored 'General case' 0 CA--C 1.566 1.581 0 O-C-N 121.674 -0.641 . . . . 0.0 111.831 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -62.9 105.41 0.67 Allowed 'General case' 0 CA--C 1.572 1.805 0 O-C-N 121.465 -0.772 . . . . 0.0 112.905 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 N--CA 1.493 1.706 0 C-N-CA 124.763 1.225 . . . . 0.0 113.462 -170.95 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 . . . . . 0 N--CA 1.5 2.052 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -152.64 74.01 1.04 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.996 -1.065 . . . . 0.0 112.338 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.0 p -159.1 -179.01 7.63 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.181 0.991 . . . . 0.0 113.416 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.2 m -86.92 119.67 27.38 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.873 0.869 . . . . 0.0 110.131 172.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -120.71 98.22 5.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.654 -0.654 . . . . 0.0 109.961 -173.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -88.58 138.35 31.5 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.333 -0.854 . . . . 0.0 112.168 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.43 125.13 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -95.46 -52.71 4.03 Favored 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 124.647 1.179 . . . . 0.0 112.841 172.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.8 ptt85 -159.7 128.75 5.17 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 120.041 1.291 . . . . 0.0 112.131 -168.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.6 p -97.09 101.82 13.47 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.829 0.852 . . . . 0.0 112.135 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -97.17 112.36 24.18 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.837 -0.54 . . . . 0.0 109.99 -166.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.266 41.9 t30 62.02 24.39 14.51 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -170.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -74.78 -32.97 62.18 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -172.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -53.04 -42.01 65.34 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 164.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -64.17 -47.64 79.08 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 173.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -52.08 -54.04 35.06 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 166.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.45 ' HB3' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -63.36 -34.43 77.7 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 171.059 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -58.85 -48.53 81.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.272 -1.518 . . . . 0.0 114.559 165.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -55.16 -34.64 63.98 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 166.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.3 mmt -68.31 -37.33 80.49 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 168.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.39 56.4 0.69 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 115.983 1.153 . . . . 0.0 115.983 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 p -124.83 156.31 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-O 122.348 1.07 . . . . 0.0 111.789 173.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -66.09 157.79 30.19 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.288 12.4 tt -58.72 -38.95 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -64.2 -55.38 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.181 0.9 . . . . 0.0 112.708 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -57.76 -30.12 65.37 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 167.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.45 ' HG3' ' HB3' ' A' ' 18' ' ' MET . 6.3 mtp180 -60.19 -55.73 30.22 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 167.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -61.05 -37.78 83.86 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.7 mt -61.15 -48.52 81.2 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 164.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.36 -41.0 75.44 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 171.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.02 -47.95 74.03 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 164.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -114.99 36.84 3.69 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -79.67 43.82 0.59 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.338 20.0 p30 36.74 37.19 0.06 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 119.956 3.317 . . . . 0.0 119.956 -174.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 tt -75.51 115.22 14.95 Favored 'General case' 0 CA--C 1.558 1.256 0 O-C-N 120.91 -1.119 . . . . 0.0 112.844 -158.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -106.31 110.63 22.92 Favored 'General case' 0 CA--C 1.558 1.26 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.036 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.7 mt -86.65 97.05 10.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 169.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 86.5 m -86.45 92.49 8.86 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.9 mt -87.57 120.88 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 -174.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.9 p -122.95 108.22 12.71 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -84.87 130.55 34.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.542 -0.724 . . . . 0.0 111.652 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -135.88 68.54 1.45 Allowed 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.198 0.599 . . . . 0.0 110.742 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.65 76.31 0.25 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 116.79 1.476 . . . . 0.0 116.79 176.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.321 8.0 m120 73.03 -37.64 0.39 Allowed 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -170.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -67.06 135.07 53.09 Favored 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 119.701 1.137 . . . . 0.0 112.989 162.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -121.51 115.08 22.18 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 168.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.3 m -94.96 103.37 15.22 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 172.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 52.9 t -110.85 110.85 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -171.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -86.1 90.18 8.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.766 -0.583 . . . . 0.0 110.258 176.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -73.14 95.62 2.1 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.034 0.934 . . . . 0.0 110.51 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.1 m -109.3 97.14 6.79 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -161.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.3 p -127.79 163.27 24.73 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.924 0.868 . . . . 0.0 113.255 -170.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.15 -23.23 63.75 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 166.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -77.65 -53.92 6.99 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 119.555 1.071 . . . . 0.0 113.339 165.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -156.0 151.71 27.24 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 119.74 1.155 . . . . 0.0 112.264 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -109.31 108.77 19.46 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.508 0.723 . . . . 0.0 110.357 170.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 pp -135.83 145.25 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-O 121.646 0.736 . . . . 0.0 111.874 -171.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -97.29 115.45 27.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -0.978 . . . . 0.0 111.545 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.83 103.25 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.33 101.47 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 173.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -119.63 136.26 54.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.861 -0.524 . . . . 0.0 112.374 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -92.81 144.02 25.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.692 -0.63 . . . . 0.0 110.716 164.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.94 115.58 3.82 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.77 -15.76 59.81 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 119.698 2.639 . . . . 0.0 119.698 -172.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.8 t -85.25 111.64 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.678 2.239 . . . . 0.0 108.684 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.261 7.4 t -78.78 124.32 28.09 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -165.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -134.4 163.71 29.06 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 124.071 0.949 . . . . 0.0 112.396 -170.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -85.41 109.39 18.4 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 121.865 0.84 . . . . 0.0 112.194 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -93.55 165.97 12.48 Favored 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 124.9 1.28 . . . . 0.0 112.256 172.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.252 0.6 OUTLIER -139.28 155.96 47.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.612 -1.305 . . . . 0.0 113.196 166.096 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.9 mt -86.56 51.35 2.21 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 175.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.285 . . 62.41 -50.51 0.17 Allowed 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 118.472 2.767 . . . . 0.0 118.472 -168.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.9 p30 -78.07 -78.63 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -175.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.4 72.52 0.09 OUTLIER Glycine 0 N--CA 1.481 1.693 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 -170.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.4 m -145.46 105.91 4.08 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.64 112.98 20.02 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-O 121.424 0.63 . . . . 0.0 111.843 -173.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 70.9 mt -118.26 107.74 14.27 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.181 0.592 . . . . 0.0 111.112 -167.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.2 ttm-85 -88.85 121.14 30.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 111.113 174.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.01 -154.57 11.71 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.3 p -144.48 138.06 27.36 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 123.196 0.599 . . . . 0.0 110.627 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -88.0 120.07 28.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.693 -0.629 . . . . 0.0 109.866 163.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.2 t -115.62 124.6 51.34 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.176 0.59 . . . . 0.0 111.109 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.3 tp -84.61 104.92 15.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.471 -0.768 . . . . 0.0 111.586 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -105.16 78.87 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.507 0.67 . . . . 0.0 109.907 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.59 -102.02 1.25 Allowed Glycine 0 N--CA 1.49 2.285 0 O-C-N 121.547 -0.72 . . . . 0.0 114.023 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -112.51 45.39 1.31 Allowed 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 167.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -139.3 115.13 10.11 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.285 -0.884 . . . . 0.0 109.039 173.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.1 mt -86.19 104.64 15.93 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 166.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.0 mt -99.85 110.57 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -172.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.18 94.62 2.01 Favored Glycine 0 N--CA 1.481 1.646 0 C-N-CA 123.47 0.557 . . . . 0.0 112.553 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -86.91 98.86 11.46 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -119.78 142.8 48.25 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.518 0.727 . . . . 0.0 112.337 -168.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -122.71 137.43 54.92 Favored 'General case' 0 CA--C 1.563 1.456 0 O-C-N 121.471 -0.768 . . . . 0.0 109.997 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -64.89 118.05 8.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.192 -0.943 . . . . 0.0 113.182 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.7 p -76.84 67.89 2.96 Favored 'General case' 0 N--CA 1.508 2.439 0 CA-C-O 122.318 1.056 . . . . 0.0 110.623 169.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -178.43 -68.05 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -159.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -98.37 -35.92 10.14 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.075 1.879 . . . . 0.0 116.075 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.72 6.21 76.94 Favored Glycine 0 CA--C 1.558 2.737 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 -150.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -82.74 134.44 35.13 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 119.599 1.699 . . . . 0.0 112.885 -175.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -90.15 133.89 34.61 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -172.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.79 122.18 35.46 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 125.211 1.404 . . . . 0.0 108.878 -176.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -100.31 109.67 21.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.102 -0.999 . . . . 0.0 109.342 172.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.8 m -99.91 99.86 10.7 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 119.353 0.979 . . . . 0.0 109.757 172.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 80.2 t -88.31 105.04 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.019 -1.051 . . . . 0.0 108.549 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -79.48 112.89 17.18 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.339 0.656 . . . . 0.0 110.115 163.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -137.28 147.41 45.67 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.489 0.662 . . . . 0.0 109.935 171.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.77 139.1 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.008 0 O-C-N 120.776 -1.202 . . . . 0.0 109.922 167.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.5 tt -119.36 89.97 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.804 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 162.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 68.68 -99.01 0.56 Allowed Glycine 0 N--CA 1.492 2.391 0 O-C-N 120.948 -1.095 . . . . 0.0 115.529 -176.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -95.21 -3.17 48.18 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 170.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -123.4 129.69 51.64 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 119.464 1.029 . . . . 0.0 111.48 -164.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.4 tp -82.89 114.59 21.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.288 170.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.0 m -82.47 126.06 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 166.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -99.16 101.02 12.22 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 157.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.5 m -90.16 108.31 19.67 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -102.8 99.67 9.63 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.456 0.703 . . . . 0.0 110.855 -170.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 t -99.43 114.17 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -134.63 109.74 8.84 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.041 0.536 . . . . 0.0 110.853 -174.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.287 24.4 mm-40 68.17 -79.52 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 172.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -142.54 58.95 0.55 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 123.212 0.434 . . . . 0.0 113.091 167.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.18 154.79 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 123.756 0.822 . . . . 0.0 109.852 -174.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.255 0.0 OUTLIER -144.47 136.91 26.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.11 -0.994 . . . . 0.0 112.949 161.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.56 145.44 51.72 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.53 0.732 . . . . 0.0 112.204 174.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -120.04 98.22 5.98 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . 0.297 6.1 ptm180 -88.76 123.52 33.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.755 -1.216 . . . . 0.0 110.414 170.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.5 mt -109.82 131.31 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -161.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -119.31 127.1 52.88 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.365 0.666 . . . . 0.0 110.339 -175.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -83.48 144.06 29.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.238 -0.914 . . . . 0.0 112.499 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.6 tttt -69.27 122.11 18.2 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 121.683 0.754 . . . . 0.0 112.464 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.2 t70 . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -162.281 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -83.66 82.59 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.537 -1.352 . . . . 0.0 112.801 -165.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.8 t -162.6 -178.15 6.04 Favored 'General case' 0 CA--C 1.574 1.894 0 CA-C-O 123.004 1.383 . . . . 0.0 112.808 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.9 m -97.21 121.54 39.21 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.968 0.907 . . . . 0.0 109.451 169.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.461 ' CH2' HD11 ' A' ' 108' ' ' ILE . 98.9 m95 -118.72 112.02 19.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.709 -0.62 . . . . 0.0 110.644 -167.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -98.35 131.23 44.82 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 118.762 0.71 . . . . 0.0 112.167 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 p -66.92 120.9 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.336 -0.852 . . . . 0.0 113.249 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -100.81 -55.97 2.44 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -143.57 122.24 12.57 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 119.61 1.096 . . . . 0.0 112.246 -173.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.9 p -99.77 122.61 43.0 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.804 0.842 . . . . 0.0 111.936 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -76.36 -38.2 56.18 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -172.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -116.06 -78.51 0.58 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 119.269 0.94 . . . . 0.0 109.595 170.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.289 0.5 OUTLIER 47.45 35.11 3.82 Favored 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 118.427 2.751 . . . . 0.0 118.427 -175.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -150.0 -53.5 0.15 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.182 0.993 . . . . 0.0 111.095 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -66.33 -40.76 90.1 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 120.534 1.516 . . . . 0.0 114.095 164.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -45.62 -58.43 3.43 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 157.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.3 mtp -64.16 -38.18 90.13 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -60.45 -42.7 96.69 Favored 'General case' 0 CA--C 1.574 1.893 0 O-C-N 120.16 -1.588 . . . . 0.0 114.951 166.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -66.27 -28.84 69.02 Favored 'General case' 0 CA--C 1.579 2.076 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 168.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 mtm -59.81 -34.66 73.36 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 158.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.02 45.07 1.8 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 115.829 1.092 . . . . 0.0 115.829 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.1 m -127.21 147.65 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 118.837 1.318 . . . . 0.0 112.987 -173.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -72.26 162.41 29.5 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -175.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.256 0.2 OUTLIER -48.21 -44.61 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 168.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.4 t -54.89 -50.66 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 170.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -63.45 -40.78 98.04 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 169.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -57.02 -47.87 79.84 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 169.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.286 0.0 OUTLIER -64.88 -39.59 93.77 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 168.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.79 -53.77 14.16 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 176.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.4 -13.24 60.7 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 175.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.73 -54.58 8.57 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 120.328 1.422 . . . . 0.0 114.367 155.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -85.82 62.81 7.68 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.799 1.181 . . . . 0.0 112.765 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.5 p30 -121.3 9.04 10.31 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 -178.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.347 1.7 p-10 52.66 58.86 4.93 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 177.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.9 tp -75.45 118.97 18.9 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -116.63 114.4 24.04 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.342 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.7 mt -95.08 109.67 21.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.55 -0.719 . . . . 0.0 109.621 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.1 m -90.88 98.57 11.86 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.269 -0.894 . . . . 0.0 108.643 169.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.3 mt -101.47 124.61 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -146.85 135.11 21.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.404 -0.81 . . . . 0.0 112.555 166.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -86.12 145.65 26.94 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 171.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.42 88.05 1.41 Allowed 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 124.818 1.247 . . . . 0.0 109.173 -175.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.81 61.02 4.91 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 117.373 1.709 . . . . 0.0 117.373 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.6 t30 62.82 -4.53 0.24 Allowed 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 118.183 2.66 . . . . 0.0 118.183 -166.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -110.25 130.97 55.45 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.916 1.287 . . . . 0.0 110.113 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -99.63 118.33 35.93 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.507 -0.746 . . . . 0.0 110.491 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.5 m -86.47 114.24 23.06 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 166.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.4 t -122.12 99.4 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -87.12 114.15 23.47 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.317 0.58 . . . . 0.0 110.039 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -107.79 80.92 1.44 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.325 0.583 . . . . 0.0 110.515 -165.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 m -90.46 113.85 25.88 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-O 121.929 0.871 . . . . 0.0 112.205 -172.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.1 p -139.3 167.12 22.79 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.37 1.068 . . . . 0.0 109.305 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.3 57.2 0.24 Allowed 'General case' 0 CA--C 1.578 2.057 0 O-C-N 120.233 -1.542 . . . . 0.0 113.889 159.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -176.68 -57.93 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 125.303 1.441 . . . . 0.0 110.847 -170.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -96.35 -81.33 0.41 Allowed 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 119.974 1.261 . . . . 0.0 112.679 -174.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.284 68.1 m-80 53.59 65.15 1.6 Allowed 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -160.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.2 pt -122.48 121.73 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.871 -0.518 . . . . 0.0 110.031 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.01 94.57 8.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.35 -0.844 . . . . 0.0 111.347 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.2 t -98.46 114.2 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -170.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.46 97.72 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -112.52 137.87 50.11 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.302 0.641 . . . . 0.0 112.507 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -80.48 147.27 30.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.962 . . . . 0.0 112.668 169.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 70.6 mt -66.1 109.18 2.5 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.36 47.33 5.77 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 117.05 1.58 . . . . 0.0 117.05 -173.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.45 138.22 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 118.349 1.075 . . . . 0.0 110.1 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.0 m -84.36 102.8 13.0 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.437 -0.789 . . . . 0.0 109.756 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -127.15 162.53 25.91 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.289 1.042 . . . . 0.0 113.227 -172.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -86.5 121.84 29.6 Favored 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 123.669 0.788 . . . . 0.0 111.658 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -128.21 117.96 22.47 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.551 0.74 . . . . 0.0 110.816 -174.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -98.92 121.25 40.63 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.207 -0.933 . . . . 0.0 111.997 -174.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.7 mt -73.5 166.42 23.26 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.99 52.94 0.57 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 117.522 2.416 . . . . 0.0 117.522 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -163.62 -67.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.427 1.091 . . . . 0.0 109.471 168.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.87 73.59 0.05 OUTLIER Glycine 0 N--CA 1.481 1.677 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.8 m -155.68 121.37 4.98 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.52 -0.988 . . . . 0.0 109.948 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -94.44 125.89 39.37 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 122.457 1.122 . . . . 0.0 111.503 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 50.7 mt -106.55 150.16 26.43 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.299 1.04 . . . . 0.0 112.103 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.8 116.95 20.27 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.31 -161.73 35.11 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 117.551 1.781 . . . . 0.0 117.551 -175.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 71.4 p -124.88 123.67 40.43 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.919 -0.64 . . . . 0.0 111.712 -156.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -83.43 115.41 22.03 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 118.569 0.622 . . . . 0.0 110.158 158.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.8 m -115.47 132.77 56.52 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.243 0.617 . . . . 0.0 111.757 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.0 tp -87.44 109.29 19.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.378 -0.826 . . . . 0.0 112.324 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -101.76 81.34 2.13 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.551 0.691 . . . . 0.0 109.776 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.47 -94.16 0.93 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 114.795 0.678 . . . . 0.0 114.795 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -121.73 52.67 1.24 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.637 0.732 . . . . 0.0 111.485 165.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -146.86 112.4 5.61 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.8 mt -89.64 104.14 16.72 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 171.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.2 tt -94.82 118.19 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.641 -0.662 . . . . 0.0 110.21 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.83 97.85 2.32 Favored Glycine 0 N--CA 1.481 1.636 0 C-N-CA 123.411 0.529 . . . . 0.0 112.348 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -92.58 98.87 11.71 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.312 0.645 . . . . 0.0 109.609 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -123.18 134.28 54.18 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.527 0.731 . . . . 0.0 111.527 -170.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -110.81 157.08 20.21 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.498 1.142 . . . . 0.0 111.241 165.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -107.77 120.22 41.63 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.955 -1.091 . . . . 0.0 112.04 -161.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.5 t -68.0 -11.82 59.62 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 169.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -86.46 -50.68 6.7 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 119.459 1.027 . . . . 0.0 113.3 172.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.87 27.97 2.17 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 120.885 1.675 . . . . 0.0 115.405 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.76 -57.11 2.6 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 118.287 2.075 . . . . 0.0 118.287 176.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -48.46 124.95 8.85 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.833 2.053 . . . . 0.0 114.997 -168.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -67.18 145.47 55.21 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -171.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.3 tp -104.68 115.0 29.57 Favored 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 162.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -94.5 104.0 15.96 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 168.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.8 m -104.63 100.38 10.04 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.758 -0.588 . . . . 0.0 109.79 -177.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.9 t -91.63 104.65 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 120.897 -1.127 . . . . 0.0 108.812 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -82.02 115.78 21.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.883 -0.511 . . . . 0.0 109.852 164.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.79 144.76 34.11 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.037 0.535 . . . . 0.0 111.482 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.461 HD11 ' CH2' ' A' ' 6' ' ' TRP . 1.0 OUTLIER -85.72 124.75 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.291 -0.881 . . . . 0.0 111.223 177.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.255 10.9 tp -98.77 79.15 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.151 0.977 . . . . 0.0 108.986 166.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.75 -104.58 1.49 Allowed Glycine 0 N--CA 1.488 2.117 0 O-C-N 121.444 -0.785 . . . . 0.0 114.247 -171.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.26 0.71 57.47 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 117.576 2.435 . . . . 0.0 117.576 172.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -122.41 135.82 54.77 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.192 1.36 . . . . 0.0 110.959 -170.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.0 tp -90.62 119.7 31.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 111.012 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.9 p -102.58 120.34 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.136 -0.978 . . . . 0.0 110.647 172.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -89.99 115.44 27.28 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 122.967 0.507 . . . . 0.0 109.883 166.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.2 m -96.86 100.23 11.77 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.229 0.611 . . . . 0.0 109.626 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -88.07 112.4 22.61 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.434 0.694 . . . . 0.0 110.757 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.1 t -113.4 100.35 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -92.92 119.33 32.1 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.285 0.8 OUTLIER 66.07 -85.81 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 119.258 0.936 . . . . 0.0 111.648 -176.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.97 20.71 3.59 Favored Glycine 0 CA--C 1.558 2.749 0 N-CA-C 117.853 1.901 . . . . 0.0 117.853 151.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -92.3 115.79 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 121.496 2.648 . . . . 0.0 111.483 -174.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -89.22 126.23 35.41 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -127.8 106.08 8.88 Favored 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 123.502 0.721 . . . . 0.0 110.781 169.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.73 130.32 37.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 111.147 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -123.69 122.51 38.28 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.5 -0.75 . . . . 0.0 111.934 171.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.5 mt -94.23 124.56 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -174.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -104.55 133.22 49.77 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.392 1.077 . . . . 0.0 110.634 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -88.96 147.75 24.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.055 0.931 . . . . 0.0 112.304 171.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -75.19 118.36 18.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.639 -0.663 . . . . 0.0 111.821 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.1 t70 . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -165.925 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 118.888 -0.577 . . . . 0.0 111.693 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 t70 40.62 51.19 2.98 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 166.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.5 p -165.35 171.0 13.98 Favored 'General case' 0 CA--C 1.569 1.71 0 CA-C-O 122.432 1.111 . . . . 0.0 112.557 -168.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.4 m -89.4 133.92 34.31 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.04 -1.038 . . . . 0.0 111.413 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -138.37 107.82 6.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.801 -0.562 . . . . 0.0 109.927 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -97.26 133.16 42.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.11 -0.994 . . . . 0.0 112.682 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 p -62.41 117.96 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.213 -0.93 . . . . 0.0 113.411 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -102.17 -45.11 5.24 Favored 'General case' 0 CA--C 1.568 1.649 0 C-N-CA 123.961 0.904 . . . . 0.0 113.384 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -152.62 160.46 43.19 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.154 0.982 . . . . 0.0 110.968 -174.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.3 p -146.72 143.72 28.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.37 -1.456 . . . . 0.0 112.871 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -85.83 -51.38 6.44 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -137.93 53.57 1.83 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 119.834 1.197 . . . . 0.0 112.772 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -83.61 63.86 7.63 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 119.628 -1.92 . . . . 0.0 112.205 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -163.85 -57.72 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.529 1.132 . . . . 0.0 110.981 -171.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -81.96 -26.06 34.29 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -51.87 -54.38 29.88 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-N 121.791 2.087 . . . . 0.0 113.778 153.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.702 ' SD ' HG11 ' A' ' 23' ' ' VAL . 0.8 OUTLIER -51.86 -47.97 64.22 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 169.019 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -66.02 -38.83 89.42 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 170.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.0 tptp -60.14 -40.39 89.66 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 168.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.5 mtp -62.69 -52.92 61.38 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 165.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.55 59.44 0.06 OUTLIER Glycine 0 N--CA 1.487 2.042 0 CA-C-O 119.522 -0.599 . . . . 0.0 114.338 166.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.702 HG11 ' SD ' ' A' ' 18' ' ' MET . 2.8 m -103.82 147.47 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.857 0.837 . . . . 0.0 111.727 -177.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -74.28 169.03 18.45 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 168.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.267 0.2 OUTLIER -54.61 -44.34 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 176.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.49 -48.65 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-N 119.395 0.998 . . . . 0.0 112.996 172.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -54.38 -39.69 67.46 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 166.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -46.14 91.8 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 167.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -59.62 -48.81 80.21 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 166.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.7 mt -57.4 -39.76 76.81 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 169.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.04 -54.3 46.54 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 168.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.42 -38.14 41.56 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 167.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -95.17 19.9 9.92 Favored 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 172.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.305 28.0 p30 -72.97 -24.53 60.8 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 118.164 2.653 . . . . 0.0 118.164 -173.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 57.2 54.86 6.39 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 173.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.1 tp -79.77 122.52 26.71 Favored 'General case' 0 CA--C 1.563 1.445 0 CA-C-O 121.963 0.887 . . . . 0.0 112.345 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -105.48 106.22 16.62 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.871 169.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.39 100.11 7.47 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.38 0.609 . . . . 0.0 109.583 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.7 m -102.04 96.84 7.28 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -173.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.1 mt -95.38 131.81 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -164.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.2 m -141.04 108.55 5.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.577 -1.327 . . . . 0.0 107.693 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -100.64 139.2 36.66 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.94 0.876 . . . . 0.0 112.485 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -99.78 70.75 1.65 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 122.166 0.984 . . . . 0.0 110.139 164.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.88 -99.99 0.73 Allowed Glycine 0 N--CA 1.488 2.136 0 O-C-N 121.565 -0.71 . . . . 0.0 114.742 -170.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -84.47 -26.84 27.89 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -90.17 117.45 28.94 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.58 1.536 . . . . 0.0 111.101 177.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -99.48 117.33 33.64 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.374 1.07 . . . . 0.0 109.812 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.4 m -90.91 103.19 15.94 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 166.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -99.85 104.06 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -77.43 105.25 8.44 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.935 0.874 . . . . 0.0 109.991 172.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -92.4 91.47 7.67 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.099 0.96 . . . . 0.0 109.303 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.3 t -97.03 111.97 23.95 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.89 0.476 . . . . 0.0 111.336 -173.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.5 p -144.45 165.3 28.35 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -172.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.18 -23.17 67.22 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 117.611 2.449 . . . . 0.0 117.611 165.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -68.7 -52.01 35.54 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 120.367 1.44 . . . . 0.0 113.981 159.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -165.98 152.82 9.7 Favored 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 123.591 0.756 . . . . 0.0 112.144 -167.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -118.28 99.16 6.67 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 pp -136.41 143.19 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 O-C-N 121.747 -0.595 . . . . 0.0 111.994 -171.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -93.82 125.21 38.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.922 -1.111 . . . . 0.0 112.791 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.0 t -102.03 104.87 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.65 108.8 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -133.12 130.85 39.79 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.388 0.613 . . . . 0.0 112.537 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -66.98 140.5 57.73 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 111.835 157.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.8 mt -54.43 123.08 11.9 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 166.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.85 -5.96 83.13 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 119.189 2.436 . . . . 0.0 119.189 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 p -82.75 137.14 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-N 120.616 2.208 . . . . 0.0 112.748 -172.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.8 m -91.45 95.87 10.2 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.41 -0.806 . . . . 0.0 109.934 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -122.18 150.75 41.81 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -170.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -86.03 98.35 10.8 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 124.448 1.099 . . . . 0.0 113.872 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -89.98 118.6 29.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.5 -0.75 . . . . 0.0 110.966 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -72.26 108.47 5.42 Favored 'General case' 0 CA--C 1.569 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 113.114 171.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -78.21 139.79 38.94 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.914 0.886 . . . . 0.0 111.09 177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.32 66.94 0.31 Allowed 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -168.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -166.45 -66.2 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 125.779 1.632 . . . . 0.0 108.505 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.58 68.38 0.05 OUTLIER Glycine 0 N--CA 1.481 1.672 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.6 m -160.65 119.88 2.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.614 -0.933 . . . . 0.0 109.587 -177.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -88.1 113.89 24.18 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.886 0.85 . . . . 0.0 111.081 167.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 70.9 mt -93.78 109.56 21.23 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 124.325 1.05 . . . . 0.0 110.615 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 58.8 ttp85 -88.85 117.18 27.66 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.875 -0.516 . . . . 0.0 110.714 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.41 179.36 48.87 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 118.983 2.353 . . . . 0.0 118.983 -171.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.3 p -122.12 123.11 40.79 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 113.483 -1.358 . . . . 0.0 111.297 -166.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -81.92 107.56 14.74 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 118.476 0.58 . . . . 0.0 110.194 160.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 72.9 m -102.68 131.6 49.37 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.046 0.539 . . . . 0.0 111.101 176.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.9 tp -82.3 106.17 13.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.158 -0.964 . . . . 0.0 110.744 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -82.32 -49.45 10.02 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.07 -95.67 0.21 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 164.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -98.97 59.29 1.17 Allowed 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.869 0.842 . . . . 0.0 110.326 152.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -149.17 116.42 6.09 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.54 103.72 16.34 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 167.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.8 tt -90.08 111.5 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.368 -0.833 . . . . 0.0 110.1 177.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.07 98.09 2.34 Favored Glycine 0 N--CA 1.482 1.707 0 C-N-CA 123.843 0.735 . . . . 0.0 113.072 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -93.32 96.34 9.9 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -117.46 147.27 42.87 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.731 0.777 . . . . 0.0 112.533 -168.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -127.0 138.52 53.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.404 -0.81 . . . . 0.0 110.851 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -71.04 115.07 9.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 0.0 113.133 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 73.8 p -80.49 62.96 4.77 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 123.514 1.626 . . . . 0.0 112.384 170.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -174.05 -65.03 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.732 0 C-N-CA 126.236 1.815 . . . . 0.0 107.005 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -94.33 -18.24 21.8 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.05 -15.68 47.24 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 119.148 2.419 . . . . 0.0 119.148 -172.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -84.18 152.76 24.06 Favored 'General case' 0 CA--C 1.566 1.559 0 CA-C-N 118.529 1.165 . . . . 0.0 113.79 -169.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -94.4 130.27 40.8 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-O 122.114 0.959 . . . . 0.0 112.835 -168.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.0 tt -110.66 122.51 47.96 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 124.48 1.112 . . . . 0.0 109.406 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -111.51 111.67 22.86 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.2 m -108.36 100.2 9.52 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 119.441 1.019 . . . . 0.0 110.203 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.8 t -91.38 107.46 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.128 -0.983 . . . . 0.0 108.827 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -103.82 105.3 15.46 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 123.4 0.68 . . . . 0.0 110.598 -173.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -143.48 148.82 36.65 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -169.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.56 120.95 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.17 -1.581 . . . . 0.0 109.672 175.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.5 mm -101.1 88.95 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 167.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.91 -88.14 0.56 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 115.769 1.067 . . . . 0.0 115.769 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -111.0 0.31 16.94 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 173.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -129.67 127.21 40.06 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.953 1.251 . . . . 0.0 110.744 -169.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.1 tp -74.63 115.24 13.98 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.961 0.904 . . . . 0.0 110.519 171.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.0 m -103.72 119.09 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.301 -0.874 . . . . 0.0 109.583 -176.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -88.8 107.38 18.94 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 118.844 0.747 . . . . 0.0 109.842 165.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.7 m -92.35 96.32 10.2 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -87.61 106.48 18.04 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.508 0.723 . . . . 0.0 111.05 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.6 t -106.77 104.35 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -117.48 118.17 31.44 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.885 0.474 . . . . 0.0 109.781 172.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 51.4 49.68 20.47 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.0 -24.79 4.42 Favored Glycine 0 CA--C 1.554 2.507 0 N-CA-C 119.264 2.466 . . . . 0.0 119.264 -169.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.7 t -86.65 105.27 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 120.104 1.952 . . . . 0.0 109.633 -168.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -87.98 124.76 34.05 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 123.314 0.646 . . . . 0.0 112.52 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -124.66 109.85 13.67 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.554 0.742 . . . . 0.0 111.518 173.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.54 108.77 20.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.786 -0.571 . . . . 0.0 110.092 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -111.66 129.44 56.09 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.387 1.089 . . . . 0.0 111.436 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.9 mt -121.66 119.15 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -146.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -112.49 119.79 39.41 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.337 0.655 . . . . 0.0 110.418 -168.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -81.01 147.34 30.24 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 123.507 0.723 . . . . 0.0 112.781 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -58.87 118.94 6.32 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 t70 . . . . . 0 N--CA 1.488 1.464 0 C-N-CA 125.01 1.324 . . . . 0.0 112.444 -172.608 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.364 89.8 m-85 . . . . . 0 N--CA 1.495 1.792 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -77.4 80.13 3.9 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 120.537 1.517 . . . . 0.0 112.669 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.9 t -163.78 178.15 8.08 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 122.443 1.116 . . . . 0.0 112.077 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.9 m -92.2 122.41 34.66 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.459 1.104 . . . . 0.0 110.297 170.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -123.65 108.72 12.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.813 -0.555 . . . . 0.0 109.958 -171.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -97.23 139.59 32.96 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.065 -1.022 . . . . 0.0 112.707 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -60.38 119.7 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -109.19 -51.11 2.92 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.767 0.827 . . . . 0.0 113.099 -173.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -148.57 109.57 4.3 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 119.222 0.919 . . . . 0.0 109.741 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.6 p -109.18 115.01 29.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.381 -0.824 . . . . 0.0 113.056 -174.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -98.69 123.07 42.67 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 123.327 0.651 . . . . 0.0 110.656 -169.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.261 9.4 t30 67.83 18.6 9.67 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -69.74 -43.09 73.0 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -173.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.87 -34.24 75.64 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 169.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -70.79 -47.2 60.79 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -43.1 -53.26 5.02 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 158.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 15.7 mtt -67.3 -25.87 66.25 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 174.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -60.7 -43.24 98.01 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-N 121.345 1.884 . . . . 0.0 114.625 163.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -59.03 -34.63 72.13 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 162.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 76.7 mmm -62.67 -30.31 71.29 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 116.929 2.196 . . . . 0.0 116.929 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.0 53.95 1.07 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 115.157 0.823 . . . . 0.0 115.157 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.31 142.53 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 122.671 1.224 . . . . 0.0 112.063 -175.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -70.24 172.08 8.76 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.275 13.2 tt -60.58 -40.73 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 176.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.6 t -61.61 -52.16 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-N 120.402 1.456 . . . . 0.0 112.913 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -55.3 -43.79 75.16 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 168.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -64.47 -42.22 96.05 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 171.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -58.36 -46.35 86.46 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 120.143 1.338 . . . . 0.0 114.554 167.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.9 mt -60.48 -40.94 93.11 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 165.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.69 95.0 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 172.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.96 -57.41 11.8 Favored 'General case' 0 CA--C 1.566 1.596 0 O-C-N 120.804 -1.185 . . . . 0.0 113.681 164.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -84.3 53.01 2.49 Favored 'General case' 0 CA--C 1.577 2.006 0 CA-C-N 119.716 1.144 . . . . 0.0 113.81 174.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -85.89 -29.51 23.6 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -174.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 62.05 50.22 4.17 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -84.02 121.75 27.83 Favored 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 122.42 1.105 . . . . 0.0 112.014 -175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -111.34 117.29 32.71 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.479 174.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.7 mt -101.44 102.59 13.41 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.0 m -94.46 105.04 17.0 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.309 -0.87 . . . . 0.0 109.649 172.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.6 mt -94.83 131.29 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 85.8 m -145.41 128.46 16.55 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.262 -1.524 . . . . 0.0 110.147 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -111.07 139.89 46.06 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -170.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -138.21 89.97 2.44 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.672 0.789 . . . . 0.0 109.825 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.21 68.18 1.81 Allowed Glycine 0 N--CA 1.497 2.711 0 N-CA-C 116.731 1.452 . . . . 0.0 116.731 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.291 46.7 m-20 67.62 -23.79 0.12 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 118.019 2.6 . . . . 0.0 118.019 -166.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -83.19 100.8 10.8 Favored 'General case' 0 CA--C 1.565 1.552 0 CA-C-N 121.151 1.796 . . . . 0.0 110.901 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -93.36 117.62 30.3 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.029 0.931 . . . . 0.0 109.504 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.0 m -92.75 104.14 16.44 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 p -94.69 109.83 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.699 0.762 . . . . 0.0 109.974 170.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -88.55 111.67 22.13 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -101.93 92.07 4.64 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.441 0.696 . . . . 0.0 110.712 -169.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.1 m -103.37 117.05 33.6 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.106 0.562 . . . . 0.0 111.003 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 p -147.77 -177.3 5.64 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.84 40.73 0.06 Allowed 'General case' 0 CA--C 1.583 2.246 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 166.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -144.2 -62.59 0.38 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 126.519 1.927 . . . . 0.0 108.566 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.64 167.48 28.78 Favored 'General case' 0 CA--C 1.572 1.825 0 C-N-CA 124.122 0.969 . . . . 0.0 111.141 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -121.07 102.8 8.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.328 -0.858 . . . . 0.0 109.46 164.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.33 144.22 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.527 -0.733 . . . . 0.0 112.019 -172.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -94.91 119.65 33.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.339 -0.85 . . . . 0.0 112.58 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.4 t -98.94 104.03 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.8 t -91.87 103.2 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -113.54 123.52 50.18 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.308 0.575 . . . . 0.0 112.006 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -72.28 137.09 46.5 Favored 'General case' 0 CA--C 1.569 1.703 0 O-C-N 121.366 -0.834 . . . . 0.0 110.499 162.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.8 mt -59.62 113.27 2.15 Favored 'General case' 0 CA--C 1.571 1.768 0 O-C-N 121.069 -1.019 . . . . 0.0 113.389 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.29 55.83 3.6 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 116.39 1.316 . . . . 0.0 116.39 -171.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 p -136.46 136.91 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 118.008 0.904 . . . . 0.0 110.125 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 88.0 m -87.41 109.79 19.82 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.505 -0.747 . . . . 0.0 110.156 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -138.56 156.23 47.67 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.168 0.587 . . . . 0.0 112.436 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -84.38 99.04 10.38 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 121.841 0.829 . . . . 0.0 112.126 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -86.64 119.27 26.7 Favored 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 124.449 1.1 . . . . 0.0 111.682 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -83.39 126.68 32.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.099 -1.001 . . . . 0.0 113.208 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.3 mt -80.62 152.67 28.4 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 170.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.93 64.74 2.49 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 175.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -174.31 -66.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 125.465 1.506 . . . . 0.0 110.394 -177.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.3 70.17 0.03 OUTLIER Glycine 0 N--CA 1.487 2.065 0 CA-C-N 119.128 0.876 . . . . 0.0 114.207 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.5 m -167.19 128.34 1.57 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 118.041 0.92 . . . . 0.0 109.015 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -97.34 126.71 42.74 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.172 0.987 . . . . 0.0 110.623 169.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.6 mt -108.91 107.69 18.18 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 124.227 1.011 . . . . 0.0 110.769 -174.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.53 119.15 20.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.048 -1.032 . . . . 0.0 112.068 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.74 -163.88 36.99 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 117.639 1.815 . . . . 0.0 117.639 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.8 p -125.5 120.31 30.59 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.382 -0.909 . . . . 0.0 111.763 -157.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -84.81 121.65 28.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.422 -0.799 . . . . 0.0 110.427 161.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.1 m -126.93 139.3 53.16 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.358 0.663 . . . . 0.0 111.735 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.1 tp -87.72 114.67 24.55 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.679 -1.263 . . . . 0.0 111.642 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -78.07 -37.27 46.95 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 172.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.83 -84.26 0.08 OUTLIER Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -107.93 39.04 2.03 Favored 'General case' 0 CA--C 1.581 2.138 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 158.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -146.19 124.32 12.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.929 -1.107 . . . . 0.0 109.167 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.8 mt -91.4 110.49 21.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.478 -0.764 . . . . 0.0 109.15 166.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.6 tt -97.52 117.59 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.127 -0.983 . . . . 0.0 110.858 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.04 95.7 1.76 Allowed Glycine 0 N--CA 1.482 1.747 0 CA-C-O 119.401 -0.666 . . . . 0.0 113.328 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -84.25 103.8 13.74 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 117.784 0.792 . . . . 0.0 110.017 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -123.16 148.42 45.76 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -171.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -120.96 141.61 50.53 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.782 0.801 . . . . 0.0 110.621 167.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -70.79 137.85 49.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.716 -1.24 . . . . 0.0 112.808 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.286 4.9 t -70.18 -51.78 28.43 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 175.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -75.92 -44.96 37.71 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -80.22 -26.19 39.25 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.7 -38.77 3.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 117.486 1.754 . . . . 0.0 117.486 -166.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -69.22 155.57 40.19 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -162.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.96 140.13 35.43 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 114.18 -1.373 . . . . 0.0 114.679 -175.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.8 tt -135.28 115.59 13.46 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 123.832 0.853 . . . . 0.0 109.114 177.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -94.5 111.72 23.48 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.139 -0.976 . . . . 0.0 109.103 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.9 m -101.34 94.94 6.19 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.0 t -100.91 100.14 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-O 122.516 1.151 . . . . 0.0 109.56 -168.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -93.69 102.35 14.51 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.367 -172.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -131.54 133.12 44.74 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.75 0.82 . . . . 0.0 111.268 -161.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.0 mt -104.0 123.3 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.719 -1.238 . . . . 0.0 110.172 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 45.1 mm -83.55 -47.33 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.98 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.832 167.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -163.09 -89.12 0.07 OUTLIER Glycine 0 N--CA 1.487 2.085 0 CA-C-N 119.058 0.844 . . . . 0.0 112.507 172.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 45.0 p30 -81.62 3.76 24.06 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 174.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -136.97 131.42 32.94 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 119.233 0.924 . . . . 0.0 111.033 -168.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.7 tp -86.14 113.02 21.85 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.446 1.098 . . . . 0.0 109.695 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.6 t -98.98 105.09 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -174.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -96.08 101.74 13.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -0.984 . . . . 0.0 109.997 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.5 m -91.63 103.96 16.49 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.585 0.754 . . . . 0.0 109.207 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -89.26 110.69 21.43 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.338 0.655 . . . . 0.0 110.194 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.1 t -112.79 93.96 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -94.71 114.65 26.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.632 -0.668 . . . . 0.0 111.31 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.317 0.4 OUTLIER 62.07 -62.55 0.1 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 174.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.83 43.41 0.5 Allowed Glycine 0 CA--C 1.551 2.293 0 CA-C-O 118.915 -0.936 . . . . 0.0 114.483 156.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.8 t -139.15 118.61 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 118.982 1.391 . . . . 0.0 107.761 -172.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.2 mp0 -93.68 144.52 25.32 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.81 121.19 10.96 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.208 0.528 . . . . 0.0 112.408 164.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -94.67 107.66 19.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.694 -0.629 . . . . 0.0 111.256 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -89.7 111.61 22.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.722 -0.611 . . . . 0.0 109.601 167.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.2 mt -101.09 114.06 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -172.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -105.81 122.7 46.63 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.673 0.789 . . . . 0.0 109.625 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -83.14 143.27 30.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 112.585 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -65.14 118.44 9.22 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.9 t0 . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -165.67 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.283 93.2 m-85 . . . . . 0 N--CA 1.502 2.137 0 N-CA-C 118.81 2.893 . . . . 0.0 118.81 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -73.77 72.37 1.51 Allowed 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 117.283 2.327 . . . . 0.0 117.283 -160.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.9 p -152.17 -176.36 5.64 Favored 'General case' 0 CA--C 1.572 1.821 0 CA-C-O 121.976 0.893 . . . . 0.0 112.852 178.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.1 m -89.37 127.64 35.83 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.013 0.925 . . . . 0.0 110.788 176.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -130.02 116.17 18.18 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.178 0.591 . . . . 0.0 109.416 -173.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -99.64 135.77 40.56 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 119.408 1.004 . . . . 0.0 111.944 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p -66.05 116.43 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -96.0 -50.73 4.74 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -144.2 111.25 5.81 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 119.977 1.262 . . . . 0.0 111.054 -172.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.2 m -96.18 101.34 12.98 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.858 0.863 . . . . 0.0 111.317 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -93.5 120.52 33.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.509 -0.744 . . . . 0.0 110.31 -172.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.264 28.5 t30 65.49 20.56 11.72 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -72.51 -40.17 67.04 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.64 -38.07 74.39 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 168.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -67.55 -46.75 71.85 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 119.91 1.232 . . . . 0.0 114.069 171.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -46.55 -56.32 6.2 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 161.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.4 mtp -65.82 -29.84 70.38 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 176.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.63 -50.96 71.43 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 120.241 1.382 . . . . 0.0 114.203 163.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -57.4 -32.1 66.51 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 165.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.0 mmt -64.44 -34.74 78.89 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 168.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.99 51.36 1.93 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 116.072 1.189 . . . . 0.0 116.072 -176.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -114.89 160.23 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-O 122.169 0.985 . . . . 0.0 112.408 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -56.72 145.95 27.32 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 172.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.274 0.1 OUTLIER -54.98 -47.22 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 175.057 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.28 -49.53 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 173.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -58.35 -45.66 87.75 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 170.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -44.27 -55.12 5.13 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 163.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -65.69 -46.66 78.18 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.5 mt -58.48 -47.53 83.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 169.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.24 -21.63 66.35 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 119.062 2.986 . . . . 0.0 119.062 178.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.08 93.64 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 165.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -130.49 68.09 1.47 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 119.577 1.081 . . . . 0.0 111.781 169.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -84.41 44.66 1.05 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 176.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 42.7 40.57 2.08 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -172.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -86.68 116.77 25.0 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.695 -1.253 . . . . 0.0 112.173 -161.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -111.2 118.01 34.77 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.718 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.7 mt -94.28 101.53 13.5 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 172.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 43.8 m -95.14 105.66 17.61 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.883 0.849 . . . . 0.0 108.731 170.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.9 mt -90.57 101.4 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -171.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 87.7 m -99.08 101.48 12.86 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -102.45 127.49 49.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.581 -0.7 . . . . 0.0 112.347 -167.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -79.94 -49.87 11.26 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 161.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.65 -90.92 0.08 OUTLIER Glycine 0 N--CA 1.486 1.97 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -70.12 -29.28 66.19 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 158.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -85.47 126.71 34.03 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-N 119.772 1.169 . . . . 0.0 112.105 169.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -117.83 125.39 50.46 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.482 1.113 . . . . 0.0 108.475 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.0 m -99.52 95.85 7.27 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 168.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.5 t -88.98 105.88 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -89.91 102.07 14.77 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -170.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -93.41 88.09 5.83 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.202 0.601 . . . . 0.0 109.53 -170.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.1 t -98.49 109.26 22.05 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.321 0.648 . . . . 0.0 110.798 -171.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.7 p -134.08 166.15 23.41 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -169.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.55 -26.32 61.25 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 117.838 2.533 . . . . 0.0 117.838 165.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -79.81 -52.34 8.04 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -160.91 163.22 32.07 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-N 119.33 0.968 . . . . 0.0 112.726 -177.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -110.39 118.83 37.35 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.387 0.675 . . . . 0.0 109.53 167.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.2 pt -131.41 133.08 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 CA-C-O 121.785 0.802 . . . . 0.0 111.879 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -98.77 99.24 10.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.605 0.762 . . . . 0.0 109.664 -175.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.35 99.67 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.417 -0.802 . . . . 0.0 109.868 -165.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 56.9 t -85.7 115.8 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 123.458 0.703 . . . . 0.0 109.319 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -134.35 140.68 46.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.829 -0.544 . . . . 0.0 111.769 173.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -92.95 140.06 29.88 Favored 'General case' 0 CA--C 1.565 1.528 0 O-C-N 121.896 -0.502 . . . . 0.0 110.865 163.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -56.92 131.8 50.73 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 176.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.35 -16.68 37.96 Favored Glycine 0 CA--C 1.553 2.437 0 N-CA-C 119.426 2.53 . . . . 0.0 119.426 -172.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.8 t -81.84 132.37 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-N 120.176 1.988 . . . . 0.0 110.408 -175.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.9 m -79.87 104.74 10.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.716 -0.615 . . . . 0.0 110.085 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -124.7 166.85 15.44 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-O 122.106 0.955 . . . . 0.0 112.405 -173.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -91.23 99.01 12.08 Favored 'General case' 0 CA--C 1.571 1.75 0 C-N-CA 123.362 0.665 . . . . 0.0 111.454 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -92.58 104.89 17.14 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.829 0.852 . . . . 0.0 110.174 175.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -95.64 125.86 40.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 112.025 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.7 mt -80.21 150.24 30.17 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.166 0.586 . . . . 0.0 112.425 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.38 44.98 0.16 Allowed 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -149.75 -59.54 0.2 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 124.769 1.228 . . . . 0.0 110.234 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.53 73.37 0.04 OUTLIER Glycine 0 N--CA 1.486 1.977 0 CA-C-N 118.935 0.789 . . . . 0.0 112.678 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 m -167.8 124.77 1.13 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 117.869 0.834 . . . . 0.0 109.959 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -102.08 125.98 48.91 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.852 0.861 . . . . 0.0 111.033 171.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.6 mt -117.83 123.36 45.72 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.607 0.763 . . . . 0.0 110.865 -175.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -102.77 118.79 37.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.102 -0.999 . . . . 0.0 110.85 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.43 -177.71 47.88 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 118.29 2.076 . . . . 0.0 118.29 -172.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.8 p -119.54 124.91 47.57 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 113.812 -1.194 . . . . 0.0 111.215 -167.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -83.46 126.01 32.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.977 -0.452 . . . . 0.0 111.419 163.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.8 m -120.42 135.06 55.16 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.196 0.598 . . . . 0.0 111.026 172.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.6 tp -89.15 106.83 18.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 111.466 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -98.52 -179.08 4.21 Favored 'General case' 0 CA--C 1.575 1.904 0 C-N-CA 123.895 0.878 . . . . 0.0 110.828 168.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.91 106.87 0.88 Allowed Glycine 0 N--CA 1.494 2.537 0 O-C-N 120.265 -1.522 . . . . 0.0 115.894 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.42 9.3 p30 59.4 13.53 3.25 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 119.558 3.17 . . . . 0.0 119.558 -166.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -137.22 125.51 23.25 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 120.293 1.406 . . . . 0.0 111.867 -169.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.9 mt -89.25 109.0 19.93 Favored 'General case' 0 CA--C 1.564 1.484 0 O-C-N 121.098 -1.001 . . . . 0.0 108.379 159.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.6 tt -96.8 115.54 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.526 -0.734 . . . . 0.0 110.103 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.58 104.35 2.58 Favored Glycine 0 N--CA 1.482 1.754 0 C-N-CA 123.875 0.75 . . . . 0.0 112.374 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -92.15 95.45 9.75 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -114.95 148.96 38.05 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.477 1.132 . . . . 0.0 112.876 -168.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -121.87 135.46 54.89 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.713 0.805 . . . . 0.0 109.456 166.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -75.5 104.85 6.24 Favored 'General case' 0 CA--C 1.562 1.414 0 O-C-N 121.084 -1.01 . . . . 0.0 111.845 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 t -61.94 -16.45 51.09 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 118.385 2.735 . . . . 0.0 118.385 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -70.19 -28.99 65.74 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 168.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . 0.25 3.1 p-10 -145.53 7.46 1.13 Allowed 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 119.436 3.125 . . . . 0.0 119.436 -177.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.11 -19.7 47.75 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 119.15 2.42 . . . . 0.0 119.15 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -73.81 139.98 45.51 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -169.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -74.12 141.1 45.64 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 tt -126.77 121.05 30.87 Favored 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 123.589 0.756 . . . . 0.0 109.538 168.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -100.15 110.13 22.4 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.2 m -96.92 131.23 43.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.564 -0.71 . . . . 0.0 110.193 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.8 t -129.45 99.67 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -104.31 105.77 16.02 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.144 0.978 . . . . 0.0 108.606 -172.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -126.4 137.94 53.49 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -162.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.1 mm -88.99 127.19 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.386 -0.821 . . . . 0.0 109.51 167.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 49.2 mm -104.18 -80.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 168.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -165.32 113.19 0.54 Allowed Glycine 0 N--CA 1.487 2.093 0 O-C-N 121.357 -0.839 . . . . 0.0 111.056 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.251 31.3 m-20 60.5 1.31 0.39 Allowed 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 -166.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -136.58 138.69 41.5 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 124.339 1.056 . . . . 0.0 111.071 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.3 tp -94.06 109.77 21.51 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 168.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.2 m -95.07 113.37 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . 0.28 0.1 OUTLIER -124.7 119.44 28.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.82 -1.175 . . . . 0.0 113.315 -175.561 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.4 m -107.65 123.87 49.14 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.166 0.986 . . . . 0.0 109.982 -167.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -105.81 111.74 24.52 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.2 t -108.42 102.45 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -104.61 81.09 1.74 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.305 -0.872 . . . . 0.0 110.602 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 63.63 73.58 0.44 Allowed 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 123.779 0.831 . . . . 0.0 112.624 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.97 -36.9 2.33 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 118.732 2.253 . . . . 0.0 118.732 -173.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.81 99.27 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 119.229 1.515 . . . . 0.0 112.663 -169.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -90.42 112.23 23.77 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 123.375 0.67 . . . . 0.0 112.085 -172.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.36 119.64 37.65 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.077 0.551 . . . . 0.0 112.195 176.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -107.34 105.65 15.69 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.016 0.526 . . . . 0.0 109.962 -174.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -91.02 115.15 27.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.41 -0.806 . . . . 0.0 108.963 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.4 mt -105.01 118.94 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -103.01 152.06 21.77 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.048 0.939 . . . . 0.0 111.421 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -101.72 152.68 20.56 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.715 -1.241 . . . . 0.0 111.723 169.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -66.22 105.44 1.41 Allowed 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 123.758 0.823 . . . . 0.0 112.689 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.6 t0 . . . . . 0 N--CA 1.487 1.397 0 C-N-CA 124.922 1.289 . . . . 0.0 114.251 -178.721 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.33 77.0 m-85 . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -70.55 76.9 0.58 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 120.229 1.377 . . . . 0.0 114.006 -172.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.1 t -168.73 173.98 6.9 Favored 'General case' 0 CA--C 1.572 1.821 0 CA-C-O 122.622 1.201 . . . . 0.0 111.93 -165.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.9 m -90.96 133.61 35.14 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.268 -0.895 . . . . 0.0 110.353 171.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -132.2 101.18 5.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.948 -0.47 . . . . 0.0 110.068 -172.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -91.28 135.32 33.88 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.475 -0.766 . . . . 0.0 111.988 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -61.2 121.32 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -99.51 -45.2 5.89 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 117.416 -1.278 . . . . 0.0 114.223 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.57 116.34 1.26 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 120.293 1.406 . . . . 0.0 110.088 -169.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.1 p -100.32 105.41 16.93 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.539 0.736 . . . . 0.0 111.921 -177.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -90.43 126.04 35.77 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.192 0.597 . . . . 0.0 111.635 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.257 45.3 t30 60.1 26.29 15.65 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 117.681 2.474 . . . . 0.0 117.681 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -72.19 -42.84 65.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -60.13 -40.53 90.11 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 117.616 2.451 . . . . 0.0 117.616 171.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.74 -44.18 70.79 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 172.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -44.16 -57.71 3.27 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 158.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.2 mtt -57.0 -42.68 80.73 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 172.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -58.35 -43.92 88.54 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 168.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -59.79 -35.14 74.05 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 168.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 58.0 mtm -66.84 -37.73 85.05 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 170.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.77 59.39 0.45 Allowed Glycine 0 N--CA 1.487 2.089 0 C-N-CA 123.776 0.703 . . . . 0.0 114.745 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.426 HG13 ' HG2' ' A' ' 28' ' ' ARG . 2.4 p -129.31 136.95 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 122.278 1.037 . . . . 0.0 110.413 177.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -63.02 143.91 57.36 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.276 13.7 tt -51.03 -42.49 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -176.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.8 t -60.81 -50.36 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 119.59 1.086 . . . . 0.0 113.125 171.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -56.41 -42.33 77.83 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 167.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HG2' HG13 ' A' ' 23' ' ' VAL . 57.4 mtm-85 -58.79 -47.05 86.08 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 169.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -59.12 -46.35 88.55 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 170.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.51 -47.75 80.42 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 171.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.09 -25.73 63.65 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.19 76.62 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-N 121.31 1.868 . . . . 0.0 115.043 156.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -78.82 59.42 2.57 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 171.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -97.03 -27.28 14.68 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -175.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.387 1.3 p-10 57.8 55.68 5.28 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -173.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.0 tp -80.17 121.43 25.57 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.419 1.104 . . . . 0.0 113.902 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -106.18 118.33 36.34 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.81 167.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.2 mt -97.4 101.01 12.45 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 51.7 m -94.41 109.5 21.36 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.998 -1.064 . . . . 0.0 109.421 171.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.2 mt -103.79 112.75 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -166.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 87.6 m -103.31 106.3 16.78 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -89.04 108.97 19.88 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.297 0.639 . . . . 0.0 111.948 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.7 70.76 6.71 Favored 'General case' 0 CA--C 1.572 1.809 0 O-C-N 121.587 -0.696 . . . . 0.0 110.486 166.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.99 -96.49 0.22 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 115.515 0.966 . . . . 0.0 115.515 -174.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -87.93 -23.19 23.97 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 169.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -88.85 111.36 21.96 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 121.046 1.748 . . . . 0.0 111.974 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -94.63 117.44 30.14 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.518 0.727 . . . . 0.0 109.181 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.6 m -93.83 97.99 10.77 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.9 t -92.82 105.46 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -86.34 101.79 13.42 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.178 0.591 . . . . 0.0 109.606 -176.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -90.85 97.55 11.25 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.234 0.614 . . . . 0.0 109.837 -172.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -110.54 102.83 11.39 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 122.991 0.516 . . . . 0.0 110.845 -175.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.8 p -140.31 -178.92 5.71 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.028 0.931 . . . . 0.0 111.72 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.86 -29.99 67.38 Favored 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 159.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -97.95 -17.62 19.11 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 174.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -130.07 142.07 50.65 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 121.382 1.901 . . . . 0.0 111.975 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -144.29 74.33 1.42 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.016 -1.052 . . . . 0.0 109.796 162.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.2 pt -143.07 130.16 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.283 -0.886 . . . . 0.0 112.007 -166.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.82 99.84 11.64 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.248 1.019 . . . . 0.0 111.559 172.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.9 t -91.42 98.28 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.174 -0.954 . . . . 0.0 109.19 -169.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.1 t -86.4 119.49 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 123.344 0.658 . . . . 0.0 109.312 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -140.64 133.42 28.97 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.328 0.585 . . . . 0.0 111.532 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -86.45 139.8 30.56 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 121.808 -0.557 . . . . 0.0 111.246 167.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.75 128.43 36.53 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.89 -11.48 59.77 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 119.642 2.617 . . . . 0.0 119.642 -172.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.2 t -85.59 133.01 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 120.43 2.115 . . . . 0.0 110.33 -175.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -77.4 114.11 15.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.508 -0.745 . . . . 0.0 111.466 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -138.56 163.05 33.03 Favored 'General case' 0 CA--C 1.572 1.791 0 C-N-CA 123.264 0.626 . . . . 0.0 112.607 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -85.89 111.17 19.96 Favored 'General case' 0 CA--C 1.57 1.727 0 O-C-N 121.515 -0.741 . . . . 0.0 111.752 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -102.4 156.15 17.78 Favored 'General case' 0 CA--C 1.572 1.796 0 CA-C-O 122.17 0.986 . . . . 0.0 112.678 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -127.18 149.41 49.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.4 -0.812 . . . . 0.0 111.532 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.4 mt -92.97 -113.28 0.1 Allowed 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 118.804 -0.617 . . . . 0.0 110.263 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -146.5 58.91 1.21 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 120.776 1.625 . . . . 0.0 112.718 170.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -159.9 -78.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.116 0.966 . . . . 0.0 108.456 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.18 76.57 0.06 OUTLIER Glycine 0 N--CA 1.481 1.667 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.7 m -147.4 122.22 9.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.731 -0.864 . . . . 0.0 109.212 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -97.96 116.55 30.41 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.403 0.681 . . . . 0.0 110.683 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 70.9 mt -115.48 106.01 13.47 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.46 0.704 . . . . 0.0 110.91 -170.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -82.62 118.73 23.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.41 -0.806 . . . . 0.0 111.743 174.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.56 -167.96 41.06 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 117.741 1.856 . . . . 0.0 117.741 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.8 p -128.22 124.92 37.92 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.675 -0.763 . . . . 0.0 111.534 -163.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -85.92 129.41 34.84 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 118.194 0.452 . . . . 0.0 111.361 161.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.8 t -122.83 137.39 54.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.721 -0.612 . . . . 0.0 111.79 173.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.8 tp -90.93 107.68 19.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.898 -1.126 . . . . 0.0 111.572 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -103.48 75.96 1.38 Allowed 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 121.512 0.672 . . . . 0.0 109.747 171.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.25 -102.54 0.95 Allowed Glycine 0 N--CA 1.491 2.35 0 O-C-N 121.38 -0.825 . . . . 0.0 115.137 -177.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -95.67 22.33 7.31 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -129.84 114.53 16.02 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.713 -1.242 . . . . 0.0 110.03 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.9 mt -84.03 104.68 14.3 Favored 'General case' 0 CA--C 1.564 1.481 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 161.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.1 tt -94.1 114.53 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.466 -0.771 . . . . 0.0 110.231 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -103.07 99.18 1.76 Allowed Glycine 0 N--CA 1.482 1.706 0 C-N-CA 123.689 0.661 . . . . 0.0 113.289 -174.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -90.5 92.75 9.0 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -120.27 134.64 55.22 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.18 0.592 . . . . 0.0 112.503 -168.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -115.68 145.08 43.06 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.514 0.725 . . . . 0.0 109.875 169.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -70.2 123.95 22.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.446 -1.409 . . . . 0.0 112.675 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.281 9.8 t -81.05 59.78 3.97 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 122.625 1.202 . . . . 0.0 113.824 169.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -168.12 -63.31 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.767 0 C-N-CA 125.916 1.686 . . . . 0.0 107.796 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -80.34 -38.72 30.0 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.146 1.535 . . . . 0.0 115.146 171.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.74 -31.17 9.04 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 117.359 1.704 . . . . 0.0 117.359 -158.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -65.86 143.21 57.6 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -165.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -69.13 129.63 40.43 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 175.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.5 tt -121.59 86.06 2.51 Favored 'General case' 0 CA--C 1.563 1.472 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 168.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -83.05 109.06 16.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.987 -1.07 . . . . 0.0 109.735 -167.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 m -111.89 111.38 22.29 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.84 -0.538 . . . . 0.0 110.085 -166.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.0 t -107.1 101.63 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.022 -1.049 . . . . 0.0 109.05 -175.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.4 mtm-85 -84.3 117.32 23.49 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.296 0.639 . . . . 0.0 110.887 174.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -147.76 135.07 20.59 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.816 -1.177 . . . . 0.0 113.347 -173.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 mp -85.14 113.95 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.135 -0.978 . . . . 0.0 108.381 177.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.22 84.58 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.29 -84.41 0.73 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 114.728 0.651 . . . . 0.0 114.728 -173.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -103.52 -40.31 6.39 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -101.87 140.34 36.28 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 120.255 1.388 . . . . 0.0 113.096 -169.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.0 tp -76.73 111.34 12.14 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.834 0.853 . . . . 0.0 110.723 172.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 m -99.24 120.04 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -103.32 99.46 9.3 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.542 0.737 . . . . 0.0 109.377 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.4 m -94.18 112.02 23.79 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.301 0.64 . . . . 0.0 110.172 -171.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -90.09 133.3 34.94 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.669 0.788 . . . . 0.0 111.565 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.2 t -119.85 101.61 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 163.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -95.05 94.14 7.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.39 -0.818 . . . . 0.0 109.728 171.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.287 4.6 mm-40 70.35 -69.81 0.17 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -153.13 62.06 0.38 Allowed Glycine 0 N--CA 1.486 2.021 0 CA-C-O 119.784 -0.453 . . . . 0.0 113.683 165.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.5 p -144.58 113.59 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 117.77 0.785 . . . . 0.0 109.05 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -87.56 118.47 27.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.705 -0.622 . . . . 0.0 111.368 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -130.78 131.35 44.63 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 122.839 0.456 . . . . 0.0 111.686 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -115.46 118.02 32.01 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.435 -0.79 . . . . 0.0 111.169 -173.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -93.69 104.62 16.71 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 167.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.76 127.04 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -115.66 130.33 56.82 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.886 0.874 . . . . 0.0 110.264 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -78.61 143.98 35.92 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 121.77 0.795 . . . . 0.0 113.04 176.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -61.95 115.03 3.72 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 123.927 0.891 . . . . 0.0 112.769 171.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.2 t70 . . . . . 0 N--CA 1.489 1.476 0 C-N-CA 124.93 1.292 . . . . 0.0 112.345 -170.401 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 . . . . . 0 CA--C 1.581 2.149 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.6 90.06 8.23 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 119.799 -1.813 . . . . 0.0 114.03 -157.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.2 m -158.13 -175.22 5.22 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 124.499 1.12 . . . . 0.0 110.808 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.0 m -99.69 113.09 25.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.808 -1.182 . . . . 0.0 109.441 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -117.81 108.16 15.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.912 -0.493 . . . . 0.0 109.84 -170.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -93.26 140.51 29.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.269 -0.895 . . . . 0.0 112.31 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.4 p -63.75 116.52 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -98.66 -59.35 1.76 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.547 0.739 . . . . 0.0 111.798 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -141.28 166.08 25.76 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.837 0.827 . . . . 0.0 110.846 177.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.4 m -153.71 126.41 8.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 119.236 -2.165 . . . . 0.0 112.142 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -100.8 121.82 42.35 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.741 0.816 . . . . 0.0 109.932 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.267 14.0 t30 65.29 13.57 8.86 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 171.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -63.59 -40.32 96.64 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.21 -27.04 68.71 Favored 'General case' 0 CA--C 1.577 2.014 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 169.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -73.92 -49.44 24.76 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 120.32 1.418 . . . . 0.0 113.8 165.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -46.8 -51.45 16.41 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 166.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -40.73 76.01 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 166.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -59.89 -45.9 91.04 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 168.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -54.59 -38.44 66.74 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 167.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.6 mtm -68.59 -21.7 64.5 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 168.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.12 49.21 1.77 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 116.212 1.245 . . . . 0.0 116.212 175.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.65 151.9 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 118.673 1.236 . . . . 0.0 113.614 -177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -63.08 144.59 56.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.283 13.2 tt -52.66 -45.13 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.3 t -55.5 -52.31 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 124.023 0.929 . . . . 0.0 113.457 168.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -61.56 -46.11 91.27 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 176.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.7 ptt85 -69.68 -28.81 66.17 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 117.975 2.584 . . . . 0.0 117.975 171.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -62.5 -49.1 76.69 Favored 'General case' 0 CA--C 1.572 1.807 0 CA-C-N 120.09 1.314 . . . . 0.0 114.302 161.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.28 -59.89 4.69 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 170.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.08 -16.79 20.94 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 118.915 2.931 . . . . 0.0 118.915 175.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.05 -86.49 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 117.693 -1.146 . . . . 0.0 112.701 159.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -106.4 48.93 0.82 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 121.814 2.097 . . . . 0.0 115.21 -171.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.0 54.27 2.7 Favored 'General case' 0 CA--C 1.576 1.977 0 O-C-N 120.765 -1.209 . . . . 0.0 113.869 166.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 50.7 50.8 18.24 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 117.563 2.431 . . . . 0.0 117.563 171.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -87.0 124.02 32.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.787 -1.196 . . . . 0.0 113.708 -169.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -119.75 121.41 39.11 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.086 0.954 . . . . 0.0 110.406 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.4 mt -91.44 102.19 14.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.553 -0.717 . . . . 0.0 109.301 176.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 87.0 m -95.21 103.5 15.36 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.4 mt -101.67 128.37 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -167.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.3 p -128.99 122.34 29.9 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 171.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -94.33 131.95 39.43 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.823 0.82 . . . . 0.0 111.251 168.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -97.72 36.86 1.45 Allowed 'General case' 0 CA--C 1.582 2.2 0 C-N-CA 124.603 1.161 . . . . 0.0 113.528 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.79 92.06 0.23 Allowed Glycine 0 N--CA 1.492 2.413 0 O-C-N 120.196 -1.565 . . . . 0.0 113.536 -168.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.279 16.8 t-20 71.58 -61.18 0.5 Allowed 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -74.76 133.65 41.95 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -172.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -111.26 134.24 53.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.492 -0.755 . . . . 0.0 112.132 -173.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.2 m -107.16 113.54 27.04 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 161.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.4 t -110.53 104.87 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -81.66 103.9 11.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 110.189 175.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -90.39 96.26 10.57 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.8 t -102.27 117.05 33.92 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.361 0.664 . . . . 0.0 111.274 -170.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.9 p -143.26 164.81 29.2 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.683 0.754 . . . . 0.0 112.903 -173.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.07 -25.51 65.44 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 159.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -73.03 -50.28 23.93 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -162.88 153.87 17.13 Favored 'General case' 0 CA--C 1.572 1.813 0 C-N-CA 124.408 1.083 . . . . 0.0 111.828 -171.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -129.87 104.14 7.21 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.517 -0.74 . . . . 0.0 109.128 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.28 142.13 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.48 -0.762 . . . . 0.0 112.15 -170.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -89.2 114.65 26.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.578 -0.701 . . . . 0.0 112.614 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.9 t -96.82 102.54 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.39 124.48 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 123.065 0.546 . . . . 0.0 109.598 -175.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -146.32 139.1 25.46 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.238 0.615 . . . . 0.0 111.344 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -97.65 142.37 29.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.26 164.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.74 112.36 3.67 Favored 'General case' 0 CA--C 1.566 1.571 0 O-C-N 121.584 -0.697 . . . . 0.0 112.617 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.56 -18.05 58.14 Favored Glycine 0 CA--C 1.558 2.723 0 N-CA-C 119.488 2.555 . . . . 0.0 119.488 -163.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 65.3 t -94.77 112.65 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 120.453 2.127 . . . . 0.0 109.039 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 t -73.07 139.48 46.56 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -131.54 166.81 20.54 Favored 'General case' 0 CA--C 1.574 1.866 0 C-N-CA 124.295 1.038 . . . . 0.0 112.832 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -93.1 120.71 33.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.433 -0.792 . . . . 0.0 110.543 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -119.92 123.27 43.15 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.345 0.658 . . . . 0.0 111.8 -176.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -81.48 127.17 32.53 Favored 'General case' 0 CA--C 1.566 1.584 0 O-C-N 121.329 -0.857 . . . . 0.0 109.703 161.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 57.3 mt -63.36 177.59 0.64 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 168.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.86 35.31 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 118.341 2.719 . . . . 0.0 118.341 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -154.6 -82.7 0.07 Allowed 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.753 1.221 . . . . 0.0 108.951 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.0 74.17 0.09 OUTLIER Glycine 0 N--CA 1.483 1.81 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 55.5 m -152.63 110.36 3.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.91 -0.759 . . . . 0.0 109.301 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -84.84 115.12 22.57 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-O 122.066 0.936 . . . . 0.0 112.224 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.2 mt -107.7 152.24 24.6 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 125.015 1.326 . . . . 0.0 111.442 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -116.26 111.39 20.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.042 -1.036 . . . . 0.0 109.795 174.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.24 -174.99 38.78 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 114.667 0.627 . . . . 0.0 114.667 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.9 m -117.25 -58.5 2.04 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -163.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . 0.272 69.6 m95 76.46 91.3 0.07 Allowed 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.488 1.115 . . . . 0.0 111.284 -153.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.2 m -105.37 127.88 53.2 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.261 0.624 . . . . 0.0 110.731 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.1 tp -78.53 102.64 8.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.0 111.158 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -81.54 -58.06 3.19 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.69 -96.21 1.12 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 160.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -102.34 57.21 0.79 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 117.774 0.787 . . . . 0.0 110.878 154.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -147.53 111.9 5.24 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -173.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.7 mt -86.4 101.86 13.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.582 -0.698 . . . . 0.0 109.746 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.8 tt -88.77 107.28 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.262 1.029 . . . . 0.0 110.638 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.73 93.14 1.72 Allowed Glycine 0 N--CA 1.48 1.592 0 C-N-CA 123.63 0.633 . . . . 0.0 112.954 174.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -86.75 92.44 8.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -112.07 108.31 17.56 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.352 0.661 . . . . 0.0 111.088 -165.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -89.97 129.75 36.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.972 -1.08 . . . . 0.0 110.851 177.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -61.14 135.66 57.83 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.7 p -64.32 -64.0 0.99 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 161.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -86.94 72.67 10.07 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 121.526 -0.734 . . . . 0.0 111.038 171.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 171.11 -39.32 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 126.527 1.931 . . . . 0.0 112.627 168.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 70.38 22.69 77.7 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 118.491 2.156 . . . . 0.0 118.491 -164.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -121.83 157.89 30.09 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.482 1.134 . . . . 0.0 113.394 -169.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -84.97 124.97 32.29 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -166.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.15 111.77 20.72 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.02 0.928 . . . . 0.0 108.717 170.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -103.65 111.99 24.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.301 -0.874 . . . . 0.0 108.883 -173.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.4 m -111.03 104.06 12.59 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 119.771 1.169 . . . . 0.0 110.828 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.7 t -90.25 104.06 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.13 -0.981 . . . . 0.0 108.62 177.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.5 118.86 24.57 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.584 0.754 . . . . 0.0 110.381 171.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -149.4 147.64 28.52 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 119.511 1.051 . . . . 0.0 113.524 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 mp -93.63 123.53 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.969 -1.082 . . . . 0.0 109.261 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 44.4 mm -103.5 92.11 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 170.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.11 -97.58 1.16 Allowed Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.339 -0.851 . . . . 0.0 114.176 -173.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -130.4 49.3 2.31 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 121.897 0.856 . . . . 0.0 111.773 166.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -144.25 116.68 8.56 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 124.015 0.926 . . . . 0.0 108.581 -173.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.8 tp -89.0 115.18 26.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.694 -0.629 . . . . 0.0 110.621 -173.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.4 m -105.56 121.09 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -98.24 108.57 21.3 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.732 0.813 . . . . 0.0 109.914 171.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.4 m -91.0 98.51 11.82 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -90.51 114.07 26.19 Favored 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 124.395 1.078 . . . . 0.0 111.349 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.56 105.91 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-N 119.203 0.91 . . . . 0.0 108.576 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -108.65 114.41 28.2 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 118.917 0.78 . . . . 0.0 109.774 167.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 53.66 50.21 17.63 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.21 -26.41 4.43 Favored Glycine 0 CA--C 1.554 2.472 0 N-CA-C 119.296 2.479 . . . . 0.0 119.296 -168.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.9 t -83.59 104.38 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 120.262 2.031 . . . . 0.0 109.928 -170.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -87.37 132.26 34.02 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -130.9 121.93 26.09 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.671 0.789 . . . . 0.0 111.717 171.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -101.0 106.09 17.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.445 -0.784 . . . . 0.0 110.948 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -93.94 125.52 38.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.794 -0.566 . . . . 0.0 111.47 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.8 mt -116.81 116.84 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -165.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -113.46 130.23 56.37 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.028 0.931 . . . . 0.0 110.445 -172.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -82.77 140.7 32.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.904 . . . . 0.0 112.054 174.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -62.77 107.19 0.92 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.554 -0.716 . . . . 0.0 111.518 162.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -162.487 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.3 92.6 m-85 . . . . . 0 N--CA 1.501 2.097 0 CA-C-O 122.308 1.051 . . . . 0.0 113.154 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.27 17.6 m-20 66.79 50.76 1.09 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.9 t -157.28 -170.02 3.11 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 121.197 -0.94 . . . . 0.0 111.543 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.0 m -97.59 116.85 30.61 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.986 -1.071 . . . . 0.0 109.803 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -116.76 105.34 12.28 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.338 0.655 . . . . 0.0 109.538 -169.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -93.72 132.66 37.86 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.45 0.7 . . . . 0.0 110.86 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 p -57.07 116.56 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.952 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.46 -49.7 5.79 Favored 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 124.411 1.084 . . . . 0.0 112.913 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -149.71 116.62 5.94 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.529 1.059 . . . . 0.0 110.744 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.9 p -97.29 100.67 12.13 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.686 0.794 . . . . 0.0 111.564 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -95.14 125.37 39.74 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.421 0.688 . . . . 0.0 110.665 -169.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.268 42.7 t30 63.56 25.69 14.47 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -73.52 -45.73 52.03 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 115.605 1.705 . . . . 0.0 115.605 -173.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -61.41 -27.8 68.8 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -74.42 -46.28 41.12 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.966 1.257 . . . . 0.0 114.092 165.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -49.48 -52.71 27.42 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 164.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -31.2 72.32 Favored 'General case' 0 CA--C 1.574 1.888 0 N-CA-C 116.313 1.968 . . . . 0.0 116.313 172.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.47 -37.89 86.11 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 121.16 1.8 . . . . 0.0 115.476 163.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -60.05 -39.47 86.07 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 165.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 83.0 mmm -60.68 -45.68 93.25 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 165.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.78 51.42 0.57 Allowed Glycine 0 N--CA 1.484 1.878 0 C-N-CA 124.294 0.95 . . . . 0.0 114.8 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.4 m -108.61 142.4 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.479 1.133 . . . . 0.0 112.776 -178.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -66.5 154.89 39.14 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.305 0.1 OUTLIER -43.77 -56.1 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 -173.373 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.83 -51.55 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 CA-C-N 119.563 1.074 . . . . 0.0 113.082 175.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -55.67 -42.07 74.58 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 170.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.1 ttp85 -60.72 -50.63 72.72 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 169.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -60.53 -43.45 97.13 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 169.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.61 -38.72 88.68 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 167.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.68 -41.5 96.01 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 169.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.26 -51.42 67.79 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 162.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -96.61 58.89 1.74 Allowed 'General case' 0 CA--C 1.572 1.82 0 CA-C-N 119.328 0.967 . . . . 0.0 111.965 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -96.57 -16.33 21.12 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.696 2.109 . . . . 0.0 116.696 -170.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 55.31 57.31 5.55 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 119.878 1.217 . . . . 0.0 114.162 -167.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.4 tp -80.73 117.42 21.39 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 121.969 0.89 . . . . 0.0 111.301 -176.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -122.01 109.52 14.68 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.011 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 84.3 mt -94.89 106.68 18.69 Favored 'General case' 0 CA--C 1.563 1.442 0 C-N-CA 123.31 0.644 . . . . 0.0 110.227 -174.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.0 m -92.11 109.05 20.4 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.268 -0.895 . . . . 0.0 109.894 170.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.4 mt -101.5 133.99 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.739 0 C-N-CA 124.409 1.084 . . . . 0.0 108.53 -170.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t -153.02 125.67 8.27 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.939 -1.101 . . . . 0.0 111.729 171.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -87.29 116.94 25.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.129 -0.982 . . . . 0.0 112.08 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -103.11 75.29 1.36 Allowed 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.413 0.685 . . . . 0.0 110.256 171.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.68 75.29 0.43 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 115.947 1.139 . . . . 0.0 115.947 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.276 10.9 t-20 70.28 -48.67 0.64 Allowed 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -167.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -68.94 114.14 6.97 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 119.313 0.96 . . . . 0.0 113.352 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -88.43 120.48 29.85 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.154 0.582 . . . . 0.0 111.181 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.1 m -89.39 109.34 20.26 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 167.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.0 t -109.71 109.01 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -82.89 106.06 14.4 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -85.57 84.94 7.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.999 0.52 . . . . 0.0 109.906 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 t -85.84 111.06 19.84 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.564 0.345 . . . . 0.0 110.848 -176.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.2 p -142.93 159.85 41.46 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -169.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.34 -27.75 56.86 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 118.321 2.711 . . . . 0.0 118.321 169.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -74.24 -46.86 38.94 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 164.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.7 ptt-85 -167.02 150.76 6.71 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.772 0.829 . . . . 0.0 112.171 -170.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.65 96.62 6.08 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.585 0.754 . . . . 0.0 110.878 171.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.6 pt -119.59 127.47 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.569 -0.707 . . . . 0.0 112.416 -169.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.38 112.13 13.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.542 -0.724 . . . . 0.0 112.166 170.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.5 t -104.75 102.15 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.24 116.79 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -133.14 135.34 45.12 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.438 0.637 . . . . 0.0 111.53 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -80.61 136.27 36.2 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.595 -0.69 . . . . 0.0 111.328 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 57.1 mt -60.06 125.24 22.88 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -176.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.18 -5.7 70.87 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 119.708 2.643 . . . . 0.0 119.708 -172.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.4 t -88.75 133.0 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 120.122 1.961 . . . . 0.0 109.736 -176.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.7 p -72.92 110.26 7.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.65 -0.657 . . . . 0.0 111.947 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -126.83 163.02 24.52 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 124.013 0.925 . . . . 0.0 112.039 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -84.32 106.54 16.01 Favored 'General case' 0 CA--C 1.569 1.689 0 O-C-N 121.297 -0.877 . . . . 0.0 111.586 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -102.44 167.86 9.68 Favored 'General case' 0 CA--C 1.571 1.759 0 C-N-CA 124.749 1.22 . . . . 0.0 112.445 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -146.96 131.53 17.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.705 -1.247 . . . . 0.0 111.575 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.9 mt -84.83 62.77 7.63 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.271 . . 61.46 -36.49 0.11 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 120.409 3.485 . . . . 0.0 120.409 175.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -86.91 -85.89 0.16 Allowed 'General case' 0 CA--C 1.565 1.555 0 CA-C-N 120.052 1.297 . . . . 0.0 110.2 177.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.61 74.5 0.1 OUTLIER Glycine 0 N--CA 1.482 1.747 0 O-C-N 121.587 -0.696 . . . . 0.0 113.536 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.5 m -146.9 123.97 11.42 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.519 -0.989 . . . . 0.0 109.985 162.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -78.42 130.84 36.56 Favored 'General case' 0 CA--C 1.566 1.587 0 CA-C-O 122.155 0.978 . . . . 0.0 112.435 173.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.6 mt -131.61 111.52 11.8 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.242 -165.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -86.61 114.5 23.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.095 -1.003 . . . . 0.0 111.052 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.37 178.63 47.91 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 116.399 1.32 . . . . 0.0 116.399 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.1 p -92.21 165.31 13.19 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.27 1.033 . . . . 0.0 113.494 -174.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -127.23 108.83 11.22 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 143.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.4 m -100.36 137.48 38.72 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.49 0.716 . . . . 0.0 110.949 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.7 tp -85.3 94.75 9.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.215 -0.928 . . . . 0.0 111.398 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -84.49 79.18 9.66 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-O 121.836 0.827 . . . . 0.0 110.866 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.55 -94.58 0.95 Allowed Glycine 0 N--CA 1.489 2.222 0 O-C-N 121.722 -0.612 . . . . 0.0 113.908 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -126.5 63.62 1.27 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.822 0.82 . . . . 0.0 109.695 163.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -152.45 125.19 8.39 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.7 mt -90.74 105.12 17.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.56 -1.338 . . . . 0.0 109.571 171.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.1 tt -105.18 125.68 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 123.743 0.817 . . . . 0.0 110.616 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.65 118.53 1.99 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 115.58 0.992 . . . . 0.0 115.58 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -95.27 99.91 11.79 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.215 0.606 . . . . 0.0 110.229 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -107.62 107.25 17.98 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -167.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -90.48 136.58 32.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.377 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -75.54 124.86 27.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.999 -1.063 . . . . 0.0 113.239 -173.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.5 p -80.8 62.7 4.93 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 122.332 1.063 . . . . 0.0 112.723 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.4 t0 171.85 -41.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 126.732 2.013 . . . . 0.0 110.283 -166.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -121.49 -18.47 7.24 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -175.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.08 -34.91 3.64 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 118.516 2.166 . . . . 0.0 118.516 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -69.89 139.94 53.08 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -166.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -81.79 128.06 33.62 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.8 tt -106.41 85.62 2.21 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.253 8.5 p30 -81.11 110.36 16.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.334 -0.854 . . . . 0.0 110.803 -173.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.9 m -114.18 112.18 22.75 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.916 -164.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.3 t -102.39 103.86 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.1 mtm180 -85.68 120.64 27.34 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.611 -0.681 . . . . 0.0 110.211 164.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.74 157.92 43.77 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.2 mm -94.31 118.14 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.661 -1.274 . . . . 0.0 109.818 -175.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.2 tt -88.76 71.02 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.14 0.971 . . . . 0.0 111.339 171.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.68 -79.22 0.97 Allowed Glycine 0 N--CA 1.491 2.332 0 O-C-N 120.704 -1.248 . . . . 0.0 114.874 -172.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -107.67 -33.64 7.23 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -93.84 146.22 24.05 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 120.482 1.492 . . . . 0.0 112.82 -174.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.3 tp -86.9 115.87 24.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 110.79 174.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 19.6 m -98.03 115.83 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.354 -0.841 . . . . 0.0 109.752 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -97.39 101.73 13.33 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 171.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.1 m -95.03 105.87 17.82 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.216 0.607 . . . . 0.0 109.558 -176.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -92.84 113.83 26.22 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 124.159 0.984 . . . . 0.0 109.505 -177.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.5 t -113.28 112.64 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -123.11 94.42 4.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.691 -0.63 . . . . 0.0 110.059 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 50.9 55.21 9.9 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 103.26 -49.87 0.93 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 117.094 1.598 . . . . 0.0 117.094 -169.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.1 p -76.45 113.4 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 119.211 1.506 . . . . 0.0 113.151 -165.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -92.18 116.89 29.34 Favored 'General case' 0 CA--C 1.563 1.446 0 O-C-N 121.91 -0.494 . . . . 0.0 111.155 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.42 139.76 48.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.914 -0.491 . . . . 0.0 111.734 163.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -120.27 110.31 16.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.886 . . . . 0.0 110.467 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -89.19 108.47 19.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.62 -0.675 . . . . 0.0 110.458 164.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.7 mp -90.22 120.89 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -110.53 131.82 54.72 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 124.05 0.94 . . . . 0.0 110.116 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -90.51 149.02 22.36 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-O 121.864 0.84 . . . . 0.0 111.817 174.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -68.25 106.87 2.59 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 112.035 173.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.046 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -75.36 77.25 2.44 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 -171.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.8 t -148.14 -177.46 5.76 Favored 'General case' 0 CA--C 1.574 1.891 0 CA-C-O 122.389 1.09 . . . . 0.0 111.266 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -95.19 115.87 27.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.126 -0.984 . . . . 0.0 109.667 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -117.37 103.72 10.41 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.97 0.508 . . . . 0.0 110.402 -169.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -86.71 135.69 33.29 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 123.539 0.735 . . . . 0.0 111.998 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.2 p -63.54 119.18 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.338 -0.851 . . . . 0.0 113.228 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -103.77 -53.2 2.81 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 124.021 0.929 . . . . 0.0 113.084 -173.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -149.05 85.54 1.47 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 119.212 0.915 . . . . 0.0 111.095 -172.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.4 p -73.32 120.2 18.61 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 178.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -104.28 115.22 30.02 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 123.544 0.737 . . . . 0.0 109.831 -169.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.1 t30 62.05 17.7 9.31 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 118.116 2.635 . . . . 0.0 118.116 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -75.85 -35.83 59.8 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -168.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.95 -26.17 68.03 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 162.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -71.36 -47.49 56.03 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 119.917 1.235 . . . . 0.0 114.245 166.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -43.9 -50.68 7.97 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 160.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.7 mtt -64.84 -32.98 74.93 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 172.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.42 -43.41 93.05 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 120.897 1.681 . . . . 0.0 115.326 162.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -62.09 -34.73 76.86 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 169.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 22.1 mmt -60.3 -30.28 69.39 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 164.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.94 50.41 3.29 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 115.612 1.005 . . . . 0.0 115.612 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.3 m -89.8 160.63 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 121.984 0.897 . . . . 0.0 113.208 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -70.86 154.75 41.55 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 165.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.269 14.7 tt -59.14 -36.87 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.11 -56.0 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-N 119.558 1.072 . . . . 0.0 112.922 172.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -65.19 -28.78 69.63 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 116.788 2.144 . . . . 0.0 116.788 172.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.5 ttp85 -58.9 -42.23 89.09 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 117.27 2.322 . . . . 0.0 117.27 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.5 OUTLIER -77.36 -48.24 17.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 162.343 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.84 -51.33 62.66 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -175.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.19 -37.04 85.64 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 173.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.71 -51.42 65.05 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 168.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -100.12 47.76 0.93 Allowed 'General case' 0 CA--C 1.574 1.881 0 CA-C-N 118.954 0.797 . . . . 0.0 112.703 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -83.99 16.27 2.96 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -169.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 53.44 50.19 17.94 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.164 -1.585 . . . . 0.0 115.136 -170.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.2 tp -80.23 120.65 24.61 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 121.88 0.847 . . . . 0.0 112.873 -171.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -111.87 121.06 44.0 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.287 172.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.6 mt -101.9 102.54 13.12 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.969 0.508 . . . . 0.0 109.966 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.2 m -89.86 108.82 19.93 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.328 -0.858 . . . . 0.0 109.231 169.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.0 mt -101.57 128.9 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -172.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 t -145.31 133.65 21.78 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.894 -1.129 . . . . 0.0 111.56 171.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -99.95 118.87 37.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.194 -0.942 . . . . 0.0 112.3 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -100.81 71.2 1.44 Allowed 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 123.137 0.575 . . . . 0.0 110.636 169.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 62.39 77.33 0.21 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 116.552 1.381 . . . . 0.0 116.552 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.278 7.1 t30 72.21 -24.72 0.18 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -170.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -90.0 109.62 20.64 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 119.657 1.117 . . . . 0.0 111.901 172.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -83.04 118.01 23.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.516 -0.74 . . . . 0.0 111.161 169.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.6 m -86.23 107.55 17.97 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 164.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.07 112.67 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -87.24 111.36 20.94 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.286 0.634 . . . . 0.0 110.351 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -89.99 89.46 7.72 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.289 0.635 . . . . 0.0 109.467 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.7 m -97.4 107.7 20.27 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.8 p -145.84 174.0 11.62 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.02 0.914 . . . . 0.0 113.23 -171.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.85 -30.32 65.69 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 118.432 2.753 . . . . 0.0 118.432 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.2 -31.64 30.24 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 168.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -159.24 155.27 26.7 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 119.926 1.239 . . . . 0.0 113.357 -159.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -134.64 99.88 4.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.068 -1.02 . . . . 0.0 108.748 165.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.6 pt -132.22 129.75 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.854 -0.529 . . . . 0.0 111.704 -169.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.13 109.66 19.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.203 -0.936 . . . . 0.0 111.762 174.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.8 t -100.43 107.8 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -175.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -92.36 109.99 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -120.26 129.03 53.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.856 -0.528 . . . . 0.0 111.203 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -80.63 130.87 35.36 Favored 'General case' 0 CA--C 1.562 1.425 0 O-C-N 121.666 -0.646 . . . . 0.0 111.117 168.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.3 mt -61.45 124.22 20.03 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.72 -17.45 58.58 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 119.354 2.502 . . . . 0.0 119.354 -166.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.5 t -89.46 134.93 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-N 120.768 2.284 . . . . 0.0 110.41 -176.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -76.87 116.43 17.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.579 -0.701 . . . . 0.0 112.594 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -135.68 159.2 42.38 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 123.651 0.78 . . . . 0.0 111.297 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.03 94.29 7.48 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 121.306 -0.871 . . . . 0.0 112.404 -172.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -89.39 145.76 25.12 Favored 'General case' 0 CA--C 1.569 1.701 0 O-C-N 121.499 -0.751 . . . . 0.0 112.458 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -128.33 126.01 39.89 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.428 -0.795 . . . . 0.0 110.832 -174.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.7 mt -94.65 74.1 3.7 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -173.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.32 . . 65.7 -61.52 0.26 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -67.63 -18.24 64.89 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 119.141 3.015 . . . . 0.0 119.141 174.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.89 31.35 5.73 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 117.515 1.766 . . . . 0.0 117.515 -163.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.1 m -81.45 99.07 8.54 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.129 0.965 . . . . 0.0 109.176 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -85.72 99.39 11.3 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -160.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.6 mt -112.55 113.87 26.24 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.787 0.835 . . . . 0.0 110.832 -167.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -97.22 123.5 41.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.944 . . . . 0.0 111.336 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.71 179.76 46.4 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 118.061 1.984 . . . . 0.0 118.061 -169.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 80.7 p -114.32 134.03 55.25 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.013 -1.093 . . . . 0.0 111.357 -169.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -89.85 119.54 30.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.852 . . . . 0.0 109.974 162.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.6 m -117.17 125.71 51.63 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.175 0.59 . . . . 0.0 110.997 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 tp -91.48 100.22 13.02 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.263 0.625 . . . . 0.0 111.243 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.86 68.79 2.06 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.456 0.703 . . . . 0.0 111.801 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.19 69.23 1.42 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 116.208 1.243 . . . . 0.0 116.208 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.256 1.1 t30 59.46 29.08 18.6 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 -168.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -138.01 111.66 8.2 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.4 mt -95.45 105.1 17.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.488 -0.758 . . . . 0.0 109.72 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.5 tt -95.02 121.12 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.978 0.894 . . . . 0.0 109.807 173.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.8 101.95 2.83 Favored Glycine 0 N--CA 1.479 1.557 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.467 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -91.83 96.44 10.41 Favored 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -121.3 149.45 42.88 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.163 0.982 . . . . 0.0 112.201 -168.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -121.77 139.56 53.44 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 121.857 0.837 . . . . 0.0 109.669 167.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.7 mmm-85 -61.8 115.69 4.21 Favored 'General case' 0 CA--C 1.562 1.427 0 O-C-N 121.451 -0.781 . . . . 0.0 112.889 166.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.8 p -60.22 -55.97 27.22 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 169.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -83.59 55.03 3.05 Favored 'General case' 0 CA--C 1.578 2.036 0 O-C-N 121.58 -0.7 . . . . 0.0 112.375 171.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -175.32 -35.7 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 172.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.81 21.23 77.03 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 118.588 2.195 . . . . 0.0 118.588 -165.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -119.59 145.98 45.92 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.484 1.142 . . . . 0.0 113.154 -168.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.26 135.99 34.11 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -168.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.6 tt -123.8 130.78 53.16 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.612 1.165 . . . . 0.0 110.625 174.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -111.93 116.16 30.16 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.6 m -109.5 102.71 11.55 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 120.649 1.568 . . . . 0.0 110.493 171.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.8 t -102.59 90.91 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -174.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -99.58 137.22 38.38 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.336 1.065 . . . . 0.0 113.071 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -157.89 154.03 27.25 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.89 -174.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.5 mm -93.69 108.74 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.436 -0.79 . . . . 0.0 109.453 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.254 16.4 tt -86.29 71.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 122.152 0.977 . . . . 0.0 111.234 172.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.46 -84.92 0.95 Allowed Glycine 0 N--CA 1.489 2.228 0 O-C-N 121.012 -1.055 . . . . 0.0 114.56 -174.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -129.72 65.1 1.49 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 122.665 0.386 . . . . 0.0 110.044 167.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -164.36 125.37 2.16 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.424 0.69 . . . . 0.0 110.009 170.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.1 tp -83.22 102.81 12.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.609 -0.682 . . . . 0.0 109.197 171.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.4 m -91.7 98.45 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -96.17 95.3 8.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.095 -1.003 . . . . 0.0 110.757 -170.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.9 m -89.6 102.58 15.26 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.236 0.614 . . . . 0.0 111.184 -166.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -90.24 119.78 30.84 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.745 0.818 . . . . 0.0 110.85 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.8 t -120.2 104.61 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -113.41 118.27 34.08 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.094 0.557 . . . . 0.0 110.657 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.28 53.0 mt-10 64.9 -79.33 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 123.834 0.854 . . . . 0.0 112.829 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -151.3 58.25 0.43 Allowed Glycine 0 N--CA 1.487 2.051 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.993 157.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.2 p -133.79 112.79 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 118.34 1.07 . . . . 0.0 109.834 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -89.64 124.5 34.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.476 -0.765 . . . . 0.0 111.264 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.24 127.14 20.68 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 170.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -98.68 121.71 40.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.926 . . . . 0.0 111.535 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -85.75 106.98 17.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.319 157.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.7 mt -96.6 115.26 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -176.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -111.3 134.15 53.1 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 122.985 0.514 . . . . 0.0 111.184 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -94.7 147.07 23.7 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-O 121.74 0.781 . . . . 0.0 112.417 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -72.84 116.1 12.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.425 -0.797 . . . . 0.0 112.312 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -172.787 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.264 0 CA-C-O 121.527 0.679 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.302 96.4 m-85 73.82 -54.97 0.68 Allowed 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 174.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -76.84 82.45 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.832 1.197 . . . . 0.0 112.847 -171.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.9 m -170.59 172.85 5.71 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 124.86 1.264 . . . . 0.0 110.832 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.6 m -83.63 113.93 21.19 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.089 -1.007 . . . . 0.0 111.217 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -118.04 113.76 22.11 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.547 0.739 . . . . 0.0 109.914 -175.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -108.33 140.71 41.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.509 -0.745 . . . . 0.0 112.398 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.8 p -62.35 119.19 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -91.35 -54.26 3.99 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 123.765 0.826 . . . . 0.0 112.641 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -148.22 122.85 9.83 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 118.679 0.672 . . . . 0.0 110.226 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.9 m -108.83 115.06 29.36 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.466 0.706 . . . . 0.0 110.843 -172.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -110.99 111.86 23.28 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -161.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.281 12.5 t30 67.07 19.65 10.46 Favored 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 117.573 2.435 . . . . 0.0 117.573 -174.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -72.56 -38.4 67.96 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.48 -29.01 69.7 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 165.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -72.24 -53.3 12.93 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 119.551 1.069 . . . . 0.0 113.595 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -42.82 -53.93 4.38 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 162.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.9 mtt -65.45 -27.13 68.29 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 116.755 2.132 . . . . 0.0 116.755 172.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -64.4 -39.87 94.68 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 166.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -63.17 -32.3 73.66 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 165.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.6 mtm -73.94 -14.35 61.03 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 169.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.11 56.49 2.7 Favored Glycine 0 N--CA 1.487 2.039 0 CA-C-N 120.118 1.327 . . . . 0.0 115.824 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.261 6.0 p -125.35 142.47 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-O 121.795 0.807 . . . . 0.0 112.614 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -62.39 146.2 51.95 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -172.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.288 0.0 OUTLIER -44.26 -46.89 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 176.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.8 t -55.53 -61.57 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 C-N-CA 124.204 1.002 . . . . 0.0 113.345 171.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -60.23 -42.65 95.68 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 173.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.8 ttp85 -59.02 -48.21 82.42 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 173.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -66.22 -38.58 88.28 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.9 mt -65.29 -33.24 75.5 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 167.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.13 -32.77 70.93 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 168.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.97 -57.07 14.44 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 154.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -90.05 66.06 6.68 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.56 1.172 . . . . 0.0 112.054 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -101.95 -31.71 10.55 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 116.733 2.123 . . . . 0.0 116.733 -162.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 64.61 50.28 2.17 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 119.781 1.173 . . . . 0.0 113.986 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 tp -89.45 112.13 23.19 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.081 -1.012 . . . . 0.0 111.264 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -103.4 108.67 20.0 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.963 1.305 . . . . 0.0 109.046 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.6 mt -100.21 104.05 15.54 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.607 0.763 . . . . 0.0 109.542 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.2 m -94.9 102.72 14.57 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.557 -0.714 . . . . 0.0 109.448 171.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.9 mt -86.34 121.68 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.776 0.83 . . . . 0.0 108.983 -175.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.4 p -128.34 119.53 25.25 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.618 -0.676 . . . . 0.0 110.429 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -74.84 127.89 34.27 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 122.443 1.115 . . . . 0.0 112.348 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -110.94 -28.3 8.42 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -168.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.05 74.37 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 C-N-CA 124.6 1.095 . . . . 0.0 110.568 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.29 14.7 t-20 66.73 -55.96 0.42 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -150.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -53.59 148.97 8.64 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -113.95 114.8 26.69 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 171.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.1 m -87.17 100.47 12.69 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 170.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.1 t -107.21 113.59 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -171.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -83.39 109.22 17.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.357 0.663 . . . . 0.0 109.52 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -103.82 88.65 3.1 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -170.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.4 m -96.0 120.25 35.95 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.777 0.831 . . . . 0.0 111.142 -171.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.1 p -142.94 169.29 17.84 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.782 1.031 . . . . 0.0 113.782 -172.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.52 -31.27 61.94 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 163.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -79.92 -51.26 9.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 170.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -159.23 148.57 18.54 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -165.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -103.62 102.77 12.65 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 164.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.5 pt -119.05 123.96 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.613 -0.68 . . . . 0.0 111.114 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -90.25 105.4 17.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 0.0 109.935 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.5 105.68 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -170.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.7 t -91.68 99.14 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -110.79 132.63 54.03 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.244 0.545 . . . . 0.0 111.883 178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -84.78 145.7 27.75 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.443 0.64 . . . . 0.0 111.593 168.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.0 mt -63.57 102.13 0.4 Allowed 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.36 -5.16 44.58 Favored Glycine 0 CA--C 1.551 2.342 0 N-CA-C 119.19 2.436 . . . . 0.0 119.19 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.2 p -78.26 139.73 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 120.963 2.381 . . . . 0.0 112.895 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 66.0 m -86.4 105.95 17.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.556 -0.715 . . . . 0.0 109.87 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -132.0 158.37 41.67 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.436 0.694 . . . . 0.0 111.971 -175.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -82.33 95.75 7.71 Favored 'General case' 0 CA--C 1.568 1.652 0 O-C-N 121.647 -0.658 . . . . 0.0 111.202 174.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -83.92 137.81 33.47 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.558 0.694 . . . . 0.0 111.589 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -120.17 133.27 55.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.718 -0.614 . . . . 0.0 109.969 177.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.0 mt -81.72 -132.04 0.03 OUTLIER 'General case' 0 CA--C 1.576 1.958 0 O-C-N 122.093 -0.379 . . . . 0.0 111.31 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.55 -45.57 11.64 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.6 p30 -99.26 -76.38 0.54 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.741 0.816 . . . . 0.0 111.958 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.88 82.05 0.12 Allowed Glycine 0 N--CA 1.482 1.722 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -169.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.0 m -143.1 100.38 3.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.62 113.92 22.9 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.581 0.705 . . . . 0.0 111.516 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.0 mt -118.28 105.84 12.17 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.514 0.726 . . . . 0.0 110.826 -169.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -79.46 119.85 23.04 Favored 'General case' 0 CA--C 1.566 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 111.589 172.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.25 -158.37 30.41 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.8 p -127.17 142.79 51.41 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 123.135 0.574 . . . . 0.0 112.536 -158.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -100.64 116.58 32.9 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.53 -0.731 . . . . 0.0 109.316 158.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 t -122.77 130.29 52.74 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.276 0.631 . . . . 0.0 111.748 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.8 tp -84.06 116.4 22.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.849 -1.157 . . . . 0.0 111.961 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -139.78 100.29 3.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.895 -0.503 . . . . 0.0 110.923 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.27 67.29 2.13 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 116.444 1.337 . . . . 0.0 116.444 174.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.288 21.1 t-20 72.91 -55.55 0.68 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 113.763 1.024 . . . . 0.0 113.763 -157.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -81.77 134.76 35.47 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -152.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.8 mt -85.83 108.32 18.07 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.805 0.812 . . . . 0.0 109.018 170.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.7 mm -96.35 113.02 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -170.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.59 87.87 1.55 Allowed Glycine 0 N--CA 1.48 1.578 0 CA-C-O 119.558 -0.579 . . . . 0.0 112.951 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -86.58 97.68 10.66 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.744 0.783 . . . . 0.0 109.62 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -120.23 161.95 20.22 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-O 123.421 1.581 . . . . 0.0 111.92 -174.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -143.54 149.03 36.86 Favored 'General case' 0 CA--C 1.559 1.325 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.739 164.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -67.46 113.19 5.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.019 -1.051 . . . . 0.0 112.576 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.5 t -65.78 -19.81 66.03 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 165.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.14 -28.58 70.16 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 117.159 2.281 . . . . 0.0 117.159 157.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -130.23 -46.11 1.11 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 -167.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.34 -24.41 24.49 Favored Glycine 0 CA--C 1.554 2.527 0 N-CA-C 117.432 1.733 . . . . 0.0 117.432 -155.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -76.97 139.74 40.22 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 119.842 1.821 . . . . 0.0 114.577 -174.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.04 141.1 49.29 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tt -129.91 120.93 25.68 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.145 0.578 . . . . 0.0 110.061 171.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -109.87 113.9 27.02 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.934 -1.104 . . . . 0.0 109.38 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.1 m -114.35 102.53 10.19 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 119.279 0.945 . . . . 0.0 110.479 -177.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.7 t -90.23 106.13 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 120.809 -1.182 . . . . 0.0 109.595 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -86.03 115.42 23.62 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 123.477 0.711 . . . . 0.0 110.907 170.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -140.45 144.19 35.96 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 123.516 0.727 . . . . 0.0 111.914 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.3 mm -97.76 109.64 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.28 -0.888 . . . . 0.0 109.122 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.252 11.0 tp -93.01 85.02 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-O 121.945 0.878 . . . . 0.0 110.225 169.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.32 -86.89 0.91 Allowed Glycine 0 N--CA 1.49 2.282 0 O-C-N 121.289 -0.882 . . . . 0.0 114.589 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -135.42 53.57 1.96 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.386 0.613 . . . . 0.0 111.995 166.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -146.43 121.25 9.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.126 -0.984 . . . . 0.0 108.359 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.9 tp -82.7 101.23 10.73 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.3 m -101.6 105.47 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.631 -0.668 . . . . 0.0 109.279 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -92.77 109.25 20.67 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.633 -0.667 . . . . 0.0 111.246 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.3 m -91.21 108.62 20.0 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -97.64 119.49 36.31 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 123.977 0.911 . . . . 0.0 109.688 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.6 t -118.29 106.33 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -99.12 116.15 30.67 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 119.038 0.835 . . . . 0.0 109.77 172.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.265 42.0 mt-10 66.12 -79.33 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 123.65 0.78 . . . . 0.0 112.046 -176.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -148.86 42.25 0.83 Allowed Glycine 0 CA--C 1.553 2.455 0 CA-C-O 118.441 -1.199 . . . . 0.0 116.072 157.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -114.41 115.46 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-N 119.729 1.764 . . . . 0.0 110.625 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -81.99 130.34 35.05 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.45 126.13 34.26 Favored 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 123.235 0.614 . . . . 0.0 111.177 163.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -114.64 105.24 12.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.658 -0.651 . . . . 0.0 111.1 -169.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -98.58 117.83 33.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.88 -0.513 . . . . 0.0 111.209 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.9 mt -93.04 115.25 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -103.88 116.86 33.05 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -83.43 157.4 22.49 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 121.611 0.72 . . . . 0.0 111.674 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -66.64 104.27 1.26 Allowed 'General case' 0 CA--C 1.57 1.715 0 O-C-N 120.974 -1.079 . . . . 0.0 112.027 176.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 N--CA 1.491 1.594 0 C-N-CA 124.923 1.289 . . . . 0.0 114.25 -173.761 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.343 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.323 88.9 m-85 72.46 -52.63 0.7 Allowed 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 171.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.25 80.92 1.33 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 120.007 1.276 . . . . 0.0 112.857 -172.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.3 m -174.58 175.69 2.46 Favored 'General case' 0 CA--C 1.572 1.793 0 C-N-CA 125.381 1.473 . . . . 0.0 110.325 -173.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 t -98.62 134.6 41.33 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.906 -1.121 . . . . 0.0 111.462 168.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -126.78 105.01 8.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.431 -0.793 . . . . 0.0 109.15 -166.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -97.02 137.91 35.37 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.493 -0.754 . . . . 0.0 112.513 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -64.3 128.65 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.831 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -170.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -111.12 -49.56 3.01 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.96 135.98 12.82 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 120.295 1.407 . . . . 0.0 111.722 173.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.1 p -107.2 129.64 54.83 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.929 0.892 . . . . 0.0 112.037 174.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -69.68 -66.52 0.58 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -141.92 59.7 1.48 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.158 0.89 . . . . 0.0 111.852 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -82.87 54.68 2.79 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.391 -1.443 . . . . 0.0 112.947 174.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -154.78 -55.79 0.1 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.595 1.558 . . . . 0.0 108.72 -170.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -68.77 -30.41 69.0 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 121.292 1.86 . . . . 0.0 115.67 160.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -52.22 -53.11 47.56 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 121.302 1.865 . . . . 0.0 114.644 156.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -40.27 93.71 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 170.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.27 -32.92 74.45 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 167.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -62.61 -39.08 92.66 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 159.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.1 mmm -63.18 -34.96 78.76 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 116.029 1.862 . . . . 0.0 116.029 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.71 52.81 0.74 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.426 HG23 ' HG2' ' A' ' 28' ' ' ARG . 6.7 m -130.54 143.67 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 122.127 0.965 . . . . 0.0 112.533 -174.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -65.33 157.82 28.13 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.268 10.8 tp -49.78 -39.48 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 N-CA-C 118.447 2.758 . . . . 0.0 118.447 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.5 t -62.01 -54.04 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-N 119.491 1.041 . . . . 0.0 112.381 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -56.98 -36.69 70.63 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 167.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HG2' HG23 ' A' ' 23' ' ' VAL . 76.4 mtm-85 -62.58 -46.08 89.94 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 121.219 1.827 . . . . 0.0 115.183 169.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -58.07 -49.24 77.6 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 166.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.53 -35.42 70.68 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 116.493 2.034 . . . . 0.0 116.493 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.36 99.07 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 163.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.85 -58.44 8.37 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 162.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -90.24 56.26 3.33 Favored 'General case' 0 CA--C 1.574 1.873 0 CA-C-O 122.316 1.055 . . . . 0.0 113.112 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -88.96 -31.83 17.96 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 71.02 64.11 0.17 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 124.722 1.209 . . . . 0.0 113.409 173.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.6 tp -97.44 125.8 42.31 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.707 0.765 . . . . 0.0 113.042 -167.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -103.36 126.07 50.32 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.891 163.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.9 mt -104.16 103.76 13.59 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 m -91.3 107.88 19.51 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.227 -0.92 . . . . 0.0 108.822 172.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 73.5 mt -100.76 96.95 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -169.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.0 m -98.95 100.49 11.67 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -87.49 121.67 30.22 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 121.6 -0.687 . . . . 0.0 111.813 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -109.36 82.45 1.6 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.18 0.991 . . . . 0.0 109.741 161.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.11 -110.69 3.29 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 114.807 0.683 . . . . 0.0 114.807 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -81.65 -23.6 36.82 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -81.07 115.89 20.74 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 119.871 1.214 . . . . 0.0 111.482 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -101.83 110.37 22.34 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.7 m -91.36 97.39 11.06 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.6 t -95.75 106.27 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -85.21 106.84 16.94 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -94.8 90.4 6.04 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -173.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 m -104.49 115.89 31.14 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.403 0.681 . . . . 0.0 111.018 -173.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.3 p -146.84 -178.5 6.22 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.61 54.22 0.59 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -175.92 -57.29 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.859 0 C-N-CA 125.731 1.612 . . . . 0.0 109.797 -159.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.5 ptp85 -146.33 149.18 33.33 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.175 0.99 . . . . 0.0 111.777 -160.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -135.09 94.27 3.12 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 165.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.8 pt -129.69 124.24 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.323 0.582 . . . . 0.0 111.073 -172.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.42 101.65 14.33 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.982 0.913 . . . . 0.0 111.747 176.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.4 t -91.78 106.4 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.58 106.46 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -122.14 137.07 54.96 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.489 0.662 . . . . 0.0 112.305 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -81.61 140.25 34.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.381 -0.825 . . . . 0.0 111.579 167.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.83 113.59 2.58 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.32 -11.72 56.92 Favored Glycine 0 CA--C 1.55 2.232 0 N-CA-C 118.506 2.162 . . . . 0.0 118.506 -171.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.2 p -78.48 140.27 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-N 120.53 2.165 . . . . 0.0 113.569 -171.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.2 m -84.88 104.18 14.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.728 -0.608 . . . . 0.0 109.539 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -136.99 165.34 26.22 Favored 'General case' 0 CA--C 1.569 1.711 0 CA-C-O 121.675 0.75 . . . . 0.0 112.581 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -87.57 98.9 11.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.559 -0.713 . . . . 0.0 111.791 175.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -86.55 156.37 20.1 Favored 'General case' 0 CA--C 1.567 1.618 0 C-N-CA 123.631 0.772 . . . . 0.0 112.421 173.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -128.75 131.96 47.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.724 -1.235 . . . . 0.0 110.695 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 33.8 mt -86.72 169.97 12.18 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.847 0.832 . . . . 0.0 113.066 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.35 46.9 0.11 Allowed 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 118.773 2.879 . . . . 0.0 118.773 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -138.9 -80.56 0.32 Allowed 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 159.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.19 79.74 0.05 OUTLIER Glycine 0 N--CA 1.48 1.589 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 97.2 m -152.46 128.8 10.57 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.462 -1.022 . . . . 0.0 111.143 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -79.62 131.33 35.96 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.9 mt -124.05 104.32 8.81 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.677 0.791 . . . . 0.0 110.879 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -76.38 114.8 15.48 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.983 0.913 . . . . 0.0 112.095 172.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.94 -164.02 36.78 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 117.083 1.593 . . . . 0.0 117.083 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.9 p -120.57 121.93 39.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -160.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -86.32 112.86 21.82 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 122.906 0.482 . . . . 0.0 110.776 161.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.3 m -119.17 130.2 55.4 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.738 -0.601 . . . . 0.0 112.431 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.8 tp -88.72 130.48 35.32 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.185 -0.947 . . . . 0.0 112.258 177.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -107.45 -79.05 0.58 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 123.512 0.725 . . . . 0.0 110.903 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.15 88.92 0.11 Allowed Glycine 0 N--CA 1.49 2.298 0 CA-C-N 119.803 1.183 . . . . 0.0 111.852 -173.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.26 63.0 m-80 65.4 10.03 6.22 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -156.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -132.99 117.73 17.98 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.374 1.069 . . . . 0.0 109.78 -169.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.37 109.24 20.84 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 168.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.9 tp -91.93 117.67 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.415 -0.803 . . . . 0.0 110.248 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.21 98.21 2.02 Favored Glycine 0 N--CA 1.483 1.795 0 C-N-CA 123.461 0.553 . . . . 0.0 112.424 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -94.84 98.1 10.49 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -124.06 146.48 48.55 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.021 0.915 . . . . 0.0 113.044 -166.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -120.12 148.76 43.21 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.527 0.731 . . . . 0.0 109.693 164.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -73.9 148.55 42.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.148 -1.595 . . . . 0.0 113.433 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.7 p -70.97 -73.59 0.17 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.568 -0.707 . . . . 0.0 111.754 167.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.86 -41.78 97.7 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.844 2.165 . . . . 0.0 116.844 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.31 -14.1 39.13 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 174.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.05 -39.57 2.98 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 118.327 2.091 . . . . 0.0 118.327 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -80.27 162.08 24.79 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -156.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.26 135.66 47.57 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -177.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.5 tt -125.61 130.8 52.36 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 124.185 0.994 . . . . 0.0 109.395 168.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -107.21 129.15 54.9 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.209 -0.932 . . . . 0.0 109.702 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -123.74 108.53 12.63 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.41 -0.806 . . . . 0.0 109.182 171.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.8 t -98.12 110.22 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -87.58 114.99 24.7 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.496 0.718 . . . . 0.0 111.122 172.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -132.19 133.92 44.77 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 119.284 0.947 . . . . 0.0 111.869 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.39 108.77 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.952 -1.093 . . . . 0.0 108.541 173.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.0 pt -97.23 94.03 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 C-N-CA 124.296 1.039 . . . . 0.0 109.028 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.1 -101.67 1.36 Allowed Glycine 0 N--CA 1.492 2.38 0 O-C-N 121.239 -0.913 . . . . 0.0 113.01 -169.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -131.74 53.31 2.0 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.368 0.604 . . . . 0.0 112.009 161.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -134.99 125.37 26.45 Favored 'General case' 0 CA--C 1.563 1.448 0 O-C-N 121.44 -0.787 . . . . 0.0 109.381 167.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.7 tp -78.29 107.67 11.06 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.746 0.818 . . . . 0.0 110.487 175.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -92.38 118.85 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.334 -0.854 . . . . 0.0 110.931 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -95.27 106.89 18.97 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.79 0.836 . . . . 0.0 109.679 172.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.1 m -91.47 104.12 16.66 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.083 0.553 . . . . 0.0 109.864 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -95.61 121.22 37.08 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.181 0.592 . . . . 0.0 111.749 -174.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.6 t -120.63 121.04 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -136.52 98.31 3.78 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.862 -0.524 . . . . 0.0 110.191 168.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 66.19 68.53 0.45 Allowed 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 168.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.68 44.47 57.02 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 118.303 2.081 . . . . 0.0 118.303 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -156.53 150.99 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 118.439 1.12 . . . . 0.0 110.401 -176.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.47 126.12 32.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.165 -0.96 . . . . 0.0 110.313 174.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -128.02 105.67 8.55 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.071 0.548 . . . . 0.0 111.286 171.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -85.42 118.47 24.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 110.967 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.4 mtt-85 -99.84 110.32 22.69 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 164.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.7 mt -81.65 133.27 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -120.65 121.78 39.07 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.065 0.946 . . . . 0.0 109.189 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -77.7 142.37 38.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 112.609 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -69.16 111.25 4.99 Favored 'General case' 0 CA--C 1.568 1.655 0 O-C-N 121.451 -0.78 . . . . 0.0 111.785 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 N--CA 1.488 1.468 0 C-N-CA 124.938 1.295 . . . . 0.0 112.587 -170.148 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 1.397 0 CA-C-O 122.144 0.973 . . . . 0.0 113.032 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.328 54.2 m-85 74.99 -49.8 0.66 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 117.712 2.486 . . . . 0.0 117.712 166.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -75.35 76.59 2.44 Favored 'General case' 0 CA--C 1.573 1.838 0 CA-C-N 120.459 1.481 . . . . 0.0 113.979 -170.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.0 t -162.71 -178.86 6.44 Favored 'General case' 0 CA--C 1.576 1.974 0 CA-C-O 122.682 1.229 . . . . 0.0 112.367 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.1 m -87.58 129.08 35.23 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.243 1.017 . . . . 0.0 110.42 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -128.01 111.75 13.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.828 -0.545 . . . . 0.0 109.603 -173.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.52 137.54 36.3 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.418 0.687 . . . . 0.0 111.756 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.1 p -64.36 118.14 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -105.75 -59.87 1.71 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.758 0.823 . . . . 0.0 112.076 -174.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -134.24 166.62 22.37 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.55 1.167 . . . . 0.0 111.372 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.6 m -151.51 123.73 8.25 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 119.581 -1.949 . . . . 0.0 109.761 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -82.4 -81.46 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -159.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -108.32 55.97 0.63 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 120.29 1.405 . . . . 0.0 112.435 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -87.38 66.11 8.98 Favored 'General case' 0 CA--C 1.573 1.843 0 CA-C-O 122.63 1.205 . . . . 0.0 111.543 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -158.05 -66.35 0.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.969 0.908 . . . . 0.0 109.961 -167.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -60.67 -47.28 86.96 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 166.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -44.61 -58.69 2.87 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 162.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 37.4 mtp -59.07 -43.32 91.74 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -61.06 -41.74 97.19 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 166.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -62.24 -37.07 84.01 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 168.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 55.7 mtm -65.14 -20.03 66.26 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 164.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.24 47.64 2.78 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.3 m -123.12 142.51 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-N 118.385 1.092 . . . . 0.0 111.504 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -75.24 169.67 17.59 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.27 0.3 OUTLIER -52.91 -42.21 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 176.19 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.3 t -58.36 -48.87 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.027 -1.046 . . . . 0.0 113.357 170.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -61.79 -40.32 94.79 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 168.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 mpp_? -57.15 -34.6 68.59 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 164.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -70.25 -55.79 8.39 Favored 'General case' 0 CA--C 1.572 1.827 0 CA-C-N 120.364 1.438 . . . . 0.0 113.434 164.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.0 mt -66.08 -52.59 47.34 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.74 -4.7 36.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 172.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.36 -57.95 3.51 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 119.692 1.133 . . . . 0.0 113.123 152.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -90.49 52.96 2.32 Favored 'General case' 0 CA--C 1.573 1.841 0 C-N-CA 123.767 0.827 . . . . 0.0 112.903 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -92.98 2.25 56.89 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 55.25 58.45 4.67 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 124.687 1.195 . . . . 0.0 113.957 -175.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.3 tp -92.09 116.47 28.96 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-O 122.065 0.936 . . . . 0.0 111.873 -166.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -115.52 112.1 21.71 Favored 'General case' 0 CA--C 1.561 1.378 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.391 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.0 mt -99.09 100.13 11.24 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.0 m -92.62 108.96 20.37 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.335 -0.853 . . . . 0.0 109.613 174.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -107.96 137.6 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 C-N-CA 124.298 1.039 . . . . 0.0 108.673 -165.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 93.1 m -147.75 122.56 9.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.139 -1.6 . . . . 0.0 110.481 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -86.97 108.97 19.06 Favored 'General case' 0 CA--C 1.565 1.522 0 O-C-N 121.55 -0.719 . . . . 0.0 112.112 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -91.71 76.11 5.7 Favored 'General case' 0 CA--C 1.57 1.725 0 O-C-N 121.477 -0.765 . . . . 0.0 110.054 168.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.69 -98.57 0.54 Allowed Glycine 0 N--CA 1.492 2.404 0 O-C-N 121.443 -0.786 . . . . 0.0 114.778 -174.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -95.74 -11.59 26.77 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 165.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -95.76 101.97 13.71 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 120.791 1.632 . . . . 0.0 110.551 -175.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.49 111.55 18.61 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.379 -0.826 . . . . 0.0 111.135 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.2 m -86.24 105.22 16.46 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.735 0.814 . . . . 0.0 109.069 174.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.5 t -112.52 103.26 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -85.79 107.43 17.63 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.284 0.634 . . . . 0.0 110.722 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -98.49 87.46 3.85 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.1 t -88.35 117.44 27.28 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 122.856 0.462 . . . . 0.0 111.171 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.3 p -146.73 165.04 30.83 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.623 0.725 . . . . 0.0 112.678 -172.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.68 -27.2 62.68 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 118.012 2.597 . . . . 0.0 118.012 165.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -75.42 -51.88 12.04 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 167.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -162.36 151.43 15.37 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.595 0.758 . . . . 0.0 111.727 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -113.88 91.67 3.72 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.801 0.84 . . . . 0.0 110.532 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.6 pt -114.89 125.0 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 121.448 0.642 . . . . 0.0 111.88 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -86.26 101.21 12.85 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.6 0.76 . . . . 0.0 110.971 172.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.69 105.44 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -174.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.3 t -94.58 96.93 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -105.97 128.04 53.55 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.431 0.634 . . . . 0.0 112.077 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -85.23 129.08 34.88 Favored 'General case' 0 CA--C 1.563 1.474 0 O-C-N 121.511 -0.743 . . . . 0.0 111.157 173.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.0 125.92 25.54 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -173.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.79 -16.75 44.6 Favored Glycine 0 CA--C 1.555 2.533 0 N-CA-C 119.106 2.403 . . . . 0.0 119.106 -168.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.3 t -86.26 130.78 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 120.278 2.039 . . . . 0.0 109.938 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.5 t -75.21 121.9 22.84 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -142.7 161.68 37.44 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-O 121.732 0.777 . . . . 0.0 112.201 -172.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -91.63 104.2 16.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.489 -0.757 . . . . 0.0 111.517 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -100.85 142.02 32.91 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 124.164 0.986 . . . . 0.0 111.631 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -134.82 100.94 4.75 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.907 -1.121 . . . . 0.0 110.615 -167.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.0 mt -76.36 93.34 3.45 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -168.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.3 . . 58.07 -64.31 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 119.85 3.278 . . . . 0.0 119.85 170.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -82.98 -83.71 0.13 Allowed 'General case' 0 CA--C 1.57 1.719 0 CA-C-N 118.853 0.752 . . . . 0.0 109.73 164.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.48 55.01 0.2 Allowed Glycine 0 N--CA 1.487 2.057 0 N-CA-C 116.267 1.267 . . . . 0.0 116.267 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.8 m -88.02 101.11 13.46 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 118.068 0.934 . . . . 0.0 108.545 165.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -88.63 112.41 23.05 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 122.794 0.438 . . . . 0.0 111.076 -169.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.8 mt -127.38 112.29 14.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.748 -0.595 . . . . 0.0 111.716 -161.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 51.5 ptt85 -90.94 118.19 30.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.104 -0.997 . . . . 0.0 111.338 172.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.3 -158.94 32.1 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 117.776 1.87 . . . . 0.0 117.776 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.7 p -130.15 129.85 44.01 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -156.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -92.48 132.26 36.95 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.033 -1.042 . . . . 0.0 111.081 164.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.5 m -129.97 127.31 39.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.566 -0.708 . . . . 0.0 111.425 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.6 tp -81.9 125.25 30.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.462 -0.774 . . . . 0.0 111.638 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -130.96 79.59 1.9 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.381 -0.824 . . . . 0.0 109.115 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.47 -109.5 3.02 Favored Glycine 0 N--CA 1.488 2.11 0 O-C-N 121.648 -0.657 . . . . 0.0 113.747 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -111.02 44.22 1.33 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 167.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -144.5 114.06 7.14 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 25.1 mt -89.49 107.49 19.1 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 167.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.9 tt -96.88 119.47 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.296 -0.878 . . . . 0.0 110.409 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -101.95 98.88 1.8 Allowed Glycine 0 N--CA 1.482 1.76 0 C-N-CA 124.1 0.857 . . . . 0.0 113.215 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.17 101.55 13.93 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -121.88 143.11 49.63 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.707 0.765 . . . . 0.0 111.916 -173.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -110.72 138.73 46.74 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.69 0.757 . . . . 0.0 109.384 163.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -62.0 111.34 1.88 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.288 -0.882 . . . . 0.0 112.597 171.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.297 5.8 t -68.66 -14.74 63.22 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 174.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -73.78 -20.46 60.47 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 158.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -133.92 -41.44 0.83 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -166.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.85 -26.94 22.32 Favored Glycine 0 CA--C 1.556 2.643 0 N-CA-C 117.368 1.707 . . . . 0.0 117.368 -153.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -66.06 129.92 41.45 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -167.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.04 129.68 35.54 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -175.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.9 tt -121.7 120.29 34.26 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 124.917 1.287 . . . . 0.0 108.908 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -105.47 113.13 26.51 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.314 -0.866 . . . . 0.0 109.065 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.6 m -101.93 111.48 23.75 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.303 -0.873 . . . . 0.0 110.368 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.34 102.5 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -80.82 115.99 20.58 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.767 0.827 . . . . 0.0 110.194 167.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -143.97 142.24 30.62 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -95.15 106.14 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.899 . . . . 0.0 109.44 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.0 pt -88.75 72.82 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.924 0 O-C-N 121.017 -1.052 . . . . 0.0 111.158 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 85.15 -86.84 1.55 Allowed Glycine 0 N--CA 1.491 2.312 0 O-C-N 120.531 -1.355 . . . . 0.0 113.096 -168.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -139.43 53.81 1.71 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 166.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -144.79 118.19 9.05 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 121.212 -0.93 . . . . 0.0 108.6 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.3 tp -78.53 110.23 13.43 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.107 0.956 . . . . 0.0 110.92 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.5 t -97.77 115.32 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -96.82 93.88 6.93 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.733 0.813 . . . . 0.0 109.778 171.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 48.8 m -84.04 101.97 12.15 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 122.864 0.466 . . . . 0.0 109.784 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -87.09 111.05 20.53 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.128 0.571 . . . . 0.0 110.892 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.3 t -103.1 102.06 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -128.85 109.91 11.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.779 -0.576 . . . . 0.0 109.723 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 53.63 57.59 5.96 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 174.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.35 -33.73 3.16 Favored Glycine 0 CA--C 1.552 2.405 0 N-CA-C 118.758 2.263 . . . . 0.0 118.758 -167.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.4 t -89.87 121.28 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 119.887 1.843 . . . . 0.0 110.708 -166.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -89.4 123.87 33.95 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.229 0.612 . . . . 0.0 111.348 166.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.94 108.47 8.42 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.012 0.525 . . . . 0.0 110.881 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -88.91 114.83 25.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 111.622 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -89.64 121.78 32.15 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 119.275 0.943 . . . . 0.0 109.873 162.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.6 mt -120.54 120.72 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -163.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -118.67 126.57 52.21 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.012 0.925 . . . . 0.0 110.747 -165.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -87.23 152.93 21.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.162 -0.961 . . . . 0.0 113.261 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -62.18 110.95 1.77 Allowed 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 124.063 0.945 . . . . 0.0 113.309 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.489 1.484 0 C-N-CA 125.175 1.39 . . . . 0.0 113.251 -174.498 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.22 0 CA-C-O 121.703 0.764 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -80.85 63.39 5.22 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.269 -0.895 . . . . 0.0 112.567 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -88.12 88.42 7.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.997 -1.065 . . . . 0.0 111.744 -166.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.1 m -171.6 164.62 6.78 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 122.754 1.264 . . . . 0.0 113.24 -172.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.6 m -89.72 131.08 35.87 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 124.024 0.93 . . . . 0.0 110.9 170.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -131.33 110.12 10.85 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.356 0.662 . . . . 0.0 109.779 -170.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -100.84 135.64 41.98 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.01 -1.056 . . . . 0.0 112.303 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.7 121.88 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -106.53 -49.08 3.4 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -153.17 111.52 3.66 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 118.911 0.778 . . . . 0.0 109.746 -164.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.2 p -102.0 108.62 20.12 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.512 0.725 . . . . 0.0 112.385 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -102.93 115.46 30.65 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.285 38.7 t30 67.93 11.43 8.36 Favored 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 118.458 2.762 . . . . 0.0 118.458 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -64.79 -42.84 94.75 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -61.17 -32.53 72.27 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 170.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -72.99 -42.73 63.0 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 171.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -46.48 -54.31 9.51 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 160.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.7 mtt -61.75 -39.16 90.63 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 172.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -53.35 -48.76 68.27 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 166.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.1 tttp -62.18 -28.63 69.8 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 168.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.5 mmt -65.47 -43.83 89.08 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 168.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.89 63.72 0.36 Allowed Glycine 0 N--CA 1.487 2.099 0 C-N-CA 123.855 0.741 . . . . 0.0 113.742 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 p -138.25 146.49 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.403 1.097 . . . . 0.0 111.638 -176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -59.2 143.92 47.55 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.31 12.9 tt -52.89 -44.15 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.8 t -56.58 -56.55 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.305 0.957 . . . . 0.0 113.197 170.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -63.6 -45.15 91.67 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.2 ptt85 -67.66 -30.61 70.19 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 171.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -68.55 -43.4 76.71 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 120.009 1.277 . . . . 0.0 114.219 165.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.5 mt -62.35 -50.57 71.06 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 169.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.65 -12.53 54.2 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 118.6 2.815 . . . . 0.0 118.6 168.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.76 -59.96 2.55 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 155.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -91.62 53.53 2.27 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 118.765 0.711 . . . . 0.0 112.82 -170.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.6 p30 -102.97 -4.22 24.98 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 118.582 2.808 . . . . 0.0 118.582 -171.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 59.18 56.16 4.02 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-N 121.655 2.025 . . . . 0.0 114.131 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.4 tp -82.63 119.75 24.68 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.981 -1.074 . . . . 0.0 112.1 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -101.55 119.85 39.4 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.199 170.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.8 mt -102.42 107.34 18.29 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.251 88.6 m -88.13 101.09 13.47 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.854 -1.154 . . . . 0.0 108.736 163.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 85.5 mt -94.99 119.45 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.8 t -127.82 131.21 49.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.808 -0.558 . . . . 0.0 111.614 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -79.73 127.21 31.93 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 121.768 0.794 . . . . 0.0 111.472 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -131.96 64.48 1.59 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 124.05 0.94 . . . . 0.0 110.563 -168.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.3 69.25 1.37 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 116.756 1.463 . . . . 0.0 116.756 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.281 14.9 t30 66.82 -15.04 0.15 Allowed 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 -164.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -92.19 154.23 18.8 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 120.684 -1.26 . . . . 0.0 112.231 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -116.4 120.3 38.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.476 -0.765 . . . . 0.0 109.392 165.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.9 m -89.03 107.62 19.14 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 167.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.0 t -104.25 108.01 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -93.18 104.19 16.4 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -86.28 126.3 34.2 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.189 0.595 . . . . 0.0 110.71 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.2 t -135.17 118.73 16.95 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 122.765 0.426 . . . . 0.0 110.255 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 p -147.61 172.83 13.41 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.46 59.08 0.79 Allowed 'General case' 0 CA--C 1.575 1.925 0 O-C-N 120.513 -1.367 . . . . 0.0 113.491 154.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -168.78 -60.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.114 0.966 . . . . 0.0 110.174 -175.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -154.58 143.57 21.01 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 118.588 0.631 . . . . 0.0 111.951 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -115.2 103.11 10.52 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 173.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.6 pt -138.29 141.18 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 121.5 0.667 . . . . 0.0 111.909 -174.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -104.13 105.78 16.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.171 -0.956 . . . . 0.0 109.7 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.32 103.19 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.2 t -97.89 104.11 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -117.78 149.71 40.35 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.125 0.57 . . . . 0.0 112.476 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -94.07 142.41 27.43 Favored 'General case' 0 CA--C 1.568 1.635 0 O-C-N 121.733 -0.604 . . . . 0.0 111.698 171.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.1 mt -71.95 101.91 2.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.004 -1.06 . . . . 0.0 111.699 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.6 -46.15 1.07 Allowed Glycine 0 CA--C 1.549 2.215 0 N-CA-C 116.37 1.308 . . . . 0.0 116.37 -168.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.73 141.46 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.844 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.1 m -92.51 77.86 5.0 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.191 0.996 . . . . 0.0 110.729 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -101.64 166.27 10.79 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -167.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -82.24 93.75 7.17 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-O 121.62 0.724 . . . . 0.0 111.531 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -84.52 164.98 18.44 Favored 'General case' 0 CA--C 1.571 1.756 0 CA-C-O 122.141 0.972 . . . . 0.0 111.498 166.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -153.65 132.75 12.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.325 -1.485 . . . . 0.0 110.801 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.3 mt -75.6 -64.04 1.16 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -164.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -154.36 -70.99 0.13 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 118.926 0.785 . . . . 0.0 111.391 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -83.24 -69.53 0.63 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.958 0.799 . . . . 0.0 112.941 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.74 50.58 0.4 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 116.734 1.454 . . . . 0.0 116.734 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.1 m -112.71 98.33 7.15 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -92.79 140.73 29.21 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 122.439 1.114 . . . . 0.0 112.147 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.8 mt -136.59 119.82 16.72 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 123.78 0.832 . . . . 0.0 110.206 -162.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -90.47 122.91 33.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.964 -1.085 . . . . 0.0 110.034 169.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.75 -173.32 45.46 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 117.633 1.813 . . . . 0.0 117.633 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 75.9 p -115.59 131.47 56.92 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.092 -1.054 . . . . 0.0 111.327 -170.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -87.78 113.92 23.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.195 -0.94 . . . . 0.0 109.621 161.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.6 m -110.94 117.42 33.33 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.419 0.688 . . . . 0.0 110.909 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.9 tp -84.76 99.1 10.64 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.144 -0.972 . . . . 0.0 111.584 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -95.52 85.21 4.14 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.444 0.698 . . . . 0.0 110.687 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.37 -90.59 0.62 Allowed Glycine 0 N--CA 1.491 2.359 0 O-C-N 121.425 -0.797 . . . . 0.0 114.601 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -125.52 53.44 1.55 Allowed 'General case' 0 CA--C 1.575 1.935 0 CA-C-O 121.363 0.601 . . . . 0.0 111.552 162.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -145.0 111.15 5.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.089 -1.007 . . . . 0.0 108.533 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 mt -85.89 102.34 13.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.968 . . . . 0.0 109.075 172.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.6 mt -100.6 108.55 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -172.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.12 101.72 2.75 Favored Glycine 0 N--CA 1.482 1.705 0 C-N-CA 123.235 0.445 . . . . 0.0 113.18 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -95.34 94.28 7.76 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.551 0.74 . . . . 0.0 109.06 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -121.47 138.33 54.33 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -163.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -119.49 138.4 53.17 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.516 0.726 . . . . 0.0 110.085 170.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -70.08 130.21 41.51 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -171.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 36.9 p -81.43 68.69 7.86 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.337 1.065 . . . . 0.0 110.851 170.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -177.7 -62.28 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.774 0 C-N-CA 125.927 1.691 . . . . 0.0 107.417 -164.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -135.37 20.37 3.39 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.4 10.6 36.57 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 121.03 3.172 . . . . 0.0 121.03 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -95.46 138.71 32.76 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 118.121 0.96 . . . . 0.0 112.217 -159.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -80.34 128.25 33.34 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -163.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.86 122.87 39.13 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 124.742 1.217 . . . . 0.0 108.423 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -98.61 114.7 27.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.618 -0.676 . . . . 0.0 109.278 172.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.1 m -108.22 96.85 6.65 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 119.564 1.075 . . . . 0.0 109.701 175.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.3 t -95.65 105.17 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.885 -1.134 . . . . 0.0 108.91 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -88.9 122.02 31.85 Favored 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 123.565 0.746 . . . . 0.0 111.052 169.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -144.87 155.24 43.35 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.281 -0.887 . . . . 0.0 112.38 171.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mp -94.76 118.79 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.649 -1.282 . . . . 0.0 109.657 -176.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.7 mt -95.79 87.55 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 106.941 -1.504 . . . . 0.0 106.941 164.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.0 -94.83 0.38 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 115.742 1.057 . . . . 0.0 115.742 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -101.75 14.56 31.6 Favored 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 169.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -134.38 109.76 8.99 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 119.717 1.144 . . . . 0.0 111.002 -161.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.6 tp -76.46 104.61 7.07 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.918 0.887 . . . . 0.0 110.899 173.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.5 p -88.47 104.77 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 123.05 0.54 . . . . 0.0 110.219 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -90.0 99.85 12.78 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.456 0.646 . . . . 0.0 109.421 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 33.4 m -98.96 104.89 16.97 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.006 -168.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -87.1 125.79 34.36 Favored 'General case' 0 CA--C 1.563 1.476 0 C-N-CA 123.257 0.623 . . . . 0.0 111.048 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.4 t -121.69 109.0 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 168.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -113.87 107.11 15.26 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.265 10.2 mm-40 65.03 -78.68 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 123.914 0.885 . . . . 0.0 112.992 -171.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -152.6 58.32 0.42 Allowed Glycine 0 N--CA 1.486 2.001 0 CA-C-O 119.511 -0.605 . . . . 0.0 114.108 164.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.9 p -129.19 104.21 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -89.43 112.31 23.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.602 -0.687 . . . . 0.0 110.915 -176.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.77 117.34 25.46 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.019 0.527 . . . . 0.0 112.236 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -105.62 102.22 11.69 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.456 0.703 . . . . 0.0 109.704 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . 0.258 15.1 ptm180 -95.92 111.98 23.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.441 -0.787 . . . . 0.0 110.733 168.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.4 mt -97.94 125.01 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -170.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -105.45 116.73 32.44 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.618 0.767 . . . . 0.0 109.068 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -82.78 141.93 31.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.231 -0.918 . . . . 0.0 111.745 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -66.94 124.36 22.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 113.338 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 124.822 1.249 . . . . 0.0 111.88 -170.103 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.305 0 CA-C-O 121.15 0.5 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 64.91 65.03 0.62 Allowed 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -130.55 75.83 1.68 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.952 -1.093 . . . . 0.0 110.701 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.1 p -171.15 168.63 6.75 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.795 1.284 . . . . 0.0 113.5 -175.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.7 m -77.23 135.87 38.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.219 -0.926 . . . . 0.0 111.75 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -133.16 101.74 5.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.678 -0.639 . . . . 0.0 109.393 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -97.31 137.84 35.7 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.252 -0.905 . . . . 0.0 112.223 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.266 4.5 p -63.03 115.54 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.81 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -173.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -84.55 -47.4 10.61 Favored 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 123.687 0.795 . . . . 0.0 113.054 170.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -155.15 159.0 39.84 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 122.563 1.173 . . . . 0.0 111.033 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.7 m -147.66 113.03 5.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 119.871 -1.768 . . . . 0.0 109.315 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -83.36 -95.79 0.06 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -162.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -85.06 52.56 2.47 Favored 'General case' 0 CA--C 1.579 2.063 0 CA-C-N 120.635 1.561 . . . . 0.0 113.523 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -82.9 -48.45 10.7 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.526 1.13 . . . . 0.0 114.03 -172.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -58.0 -29.27 65.15 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 169.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 -46.48 34.11 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 169.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -47.64 -51.2 22.28 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 161.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.0 mtm -59.27 -30.77 68.53 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 170.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -65.74 -44.38 86.16 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 166.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -58.63 -37.49 76.01 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 165.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.5 mmm -64.84 -41.57 95.62 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 167.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.43 48.37 0.81 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 115.989 1.156 . . . . 0.0 115.989 174.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.29 10.7 p -113.12 138.84 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 118.534 1.167 . . . . 0.0 112.309 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -62.69 152.39 35.58 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 12.5 tt -48.11 -40.16 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 118.285 2.698 . . . . 0.0 118.285 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.4 t -66.11 -62.28 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-N 119.861 1.209 . . . . 0.0 111.96 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -62.56 -20.03 64.28 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 117.949 2.574 . . . . 0.0 117.949 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.5 ttp85 -76.37 -49.44 16.79 Favored 'General case' 0 CA--C 1.569 1.708 0 C-N-CA 125.292 1.437 . . . . 0.0 114.26 167.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -41.54 98.61 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 169.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.28 -40.63 86.69 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 165.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.72 -31.19 71.69 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 117.729 2.492 . . . . 0.0 117.729 169.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.9 -43.72 69.92 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 157.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -82.41 14.93 2.72 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.313 19.4 p30 -78.36 92.99 4.61 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 121.534 1.97 . . . . 0.0 110.597 170.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -68.8 84.68 0.31 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.767 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.0 tp -86.91 124.75 33.46 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 122.489 1.138 . . . . 0.0 112.731 -167.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -99.48 114.81 27.99 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.57 165.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.2 mt -96.96 95.52 7.88 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.9 m -88.32 98.19 11.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.035 -1.041 . . . . 0.0 108.473 173.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.0 mt -89.76 119.11 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.3 p -121.59 122.14 38.99 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -97.37 130.61 44.5 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -118.02 77.18 1.13 Allowed 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 162.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.61 -106.5 1.08 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 116.404 1.322 . . . . 0.0 116.404 -175.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -84.64 -15.9 43.85 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 169.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -89.03 153.76 20.75 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 119.809 1.186 . . . . 0.0 112.346 168.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -143.51 136.54 27.72 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.606 0.763 . . . . 0.0 109.836 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.9 m -109.82 111.45 22.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.236 -0.915 . . . . 0.0 108.884 164.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.4 p -95.68 120.48 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 121.428 0.632 . . . . 0.0 110.123 168.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -82.4 114.44 20.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 109.484 173.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -93.06 91.25 7.25 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.7 t -112.34 105.42 13.7 Favored 'General case' 0 CA--C 1.562 1.418 0 CA-C-O 121.384 0.611 . . . . 0.0 111.105 -172.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.0 p -143.91 -179.16 6.31 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.393 1.077 . . . . 0.0 111.904 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.11 -25.82 24.11 Favored 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 118.265 2.691 . . . . 0.0 118.265 160.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -96.76 -18.02 19.89 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -148.61 146.43 28.23 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 120.469 1.486 . . . . 0.0 112.155 -171.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -135.19 77.79 1.7 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 156.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.0 pt -126.88 139.88 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 121.216 -0.928 . . . . 0.0 111.953 -167.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.17 105.44 17.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.575 -0.703 . . . . 0.0 109.797 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.3 t -89.69 98.05 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.0 t -89.97 106.85 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -121.63 164.02 18.01 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-O 122.619 1.2 . . . . 0.0 112.752 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -126.5 145.68 50.41 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.452 -0.78 . . . . 0.0 109.683 171.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.75 108.53 1.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.974 . . . . 0.0 113.584 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.65 -23.87 27.03 Favored Glycine 0 CA--C 1.548 2.146 0 N-CA-C 117.985 1.954 . . . . 0.0 117.985 -170.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.8 p -68.67 134.92 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 120.308 2.054 . . . . 0.0 113.588 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -85.38 106.42 16.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.751 -0.593 . . . . 0.0 109.796 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -127.5 158.04 38.48 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.766 0.793 . . . . 0.0 112.151 -176.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -85.72 107.5 17.62 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.549 -0.719 . . . . 0.0 111.413 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -105.54 128.99 53.9 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 124.074 0.95 . . . . 0.0 110.236 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -107.19 125.51 51.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.595 -0.691 . . . . 0.0 111.65 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.9 mt -92.6 78.34 4.91 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.308 . . 63.57 -51.44 0.23 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 120.322 3.453 . . . . 0.0 120.322 162.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -74.22 -81.52 0.07 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 121.39 1.905 . . . . 0.0 109.33 167.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.9 80.88 0.06 OUTLIER Glycine 0 N--CA 1.481 1.692 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.6 m -145.75 109.94 4.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.407 -1.055 . . . . 0.0 108.752 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -84.56 121.84 28.18 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.922 0.867 . . . . 0.0 112.373 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mt -129.65 120.21 24.82 Favored 'General case' 0 CA--C 1.562 1.412 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.515 -168.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -93.08 118.99 31.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.922 . . . . 0.0 111.97 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.51 -170.55 42.06 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 118.069 1.988 . . . . 0.0 118.069 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.0 p -126.24 121.22 32.07 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.49 -0.855 . . . . 0.0 111.679 -163.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -78.29 123.05 26.51 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 119.048 0.84 . . . . 0.0 110.995 160.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.8 m -125.3 137.38 54.07 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.364 0.665 . . . . 0.0 111.721 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 tp -91.25 104.51 17.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 111.586 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -91.46 82.64 5.36 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.63 -0.669 . . . . 0.0 109.55 171.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.44 -94.75 0.66 Allowed Glycine 0 N--CA 1.492 2.373 0 O-C-N 121.545 -0.722 . . . . 0.0 114.382 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -125.23 59.62 1.24 Allowed 'General case' 0 CA--C 1.571 1.788 0 CA-C-O 121.802 0.811 . . . . 0.0 110.926 159.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -140.77 111.49 6.95 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 170.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.5 mt -84.44 100.55 11.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.192 -0.943 . . . . 0.0 109.561 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.6 tt -97.78 128.9 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 123.743 0.817 . . . . 0.0 110.798 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.64 102.77 0.64 Allowed Glycine 0 N--CA 1.481 1.658 0 CA-C-O 119.234 -0.759 . . . . 0.0 114.005 -172.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -90.32 98.55 11.84 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.051 0.925 . . . . 0.0 109.492 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -110.53 106.5 15.82 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.639 0.733 . . . . 0.0 110.576 -171.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -90.99 125.87 35.91 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.224 -0.923 . . . . 0.0 111.772 -168.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.8 ttp85 -66.18 119.66 11.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.132 -0.98 . . . . 0.0 112.432 -174.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.303 5.4 t -59.87 -35.08 74.06 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 117.316 2.339 . . . . 0.0 117.316 -169.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -98.37 42.68 1.09 Allowed 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 168.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -156.62 -50.99 0.08 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.736 -1.228 . . . . 0.0 113.591 173.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.32 8.72 62.54 Favored Glycine 0 CA--C 1.555 2.544 0 N-CA-C 118.471 2.148 . . . . 0.0 118.471 -160.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -89.11 119.78 29.92 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 119.965 1.883 . . . . 0.0 111.389 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -73.07 122.8 22.38 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.6 tt -97.12 108.97 21.8 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -96.23 98.82 10.61 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -165.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.1 m -104.88 108.31 19.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.795 -0.565 . . . . 0.0 109.9 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.7 t -98.72 105.9 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.4 mtm180 -87.58 105.76 17.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.663 -0.648 . . . . 0.0 110.002 167.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.01 162.72 26.15 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.659 0.783 . . . . 0.0 111.729 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.3 mt -127.78 135.61 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.536 -1.352 . . . . 0.0 110.142 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.7 mm -98.15 -76.54 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.74 -112.08 3.44 Favored Glycine 0 N--CA 1.491 2.332 0 CA-C-N 118.687 0.676 . . . . 0.0 111.802 170.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -92.91 47.11 1.26 Allowed 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -146.93 118.78 8.11 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.401 1.08 . . . . 0.0 108.74 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.0 tp -81.91 115.5 21.12 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.482 0.713 . . . . 0.0 109.512 167.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.3 t -100.65 103.53 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -96.81 103.25 15.15 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 123.446 0.698 . . . . 0.0 109.825 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.8 m -99.64 103.25 14.93 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 123.266 0.626 . . . . 0.0 109.835 -173.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -95.0 123.8 38.68 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.775 0.83 . . . . 0.0 111.207 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.02 102.11 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-N 119.307 0.958 . . . . 0.0 108.779 173.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -86.51 102.96 14.59 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.183 -0.948 . . . . 0.0 110.007 167.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.319 0.1 OUTLIER 62.01 -41.42 0.15 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 120.001 3.334 . . . . 0.0 120.001 177.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -173.82 25.42 0.08 OUTLIER Glycine 0 CA--C 1.552 2.369 0 N-CA-C 117.716 1.846 . . . . 0.0 117.716 172.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.0 t -136.57 121.63 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 120.304 2.052 . . . . 0.0 107.532 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.24 140.19 29.8 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -174.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -129.79 125.1 34.98 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.545 0.738 . . . . 0.0 112.045 166.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -99.27 108.88 21.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.704 -0.622 . . . . 0.0 110.601 174.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -96.16 117.99 31.83 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 169.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 76.5 mt -108.55 120.8 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -171.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -117.32 122.77 44.81 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.835 0.854 . . . . 0.0 109.268 -172.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -77.86 148.27 34.73 Favored 'General case' 0 CA--C 1.568 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 112.837 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -58.9 113.57 2.13 Favored 'General case' 0 CA--C 1.57 1.721 0 C-N-CA 123.906 0.882 . . . . 0.0 113.131 175.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 N--CA 1.489 1.495 0 C-N-CA 124.826 1.251 . . . . 0.0 112.752 -171.328 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.206 0 CA-C-O 121.085 0.469 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.254 91.7 m-85 67.31 -21.58 0.11 Allowed 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 118.99 2.959 . . . . 0.0 118.99 173.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.99 81.63 5.24 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 124.744 1.218 . . . . 0.0 112.897 -164.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.6 m -168.13 173.97 7.56 Favored 'General case' 0 CA--C 1.57 1.738 0 CA-C-O 122.607 1.194 . . . . 0.0 111.703 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.3 m -86.92 131.62 34.05 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.808 0.843 . . . . 0.0 110.804 170.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -132.65 109.36 9.66 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -172.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.24 134.46 48.32 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.281 -0.887 . . . . 0.0 111.716 -175.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -57.7 118.95 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -176.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -114.26 -52.8 2.71 Favored 'General case' 0 CA--C 1.564 1.509 0 C-N-CA 123.592 0.757 . . . . 0.0 113.023 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -144.75 74.17 1.4 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 119.466 1.03 . . . . 0.0 111.918 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.9 p -74.95 127.46 33.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.978 . . . . 0.0 113.454 175.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -79.22 -73.02 0.36 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -166.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -91.97 118.76 31.08 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 156.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -135.34 46.01 2.43 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-O 121.725 0.774 . . . . 0.0 112.406 164.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -146.05 -57.43 0.3 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.166 -0.959 . . . . 0.0 110.551 -173.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -62.39 -33.31 74.5 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 170.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -54.64 -59.77 4.25 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 120.141 1.337 . . . . 0.0 114.144 163.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.51 -47.39 63.31 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 169.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -59.83 -42.95 94.67 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 171.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -56.7 -39.32 73.65 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 165.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 90.5 mtp -64.41 -22.92 67.11 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 172.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.73 39.84 4.85 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 116.712 1.445 . . . . 0.0 116.712 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.446 HG23 ' HG2' ' A' ' 28' ' ' ARG . 6.2 m -105.76 138.05 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.631 0.729 . . . . 0.0 110.938 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -63.08 160.73 14.6 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.277 9.8 tp -53.57 -39.59 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.34 -52.85 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-N 119.647 1.112 . . . . 0.0 112.631 169.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -59.24 -34.79 72.63 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 168.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.446 ' HG2' HG23 ' A' ' 23' ' ' VAL . 84.6 mtm-85 -64.3 -47.92 77.61 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 121.428 1.922 . . . . 0.0 114.797 168.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -58.87 -48.96 79.56 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 168.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.4 mt -58.18 -53.36 59.2 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.611 1.338 . . . . 0.0 114.611 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.42 -47.55 78.8 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 116.431 2.012 . . . . 0.0 116.431 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.88 -47.66 67.69 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 168.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -98.69 32.98 2.4 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -85.78 -19.64 30.42 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -168.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 65.5 63.47 0.63 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 120.018 1.281 . . . . 0.0 113.572 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.74 117.28 21.93 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.204 -0.935 . . . . 0.0 111.792 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -103.21 110.8 22.9 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.534 174.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.7 mt -94.48 101.49 13.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 122.992 0.517 . . . . 0.0 109.776 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.9 m -94.94 111.98 23.72 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.36 136.63 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 124.089 0.956 . . . . 0.0 108.703 -168.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.1 m -149.13 124.24 10.1 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 119.903 -1.748 . . . . 0.0 111.235 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -77.34 132.54 38.64 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.374 1.07 . . . . 0.0 112.034 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -130.33 80.96 1.98 Allowed 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 123.524 0.73 . . . . 0.0 109.364 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.39 70.61 0.93 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 117.269 1.667 . . . . 0.0 117.269 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.309 17.3 m120 69.89 -23.49 0.16 Allowed 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -169.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -86.99 152.9 21.99 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 120.037 1.29 . . . . 0.0 112.785 169.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -121.73 133.68 54.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 111.054 173.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.0 m -97.69 117.79 32.77 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.0 t -120.37 112.57 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -83.2 117.21 22.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 0.0 110.85 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -95.32 80.07 3.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.815 -0.553 . . . . 0.0 110.903 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.5 t -97.42 111.36 23.65 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -171.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.5 p -149.93 177.01 10.24 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.77 59.08 0.21 Allowed 'General case' 0 CA--C 1.58 2.126 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 165.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -145.27 -53.84 0.29 Allowed 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 125.746 1.618 . . . . 0.0 110.096 167.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -156.95 -50.57 0.07 Allowed 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -172.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.299 36.6 t-20 76.62 106.13 0.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 120.06 1.3 . . . . 0.0 112.729 -165.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.8 pt -134.7 139.27 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-O 121.294 0.569 . . . . 0.0 111.257 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.73 124.46 30.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.516 -0.74 . . . . 0.0 111.829 168.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.4 t -110.4 101.62 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.9 t -101.04 115.03 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -140.94 151.89 44.57 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -171.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -90.56 139.39 30.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.497 -0.752 . . . . 0.0 111.882 168.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.07 131.46 49.63 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.08 -8.91 59.16 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 119.816 2.686 . . . . 0.0 119.816 -174.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.3 t -89.13 137.02 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-N 120.201 2.001 . . . . 0.0 110.193 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.1 p -76.11 97.85 4.2 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.48 -0.762 . . . . 0.0 111.19 176.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -118.41 164.56 15.06 Favored 'General case' 0 CA--C 1.569 1.689 0 C-N-CA 123.968 0.907 . . . . 0.0 111.879 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -86.31 98.56 11.03 Favored 'General case' 0 CA--C 1.568 1.65 0 O-C-N 121.363 -0.836 . . . . 0.0 111.171 173.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -82.69 114.14 20.85 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 124.074 0.95 . . . . 0.0 110.824 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -96.48 100.09 11.7 Favored 'General case' 0 CA--C 1.566 1.588 0 O-C-N 121.762 -0.586 . . . . 0.0 109.792 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.81 150.08 42.5 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -37.03 -48.9 0.81 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 119.966 3.321 . . . . 0.0 119.966 -176.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -66.26 -23.19 66.36 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 170.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.68 17.99 1.03 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 119.363 2.505 . . . . 0.0 119.363 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.8 m -109.25 126.51 53.4 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 120.477 2.138 . . . . 0.0 112.015 -162.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -96.77 106.86 19.23 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-O 121.486 0.66 . . . . 0.0 111.717 -167.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.3 mt -104.82 116.61 32.3 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.223 1.009 . . . . 0.0 112.256 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 59.7 ttp85 -86.97 117.55 25.76 Favored 'General case' 0 CA--C 1.567 1.618 0 O-C-N 120.834 -1.166 . . . . 0.0 111.27 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 160.6 -165.64 35.12 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.2 p -106.48 138.37 42.77 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.329 -0.512 . . . . 0.0 112.062 -168.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -88.86 106.63 18.51 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 146.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.2 m -106.4 135.9 47.08 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.019 0.527 . . . . 0.0 110.872 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.5 tp -85.01 98.84 10.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.962 -1.086 . . . . 0.0 110.942 175.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.19 79.44 5.72 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.471 0.653 . . . . 0.0 109.347 175.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.2 -99.43 0.32 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -89.7 -10.46 45.66 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -102.04 140.14 36.72 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 121.155 1.798 . . . . 0.0 111.577 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.9 mt -94.84 97.25 9.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.951 -1.093 . . . . 0.0 108.795 161.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.0 tt -90.1 117.38 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 122.15 0.976 . . . . 0.0 110.551 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.71 93.51 1.89 Allowed Glycine 0 N--CA 1.477 1.38 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.425 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -90.2 87.86 7.01 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -117.19 145.96 43.53 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.81 0.814 . . . . 0.0 112.139 -170.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -124.67 131.02 53.49 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.552 0.741 . . . . 0.0 109.001 172.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -76.28 122.78 24.9 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 121.093 -1.005 . . . . 0.0 113.109 -172.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 73.0 p -55.34 -52.4 63.6 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -89.64 65.35 6.87 Favored 'General case' 0 CA--C 1.572 1.797 0 CA-C-N 118.879 0.763 . . . . 0.0 111.824 167.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.54 -47.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 164.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.25 -20.97 47.9 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 118.064 1.986 . . . . 0.0 118.064 -157.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -77.98 147.84 34.71 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.57 1.148 . . . . 0.0 114.007 -172.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.22 133.29 35.42 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.9 tt -117.06 100.09 7.5 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -90.64 110.21 21.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.457 -0.777 . . . . 0.0 109.709 -173.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.3 m -109.97 98.13 7.5 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 119.657 1.117 . . . . 0.0 110.926 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.2 t -93.7 94.92 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.564 -1.335 . . . . 0.0 109.073 -174.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -83.18 127.82 33.95 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.738 0.699 . . . . 0.0 112.242 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -142.43 140.83 32.09 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.326 0.584 . . . . 0.0 112.422 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.4 mm -87.12 119.58 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.426 -0.796 . . . . 0.0 109.12 171.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.9 mt -113.4 88.81 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.84 -107.92 2.2 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 115.728 1.051 . . . . 0.0 115.728 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -90.45 13.78 14.75 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 172.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -138.97 127.62 23.26 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 120.01 1.277 . . . . 0.0 111.192 -172.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.4 tp -78.95 105.87 10.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.453 -0.78 . . . . 0.0 109.159 162.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.5 t -96.08 110.08 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 174.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -113.51 123.28 49.63 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.5 m -96.78 111.4 23.59 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 122.75 0.42 . . . . 0.0 110.001 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -83.7 123.15 29.53 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.987 0.515 . . . . 0.0 110.596 167.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.1 t -117.42 106.14 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 168.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -109.19 101.98 10.96 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.063 0.545 . . . . 0.0 109.639 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 52.24 53.51 12.3 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.15 -31.46 3.44 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 118.722 2.249 . . . . 0.0 118.722 -167.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 98.0 t -78.13 109.54 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 119.869 1.834 . . . . 0.0 110.307 -169.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.48 132.05 39.55 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 123.491 0.716 . . . . 0.0 112.535 -170.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -138.62 112.48 8.43 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.689 0.796 . . . . 0.0 111.427 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -95.19 110.34 22.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.607 -0.683 . . . . 0.0 110.375 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.8 mmm-85 -91.05 116.96 29.21 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.7 mt -104.87 106.4 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -101.53 121.52 42.13 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.908 0.883 . . . . 0.0 110.01 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -82.7 153.32 25.4 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 121.157 -0.964 . . . . 0.0 113.286 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -59.33 105.68 0.37 Allowed 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 178.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.6 t0 . . . . . 0 N--CA 1.489 1.478 0 C-N-CA 125.34 1.456 . . . . 0.0 114.828 178.129 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.563 1.443 0 CA-C-O 122.171 0.986 . . . . 0.0 113.025 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.334 55.7 m-85 65.2 -140.79 0.21 Allowed 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 124.377 1.071 . . . . 0.0 112.407 178.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 38.18 54.09 1.7 Allowed 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 119.214 3.042 . . . . 0.0 119.214 161.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.4 m -175.62 170.6 2.89 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.702 1.201 . . . . 0.0 110.155 -168.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.3 m -79.36 123.42 27.47 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.043 -1.036 . . . . 0.0 110.58 164.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -121.99 118.52 29.02 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -104.68 137.06 43.06 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.417 -0.802 . . . . 0.0 111.417 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.251 4.0 p -66.13 117.96 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.868 0 O-C-N 121.074 -1.016 . . . . 0.0 113.183 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -90.91 -55.76 3.43 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 124.256 1.022 . . . . 0.0 112.715 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.7 ptm85 -144.71 174.44 10.97 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-O 122.441 1.115 . . . . 0.0 111.968 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.1 m -156.93 145.29 19.61 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 119.603 -1.935 . . . . 0.0 111.623 -176.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.16 -110.02 0.18 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.951 -174.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -82.13 60.44 4.91 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 122.063 2.21 . . . . 0.0 113.75 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -104.81 67.68 0.81 Allowed 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 122.679 1.228 . . . . 0.0 111.828 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -158.22 -48.44 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.707 1.203 . . . . 0.0 110.039 165.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -57.2 -36.97 71.5 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 164.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -48.72 -51.96 26.07 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 160.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -63.52 -39.76 95.26 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -60.83 -45.03 96.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.447 -1.408 . . . . 0.0 114.644 168.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -55.36 -37.92 68.14 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 165.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.4 mmt -66.47 -16.06 63.83 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 164.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.32 39.51 6.79 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 117.266 1.666 . . . . 0.0 117.266 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.426 HG23 ' HG2' ' A' ' 28' ' ' ARG . 17.9 m -111.96 143.35 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 118.445 1.123 . . . . 0.0 111.909 -177.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -64.31 157.97 24.67 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -174.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.29 0.1 OUTLIER -52.52 -49.65 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 -177.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.0 t -62.43 -45.43 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-N 119.683 1.128 . . . . 0.0 113.483 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -53.18 -43.75 67.37 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 166.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HG2' HG23 ' A' ' 23' ' ' VAL . 82.5 mtm-85 -62.49 -41.35 98.74 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 168.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.78 -45.25 95.11 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 168.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.0 mt -63.13 -44.45 95.58 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.72 -34.6 78.7 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 169.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.42 -55.97 27.94 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 120.159 1.345 . . . . 0.0 114.545 160.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -80.97 58.18 3.34 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 122.581 1.181 . . . . 0.0 113.165 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -86.36 -26.46 24.82 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 117.838 2.532 . . . . 0.0 117.838 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.379 19.7 p30 46.28 47.9 13.44 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 117.799 2.518 . . . . 0.0 117.799 -168.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.7 tp -73.37 124.56 25.99 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 122.113 0.958 . . . . 0.0 113.519 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -118.86 125.55 49.78 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.199 1.0 . . . . 0.0 109.032 175.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.8 mt -106.94 100.89 10.36 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.441 0.696 . . . . 0.0 109.562 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.1 m -93.25 110.14 21.66 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.466 -0.771 . . . . 0.0 108.978 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.1 mt -98.92 112.52 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -168.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.5 m -111.02 104.87 13.48 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -88.92 112.03 22.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.078 -1.014 . . . . 0.0 112.265 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.81 78.94 2.62 Favored 'General case' 0 CA--C 1.568 1.653 0 CA-C-O 121.641 0.734 . . . . 0.0 109.943 163.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.65 -104.15 1.02 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 115.369 0.908 . . . . 0.0 115.369 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -81.03 -27.88 35.62 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 166.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -75.34 109.66 9.05 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.397 1.453 . . . . 0.0 112.173 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -90.85 106.93 18.86 Favored 'General case' 0 CA--C 1.559 1.324 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 169.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.6 m -90.14 95.93 10.43 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.1 t -99.84 108.99 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -171.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -87.72 100.46 12.85 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.709 0.804 . . . . 0.0 109.166 -173.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -92.77 86.56 5.56 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.022 0.529 . . . . 0.0 110.346 -170.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.4 t -90.53 122.19 33.13 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.01 0.524 . . . . 0.0 111.769 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.7 p -147.92 168.82 21.27 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -167.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.77 38.38 0.03 OUTLIER 'General case' 0 CA--C 1.584 2.271 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 164.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -150.59 -57.12 0.17 Allowed 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 126.533 1.933 . . . . 0.0 108.536 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -155.25 156.85 36.32 Favored 'General case' 0 CA--C 1.566 1.558 0 C-N-CA 124.232 1.013 . . . . 0.0 111.539 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -114.61 106.96 14.86 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.459 0.704 . . . . 0.0 109.336 164.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.7 pt -126.14 128.63 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.668 -0.645 . . . . 0.0 111.217 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -82.47 99.78 9.66 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 121.656 0.741 . . . . 0.0 111.972 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -85.27 100.37 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.48 110.48 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -129.92 127.97 41.2 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.358 0.599 . . . . 0.0 111.652 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.1 mp0 -71.66 141.63 49.9 Favored 'General case' 0 CA--C 1.566 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 110.915 161.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.21 109.11 1.43 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.246 -0.909 . . . . 0.0 113.141 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.84 -0.76 48.44 Favored Glycine 0 CA--C 1.553 2.46 0 N-CA-C 119.026 2.37 . . . . 0.0 119.026 -167.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.0 p -81.24 139.17 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 120.983 2.392 . . . . 0.0 113.223 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.3 m -89.03 109.51 20.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.745 -0.597 . . . . 0.0 109.67 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -138.81 162.04 35.76 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 123.325 0.65 . . . . 0.0 112.34 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -87.57 103.6 15.71 Favored 'General case' 0 CA--C 1.568 1.659 0 O-C-N 121.234 -0.916 . . . . 0.0 111.704 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -89.75 141.23 28.81 Favored 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 123.78 0.832 . . . . 0.0 111.989 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -136.73 107.5 6.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.999 -1.063 . . . . 0.0 110.856 -169.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.7 mt -77.59 88.24 3.9 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -171.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.288 . . 63.41 -53.25 0.21 Allowed 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 119.099 3.0 . . . . 0.0 119.099 174.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -91.59 -76.63 0.44 Allowed 'General case' 0 CA--C 1.572 1.792 0 CA-C-N 119.128 0.876 . . . . 0.0 110.7 170.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.73 56.81 0.1 OUTLIER Glycine 0 N--CA 1.494 2.533 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.3 m -69.76 -36.23 75.59 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 117.159 2.281 . . . . 0.0 117.159 -173.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 77.32 78.57 0.08 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 124.637 1.175 . . . . 0.0 112.634 164.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.0 mt -127.96 103.44 7.25 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.057 0.543 . . . . 0.0 111.286 -161.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -76.53 120.29 21.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.921 -1.112 . . . . 0.0 112.533 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.51 -169.61 42.44 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 118.098 1.999 . . . . 0.0 118.098 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 p -125.77 135.55 52.16 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 114.136 -1.032 . . . . 0.0 111.774 -164.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -95.11 116.18 28.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.754 -0.591 . . . . 0.0 110.425 164.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.8 t -109.81 132.32 54.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.9 -0.5 . . . . 0.0 111.914 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.5 tp -86.73 106.11 17.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.055 -1.028 . . . . 0.0 112.374 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -84.99 168.84 14.57 Favored 'General case' 0 CA--C 1.577 1.999 0 C-N-CA 123.518 0.727 . . . . 0.0 110.683 157.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -33.32 -63.29 0.35 Allowed Glycine 0 N--CA 1.502 3.052 0 N-CA-C 121.239 3.256 . . . . 0.0 121.239 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -108.16 17.63 22.06 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 165.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -139.37 124.19 18.6 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 121.066 1.757 . . . . 0.0 112.308 -161.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.8 mt -89.29 106.77 18.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.938 -1.101 . . . . 0.0 108.787 162.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.2 113.38 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.794 0.807 . . . . 0.0 109.998 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.99 93.02 1.33 Allowed Glycine 0 N--CA 1.479 1.534 0 C-N-CA 123.844 0.735 . . . . 0.0 112.833 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -89.33 104.29 16.85 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.511 0.672 . . . . 0.0 110.329 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -124.6 149.64 46.84 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.072 0.949 . . . . 0.0 111.972 -168.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -125.02 139.75 53.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.356 -0.84 . . . . 0.0 110.751 169.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -66.69 119.85 12.48 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.0 p -82.86 72.16 9.95 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 122.542 1.163 . . . . 0.0 109.901 167.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 175.91 -64.09 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 126.114 1.766 . . . . 0.0 107.37 -167.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -93.6 -33.31 13.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.68 -35.06 4.2 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 116.865 1.506 . . . . 0.0 116.865 -154.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -53.53 147.61 10.71 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 117.367 2.358 . . . . 0.0 117.367 -173.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -86.21 129.71 34.76 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -175.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.6 tt -113.75 124.11 51.47 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.203 1.001 . . . . 0.0 108.991 169.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -113.7 111.98 22.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.43 -0.793 . . . . 0.0 109.21 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 m -102.5 112.88 25.81 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.767 0.712 . . . . 0.0 110.315 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.4 t -97.88 88.47 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.289 -0.882 . . . . 0.0 108.694 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -79.12 106.43 11.15 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.545 0.738 . . . . 0.0 110.985 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -137.6 140.63 41.07 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -171.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.1 mp -86.65 113.76 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -96.16 91.31 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.2 -89.77 0.7 Allowed Glycine 0 N--CA 1.491 2.345 0 O-C-N 121.016 -1.052 . . . . 0.0 114.745 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -134.4 42.39 2.86 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 166.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -136.66 125.95 24.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.892 -1.13 . . . . 0.0 109.058 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.5 tp -84.23 105.6 15.21 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.88 123.1 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . 0.274 17.9 pt20 -116.85 104.04 10.91 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.373 0.606 . . . . 0.0 112.379 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.0 m -87.13 109.75 19.65 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.727 0.811 . . . . 0.0 109.974 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -87.43 113.59 23.27 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.158 0.583 . . . . 0.0 110.701 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -101.58 98.54 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -115.54 104.14 11.43 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 118.832 0.742 . . . . 0.0 110.106 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 54.64 55.02 8.42 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 174.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.15 -23.46 6.08 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 119.066 2.386 . . . . 0.0 119.066 -167.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.3 t -90.03 111.06 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 120.062 1.931 . . . . 0.0 108.929 -172.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.93 114.65 27.24 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.389 0.675 . . . . 0.0 111.405 174.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -121.12 108.35 13.7 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.319 0.647 . . . . 0.0 111.294 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.24 126.79 40.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 111.787 -176.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.7 mmm-85 -103.66 127.93 51.05 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 167.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.81 120.91 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -175.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -114.26 133.07 55.9 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.857 0.863 . . . . 0.0 111.374 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -95.5 153.69 17.58 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-O 122.155 0.979 . . . . 0.0 112.051 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -65.45 109.18 2.22 Favored 'General case' 0 CA--C 1.571 1.759 0 C-N-CA 124.097 0.959 . . . . 0.0 113.025 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 t70 . . . . . 0 N--CA 1.489 1.5 0 C-N-CA 125.188 1.395 . . . . 0.0 113.96 -178.949 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.231 0 CA-C-O 121.914 0.864 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -83.86 -69.31 0.65 Allowed 'General case' 0 CA--C 1.568 1.644 0 O-C-N 121.884 -0.51 . . . . 0.0 111.581 -170.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.9 t70 48.37 64.09 1.81 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.0 m -167.41 156.65 10.19 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 122.619 1.199 . . . . 0.0 114.147 -163.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.6 m -94.25 127.83 40.34 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.834 0.853 . . . . 0.0 110.963 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -128.03 104.87 8.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.656 -0.652 . . . . 0.0 109.875 -172.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -98.25 138.02 36.14 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.184 -0.948 . . . . 0.0 112.468 -177.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.9 p -62.92 120.97 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -99.65 -57.37 2.16 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 124.188 0.995 . . . . 0.0 112.112 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -152.84 124.43 7.76 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 119.859 1.209 . . . . 0.0 112.367 -176.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.7 p -97.02 103.45 15.38 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.585 0.754 . . . . 0.0 112.663 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -100.51 116.01 31.46 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.915 0.486 . . . . 0.0 110.323 -164.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.278 39.0 t30 65.73 20.29 11.49 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 -169.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -72.08 -36.37 69.49 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -57.33 -32.24 66.5 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.886 2.18 . . . . 0.0 116.886 169.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -71.98 -47.05 54.9 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -50.6 -52.9 34.94 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 163.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.2 mmt -47.65 -57.35 5.6 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 166.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -43.83 -52.13 6.93 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 168.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -56.7 -35.72 68.82 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 171.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 27.5 mtm -73.41 -19.81 60.89 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.37 63.59 0.98 Allowed Glycine 0 N--CA 1.491 2.321 0 CA-C-N 120.367 1.44 . . . . 0.0 114.659 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.7 m -126.91 156.08 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 121.675 0.75 . . . . 0.0 112.437 -169.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -70.28 153.2 43.32 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.857 -1.152 . . . . 0.0 113.733 168.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 11.9 tt -59.21 -38.41 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 172.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.3 t -58.7 -48.16 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 C-N-CA 123.798 0.839 . . . . 0.0 113.253 166.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -55.94 -38.86 70.88 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 167.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -57.58 -52.04 67.02 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 120.587 1.54 . . . . 0.0 115.084 168.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -60.16 -46.46 89.62 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.81 -45.94 90.29 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 171.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.09 92.67 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.84 -57.12 11.28 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 161.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -93.95 52.76 1.69 Allowed 'General case' 0 CA--C 1.575 1.938 0 CA-C-N 119.635 1.107 . . . . 0.0 113.432 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -85.44 -13.35 49.53 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 -173.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 57.93 45.46 18.21 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -174.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.8 tp -82.93 120.57 25.86 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-O 122.06 0.933 . . . . 0.0 112.39 -172.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -104.75 112.05 25.01 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.456 169.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.9 mt -90.17 100.98 13.71 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 m -93.47 92.39 7.59 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.5 mt -94.76 95.84 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -168.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 86.0 m -99.01 126.52 44.73 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.287 0.635 . . . . 0.0 109.769 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -83.18 126.08 32.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.909 . . . . 0.0 112.014 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -131.01 58.58 1.71 Allowed 'General case' 0 CA--C 1.574 1.866 0 C-N-CA 123.669 0.788 . . . . 0.0 111.869 -167.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.23 72.19 0.74 Allowed Glycine 0 N--CA 1.497 2.732 0 N-CA-C 116.591 1.397 . . . . 0.0 116.591 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.294 18.4 t30 68.63 -24.45 0.14 Allowed 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 -164.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -83.79 155.93 22.77 Favored 'General case' 0 CA--C 1.561 1.391 0 O-C-N 120.656 -1.277 . . . . 0.0 113.604 169.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -119.58 121.59 39.69 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 164.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.9 m -93.8 102.8 14.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.36 103.71 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -172.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -81.14 110.4 16.61 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -97.92 83.97 3.24 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.358 0.663 . . . . 0.0 109.733 -175.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.7 t -94.94 115.16 27.1 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.601 0.36 . . . . 0.0 111.936 -170.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.5 p -150.67 168.0 25.66 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.836 0.854 . . . . 0.0 113.134 -166.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.1 -30.03 65.95 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 118.027 2.602 . . . . 0.0 118.027 166.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -73.6 -43.96 58.36 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 167.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.55 154.65 12.07 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.82 0.848 . . . . 0.0 112.428 -165.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -119.66 108.2 14.16 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 161.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.0 pt -129.73 128.37 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.558 -0.714 . . . . 0.0 111.073 -174.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.32 99.62 12.38 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.841 0.857 . . . . 0.0 111.387 173.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.3 t -92.09 102.45 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -176.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.15 93.22 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -106.5 143.49 34.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.716 -0.615 . . . . 0.0 111.78 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -87.73 146.19 25.78 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 121.658 -0.651 . . . . 0.0 112.0 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.6 mt -70.26 109.75 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.095 -1.003 . . . . 0.0 111.839 169.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.42 52.73 2.44 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 116.394 1.318 . . . . 0.0 116.394 -171.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.5 p -143.63 138.48 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 118.327 1.064 . . . . 0.0 109.971 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.3 m -83.74 108.08 16.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.342 -0.849 . . . . 0.0 109.8 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -131.95 165.95 22.77 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-O 121.682 0.753 . . . . 0.0 112.331 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -90.1 108.77 19.94 Favored 'General case' 0 CA--C 1.571 1.779 0 O-C-N 121.619 -0.675 . . . . 0.0 111.506 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -100.5 117.68 35.15 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.742 0.817 . . . . 0.0 110.444 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -98.54 123.66 42.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.119 -0.988 . . . . 0.0 112.919 -175.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.07 158.61 25.0 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.4 69.96 2.93 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 170.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -171.8 -70.36 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 125.292 1.437 . . . . 0.0 108.273 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.45 68.24 0.01 OUTLIER Glycine 0 N--CA 1.483 1.796 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -171.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.3 m -162.14 127.74 3.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.584 -0.951 . . . . 0.0 109.846 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -97.95 126.08 43.18 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.901 0.88 . . . . 0.0 110.439 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.73 111.5 22.51 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.753 -0.592 . . . . 0.0 110.607 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -84.47 123.39 30.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.157 -0.965 . . . . 0.0 111.527 171.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.53 -168.26 39.39 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 117.659 1.824 . . . . 0.0 117.659 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 71.3 p -124.27 123.6 40.58 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.544 -0.828 . . . . 0.0 111.62 -163.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -83.98 114.67 21.87 Favored 'General case' 0 CA--C 1.57 1.735 0 O-C-N 121.992 -0.442 . . . . 0.0 111.433 163.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.7 m -114.36 126.54 55.11 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 123.396 0.679 . . . . 0.0 111.071 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.2 tp -94.12 115.56 27.87 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.176 -0.953 . . . . 0.0 112.103 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -100.3 80.94 2.31 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 170.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.88 -87.23 0.55 Allowed Glycine 0 N--CA 1.494 2.515 0 O-C-N 121.052 -1.03 . . . . 0.0 115.083 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -123.39 29.4 6.67 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 166.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -125.06 109.68 13.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.461 -1.399 . . . . 0.0 108.972 177.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.81 106.4 18.44 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.354 0.661 . . . . 0.0 109.524 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.8 tt -96.93 118.67 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.866 -1.146 . . . . 0.0 110.644 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.72 98.06 2.35 Favored Glycine 0 N--CA 1.48 1.605 0 C-N-CA 123.249 0.452 . . . . 0.0 112.098 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -85.4 93.87 8.84 Favored 'General case' 0 CA--C 1.565 1.552 0 C-N-CA 123.251 0.621 . . . . 0.0 109.354 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -121.79 143.63 49.28 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.298 1.047 . . . . 0.0 113.442 -166.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -119.34 137.8 53.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.391 -0.818 . . . . 0.0 109.146 165.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -69.78 107.34 3.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 0.0 111.664 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.312 13.8 t -74.81 -5.88 45.92 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 118.139 2.644 . . . . 0.0 118.139 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -95.0 -18.1 21.36 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 158.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -123.79 -21.64 5.12 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 117.29 2.329 . . . . 0.0 117.29 -173.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.24 -30.92 7.12 Favored Glycine 0 N--CA 1.496 2.684 0 CA-C-N 121.885 2.129 . . . . 0.0 118.351 -175.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -78.76 151.56 31.96 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 118.45 1.125 . . . . 0.0 113.585 -167.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -98.63 132.62 43.89 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.599 0.714 . . . . 0.0 112.004 -164.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.3 tt -131.11 122.55 26.86 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 124.1 0.96 . . . . 0.0 109.908 -170.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -109.85 116.84 32.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.126 -0.984 . . . . 0.0 109.352 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.7 m -106.52 104.06 13.67 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 119.019 0.827 . . . . 0.0 110.008 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.5 t -92.36 107.8 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.25 -0.906 . . . . 0.0 108.675 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -85.3 103.76 14.53 Favored 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 124.074 0.95 . . . . 0.0 110.433 170.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -127.46 147.35 50.3 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 124.254 1.022 . . . . 0.0 109.534 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . 0.25 5.8 mt -113.72 117.47 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 119.771 -1.83 . . . . 0.0 111.175 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.2 tp -92.35 74.71 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.769 0 CA-C-O 122.124 0.964 . . . . 0.0 110.741 172.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.94 -98.48 0.71 Allowed Glycine 0 N--CA 1.49 2.281 0 O-C-N 121.067 -1.021 . . . . 0.0 115.193 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -80.7 -10.62 59.72 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.892 2.553 . . . . 0.0 117.892 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -128.28 127.64 43.15 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-N 119.736 1.153 . . . . 0.0 112.457 -165.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.9 tp -80.94 124.11 28.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.858 0.863 . . . . 0.0 111.147 170.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.2 m -103.17 116.54 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -91.13 103.49 16.18 Favored 'General case' 0 CA--C 1.558 1.281 0 O-C-N 121.277 -0.889 . . . . 0.0 109.093 167.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.4 m -90.66 104.57 17.14 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -92.16 106.92 18.83 Favored 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 123.76 0.824 . . . . 0.0 110.621 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.89 111.39 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.403 ' O ' HG12 ' A' ' 122' ' ' VAL . 91.7 t80 -142.04 110.82 6.19 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.988 0.515 . . . . 0.0 110.463 -175.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 54.31 50.52 16.14 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 168.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.69 38.01 44.1 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 118.507 2.163 . . . . 0.0 118.507 -170.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 119' ' ' TYR . 0.5 OUTLIER -146.55 148.15 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 118.812 1.306 . . . . 0.0 110.216 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -130.06 115.82 17.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.729 -0.607 . . . . 0.0 109.981 171.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.22 127.3 54.64 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.009 0.524 . . . . 0.0 112.276 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -108.71 105.09 14.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.595 -0.691 . . . . 0.0 110.099 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -87.85 115.13 25.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.346 -0.847 . . . . 0.0 110.494 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 22.7 mt -99.53 123.16 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -120.99 119.54 32.83 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 124.291 1.036 . . . . 0.0 109.604 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -80.36 142.85 34.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.913 -1.117 . . . . 0.0 113.073 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 52.6 tttt -69.34 113.67 6.87 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.7 t70 . . . . . 0 N--CA 1.49 1.552 0 C-N-CA 124.761 1.224 . . . . 0.0 113.734 172.675 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.349 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 60.03 65.12 1.15 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 172.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -148.99 81.29 1.43 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.659 -0.651 . . . . 0.0 110.431 -176.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.3 m -171.95 170.26 5.45 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.577 1.179 . . . . 0.0 111.763 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.2 m -90.39 130.73 36.44 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.912 -1.117 . . . . 0.0 110.712 170.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -135.39 113.56 11.33 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.576 -0.703 . . . . 0.0 109.762 -171.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -116.13 143.38 45.56 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.651 -1.281 . . . . 0.0 113.649 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.88 115.86 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -168.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.08 -48.75 7.19 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 124.388 1.075 . . . . 0.0 112.86 169.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -136.61 109.73 7.75 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 119.377 0.99 . . . . 0.0 110.225 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.0 p -91.98 101.06 13.61 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.018 -1.051 . . . . 0.0 111.013 167.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -106.96 113.11 26.39 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -165.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.294 13.1 t30 69.67 16.65 7.94 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 117.53 2.419 . . . . 0.0 117.53 -176.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -66.73 -37.92 85.62 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.44 -43.17 83.68 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 167.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -69.29 -43.15 74.44 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 171.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -48.62 -54.34 15.0 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 162.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 mtt -66.7 -24.7 66.29 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 170.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.65 -42.92 81.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.295 -1.503 . . . . 0.0 114.216 164.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -57.47 -33.15 67.69 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 163.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 mmt -64.05 -42.58 96.99 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 164.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.87 56.35 0.96 Allowed Glycine 0 N--CA 1.485 1.951 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -117.44 147.86 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-N 117.983 0.892 . . . . 0.0 112.512 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -56.45 139.72 48.16 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.297 0.0 OUTLIER -47.35 -45.54 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 178.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.4 t -55.07 -60.02 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 C-N-CA 124.288 1.035 . . . . 0.0 113.643 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -63.19 -38.73 92.31 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -58.03 -49.67 76.09 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 170.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -59.18 -47.77 84.08 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 167.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.4 mt -59.0 -41.5 87.8 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 171.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.86 -41.46 87.27 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.84 -52.79 64.02 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 161.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -91.4 35.72 0.94 Allowed 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -77.89 -22.68 49.36 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 66.61 60.6 0.57 Allowed 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 120.472 1.487 . . . . 0.0 113.056 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.4 tp -86.7 120.87 28.46 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 121.415 -0.803 . . . . 0.0 112.979 -171.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -98.4 121.2 40.03 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 124.53 1.132 . . . . 0.0 110.355 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.4 mt -101.76 101.64 12.15 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 123.709 0.804 . . . . 0.0 109.253 174.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.4 m -88.84 95.03 10.13 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.155 -0.966 . . . . 0.0 108.775 172.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 73.6 mt -93.06 118.7 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -173.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -137.01 146.78 45.71 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 123.33 0.652 . . . . 0.0 110.725 171.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -130.53 157.92 41.37 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -127.55 84.23 2.23 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-N 114.482 -1.235 . . . . 0.0 108.706 167.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.73 -82.2 0.84 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 116.206 1.243 . . . . 0.0 116.206 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -116.07 -16.33 11.05 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 168.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -85.79 131.19 34.37 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 121.245 1.839 . . . . 0.0 111.833 173.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -113.61 131.16 56.22 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 124.363 1.065 . . . . 0.0 110.023 177.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 m -103.71 111.87 24.55 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 163.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.7 t -108.99 102.87 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -84.98 109.82 18.45 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -108.16 103.95 13.25 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.896 0.478 . . . . 0.0 110.043 -166.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 t -115.32 118.95 34.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.305 0.642 . . . . 0.0 111.745 -172.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.5 p -138.38 175.5 9.52 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.779 0.8 . . . . 0.0 112.965 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.74 62.26 1.05 Allowed 'General case' 0 CA--C 1.576 1.98 0 O-C-N 120.395 -1.441 . . . . 0.0 113.54 153.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -169.18 -61.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.932 1.293 . . . . 0.0 109.225 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.402 ' HG3' HH11 ' A' ' 56' ' ' ARG . 32.0 ptt85 -142.47 141.49 32.16 Favored 'General case' 0 CA--C 1.567 1.608 0 C-N-CA 124.035 0.934 . . . . 0.0 110.545 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -129.68 92.43 3.33 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.17 153.02 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 CA-C-O 121.91 0.862 . . . . 0.0 111.879 -170.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.38 108.41 18.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.932 . . . . 0.0 110.564 168.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.84 97.77 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.3 t -102.7 125.65 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -173.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -150.77 151.05 31.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.606 -0.684 . . . . 0.0 111.662 -176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -97.3 143.82 27.69 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.285 -0.885 . . . . 0.0 111.004 165.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.8 mt -57.35 122.03 11.59 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.88 -4.77 73.47 Favored Glycine 0 CA--C 1.555 2.537 0 N-CA-C 119.868 2.707 . . . . 0.0 119.868 -170.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -93.64 132.18 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-N 120.489 2.144 . . . . 0.0 109.769 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -74.94 117.98 17.39 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -134.8 161.09 36.16 Favored 'General case' 0 CA--C 1.571 1.753 0 C-N-CA 123.844 0.858 . . . . 0.0 112.013 -176.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -89.41 115.89 27.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.357 -0.84 . . . . 0.0 111.88 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -113.23 129.92 56.38 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 123.868 0.867 . . . . 0.0 111.129 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -98.49 131.32 44.83 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.996 -1.065 . . . . 0.0 110.895 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.6 mt -62.89 -56.1 20.23 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 170.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -154.95 -65.15 0.13 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 119.116 0.871 . . . . 0.0 111.948 177.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -84.16 -76.08 0.31 Allowed 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.396 0.679 . . . . 0.0 111.96 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.66 58.23 0.4 Allowed Glycine 0 N--CA 1.488 2.151 0 CA-C-N 118.795 0.725 . . . . 0.0 114.51 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 m -105.94 90.95 3.53 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -82.59 117.67 22.73 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.936 0.874 . . . . 0.0 112.44 -168.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.8 mt -115.58 108.66 16.71 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.671 0.789 . . . . 0.0 109.393 -171.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -98.1 96.72 8.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.758 -0.589 . . . . 0.0 110.669 -170.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.29 -153.46 10.97 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 116.338 1.295 . . . . 0.0 116.338 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.7 p -129.68 128.8 43.29 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -152.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -91.22 119.51 31.36 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.057 -1.027 . . . . 0.0 109.393 158.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.3 m -122.02 136.04 54.89 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.267 0.556 . . . . 0.0 111.308 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.8 tp -86.12 109.11 18.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.961 -1.087 . . . . 0.0 111.138 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.23 15.08 2.55 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 171.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.09 -80.53 0.27 Allowed Glycine 0 N--CA 1.488 2.148 0 O-C-N 120.827 -1.171 . . . . 0.0 112.087 -170.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -83.89 -28.8 27.67 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -125.45 140.06 53.1 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.781 1.173 . . . . 0.0 111.556 -165.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.5 mt -89.24 104.54 17.08 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 167.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.1 pt -93.97 116.41 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.997 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.82 99.95 2.61 Favored Glycine 0 N--CA 1.482 1.703 0 C-N-CA 123.591 0.615 . . . . 0.0 112.944 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -97.05 98.44 10.06 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -128.61 167.39 17.23 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-O 123.338 1.542 . . . . 0.0 111.657 -170.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.0 154.64 36.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.706 -1.246 . . . . 0.0 110.256 165.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -70.66 109.99 5.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 112.195 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.8 t -66.4 -17.87 65.03 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -84.96 -22.21 29.26 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 165.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -120.12 -22.49 6.63 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.98 -39.4 2.78 Favored Glycine 0 N--CA 1.492 2.37 0 CA-C-N 121.37 1.895 . . . . 0.0 117.258 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -72.05 144.86 48.6 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -165.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.66 140.39 55.46 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -173.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.1 tt -126.16 127.24 45.41 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.549 0.69 . . . . 0.0 111.323 167.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -96.67 149.08 22.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.506 -0.746 . . . . 0.0 110.604 163.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.4 m -145.32 105.54 4.06 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 119.928 -1.732 . . . . 0.0 109.589 162.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.7 t -93.11 114.26 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.094 -1.004 . . . . 0.0 109.03 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.4 mtm-85 -89.05 121.57 31.53 Favored 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 123.787 0.835 . . . . 0.0 111.265 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -143.61 141.48 30.64 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 123.671 0.788 . . . . 0.0 110.424 -177.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.29 126.57 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 120.733 -1.23 . . . . 0.0 109.759 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.1 tp -116.52 91.68 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.754 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 164.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.04 -112.32 4.15 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 120.898 -1.126 . . . . 0.0 114.611 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -99.62 20.31 14.22 Favored 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 167.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -126.14 127.16 45.32 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.788 1.176 . . . . 0.0 111.056 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.5 tp -87.62 114.78 24.54 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.241 1.016 . . . . 0.0 109.982 171.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.4 m -91.35 119.43 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.585 -0.697 . . . . 0.0 109.876 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -99.71 103.68 15.36 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 166.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.5 m -89.81 94.96 10.03 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -81.08 131.45 35.3 Favored 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 123.944 0.898 . . . . 0.0 111.249 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.1 t -134.98 114.37 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 CA-C-N 119.147 0.885 . . . . 0.0 109.274 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -113.94 122.12 45.99 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.31 5.2 mm-40 70.69 -85.47 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 124.23 1.012 . . . . 0.0 112.0 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -151.22 50.49 0.53 Allowed Glycine 0 N--CA 1.487 2.1 0 CA-C-O 119.416 -0.658 . . . . 0.0 114.109 158.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.35 109.08 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -77.81 129.61 35.65 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -124.08 114.3 19.53 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.532 0.682 . . . . 0.0 110.622 163.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -99.7 104.39 16.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.861 -0.525 . . . . 0.0 109.683 -176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 -93.3 112.7 24.7 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.531 0.682 . . . . 0.0 109.612 172.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.8 mt -99.1 114.74 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.555 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -173.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -108.44 111.33 23.17 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.685 0.794 . . . . 0.0 109.891 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -79.97 144.79 32.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.003 -1.061 . . . . 0.0 112.467 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -66.1 120.34 13.02 Favored 'General case' 0 CA--C 1.569 1.692 0 CA-C-O 121.684 0.754 . . . . 0.0 112.961 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.8 t70 . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -158.895 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.347 0 CA-C-O 122.106 0.955 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 55.01 35.03 23.75 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 171.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -146.71 51.82 1.11 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.379 -1.45 . . . . 0.0 113.78 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 p -160.87 176.75 11.1 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.127 -0.983 . . . . 0.0 113.593 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.4 m -78.4 116.58 18.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.72 . . . . 0.0 110.264 160.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -109.73 111.34 22.73 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -95.04 138.65 32.48 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.429 -0.794 . . . . 0.0 111.75 -177.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.02 122.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -110.29 -55.62 2.44 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.581 0.752 . . . . 0.0 112.742 -174.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -158.56 119.8 3.43 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 120.042 1.292 . . . . 0.0 111.064 -171.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.0 p -110.29 124.72 52.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.031 -1.043 . . . . 0.0 113.099 -174.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -78.43 -48.4 15.5 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -170.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -134.83 54.75 1.93 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 119.97 1.259 . . . . 0.0 112.599 168.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -84.45 58.77 5.04 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.018 -1.676 . . . . 0.0 112.419 167.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -151.61 -61.19 0.17 Allowed 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 125.101 1.36 . . . . 0.0 109.43 -176.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -62.02 -48.95 77.97 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 120.846 1.657 . . . . 0.0 114.096 170.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -47.65 -52.8 16.83 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 163.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.8 mtp -55.17 -49.14 72.62 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 171.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -52.84 -46.38 67.78 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 165.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -60.13 -36.22 77.0 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 170.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.7 mtm -72.34 -59.14 2.88 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 119.607 1.094 . . . . 0.0 113.114 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.89 72.14 0.02 OUTLIER Glycine 0 N--CA 1.487 2.047 0 CA-C-N 118.268 0.486 . . . . 0.0 113.779 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 m -118.36 155.44 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-O 122.025 0.917 . . . . 0.0 112.605 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -79.2 153.29 30.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.353 -0.842 . . . . 0.0 110.921 152.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.29 12.9 tt -56.78 -37.61 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 172.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.9 t -58.75 -53.73 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 C-N-CA 124.362 1.065 . . . . 0.0 113.276 166.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -55.34 -36.16 65.98 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 168.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -57.36 -52.08 66.81 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 172.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -64.61 -44.74 89.59 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 166.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -60.98 -58.06 10.02 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.66 -15.9 63.82 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 173.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.96 -52.47 42.41 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 156.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -91.51 -18.31 24.33 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 118.216 2.673 . . . . 0.0 118.216 -172.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -73.32 62.17 0.69 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 50.12 51.58 16.41 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 163.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 tt -91.07 109.55 20.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.116 -0.99 . . . . 0.0 111.588 -170.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -97.75 138.15 35.55 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-O 121.848 0.832 . . . . 0.0 111.937 166.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.2 mt -103.91 97.41 7.41 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 164.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.2 m -88.26 103.43 15.79 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.173 -0.955 . . . . 0.0 108.907 176.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.3 mt -94.01 108.58 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -168.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 m -105.26 111.19 23.84 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -87.34 137.92 31.92 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -135.84 80.36 1.82 Allowed 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 124.123 0.969 . . . . 0.0 109.166 172.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.12 -89.58 0.5 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 116.061 1.184 . . . . 0.0 116.061 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.13 15.33 19.5 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 167.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -134.3 116.13 14.91 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 119.942 1.246 . . . . 0.0 110.259 -166.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -104.8 129.53 53.06 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.715 -0.616 . . . . 0.0 110.847 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.1 m -100.77 104.43 15.69 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 164.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.2 t -101.47 108.39 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -80.21 110.35 15.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 111.003 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -83.73 95.07 8.29 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 t -116.55 114.71 24.53 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.005 0.907 . . . . 0.0 111.31 -170.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.8 t -154.53 175.41 13.65 Favored 'General case' 0 CA--C 1.572 1.8 0 C-N-CA 125.968 1.707 . . . . 0.0 109.087 -171.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.2 -27.11 63.59 Favored 'General case' 0 CA--C 1.581 2.171 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 155.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -85.42 -32.58 22.27 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.1 mmt-85 -137.42 140.41 41.3 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.197 0.908 . . . . 0.0 110.32 -175.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -135.33 76.07 1.6 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 158.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.3 142.6 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 122.026 0.917 . . . . 0.0 111.058 -168.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.4 113.67 26.0 Favored 'General case' 0 CA--C 1.564 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 111.461 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.1 t -90.93 98.35 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.5 t -91.6 119.4 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -136.6 129.78 31.31 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.159 0.504 . . . . 0.0 112.315 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.12 135.82 33.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.801 -0.562 . . . . 0.0 110.5 164.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.43 125.24 22.94 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.75 -16.76 44.37 Favored Glycine 0 CA--C 1.556 2.601 0 N-CA-C 119.447 2.539 . . . . 0.0 119.447 -167.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.0 t -86.21 130.28 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 CA-C-N 120.561 2.18 . . . . 0.0 109.98 -177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.0 t -74.44 121.33 21.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.575 -0.703 . . . . 0.0 112.76 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -142.58 164.72 29.36 Favored 'General case' 0 CA--C 1.573 1.86 0 C-N-CA 123.333 0.653 . . . . 0.0 111.775 -172.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -87.45 116.33 25.49 Favored 'General case' 0 CA--C 1.569 1.696 0 O-C-N 121.339 -0.851 . . . . 0.0 112.909 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -98.99 143.41 29.3 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.876 0.87 . . . . 0.0 111.231 166.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -120.59 132.63 55.24 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.983 0.897 . . . . 0.0 110.682 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.8 mt -84.54 168.19 15.63 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 121.979 0.895 . . . . 0.0 112.9 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.11 -36.67 80.33 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 118.94 2.941 . . . . 0.0 118.94 -173.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.34 -76.48 0.1 Allowed 'General case' 0 CA--C 1.571 1.775 0 CA-C-N 120.113 1.324 . . . . 0.0 111.697 169.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.44 64.0 0.05 OUTLIER Glycine 0 N--CA 1.483 1.806 0 O-C-N 121.841 -0.537 . . . . 0.0 112.543 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.8 m -123.04 107.17 11.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -95.26 128.91 42.47 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-O 122.07 0.938 . . . . 0.0 111.419 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.3 mt -132.69 116.24 16.37 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.076 -156.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -92.47 118.68 31.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.475 -0.765 . . . . 0.0 110.667 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.76 -177.92 42.45 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 117.981 1.953 . . . . 0.0 117.981 -173.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.6 p -126.28 132.13 51.73 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 113.972 -1.114 . . . . 0.0 110.37 -173.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -92.59 122.66 35.23 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.335 -0.853 . . . . 0.0 110.541 169.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.3 m -109.66 118.81 37.53 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.318 0.647 . . . . 0.0 110.831 175.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.5 tp -82.83 103.93 12.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.515 -0.74 . . . . 0.0 111.85 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -105.25 89.78 3.23 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.191 0.52 . . . . 0.0 110.26 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.69 -94.49 0.76 Allowed Glycine 0 N--CA 1.492 2.389 0 O-C-N 121.501 -0.75 . . . . 0.0 113.782 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -127.36 48.4 2.23 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 159.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -129.8 111.87 13.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.089 -1.007 . . . . 0.0 108.49 173.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.4 mt -84.55 108.37 17.28 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.439 -0.788 . . . . 0.0 109.452 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.0 mt -102.22 104.22 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -172.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.51 100.71 2.67 Favored Glycine 0 N--CA 1.483 1.812 0 C-N-CA 123.886 0.755 . . . . 0.0 113.096 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.52 95.92 9.91 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.973 0.509 . . . . 0.0 109.729 -175.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -110.76 147.75 33.78 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.589 0.709 . . . . 0.0 112.868 -171.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -119.04 139.43 51.74 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.644 0.778 . . . . 0.0 109.131 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -69.17 114.9 7.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.928 -1.107 . . . . 0.0 112.885 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 t -66.09 -16.77 64.22 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 117.916 2.562 . . . . 0.0 117.916 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -92.56 -10.65 36.84 Favored 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 165.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -141.15 -16.9 0.83 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 -169.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.94 -42.5 2.76 Favored Glycine 0 N--CA 1.493 2.458 0 CA-C-N 121.949 2.159 . . . . 0.0 117.707 -175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -70.24 147.91 49.19 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -161.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -77.43 132.2 38.36 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -173.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.0 tt -123.61 111.45 16.25 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 124.352 1.061 . . . . 0.0 108.751 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -101.63 113.62 26.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.104 -0.997 . . . . 0.0 109.577 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.0 m -107.2 108.69 20.24 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 119.196 0.907 . . . . 0.0 111.027 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.2 97.86 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.006 -1.059 . . . . 0.0 108.376 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -86.89 117.91 25.93 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.088 0.955 . . . . 0.0 110.899 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -146.97 142.81 27.92 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.326 -0.859 . . . . 0.0 112.864 -178.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.2 mp -90.84 110.01 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.0 tp -90.07 80.42 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.119 0.962 . . . . 0.0 110.155 169.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.67 -88.92 0.74 Allowed Glycine 0 N--CA 1.49 2.266 0 O-C-N 121.209 -0.932 . . . . 0.0 114.933 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -117.84 22.05 12.52 Favored 'General case' 0 CA--C 1.581 2.171 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 175.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -137.99 123.6 19.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.53 -1.356 . . . . 0.0 109.858 -175.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.7 tp -78.49 110.03 13.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.524 -0.735 . . . . 0.0 110.127 168.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.89 118.12 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.277 -0.89 . . . . 0.0 108.871 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . 0.269 21.3 pt20 -103.52 104.42 14.49 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.777 0.799 . . . . 0.0 110.724 172.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.0 m -91.56 108.39 19.87 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.755 0.822 . . . . 0.0 109.152 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -94.14 112.13 23.92 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.386 0.674 . . . . 0.0 110.865 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.01 97.39 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -109.6 113.19 25.76 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.152 0.581 . . . . 0.0 109.873 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 54.78 46.14 25.2 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.04 -25.23 4.86 Favored Glycine 0 CA--C 1.556 2.65 0 N-CA-C 119.125 2.41 . . . . 0.0 119.125 -166.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.5 t -83.6 108.61 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 119.989 1.894 . . . . 0.0 110.069 -168.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -86.46 119.47 26.76 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.151 0.58 . . . . 0.0 112.479 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -124.97 117.0 23.06 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.645 0.778 . . . . 0.0 111.888 175.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -106.45 108.68 20.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.537 -0.727 . . . . 0.0 110.174 -170.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -97.43 116.01 28.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.911 -0.493 . . . . 0.0 110.482 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.7 mt -90.48 118.81 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -111.63 123.83 51.05 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.372 1.069 . . . . 0.0 109.221 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -83.92 148.35 26.99 Favored 'General case' 0 CA--C 1.565 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 112.721 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -59.24 113.42 2.13 Favored 'General case' 0 CA--C 1.57 1.735 0 C-N-CA 123.687 0.795 . . . . 0.0 113.05 167.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 N--CA 1.489 1.488 0 C-N-CA 124.949 1.3 . . . . 0.0 113.096 -175.139 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.282 0 CA-C-O 121.231 0.539 . . . . 0.0 111.984 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.327 62.9 m-85 71.43 -49.38 0.68 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.13 93.88 1.09 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 120.259 1.39 . . . . 0.0 112.374 -170.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.4 m -176.76 166.45 2.57 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 122.651 1.215 . . . . 0.0 111.805 -163.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.3 m -94.94 122.79 37.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.485 -0.759 . . . . 0.0 110.326 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -127.14 111.79 14.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.762 -0.586 . . . . 0.0 109.691 -170.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -105.34 133.19 50.51 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.977 -1.077 . . . . 0.0 112.011 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.58 115.79 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -98.47 -54.71 2.96 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 124.483 1.113 . . . . 0.0 111.85 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 56.1 mtm-85 -133.79 106.98 7.62 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.427 1.012 . . . . 0.0 109.458 -177.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.5 p -94.34 97.74 10.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.856 -0.527 . . . . 0.0 111.196 174.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.4 127.03 52.76 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.157 0.583 . . . . 0.0 110.06 -159.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.269 37.8 t30 62.76 40.45 9.97 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -169.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -77.99 -49.82 13.32 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -172.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.02 -40.79 77.38 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 171.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -62.76 -47.65 82.6 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.21 1.368 . . . . 0.0 114.629 171.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -53.52 -53.03 57.39 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 166.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.9 mtp -60.83 -41.89 96.65 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -60.02 -42.52 94.51 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 165.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -40.69 73.89 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 166.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 56.6 mtm -61.84 -54.77 37.6 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-N 119.552 1.069 . . . . 0.0 112.763 166.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.99 54.83 0.08 OUTLIER Glycine 0 N--CA 1.487 2.041 0 CA-C-O 119.122 -0.821 . . . . 0.0 113.909 164.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.4 m -126.77 151.18 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 122.651 1.215 . . . . 0.0 112.911 -169.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -72.77 164.48 26.49 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.259 14.0 tt -55.43 -36.86 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 175.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.9 t -65.18 -51.57 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-N 120.09 1.314 . . . . 0.0 112.658 173.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -52.16 -47.08 65.66 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 166.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -57.87 -48.51 79.63 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -60.91 -46.25 91.42 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 171.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.5 mt -60.59 -48.16 83.02 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 171.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.24 -21.14 62.16 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.11 -49.36 15.44 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 120.962 1.71 . . . . 0.0 114.415 167.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -77.91 17.62 0.56 Allowed 'General case' 0 CA--C 1.58 2.124 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 175.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.2 p30 -74.94 -17.91 60.48 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 118.93 2.937 . . . . 0.0 118.93 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 61.53 62.19 1.36 Allowed 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 120.562 1.528 . . . . 0.0 113.484 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 tt -88.56 117.52 27.57 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.418 -0.801 . . . . 0.0 112.257 -164.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -101.21 127.83 47.6 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.54 0.736 . . . . 0.0 110.173 173.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.4 mt -98.48 102.4 14.13 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 166.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.5 m -94.62 107.56 19.55 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.098 -1.002 . . . . 0.0 108.441 171.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.7 mt -104.07 129.01 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -165.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 89.3 m -135.53 123.54 22.8 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.271 -0.893 . . . . 0.0 109.326 174.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.7 tm0? -98.74 132.94 43.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.321 -0.862 . . . . 0.0 112.186 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -127.69 87.6 2.65 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 123.565 0.746 . . . . 0.0 110.947 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.78 -89.5 0.96 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 115.139 0.816 . . . . 0.0 115.139 173.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -108.65 -2.5 18.68 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 166.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -108.99 144.13 37.37 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.34 1.427 . . . . 0.0 112.415 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -110.19 120.42 42.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.4 0.68 . . . . 0.0 109.986 167.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.1 m -86.41 102.72 14.3 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 164.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.3 t -104.6 101.52 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -83.8 107.44 16.21 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.262 -0.899 . . . . 0.0 110.017 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -86.6 92.9 9.05 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.005 0.522 . . . . 0.0 110.066 176.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.3 m -96.24 108.72 21.24 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 120.941 0.4 . . . . 0.0 109.991 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.3 p -143.51 158.02 43.98 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.468 0.651 . . . . 0.0 111.776 -174.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.61 -25.0 64.27 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.429 2.381 . . . . 0.0 117.429 165.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -53.96 15.66 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 165.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.79 152.52 25.19 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-N 119.148 0.886 . . . . 0.0 111.676 174.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -106.08 98.14 7.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.689 -0.632 . . . . 0.0 109.837 166.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.2 pt -122.93 132.85 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 121.989 0.9 . . . . 0.0 111.765 -174.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -94.85 98.46 10.75 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.693 0.797 . . . . 0.0 108.917 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.45 93.3 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -166.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.6 t -94.21 98.42 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -176.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -109.88 141.49 42.52 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.285 0.564 . . . . 0.0 112.116 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.38 138.75 31.16 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.465 0.65 . . . . 0.0 111.292 166.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.66 129.03 39.08 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.95 -7.12 63.95 Favored Glycine 0 CA--C 1.555 2.569 0 N-CA-C 119.969 2.748 . . . . 0.0 119.969 -170.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.9 t -97.78 133.74 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 120.634 2.217 . . . . 0.0 110.414 -170.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.7 p -74.57 104.35 5.23 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.439 0.696 . . . . 0.0 112.626 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -118.07 138.74 52.03 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 123.292 0.637 . . . . 0.0 111.928 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 -74.77 115.37 14.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.581 -0.7 . . . . 0.0 112.244 172.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -111.56 152.02 28.04 Favored 'General case' 0 CA--C 1.569 1.689 0 C-N-CA 124.093 0.957 . . . . 0.0 112.591 -175.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -119.81 136.39 54.48 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.086 0.954 . . . . 0.0 111.633 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.2 mt -105.99 64.12 0.68 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.292 -0.88 . . . . 0.0 113.097 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.32 . . 66.47 -66.76 0.17 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.29 -22.33 41.02 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 119.926 3.306 . . . . 0.0 119.926 176.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.49 21.94 8.93 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 118.229 2.052 . . . . 0.0 118.229 -170.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 83.8 m -82.32 108.01 15.43 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 119.763 1.782 . . . . 0.0 109.334 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -78.33 128.57 33.86 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.267 0.627 . . . . 0.0 112.342 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.0 mt -140.37 105.1 4.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.993 -0.442 . . . . 0.0 110.759 -166.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -81.76 123.79 29.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.654 -1.279 . . . . 0.0 110.896 171.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.22 176.84 40.12 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 118.649 2.22 . . . . 0.0 118.649 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.5 p -126.03 130.2 50.69 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 113.674 -1.263 . . . . 0.0 110.866 -169.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -97.72 123.48 41.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.677 -0.639 . . . . 0.0 111.744 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.2 m -106.07 120.19 41.15 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.408 0.683 . . . . 0.0 110.67 172.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.3 tp -84.22 121.14 27.07 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.336 0.588 . . . . 0.0 111.542 175.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -89.43 -48.21 7.49 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 164.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.56 -87.05 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 CA-C-N 119.177 0.899 . . . . 0.0 110.988 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -82.17 -4.32 56.75 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 156.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.98 138.15 43.69 Favored 'General case' 0 CA--C 1.57 1.714 0 C-N-CA 125.183 1.393 . . . . 0.0 111.69 174.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mt -130.12 124.56 33.0 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 169.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.15 119.4 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.17 -0.956 . . . . 0.0 110.377 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.22 108.78 3.12 Favored Glycine 0 N--CA 1.486 1.99 0 C-N-CA 123.587 0.613 . . . . 0.0 112.972 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.57 94.12 7.57 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.2 0.6 . . . . 0.0 110.652 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.94 142.13 41.73 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -170.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -124.72 138.3 54.29 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.305 1.042 . . . . 0.0 108.194 174.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.79 107.94 9.47 Favored 'General case' 0 CA--C 1.568 1.672 0 O-C-N 120.817 -1.177 . . . . 0.0 113.67 -168.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.6 p -78.11 69.75 4.37 Favored 'General case' 0 N--CA 1.506 2.342 0 CA-C-O 124.067 1.889 . . . . 0.0 112.442 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.8 t70 169.15 -51.89 0.01 OUTLIER 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 113.028 -1.896 . . . . 0.0 109.047 -148.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -142.12 -5.48 0.99 Allowed 'General case' 0 CA--C 1.582 2.18 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.4 -40.39 2.94 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 118.501 2.16 . . . . 0.0 118.501 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -60.6 149.69 34.1 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -165.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.12 127.74 32.98 Favored 'General case' 0 CA--C 1.565 1.545 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -169.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.1 tt -119.74 115.29 23.61 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 124.524 1.13 . . . . 0.0 108.296 174.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -101.97 118.23 36.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.037 -1.039 . . . . 0.0 110.902 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.2 m -100.28 111.07 23.32 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 73.9 t -97.72 108.59 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -95.44 129.41 42.61 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.419 0.688 . . . . 0.0 110.791 170.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -145.33 137.42 25.66 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.854 -0.529 . . . . 0.0 111.216 172.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.4 mp -87.6 109.35 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 173.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.253 11.3 tp -92.35 74.14 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 122.221 1.01 . . . . 0.0 110.378 168.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.72 -98.11 0.67 Allowed Glycine 0 N--CA 1.489 2.216 0 O-C-N 121.09 -1.006 . . . . 0.0 115.481 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -87.85 -2.14 58.42 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 174.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -132.2 125.9 32.27 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 119.585 1.084 . . . . 0.0 110.586 -168.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.3 tp -83.13 114.98 21.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.48 -0.763 . . . . 0.0 109.643 168.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.9 m -92.49 105.12 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -101.39 98.96 9.26 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.8 m -102.21 118.15 36.27 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.668 0.787 . . . . 0.0 110.397 -169.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -100.23 107.21 18.99 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.715 0.806 . . . . 0.0 110.888 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.2 t -106.33 107.83 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -118.34 118.94 33.15 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.184 0.593 . . . . 0.0 110.624 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.328 51.9 mt-10 66.2 -81.91 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 124.677 1.191 . . . . 0.0 113.43 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -146.69 45.76 0.77 Allowed Glycine 0 N--CA 1.489 2.21 0 CA-C-O 119.233 -0.76 . . . . 0.0 114.941 158.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.7 t -135.49 117.15 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -100.95 124.12 46.17 Favored 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 123.655 0.782 . . . . 0.0 111.845 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.81 120.01 37.87 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.057 0.543 . . . . 0.0 112.029 170.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -98.63 101.73 13.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.705 -0.622 . . . . 0.0 110.845 -176.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -84.18 111.31 19.24 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 121.072 0.463 . . . . 0.0 110.272 169.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 95.9 mt -90.6 117.45 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -106.57 120.54 42.21 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.4 0.68 . . . . 0.0 109.732 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -84.84 143.32 29.15 Favored 'General case' 0 CA--C 1.566 1.581 0 O-C-N 121.674 -0.641 . . . . 0.0 111.831 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -62.9 105.41 0.67 Allowed 'General case' 0 CA--C 1.572 1.805 0 O-C-N 121.465 -0.772 . . . . 0.0 112.905 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 N--CA 1.493 1.706 0 C-N-CA 124.763 1.225 . . . . 0.0 113.462 -170.95 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.238 0 CA-C-O 121.063 0.459 . . . . 0.0 111.392 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 66.6 82.25 0.19 Allowed 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 124.398 1.079 . . . . 0.0 112.44 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -152.64 74.01 1.04 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.996 -1.065 . . . . 0.0 112.338 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.0 p -159.1 -179.01 7.63 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.181 0.991 . . . . 0.0 113.416 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.2 m -86.92 119.67 27.38 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.873 0.869 . . . . 0.0 110.131 172.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -120.71 98.22 5.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.654 -0.654 . . . . 0.0 109.961 -173.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -88.58 138.35 31.5 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.333 -0.854 . . . . 0.0 112.168 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.43 125.13 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -95.46 -52.71 4.03 Favored 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 124.647 1.179 . . . . 0.0 112.841 172.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.8 ptt85 -159.7 128.75 5.17 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 120.041 1.291 . . . . 0.0 112.131 -168.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.6 p -97.09 101.82 13.47 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.829 0.852 . . . . 0.0 112.135 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -97.17 112.36 24.18 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.837 -0.54 . . . . 0.0 109.99 -166.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.266 41.9 t30 62.02 24.39 14.51 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -170.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -74.78 -32.97 62.18 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -172.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -53.04 -42.01 65.34 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 164.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -64.17 -47.64 79.08 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 173.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -52.08 -54.04 35.06 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 166.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.45 ' HB3' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -63.36 -34.43 77.7 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 171.059 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -58.85 -48.53 81.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.272 -1.518 . . . . 0.0 114.559 165.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -55.16 -34.64 63.98 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 166.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.3 mmt -68.31 -37.33 80.49 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 168.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.39 56.4 0.69 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 115.983 1.153 . . . . 0.0 115.983 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 p -124.83 156.31 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-O 122.348 1.07 . . . . 0.0 111.789 173.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -66.09 157.79 30.19 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.288 12.4 tt -58.72 -38.95 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -64.2 -55.38 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.181 0.9 . . . . 0.0 112.708 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -57.76 -30.12 65.37 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 167.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.45 ' HG3' ' HB3' ' A' ' 18' ' ' MET . 6.3 mtp180 -60.19 -55.73 30.22 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 167.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -61.05 -37.78 83.86 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.7 mt -61.15 -48.52 81.2 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 164.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.36 -41.0 75.44 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 171.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.02 -47.95 74.03 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 164.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -114.99 36.84 3.69 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -79.67 43.82 0.59 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.338 20.0 p30 36.74 37.19 0.06 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 119.956 3.317 . . . . 0.0 119.956 -174.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 tt -75.51 115.22 14.95 Favored 'General case' 0 CA--C 1.558 1.256 0 O-C-N 120.91 -1.119 . . . . 0.0 112.844 -158.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -106.31 110.63 22.92 Favored 'General case' 0 CA--C 1.558 1.26 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.036 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.7 mt -86.65 97.05 10.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 169.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 86.5 m -86.45 92.49 8.86 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.9 mt -87.57 120.88 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 -174.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.9 p -122.95 108.22 12.71 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -84.87 130.55 34.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.542 -0.724 . . . . 0.0 111.652 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -135.88 68.54 1.45 Allowed 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.198 0.599 . . . . 0.0 110.742 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.65 76.31 0.25 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 116.79 1.476 . . . . 0.0 116.79 176.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.321 8.0 m120 73.03 -37.64 0.39 Allowed 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -170.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -67.06 135.07 53.09 Favored 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 119.701 1.137 . . . . 0.0 112.989 162.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -121.51 115.08 22.18 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 168.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.3 m -94.96 103.37 15.22 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 172.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 52.9 t -110.85 110.85 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -171.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -86.1 90.18 8.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.766 -0.583 . . . . 0.0 110.258 176.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -73.14 95.62 2.1 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.034 0.934 . . . . 0.0 110.51 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.1 m -109.3 97.14 6.79 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -161.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.3 p -127.79 163.27 24.73 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.924 0.868 . . . . 0.0 113.255 -170.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.15 -23.23 63.75 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 166.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -77.65 -53.92 6.99 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 119.555 1.071 . . . . 0.0 113.339 165.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -156.0 151.71 27.24 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 119.74 1.155 . . . . 0.0 112.264 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -109.31 108.77 19.46 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.508 0.723 . . . . 0.0 110.357 170.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 pp -135.83 145.25 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-O 121.646 0.736 . . . . 0.0 111.874 -171.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -97.29 115.45 27.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -0.978 . . . . 0.0 111.545 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.83 103.25 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.33 101.47 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 173.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -119.63 136.26 54.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.861 -0.524 . . . . 0.0 112.374 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -92.81 144.02 25.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.692 -0.63 . . . . 0.0 110.716 164.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.94 115.58 3.82 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.77 -15.76 59.81 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 119.698 2.639 . . . . 0.0 119.698 -172.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.8 t -85.25 111.64 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.678 2.239 . . . . 0.0 108.684 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.261 7.4 t -78.78 124.32 28.09 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -165.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -134.4 163.71 29.06 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 124.071 0.949 . . . . 0.0 112.396 -170.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -85.41 109.39 18.4 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 121.865 0.84 . . . . 0.0 112.194 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -93.55 165.97 12.48 Favored 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 124.9 1.28 . . . . 0.0 112.256 172.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.252 0.6 OUTLIER -139.28 155.96 47.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.612 -1.305 . . . . 0.0 113.196 166.096 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.9 mt -86.56 51.35 2.21 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 175.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.285 . . 62.41 -50.51 0.17 Allowed 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 118.472 2.767 . . . . 0.0 118.472 -168.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.9 p30 -78.07 -78.63 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -175.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.4 72.52 0.09 OUTLIER Glycine 0 N--CA 1.481 1.693 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 -170.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.4 m -145.46 105.91 4.08 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.64 112.98 20.02 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-O 121.424 0.63 . . . . 0.0 111.843 -173.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 70.9 mt -118.26 107.74 14.27 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.181 0.592 . . . . 0.0 111.112 -167.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.2 ttm-85 -88.85 121.14 30.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 111.113 174.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.01 -154.57 11.71 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.3 p -144.48 138.06 27.36 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 123.196 0.599 . . . . 0.0 110.627 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -88.0 120.07 28.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.693 -0.629 . . . . 0.0 109.866 163.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.2 t -115.62 124.6 51.34 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.176 0.59 . . . . 0.0 111.109 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.3 tp -84.61 104.92 15.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.471 -0.768 . . . . 0.0 111.586 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -105.16 78.87 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.507 0.67 . . . . 0.0 109.907 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.59 -102.02 1.25 Allowed Glycine 0 N--CA 1.49 2.285 0 O-C-N 121.547 -0.72 . . . . 0.0 114.023 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -112.51 45.39 1.31 Allowed 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 167.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -139.3 115.13 10.11 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.285 -0.884 . . . . 0.0 109.039 173.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.1 mt -86.19 104.64 15.93 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 166.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.0 mt -99.85 110.57 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -172.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.18 94.62 2.01 Favored Glycine 0 N--CA 1.481 1.646 0 C-N-CA 123.47 0.557 . . . . 0.0 112.553 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -86.91 98.86 11.46 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -119.78 142.8 48.25 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.518 0.727 . . . . 0.0 112.337 -168.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -122.71 137.43 54.92 Favored 'General case' 0 CA--C 1.563 1.456 0 O-C-N 121.471 -0.768 . . . . 0.0 109.997 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -64.89 118.05 8.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.192 -0.943 . . . . 0.0 113.182 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.7 p -76.84 67.89 2.96 Favored 'General case' 0 N--CA 1.508 2.439 0 CA-C-O 122.318 1.056 . . . . 0.0 110.623 169.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -178.43 -68.05 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -159.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -98.37 -35.92 10.14 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.075 1.879 . . . . 0.0 116.075 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.72 6.21 76.94 Favored Glycine 0 CA--C 1.558 2.737 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 -150.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -82.74 134.44 35.13 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 119.599 1.699 . . . . 0.0 112.885 -175.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -90.15 133.89 34.61 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -172.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.79 122.18 35.46 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 125.211 1.404 . . . . 0.0 108.878 -176.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -100.31 109.67 21.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.102 -0.999 . . . . 0.0 109.342 172.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.8 m -99.91 99.86 10.7 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 119.353 0.979 . . . . 0.0 109.757 172.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 80.2 t -88.31 105.04 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.019 -1.051 . . . . 0.0 108.549 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -79.48 112.89 17.18 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.339 0.656 . . . . 0.0 110.115 163.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -137.28 147.41 45.67 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.489 0.662 . . . . 0.0 109.935 171.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.77 139.1 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.008 0 O-C-N 120.776 -1.202 . . . . 0.0 109.922 167.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.5 tt -119.36 89.97 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.804 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 162.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 68.68 -99.01 0.56 Allowed Glycine 0 N--CA 1.492 2.391 0 O-C-N 120.948 -1.095 . . . . 0.0 115.529 -176.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -95.21 -3.17 48.18 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 170.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -123.4 129.69 51.64 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 119.464 1.029 . . . . 0.0 111.48 -164.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.4 tp -82.89 114.59 21.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.288 170.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.0 m -82.47 126.06 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 166.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -99.16 101.02 12.22 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 157.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.5 m -90.16 108.31 19.67 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -102.8 99.67 9.63 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.456 0.703 . . . . 0.0 110.855 -170.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 t -99.43 114.17 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -134.63 109.74 8.84 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.041 0.536 . . . . 0.0 110.853 -174.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.287 24.4 mm-40 68.17 -79.52 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 172.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -142.54 58.95 0.55 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 123.212 0.434 . . . . 0.0 113.091 167.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.18 154.79 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 123.756 0.822 . . . . 0.0 109.852 -174.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.255 0.0 OUTLIER -144.47 136.91 26.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.11 -0.994 . . . . 0.0 112.949 161.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.56 145.44 51.72 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.53 0.732 . . . . 0.0 112.204 174.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -120.04 98.22 5.98 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . 0.297 6.1 ptm180 -88.76 123.52 33.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.755 -1.216 . . . . 0.0 110.414 170.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.5 mt -109.82 131.31 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -161.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -119.31 127.1 52.88 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.365 0.666 . . . . 0.0 110.339 -175.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -83.48 144.06 29.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.238 -0.914 . . . . 0.0 112.499 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.6 tttt -69.27 122.11 18.2 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 121.683 0.754 . . . . 0.0 112.464 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.2 t70 . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -162.281 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.291 0 CA-C-O 121.912 0.863 . . . . 0.0 112.396 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -131.1 66.18 1.54 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -171.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -83.66 82.59 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.537 -1.352 . . . . 0.0 112.801 -165.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.8 t -162.6 -178.15 6.04 Favored 'General case' 0 CA--C 1.574 1.894 0 CA-C-O 123.004 1.383 . . . . 0.0 112.808 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.9 m -97.21 121.54 39.21 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.968 0.907 . . . . 0.0 109.451 169.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.461 ' CH2' HD11 ' A' ' 108' ' ' ILE . 98.9 m95 -118.72 112.02 19.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.709 -0.62 . . . . 0.0 110.644 -167.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -98.35 131.23 44.82 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 118.762 0.71 . . . . 0.0 112.167 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 p -66.92 120.9 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.336 -0.852 . . . . 0.0 113.249 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -100.81 -55.97 2.44 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -143.57 122.24 12.57 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 119.61 1.096 . . . . 0.0 112.246 -173.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.9 p -99.77 122.61 43.0 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.804 0.842 . . . . 0.0 111.936 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -76.36 -38.2 56.18 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -172.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -116.06 -78.51 0.58 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 119.269 0.94 . . . . 0.0 109.595 170.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.289 0.5 OUTLIER 47.45 35.11 3.82 Favored 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 118.427 2.751 . . . . 0.0 118.427 -175.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -150.0 -53.5 0.15 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.182 0.993 . . . . 0.0 111.095 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -66.33 -40.76 90.1 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 120.534 1.516 . . . . 0.0 114.095 164.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -45.62 -58.43 3.43 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 157.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.3 mtp -64.16 -38.18 90.13 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -60.45 -42.7 96.69 Favored 'General case' 0 CA--C 1.574 1.893 0 O-C-N 120.16 -1.588 . . . . 0.0 114.951 166.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -66.27 -28.84 69.02 Favored 'General case' 0 CA--C 1.579 2.076 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 168.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 mtm -59.81 -34.66 73.36 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 158.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.02 45.07 1.8 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 115.829 1.092 . . . . 0.0 115.829 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.1 m -127.21 147.65 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 118.837 1.318 . . . . 0.0 112.987 -173.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -72.26 162.41 29.5 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -175.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.256 0.2 OUTLIER -48.21 -44.61 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 168.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.4 t -54.89 -50.66 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 170.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -63.45 -40.78 98.04 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 169.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -57.02 -47.87 79.84 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 169.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.286 0.0 OUTLIER -64.88 -39.59 93.77 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 168.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.79 -53.77 14.16 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 176.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.4 -13.24 60.7 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 175.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.73 -54.58 8.57 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 120.328 1.422 . . . . 0.0 114.367 155.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -85.82 62.81 7.68 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.799 1.181 . . . . 0.0 112.765 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.5 p30 -121.3 9.04 10.31 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 -178.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.347 1.7 p-10 52.66 58.86 4.93 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 177.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.9 tp -75.45 118.97 18.9 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -116.63 114.4 24.04 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.342 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.7 mt -95.08 109.67 21.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.55 -0.719 . . . . 0.0 109.621 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.1 m -90.88 98.57 11.86 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.269 -0.894 . . . . 0.0 108.643 169.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.3 mt -101.47 124.61 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -146.85 135.11 21.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.404 -0.81 . . . . 0.0 112.555 166.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -86.12 145.65 26.94 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 171.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.42 88.05 1.41 Allowed 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 124.818 1.247 . . . . 0.0 109.173 -175.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.81 61.02 4.91 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 117.373 1.709 . . . . 0.0 117.373 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.6 t30 62.82 -4.53 0.24 Allowed 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 118.183 2.66 . . . . 0.0 118.183 -166.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -110.25 130.97 55.45 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.916 1.287 . . . . 0.0 110.113 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -99.63 118.33 35.93 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.507 -0.746 . . . . 0.0 110.491 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.5 m -86.47 114.24 23.06 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 166.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.4 t -122.12 99.4 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -87.12 114.15 23.47 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.317 0.58 . . . . 0.0 110.039 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -107.79 80.92 1.44 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.325 0.583 . . . . 0.0 110.515 -165.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 m -90.46 113.85 25.88 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-O 121.929 0.871 . . . . 0.0 112.205 -172.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.1 p -139.3 167.12 22.79 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.37 1.068 . . . . 0.0 109.305 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.3 57.2 0.24 Allowed 'General case' 0 CA--C 1.578 2.057 0 O-C-N 120.233 -1.542 . . . . 0.0 113.889 159.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -176.68 -57.93 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 125.303 1.441 . . . . 0.0 110.847 -170.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -96.35 -81.33 0.41 Allowed 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 119.974 1.261 . . . . 0.0 112.679 -174.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.284 68.1 m-80 53.59 65.15 1.6 Allowed 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -160.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.2 pt -122.48 121.73 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.871 -0.518 . . . . 0.0 110.031 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.01 94.57 8.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.35 -0.844 . . . . 0.0 111.347 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.2 t -98.46 114.2 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -170.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.46 97.72 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -112.52 137.87 50.11 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.302 0.641 . . . . 0.0 112.507 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -80.48 147.27 30.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.962 . . . . 0.0 112.668 169.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 70.6 mt -66.1 109.18 2.5 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.36 47.33 5.77 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 117.05 1.58 . . . . 0.0 117.05 -173.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.45 138.22 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 118.349 1.075 . . . . 0.0 110.1 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.0 m -84.36 102.8 13.0 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.437 -0.789 . . . . 0.0 109.756 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -127.15 162.53 25.91 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.289 1.042 . . . . 0.0 113.227 -172.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -86.5 121.84 29.6 Favored 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 123.669 0.788 . . . . 0.0 111.658 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -128.21 117.96 22.47 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.551 0.74 . . . . 0.0 110.816 -174.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -98.92 121.25 40.63 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.207 -0.933 . . . . 0.0 111.997 -174.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.7 mt -73.5 166.42 23.26 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.99 52.94 0.57 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 117.522 2.416 . . . . 0.0 117.522 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -163.62 -67.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.427 1.091 . . . . 0.0 109.471 168.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.87 73.59 0.05 OUTLIER Glycine 0 N--CA 1.481 1.677 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.8 m -155.68 121.37 4.98 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.52 -0.988 . . . . 0.0 109.948 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -94.44 125.89 39.37 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 122.457 1.122 . . . . 0.0 111.503 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 50.7 mt -106.55 150.16 26.43 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.299 1.04 . . . . 0.0 112.103 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.8 116.95 20.27 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.31 -161.73 35.11 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 117.551 1.781 . . . . 0.0 117.551 -175.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 71.4 p -124.88 123.67 40.43 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.919 -0.64 . . . . 0.0 111.712 -156.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -83.43 115.41 22.03 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 118.569 0.622 . . . . 0.0 110.158 158.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.8 m -115.47 132.77 56.52 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.243 0.617 . . . . 0.0 111.757 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.0 tp -87.44 109.29 19.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.378 -0.826 . . . . 0.0 112.324 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -101.76 81.34 2.13 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.551 0.691 . . . . 0.0 109.776 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.47 -94.16 0.93 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 114.795 0.678 . . . . 0.0 114.795 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -121.73 52.67 1.24 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.637 0.732 . . . . 0.0 111.485 165.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -146.86 112.4 5.61 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.8 mt -89.64 104.14 16.72 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 171.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.2 tt -94.82 118.19 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.641 -0.662 . . . . 0.0 110.21 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.83 97.85 2.32 Favored Glycine 0 N--CA 1.481 1.636 0 C-N-CA 123.411 0.529 . . . . 0.0 112.348 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -92.58 98.87 11.71 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.312 0.645 . . . . 0.0 109.609 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -123.18 134.28 54.18 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.527 0.731 . . . . 0.0 111.527 -170.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -110.81 157.08 20.21 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.498 1.142 . . . . 0.0 111.241 165.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -107.77 120.22 41.63 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.955 -1.091 . . . . 0.0 112.04 -161.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.5 t -68.0 -11.82 59.62 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 169.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -86.46 -50.68 6.7 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 119.459 1.027 . . . . 0.0 113.3 172.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.87 27.97 2.17 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 120.885 1.675 . . . . 0.0 115.405 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.76 -57.11 2.6 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 118.287 2.075 . . . . 0.0 118.287 176.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -48.46 124.95 8.85 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.833 2.053 . . . . 0.0 114.997 -168.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -67.18 145.47 55.21 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -171.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.3 tp -104.68 115.0 29.57 Favored 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 162.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -94.5 104.0 15.96 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 168.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.8 m -104.63 100.38 10.04 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.758 -0.588 . . . . 0.0 109.79 -177.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.9 t -91.63 104.65 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 120.897 -1.127 . . . . 0.0 108.812 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -82.02 115.78 21.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.883 -0.511 . . . . 0.0 109.852 164.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.79 144.76 34.11 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.037 0.535 . . . . 0.0 111.482 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.461 HD11 ' CH2' ' A' ' 6' ' ' TRP . 1.0 OUTLIER -85.72 124.75 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.291 -0.881 . . . . 0.0 111.223 177.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.255 10.9 tp -98.77 79.15 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.151 0.977 . . . . 0.0 108.986 166.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.75 -104.58 1.49 Allowed Glycine 0 N--CA 1.488 2.117 0 O-C-N 121.444 -0.785 . . . . 0.0 114.247 -171.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.26 0.71 57.47 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 117.576 2.435 . . . . 0.0 117.576 172.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -122.41 135.82 54.77 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.192 1.36 . . . . 0.0 110.959 -170.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.0 tp -90.62 119.7 31.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 111.012 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.9 p -102.58 120.34 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.136 -0.978 . . . . 0.0 110.647 172.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -89.99 115.44 27.28 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 122.967 0.507 . . . . 0.0 109.883 166.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.2 m -96.86 100.23 11.77 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.229 0.611 . . . . 0.0 109.626 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -88.07 112.4 22.61 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.434 0.694 . . . . 0.0 110.757 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.1 t -113.4 100.35 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -92.92 119.33 32.1 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.285 0.8 OUTLIER 66.07 -85.81 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 119.258 0.936 . . . . 0.0 111.648 -176.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.97 20.71 3.59 Favored Glycine 0 CA--C 1.558 2.749 0 N-CA-C 117.853 1.901 . . . . 0.0 117.853 151.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -92.3 115.79 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 121.496 2.648 . . . . 0.0 111.483 -174.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -89.22 126.23 35.41 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -127.8 106.08 8.88 Favored 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 123.502 0.721 . . . . 0.0 110.781 169.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.73 130.32 37.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 111.147 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -123.69 122.51 38.28 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.5 -0.75 . . . . 0.0 111.934 171.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.5 mt -94.23 124.56 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -174.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -104.55 133.22 49.77 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.392 1.077 . . . . 0.0 110.634 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -88.96 147.75 24.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.055 0.931 . . . . 0.0 112.304 171.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -75.19 118.36 18.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.639 -0.663 . . . . 0.0 111.821 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.1 t70 . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -165.925 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.563 1.447 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -122.02 -54.9 1.9 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 123.828 0.851 . . . . 0.0 111.693 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 t70 40.62 51.19 2.98 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 166.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.5 p -165.35 171.0 13.98 Favored 'General case' 0 CA--C 1.569 1.71 0 CA-C-O 122.432 1.111 . . . . 0.0 112.557 -168.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.4 m -89.4 133.92 34.31 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.04 -1.038 . . . . 0.0 111.413 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -138.37 107.82 6.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.801 -0.562 . . . . 0.0 109.927 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -97.26 133.16 42.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.11 -0.994 . . . . 0.0 112.682 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 p -62.41 117.96 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.213 -0.93 . . . . 0.0 113.411 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -102.17 -45.11 5.24 Favored 'General case' 0 CA--C 1.568 1.649 0 C-N-CA 123.961 0.904 . . . . 0.0 113.384 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -152.62 160.46 43.19 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.154 0.982 . . . . 0.0 110.968 -174.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.3 p -146.72 143.72 28.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.37 -1.456 . . . . 0.0 112.871 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -85.83 -51.38 6.44 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -137.93 53.57 1.83 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 119.834 1.197 . . . . 0.0 112.772 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -83.61 63.86 7.63 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 119.628 -1.92 . . . . 0.0 112.205 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -163.85 -57.72 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.529 1.132 . . . . 0.0 110.981 -171.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -81.96 -26.06 34.29 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -51.87 -54.38 29.88 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-N 121.791 2.087 . . . . 0.0 113.778 153.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.702 ' SD ' HG11 ' A' ' 23' ' ' VAL . 0.8 OUTLIER -51.86 -47.97 64.22 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 169.019 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -66.02 -38.83 89.42 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 170.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.0 tptp -60.14 -40.39 89.66 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 168.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.5 mtp -62.69 -52.92 61.38 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 165.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.55 59.44 0.06 OUTLIER Glycine 0 N--CA 1.487 2.042 0 CA-C-O 119.522 -0.599 . . . . 0.0 114.338 166.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.702 HG11 ' SD ' ' A' ' 18' ' ' MET . 2.8 m -103.82 147.47 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.857 0.837 . . . . 0.0 111.727 -177.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -74.28 169.03 18.45 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 168.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.267 0.2 OUTLIER -54.61 -44.34 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 176.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.49 -48.65 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-N 119.395 0.998 . . . . 0.0 112.996 172.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -54.38 -39.69 67.46 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 166.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -46.14 91.8 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 167.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -59.62 -48.81 80.21 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 166.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.7 mt -57.4 -39.76 76.81 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 169.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.04 -54.3 46.54 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 168.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.42 -38.14 41.56 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 167.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -95.17 19.9 9.92 Favored 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 172.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.305 28.0 p30 -72.97 -24.53 60.8 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 118.164 2.653 . . . . 0.0 118.164 -173.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 57.2 54.86 6.39 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 173.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.1 tp -79.77 122.52 26.71 Favored 'General case' 0 CA--C 1.563 1.445 0 CA-C-O 121.963 0.887 . . . . 0.0 112.345 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -105.48 106.22 16.62 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.871 169.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.39 100.11 7.47 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.38 0.609 . . . . 0.0 109.583 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.7 m -102.04 96.84 7.28 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -173.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.1 mt -95.38 131.81 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -164.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.2 m -141.04 108.55 5.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.577 -1.327 . . . . 0.0 107.693 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -100.64 139.2 36.66 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.94 0.876 . . . . 0.0 112.485 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -99.78 70.75 1.65 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 122.166 0.984 . . . . 0.0 110.139 164.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.88 -99.99 0.73 Allowed Glycine 0 N--CA 1.488 2.136 0 O-C-N 121.565 -0.71 . . . . 0.0 114.742 -170.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -84.47 -26.84 27.89 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -90.17 117.45 28.94 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.58 1.536 . . . . 0.0 111.101 177.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -99.48 117.33 33.64 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.374 1.07 . . . . 0.0 109.812 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.4 m -90.91 103.19 15.94 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 166.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -99.85 104.06 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -77.43 105.25 8.44 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.935 0.874 . . . . 0.0 109.991 172.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -92.4 91.47 7.67 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.099 0.96 . . . . 0.0 109.303 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.3 t -97.03 111.97 23.95 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.89 0.476 . . . . 0.0 111.336 -173.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.5 p -144.45 165.3 28.35 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -172.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.18 -23.17 67.22 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 117.611 2.449 . . . . 0.0 117.611 165.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -68.7 -52.01 35.54 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 120.367 1.44 . . . . 0.0 113.981 159.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -165.98 152.82 9.7 Favored 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 123.591 0.756 . . . . 0.0 112.144 -167.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -118.28 99.16 6.67 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 pp -136.41 143.19 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 O-C-N 121.747 -0.595 . . . . 0.0 111.994 -171.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -93.82 125.21 38.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.922 -1.111 . . . . 0.0 112.791 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.0 t -102.03 104.87 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.65 108.8 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -133.12 130.85 39.79 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.388 0.613 . . . . 0.0 112.537 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -66.98 140.5 57.73 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 111.835 157.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.8 mt -54.43 123.08 11.9 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 166.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.85 -5.96 83.13 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 119.189 2.436 . . . . 0.0 119.189 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 p -82.75 137.14 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-N 120.616 2.208 . . . . 0.0 112.748 -172.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.8 m -91.45 95.87 10.2 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.41 -0.806 . . . . 0.0 109.934 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -122.18 150.75 41.81 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -170.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -86.03 98.35 10.8 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 124.448 1.099 . . . . 0.0 113.872 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -89.98 118.6 29.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.5 -0.75 . . . . 0.0 110.966 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -72.26 108.47 5.42 Favored 'General case' 0 CA--C 1.569 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 113.114 171.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -78.21 139.79 38.94 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.914 0.886 . . . . 0.0 111.09 177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.32 66.94 0.31 Allowed 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -168.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -166.45 -66.2 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 125.779 1.632 . . . . 0.0 108.505 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.58 68.38 0.05 OUTLIER Glycine 0 N--CA 1.481 1.672 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.6 m -160.65 119.88 2.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.614 -0.933 . . . . 0.0 109.587 -177.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -88.1 113.89 24.18 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.886 0.85 . . . . 0.0 111.081 167.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 70.9 mt -93.78 109.56 21.23 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 124.325 1.05 . . . . 0.0 110.615 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 58.8 ttp85 -88.85 117.18 27.66 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.875 -0.516 . . . . 0.0 110.714 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.41 179.36 48.87 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 118.983 2.353 . . . . 0.0 118.983 -171.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.3 p -122.12 123.11 40.79 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 113.483 -1.358 . . . . 0.0 111.297 -166.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -81.92 107.56 14.74 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 118.476 0.58 . . . . 0.0 110.194 160.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 72.9 m -102.68 131.6 49.37 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.046 0.539 . . . . 0.0 111.101 176.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.9 tp -82.3 106.17 13.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.158 -0.964 . . . . 0.0 110.744 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -82.32 -49.45 10.02 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.07 -95.67 0.21 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 164.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -98.97 59.29 1.17 Allowed 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.869 0.842 . . . . 0.0 110.326 152.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -149.17 116.42 6.09 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.54 103.72 16.34 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 167.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.8 tt -90.08 111.5 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.368 -0.833 . . . . 0.0 110.1 177.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.07 98.09 2.34 Favored Glycine 0 N--CA 1.482 1.707 0 C-N-CA 123.843 0.735 . . . . 0.0 113.072 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -93.32 96.34 9.9 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -117.46 147.27 42.87 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.731 0.777 . . . . 0.0 112.533 -168.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -127.0 138.52 53.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.404 -0.81 . . . . 0.0 110.851 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -71.04 115.07 9.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 0.0 113.133 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 73.8 p -80.49 62.96 4.77 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 123.514 1.626 . . . . 0.0 112.384 170.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -174.05 -65.03 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.732 0 C-N-CA 126.236 1.815 . . . . 0.0 107.005 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -94.33 -18.24 21.8 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.05 -15.68 47.24 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 119.148 2.419 . . . . 0.0 119.148 -172.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -84.18 152.76 24.06 Favored 'General case' 0 CA--C 1.566 1.559 0 CA-C-N 118.529 1.165 . . . . 0.0 113.79 -169.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -94.4 130.27 40.8 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-O 122.114 0.959 . . . . 0.0 112.835 -168.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.0 tt -110.66 122.51 47.96 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 124.48 1.112 . . . . 0.0 109.406 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -111.51 111.67 22.86 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.2 m -108.36 100.2 9.52 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 119.441 1.019 . . . . 0.0 110.203 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.8 t -91.38 107.46 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.128 -0.983 . . . . 0.0 108.827 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -103.82 105.3 15.46 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 123.4 0.68 . . . . 0.0 110.598 -173.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -143.48 148.82 36.65 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -169.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.56 120.95 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.17 -1.581 . . . . 0.0 109.672 175.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.5 mm -101.1 88.95 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 167.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.91 -88.14 0.56 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 115.769 1.067 . . . . 0.0 115.769 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -111.0 0.31 16.94 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 173.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -129.67 127.21 40.06 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.953 1.251 . . . . 0.0 110.744 -169.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.1 tp -74.63 115.24 13.98 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.961 0.904 . . . . 0.0 110.519 171.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.0 m -103.72 119.09 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.301 -0.874 . . . . 0.0 109.583 -176.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -88.8 107.38 18.94 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 118.844 0.747 . . . . 0.0 109.842 165.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.7 m -92.35 96.32 10.2 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -87.61 106.48 18.04 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.508 0.723 . . . . 0.0 111.05 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.6 t -106.77 104.35 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -117.48 118.17 31.44 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.885 0.474 . . . . 0.0 109.781 172.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 51.4 49.68 20.47 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.0 -24.79 4.42 Favored Glycine 0 CA--C 1.554 2.507 0 N-CA-C 119.264 2.466 . . . . 0.0 119.264 -169.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.7 t -86.65 105.27 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 120.104 1.952 . . . . 0.0 109.633 -168.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -87.98 124.76 34.05 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 123.314 0.646 . . . . 0.0 112.52 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -124.66 109.85 13.67 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.554 0.742 . . . . 0.0 111.518 173.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.54 108.77 20.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.786 -0.571 . . . . 0.0 110.092 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -111.66 129.44 56.09 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.387 1.089 . . . . 0.0 111.436 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.9 mt -121.66 119.15 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -146.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -112.49 119.79 39.41 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.337 0.655 . . . . 0.0 110.418 -168.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -81.01 147.34 30.24 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 123.507 0.723 . . . . 0.0 112.781 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -58.87 118.94 6.32 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 t70 . . . . . 0 N--CA 1.488 1.464 0 C-N-CA 125.01 1.324 . . . . 0.0 112.444 -172.608 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.426 0 CA-C-O 122.178 0.989 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.364 89.8 m-85 69.35 -62.88 0.4 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -77.4 80.13 3.9 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 120.537 1.517 . . . . 0.0 112.669 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.9 t -163.78 178.15 8.08 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 122.443 1.116 . . . . 0.0 112.077 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.9 m -92.2 122.41 34.66 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.459 1.104 . . . . 0.0 110.297 170.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -123.65 108.72 12.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.813 -0.555 . . . . 0.0 109.958 -171.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -97.23 139.59 32.96 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.065 -1.022 . . . . 0.0 112.707 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -60.38 119.7 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -109.19 -51.11 2.92 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.767 0.827 . . . . 0.0 113.099 -173.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -148.57 109.57 4.3 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 119.222 0.919 . . . . 0.0 109.741 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.6 p -109.18 115.01 29.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.381 -0.824 . . . . 0.0 113.056 -174.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -98.69 123.07 42.67 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 123.327 0.651 . . . . 0.0 110.656 -169.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.261 9.4 t30 67.83 18.6 9.67 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -69.74 -43.09 73.0 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -173.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.87 -34.24 75.64 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 169.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -70.79 -47.2 60.79 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -43.1 -53.26 5.02 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 158.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 15.7 mtt -67.3 -25.87 66.25 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 174.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -60.7 -43.24 98.01 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-N 121.345 1.884 . . . . 0.0 114.625 163.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -59.03 -34.63 72.13 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 162.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 76.7 mmm -62.67 -30.31 71.29 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 116.929 2.196 . . . . 0.0 116.929 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.0 53.95 1.07 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 115.157 0.823 . . . . 0.0 115.157 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.31 142.53 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 122.671 1.224 . . . . 0.0 112.063 -175.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -70.24 172.08 8.76 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.275 13.2 tt -60.58 -40.73 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 176.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.6 t -61.61 -52.16 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-N 120.402 1.456 . . . . 0.0 112.913 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -55.3 -43.79 75.16 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 168.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -64.47 -42.22 96.05 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 171.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -58.36 -46.35 86.46 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 120.143 1.338 . . . . 0.0 114.554 167.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.9 mt -60.48 -40.94 93.11 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 165.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.69 95.0 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 172.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.96 -57.41 11.8 Favored 'General case' 0 CA--C 1.566 1.596 0 O-C-N 120.804 -1.185 . . . . 0.0 113.681 164.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -84.3 53.01 2.49 Favored 'General case' 0 CA--C 1.577 2.006 0 CA-C-N 119.716 1.144 . . . . 0.0 113.81 174.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -85.89 -29.51 23.6 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -174.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 62.05 50.22 4.17 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -84.02 121.75 27.83 Favored 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 122.42 1.105 . . . . 0.0 112.014 -175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -111.34 117.29 32.71 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.479 174.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.7 mt -101.44 102.59 13.41 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.0 m -94.46 105.04 17.0 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.309 -0.87 . . . . 0.0 109.649 172.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.6 mt -94.83 131.29 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 85.8 m -145.41 128.46 16.55 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.262 -1.524 . . . . 0.0 110.147 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -111.07 139.89 46.06 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -170.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -138.21 89.97 2.44 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.672 0.789 . . . . 0.0 109.825 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.21 68.18 1.81 Allowed Glycine 0 N--CA 1.497 2.711 0 N-CA-C 116.731 1.452 . . . . 0.0 116.731 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.291 46.7 m-20 67.62 -23.79 0.12 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 118.019 2.6 . . . . 0.0 118.019 -166.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -83.19 100.8 10.8 Favored 'General case' 0 CA--C 1.565 1.552 0 CA-C-N 121.151 1.796 . . . . 0.0 110.901 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -93.36 117.62 30.3 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.029 0.931 . . . . 0.0 109.504 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.0 m -92.75 104.14 16.44 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 p -94.69 109.83 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.699 0.762 . . . . 0.0 109.974 170.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -88.55 111.67 22.13 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -101.93 92.07 4.64 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.441 0.696 . . . . 0.0 110.712 -169.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.1 m -103.37 117.05 33.6 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.106 0.562 . . . . 0.0 111.003 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 p -147.77 -177.3 5.64 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.84 40.73 0.06 Allowed 'General case' 0 CA--C 1.583 2.246 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 166.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -144.2 -62.59 0.38 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 126.519 1.927 . . . . 0.0 108.566 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.64 167.48 28.78 Favored 'General case' 0 CA--C 1.572 1.825 0 C-N-CA 124.122 0.969 . . . . 0.0 111.141 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -121.07 102.8 8.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.328 -0.858 . . . . 0.0 109.46 164.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.33 144.22 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.527 -0.733 . . . . 0.0 112.019 -172.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -94.91 119.65 33.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.339 -0.85 . . . . 0.0 112.58 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.4 t -98.94 104.03 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.8 t -91.87 103.2 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -113.54 123.52 50.18 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.308 0.575 . . . . 0.0 112.006 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -72.28 137.09 46.5 Favored 'General case' 0 CA--C 1.569 1.703 0 O-C-N 121.366 -0.834 . . . . 0.0 110.499 162.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.8 mt -59.62 113.27 2.15 Favored 'General case' 0 CA--C 1.571 1.768 0 O-C-N 121.069 -1.019 . . . . 0.0 113.389 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.29 55.83 3.6 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 116.39 1.316 . . . . 0.0 116.39 -171.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 p -136.46 136.91 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 118.008 0.904 . . . . 0.0 110.125 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 88.0 m -87.41 109.79 19.82 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.505 -0.747 . . . . 0.0 110.156 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -138.56 156.23 47.67 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.168 0.587 . . . . 0.0 112.436 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -84.38 99.04 10.38 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 121.841 0.829 . . . . 0.0 112.126 176.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -86.64 119.27 26.7 Favored 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 124.449 1.1 . . . . 0.0 111.682 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -83.39 126.68 32.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.099 -1.001 . . . . 0.0 113.208 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.3 mt -80.62 152.67 28.4 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 170.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.93 64.74 2.49 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 175.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -174.31 -66.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 125.465 1.506 . . . . 0.0 110.394 -177.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.3 70.17 0.03 OUTLIER Glycine 0 N--CA 1.487 2.065 0 CA-C-N 119.128 0.876 . . . . 0.0 114.207 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.5 m -167.19 128.34 1.57 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 118.041 0.92 . . . . 0.0 109.015 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -97.34 126.71 42.74 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.172 0.987 . . . . 0.0 110.623 169.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.6 mt -108.91 107.69 18.18 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 124.227 1.011 . . . . 0.0 110.769 -174.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.53 119.15 20.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.048 -1.032 . . . . 0.0 112.068 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.74 -163.88 36.99 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 117.639 1.815 . . . . 0.0 117.639 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.8 p -125.5 120.31 30.59 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.382 -0.909 . . . . 0.0 111.763 -157.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -84.81 121.65 28.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.422 -0.799 . . . . 0.0 110.427 161.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.1 m -126.93 139.3 53.16 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.358 0.663 . . . . 0.0 111.735 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.1 tp -87.72 114.67 24.55 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.679 -1.263 . . . . 0.0 111.642 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -78.07 -37.27 46.95 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 172.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.83 -84.26 0.08 OUTLIER Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -107.93 39.04 2.03 Favored 'General case' 0 CA--C 1.581 2.138 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 158.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -146.19 124.32 12.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.929 -1.107 . . . . 0.0 109.167 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.8 mt -91.4 110.49 21.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.478 -0.764 . . . . 0.0 109.15 166.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.6 tt -97.52 117.59 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.127 -0.983 . . . . 0.0 110.858 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.04 95.7 1.76 Allowed Glycine 0 N--CA 1.482 1.747 0 CA-C-O 119.401 -0.666 . . . . 0.0 113.328 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -84.25 103.8 13.74 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 117.784 0.792 . . . . 0.0 110.017 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -123.16 148.42 45.76 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -171.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -120.96 141.61 50.53 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.782 0.801 . . . . 0.0 110.621 167.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -70.79 137.85 49.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.716 -1.24 . . . . 0.0 112.808 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.286 4.9 t -70.18 -51.78 28.43 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 175.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -75.92 -44.96 37.71 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -80.22 -26.19 39.25 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.7 -38.77 3.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 117.486 1.754 . . . . 0.0 117.486 -166.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -69.22 155.57 40.19 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -162.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.96 140.13 35.43 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 114.18 -1.373 . . . . 0.0 114.679 -175.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.8 tt -135.28 115.59 13.46 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 123.832 0.853 . . . . 0.0 109.114 177.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -94.5 111.72 23.48 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.139 -0.976 . . . . 0.0 109.103 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.9 m -101.34 94.94 6.19 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.0 t -100.91 100.14 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-O 122.516 1.151 . . . . 0.0 109.56 -168.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -93.69 102.35 14.51 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.367 -172.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -131.54 133.12 44.74 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.75 0.82 . . . . 0.0 111.268 -161.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.0 mt -104.0 123.3 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.719 -1.238 . . . . 0.0 110.172 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 45.1 mm -83.55 -47.33 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.98 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.832 167.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -163.09 -89.12 0.07 OUTLIER Glycine 0 N--CA 1.487 2.085 0 CA-C-N 119.058 0.844 . . . . 0.0 112.507 172.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 45.0 p30 -81.62 3.76 24.06 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 174.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -136.97 131.42 32.94 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 119.233 0.924 . . . . 0.0 111.033 -168.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.7 tp -86.14 113.02 21.85 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.446 1.098 . . . . 0.0 109.695 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.6 t -98.98 105.09 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -174.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -96.08 101.74 13.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -0.984 . . . . 0.0 109.997 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.5 m -91.63 103.96 16.49 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.585 0.754 . . . . 0.0 109.207 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -89.26 110.69 21.43 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.338 0.655 . . . . 0.0 110.194 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.1 t -112.79 93.96 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -94.71 114.65 26.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.632 -0.668 . . . . 0.0 111.31 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.317 0.4 OUTLIER 62.07 -62.55 0.1 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 174.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.83 43.41 0.5 Allowed Glycine 0 CA--C 1.551 2.293 0 CA-C-O 118.915 -0.936 . . . . 0.0 114.483 156.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.8 t -139.15 118.61 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 118.982 1.391 . . . . 0.0 107.761 -172.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.2 mp0 -93.68 144.52 25.32 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.81 121.19 10.96 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.208 0.528 . . . . 0.0 112.408 164.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -94.67 107.66 19.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.694 -0.629 . . . . 0.0 111.256 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -89.7 111.61 22.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.722 -0.611 . . . . 0.0 109.601 167.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.2 mt -101.09 114.06 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -172.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -105.81 122.7 46.63 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.673 0.789 . . . . 0.0 109.625 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -83.14 143.27 30.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 112.585 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -65.14 118.44 9.22 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.9 t0 . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -165.67 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.361 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.283 93.2 m-85 73.4 -43.59 0.56 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 118.81 2.893 . . . . 0.0 118.81 170.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -73.77 72.37 1.51 Allowed 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 117.283 2.327 . . . . 0.0 117.283 -160.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.9 p -152.17 -176.36 5.64 Favored 'General case' 0 CA--C 1.572 1.821 0 CA-C-O 121.976 0.893 . . . . 0.0 112.852 178.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.1 m -89.37 127.64 35.83 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.013 0.925 . . . . 0.0 110.788 176.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -130.02 116.17 18.18 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.178 0.591 . . . . 0.0 109.416 -173.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -99.64 135.77 40.56 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 119.408 1.004 . . . . 0.0 111.944 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p -66.05 116.43 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -96.0 -50.73 4.74 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -144.2 111.25 5.81 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 119.977 1.262 . . . . 0.0 111.054 -172.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.2 m -96.18 101.34 12.98 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.858 0.863 . . . . 0.0 111.317 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -93.5 120.52 33.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.509 -0.744 . . . . 0.0 110.31 -172.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.264 28.5 t30 65.49 20.56 11.72 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -72.51 -40.17 67.04 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.64 -38.07 74.39 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 168.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -67.55 -46.75 71.85 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 119.91 1.232 . . . . 0.0 114.069 171.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -46.55 -56.32 6.2 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 161.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.4 mtp -65.82 -29.84 70.38 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 176.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.63 -50.96 71.43 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 120.241 1.382 . . . . 0.0 114.203 163.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -57.4 -32.1 66.51 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 165.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.0 mmt -64.44 -34.74 78.89 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 168.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.99 51.36 1.93 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 116.072 1.189 . . . . 0.0 116.072 -176.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -114.89 160.23 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-O 122.169 0.985 . . . . 0.0 112.408 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -56.72 145.95 27.32 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 172.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.274 0.1 OUTLIER -54.98 -47.22 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 175.057 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.28 -49.53 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 173.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -58.35 -45.66 87.75 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 170.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -44.27 -55.12 5.13 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 163.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -65.69 -46.66 78.18 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.5 mt -58.48 -47.53 83.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 169.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.24 -21.63 66.35 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 119.062 2.986 . . . . 0.0 119.062 178.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.08 93.64 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 165.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -130.49 68.09 1.47 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 119.577 1.081 . . . . 0.0 111.781 169.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -84.41 44.66 1.05 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 176.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 42.7 40.57 2.08 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -172.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -86.68 116.77 25.0 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.695 -1.253 . . . . 0.0 112.173 -161.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -111.2 118.01 34.77 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.718 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.7 mt -94.28 101.53 13.5 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 172.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 43.8 m -95.14 105.66 17.61 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.883 0.849 . . . . 0.0 108.731 170.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.9 mt -90.57 101.4 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -171.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 87.7 m -99.08 101.48 12.86 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -102.45 127.49 49.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.581 -0.7 . . . . 0.0 112.347 -167.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -79.94 -49.87 11.26 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 161.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.65 -90.92 0.08 OUTLIER Glycine 0 N--CA 1.486 1.97 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -70.12 -29.28 66.19 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 158.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -85.47 126.71 34.03 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-N 119.772 1.169 . . . . 0.0 112.105 169.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -117.83 125.39 50.46 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.482 1.113 . . . . 0.0 108.475 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.0 m -99.52 95.85 7.27 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 168.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.5 t -88.98 105.88 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -89.91 102.07 14.77 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -170.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -93.41 88.09 5.83 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.202 0.601 . . . . 0.0 109.53 -170.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.1 t -98.49 109.26 22.05 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.321 0.648 . . . . 0.0 110.798 -171.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.7 p -134.08 166.15 23.41 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -169.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.55 -26.32 61.25 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 117.838 2.533 . . . . 0.0 117.838 165.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -79.81 -52.34 8.04 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -160.91 163.22 32.07 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-N 119.33 0.968 . . . . 0.0 112.726 -177.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -110.39 118.83 37.35 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.387 0.675 . . . . 0.0 109.53 167.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.2 pt -131.41 133.08 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 CA-C-O 121.785 0.802 . . . . 0.0 111.879 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -98.77 99.24 10.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.605 0.762 . . . . 0.0 109.664 -175.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.35 99.67 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.417 -0.802 . . . . 0.0 109.868 -165.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 56.9 t -85.7 115.8 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 123.458 0.703 . . . . 0.0 109.319 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -134.35 140.68 46.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.829 -0.544 . . . . 0.0 111.769 173.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -92.95 140.06 29.88 Favored 'General case' 0 CA--C 1.565 1.528 0 O-C-N 121.896 -0.502 . . . . 0.0 110.865 163.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -56.92 131.8 50.73 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 176.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.35 -16.68 37.96 Favored Glycine 0 CA--C 1.553 2.437 0 N-CA-C 119.426 2.53 . . . . 0.0 119.426 -172.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.8 t -81.84 132.37 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-N 120.176 1.988 . . . . 0.0 110.408 -175.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.9 m -79.87 104.74 10.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.716 -0.615 . . . . 0.0 110.085 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -124.7 166.85 15.44 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-O 122.106 0.955 . . . . 0.0 112.405 -173.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -91.23 99.01 12.08 Favored 'General case' 0 CA--C 1.571 1.75 0 C-N-CA 123.362 0.665 . . . . 0.0 111.454 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -92.58 104.89 17.14 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.829 0.852 . . . . 0.0 110.174 175.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -95.64 125.86 40.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 112.025 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.7 mt -80.21 150.24 30.17 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.166 0.586 . . . . 0.0 112.425 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.38 44.98 0.16 Allowed 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -149.75 -59.54 0.2 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 124.769 1.228 . . . . 0.0 110.234 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.53 73.37 0.04 OUTLIER Glycine 0 N--CA 1.486 1.977 0 CA-C-N 118.935 0.789 . . . . 0.0 112.678 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 m -167.8 124.77 1.13 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 117.869 0.834 . . . . 0.0 109.959 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -102.08 125.98 48.91 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.852 0.861 . . . . 0.0 111.033 171.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.6 mt -117.83 123.36 45.72 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.607 0.763 . . . . 0.0 110.865 -175.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -102.77 118.79 37.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.102 -0.999 . . . . 0.0 110.85 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.43 -177.71 47.88 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 118.29 2.076 . . . . 0.0 118.29 -172.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.8 p -119.54 124.91 47.57 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 113.812 -1.194 . . . . 0.0 111.215 -167.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -83.46 126.01 32.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.977 -0.452 . . . . 0.0 111.419 163.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.8 m -120.42 135.06 55.16 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.196 0.598 . . . . 0.0 111.026 172.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.6 tp -89.15 106.83 18.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 111.466 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -98.52 -179.08 4.21 Favored 'General case' 0 CA--C 1.575 1.904 0 C-N-CA 123.895 0.878 . . . . 0.0 110.828 168.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.91 106.87 0.88 Allowed Glycine 0 N--CA 1.494 2.537 0 O-C-N 120.265 -1.522 . . . . 0.0 115.894 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.42 9.3 p30 59.4 13.53 3.25 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 119.558 3.17 . . . . 0.0 119.558 -166.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -137.22 125.51 23.25 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 120.293 1.406 . . . . 0.0 111.867 -169.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.9 mt -89.25 109.0 19.93 Favored 'General case' 0 CA--C 1.564 1.484 0 O-C-N 121.098 -1.001 . . . . 0.0 108.379 159.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.6 tt -96.8 115.54 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.526 -0.734 . . . . 0.0 110.103 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.58 104.35 2.58 Favored Glycine 0 N--CA 1.482 1.754 0 C-N-CA 123.875 0.75 . . . . 0.0 112.374 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -92.15 95.45 9.75 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -114.95 148.96 38.05 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.477 1.132 . . . . 0.0 112.876 -168.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -121.87 135.46 54.89 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.713 0.805 . . . . 0.0 109.456 166.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -75.5 104.85 6.24 Favored 'General case' 0 CA--C 1.562 1.414 0 O-C-N 121.084 -1.01 . . . . 0.0 111.845 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 t -61.94 -16.45 51.09 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 118.385 2.735 . . . . 0.0 118.385 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -70.19 -28.99 65.74 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 168.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . 0.25 3.1 p-10 -145.53 7.46 1.13 Allowed 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 119.436 3.125 . . . . 0.0 119.436 -177.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.11 -19.7 47.75 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 119.15 2.42 . . . . 0.0 119.15 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -73.81 139.98 45.51 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -169.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -74.12 141.1 45.64 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 tt -126.77 121.05 30.87 Favored 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 123.589 0.756 . . . . 0.0 109.538 168.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -100.15 110.13 22.4 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.2 m -96.92 131.23 43.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.564 -0.71 . . . . 0.0 110.193 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.8 t -129.45 99.67 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -104.31 105.77 16.02 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.144 0.978 . . . . 0.0 108.606 -172.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -126.4 137.94 53.49 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -162.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.1 mm -88.99 127.19 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.386 -0.821 . . . . 0.0 109.51 167.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 49.2 mm -104.18 -80.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 168.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -165.32 113.19 0.54 Allowed Glycine 0 N--CA 1.487 2.093 0 O-C-N 121.357 -0.839 . . . . 0.0 111.056 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.251 31.3 m-20 60.5 1.31 0.39 Allowed 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 -166.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -136.58 138.69 41.5 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 124.339 1.056 . . . . 0.0 111.071 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.3 tp -94.06 109.77 21.51 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 168.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.2 m -95.07 113.37 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . 0.28 0.1 OUTLIER -124.7 119.44 28.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.82 -1.175 . . . . 0.0 113.315 -175.561 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.4 m -107.65 123.87 49.14 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.166 0.986 . . . . 0.0 109.982 -167.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -105.81 111.74 24.52 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.2 t -108.42 102.45 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -104.61 81.09 1.74 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.305 -0.872 . . . . 0.0 110.602 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 63.63 73.58 0.44 Allowed 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 123.779 0.831 . . . . 0.0 112.624 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.97 -36.9 2.33 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 118.732 2.253 . . . . 0.0 118.732 -173.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.81 99.27 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 119.229 1.515 . . . . 0.0 112.663 -169.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -90.42 112.23 23.77 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 123.375 0.67 . . . . 0.0 112.085 -172.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.36 119.64 37.65 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.077 0.551 . . . . 0.0 112.195 176.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -107.34 105.65 15.69 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.016 0.526 . . . . 0.0 109.962 -174.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -91.02 115.15 27.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.41 -0.806 . . . . 0.0 108.963 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 82.4 mt -105.01 118.94 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -103.01 152.06 21.77 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.048 0.939 . . . . 0.0 111.421 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -101.72 152.68 20.56 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.715 -1.241 . . . . 0.0 111.723 169.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -66.22 105.44 1.41 Allowed 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 123.758 0.823 . . . . 0.0 112.689 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.6 t0 . . . . . 0 N--CA 1.487 1.397 0 C-N-CA 124.922 1.289 . . . . 0.0 114.251 -178.721 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.357 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.33 77.0 m-85 73.34 -58.1 0.61 Allowed 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 171.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -70.55 76.9 0.58 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 120.229 1.377 . . . . 0.0 114.006 -172.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.1 t -168.73 173.98 6.9 Favored 'General case' 0 CA--C 1.572 1.821 0 CA-C-O 122.622 1.201 . . . . 0.0 111.93 -165.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.9 m -90.96 133.61 35.14 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.268 -0.895 . . . . 0.0 110.353 171.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -132.2 101.18 5.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.948 -0.47 . . . . 0.0 110.068 -172.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -91.28 135.32 33.88 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.475 -0.766 . . . . 0.0 111.988 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -61.2 121.32 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -99.51 -45.2 5.89 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 117.416 -1.278 . . . . 0.0 114.223 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.57 116.34 1.26 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 120.293 1.406 . . . . 0.0 110.088 -169.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.1 p -100.32 105.41 16.93 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.539 0.736 . . . . 0.0 111.921 -177.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -90.43 126.04 35.77 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.192 0.597 . . . . 0.0 111.635 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.257 45.3 t30 60.1 26.29 15.65 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 117.681 2.474 . . . . 0.0 117.681 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -72.19 -42.84 65.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -60.13 -40.53 90.11 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 117.616 2.451 . . . . 0.0 117.616 171.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.74 -44.18 70.79 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 172.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -44.16 -57.71 3.27 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 158.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.2 mtt -57.0 -42.68 80.73 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 172.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -58.35 -43.92 88.54 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 168.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -59.79 -35.14 74.05 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 168.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 58.0 mtm -66.84 -37.73 85.05 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 170.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.77 59.39 0.45 Allowed Glycine 0 N--CA 1.487 2.089 0 C-N-CA 123.776 0.703 . . . . 0.0 114.745 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.426 HG13 ' HG2' ' A' ' 28' ' ' ARG . 2.4 p -129.31 136.95 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 122.278 1.037 . . . . 0.0 110.413 177.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -63.02 143.91 57.36 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.276 13.7 tt -51.03 -42.49 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -176.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.8 t -60.81 -50.36 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 119.59 1.086 . . . . 0.0 113.125 171.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -56.41 -42.33 77.83 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 167.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HG2' HG13 ' A' ' 23' ' ' VAL . 57.4 mtm-85 -58.79 -47.05 86.08 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 169.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -59.12 -46.35 88.55 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 170.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.51 -47.75 80.42 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 171.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.09 -25.73 63.65 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.19 76.62 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-N 121.31 1.868 . . . . 0.0 115.043 156.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -78.82 59.42 2.57 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 171.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -97.03 -27.28 14.68 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -175.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.387 1.3 p-10 57.8 55.68 5.28 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -173.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.0 tp -80.17 121.43 25.57 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.419 1.104 . . . . 0.0 113.902 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -106.18 118.33 36.34 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.81 167.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.2 mt -97.4 101.01 12.45 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 51.7 m -94.41 109.5 21.36 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.998 -1.064 . . . . 0.0 109.421 171.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.2 mt -103.79 112.75 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -166.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 87.6 m -103.31 106.3 16.78 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -89.04 108.97 19.88 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.297 0.639 . . . . 0.0 111.948 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.7 70.76 6.71 Favored 'General case' 0 CA--C 1.572 1.809 0 O-C-N 121.587 -0.696 . . . . 0.0 110.486 166.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.99 -96.49 0.22 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 115.515 0.966 . . . . 0.0 115.515 -174.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -87.93 -23.19 23.97 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 169.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -88.85 111.36 21.96 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 121.046 1.748 . . . . 0.0 111.974 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -94.63 117.44 30.14 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.518 0.727 . . . . 0.0 109.181 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.6 m -93.83 97.99 10.77 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.9 t -92.82 105.46 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -86.34 101.79 13.42 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.178 0.591 . . . . 0.0 109.606 -176.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -90.85 97.55 11.25 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.234 0.614 . . . . 0.0 109.837 -172.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -110.54 102.83 11.39 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 122.991 0.516 . . . . 0.0 110.845 -175.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.8 p -140.31 -178.92 5.71 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.028 0.931 . . . . 0.0 111.72 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.86 -29.99 67.38 Favored 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 159.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -97.95 -17.62 19.11 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 174.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -130.07 142.07 50.65 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 121.382 1.901 . . . . 0.0 111.975 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -144.29 74.33 1.42 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.016 -1.052 . . . . 0.0 109.796 162.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.2 pt -143.07 130.16 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.283 -0.886 . . . . 0.0 112.007 -166.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.82 99.84 11.64 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.248 1.019 . . . . 0.0 111.559 172.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.9 t -91.42 98.28 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.174 -0.954 . . . . 0.0 109.19 -169.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.1 t -86.4 119.49 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 123.344 0.658 . . . . 0.0 109.312 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -140.64 133.42 28.97 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.328 0.585 . . . . 0.0 111.532 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -86.45 139.8 30.56 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 121.808 -0.557 . . . . 0.0 111.246 167.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.75 128.43 36.53 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.89 -11.48 59.77 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 119.642 2.617 . . . . 0.0 119.642 -172.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.2 t -85.59 133.01 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 120.43 2.115 . . . . 0.0 110.33 -175.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -77.4 114.11 15.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.508 -0.745 . . . . 0.0 111.466 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -138.56 163.05 33.03 Favored 'General case' 0 CA--C 1.572 1.791 0 C-N-CA 123.264 0.626 . . . . 0.0 112.607 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -85.89 111.17 19.96 Favored 'General case' 0 CA--C 1.57 1.727 0 O-C-N 121.515 -0.741 . . . . 0.0 111.752 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -102.4 156.15 17.78 Favored 'General case' 0 CA--C 1.572 1.796 0 CA-C-O 122.17 0.986 . . . . 0.0 112.678 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -127.18 149.41 49.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.4 -0.812 . . . . 0.0 111.532 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.4 mt -92.97 -113.28 0.1 Allowed 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 118.804 -0.617 . . . . 0.0 110.263 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -146.5 58.91 1.21 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 120.776 1.625 . . . . 0.0 112.718 170.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -159.9 -78.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.116 0.966 . . . . 0.0 108.456 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.18 76.57 0.06 OUTLIER Glycine 0 N--CA 1.481 1.667 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.7 m -147.4 122.22 9.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.731 -0.864 . . . . 0.0 109.212 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -97.96 116.55 30.41 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.403 0.681 . . . . 0.0 110.683 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 70.9 mt -115.48 106.01 13.47 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.46 0.704 . . . . 0.0 110.91 -170.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -82.62 118.73 23.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.41 -0.806 . . . . 0.0 111.743 174.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.56 -167.96 41.06 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 117.741 1.856 . . . . 0.0 117.741 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.8 p -128.22 124.92 37.92 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.675 -0.763 . . . . 0.0 111.534 -163.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -85.92 129.41 34.84 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 118.194 0.452 . . . . 0.0 111.361 161.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.8 t -122.83 137.39 54.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.721 -0.612 . . . . 0.0 111.79 173.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.8 tp -90.93 107.68 19.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.898 -1.126 . . . . 0.0 111.572 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -103.48 75.96 1.38 Allowed 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 121.512 0.672 . . . . 0.0 109.747 171.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.25 -102.54 0.95 Allowed Glycine 0 N--CA 1.491 2.35 0 O-C-N 121.38 -0.825 . . . . 0.0 115.137 -177.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -95.67 22.33 7.31 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -129.84 114.53 16.02 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.713 -1.242 . . . . 0.0 110.03 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.9 mt -84.03 104.68 14.3 Favored 'General case' 0 CA--C 1.564 1.481 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 161.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.1 tt -94.1 114.53 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.466 -0.771 . . . . 0.0 110.231 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -103.07 99.18 1.76 Allowed Glycine 0 N--CA 1.482 1.706 0 C-N-CA 123.689 0.661 . . . . 0.0 113.289 -174.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -90.5 92.75 9.0 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -120.27 134.64 55.22 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.18 0.592 . . . . 0.0 112.503 -168.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -115.68 145.08 43.06 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.514 0.725 . . . . 0.0 109.875 169.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -70.2 123.95 22.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.446 -1.409 . . . . 0.0 112.675 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.281 9.8 t -81.05 59.78 3.97 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 122.625 1.202 . . . . 0.0 113.824 169.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -168.12 -63.31 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.767 0 C-N-CA 125.916 1.686 . . . . 0.0 107.796 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -80.34 -38.72 30.0 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.146 1.535 . . . . 0.0 115.146 171.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.74 -31.17 9.04 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 117.359 1.704 . . . . 0.0 117.359 -158.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -65.86 143.21 57.6 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -165.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -69.13 129.63 40.43 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 175.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.5 tt -121.59 86.06 2.51 Favored 'General case' 0 CA--C 1.563 1.472 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 168.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -83.05 109.06 16.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.987 -1.07 . . . . 0.0 109.735 -167.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 m -111.89 111.38 22.29 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.84 -0.538 . . . . 0.0 110.085 -166.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.0 t -107.1 101.63 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.022 -1.049 . . . . 0.0 109.05 -175.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.4 mtm-85 -84.3 117.32 23.49 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.296 0.639 . . . . 0.0 110.887 174.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -147.76 135.07 20.59 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.816 -1.177 . . . . 0.0 113.347 -173.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 mp -85.14 113.95 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.135 -0.978 . . . . 0.0 108.381 177.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.22 84.58 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.29 -84.41 0.73 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 114.728 0.651 . . . . 0.0 114.728 -173.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -103.52 -40.31 6.39 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -101.87 140.34 36.28 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 120.255 1.388 . . . . 0.0 113.096 -169.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.0 tp -76.73 111.34 12.14 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.834 0.853 . . . . 0.0 110.723 172.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 m -99.24 120.04 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -103.32 99.46 9.3 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.542 0.737 . . . . 0.0 109.377 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.4 m -94.18 112.02 23.79 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.301 0.64 . . . . 0.0 110.172 -171.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -90.09 133.3 34.94 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.669 0.788 . . . . 0.0 111.565 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.2 t -119.85 101.61 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 163.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -95.05 94.14 7.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.39 -0.818 . . . . 0.0 109.728 171.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.287 4.6 mm-40 70.35 -69.81 0.17 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -153.13 62.06 0.38 Allowed Glycine 0 N--CA 1.486 2.021 0 CA-C-O 119.784 -0.453 . . . . 0.0 113.683 165.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.5 p -144.58 113.59 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 117.77 0.785 . . . . 0.0 109.05 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -87.56 118.47 27.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.705 -0.622 . . . . 0.0 111.368 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -130.78 131.35 44.63 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 122.839 0.456 . . . . 0.0 111.686 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -115.46 118.02 32.01 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.435 -0.79 . . . . 0.0 111.169 -173.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -93.69 104.62 16.71 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 167.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.76 127.04 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -115.66 130.33 56.82 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.886 0.874 . . . . 0.0 110.264 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -78.61 143.98 35.92 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 121.77 0.795 . . . . 0.0 113.04 176.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -61.95 115.03 3.72 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 123.927 0.891 . . . . 0.0 112.769 171.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.2 t70 . . . . . 0 N--CA 1.489 1.476 0 C-N-CA 124.93 1.292 . . . . 0.0 112.345 -170.401 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.293 0 CA-C-O 122.139 0.971 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -81.23 36.38 0.41 Allowed 'General case' 0 CA--C 1.581 2.149 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.6 90.06 8.23 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 119.799 -1.813 . . . . 0.0 114.03 -157.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.2 m -158.13 -175.22 5.22 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 124.499 1.12 . . . . 0.0 110.808 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.0 m -99.69 113.09 25.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.808 -1.182 . . . . 0.0 109.441 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -117.81 108.16 15.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.912 -0.493 . . . . 0.0 109.84 -170.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -93.26 140.51 29.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.269 -0.895 . . . . 0.0 112.31 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.4 p -63.75 116.52 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -98.66 -59.35 1.76 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.547 0.739 . . . . 0.0 111.798 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -141.28 166.08 25.76 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.837 0.827 . . . . 0.0 110.846 177.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.4 m -153.71 126.41 8.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 119.236 -2.165 . . . . 0.0 112.142 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -100.8 121.82 42.35 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.741 0.816 . . . . 0.0 109.932 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.267 14.0 t30 65.29 13.57 8.86 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 171.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -63.59 -40.32 96.64 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.21 -27.04 68.71 Favored 'General case' 0 CA--C 1.577 2.014 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 169.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -73.92 -49.44 24.76 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 120.32 1.418 . . . . 0.0 113.8 165.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -46.8 -51.45 16.41 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 166.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -40.73 76.01 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 166.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -59.89 -45.9 91.04 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 168.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -54.59 -38.44 66.74 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 167.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.6 mtm -68.59 -21.7 64.5 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 168.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.12 49.21 1.77 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 116.212 1.245 . . . . 0.0 116.212 175.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.65 151.9 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 118.673 1.236 . . . . 0.0 113.614 -177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -63.08 144.59 56.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.283 13.2 tt -52.66 -45.13 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.3 t -55.5 -52.31 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 124.023 0.929 . . . . 0.0 113.457 168.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -61.56 -46.11 91.27 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 176.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.7 ptt85 -69.68 -28.81 66.17 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 117.975 2.584 . . . . 0.0 117.975 171.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -62.5 -49.1 76.69 Favored 'General case' 0 CA--C 1.572 1.807 0 CA-C-N 120.09 1.314 . . . . 0.0 114.302 161.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.28 -59.89 4.69 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 170.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.08 -16.79 20.94 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 118.915 2.931 . . . . 0.0 118.915 175.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.05 -86.49 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 117.693 -1.146 . . . . 0.0 112.701 159.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -106.4 48.93 0.82 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 121.814 2.097 . . . . 0.0 115.21 -171.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.0 54.27 2.7 Favored 'General case' 0 CA--C 1.576 1.977 0 O-C-N 120.765 -1.209 . . . . 0.0 113.869 166.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 50.7 50.8 18.24 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 117.563 2.431 . . . . 0.0 117.563 171.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -87.0 124.02 32.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.787 -1.196 . . . . 0.0 113.708 -169.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -119.75 121.41 39.11 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.086 0.954 . . . . 0.0 110.406 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.4 mt -91.44 102.19 14.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.553 -0.717 . . . . 0.0 109.301 176.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 87.0 m -95.21 103.5 15.36 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.4 mt -101.67 128.37 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -167.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.3 p -128.99 122.34 29.9 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 171.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -94.33 131.95 39.43 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.823 0.82 . . . . 0.0 111.251 168.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -97.72 36.86 1.45 Allowed 'General case' 0 CA--C 1.582 2.2 0 C-N-CA 124.603 1.161 . . . . 0.0 113.528 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.79 92.06 0.23 Allowed Glycine 0 N--CA 1.492 2.413 0 O-C-N 120.196 -1.565 . . . . 0.0 113.536 -168.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.279 16.8 t-20 71.58 -61.18 0.5 Allowed 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -74.76 133.65 41.95 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -172.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -111.26 134.24 53.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.492 -0.755 . . . . 0.0 112.132 -173.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.2 m -107.16 113.54 27.04 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 161.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.4 t -110.53 104.87 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -81.66 103.9 11.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 110.189 175.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -90.39 96.26 10.57 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.8 t -102.27 117.05 33.92 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.361 0.664 . . . . 0.0 111.274 -170.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.9 p -143.26 164.81 29.2 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.683 0.754 . . . . 0.0 112.903 -173.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.07 -25.51 65.44 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 159.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -73.03 -50.28 23.93 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -162.88 153.87 17.13 Favored 'General case' 0 CA--C 1.572 1.813 0 C-N-CA 124.408 1.083 . . . . 0.0 111.828 -171.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -129.87 104.14 7.21 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.517 -0.74 . . . . 0.0 109.128 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.28 142.13 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.48 -0.762 . . . . 0.0 112.15 -170.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -89.2 114.65 26.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.578 -0.701 . . . . 0.0 112.614 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.9 t -96.82 102.54 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.39 124.48 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 123.065 0.546 . . . . 0.0 109.598 -175.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -146.32 139.1 25.46 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.238 0.615 . . . . 0.0 111.344 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -97.65 142.37 29.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.26 164.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.74 112.36 3.67 Favored 'General case' 0 CA--C 1.566 1.571 0 O-C-N 121.584 -0.697 . . . . 0.0 112.617 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.56 -18.05 58.14 Favored Glycine 0 CA--C 1.558 2.723 0 N-CA-C 119.488 2.555 . . . . 0.0 119.488 -163.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 65.3 t -94.77 112.65 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 120.453 2.127 . . . . 0.0 109.039 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 t -73.07 139.48 46.56 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -131.54 166.81 20.54 Favored 'General case' 0 CA--C 1.574 1.866 0 C-N-CA 124.295 1.038 . . . . 0.0 112.832 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -93.1 120.71 33.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.433 -0.792 . . . . 0.0 110.543 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -119.92 123.27 43.15 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.345 0.658 . . . . 0.0 111.8 -176.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -81.48 127.17 32.53 Favored 'General case' 0 CA--C 1.566 1.584 0 O-C-N 121.329 -0.857 . . . . 0.0 109.703 161.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 57.3 mt -63.36 177.59 0.64 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 168.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.86 35.31 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 118.341 2.719 . . . . 0.0 118.341 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -154.6 -82.7 0.07 Allowed 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.753 1.221 . . . . 0.0 108.951 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.0 74.17 0.09 OUTLIER Glycine 0 N--CA 1.483 1.81 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 55.5 m -152.63 110.36 3.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.91 -0.759 . . . . 0.0 109.301 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -84.84 115.12 22.57 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-O 122.066 0.936 . . . . 0.0 112.224 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.2 mt -107.7 152.24 24.6 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 125.015 1.326 . . . . 0.0 111.442 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -116.26 111.39 20.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.042 -1.036 . . . . 0.0 109.795 174.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.24 -174.99 38.78 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 114.667 0.627 . . . . 0.0 114.667 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.9 m -117.25 -58.5 2.04 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -163.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . 0.272 69.6 m95 76.46 91.3 0.07 Allowed 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.488 1.115 . . . . 0.0 111.284 -153.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.2 m -105.37 127.88 53.2 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.261 0.624 . . . . 0.0 110.731 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.1 tp -78.53 102.64 8.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.0 111.158 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -81.54 -58.06 3.19 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.69 -96.21 1.12 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 160.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -102.34 57.21 0.79 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 117.774 0.787 . . . . 0.0 110.878 154.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -147.53 111.9 5.24 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -173.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.7 mt -86.4 101.86 13.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.582 -0.698 . . . . 0.0 109.746 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.8 tt -88.77 107.28 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.262 1.029 . . . . 0.0 110.638 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.73 93.14 1.72 Allowed Glycine 0 N--CA 1.48 1.592 0 C-N-CA 123.63 0.633 . . . . 0.0 112.954 174.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -86.75 92.44 8.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -112.07 108.31 17.56 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.352 0.661 . . . . 0.0 111.088 -165.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -89.97 129.75 36.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.972 -1.08 . . . . 0.0 110.851 177.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -61.14 135.66 57.83 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.7 p -64.32 -64.0 0.99 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 161.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -86.94 72.67 10.07 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 121.526 -0.734 . . . . 0.0 111.038 171.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 171.11 -39.32 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 126.527 1.931 . . . . 0.0 112.627 168.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 70.38 22.69 77.7 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 118.491 2.156 . . . . 0.0 118.491 -164.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -121.83 157.89 30.09 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.482 1.134 . . . . 0.0 113.394 -169.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -84.97 124.97 32.29 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -166.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.15 111.77 20.72 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.02 0.928 . . . . 0.0 108.717 170.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -103.65 111.99 24.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.301 -0.874 . . . . 0.0 108.883 -173.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.4 m -111.03 104.06 12.59 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 119.771 1.169 . . . . 0.0 110.828 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.7 t -90.25 104.06 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.13 -0.981 . . . . 0.0 108.62 177.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.5 118.86 24.57 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.584 0.754 . . . . 0.0 110.381 171.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -149.4 147.64 28.52 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 119.511 1.051 . . . . 0.0 113.524 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 mp -93.63 123.53 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.969 -1.082 . . . . 0.0 109.261 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 44.4 mm -103.5 92.11 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 170.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.11 -97.58 1.16 Allowed Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.339 -0.851 . . . . 0.0 114.176 -173.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -130.4 49.3 2.31 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 121.897 0.856 . . . . 0.0 111.773 166.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -144.25 116.68 8.56 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 124.015 0.926 . . . . 0.0 108.581 -173.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.8 tp -89.0 115.18 26.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.694 -0.629 . . . . 0.0 110.621 -173.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.4 m -105.56 121.09 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -98.24 108.57 21.3 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.732 0.813 . . . . 0.0 109.914 171.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.4 m -91.0 98.51 11.82 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -90.51 114.07 26.19 Favored 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 124.395 1.078 . . . . 0.0 111.349 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.56 105.91 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-N 119.203 0.91 . . . . 0.0 108.576 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -108.65 114.41 28.2 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 118.917 0.78 . . . . 0.0 109.774 167.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 53.66 50.21 17.63 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.21 -26.41 4.43 Favored Glycine 0 CA--C 1.554 2.472 0 N-CA-C 119.296 2.479 . . . . 0.0 119.296 -168.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.9 t -83.59 104.38 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 120.262 2.031 . . . . 0.0 109.928 -170.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -87.37 132.26 34.02 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -130.9 121.93 26.09 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.671 0.789 . . . . 0.0 111.717 171.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -101.0 106.09 17.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.445 -0.784 . . . . 0.0 110.948 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -93.94 125.52 38.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.794 -0.566 . . . . 0.0 111.47 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.8 mt -116.81 116.84 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -165.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -113.46 130.23 56.37 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.028 0.931 . . . . 0.0 110.445 -172.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -82.77 140.7 32.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.904 . . . . 0.0 112.054 174.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -62.77 107.19 0.92 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.554 -0.716 . . . . 0.0 111.518 162.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -162.487 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.57 1.723 0 N-CA-C 117.931 2.567 . . . . 0.0 117.931 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.3 92.6 m-85 72.26 164.39 0.28 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 119.897 1.226 . . . . 0.0 113.154 -163.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.27 17.6 m-20 66.79 50.76 1.09 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.9 t -157.28 -170.02 3.11 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 121.197 -0.94 . . . . 0.0 111.543 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.0 m -97.59 116.85 30.61 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.986 -1.071 . . . . 0.0 109.803 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -116.76 105.34 12.28 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.338 0.655 . . . . 0.0 109.538 -169.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -93.72 132.66 37.86 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.45 0.7 . . . . 0.0 110.86 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 p -57.07 116.56 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.952 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.46 -49.7 5.79 Favored 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 124.411 1.084 . . . . 0.0 112.913 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -149.71 116.62 5.94 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.529 1.059 . . . . 0.0 110.744 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.9 p -97.29 100.67 12.13 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.686 0.794 . . . . 0.0 111.564 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -95.14 125.37 39.74 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.421 0.688 . . . . 0.0 110.665 -169.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.268 42.7 t30 63.56 25.69 14.47 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -73.52 -45.73 52.03 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 115.605 1.705 . . . . 0.0 115.605 -173.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -61.41 -27.8 68.8 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -74.42 -46.28 41.12 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.966 1.257 . . . . 0.0 114.092 165.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -49.48 -52.71 27.42 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 164.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -31.2 72.32 Favored 'General case' 0 CA--C 1.574 1.888 0 N-CA-C 116.313 1.968 . . . . 0.0 116.313 172.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.47 -37.89 86.11 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 121.16 1.8 . . . . 0.0 115.476 163.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -60.05 -39.47 86.07 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 165.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 83.0 mmm -60.68 -45.68 93.25 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 165.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.78 51.42 0.57 Allowed Glycine 0 N--CA 1.484 1.878 0 C-N-CA 124.294 0.95 . . . . 0.0 114.8 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.4 m -108.61 142.4 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.479 1.133 . . . . 0.0 112.776 -178.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -66.5 154.89 39.14 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.305 0.1 OUTLIER -43.77 -56.1 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 -173.373 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.83 -51.55 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 CA-C-N 119.563 1.074 . . . . 0.0 113.082 175.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -55.67 -42.07 74.58 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 170.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.1 ttp85 -60.72 -50.63 72.72 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 169.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -60.53 -43.45 97.13 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 169.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.61 -38.72 88.68 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 167.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.68 -41.5 96.01 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 169.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.26 -51.42 67.79 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 162.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -96.61 58.89 1.74 Allowed 'General case' 0 CA--C 1.572 1.82 0 CA-C-N 119.328 0.967 . . . . 0.0 111.965 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -96.57 -16.33 21.12 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.696 2.109 . . . . 0.0 116.696 -170.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 55.31 57.31 5.55 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 119.878 1.217 . . . . 0.0 114.162 -167.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.4 tp -80.73 117.42 21.39 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 121.969 0.89 . . . . 0.0 111.301 -176.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -122.01 109.52 14.68 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.011 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 84.3 mt -94.89 106.68 18.69 Favored 'General case' 0 CA--C 1.563 1.442 0 C-N-CA 123.31 0.644 . . . . 0.0 110.227 -174.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.0 m -92.11 109.05 20.4 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.268 -0.895 . . . . 0.0 109.894 170.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.4 mt -101.5 133.99 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.739 0 C-N-CA 124.409 1.084 . . . . 0.0 108.53 -170.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t -153.02 125.67 8.27 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.939 -1.101 . . . . 0.0 111.729 171.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -87.29 116.94 25.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.129 -0.982 . . . . 0.0 112.08 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -103.11 75.29 1.36 Allowed 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.413 0.685 . . . . 0.0 110.256 171.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.68 75.29 0.43 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 115.947 1.139 . . . . 0.0 115.947 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.276 10.9 t-20 70.28 -48.67 0.64 Allowed 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -167.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -68.94 114.14 6.97 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 119.313 0.96 . . . . 0.0 113.352 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -88.43 120.48 29.85 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.154 0.582 . . . . 0.0 111.181 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.1 m -89.39 109.34 20.26 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 167.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.0 t -109.71 109.01 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -82.89 106.06 14.4 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -85.57 84.94 7.46 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.999 0.52 . . . . 0.0 109.906 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 t -85.84 111.06 19.84 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.564 0.345 . . . . 0.0 110.848 -176.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.2 p -142.93 159.85 41.46 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -169.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.34 -27.75 56.86 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 118.321 2.711 . . . . 0.0 118.321 169.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -74.24 -46.86 38.94 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 164.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.7 ptt-85 -167.02 150.76 6.71 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.772 0.829 . . . . 0.0 112.171 -170.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.65 96.62 6.08 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.585 0.754 . . . . 0.0 110.878 171.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.6 pt -119.59 127.47 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.569 -0.707 . . . . 0.0 112.416 -169.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.38 112.13 13.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.542 -0.724 . . . . 0.0 112.166 170.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.5 t -104.75 102.15 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.24 116.79 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -133.14 135.34 45.12 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.438 0.637 . . . . 0.0 111.53 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -80.61 136.27 36.2 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.595 -0.69 . . . . 0.0 111.328 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 57.1 mt -60.06 125.24 22.88 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -176.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.18 -5.7 70.87 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 119.708 2.643 . . . . 0.0 119.708 -172.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.4 t -88.75 133.0 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 120.122 1.961 . . . . 0.0 109.736 -176.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.7 p -72.92 110.26 7.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.65 -0.657 . . . . 0.0 111.947 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -126.83 163.02 24.52 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 124.013 0.925 . . . . 0.0 112.039 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -84.32 106.54 16.01 Favored 'General case' 0 CA--C 1.569 1.689 0 O-C-N 121.297 -0.877 . . . . 0.0 111.586 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -102.44 167.86 9.68 Favored 'General case' 0 CA--C 1.571 1.759 0 C-N-CA 124.749 1.22 . . . . 0.0 112.445 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -146.96 131.53 17.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.705 -1.247 . . . . 0.0 111.575 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.9 mt -84.83 62.77 7.63 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.271 . . 61.46 -36.49 0.11 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 120.409 3.485 . . . . 0.0 120.409 175.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -86.91 -85.89 0.16 Allowed 'General case' 0 CA--C 1.565 1.555 0 CA-C-N 120.052 1.297 . . . . 0.0 110.2 177.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.61 74.5 0.1 OUTLIER Glycine 0 N--CA 1.482 1.747 0 O-C-N 121.587 -0.696 . . . . 0.0 113.536 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.5 m -146.9 123.97 11.42 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.519 -0.989 . . . . 0.0 109.985 162.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -78.42 130.84 36.56 Favored 'General case' 0 CA--C 1.566 1.587 0 CA-C-O 122.155 0.978 . . . . 0.0 112.435 173.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.6 mt -131.61 111.52 11.8 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.242 -165.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -86.61 114.5 23.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.095 -1.003 . . . . 0.0 111.052 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.37 178.63 47.91 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 116.399 1.32 . . . . 0.0 116.399 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.1 p -92.21 165.31 13.19 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.27 1.033 . . . . 0.0 113.494 -174.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -127.23 108.83 11.22 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 143.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.4 m -100.36 137.48 38.72 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.49 0.716 . . . . 0.0 110.949 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.7 tp -85.3 94.75 9.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.215 -0.928 . . . . 0.0 111.398 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -84.49 79.18 9.66 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-O 121.836 0.827 . . . . 0.0 110.866 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.55 -94.58 0.95 Allowed Glycine 0 N--CA 1.489 2.222 0 O-C-N 121.722 -0.612 . . . . 0.0 113.908 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -126.5 63.62 1.27 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.822 0.82 . . . . 0.0 109.695 163.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -152.45 125.19 8.39 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.7 mt -90.74 105.12 17.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.56 -1.338 . . . . 0.0 109.571 171.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.1 tt -105.18 125.68 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 123.743 0.817 . . . . 0.0 110.616 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.65 118.53 1.99 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 115.58 0.992 . . . . 0.0 115.58 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -95.27 99.91 11.79 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.215 0.606 . . . . 0.0 110.229 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -107.62 107.25 17.98 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -167.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -90.48 136.58 32.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.377 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -75.54 124.86 27.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.999 -1.063 . . . . 0.0 113.239 -173.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.5 p -80.8 62.7 4.93 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 122.332 1.063 . . . . 0.0 112.723 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.4 t0 171.85 -41.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 126.732 2.013 . . . . 0.0 110.283 -166.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -121.49 -18.47 7.24 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -175.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.08 -34.91 3.64 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 118.516 2.166 . . . . 0.0 118.516 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -69.89 139.94 53.08 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -166.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -81.79 128.06 33.62 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.8 tt -106.41 85.62 2.21 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.253 8.5 p30 -81.11 110.36 16.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.334 -0.854 . . . . 0.0 110.803 -173.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.9 m -114.18 112.18 22.75 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.916 -164.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.3 t -102.39 103.86 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.1 mtm180 -85.68 120.64 27.34 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.611 -0.681 . . . . 0.0 110.211 164.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.74 157.92 43.77 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.2 mm -94.31 118.14 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.661 -1.274 . . . . 0.0 109.818 -175.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.2 tt -88.76 71.02 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.14 0.971 . . . . 0.0 111.339 171.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.68 -79.22 0.97 Allowed Glycine 0 N--CA 1.491 2.332 0 O-C-N 120.704 -1.248 . . . . 0.0 114.874 -172.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -107.67 -33.64 7.23 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -93.84 146.22 24.05 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 120.482 1.492 . . . . 0.0 112.82 -174.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.3 tp -86.9 115.87 24.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 110.79 174.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 19.6 m -98.03 115.83 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.354 -0.841 . . . . 0.0 109.752 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -97.39 101.73 13.33 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 171.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.1 m -95.03 105.87 17.82 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.216 0.607 . . . . 0.0 109.558 -176.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -92.84 113.83 26.22 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 124.159 0.984 . . . . 0.0 109.505 -177.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.5 t -113.28 112.64 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -123.11 94.42 4.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.691 -0.63 . . . . 0.0 110.059 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 50.9 55.21 9.9 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 103.26 -49.87 0.93 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 117.094 1.598 . . . . 0.0 117.094 -169.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.1 p -76.45 113.4 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 119.211 1.506 . . . . 0.0 113.151 -165.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -92.18 116.89 29.34 Favored 'General case' 0 CA--C 1.563 1.446 0 O-C-N 121.91 -0.494 . . . . 0.0 111.155 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.42 139.76 48.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.914 -0.491 . . . . 0.0 111.734 163.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -120.27 110.31 16.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.886 . . . . 0.0 110.467 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -89.19 108.47 19.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.62 -0.675 . . . . 0.0 110.458 164.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.7 mp -90.22 120.89 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -110.53 131.82 54.72 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 124.05 0.94 . . . . 0.0 110.116 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -90.51 149.02 22.36 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-O 121.864 0.84 . . . . 0.0 111.817 174.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -68.25 106.87 2.59 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 112.035 173.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.046 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.304 0 CA-C-O 121.623 0.725 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -71.08 -34.82 71.54 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -75.36 77.25 2.44 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 -171.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.8 t -148.14 -177.46 5.76 Favored 'General case' 0 CA--C 1.574 1.891 0 CA-C-O 122.389 1.09 . . . . 0.0 111.266 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -95.19 115.87 27.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.126 -0.984 . . . . 0.0 109.667 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -117.37 103.72 10.41 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.97 0.508 . . . . 0.0 110.402 -169.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -86.71 135.69 33.29 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 123.539 0.735 . . . . 0.0 111.998 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.2 p -63.54 119.18 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.338 -0.851 . . . . 0.0 113.228 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -103.77 -53.2 2.81 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 124.021 0.929 . . . . 0.0 113.084 -173.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -149.05 85.54 1.47 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 119.212 0.915 . . . . 0.0 111.095 -172.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.4 p -73.32 120.2 18.61 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 178.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -104.28 115.22 30.02 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 123.544 0.737 . . . . 0.0 109.831 -169.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.1 t30 62.05 17.7 9.31 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 118.116 2.635 . . . . 0.0 118.116 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -75.85 -35.83 59.8 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -168.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.95 -26.17 68.03 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 162.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -71.36 -47.49 56.03 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 119.917 1.235 . . . . 0.0 114.245 166.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -43.9 -50.68 7.97 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 160.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 43.7 mtt -64.84 -32.98 74.93 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 172.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.42 -43.41 93.05 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 120.897 1.681 . . . . 0.0 115.326 162.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -62.09 -34.73 76.86 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 169.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 22.1 mmt -60.3 -30.28 69.39 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 164.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.94 50.41 3.29 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 115.612 1.005 . . . . 0.0 115.612 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.3 m -89.8 160.63 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 121.984 0.897 . . . . 0.0 113.208 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -70.86 154.75 41.55 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 165.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.269 14.7 tt -59.14 -36.87 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.11 -56.0 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-N 119.558 1.072 . . . . 0.0 112.922 172.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -65.19 -28.78 69.63 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 116.788 2.144 . . . . 0.0 116.788 172.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.5 ttp85 -58.9 -42.23 89.09 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 117.27 2.322 . . . . 0.0 117.27 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.5 OUTLIER -77.36 -48.24 17.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 162.343 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.84 -51.33 62.66 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -175.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.19 -37.04 85.64 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 173.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.71 -51.42 65.05 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 168.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -100.12 47.76 0.93 Allowed 'General case' 0 CA--C 1.574 1.881 0 CA-C-N 118.954 0.797 . . . . 0.0 112.703 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -83.99 16.27 2.96 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -169.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 53.44 50.19 17.94 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.164 -1.585 . . . . 0.0 115.136 -170.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.2 tp -80.23 120.65 24.61 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 121.88 0.847 . . . . 0.0 112.873 -171.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -111.87 121.06 44.0 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.287 172.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.6 mt -101.9 102.54 13.12 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.969 0.508 . . . . 0.0 109.966 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.2 m -89.86 108.82 19.93 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.328 -0.858 . . . . 0.0 109.231 169.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.0 mt -101.57 128.9 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -172.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 t -145.31 133.65 21.78 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.894 -1.129 . . . . 0.0 111.56 171.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -99.95 118.87 37.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.194 -0.942 . . . . 0.0 112.3 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -100.81 71.2 1.44 Allowed 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 123.137 0.575 . . . . 0.0 110.636 169.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 62.39 77.33 0.21 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 116.552 1.381 . . . . 0.0 116.552 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.278 7.1 t30 72.21 -24.72 0.18 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -170.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -90.0 109.62 20.64 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 119.657 1.117 . . . . 0.0 111.901 172.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -83.04 118.01 23.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.516 -0.74 . . . . 0.0 111.161 169.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.6 m -86.23 107.55 17.97 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 164.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.07 112.67 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -87.24 111.36 20.94 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.286 0.634 . . . . 0.0 110.351 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -89.99 89.46 7.72 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.289 0.635 . . . . 0.0 109.467 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.7 m -97.4 107.7 20.27 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.8 p -145.84 174.0 11.62 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.02 0.914 . . . . 0.0 113.23 -171.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.85 -30.32 65.69 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 118.432 2.753 . . . . 0.0 118.432 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.2 -31.64 30.24 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 168.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -159.24 155.27 26.7 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 119.926 1.239 . . . . 0.0 113.357 -159.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -134.64 99.88 4.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.068 -1.02 . . . . 0.0 108.748 165.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.6 pt -132.22 129.75 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.854 -0.529 . . . . 0.0 111.704 -169.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.13 109.66 19.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.203 -0.936 . . . . 0.0 111.762 174.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.8 t -100.43 107.8 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -175.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -92.36 109.99 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -120.26 129.03 53.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.856 -0.528 . . . . 0.0 111.203 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -80.63 130.87 35.36 Favored 'General case' 0 CA--C 1.562 1.425 0 O-C-N 121.666 -0.646 . . . . 0.0 111.117 168.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.3 mt -61.45 124.22 20.03 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.72 -17.45 58.58 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 119.354 2.502 . . . . 0.0 119.354 -166.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.5 t -89.46 134.93 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-N 120.768 2.284 . . . . 0.0 110.41 -176.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -76.87 116.43 17.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.579 -0.701 . . . . 0.0 112.594 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -135.68 159.2 42.38 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 123.651 0.78 . . . . 0.0 111.297 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.03 94.29 7.48 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 121.306 -0.871 . . . . 0.0 112.404 -172.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -89.39 145.76 25.12 Favored 'General case' 0 CA--C 1.569 1.701 0 O-C-N 121.499 -0.751 . . . . 0.0 112.458 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -128.33 126.01 39.89 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.428 -0.795 . . . . 0.0 110.832 -174.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.7 mt -94.65 74.1 3.7 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -173.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.32 . . 65.7 -61.52 0.26 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -67.63 -18.24 64.89 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 119.141 3.015 . . . . 0.0 119.141 174.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.89 31.35 5.73 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 117.515 1.766 . . . . 0.0 117.515 -163.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.1 m -81.45 99.07 8.54 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.129 0.965 . . . . 0.0 109.176 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -85.72 99.39 11.3 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -160.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.6 mt -112.55 113.87 26.24 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.787 0.835 . . . . 0.0 110.832 -167.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -97.22 123.5 41.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.944 . . . . 0.0 111.336 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.71 179.76 46.4 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 118.061 1.984 . . . . 0.0 118.061 -169.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 80.7 p -114.32 134.03 55.25 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.013 -1.093 . . . . 0.0 111.357 -169.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -89.85 119.54 30.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.852 . . . . 0.0 109.974 162.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.6 m -117.17 125.71 51.63 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.175 0.59 . . . . 0.0 110.997 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 tp -91.48 100.22 13.02 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.263 0.625 . . . . 0.0 111.243 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.86 68.79 2.06 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.456 0.703 . . . . 0.0 111.801 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.19 69.23 1.42 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 116.208 1.243 . . . . 0.0 116.208 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.256 1.1 t30 59.46 29.08 18.6 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 -168.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -138.01 111.66 8.2 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.4 mt -95.45 105.1 17.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.488 -0.758 . . . . 0.0 109.72 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.5 tt -95.02 121.12 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.978 0.894 . . . . 0.0 109.807 173.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.8 101.95 2.83 Favored Glycine 0 N--CA 1.479 1.557 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.467 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -91.83 96.44 10.41 Favored 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -121.3 149.45 42.88 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.163 0.982 . . . . 0.0 112.201 -168.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -121.77 139.56 53.44 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 121.857 0.837 . . . . 0.0 109.669 167.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.7 mmm-85 -61.8 115.69 4.21 Favored 'General case' 0 CA--C 1.562 1.427 0 O-C-N 121.451 -0.781 . . . . 0.0 112.889 166.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.8 p -60.22 -55.97 27.22 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 169.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -83.59 55.03 3.05 Favored 'General case' 0 CA--C 1.578 2.036 0 O-C-N 121.58 -0.7 . . . . 0.0 112.375 171.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -175.32 -35.7 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 172.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.81 21.23 77.03 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 118.588 2.195 . . . . 0.0 118.588 -165.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -119.59 145.98 45.92 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.484 1.142 . . . . 0.0 113.154 -168.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.26 135.99 34.11 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -168.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.6 tt -123.8 130.78 53.16 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.612 1.165 . . . . 0.0 110.625 174.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -111.93 116.16 30.16 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.6 m -109.5 102.71 11.55 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 120.649 1.568 . . . . 0.0 110.493 171.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.8 t -102.59 90.91 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -174.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -99.58 137.22 38.38 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.336 1.065 . . . . 0.0 113.071 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -157.89 154.03 27.25 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.89 -174.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.5 mm -93.69 108.74 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.436 -0.79 . . . . 0.0 109.453 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.254 16.4 tt -86.29 71.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 122.152 0.977 . . . . 0.0 111.234 172.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.46 -84.92 0.95 Allowed Glycine 0 N--CA 1.489 2.228 0 O-C-N 121.012 -1.055 . . . . 0.0 114.56 -174.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -129.72 65.1 1.49 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 122.665 0.386 . . . . 0.0 110.044 167.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -164.36 125.37 2.16 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.424 0.69 . . . . 0.0 110.009 170.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.1 tp -83.22 102.81 12.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.609 -0.682 . . . . 0.0 109.197 171.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.4 m -91.7 98.45 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -96.17 95.3 8.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.095 -1.003 . . . . 0.0 110.757 -170.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.9 m -89.6 102.58 15.26 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.236 0.614 . . . . 0.0 111.184 -166.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -90.24 119.78 30.84 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.745 0.818 . . . . 0.0 110.85 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.8 t -120.2 104.61 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -113.41 118.27 34.08 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.094 0.557 . . . . 0.0 110.657 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.28 53.0 mt-10 64.9 -79.33 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 123.834 0.854 . . . . 0.0 112.829 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -151.3 58.25 0.43 Allowed Glycine 0 N--CA 1.487 2.051 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.993 157.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.2 p -133.79 112.79 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 118.34 1.07 . . . . 0.0 109.834 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -89.64 124.5 34.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.476 -0.765 . . . . 0.0 111.264 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.24 127.14 20.68 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 170.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -98.68 121.71 40.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.926 . . . . 0.0 111.535 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -85.75 106.98 17.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.319 157.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.7 mt -96.6 115.26 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -176.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -111.3 134.15 53.1 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 122.985 0.514 . . . . 0.0 111.184 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -94.7 147.07 23.7 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-O 121.74 0.781 . . . . 0.0 112.417 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -72.84 116.1 12.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.425 -0.797 . . . . 0.0 112.312 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -172.787 . . . . . . . . 0 0 . 1 stop_ save_